*********** PTASSAMj00 ******** FILEIN user.vek ../../CSA/PIK_SPRITE/ ULMN 4 1a30_c00 HIV-1 PROTEASE user 1 4 # 1 A 25 ASP A 52 ASP.? 15.11 CA CA A 208 A 26 THR A 57 THR.? 15.79 CA CA A 208 B 25 ASP A 61 ASP~? 12.37 CA CA A 208 B 26 THR A 58 THR~? 10.52 CA CA A 208 coo 16.19 28.53 6.78 15.21 26.90 5.90 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo 15.74 30.96 2.61 17.31 31.07 1.15 78.12 -88.42 -27.00 77.65 -90.24 -28.10 coo 15.69 25.44 0.11 15.17 25.11 2.13 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo 19.75 27.40 1.82 20.01 29.54 2.05 76.40 -85.04 -26.81 78.11 -83.80 -26.40 ULMN 4 1a30_c00 HIV-1 PROTEASE user 2 4 # 2 A 25 ASP A 52 ASP.? 15.11 CA CA A 208 A 26 THR A 58 THR~? 10.52 CA CA A 208 B 25 ASP A 61 ASP~? 12.37 CA CA A 208 B 26 THR A 57 THR.? 15.79 CA CA A 208 coo 16.19 28.53 6.78 15.21 26.90 5.90 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo 15.74 30.96 2.61 17.31 31.07 1.15 76.40 -85.04 -26.81 78.11 -83.80 -26.40 coo 15.69 25.44 0.11 15.17 25.11 2.13 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo 19.75 27.40 1.82 20.01 29.54 2.05 78.12 -88.42 -27.00 77.65 -90.24 -28.10 ULMN 4 1a30_c00 HIV-1 PROTEASE user 3 4 # 3 A 25 ASP A 61 ASP~? 12.37 CA CA A 208 A 26 THR A 57 THR.? 15.79 CA CA A 208 B 25 ASP A 52 ASP.? 15.11 CA CA A 208 B 26 THR A 58 THR~? 10.52 CA CA A 208 coo 16.19 28.53 6.78 15.21 26.90 5.90 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo 15.74 30.96 2.61 17.31 31.07 1.15 78.12 -88.42 -27.00 77.65 -90.24 -28.10 coo 15.69 25.44 0.11 15.17 25.11 2.13 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo 19.75 27.40 1.82 20.01 29.54 2.05 76.40 -85.04 -26.81 78.11 -83.80 -26.40 ULMN 4 1a30_c00 HIV-1 PROTEASE user 4 4 # 4 A 25 ASP A 61 ASP~? 12.37 CA CA A 208 A 26 THR A 58 THR~? 10.52 CA CA A 208 B 25 ASP A 52 ASP.? 15.11 CA CA A 208 B 26 THR A 57 THR.? 15.79 CA CA A 208 coo 16.19 28.53 6.78 15.21 26.90 5.90 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo 15.74 30.96 2.61 17.31 31.07 1.15 76.40 -85.04 -26.81 78.11 -83.80 -26.40 coo 15.69 25.44 0.11 15.17 25.11 2.13 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo 19.75 27.40 1.82 20.01 29.54 2.05 78.12 -88.42 -27.00 77.65 -90.24 -28.10 1a30_c00 source 1a30 HIV-1 PROTEASE : 4 hits 1a30_c00 naa= 4 ULMN 4 1a6d_c00 THERMOSOME user 1 4 # 1 A 63 ASP A 49 ASP.? -3.00 CA CA A 208s A 96 THR A 58 THR~? 10.52 CA CA A 208 A 97 THR A 57 THR.? 15.79 CA CA A 208 A 390 ASP A 48 ASP.? 7.38 CA CA A 208 coo 16.18 44.42 -24.56 14.59 45.14 -25.79 75.72 -77.89 -27.98 74.67 -77.10 -29.65 coo 9.05 49.19 -22.25 9.14 47.35 -23.29 76.40 -85.04 -26.81 78.11 -83.80 -26.40 coo 10.51 49.37 -18.77 12.36 48.66 -18.03 78.12 -88.42 -27.00 77.65 -90.24 -28.10 coo 17.04 49.84 -29.27 15.57 48.57 -28.45 72.05 -78.20 -23.17 73.82 -77.79 -22.11 ULMN 4 1a6d_c00 THERMOSOME user 2 4 # 2 A 63 ASP B 49 ASP.? -3.05 CA CA B 208s A 96 THR B 58 THR~? 10.41 CA CA B 208 A 97 THR B 57 THR.? 15.82 CA CA B 208 A 390 ASP B 48 ASP.? 7.20 CA CA B 208 coo 16.18 44.42 -24.56 14.59 45.14 -25.79 94.52 -28.97 -11.62 93.03 -30.41 -11.73 coo 9.05 49.19 -22.25 9.14 47.35 -23.29 100.65 -27.90 -8.43 100.12 -29.92 -7.97 coo 10.51 49.37 -18.77 12.36 48.66 -18.03 103.33 -27.21 -5.87 103.96 -25.48 -4.75 coo 17.04 49.84 -29.27 15.57 48.57 -28.45 97.60 -30.12 -16.68 98.20 -32.01 -15.99 ULMN 4 1a6d_c00 THERMOSOME user 3 4 # 3 A 63 ASP C 49 ASP.? -2.87 CA CA C 208s A 96 THR C 58 THR~? 10.65 CA CA C 208 A 97 THR C 57 THR.? 15.66 CA CA C 208 A 390 ASP C 48 ASP.? 7.17 CA CA C 208 coo 16.18 44.42 -24.56 14.59 45.14 -25.79 22.13 -48.50 -9.42 23.00 -46.66 -10.00 coo 9.05 49.19 -22.25 9.14 47.35 -23.29 19.91 -49.60 -2.59 18.80 -50.74 -4.02 coo 10.51 49.37 -18.77 12.36 48.66 -18.03 17.34 -49.58 0.14 17.08 -48.15 1.75 coo 17.04 49.84 -29.27 15.57 48.57 -28.45 26.68 -52.06 -7.74 25.46 -53.53 -8.54 1a6d_c00 source 1a6d THERMOSOME : 3 hits 1a6d_c00 naa= 4 ULMN 4 1am5_c03 PEPSIN user 1 4 # 1 32 ASP A 52 ASP.? 15.11 CA CA A 208 33 THR A 57 THR.? 15.79 CA CA A 208 215 ASP A 61 ASP~? 12.37 CA CA A 208 216 THR A 58 THR~? 10.52 CA CA A 208 coo -7.18 8.92 145.10 -8.77 8.81 143.59 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo -7.95 13.74 144.22 -6.52 14.95 143.16 78.12 -88.42 -27.00 77.65 -90.24 -28.10 coo -8.20 12.64 138.30 -8.86 10.97 139.38 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo -4.16 12.12 140.59 -3.78 13.08 142.45 76.40 -85.04 -26.81 78.11 -83.80 -26.40 ULMN 4 1am5_c03 PEPSIN user 2 4 # 2 32 ASP A 52 ASP.? 15.11 CA CA A 208 33 THR A 58 THR~? 10.52 CA CA A 208 215 ASP A 61 ASP~? 12.37 CA CA A 208 216 THR A 57 THR.? 15.79 CA CA A 208 coo -7.18 8.92 145.10 -8.77 8.81 143.59 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo -7.95 13.74 144.22 -6.52 14.95 143.16 76.40 -85.04 -26.81 78.11 -83.80 -26.40 coo -8.20 12.64 138.30 -8.86 10.97 139.38 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo -4.16 12.12 140.59 -3.78 13.08 142.45 78.12 -88.42 -27.00 77.65 -90.24 -28.10 ULMN 4 1am5_c03 PEPSIN user 3 4 # 3 32 ASP A 61 ASP~? 12.37 CA CA A 208 33 THR A 57 THR.? 15.79 CA CA A 208 215 ASP A 52 ASP.? 15.11 CA CA A 208 216 THR A 58 THR~? 10.52 CA CA A 208 coo -7.18 8.92 145.10 -8.77 8.81 143.59 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo -7.95 13.74 144.22 -6.52 14.95 143.16 78.12 -88.42 -27.00 77.65 -90.24 -28.10 coo -8.20 12.64 138.30 -8.86 10.97 139.38 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo -4.16 12.12 140.59 -3.78 13.08 142.45 76.40 -85.04 -26.81 78.11 -83.80 -26.40 ULMN 4 1am5_c03 PEPSIN user 4 4 # 4 32 ASP A 61 ASP~? 12.37 CA CA A 208 33 THR A 58 THR~? 10.52 CA CA A 208 215 ASP A 52 ASP.? 15.11 CA CA A 208 216 THR A 57 THR.? 15.79 CA CA A 208 coo -7.18 8.92 145.10 -8.77 8.81 143.59 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo -7.95 13.74 144.22 -6.52 14.95 143.16 76.40 -85.04 -26.81 78.11 -83.80 -26.40 coo -8.20 12.64 138.30 -8.86 10.97 139.38 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo -4.16 12.12 140.59 -3.78 13.08 142.45 78.12 -88.42 -27.00 77.65 -90.24 -28.10 ULMN 4 1am5_c03 PEPSIN user 5 4 # 5 32 ASP C 52 ASP.? 15.77 CA CA C 208 33 THR C 57 THR.? 15.66 CA CA C 208 215 ASP C 61 ASP~? 12.61 CA CA C 208 216 THR C 58 THR~? 10.65 CA CA C 208 coo -7.18 8.92 145.10 -8.77 8.81 143.59 21.29 -54.58 -0.38 20.26 -54.47 1.43 coo -7.95 13.74 144.22 -6.52 14.95 143.16 17.34 -49.58 0.14 17.08 -48.15 1.75 coo -8.20 12.64 138.30 -8.86 10.97 139.38 16.71 -46.53 -3.05 15.59 -48.22 -3.69 coo -4.16 12.12 140.59 -3.78 13.08 142.45 19.91 -49.60 -2.59 18.80 -50.74 -4.02 ULMN 4 1am5_c03 PEPSIN user 6 4 # 6 32 ASP C 52 ASP.? 15.77 CA CA C 208 33 THR C 58 THR~? 10.65 CA CA C 208 215 ASP C 61 ASP~? 12.61 CA CA C 208 216 THR C 57 THR.? 15.66 CA CA C 208 coo -7.18 8.92 145.10 -8.77 8.81 143.59 21.29 -54.58 -0.38 20.26 -54.47 1.43 coo -7.95 13.74 144.22 -6.52 14.95 143.16 19.91 -49.60 -2.59 18.80 -50.74 -4.02 coo -8.20 12.64 138.30 -8.86 10.97 139.38 16.71 -46.53 -3.05 15.59 -48.22 -3.69 coo -4.16 12.12 140.59 -3.78 13.08 142.45 17.34 -49.58 0.14 17.08 -48.15 1.75 ULMN 4 1am5_c03 PEPSIN user 7 4 # 7 32 ASP C 61 ASP~? 12.61 CA CA C 208 33 THR C 57 THR.? 15.66 CA CA C 208 215 ASP C 52 ASP.? 15.77 CA CA C 208 216 THR C 58 THR~? 10.65 CA CA C 208 coo -7.18 8.92 145.10 -8.77 8.81 143.59 16.71 -46.53 -3.05 15.59 -48.22 -3.69 coo -7.95 13.74 144.22 -6.52 14.95 143.16 17.34 -49.58 0.14 17.08 -48.15 1.75 coo -8.20 12.64 138.30 -8.86 10.97 139.38 21.29 -54.58 -0.38 20.26 -54.47 1.43 coo -4.16 12.12 140.59 -3.78 13.08 142.45 19.91 -49.60 -2.59 18.80 -50.74 -4.02 ULMN 4 1am5_c03 PEPSIN user 8 4 # 8 32 ASP C 61 ASP~? 12.61 CA CA C 208 33 THR C 58 THR~? 10.65 CA CA C 208 215 ASP C 52 ASP.? 15.77 CA CA C 208 216 THR C 57 THR.? 15.66 CA CA C 208 coo -7.18 8.92 145.10 -8.77 8.81 143.59 16.71 -46.53 -3.05 15.59 -48.22 -3.69 coo -7.95 13.74 144.22 -6.52 14.95 143.16 19.91 -49.60 -2.59 18.80 -50.74 -4.02 coo -8.20 12.64 138.30 -8.86 10.97 139.38 21.29 -54.58 -0.38 20.26 -54.47 1.43 coo -4.16 12.12 140.59 -3.78 13.08 142.45 17.34 -49.58 0.14 17.08 -48.15 1.75 1am5_c03 source 1am5 PEPSIN : 8 hits 1am5_c03 naa= 4 ULMN 4 1apt_c03 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 1 4 # 1 E 33 ASP A 52 ASP.? 15.11 CA CA A 208 E 34 THR A 57 THR.? 15.79 CA CA A 208 E 213 ASP A 61 ASP~? 12.37 CA CA A 208 E 214 THR A 58 THR~? 10.52 CA CA A 208 coo 26.30 12.96 16.78 25.46 12.99 18.72 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo 25.06 17.67 17.27 23.51 18.60 16.07 78.12 -88.42 -27.00 77.65 -90.24 -28.10 coo 20.15 16.04 19.79 21.65 14.49 19.86 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo 20.70 15.28 14.97 22.26 16.39 13.96 76.40 -85.04 -26.81 78.11 -83.80 -26.40 ULMN 4 1apt_c03 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 2 4 # 2 E 33 ASP A 52 ASP.? 15.11 CA CA A 208 E 34 THR A 58 THR~? 10.52 CA CA A 208 E 213 ASP A 61 ASP~? 12.37 CA CA A 208 E 214 THR A 57 THR.? 15.79 CA CA A 208 coo 26.30 12.96 16.78 25.46 12.99 18.72 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo 25.06 17.67 17.27 23.51 18.60 16.07 76.40 -85.04 -26.81 78.11 -83.80 -26.40 coo 20.15 16.04 19.79 21.65 14.49 19.86 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo 20.70 15.28 14.97 22.26 16.39 13.96 78.12 -88.42 -27.00 77.65 -90.24 -28.10 ULMN 4 1apt_c03 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 3 4 # 3 E 33 ASP A 61 ASP~? 12.37 CA CA A 208 E 34 THR A 57 THR.? 15.79 CA CA A 208 E 213 ASP A 52 ASP.? 15.11 CA CA A 208 E 214 THR A 58 THR~? 10.52 CA CA A 208 coo 26.30 12.96 16.78 25.46 12.99 18.72 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo 25.06 17.67 17.27 23.51 18.60 16.07 78.12 -88.42 -27.00 77.65 -90.24 -28.10 coo 20.15 16.04 19.79 21.65 14.49 19.86 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo 20.70 15.28 14.97 22.26 16.39 13.96 76.40 -85.04 -26.81 78.11 -83.80 -26.40 ULMN 4 1apt_c03 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 4 4 # 4 E 33 ASP A 61 ASP~? 12.37 CA CA A 208 E 34 THR A 58 THR~? 10.52 CA CA A 208 E 213 ASP A 52 ASP.? 15.11 CA CA A 208 E 214 THR A 57 THR.? 15.79 CA CA A 208 coo 26.30 12.96 16.78 25.46 12.99 18.72 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo 25.06 17.67 17.27 23.51 18.60 16.07 76.40 -85.04 -26.81 78.11 -83.80 -26.40 coo 20.15 16.04 19.79 21.65 14.49 19.86 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo 20.70 15.28 14.97 22.26 16.39 13.96 78.12 -88.42 -27.00 77.65 -90.24 -28.10 1apt_c03 source 1apt ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET (LYSTA IS : 4 hits 1apt_c03 naa= 4 ULMN 4 1aq0_c00 1,3-1,4-BETA-GLUCANASE user 1 4 # 1 A 232 GLU B 7 GLU^? 19.70 O15 C8E B 209 A 280 GLU B 25 GLU^? 27.65 O15 C8E B 209 A 283 LYS B 84 LYS.? 25.86 O15 C8E B 209 A 288 GLU B 93 GLU^? 27.23 O15 C8E B 209 coo 5.76 85.47 37.35 6.76 85.56 39.24 73.39 -38.66 -35.65 75.17 -39.55 -36.49 coo 4.25 95.66 42.75 4.18 93.57 42.69 73.50 -42.12 -45.68 71.97 -42.23 -44.24 coo 9.66 95.18 46.95 8.19 90.97 44.00 79.44 -47.69 -46.65 75.97 -44.45 -44.18 coo 13.49 92.75 43.16 12.39 91.15 42.33 75.25 -49.35 -42.08 74.13 -47.63 -42.56 1aq0_c00 source 1aq0 1,3-1,4-BETA-GLUCANASE : 1 hits 1aq0_c00 naa= 4 ULMN 4 1aq0_c01 1,3-1,4-BETA-GLUCANASE user 1 4 # 1 B 232 GLU B 7 GLU^? 19.70 O15 C8E B 209 B 280 GLU B 25 GLU^? 27.65 O15 C8E B 209 B 283 LYS B 84 LYS.? 25.86 O15 C8E B 209 B 288 GLU B 93 GLU^? 27.23 O15 C8E B 209 coo -0.96 61.87 2.24 -2.27 63.48 2.70 73.39 -38.66 -35.65 75.17 -39.55 -36.49 coo -4.32 67.50 -7.41 -4.63 66.46 -5.59 73.50 -42.12 -45.68 71.97 -42.23 -44.24 coo -6.22 73.35 -4.20 -4.99 69.00 -1.28 79.44 -47.69 -46.65 75.97 -44.45 -44.18 coo -1.91 73.68 -0.16 -1.91 71.74 0.71 75.25 -49.35 -42.08 74.13 -47.63 -42.56 1aq0_c01 source 1aq0 1,3-1,4-BETA-GLUCANASE : 1 hits 1aq0_c01 naa= 4 ULMN 4 1avf_c02 GASTRICSIN user 1 4 # 1 A 32 ASP A 52 ASP.? 15.11 CA CA A 208 A 33 THR A 57 THR.? 15.79 CA CA A 208 A 217 ASP A 61 ASP~? 12.37 CA CA A 208 A 218 THR A 58 THR~? 10.52 CA CA A 208 coo -10.06 2.54 49.69 -8.83 3.73 50.96 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo -10.81 0.28 53.82 -9.79 -1.53 54.36 78.12 -88.42 -27.00 77.65 -90.24 -28.10 coo -5.22 1.43 56.08 -5.36 2.84 54.49 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo -5.86 -1.53 52.32 -7.81 -2.38 51.94 76.40 -85.04 -26.81 78.11 -83.80 -26.40 ULMN 4 1avf_c02 GASTRICSIN user 2 4 # 2 A 32 ASP A 52 ASP.? 15.11 CA CA A 208 A 33 THR A 58 THR~? 10.52 CA CA A 208 A 217 ASP A 61 ASP~? 12.37 CA CA A 208 A 218 THR A 57 THR.? 15.79 CA CA A 208 coo -10.06 2.54 49.69 -8.83 3.73 50.96 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo -10.81 0.28 53.82 -9.79 -1.53 54.36 76.40 -85.04 -26.81 78.11 -83.80 -26.40 coo -5.22 1.43 56.08 -5.36 2.84 54.49 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo -5.86 -1.53 52.32 -7.81 -2.38 51.94 78.12 -88.42 -27.00 77.65 -90.24 -28.10 ULMN 4 1avf_c02 GASTRICSIN user 3 4 # 3 A 32 ASP A 61 ASP~? 12.37 CA CA A 208 A 33 THR A 58 THR~? 10.52 CA CA A 208 A 217 ASP A 52 ASP.? 15.11 CA CA A 208 A 218 THR A 57 THR.? 15.79 CA CA A 208 coo -10.06 2.54 49.69 -8.83 3.73 50.96 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo -10.81 0.28 53.82 -9.79 -1.53 54.36 76.40 -85.04 -26.81 78.11 -83.80 -26.40 coo -5.22 1.43 56.08 -5.36 2.84 54.49 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo -5.86 -1.53 52.32 -7.81 -2.38 51.94 78.12 -88.42 -27.00 77.65 -90.24 -28.10 ULMN 4 1avf_c02 GASTRICSIN user 4 4 # 4 A 32 ASP B 52 ASP.? 15.59 CA CA B 208 A 33 THR B 57 THR.? 15.82 CA CA B 208 A 217 ASP B 61 ASP~? 12.48 CA CA B 208 A 218 THR B 58 THR~? 10.41 CA CA B 208 coo -10.06 2.54 49.69 -8.83 3.73 50.96 105.61 -28.95 -11.53 106.78 -28.70 -9.81 coo -10.81 0.28 53.82 -9.79 -1.53 54.36 103.33 -27.21 -5.87 103.96 -25.48 -4.75 coo -5.22 1.43 56.08 -5.36 2.84 54.49 98.68 -27.22 -4.60 99.30 -29.23 -4.23 coo -5.86 -1.53 52.32 -7.81 -2.38 51.94 100.65 -27.90 -8.43 100.12 -29.92 -7.97 ULMN 4 1avf_c02 GASTRICSIN user 5 4 # 5 A 32 ASP B 52 ASP.? 15.59 CA CA B 208 A 33 THR B 58 THR~? 10.41 CA CA B 208 A 217 ASP B 61 ASP~? 12.48 CA CA B 208 A 218 THR B 57 THR.? 15.82 CA CA B 208 coo -10.06 2.54 49.69 -8.83 3.73 50.96 105.61 -28.95 -11.53 106.78 -28.70 -9.81 coo -10.81 0.28 53.82 -9.79 -1.53 54.36 100.65 -27.90 -8.43 100.12 -29.92 -7.97 coo -5.22 1.43 56.08 -5.36 2.84 54.49 98.68 -27.22 -4.60 99.30 -29.23 -4.23 coo -5.86 -1.53 52.32 -7.81 -2.38 51.94 103.33 -27.21 -5.87 103.96 -25.48 -4.75 ULMN 4 1avf_c02 GASTRICSIN user 6 4 # 6 A 32 ASP B 61 ASP~? 12.48 CA CA B 208 A 33 THR B 58 THR~? 10.41 CA CA B 208 A 217 ASP B 52 ASP.? 15.59 CA CA B 208 A 218 THR B 57 THR.? 15.82 CA CA B 208 coo -10.06 2.54 49.69 -8.83 3.73 50.96 98.68 -27.22 -4.60 99.30 -29.23 -4.23 coo -10.81 0.28 53.82 -9.79 -1.53 54.36 100.65 -27.90 -8.43 100.12 -29.92 -7.97 coo -5.22 1.43 56.08 -5.36 2.84 54.49 105.61 -28.95 -11.53 106.78 -28.70 -9.81 coo -5.86 -1.53 52.32 -7.81 -2.38 51.94 103.33 -27.21 -5.87 103.96 -25.48 -4.75 ULMN 4 1avf_c02 GASTRICSIN user 7 4 # 7 A 32 ASP C 52 ASP.? 15.77 CA CA C 208 A 33 THR C 57 THR.? 15.66 CA CA C 208 A 217 ASP C 61 ASP~? 12.61 CA CA C 208 A 218 THR C 58 THR~? 10.65 CA CA C 208 coo -10.06 2.54 49.69 -8.83 3.73 50.96 21.29 -54.58 -0.38 20.26 -54.47 1.43 coo -10.81 0.28 53.82 -9.79 -1.53 54.36 17.34 -49.58 0.14 17.08 -48.15 1.75 coo -5.22 1.43 56.08 -5.36 2.84 54.49 16.71 -46.53 -3.05 15.59 -48.22 -3.69 coo -5.86 -1.53 52.32 -7.81 -2.38 51.94 19.91 -49.60 -2.59 18.80 -50.74 -4.02 ULMN 4 1avf_c02 GASTRICSIN user 8 4 # 8 A 32 ASP C 52 ASP.? 15.77 CA CA C 208 A 33 THR C 58 THR~? 10.65 CA CA C 208 A 217 ASP C 61 ASP~? 12.61 CA CA C 208 A 218 THR C 57 THR.? 15.66 CA CA C 208 coo -10.06 2.54 49.69 -8.83 3.73 50.96 21.29 -54.58 -0.38 20.26 -54.47 1.43 coo -10.81 0.28 53.82 -9.79 -1.53 54.36 19.91 -49.60 -2.59 18.80 -50.74 -4.02 coo -5.22 1.43 56.08 -5.36 2.84 54.49 16.71 -46.53 -3.05 15.59 -48.22 -3.69 coo -5.86 -1.53 52.32 -7.81 -2.38 51.94 17.34 -49.58 0.14 17.08 -48.15 1.75 ULMN 4 1avf_c02 GASTRICSIN user 9 4 # 9 A 32 ASP C 61 ASP~? 12.61 CA CA C 208 A 33 THR C 57 THR.? 15.66 CA CA C 208 A 217 ASP C 52 ASP.? 15.77 CA CA C 208 A 218 THR C 58 THR~? 10.65 CA CA C 208 coo -10.06 2.54 49.69 -8.83 3.73 50.96 16.71 -46.53 -3.05 15.59 -48.22 -3.69 coo -10.81 0.28 53.82 -9.79 -1.53 54.36 17.34 -49.58 0.14 17.08 -48.15 1.75 coo -5.22 1.43 56.08 -5.36 2.84 54.49 21.29 -54.58 -0.38 20.26 -54.47 1.43 coo -5.86 -1.53 52.32 -7.81 -2.38 51.94 19.91 -49.60 -2.59 18.80 -50.74 -4.02 ULMN 4 1avf_c02 GASTRICSIN user 10 4 # 10 A 32 ASP C 61 ASP~? 12.61 CA CA C 208 A 33 THR C 58 THR~? 10.65 CA CA C 208 A 217 ASP C 52 ASP.? 15.77 CA CA C 208 A 218 THR C 57 THR.? 15.66 CA CA C 208 coo -10.06 2.54 49.69 -8.83 3.73 50.96 16.71 -46.53 -3.05 15.59 -48.22 -3.69 coo -10.81 0.28 53.82 -9.79 -1.53 54.36 19.91 -49.60 -2.59 18.80 -50.74 -4.02 coo -5.22 1.43 56.08 -5.36 2.84 54.49 21.29 -54.58 -0.38 20.26 -54.47 1.43 coo -5.86 -1.53 52.32 -7.81 -2.38 51.94 17.34 -49.58 0.14 17.08 -48.15 1.75 1avf_c02 source 1avf GASTRICSIN : 10 hits 1avf_c02 naa= 4 ULMN 4 1avf_c03 GASTRICSIN user 1 4 # 1 J 32 ASP A 52 ASP.? 15.11 CA CA A 208 J 33 THR A 57 THR.? 15.79 CA CA A 208 J 217 ASP A 61 ASP~? 12.37 CA CA A 208 J 218 THR A 58 THR~? 10.52 CA CA A 208 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo -41.87 -15.43 20.67 -42.27 -13.53 19.66 78.12 -88.42 -27.00 77.65 -90.24 -28.10 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo -39.45 -13.42 16.23 -39.52 -12.66 18.27 76.40 -85.04 -26.81 78.11 -83.80 -26.40 ULMN 4 1avf_c03 GASTRICSIN user 2 4 # 2 J 32 ASP A 52 ASP.? 15.11 CA CA A 208 J 33 THR A 58 THR~? 10.52 CA CA A 208 J 217 ASP A 61 ASP~? 12.37 CA CA A 208 J 218 THR A 57 THR.? 15.79 CA CA A 208 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo -41.87 -15.43 20.67 -42.27 -13.53 19.66 76.40 -85.04 -26.81 78.11 -83.80 -26.40 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo -39.45 -13.42 16.23 -39.52 -12.66 18.27 78.12 -88.42 -27.00 77.65 -90.24 -28.10 ULMN 4 1avf_c03 GASTRICSIN user 3 4 # 3 J 32 ASP A 61 ASP~? 12.37 CA CA A 208 J 33 THR A 57 THR.? 15.79 CA CA A 208 J 217 ASP A 52 ASP.? 15.11 CA CA A 208 J 218 THR A 58 THR~? 10.52 CA CA A 208 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo -41.87 -15.43 20.67 -42.27 -13.53 19.66 78.12 -88.42 -27.00 77.65 -90.24 -28.10 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo -39.45 -13.42 16.23 -39.52 -12.66 18.27 76.40 -85.04 -26.81 78.11 -83.80 -26.40 ULMN 4 1avf_c03 GASTRICSIN user 4 4 # 4 J 32 ASP A 61 ASP~? 12.37 CA CA A 208 J 33 THR A 58 THR~? 10.52 CA CA A 208 J 217 ASP A 52 ASP.? 15.11 CA CA A 208 J 218 THR A 57 THR.? 15.79 CA CA A 208 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo -41.87 -15.43 20.67 -42.27 -13.53 19.66 76.40 -85.04 -26.81 78.11 -83.80 -26.40 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo -39.45 -13.42 16.23 -39.52 -12.66 18.27 78.12 -88.42 -27.00 77.65 -90.24 -28.10 ULMN 4 1avf_c03 GASTRICSIN user 5 4 # 5 J 32 ASP C 52 ASP.? 15.77 CA CA C 208 J 33 THR C 57 THR.? 15.66 CA CA C 208 J 217 ASP C 61 ASP~? 12.61 CA CA C 208 J 218 THR C 58 THR~? 10.65 CA CA C 208 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 21.29 -54.58 -0.38 20.26 -54.47 1.43 coo -41.87 -15.43 20.67 -42.27 -13.53 19.66 17.34 -49.58 0.14 17.08 -48.15 1.75 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 16.71 -46.53 -3.05 15.59 -48.22 -3.69 coo -39.45 -13.42 16.23 -39.52 -12.66 18.27 19.91 -49.60 -2.59 18.80 -50.74 -4.02 ULMN 4 1avf_c03 GASTRICSIN user 6 4 # 6 J 32 ASP C 52 ASP.? 15.77 CA CA C 208 J 33 THR C 58 THR~? 10.65 CA CA C 208 J 217 ASP C 61 ASP~? 12.61 CA CA C 208 J 218 THR C 57 THR.? 15.66 CA CA C 208 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 21.29 -54.58 -0.38 20.26 -54.47 1.43 coo -41.87 -15.43 20.67 -42.27 -13.53 19.66 19.91 -49.60 -2.59 18.80 -50.74 -4.02 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 16.71 -46.53 -3.05 15.59 -48.22 -3.69 coo -39.45 -13.42 16.23 -39.52 -12.66 18.27 17.34 -49.58 0.14 17.08 -48.15 1.75 ULMN 4 1avf_c03 GASTRICSIN user 7 4 # 7 J 32 ASP C 61 ASP~? 12.61 CA CA C 208 J 33 THR C 57 THR.? 15.66 CA CA C 208 J 217 ASP C 52 ASP.? 15.77 CA CA C 208 J 218 THR C 58 THR~? 10.65 CA CA C 208 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 16.71 -46.53 -3.05 15.59 -48.22 -3.69 coo -41.87 -15.43 20.67 -42.27 -13.53 19.66 17.34 -49.58 0.14 17.08 -48.15 1.75 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 21.29 -54.58 -0.38 20.26 -54.47 1.43 coo -39.45 -13.42 16.23 -39.52 -12.66 18.27 19.91 -49.60 -2.59 18.80 -50.74 -4.02 ULMN 4 1avf_c03 GASTRICSIN user 8 4 # 8 J 32 ASP C 61 ASP~? 12.61 CA CA C 208 J 33 THR C 58 THR~? 10.65 CA CA C 208 J 217 ASP C 52 ASP.? 15.77 CA CA C 208 J 218 THR C 57 THR.? 15.66 CA CA C 208 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 16.71 -46.53 -3.05 15.59 -48.22 -3.69 coo -41.87 -15.43 20.67 -42.27 -13.53 19.66 19.91 -49.60 -2.59 18.80 -50.74 -4.02 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 21.29 -54.58 -0.38 20.26 -54.47 1.43 coo -39.45 -13.42 16.23 -39.52 -12.66 18.27 17.34 -49.58 0.14 17.08 -48.15 1.75 1avf_c03 source 1avf GASTRICSIN : 8 hits 1avf_c03 naa= 4 ULMN 4 1b8f_c00 HISTIDINE AMMONIA-LYASE user 1 4 # 1 A 142 ALA C 21 ALA^? 19.73 C19 C8E C 210 A 144 GLY C 38 GLY^? 17.56 C19 C8E C 210 A 280 TYR A 51 TYR.? 9.92 O21 C8E A 210 A 414 GLU C 7 GLU^? 20.56 C16 C8E C 210 coo 8.90 -17.98 11.65 7.53 -18.34 11.16 46.78 -47.73 -31.34 46.03 -49.05 -31.56 coo 11.65 -18.01 12.88 11.72 -18.24 12.53 47.08 -49.08 -27.59 47.53 -49.11 -26.94 coo -3.84 22.59 11.63 -6.55 23.25 11.72 71.70 -83.21 -22.40 69.97 -85.02 -21.17 coo 7.29 -23.46 8.78 9.26 -22.73 8.47 43.33 -49.69 -35.12 43.56 -51.77 -34.52 1b8f_c00 source 1b8f HISTIDINE AMMONIA-LYASE : 1 hits 1b8f_c00 naa= 4 ULMN 4 1bbs_c04 RENIN user 1 4 # 1 32 ASP A 52 ASP.? 15.11 CA CA A 208 33 THR A 58 THR~? 10.52 CA CA A 208 215 ASP A 61 ASP~? 12.37 CA CA A 208 216 THR A 57 THR.? 15.79 CA CA A 208 coo 61.19 45.85 78.73 62.86 45.48 77.48 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo 62.61 41.50 79.97 61.55 39.62 79.92 76.40 -85.04 -26.81 78.11 -83.80 -26.40 coo 63.61 40.10 74.06 64.05 42.07 74.70 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo 59.26 40.01 76.00 58.92 39.80 78.11 78.12 -88.42 -27.00 77.65 -90.24 -28.10 ULMN 4 1bbs_c04 RENIN user 2 4 # 2 32 ASP A 61 ASP~? 12.37 CA CA A 208 33 THR A 58 THR~? 10.52 CA CA A 208 215 ASP A 52 ASP.? 15.11 CA CA A 208 216 THR A 57 THR.? 15.79 CA CA A 208 coo 61.19 45.85 78.73 62.86 45.48 77.48 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo 62.61 41.50 79.97 61.55 39.62 79.92 76.40 -85.04 -26.81 78.11 -83.80 -26.40 coo 63.61 40.10 74.06 64.05 42.07 74.70 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo 59.26 40.01 76.00 58.92 39.80 78.11 78.12 -88.42 -27.00 77.65 -90.24 -28.10 ULMN 4 1bbs_c04 RENIN user 3 4 # 3 32 ASP C 52 ASP.? 15.77 CA CA C 208 33 THR C 57 THR.? 15.66 CA CA C 208 215 ASP C 61 ASP~? 12.61 CA CA C 208 216 THR C 58 THR~? 10.65 CA CA C 208 coo 61.19 45.85 78.73 62.86 45.48 77.48 21.29 -54.58 -0.38 20.26 -54.47 1.43 coo 62.61 41.50 79.97 61.55 39.62 79.92 17.34 -49.58 0.14 17.08 -48.15 1.75 coo 63.61 40.10 74.06 64.05 42.07 74.70 16.71 -46.53 -3.05 15.59 -48.22 -3.69 coo 59.26 40.01 76.00 58.92 39.80 78.11 19.91 -49.60 -2.59 18.80 -50.74 -4.02 ULMN 4 1bbs_c04 RENIN user 4 4 # 4 32 ASP C 52 ASP.? 15.77 CA CA C 208 33 THR C 58 THR~? 10.65 CA CA C 208 215 ASP C 61 ASP~? 12.61 CA CA C 208 216 THR C 57 THR.? 15.66 CA CA C 208 coo 61.19 45.85 78.73 62.86 45.48 77.48 21.29 -54.58 -0.38 20.26 -54.47 1.43 coo 62.61 41.50 79.97 61.55 39.62 79.92 19.91 -49.60 -2.59 18.80 -50.74 -4.02 coo 63.61 40.10 74.06 64.05 42.07 74.70 16.71 -46.53 -3.05 15.59 -48.22 -3.69 coo 59.26 40.01 76.00 58.92 39.80 78.11 17.34 -49.58 0.14 17.08 -48.15 1.75 1bbs_c04 source 1bbs RENIN : 4 hits 1bbs_c04 naa= 4 ULMN 4 1bbs_c05 RENIN user 1 4 # 1 32 ASP A 52 ASP.? 15.11 CA CA A 208 33 THR A 58 THR~? 10.52 CA CA A 208 215 ASP A 61 ASP~? 12.37 CA CA A 208 216 THR A 57 THR.? 15.79 CA CA A 208 coo 61.19 45.85 78.73 62.86 45.48 77.48 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo 62.61 41.50 79.97 61.55 39.62 79.92 76.40 -85.04 -26.81 78.11 -83.80 -26.40 coo 63.61 40.10 74.06 64.05 42.07 74.70 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo 59.26 40.01 76.00 58.92 39.80 78.11 78.12 -88.42 -27.00 77.65 -90.24 -28.10 ULMN 4 1bbs_c05 RENIN user 2 4 # 2 32 ASP A 61 ASP~? 12.37 CA CA A 208 33 THR A 58 THR~? 10.52 CA CA A 208 215 ASP A 52 ASP.? 15.11 CA CA A 208 216 THR A 57 THR.? 15.79 CA CA A 208 coo 61.19 45.85 78.73 62.86 45.48 77.48 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo 62.61 41.50 79.97 61.55 39.62 79.92 76.40 -85.04 -26.81 78.11 -83.80 -26.40 coo 63.61 40.10 74.06 64.05 42.07 74.70 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo 59.26 40.01 76.00 58.92 39.80 78.11 78.12 -88.42 -27.00 77.65 -90.24 -28.10 ULMN 4 1bbs_c05 RENIN user 3 4 # 3 32 ASP C 52 ASP.? 15.77 CA CA C 208 33 THR C 57 THR.? 15.66 CA CA C 208 215 ASP C 61 ASP~? 12.61 CA CA C 208 216 THR C 58 THR~? 10.65 CA CA C 208 coo 61.19 45.85 78.73 62.86 45.48 77.48 21.29 -54.58 -0.38 20.26 -54.47 1.43 coo 62.61 41.50 79.97 61.55 39.62 79.92 17.34 -49.58 0.14 17.08 -48.15 1.75 coo 63.61 40.10 74.06 64.05 42.07 74.70 16.71 -46.53 -3.05 15.59 -48.22 -3.69 coo 59.26 40.01 76.00 58.92 39.80 78.11 19.91 -49.60 -2.59 18.80 -50.74 -4.02 ULMN 4 1bbs_c05 RENIN user 4 4 # 4 32 ASP C 52 ASP.? 15.77 CA CA C 208 33 THR C 58 THR~? 10.65 CA CA C 208 215 ASP C 61 ASP~? 12.61 CA CA C 208 216 THR C 57 THR.? 15.66 CA CA C 208 coo 61.19 45.85 78.73 62.86 45.48 77.48 21.29 -54.58 -0.38 20.26 -54.47 1.43 coo 62.61 41.50 79.97 61.55 39.62 79.92 19.91 -49.60 -2.59 18.80 -50.74 -4.02 coo 63.61 40.10 74.06 64.05 42.07 74.70 16.71 -46.53 -3.05 15.59 -48.22 -3.69 coo 59.26 40.01 76.00 58.92 39.80 78.11 17.34 -49.58 0.14 17.08 -48.15 1.75 1bbs_c05 source 1bbs RENIN : 4 hits 1bbs_c05 naa= 4 ULMN 4 1bbs_c10 RENIN user 1 4 # 1 32 ASP B 167 ASP.? 22.72 CA CA B 208 33 THR B 117 THR.? 21.30 CA CA B 208 215 ASP B 111 ASP.? 16.97 CA CA B 208 218 ALA B 120 ALA^? 15.95 CA CA B 208 coo 61.19 45.85 78.73 62.86 45.48 77.48 88.92 -5.85 -9.56 88.92 -7.42 -8.19 coo 62.61 41.50 79.97 61.55 39.62 79.92 93.17 -9.31 -6.81 94.03 -8.66 -8.75 coo 63.61 40.10 74.06 64.05 42.07 74.70 89.21 -14.92 -8.80 89.40 -13.99 -6.98 coo 61.04 42.48 71.22 62.11 41.40 71.19 89.14 -13.81 -14.52 87.79 -13.74 -15.22 ULMN 4 1bbs_c10 RENIN user 2 4 # 2 32 ASP C 167 ASP.? 25.18 CA CA C 208 33 THR C 117 THR.? 21.70 CA CA C 208 215 ASP C 111 ASP.? 17.21 CA CA C 208 218 ALA C 120 ALA^? 16.01 CA CA C 208 coo 61.19 45.85 78.73 62.86 45.48 77.48 31.39 -27.44 2.08 30.34 -25.78 1.31 coo 62.61 41.50 79.97 61.55 39.62 79.92 27.55 -31.30 3.26 28.51 -32.70 4.67 coo 63.61 40.10 74.06 64.05 42.07 74.70 27.11 -33.17 -3.90 25.73 -31.94 -3.00 coo 61.04 42.48 71.22 62.11 41.40 71.19 32.30 -34.87 -3.98 33.01 -34.28 -5.18 1bbs_c10 source 1bbs RENIN : 2 hits 1bbs_c10 naa= 4 ULMN 4 1bbs_c11 RENIN user 1 4 # 1 32 ASP B 167 ASP.? 22.72 CA CA B 208 33 THR B 117 THR.? 21.30 CA CA B 208 215 ASP B 111 ASP.? 16.97 CA CA B 208 218 ALA B 120 ALA^? 15.95 CA CA B 208 coo 61.19 45.85 78.73 62.86 45.48 77.48 88.92 -5.85 -9.56 88.92 -7.42 -8.19 coo 62.61 41.50 79.97 61.55 39.62 79.92 93.17 -9.31 -6.81 94.03 -8.66 -8.75 coo 63.61 40.10 74.06 64.05 42.07 74.70 89.21 -14.92 -8.80 89.40 -13.99 -6.98 coo 61.04 42.48 71.22 62.11 41.40 71.19 89.14 -13.81 -14.52 87.79 -13.74 -15.22 ULMN 4 1bbs_c11 RENIN user 2 4 # 2 32 ASP C 167 ASP.? 25.18 CA CA C 208 33 THR C 117 THR.? 21.70 CA CA C 208 215 ASP C 111 ASP.? 17.21 CA CA C 208 218 ALA C 120 ALA^? 16.01 CA CA C 208 coo 61.19 45.85 78.73 62.86 45.48 77.48 31.39 -27.44 2.08 30.34 -25.78 1.31 coo 62.61 41.50 79.97 61.55 39.62 79.92 27.55 -31.30 3.26 28.51 -32.70 4.67 coo 63.61 40.10 74.06 64.05 42.07 74.70 27.11 -33.17 -3.90 25.73 -31.94 -3.00 coo 61.04 42.48 71.22 62.11 41.40 71.19 32.30 -34.87 -3.98 33.01 -34.28 -5.18 1bbs_c11 source 1bbs RENIN : 2 hits 1bbs_c11 naa= 4 ULMN 4 1bh2_c00 GUANINE NUCLEOTIDE-BINDING PROTEIN user 1 4 # 1 43 GLU A 164 GLU^? 19.19 O21 C8E A 210 178 ARG A 162 ARG^? 10.87 O21 C8E A 210 181 THR A 122 THR^? 13.62 O21 C8E A 209 204 GLN A 173 GLN^? 19.06 O21 C8E A 210 coo 41.47 -31.24 9.85 43.56 -31.54 10.01 57.65 -86.15 -32.10 58.08 -88.26 -31.94 coo 41.39 -27.92 12.62 40.37 -30.81 12.72 60.16 -83.54 -27.36 63.31 -83.18 -27.03 coo 35.15 -30.74 16.68 33.40 -30.14 15.52 59.48 -78.76 -31.56 58.50 -77.15 -32.63 coo 40.67 -37.01 14.42 40.72 -35.28 13.16 50.75 -82.80 -28.18 49.58 -81.03 -28.20 1bh2_c00 source 1bh2 GUANINE NUCLEOTIDE-BINDING PROTEIN : 1 hits 1bh2_c00 naa= 4 ULMN 4 1cms_c03 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 1 4 # 1 34 ASP A 52 ASP.? 15.11 CA CA A 208 35 THR A 57 THR.? 15.79 CA CA A 208 216 ASP A 61 ASP~? 12.37 CA CA A 208 217 THR A 58 THR~? 10.52 CA CA A 208 coo 16.90 26.20 29.49 16.22 24.50 28.41 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo 13.84 28.82 26.85 14.18 30.39 25.32 78.12 -88.42 -27.00 77.65 -90.24 -28.10 coo 13.93 25.52 22.10 14.75 24.44 23.75 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo 17.81 28.25 23.25 17.55 29.87 24.67 76.40 -85.04 -26.81 78.11 -83.80 -26.40 ULMN 4 1cms_c03 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 2 4 # 2 34 ASP A 52 ASP.? 15.11 CA CA A 208 35 THR A 58 THR~? 10.52 CA CA A 208 216 ASP A 61 ASP~? 12.37 CA CA A 208 217 THR A 57 THR.? 15.79 CA CA A 208 coo 16.90 26.20 29.49 16.22 24.50 28.41 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo 13.84 28.82 26.85 14.18 30.39 25.32 76.40 -85.04 -26.81 78.11 -83.80 -26.40 coo 13.93 25.52 22.10 14.75 24.44 23.75 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo 17.81 28.25 23.25 17.55 29.87 24.67 78.12 -88.42 -27.00 77.65 -90.24 -28.10 ULMN 4 1cms_c03 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 3 4 # 3 34 ASP A 61 ASP~? 12.37 CA CA A 208 35 THR A 58 THR~? 10.52 CA CA A 208 216 ASP A 52 ASP.? 15.11 CA CA A 208 217 THR A 57 THR.? 15.79 CA CA A 208 coo 16.90 26.20 29.49 16.22 24.50 28.41 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo 13.84 28.82 26.85 14.18 30.39 25.32 76.40 -85.04 -26.81 78.11 -83.80 -26.40 coo 13.93 25.52 22.10 14.75 24.44 23.75 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo 17.81 28.25 23.25 17.55 29.87 24.67 78.12 -88.42 -27.00 77.65 -90.24 -28.10 ULMN 4 1cms_c03 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 4 4 # 4 34 ASP B 52 ASP.? 15.59 CA CA B 208 35 THR B 57 THR.? 15.82 CA CA B 208 216 ASP B 61 ASP~? 12.48 CA CA B 208 217 THR B 58 THR~? 10.41 CA CA B 208 coo 16.90 26.20 29.49 16.22 24.50 28.41 105.61 -28.95 -11.53 106.78 -28.70 -9.81 coo 13.84 28.82 26.85 14.18 30.39 25.32 103.33 -27.21 -5.87 103.96 -25.48 -4.75 coo 13.93 25.52 22.10 14.75 24.44 23.75 98.68 -27.22 -4.60 99.30 -29.23 -4.23 coo 17.81 28.25 23.25 17.55 29.87 24.67 100.65 -27.90 -8.43 100.12 -29.92 -7.97 ULMN 4 1cms_c03 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 5 4 # 5 34 ASP B 52 ASP.? 15.59 CA CA B 208 35 THR B 58 THR~? 10.41 CA CA B 208 216 ASP B 61 ASP~? 12.48 CA CA B 208 217 THR B 57 THR.? 15.82 CA CA B 208 coo 16.90 26.20 29.49 16.22 24.50 28.41 105.61 -28.95 -11.53 106.78 -28.70 -9.81 coo 13.84 28.82 26.85 14.18 30.39 25.32 100.65 -27.90 -8.43 100.12 -29.92 -7.97 coo 13.93 25.52 22.10 14.75 24.44 23.75 98.68 -27.22 -4.60 99.30 -29.23 -4.23 coo 17.81 28.25 23.25 17.55 29.87 24.67 103.33 -27.21 -5.87 103.96 -25.48 -4.75 ULMN 4 1cms_c03 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 6 4 # 6 34 ASP B 61 ASP~? 12.48 CA CA B 208 35 THR B 58 THR~? 10.41 CA CA B 208 216 ASP B 52 ASP.? 15.59 CA CA B 208 217 THR B 57 THR.? 15.82 CA CA B 208 coo 16.90 26.20 29.49 16.22 24.50 28.41 98.68 -27.22 -4.60 99.30 -29.23 -4.23 coo 13.84 28.82 26.85 14.18 30.39 25.32 100.65 -27.90 -8.43 100.12 -29.92 -7.97 coo 13.93 25.52 22.10 14.75 24.44 23.75 105.61 -28.95 -11.53 106.78 -28.70 -9.81 coo 17.81 28.25 23.25 17.55 29.87 24.67 103.33 -27.21 -5.87 103.96 -25.48 -4.75 ULMN 4 1cms_c03 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 7 4 # 7 34 ASP C 52 ASP.? 15.77 CA CA C 208 35 THR C 57 THR.? 15.66 CA CA C 208 216 ASP C 61 ASP~? 12.61 CA CA C 208 217 THR C 58 THR~? 10.65 CA CA C 208 coo 16.90 26.20 29.49 16.22 24.50 28.41 21.29 -54.58 -0.38 20.26 -54.47 1.43 coo 13.84 28.82 26.85 14.18 30.39 25.32 17.34 -49.58 0.14 17.08 -48.15 1.75 coo 13.93 25.52 22.10 14.75 24.44 23.75 16.71 -46.53 -3.05 15.59 -48.22 -3.69 coo 17.81 28.25 23.25 17.55 29.87 24.67 19.91 -49.60 -2.59 18.80 -50.74 -4.02 ULMN 4 1cms_c03 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 8 4 # 8 34 ASP C 52 ASP.? 15.77 CA CA C 208 35 THR C 58 THR~? 10.65 CA CA C 208 216 ASP C 61 ASP~? 12.61 CA CA C 208 217 THR C 57 THR.? 15.66 CA CA C 208 coo 16.90 26.20 29.49 16.22 24.50 28.41 21.29 -54.58 -0.38 20.26 -54.47 1.43 coo 13.84 28.82 26.85 14.18 30.39 25.32 19.91 -49.60 -2.59 18.80 -50.74 -4.02 coo 13.93 25.52 22.10 14.75 24.44 23.75 16.71 -46.53 -3.05 15.59 -48.22 -3.69 coo 17.81 28.25 23.25 17.55 29.87 24.67 17.34 -49.58 0.14 17.08 -48.15 1.75 1cms_c03 source 1cms CHYMOSIN B (FORMERLY KNOWN AS RENNIN) (E.C.3.4: 8 hits 1cms_c03 naa= 4 ULMN 4 1dbt_c02 OROTIDINE 5'-PHOSPHATE DECARBOXYLASEuser 1 4 # 1 A 33 LYS A 119 LYS.? 17.79 CA CA A 208 A 60 ASP A 111 ASP.? 17.05 CA CA A 208 A 62 LYS A 67 LYS~? 13.30 CA CA A 208 A 65 ASP A 61 ASP~? 12.37 CA CA A 208 coo 71.59 57.86 25.98 66.66 59.50 26.53 60.88 -84.29 -40.26 61.29 -87.76 -35.50 coo 66.44 58.31 23.16 64.45 58.00 23.81 65.36 -83.80 -40.24 66.17 -85.36 -41.35 coo 61.71 58.67 18.68 62.06 59.06 24.07 73.21 -82.07 -40.14 71.59 -78.49 -41.85 coo 57.96 61.59 10.16 57.54 63.39 9.12 78.34 -85.42 -30.67 80.16 -84.92 -29.71 ULMN 4 1dbt_c02 OROTIDINE 5'-PHOSPHATE DECARBOXYLASEuser 2 4 # 2 A 33 LYS B 119 LYS.? 18.40 CA CA B 208 A 60 ASP B 111 ASP.? 16.97 CA CA B 208 A 62 LYS B 67 LYS~? 18.13 CA CA B 208 A 65 ASP B 61 ASP~? 12.48 CA CA B 208 coo 71.59 57.86 25.98 66.66 59.50 26.53 89.22 -11.21 -11.71 95.34 -11.17 -12.31 coo 66.44 58.31 23.16 64.45 58.00 23.81 89.21 -14.92 -8.80 89.40 -13.99 -6.98 coo 61.71 58.67 18.68 62.06 59.06 24.07 89.12 -21.41 -4.23 87.66 -21.56 1.71 coo 57.96 61.59 10.16 57.54 63.39 9.12 98.68 -27.22 -4.60 99.30 -29.23 -4.23 ULMN 4 1dbt_c02 OROTIDINE 5'-PHOSPHATE DECARBOXYLASEuser 3 4 # 3 A 33 LYS C 119 LYS.? 22.44 CA CA C 208 A 60 ASP C 111 ASP.? 17.21 CA CA C 208 A 62 LYS C 67 LYS.? 18.71 CA CA C 208 A 65 ASP C 61 ASP~? 12.61 CA CA C 208 coo 71.59 57.86 25.98 66.66 59.50 26.53 30.81 -32.05 -1.80 31.88 -31.87 3.92 coo 66.44 58.31 23.16 64.45 58.00 23.81 27.11 -33.17 -3.90 25.73 -31.94 -3.00 coo 61.71 58.67 18.68 62.06 59.06 24.07 20.04 -36.06 -6.98 16.11 -31.17 -7.78 coo 57.96 61.59 10.16 57.54 63.39 9.12 16.71 -46.53 -3.05 15.59 -48.22 -3.69 1dbt_c02 source 1dbt OROTIDINE 5'-PHOSPHATE DECARBOXYLASE : 3 hits 1dbt_c02 naa= 4 ULMN 4 1dbt_c03 OROTIDINE 5'-PHOSPHATE DECARBOXYLASEuser 1 4 # 1 B 33 LYS A 119 LYS.? 17.79 CA CA A 208 B 60 ASP A 111 ASP.? 17.05 CA CA A 208 B 62 LYS A 67 LYS~? 13.30 CA CA A 208 B 65 ASP A 61 ASP~? 12.37 CA CA A 208 coo 60.66 73.37 6.16 58.97 68.44 6.56 60.88 -84.29 -40.26 61.29 -87.76 -35.50 coo 58.78 69.55 10.14 57.19 68.14 10.07 65.36 -83.80 -40.24 66.17 -85.36 -41.35 coo 57.51 66.37 15.65 56.43 65.69 10.35 73.21 -82.07 -40.14 71.59 -78.49 -41.85 coo 59.76 62.84 24.35 61.26 61.55 25.03 78.34 -85.42 -30.67 80.16 -84.92 -29.71 ULMN 4 1dbt_c03 OROTIDINE 5'-PHOSPHATE DECARBOXYLASEuser 2 4 # 2 B 33 LYS B 119 LYS.? 18.40 CA CA B 208 B 60 ASP B 111 ASP.? 16.97 CA CA B 208 B 62 LYS B 67 LYS~? 18.13 CA CA B 208 B 65 ASP B 61 ASP~? 12.48 CA CA B 208 coo 60.66 73.37 6.16 58.97 68.44 6.56 89.22 -11.21 -11.71 95.34 -11.17 -12.31 coo 58.78 69.55 10.14 57.19 68.14 10.07 89.21 -14.92 -8.80 89.40 -13.99 -6.98 coo 57.51 66.37 15.65 56.43 65.69 10.35 89.12 -21.41 -4.23 87.66 -21.56 1.71 coo 59.76 62.84 24.35 61.26 61.55 25.03 98.68 -27.22 -4.60 99.30 -29.23 -4.23 1dbt_c03 source 1dbt OROTIDINE 5'-PHOSPHATE DECARBOXYLASE : 2 hits 1dbt_c03 naa= 4 ULMN 4 1dbt_c04 OROTIDINE 5'-PHOSPHATE DECARBOXYLASEuser 1 4 # 1 C 33 LYS A 119 LYS.? 17.79 CA CA A 208 C 60 ASP A 111 ASP.? 17.05 CA CA A 208 C 62 LYS A 67 LYS~? 13.30 CA CA A 208 C 65 ASP A 61 ASP~? 12.37 CA CA A 208 coo 48.78 54.73 53.49 45.16 54.73 57.01 60.88 -84.29 -40.26 61.29 -87.76 -35.50 coo 46.15 51.25 57.34 45.59 51.66 59.34 65.36 -83.80 -40.24 66.17 -85.36 -41.35 coo 43.68 46.22 60.72 43.55 51.70 60.99 73.21 -82.07 -40.14 71.59 -78.49 -41.85 coo 39.24 37.68 61.54 37.35 37.05 60.87 78.34 -85.42 -30.67 80.16 -84.92 -29.71 ULMN 4 1dbt_c04 OROTIDINE 5'-PHOSPHATE DECARBOXYLASEuser 2 4 # 2 C 33 LYS B 119 LYS.? 18.40 CA CA B 208 C 60 ASP B 111 ASP.? 16.97 CA CA B 208 C 62 LYS B 67 LYS~? 18.13 CA CA B 208 C 65 ASP B 61 ASP~? 12.48 CA CA B 208 coo 48.78 54.73 53.49 45.16 54.73 57.01 89.22 -11.21 -11.71 95.34 -11.17 -12.31 coo 46.15 51.25 57.34 45.59 51.66 59.34 89.21 -14.92 -8.80 89.40 -13.99 -6.98 coo 43.68 46.22 60.72 43.55 51.70 60.99 89.12 -21.41 -4.23 87.66 -21.56 1.71 coo 39.24 37.68 61.54 37.35 37.05 60.87 98.68 -27.22 -4.60 99.30 -29.23 -4.23 ULMN 4 1dbt_c04 OROTIDINE 5'-PHOSPHATE DECARBOXYLASEuser 3 4 # 3 C 33 LYS C 119 LYS.? 22.44 CA CA C 208 C 60 ASP C 111 ASP.? 17.21 CA CA C 208 C 62 LYS C 67 LYS.? 18.71 CA CA C 208 C 65 ASP C 61 ASP~? 12.61 CA CA C 208 coo 48.78 54.73 53.49 45.16 54.73 57.01 30.81 -32.05 -1.80 31.88 -31.87 3.92 coo 46.15 51.25 57.34 45.59 51.66 59.34 27.11 -33.17 -3.90 25.73 -31.94 -3.00 coo 43.68 46.22 60.72 43.55 51.70 60.99 20.04 -36.06 -6.98 16.11 -31.17 -7.78 coo 39.24 37.68 61.54 37.35 37.05 60.87 16.71 -46.53 -3.05 15.59 -48.22 -3.69 1dbt_c04 source 1dbt OROTIDINE 5'-PHOSPHATE DECARBOXYLASE : 3 hits 1dbt_c04 naa= 4 ULMN 4 1eed_c03 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 1 4 # 1 P 32 ASP A 52 ASP.? 15.11 CA CA A 208 P 33 THR A 57 THR.? 15.79 CA CA A 208 P 215 ASP A 61 ASP~? 12.37 CA CA A 208 P 216 THR A 58 THR~? 10.52 CA CA A 208 coo 10.15 33.41 11.98 7.98 33.66 12.07 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo 9.02 32.64 7.26 9.13 30.80 6.21 78.12 -88.42 -27.00 77.65 -90.24 -28.10 coo 4.04 29.97 8.82 4.78 31.15 10.46 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo 8.39 27.75 9.42 10.09 28.44 8.32 76.40 -85.04 -26.81 78.11 -83.80 -26.40 ULMN 4 1eed_c03 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 2 4 # 2 P 32 ASP A 52 ASP.? 15.11 CA CA A 208 P 33 THR A 58 THR~? 10.52 CA CA A 208 P 215 ASP A 61 ASP~? 12.37 CA CA A 208 P 216 THR A 57 THR.? 15.79 CA CA A 208 coo 10.15 33.41 11.98 7.98 33.66 12.07 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo 9.02 32.64 7.26 9.13 30.80 6.21 76.40 -85.04 -26.81 78.11 -83.80 -26.40 coo 4.04 29.97 8.82 4.78 31.15 10.46 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo 8.39 27.75 9.42 10.09 28.44 8.32 78.12 -88.42 -27.00 77.65 -90.24 -28.10 ULMN 4 1eed_c03 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 3 4 # 3 P 32 ASP A 61 ASP~? 12.37 CA CA A 208 P 33 THR A 58 THR~? 10.52 CA CA A 208 P 215 ASP A 52 ASP.? 15.11 CA CA A 208 P 216 THR A 57 THR.? 15.79 CA CA A 208 coo 10.15 33.41 11.98 7.98 33.66 12.07 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo 9.02 32.64 7.26 9.13 30.80 6.21 76.40 -85.04 -26.81 78.11 -83.80 -26.40 coo 4.04 29.97 8.82 4.78 31.15 10.46 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo 8.39 27.75 9.42 10.09 28.44 8.32 78.12 -88.42 -27.00 77.65 -90.24 -28.10 ULMN 4 1eed_c03 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 4 4 # 4 P 32 ASP C 52 ASP.? 15.77 CA CA C 208 P 33 THR C 57 THR.? 15.66 CA CA C 208 P 215 ASP C 61 ASP~? 12.61 CA CA C 208 P 216 THR C 58 THR~? 10.65 CA CA C 208 coo 10.15 33.41 11.98 7.98 33.66 12.07 21.29 -54.58 -0.38 20.26 -54.47 1.43 coo 9.02 32.64 7.26 9.13 30.80 6.21 17.34 -49.58 0.14 17.08 -48.15 1.75 coo 4.04 29.97 8.82 4.78 31.15 10.46 16.71 -46.53 -3.05 15.59 -48.22 -3.69 coo 8.39 27.75 9.42 10.09 28.44 8.32 19.91 -49.60 -2.59 18.80 -50.74 -4.02 ULMN 4 1eed_c03 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 5 4 # 5 P 32 ASP C 52 ASP.? 15.77 CA CA C 208 P 33 THR C 58 THR~? 10.65 CA CA C 208 P 215 ASP C 61 ASP~? 12.61 CA CA C 208 P 216 THR C 57 THR.? 15.66 CA CA C 208 coo 10.15 33.41 11.98 7.98 33.66 12.07 21.29 -54.58 -0.38 20.26 -54.47 1.43 coo 9.02 32.64 7.26 9.13 30.80 6.21 19.91 -49.60 -2.59 18.80 -50.74 -4.02 coo 4.04 29.97 8.82 4.78 31.15 10.46 16.71 -46.53 -3.05 15.59 -48.22 -3.69 coo 8.39 27.75 9.42 10.09 28.44 8.32 17.34 -49.58 0.14 17.08 -48.15 1.75 1eed_c03 source 1eed ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLEX WITH TH: 5 hits 1eed_c03 naa= 4 ULMN 4 1eix_c04 OROTIDINE 5'-MONOPHOSPHATE DECARBOXYuser 1 4 # 1 A 44 LYS A 119 LYS.? 17.79 CA CA A 208 A 71 ASP A 111 ASP.? 17.05 CA CA A 208 A 73 LYS A 67 LYS~? 13.30 CA CA A 208 A 76 ASP A 61 ASP~? 12.37 CA CA A 208 coo 19.59 28.23 101.92 19.95 24.94 105.61 60.88 -84.29 -40.26 61.29 -87.76 -35.50 coo 23.19 26.70 106.03 22.83 25.75 107.86 65.36 -83.80 -40.24 66.17 -85.36 -41.35 coo 27.86 26.05 110.45 22.68 24.67 109.97 73.21 -82.07 -40.14 71.59 -78.49 -41.85 coo 36.95 24.59 112.32 38.04 22.87 111.77 78.34 -85.42 -30.67 80.16 -84.92 -29.71 ULMN 4 1eix_c04 OROTIDINE 5'-MONOPHOSPHATE DECARBOXYuser 2 4 # 2 A 44 LYS B 119 LYS.? 18.40 CA CA B 208 A 71 ASP B 111 ASP.? 16.97 CA CA B 208 A 73 LYS B 67 LYS~? 18.13 CA CA B 208 A 76 ASP B 61 ASP~? 12.48 CA CA B 208 coo 19.59 28.23 101.92 19.95 24.94 105.61 89.22 -11.21 -11.71 95.34 -11.17 -12.31 coo 23.19 26.70 106.03 22.83 25.75 107.86 89.21 -14.92 -8.80 89.40 -13.99 -6.98 coo 27.86 26.05 110.45 22.68 24.67 109.97 89.12 -21.41 -4.23 87.66 -21.56 1.71 coo 36.95 24.59 112.32 38.04 22.87 111.77 98.68 -27.22 -4.60 99.30 -29.23 -4.23 1eix_c04 source 1eix OROTIDINE 5'-MONOPHOSPHATE DECARBOXYLASE : 2 hits 1eix_c04 naa= 4 ULMN 4 1eix_c05 OROTIDINE 5'-MONOPHOSPHATE DECARBOXYuser 1 4 # 1 B 44 LYS A 119 LYS.? 17.79 CA CA A 208 B 71 ASP A 111 ASP.? 17.05 CA CA A 208 B 73 LYS A 67 LYS~? 13.30 CA CA A 208 B 76 ASP A 61 ASP~? 12.37 CA CA A 208 coo 42.51 16.13 104.66 41.59 19.58 107.89 60.88 -84.29 -40.26 61.29 -87.76 -35.50 coo 38.06 17.61 107.95 37.94 18.87 109.63 65.36 -83.80 -40.24 66.17 -85.36 -41.35 coo 32.65 18.53 110.98 37.67 20.13 111.67 73.21 -82.07 -40.14 71.59 -78.49 -41.85 coo 23.32 19.98 111.00 22.38 21.72 110.29 78.34 -85.42 -30.67 80.16 -84.92 -29.71 ULMN 4 1eix_c05 OROTIDINE 5'-MONOPHOSPHATE DECARBOXYuser 2 4 # 2 B 44 LYS B 119 LYS.? 18.40 CA CA B 208 B 71 ASP B 111 ASP.? 16.97 CA CA B 208 B 73 LYS B 67 LYS~? 18.13 CA CA B 208 B 76 ASP B 61 ASP~? 12.48 CA CA B 208 coo 42.51 16.13 104.66 41.59 19.58 107.89 89.22 -11.21 -11.71 95.34 -11.17 -12.31 coo 38.06 17.61 107.95 37.94 18.87 109.63 89.21 -14.92 -8.80 89.40 -13.99 -6.98 coo 32.65 18.53 110.98 37.67 20.13 111.67 89.12 -21.41 -4.23 87.66 -21.56 1.71 coo 23.32 19.98 111.00 22.38 21.72 110.29 98.68 -27.22 -4.60 99.30 -29.23 -4.23 1eix_c05 source 1eix OROTIDINE 5'-MONOPHOSPHATE DECARBOXYLASE : 2 hits 1eix_c05 naa= 4 ULMN 4 1eix_c06 OROTIDINE 5'-MONOPHOSPHATE DECARBOXYuser 1 4 # 1 C 44 LYS A 119 LYS.? 17.79 CA CA A 208 C 71 ASP A 111 ASP.? 17.05 CA CA A 208 C 73 LYS A 67 LYS~? 13.30 CA CA A 208 C 76 ASP A 61 ASP~? 12.37 CA CA A 208 coo 36.80 44.62 62.45 37.50 45.99 67.26 60.88 -84.29 -40.26 61.29 -87.76 -35.50 coo 41.24 46.44 65.36 41.30 47.43 67.22 65.36 -83.80 -40.24 66.17 -85.36 -41.35 coo 46.67 48.87 67.69 41.63 48.86 69.39 73.21 -82.07 -40.14 71.59 -78.49 -41.85 coo 56.00 48.26 68.98 57.09 46.84 70.05 78.34 -85.42 -30.67 80.16 -84.92 -29.71 ULMN 4 1eix_c06 OROTIDINE 5'-MONOPHOSPHATE DECARBOXYuser 2 4 # 2 C 44 LYS B 119 LYS.? 18.40 CA CA B 208 C 71 ASP B 111 ASP.? 16.97 CA CA B 208 C 73 LYS B 67 LYS~? 18.13 CA CA B 208 C 76 ASP B 61 ASP~? 12.48 CA CA B 208 coo 36.80 44.62 62.45 37.50 45.99 67.26 89.22 -11.21 -11.71 95.34 -11.17 -12.31 coo 41.24 46.44 65.36 41.30 47.43 67.22 89.21 -14.92 -8.80 89.40 -13.99 -6.98 coo 46.67 48.87 67.69 41.63 48.86 69.39 89.12 -21.41 -4.23 87.66 -21.56 1.71 coo 56.00 48.26 68.98 57.09 46.84 70.05 98.68 -27.22 -4.60 99.30 -29.23 -4.23 1eix_c06 source 1eix OROTIDINE 5'-MONOPHOSPHATE DECARBOXYLASE : 2 hits 1eix_c06 naa= 4 ULMN 4 1eix_c07 OROTIDINE 5'-MONOPHOSPHATE DECARBOXYuser 1 4 # 1 D 44 LYS A 119 LYS.? 17.79 CA CA A 208 D 71 ASP A 111 ASP.? 17.05 CA CA A 208 D 73 LYS A 67 LYS~? 13.30 CA CA A 208 D 76 ASP A 61 ASP~? 12.37 CA CA A 208 coo 59.78 36.42 71.82 59.95 40.97 70.58 60.88 -84.29 -40.26 61.29 -87.76 -35.50 coo 56.16 40.71 72.48 56.48 42.77 72.42 65.36 -83.80 -40.24 66.17 -85.36 -41.35 coo 51.52 44.76 73.92 56.76 45.26 72.14 73.21 -82.07 -40.14 71.59 -78.49 -41.85 coo 42.33 47.14 73.59 41.23 47.55 71.88 78.34 -85.42 -30.67 80.16 -84.92 -29.71 ULMN 4 1eix_c07 OROTIDINE 5'-MONOPHOSPHATE DECARBOXYuser 2 4 # 2 D 44 LYS B 119 LYS.? 18.40 CA CA B 208 D 71 ASP B 111 ASP.? 16.97 CA CA B 208 D 73 LYS B 67 LYS~? 18.13 CA CA B 208 D 76 ASP B 61 ASP~? 12.48 CA CA B 208 coo 59.78 36.42 71.82 59.95 40.97 70.58 89.22 -11.21 -11.71 95.34 -11.17 -12.31 coo 56.16 40.71 72.48 56.48 42.77 72.42 89.21 -14.92 -8.80 89.40 -13.99 -6.98 coo 51.52 44.76 73.92 56.76 45.26 72.14 89.12 -21.41 -4.23 87.66 -21.56 1.71 coo 42.33 47.14 73.59 41.23 47.55 71.88 98.68 -27.22 -4.60 99.30 -29.23 -4.23 1eix_c07 source 1eix OROTIDINE 5'-MONOPHOSPHATE DECARBOXYLASE : 2 hits 1eix_c07 naa= 4 ULMN 4 1ghs_c00 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 1 4 # 1 A 231 GLU B 7 GLU^? 19.70 O15 C8E B 209 A 279 GLU B 25 GLU^? 27.65 O15 C8E B 209 A 282 LYS B 84 LYS.? 25.86 O15 C8E B 209 A 288 GLU B 93 GLU^? 27.23 O15 C8E B 209 coo 56.45 0.46 86.18 56.87 -0.85 87.80 73.39 -38.66 -35.65 75.17 -39.55 -36.49 coo 47.04 -1.91 92.33 48.79 -2.81 91.49 73.50 -42.12 -45.68 71.97 -42.23 -44.24 coo 49.98 -4.05 98.00 52.40 -3.58 93.17 79.44 -47.69 -46.65 75.97 -44.45 -44.18 coo 54.40 -0.12 97.85 55.58 0.51 96.24 75.25 -49.35 -42.08 74.13 -47.63 -42.56 1ghs_c00 source 1ghs 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1,3-BETA-D-: 1 hits 1ghs_c00 naa= 4 ULMN 4 1ghs_c01 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 1 4 # 1 B 231 GLU B 7 GLU^? 19.70 O15 C8E B 209 B 279 GLU B 25 GLU^? 27.65 O15 C8E B 209 B 282 LYS B 84 LYS.? 25.86 O15 C8E B 209 B 288 GLU B 93 GLU^? 27.23 O15 C8E B 209 coo 47.83 -0.67 47.15 49.17 -0.90 48.81 73.39 -38.66 -35.65 75.17 -39.55 -36.49 coo 44.68 -9.78 53.79 46.22 -8.74 52.81 73.50 -42.12 -45.68 71.97 -42.23 -44.24 coo 47.92 -7.86 59.48 48.51 -6.22 53.96 79.44 -47.69 -46.65 75.97 -44.45 -44.18 coo 47.02 -1.91 59.02 47.41 -1.07 57.09 75.25 -49.35 -42.08 74.13 -47.63 -42.56 1ghs_c01 source 1ghs 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1,3-BETA-D-: 1 hits 1ghs_c01 naa= 4 ULMN 4 1hiv_c00 HIV-1 PROTEASE (HIV-1 PR) COMPLEX WIuser 1 4 # 1 A 25 ASP A 52 ASP.? 15.11 CA CA A 208 A 26 THR A 57 THR.? 15.79 CA CA A 208 B 25 ASP A 61 ASP~? 12.37 CA CA A 208 B 26 THR A 58 THR~? 10.52 CA CA A 208 coo 1.46 1.38 19.19 2.92 0.53 17.93 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo 4.01 5.49 19.73 5.03 5.84 21.56 78.12 -88.42 -27.00 77.65 -90.24 -28.10 coo 8.70 2.26 18.89 7.00 1.20 18.15 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo 6.29 1.66 22.97 5.06 3.28 23.79 76.40 -85.04 -26.81 78.11 -83.80 -26.40 ULMN 4 1hiv_c00 HIV-1 PROTEASE (HIV-1 PR) COMPLEX WIuser 2 4 # 2 A 25 ASP A 52 ASP.? 15.11 CA CA A 208 A 26 THR A 58 THR~? 10.52 CA CA A 208 B 25 ASP A 61 ASP~? 12.37 CA CA A 208 B 26 THR A 57 THR.? 15.79 CA CA A 208 coo 1.46 1.38 19.19 2.92 0.53 17.93 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo 4.01 5.49 19.73 5.03 5.84 21.56 76.40 -85.04 -26.81 78.11 -83.80 -26.40 coo 8.70 2.26 18.89 7.00 1.20 18.15 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo 6.29 1.66 22.97 5.06 3.28 23.79 78.12 -88.42 -27.00 77.65 -90.24 -28.10 ULMN 4 1hiv_c00 HIV-1 PROTEASE (HIV-1 PR) COMPLEX WIuser 3 4 # 3 A 25 ASP A 61 ASP~? 12.37 CA CA A 208 A 26 THR A 57 THR.? 15.79 CA CA A 208 B 25 ASP A 52 ASP.? 15.11 CA CA A 208 B 26 THR A 58 THR~? 10.52 CA CA A 208 coo 1.46 1.38 19.19 2.92 0.53 17.93 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo 4.01 5.49 19.73 5.03 5.84 21.56 78.12 -88.42 -27.00 77.65 -90.24 -28.10 coo 8.70 2.26 18.89 7.00 1.20 18.15 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo 6.29 1.66 22.97 5.06 3.28 23.79 76.40 -85.04 -26.81 78.11 -83.80 -26.40 ULMN 4 1hiv_c00 HIV-1 PROTEASE (HIV-1 PR) COMPLEX WIuser 4 4 # 4 A 25 ASP A 61 ASP~? 12.37 CA CA A 208 A 26 THR A 58 THR~? 10.52 CA CA A 208 B 25 ASP A 52 ASP.? 15.11 CA CA A 208 B 26 THR A 57 THR.? 15.79 CA CA A 208 coo 1.46 1.38 19.19 2.92 0.53 17.93 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo 4.01 5.49 19.73 5.03 5.84 21.56 76.40 -85.04 -26.81 78.11 -83.80 -26.40 coo 8.70 2.26 18.89 7.00 1.20 18.15 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo 6.29 1.66 22.97 5.06 3.28 23.79 78.12 -88.42 -27.00 77.65 -90.24 -28.10 1hiv_c00 source 1hiv HIV-1 PROTEASE (HIV-1 PR) COMPLEX WITH U75875 : 4 hits 1hiv_c00 naa= 4 ULMN 4 1mpp_c03 PEPSIN (RENIN) (E.C.3.4.23.23) user 1 4 # 1 32 ASP A 52 ASP.? 15.11 CA CA A 208 33 THR A 57 THR.? 15.79 CA CA A 208 215 ASP A 61 ASP~? 12.37 CA CA A 208 216 THR A 58 THR~? 10.52 CA CA A 208 coo 20.97 14.47 32.28 19.66 15.96 31.62 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo 20.74 16.43 36.65 22.27 17.66 37.53 78.12 -88.42 -27.00 77.65 -90.24 -28.10 coo 20.65 22.00 33.80 20.06 20.56 32.39 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo 24.75 19.33 34.08 24.97 17.76 35.56 76.40 -85.04 -26.81 78.11 -83.80 -26.40 ULMN 4 1mpp_c03 PEPSIN (RENIN) (E.C.3.4.23.23) user 2 4 # 2 32 ASP A 52 ASP.? 15.11 CA CA A 208 33 THR A 58 THR~? 10.52 CA CA A 208 215 ASP A 61 ASP~? 12.37 CA CA A 208 216 THR A 57 THR.? 15.79 CA CA A 208 coo 20.97 14.47 32.28 19.66 15.96 31.62 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo 20.74 16.43 36.65 22.27 17.66 37.53 76.40 -85.04 -26.81 78.11 -83.80 -26.40 coo 20.65 22.00 33.80 20.06 20.56 32.39 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo 24.75 19.33 34.08 24.97 17.76 35.56 78.12 -88.42 -27.00 77.65 -90.24 -28.10 ULMN 4 1mpp_c03 PEPSIN (RENIN) (E.C.3.4.23.23) user 3 4 # 3 32 ASP A 61 ASP~? 12.37 CA CA A 208 33 THR A 58 THR~? 10.52 CA CA A 208 215 ASP A 52 ASP.? 15.11 CA CA A 208 216 THR A 57 THR.? 15.79 CA CA A 208 coo 20.97 14.47 32.28 19.66 15.96 31.62 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo 20.74 16.43 36.65 22.27 17.66 37.53 76.40 -85.04 -26.81 78.11 -83.80 -26.40 coo 20.65 22.00 33.80 20.06 20.56 32.39 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo 24.75 19.33 34.08 24.97 17.76 35.56 78.12 -88.42 -27.00 77.65 -90.24 -28.10 ULMN 4 1mpp_c03 PEPSIN (RENIN) (E.C.3.4.23.23) user 4 4 # 4 32 ASP C 52 ASP.? 15.77 CA CA C 208 33 THR C 57 THR.? 15.66 CA CA C 208 215 ASP C 61 ASP~? 12.61 CA CA C 208 216 THR C 58 THR~? 10.65 CA CA C 208 coo 20.97 14.47 32.28 19.66 15.96 31.62 21.29 -54.58 -0.38 20.26 -54.47 1.43 coo 20.74 16.43 36.65 22.27 17.66 37.53 17.34 -49.58 0.14 17.08 -48.15 1.75 coo 20.65 22.00 33.80 20.06 20.56 32.39 16.71 -46.53 -3.05 15.59 -48.22 -3.69 coo 24.75 19.33 34.08 24.97 17.76 35.56 19.91 -49.60 -2.59 18.80 -50.74 -4.02 ULMN 4 1mpp_c03 PEPSIN (RENIN) (E.C.3.4.23.23) user 5 4 # 5 32 ASP C 52 ASP.? 15.77 CA CA C 208 33 THR C 58 THR~? 10.65 CA CA C 208 215 ASP C 61 ASP~? 12.61 CA CA C 208 216 THR C 57 THR.? 15.66 CA CA C 208 coo 20.97 14.47 32.28 19.66 15.96 31.62 21.29 -54.58 -0.38 20.26 -54.47 1.43 coo 20.74 16.43 36.65 22.27 17.66 37.53 19.91 -49.60 -2.59 18.80 -50.74 -4.02 coo 20.65 22.00 33.80 20.06 20.56 32.39 16.71 -46.53 -3.05 15.59 -48.22 -3.69 coo 24.75 19.33 34.08 24.97 17.76 35.56 17.34 -49.58 0.14 17.08 -48.15 1.75 ULMN 4 1mpp_c03 PEPSIN (RENIN) (E.C.3.4.23.23) user 6 4 # 6 32 ASP C 61 ASP~? 12.61 CA CA C 208 33 THR C 57 THR.? 15.66 CA CA C 208 215 ASP C 52 ASP.? 15.77 CA CA C 208 216 THR C 58 THR~? 10.65 CA CA C 208 coo 20.97 14.47 32.28 19.66 15.96 31.62 16.71 -46.53 -3.05 15.59 -48.22 -3.69 coo 20.74 16.43 36.65 22.27 17.66 37.53 17.34 -49.58 0.14 17.08 -48.15 1.75 coo 20.65 22.00 33.80 20.06 20.56 32.39 21.29 -54.58 -0.38 20.26 -54.47 1.43 coo 24.75 19.33 34.08 24.97 17.76 35.56 19.91 -49.60 -2.59 18.80 -50.74 -4.02 ULMN 4 1mpp_c03 PEPSIN (RENIN) (E.C.3.4.23.23) user 7 4 # 7 32 ASP C 61 ASP~? 12.61 CA CA C 208 33 THR C 58 THR~? 10.65 CA CA C 208 215 ASP C 52 ASP.? 15.77 CA CA C 208 216 THR C 57 THR.? 15.66 CA CA C 208 coo 20.97 14.47 32.28 19.66 15.96 31.62 16.71 -46.53 -3.05 15.59 -48.22 -3.69 coo 20.74 16.43 36.65 22.27 17.66 37.53 19.91 -49.60 -2.59 18.80 -50.74 -4.02 coo 20.65 22.00 33.80 20.06 20.56 32.39 21.29 -54.58 -0.38 20.26 -54.47 1.43 coo 24.75 19.33 34.08 24.97 17.76 35.56 17.34 -49.58 0.14 17.08 -48.15 1.75 1mpp_c03 source 1mpp PEPSIN (RENIN) (E.C.3.4.23.23) : 7 hits 1mpp_c03 naa= 4 ULMN 4 1ohh_c03 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 1 4 # 1 A 373 ARG A 36 ARG^? 15.77 C1 C8E A 210 E 162 LYS A 3 LYS^? 24.80 C20 C8E C 210 E 188 GLU A 93 GLU^? 23.51 C1 C8E A 210 E 189 ARG A 135 ARG^? 21.29 C1 C8E A 210 coo 101.13 34.06 -17.55 103.52 32.17 -17.47 59.00 -50.13 -20.90 61.68 -51.06 -19.88 coo 99.70 45.17 -13.94 103.86 40.77 -11.97 52.63 -38.57 -20.93 53.13 -33.95 -19.17 coo 111.54 40.04 -16.26 109.58 40.74 -16.69 64.33 -40.66 -16.04 62.38 -40.13 -16.70 coo 107.06 33.49 -18.08 106.01 34.28 -15.30 62.45 -46.81 -18.85 61.41 -44.79 -20.90 ULMN 4 1ohh_c03 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 2 4 # 2 A 373 ARG B 36 ARG^? 17.08 O15 C8E B 209 E 162 LYS B 3 LYS^? 35.51 O15 C8E B 209 E 188 GLU B 93 GLU^? 27.23 O15 C8E B 209 E 189 ARG B 135 ARG^? 22.88 O15 C8E B 209 coo 101.13 34.06 -17.55 103.52 32.17 -17.47 77.67 -37.50 -38.51 79.47 -39.58 -37.24 coo 99.70 45.17 -13.94 103.86 40.77 -11.97 68.65 -39.32 -48.24 67.06 -43.09 -50.47 coo 111.54 40.04 -16.26 109.58 40.74 -16.69 75.25 -49.35 -42.08 74.13 -47.63 -42.56 coo 107.06 33.49 -18.08 106.01 34.28 -15.30 77.46 -42.45 -38.74 74.50 -42.61 -39.42 ULMN 4 1ohh_c03 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 3 4 # 3 A 373 ARG C 36 ARG^? 17.98 C16 C8E C 210 E 162 LYS C 3 LYS.? 29.42 O21 C8E A 209 E 188 GLU C 93 GLU^? 26.90 C13 C8E C 210 E 189 ARG C 135 ARG^? 23.87 C16 C8E C 210 coo 101.13 34.06 -17.55 103.52 32.17 -17.47 45.58 -52.92 -31.76 43.11 -54.70 -31.56 coo 99.70 45.17 -13.94 103.86 40.77 -11.97 54.64 -52.54 -41.89 51.76 -56.14 -46.37 coo 111.54 40.04 -16.26 109.58 40.74 -16.69 45.29 -60.19 -41.07 45.99 -58.52 -39.91 coo 107.06 33.49 -18.08 106.01 34.28 -15.30 44.01 -56.05 -34.91 45.01 -54.65 -37.44 1ohh_c03 source 1ohh ATP SYNTHASE ALPHA CHAIN HEART ISOFORM, MITOCH: 3 hits 1ohh_c03 naa= 4 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 1 4 # 1 A 151 VAL A 22 VAL^? 19.55 C2 C8E C 209 A 194 GLY C 38 GLY^? 17.56 C19 C8E C 210 A 417 ILE A 118 ILE.? 21.11 CA CA A 208 A 457 ALA A 120 ALA^? 16.19 CA CA A 208 coo 60.43 93.31 8.03 62.16 94.30 8.93 54.15 -48.28 -24.50 51.93 -48.23 -24.31 coo 59.34 89.99 13.88 59.24 89.18 13.73 47.08 -49.08 -27.59 47.53 -49.11 -26.94 coo 39.61 128.90 22.54 40.04 128.24 23.80 62.90 -86.55 -43.71 63.10 -86.88 -44.59 coo 43.27 124.32 20.47 43.79 125.29 21.53 60.81 -81.68 -37.46 59.90 -80.57 -38.00 1pix_c00 source 1pix GLUTACONYL-COA DECARBOXYLASE A SUBUNIT : 1 hits 1pix_c00 naa= 4 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 1 4 # 1 B 151 VAL A 6 VAL^? 25.12 C2 C8E C 209 B 194 GLY C 38 GLY^? 17.56 C19 C8E C 210 B 417 ILE A 118 ILE.? 21.11 CA CA A 208 B 457 ALA A 120 ALA^? 16.19 CA CA A 208 coo 52.95 126.71 13.21 51.34 125.24 13.19 56.15 -45.66 -27.60 55.77 -45.97 -29.79 coo 50.40 126.23 20.48 50.46 127.00 20.75 47.08 -49.08 -27.59 47.53 -49.11 -26.94 coo 68.38 85.45 19.33 67.41 85.52 20.41 62.90 -86.55 -43.71 63.10 -86.88 -44.59 coo 65.50 91.13 17.77 64.65 89.88 18.00 60.81 -81.68 -37.46 59.90 -80.57 -38.00 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 2 4 # 2 B 151 VAL A 22 VAL^? 19.55 C2 C8E C 209 B 194 GLY C 38 GLY^? 17.56 C19 C8E C 210 B 417 ILE A 118 ILE.? 21.11 CA CA A 208 B 457 ALA A 120 ALA^? 16.19 CA CA A 208 coo 52.95 126.71 13.21 51.34 125.24 13.19 54.15 -48.28 -24.50 51.93 -48.23 -24.31 coo 50.40 126.23 20.48 50.46 127.00 20.75 47.08 -49.08 -27.59 47.53 -49.11 -26.94 coo 68.38 85.45 19.33 67.41 85.52 20.41 62.90 -86.55 -43.71 63.10 -86.88 -44.59 coo 65.50 91.13 17.77 64.65 89.88 18.00 60.81 -81.68 -37.46 59.90 -80.57 -38.00 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 3 4 # 3 B 151 VAL C 6 VAL^? 25.62 C19 C8E C 210 B 194 GLY C 38 GLY^? 17.56 C19 C8E C 210 B 417 ILE A 118 ILE.? 21.11 CA CA A 208 B 457 ALA A 120 ALA^? 16.19 CA CA A 208 coo 52.95 126.71 13.21 51.34 125.24 13.19 48.09 -46.15 -36.64 47.69 -44.03 -36.90 coo 50.40 126.23 20.48 50.46 127.00 20.75 47.08 -49.08 -27.59 47.53 -49.11 -26.94 coo 68.38 85.45 19.33 67.41 85.52 20.41 62.90 -86.55 -43.71 63.10 -86.88 -44.59 coo 65.50 91.13 17.77 64.65 89.88 18.00 60.81 -81.68 -37.46 59.90 -80.57 -38.00 1pix_c01 source 1pix GLUTACONYL-COA DECARBOXYLASE A SUBUNIT : 3 hits 1pix_c01 naa= 4 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 1 4 # 1 A 457 ALA A 8 ALA^? 20.71 O18 C8E A 209 A 458 ALA A 203 ALA^? 24.35 C17 C8E A 209 B 193 ALA A 10 ALA^? 16.05 O18 C8E A 209 B 194 GLY A 18 GLY^? 13.28 O18 C8E A 209 coo 43.27 124.32 20.47 43.79 125.29 21.53 61.58 -49.53 -29.33 61.65 -49.30 -30.88 coo 39.57 123.53 20.89 38.42 124.25 20.20 64.54 -44.79 -28.25 64.77 -44.19 -29.63 coo 47.95 129.15 20.31 47.81 128.95 18.79 67.31 -53.72 -29.40 67.90 -53.34 -30.78 coo 50.40 126.23 20.48 50.46 127.00 20.75 64.23 -56.43 -29.63 63.79 -57.08 -29.36 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 2 4 # 2 A 457 ALA A 203 ALA^? 24.35 C17 C8E A 209 A 458 ALA A 204 ALA^? 24.86 C17 C8E A 209 B 193 ALA B 203 ALA^? 24.58 O15 C8E B 209 B 194 GLY B 202 GLY^? 20.20 O15 C8E B 209 coo 43.27 124.32 20.47 43.79 125.29 21.53 64.54 -44.79 -28.25 64.77 -44.19 -29.63 coo 39.57 123.53 20.89 38.42 124.25 20.20 61.22 -43.46 -27.01 60.98 -43.47 -25.53 coo 47.95 129.15 20.31 47.81 128.95 18.79 69.42 -41.50 -32.95 68.05 -41.38 -32.31 coo 50.40 126.23 20.48 50.46 127.00 20.75 72.27 -41.27 -30.46 72.24 -42.05 -30.66 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 3 4 # 3 A 457 ALA B 8 ALA^? 20.90 C16 C8E B 209 A 458 ALA B 203 ALA^? 24.58 O15 C8E B 209 B 193 ALA B 10 ALA^? 16.31 C16 C8E B 209 B 194 GLY B 18 GLY^? 13.41 C16 C8E B 209 coo 43.27 124.32 20.47 43.79 125.29 21.53 71.81 -36.32 -32.47 70.60 -35.68 -31.80 coo 39.57 123.53 20.89 38.42 124.25 20.20 69.42 -41.50 -32.95 68.05 -41.38 -32.31 coo 47.95 129.15 20.31 47.81 128.95 18.79 75.45 -37.67 -26.46 74.31 -37.81 -25.41 coo 50.40 126.23 20.48 50.46 127.00 20.75 77.02 -34.15 -27.57 77.48 -33.52 -27.66 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 4 4 # 4 A 457 ALA B 203 ALA^? 24.58 O15 C8E B 209 A 458 ALA B 204 ALA^? 24.79 O15 C8E B 209 B 193 ALA A 203 ALA^? 24.35 C17 C8E A 209 B 194 GLY A 202 GLY^? 20.08 C17 C8E A 209 coo 43.27 124.32 20.47 43.79 125.29 21.53 69.42 -41.50 -32.95 68.05 -41.38 -32.31 coo 39.57 123.53 20.89 38.42 124.25 20.20 69.10 -40.47 -36.57 70.05 -40.95 -37.62 coo 47.95 129.15 20.31 47.81 128.95 18.79 64.54 -44.79 -28.25 64.77 -44.19 -29.63 coo 50.40 126.23 20.48 50.46 127.00 20.75 66.56 -47.95 -27.86 66.94 -47.39 -27.39 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 5 4 # 5 A 457 ALA C 8 ALA^? 21.06 C19 C8E C 210 A 458 ALA C 203 ALA^? 24.88 C16 C8E C 210 B 193 ALA C 10 ALA^? 16.38 C16 C8E C 210 B 194 GLY C 18 GLY^? 13.60 C19 C8E C 210 coo 43.27 124.32 20.47 43.79 125.29 21.53 41.60 -45.69 -34.21 41.31 -44.27 -34.65 coo 39.57 123.53 20.89 38.42 124.25 20.20 40.30 -47.76 -39.37 39.98 -46.52 -40.19 coo 47.95 129.15 20.31 47.81 128.95 18.79 35.38 -46.95 -31.32 34.79 -45.75 -31.96 coo 50.40 126.23 20.48 50.46 127.00 20.75 37.51 -45.80 -28.16 37.81 -45.75 -27.39 1pix_c02 source 1pix GLUTACONYL-COA DECARBOXYLASE A SUBUNIT : 5 hits 1pix_c02 naa= 4 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 1 4 # 1 A 193 ALA A 10 ALA^? 16.05 O18 C8E A 209 A 194 GLY A 18 GLY^? 13.28 O18 C8E A 209 B 457 ALA A 8 ALA^? 20.71 O18 C8E A 209 B 458 ALA A 203 ALA^? 24.35 C17 C8E A 209 coo 61.89 87.20 13.50 62.59 88.00 12.38 67.31 -53.72 -29.40 67.90 -53.34 -30.78 coo 59.34 89.99 13.88 59.24 89.18 13.73 64.23 -56.43 -29.63 63.79 -57.08 -29.36 coo 65.50 91.13 17.77 64.65 89.88 18.00 61.58 -49.53 -29.33 61.65 -49.30 -30.88 coo 68.56 91.15 20.03 69.95 90.68 19.64 64.54 -44.79 -28.25 64.77 -44.19 -29.63 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 2 4 # 2 A 193 ALA A 203 ALA^? 24.35 C17 C8E A 209 A 194 GLY A 202 GLY^? 20.08 C17 C8E A 209 B 457 ALA B 203 ALA^? 24.58 O15 C8E B 209 B 458 ALA B 204 ALA^? 24.79 O15 C8E B 209 coo 61.89 87.20 13.50 62.59 88.00 12.38 64.54 -44.79 -28.25 64.77 -44.19 -29.63 coo 59.34 89.99 13.88 59.24 89.18 13.73 66.56 -47.95 -27.86 66.94 -47.39 -27.39 coo 65.50 91.13 17.77 64.65 89.88 18.00 69.42 -41.50 -32.95 68.05 -41.38 -32.31 coo 68.56 91.15 20.03 69.95 90.68 19.64 69.10 -40.47 -36.57 70.05 -40.95 -37.62 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 3 4 # 3 A 193 ALA B 10 ALA^? 16.31 C16 C8E B 209 A 194 GLY B 18 GLY^? 13.41 C16 C8E B 209 B 457 ALA B 8 ALA^? 20.90 C16 C8E B 209 B 458 ALA B 203 ALA^? 24.58 O15 C8E B 209 coo 61.89 87.20 13.50 62.59 88.00 12.38 75.45 -37.67 -26.46 74.31 -37.81 -25.41 coo 59.34 89.99 13.88 59.24 89.18 13.73 77.02 -34.15 -27.57 77.48 -33.52 -27.66 coo 65.50 91.13 17.77 64.65 89.88 18.00 71.81 -36.32 -32.47 70.60 -35.68 -31.80 coo 68.56 91.15 20.03 69.95 90.68 19.64 69.42 -41.50 -32.95 68.05 -41.38 -32.31 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 4 4 # 4 A 193 ALA B 203 ALA^? 24.58 O15 C8E B 209 A 194 GLY B 202 GLY^? 20.20 O15 C8E B 209 B 457 ALA A 203 ALA^? 24.35 C17 C8E A 209 B 458 ALA A 204 ALA^? 24.86 C17 C8E A 209 coo 61.89 87.20 13.50 62.59 88.00 12.38 69.42 -41.50 -32.95 68.05 -41.38 -32.31 coo 59.34 89.99 13.88 59.24 89.18 13.73 72.27 -41.27 -30.46 72.24 -42.05 -30.66 coo 65.50 91.13 17.77 64.65 89.88 18.00 64.54 -44.79 -28.25 64.77 -44.19 -29.63 coo 68.56 91.15 20.03 69.95 90.68 19.64 61.22 -43.46 -27.01 60.98 -43.47 -25.53 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 5 4 # 5 A 193 ALA C 10 ALA^? 16.38 C16 C8E C 210 A 194 GLY C 18 GLY^? 13.60 C19 C8E C 210 B 457 ALA C 8 ALA^? 21.06 C19 C8E C 210 B 458 ALA C 203 ALA^? 24.88 C16 C8E C 210 coo 61.89 87.20 13.50 62.59 88.00 12.38 35.38 -46.95 -31.32 34.79 -45.75 -31.96 coo 59.34 89.99 13.88 59.24 89.18 13.73 37.51 -45.80 -28.16 37.81 -45.75 -27.39 coo 65.50 91.13 17.77 64.65 89.88 18.00 41.60 -45.69 -34.21 41.31 -44.27 -34.65 coo 68.56 91.15 20.03 69.95 90.68 19.64 40.30 -47.76 -39.37 39.98 -46.52 -40.19 1pix_c03 source 1pix GLUTACONYL-COA DECARBOXYLASE A SUBUNIT : 5 hits 1pix_c03 naa= 4 ULMN 4 1q3q_c01 THERMOSOME ALPHA SUBUNIT user 1 4 # 1 B 64 ASP B 49 ASP.? -3.05 CA CA B 208s B 97 THR B 58 THR~? 10.41 CA CA B 208 B 98 THR B 57 THR.? 15.82 CA CA B 208 B 393 ASP B 48 ASP.? 7.20 CA CA B 208 coo 65.73 -24.45 27.34 64.91 -22.86 28.45 94.52 -28.97 -11.62 93.03 -30.41 -11.73 coo 59.15 -19.67 26.64 60.83 -20.49 27.71 100.65 -27.90 -8.43 100.12 -29.92 -7.97 coo 59.06 -20.82 23.02 59.87 -22.53 21.97 103.33 -27.21 -5.87 103.96 -25.48 -4.75 coo 60.77 -26.95 32.48 62.05 -25.69 31.35 97.60 -30.12 -16.68 98.20 -32.01 -15.99 1q3q_c01 source 1q3q THERMOSOME ALPHA SUBUNIT : 1 hits 1q3q_c01 naa= 4 ULMN 4 1q3q_c03 THERMOSOME ALPHA SUBUNIT user 1 4 # 1 D 64 ASP B 49 ASP.? -3.05 CA CA B 208s D 97 THR B 58 THR~? 10.41 CA CA B 208 D 98 THR B 57 THR.? 15.82 CA CA B 208 D 393 ASP B 48 ASP.? 7.20 CA CA B 208 coo 59.28 7.65 -17.60 59.05 5.92 -18.77 94.52 -28.97 -11.62 93.03 -30.41 -11.73 coo 55.19 0.63 -16.84 56.48 2.01 -17.90 100.65 -27.90 -8.43 100.12 -29.92 -7.97 coo 54.63 1.67 -13.23 54.72 3.56 -12.17 103.33 -27.21 -5.87 103.96 -25.48 -4.75 coo 53.92 8.02 -22.70 55.50 7.17 -21.57 97.60 -30.12 -16.68 98.20 -32.01 -15.99 1q3q_c03 source 1q3q THERMOSOME ALPHA SUBUNIT : 1 hits 1q3q_c03 naa= 4 ULMN 4 1rne_c03 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 1 4 # 1 32 ASP A 52 ASP.? 15.11 CA CA A 208 33 THR A 57 THR.? 15.79 CA CA A 208 215 ASP A 61 ASP~? 12.37 CA CA A 208 216 THR A 58 THR~? 10.52 CA CA A 208 coo 11.85 17.24 72.81 11.09 15.37 72.36 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo 8.33 16.80 75.95 6.64 18.11 76.07 78.12 -88.42 -27.00 77.65 -90.24 -28.10 coo 5.22 15.03 71.43 7.19 14.88 70.83 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo 6.39 19.66 71.72 6.69 20.58 73.70 76.40 -85.04 -26.81 78.11 -83.80 -26.40 ULMN 4 1rne_c03 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 2 4 # 2 32 ASP A 52 ASP.? 15.11 CA CA A 208 33 THR A 58 THR~? 10.52 CA CA A 208 215 ASP A 61 ASP~? 12.37 CA CA A 208 216 THR A 57 THR.? 15.79 CA CA A 208 coo 11.85 17.24 72.81 11.09 15.37 72.36 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo 8.33 16.80 75.95 6.64 18.11 76.07 76.40 -85.04 -26.81 78.11 -83.80 -26.40 coo 5.22 15.03 71.43 7.19 14.88 70.83 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo 6.39 19.66 71.72 6.69 20.58 73.70 78.12 -88.42 -27.00 77.65 -90.24 -28.10 ULMN 4 1rne_c03 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 3 4 # 3 32 ASP A 61 ASP~? 12.37 CA CA A 208 33 THR A 57 THR.? 15.79 CA CA A 208 215 ASP A 52 ASP.? 15.11 CA CA A 208 216 THR A 58 THR~? 10.52 CA CA A 208 coo 11.85 17.24 72.81 11.09 15.37 72.36 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo 8.33 16.80 75.95 6.64 18.11 76.07 78.12 -88.42 -27.00 77.65 -90.24 -28.10 coo 5.22 15.03 71.43 7.19 14.88 70.83 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo 6.39 19.66 71.72 6.69 20.58 73.70 76.40 -85.04 -26.81 78.11 -83.80 -26.40 ULMN 4 1rne_c03 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 4 4 # 4 32 ASP A 61 ASP~? 12.37 CA CA A 208 33 THR A 58 THR~? 10.52 CA CA A 208 215 ASP A 52 ASP.? 15.11 CA CA A 208 216 THR A 57 THR.? 15.79 CA CA A 208 coo 11.85 17.24 72.81 11.09 15.37 72.36 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo 8.33 16.80 75.95 6.64 18.11 76.07 76.40 -85.04 -26.81 78.11 -83.80 -26.40 coo 5.22 15.03 71.43 7.19 14.88 70.83 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo 6.39 19.66 71.72 6.69 20.58 73.70 78.12 -88.42 -27.00 77.65 -90.24 -28.10 1rne_c03 source 1rne RENIN (ACTIVATED, GLYCOSYLATED, INHIBITED) (E.: 4 hits 1rne_c03 naa= 4 ULMN 4 2amg_c04 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 1 4 # 1 193 ASP A 49 ASP.? -3.00 CA CA A 208s 219 GLU A 70 GLU^? -2.69 CA CA A 208s 221 TRP A 71 TRP^? 11.26 CA CA A 208 294 ASP A 45 ASP.? -2.96 CA CA A 208s coo 27.89 102.52 14.98 29.35 101.92 13.57 75.72 -77.89 -27.98 74.67 -77.10 -29.65 coo 25.84 105.87 9.06 27.86 105.55 8.74 68.79 -75.79 -31.87 70.14 -76.30 -30.27 coo 26.57 103.90 2.48 30.28 105.00 3.20 63.94 -74.90 -35.16 60.97 -73.12 -33.30 coo 33.16 106.80 7.72 33.34 104.87 6.92 70.45 -71.75 -27.39 71.06 -73.65 -26.89 2amg_c04 source 2amg 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLASE : 1 hits 2amg_c04 naa= 4 ULMN 4 2apr_c03 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 1 4 # 1 35 ASP A 52 ASP.? 15.11 CA CA A 208 36 THR A 57 THR.? 15.79 CA CA A 208 218 ASP A 61 ASP~? 12.37 CA CA A 208 219 THR A 58 THR~? 10.52 CA CA A 208 coo 41.14 58.72 105.19 42.39 59.85 103.92 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo 41.22 55.69 101.49 39.49 55.36 100.22 78.12 -88.42 -27.00 77.65 -90.24 -28.10 coo 41.33 60.20 97.63 42.00 60.96 99.49 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo 37.29 59.30 100.22 37.00 57.33 101.12 76.40 -85.04 -26.81 78.11 -83.80 -26.40 ULMN 4 2apr_c03 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 2 4 # 2 35 ASP A 52 ASP.? 15.11 CA CA A 208 36 THR A 58 THR~? 10.52 CA CA A 208 218 ASP A 61 ASP~? 12.37 CA CA A 208 219 THR A 57 THR.? 15.79 CA CA A 208 coo 41.14 58.72 105.19 42.39 59.85 103.92 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo 41.22 55.69 101.49 39.49 55.36 100.22 76.40 -85.04 -26.81 78.11 -83.80 -26.40 coo 41.33 60.20 97.63 42.00 60.96 99.49 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo 37.29 59.30 100.22 37.00 57.33 101.12 78.12 -88.42 -27.00 77.65 -90.24 -28.10 ULMN 4 2apr_c03 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 3 4 # 3 35 ASP A 61 ASP~? 12.37 CA CA A 208 36 THR A 57 THR.? 15.79 CA CA A 208 218 ASP A 52 ASP.? 15.11 CA CA A 208 219 THR A 58 THR~? 10.52 CA CA A 208 coo 41.14 58.72 105.19 42.39 59.85 103.92 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo 41.22 55.69 101.49 39.49 55.36 100.22 78.12 -88.42 -27.00 77.65 -90.24 -28.10 coo 41.33 60.20 97.63 42.00 60.96 99.49 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo 37.29 59.30 100.22 37.00 57.33 101.12 76.40 -85.04 -26.81 78.11 -83.80 -26.40 ULMN 4 2apr_c03 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 4 4 # 4 35 ASP A 61 ASP~? 12.37 CA CA A 208 36 THR A 58 THR~? 10.52 CA CA A 208 218 ASP A 52 ASP.? 15.11 CA CA A 208 219 THR A 57 THR.? 15.79 CA CA A 208 coo 41.14 58.72 105.19 42.39 59.85 103.92 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo 41.22 55.69 101.49 39.49 55.36 100.22 76.40 -85.04 -26.81 78.11 -83.80 -26.40 coo 41.33 60.20 97.63 42.00 60.96 99.49 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo 37.29 59.30 100.22 37.00 57.33 101.12 78.12 -88.42 -27.00 77.65 -90.24 -28.10 ULMN 4 2apr_c03 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 5 4 # 5 35 ASP C 52 ASP.? 15.77 CA CA C 208 36 THR C 57 THR.? 15.66 CA CA C 208 218 ASP C 61 ASP~? 12.61 CA CA C 208 219 THR C 58 THR~? 10.65 CA CA C 208 coo 41.14 58.72 105.19 42.39 59.85 103.92 21.29 -54.58 -0.38 20.26 -54.47 1.43 coo 41.22 55.69 101.49 39.49 55.36 100.22 17.34 -49.58 0.14 17.08 -48.15 1.75 coo 41.33 60.20 97.63 42.00 60.96 99.49 16.71 -46.53 -3.05 15.59 -48.22 -3.69 coo 37.29 59.30 100.22 37.00 57.33 101.12 19.91 -49.60 -2.59 18.80 -50.74 -4.02 ULMN 4 2apr_c03 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 6 4 # 6 35 ASP C 52 ASP.? 15.77 CA CA C 208 36 THR C 58 THR~? 10.65 CA CA C 208 218 ASP C 61 ASP~? 12.61 CA CA C 208 219 THR C 57 THR.? 15.66 CA CA C 208 coo 41.14 58.72 105.19 42.39 59.85 103.92 21.29 -54.58 -0.38 20.26 -54.47 1.43 coo 41.22 55.69 101.49 39.49 55.36 100.22 19.91 -49.60 -2.59 18.80 -50.74 -4.02 coo 41.33 60.20 97.63 42.00 60.96 99.49 16.71 -46.53 -3.05 15.59 -48.22 -3.69 coo 37.29 59.30 100.22 37.00 57.33 101.12 17.34 -49.58 0.14 17.08 -48.15 1.75 ULMN 4 2apr_c03 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 7 4 # 7 35 ASP C 61 ASP~? 12.61 CA CA C 208 36 THR C 57 THR.? 15.66 CA CA C 208 218 ASP C 52 ASP.? 15.77 CA CA C 208 219 THR C 58 THR~? 10.65 CA CA C 208 coo 41.14 58.72 105.19 42.39 59.85 103.92 16.71 -46.53 -3.05 15.59 -48.22 -3.69 coo 41.22 55.69 101.49 39.49 55.36 100.22 17.34 -49.58 0.14 17.08 -48.15 1.75 coo 41.33 60.20 97.63 42.00 60.96 99.49 21.29 -54.58 -0.38 20.26 -54.47 1.43 coo 37.29 59.30 100.22 37.00 57.33 101.12 19.91 -49.60 -2.59 18.80 -50.74 -4.02 ULMN 4 2apr_c03 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 8 4 # 8 35 ASP C 61 ASP~? 12.61 CA CA C 208 36 THR C 58 THR~? 10.65 CA CA C 208 218 ASP C 52 ASP.? 15.77 CA CA C 208 219 THR C 57 THR.? 15.66 CA CA C 208 coo 41.14 58.72 105.19 42.39 59.85 103.92 16.71 -46.53 -3.05 15.59 -48.22 -3.69 coo 41.22 55.69 101.49 39.49 55.36 100.22 19.91 -49.60 -2.59 18.80 -50.74 -4.02 coo 41.33 60.20 97.63 42.00 60.96 99.49 21.29 -54.58 -0.38 20.26 -54.47 1.43 coo 37.29 59.30 100.22 37.00 57.33 101.12 17.34 -49.58 0.14 17.08 -48.15 1.75 2apr_c03 source 2apr ACID PROTEINASE (RHIZOPUSPEPSIN) (E.C.3.4.23.6: 8 hits 2apr_c03 naa= 4 ULMN 4 2jxr_c03 LIGAND CP-081282 user 1 4 # 1 A 32 ASP A 52 ASP.? 15.11 CA CA A 208 A 33 THR A 57 THR.? 15.79 CA CA A 208 A 215 ASP A 61 ASP~? 12.37 CA CA A 208 A 216 THR A 58 THR~? 10.52 CA CA A 208 coo -14.00 61.45 43.99 -14.19 63.14 42.84 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo -9.45 62.69 43.21 -8.10 61.71 41.85 78.12 -88.42 -27.00 77.65 -90.24 -28.10 coo -10.72 64.19 37.77 -12.20 64.43 39.15 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo -10.69 59.56 38.85 -9.70 58.81 40.64 76.40 -85.04 -26.81 78.11 -83.80 -26.40 ULMN 4 2jxr_c03 LIGAND CP-081282 user 2 4 # 2 A 32 ASP A 52 ASP.? 15.11 CA CA A 208 A 33 THR A 58 THR~? 10.52 CA CA A 208 A 215 ASP A 61 ASP~? 12.37 CA CA A 208 A 216 THR A 57 THR.? 15.79 CA CA A 208 coo -14.00 61.45 43.99 -14.19 63.14 42.84 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo -9.45 62.69 43.21 -8.10 61.71 41.85 76.40 -85.04 -26.81 78.11 -83.80 -26.40 coo -10.72 64.19 37.77 -12.20 64.43 39.15 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo -10.69 59.56 38.85 -9.70 58.81 40.64 78.12 -88.42 -27.00 77.65 -90.24 -28.10 ULMN 4 2jxr_c03 LIGAND CP-081282 user 3 4 # 3 A 32 ASP A 61 ASP~? 12.37 CA CA A 208 A 33 THR A 58 THR~? 10.52 CA CA A 208 A 215 ASP A 52 ASP.? 15.11 CA CA A 208 A 216 THR A 57 THR.? 15.79 CA CA A 208 coo -14.00 61.45 43.99 -14.19 63.14 42.84 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo -9.45 62.69 43.21 -8.10 61.71 41.85 76.40 -85.04 -26.81 78.11 -83.80 -26.40 coo -10.72 64.19 37.77 -12.20 64.43 39.15 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo -10.69 59.56 38.85 -9.70 58.81 40.64 78.12 -88.42 -27.00 77.65 -90.24 -28.10 2jxr_c03 source 2jxr LIGAND CP-081282 : 3 hits 2jxr_c03 naa= 4 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 1 3 # 1 A 46 ASP A 80 ASP^? 12.60 C1 C8E A 210 A 100 ARG A 135 ARG^? 21.29 C1 C8E A 210 A 116 GLN A 19 GLN^? 15.77 C17 C8E A 209 coo 32.24 20.09 5.34 30.38 19.04 5.27 58.12 -52.30 -15.93 59.10 -53.68 -17.13 coo 26.40 25.34 6.28 26.15 22.33 7.25 62.45 -46.81 -18.85 61.41 -44.79 -20.90 coo 26.74 21.94 13.78 27.57 20.97 12.08 61.68 -53.90 -25.59 60.40 -53.32 -23.97 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 2 3 # 2 A 46 ASP B 80 ASP^? 15.94 O15 C8E B 209 A 100 ARG B 135 ARG^? 22.88 O15 C8E B 209 A 116 GLN B 19 GLN^? 14.72 O15 C8E B 209 coo 32.24 20.09 5.34 30.38 19.04 5.27 82.56 -37.87 -41.00 82.97 -37.16 -39.06 coo 26.40 25.34 6.28 26.15 22.33 7.25 77.46 -42.45 -38.74 74.50 -42.61 -39.42 coo 26.74 21.94 13.78 27.57 20.97 12.08 77.54 -34.58 -33.49 79.23 -35.13 -34.67 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 3 3 # 3 A 46 ASP C 80 ASP^? 16.43 C13 C8E C 210 A 100 ARG C 135 ARG^? 23.87 C16 C8E C 210 A 116 GLN C 19 GLN^? 15.24 C19 C8E C 210 coo 32.24 20.09 5.34 30.38 19.04 5.27 47.10 -57.14 -28.79 45.64 -55.94 -27.77 coo 26.40 25.34 6.28 26.15 22.33 7.25 44.01 -56.05 -34.91 45.01 -54.65 -37.44 coo 26.74 21.94 13.78 27.57 20.97 12.08 42.90 -48.48 -28.27 43.27 -50.57 -28.10 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 4 3 # 4 A 46 ASP C 149 ASP^? 16.02 C16 C8E C 210 A 100 ARG C 36 ARG^? 17.98 C16 C8E C 210 A 116 GLN C 19 GLN^? 15.24 C19 C8E C 210 coo 32.24 20.09 5.34 30.38 19.04 5.27 38.72 -55.19 -32.44 40.02 -55.93 -30.97 coo 26.40 25.34 6.28 26.15 22.33 7.25 45.58 -52.92 -31.76 43.11 -54.70 -31.56 coo 26.74 21.94 13.78 27.57 20.97 12.08 42.90 -48.48 -28.27 43.27 -50.57 -28.10 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 5 3 # 5 A 46 ASP C 149 ASP^? 16.02 C16 C8E C 210 A 100 ARG C 135 ARG^? 23.87 C16 C8E C 210 A 116 GLN C 19 GLN^? 15.24 C19 C8E C 210 coo 32.24 20.09 5.34 30.38 19.04 5.27 38.72 -55.19 -32.44 40.02 -55.93 -30.97 coo 26.40 25.34 6.28 26.15 22.33 7.25 44.01 -56.05 -34.91 45.01 -54.65 -37.44 coo 26.74 21.94 13.78 27.57 20.97 12.08 42.90 -48.48 -28.27 43.27 -50.57 -28.10 12as_c00 source 12as ASPARAGINE SYNTHETASE : 5 hits 12as_c00 naa= 3 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 1 3 # 1 B 46 ASP A 80 ASP^? 12.60 C1 C8E A 210 B 100 ARG A 135 ARG^? 21.29 C1 C8E A 210 B 116 GLN A 19 GLN^? 15.77 C17 C8E A 209 coo 32.18 48.37 12.48 33.96 49.46 12.97 58.12 -52.30 -15.93 59.10 -53.68 -17.13 coo 39.04 43.25 11.37 38.30 45.35 13.56 62.45 -46.81 -18.85 61.41 -44.79 -20.90 coo 37.43 42.63 19.41 36.76 44.08 17.97 61.68 -53.90 -25.59 60.40 -53.32 -23.97 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 2 3 # 2 B 46 ASP B 80 ASP^? 15.94 O15 C8E B 209 B 100 ARG B 135 ARG^? 22.88 O15 C8E B 209 B 116 GLN B 19 GLN^? 14.72 O15 C8E B 209 coo 32.18 48.37 12.48 33.96 49.46 12.97 82.56 -37.87 -41.00 82.97 -37.16 -39.06 coo 39.04 43.25 11.37 38.30 45.35 13.56 77.46 -42.45 -38.74 74.50 -42.61 -39.42 coo 37.43 42.63 19.41 36.76 44.08 17.97 77.54 -34.58 -33.49 79.23 -35.13 -34.67 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 3 3 # 3 B 46 ASP C 80 ASP^? 16.43 C13 C8E C 210 B 100 ARG C 135 ARG^? 23.87 C16 C8E C 210 B 116 GLN C 19 GLN^? 15.24 C19 C8E C 210 coo 32.18 48.37 12.48 33.96 49.46 12.97 47.10 -57.14 -28.79 45.64 -55.94 -27.77 coo 39.04 43.25 11.37 38.30 45.35 13.56 44.01 -56.05 -34.91 45.01 -54.65 -37.44 coo 37.43 42.63 19.41 36.76 44.08 17.97 42.90 -48.48 -28.27 43.27 -50.57 -28.10 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 4 3 # 4 B 46 ASP C 149 ASP^? 16.02 C16 C8E C 210 B 100 ARG C 36 ARG^? 17.98 C16 C8E C 210 B 116 GLN C 19 GLN^? 15.24 C19 C8E C 210 coo 32.18 48.37 12.48 33.96 49.46 12.97 38.72 -55.19 -32.44 40.02 -55.93 -30.97 coo 39.04 43.25 11.37 38.30 45.35 13.56 45.58 -52.92 -31.76 43.11 -54.70 -31.56 coo 37.43 42.63 19.41 36.76 44.08 17.97 42.90 -48.48 -28.27 43.27 -50.57 -28.10 12as_c01 source 12as ASPARAGINE SYNTHETASE : 4 hits 12as_c01 naa= 3 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 1 3 # 1 A 140 TYR A 97 TYR^? 11.99 C1 C8E A 210 B 190 LYS A 198 LYS^? 12.09 C1 C8E A 210 B 222 ASP A 153 ASP^? 8.28 C1 C8E A 210 coo 7.17 16.59 41.26 8.01 19.20 40.73 61.97 -51.46 -14.47 63.57 -52.89 -16.21 coo 13.38 20.00 35.06 11.43 22.49 39.53 68.28 -58.05 -20.21 63.11 -55.44 -18.88 coo 9.76 26.58 38.10 11.63 25.78 38.76 63.37 -61.81 -16.17 62.75 -59.91 -16.84 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 2 3 # 2 A 140 TYR A 109 TYR^? 10.85 CA CA A 208 B 190 LYS A 63 LYS~? 3.96 CA CA A 208 B 222 ASP A 49 ASP.? -3.00 CA CA A 208s coo 7.17 16.59 41.26 8.01 19.20 40.73 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo 13.38 20.00 35.06 11.43 22.49 39.53 73.63 -82.49 -34.44 73.43 -77.00 -32.37 coo 9.76 26.58 38.10 11.63 25.78 38.76 75.72 -77.89 -27.98 74.67 -77.10 -29.65 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 3 3 # 3 A 140 TYR B 97 TYR^? 16.46 O15 C8E B 209 B 190 LYS B 198 LYS^? 12.15 O15 C8E B 209 B 222 ASP B 153 ASP^? 9.57 O15 C8E B 209 coo 7.17 16.59 41.26 8.01 19.20 40.73 83.74 -41.85 -39.80 83.62 -41.42 -37.05 coo 13.38 20.00 35.06 11.43 22.49 39.53 85.01 -40.11 -29.09 83.85 -38.63 -34.53 coo 9.76 26.58 38.10 11.63 25.78 38.76 89.74 -36.17 -33.46 87.76 -36.55 -34.22 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 4 3 # 4 A 140 TYR C 97 TYR^? 17.03 C13 C8E C 210 B 190 LYS C 198 LYS^? 12.94 C13 C8E C 210 B 222 ASP C 153 ASP^? 9.83 C13 C8E C 210 coo 7.17 16.59 41.26 8.01 19.20 40.73 44.42 -59.94 -30.24 42.23 -58.45 -29.40 coo 13.38 20.00 35.06 11.43 22.49 39.53 35.43 -55.44 -26.10 41.10 -55.85 -26.89 coo 9.76 26.58 38.10 11.63 25.78 38.76 40.09 -57.62 -20.90 41.26 -57.13 -22.61 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 5 3 # 5 A 140 TYR C 109 TYR^? 10.73 CA CA C 208 B 190 LYS C 63 LYS~? 4.21 CA CA C 208 B 222 ASP C 49 ASP.? -2.87 CA CA C 208s coo 7.17 16.59 41.26 8.01 19.20 40.73 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo 13.38 20.00 35.06 11.43 22.49 39.53 20.98 -41.61 -5.49 23.04 -43.67 -10.44 coo 9.76 26.58 38.10 11.63 25.78 38.76 22.13 -48.50 -9.42 23.00 -46.66 -10.00 1a05_c00 source 1a05 3-ISOPROPYLMALATE DEHYDROGENASE : 5 hits 1a05_c00 naa= 3 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 1 3 # 1 A 190 LYS A 63 LYS~? 3.96 CA CA A 208 A 222 ASP A 49 ASP.? -3.00 CA CA A 208s B 140 TYR A 109 TYR^? 10.85 CA CA A 208 coo -4.61 20.12 30.34 -2.74 22.65 25.95 73.63 -82.49 -34.44 73.43 -77.00 -32.37 coo -1.04 26.60 27.37 -2.94 25.93 26.69 75.72 -77.89 -27.98 74.67 -77.10 -29.65 coo 1.51 16.60 24.17 0.82 19.23 24.79 66.11 -81.19 -34.21 65.29 -83.76 -33.55 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 2 3 # 2 A 190 LYS A 198 LYS^? 12.09 C1 C8E A 210 A 222 ASP A 153 ASP^? 8.28 C1 C8E A 210 B 140 TYR A 97 TYR^? 11.99 C1 C8E A 210 coo -4.61 20.12 30.34 -2.74 22.65 25.95 68.28 -58.05 -20.21 63.11 -55.44 -18.88 coo -1.04 26.60 27.37 -2.94 25.93 26.69 63.37 -61.81 -16.17 62.75 -59.91 -16.84 coo 1.51 16.60 24.17 0.82 19.23 24.79 61.97 -51.46 -14.47 63.57 -52.89 -16.21 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 3 3 # 3 A 190 LYS B 198 LYS^? 12.15 O15 C8E B 209 A 222 ASP B 153 ASP^? 9.57 O15 C8E B 209 B 140 TYR B 97 TYR^? 16.46 O15 C8E B 209 coo -4.61 20.12 30.34 -2.74 22.65 25.95 85.01 -40.11 -29.09 83.85 -38.63 -34.53 coo -1.04 26.60 27.37 -2.94 25.93 26.69 89.74 -36.17 -33.46 87.76 -36.55 -34.22 coo 1.51 16.60 24.17 0.82 19.23 24.79 83.74 -41.85 -39.80 83.62 -41.42 -37.05 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 4 3 # 4 A 190 LYS C 63 LYS~? 4.21 CA CA C 208 A 222 ASP C 49 ASP.? -2.87 CA CA C 208s B 140 TYR C 109 TYR^? 10.73 CA CA C 208 coo -4.61 20.12 30.34 -2.74 22.65 25.95 20.98 -41.61 -5.49 23.04 -43.67 -10.44 coo -1.04 26.60 27.37 -2.94 25.93 26.69 22.13 -48.50 -9.42 23.00 -46.66 -10.00 coo 1.51 16.60 24.17 0.82 19.23 24.79 28.40 -39.89 -5.18 28.52 -40.13 -2.40 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 5 3 # 5 A 190 LYS C 198 LYS^? 12.94 C13 C8E C 210 A 222 ASP C 153 ASP^? 9.83 C13 C8E C 210 B 140 TYR C 97 TYR^? 17.03 C13 C8E C 210 coo -4.61 20.12 30.34 -2.74 22.65 25.95 35.43 -55.44 -26.10 41.10 -55.85 -26.89 coo -1.04 26.60 27.37 -2.94 25.93 26.69 40.09 -57.62 -20.90 41.26 -57.13 -22.61 coo 1.51 16.60 24.17 0.82 19.23 24.79 44.42 -59.94 -30.24 42.23 -58.45 -29.40 1a05_c01 source 1a05 3-ISOPROPYLMALATE DEHYDROGENASE : 5 hits 1a05_c01 naa= 3 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 1 3 # 1 A 49 GLU A 70 GLU^? -2.69 CA CA A 208s A 60 ASP A 61 ASP~? 12.37 CA CA A 208 A 175 TYR A 109 TYR^? 10.85 CA CA A 208 coo 46.10 28.27 19.27 45.48 26.99 20.84 68.79 -75.79 -31.87 70.14 -76.30 -30.27 coo 56.42 28.06 12.93 55.01 27.92 14.50 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo 45.02 22.04 15.38 46.16 24.00 13.76 66.11 -81.19 -34.21 65.29 -83.76 -33.55 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 2 3 # 2 A 49 GLU A 93 GLU^? 23.51 C1 C8E A 210 A 60 ASP A 149 ASP^? 14.85 C1 C8E A 210 A 175 TYR A 138 TYR^? 19.17 C16 C8E B 209 coo 46.10 28.27 19.27 45.48 26.99 20.84 64.33 -40.66 -16.04 62.38 -40.13 -16.70 coo 56.42 28.06 12.93 55.01 27.92 14.50 66.40 -51.17 -20.74 65.06 -51.90 -19.38 coo 45.02 22.04 15.38 46.16 24.00 13.76 70.50 -38.06 -22.60 71.93 -35.69 -22.96 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 3 3 # 3 A 49 GLU A 194 GLU.? 3.11 C17 C8E A 210s A 60 ASP A 45 ASP.? -2.96 CA CA A 208s A 175 TYR A 155 TYR^? 8.43 C17 C8E A 209 coo 46.10 28.27 19.27 45.48 26.99 20.84 66.12 -70.72 -14.05 67.03 -72.48 -13.31 coo 56.42 28.06 12.93 55.01 27.92 14.50 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo 45.02 22.04 15.38 46.16 24.00 13.76 60.87 -66.67 -17.05 60.42 -64.37 -18.53 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 4 3 # 4 A 49 GLU B 70 GLU^? -2.58 CA CA B 208s A 60 ASP B 61 ASP~? 12.48 CA CA B 208 A 175 TYR B 109 TYR^? 10.54 CA CA B 208 coo 46.10 28.27 19.27 45.48 26.99 20.84 89.83 -24.96 -14.47 91.03 -26.69 -14.39 coo 56.42 28.06 12.93 55.01 27.92 14.50 98.68 -27.22 -4.60 99.30 -29.23 -4.23 coo 45.02 22.04 15.38 46.16 24.00 13.76 91.74 -19.55 -12.92 94.01 -17.92 -12.82 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 5 3 # 5 A 49 GLU B 93 GLU^? 27.23 O15 C8E B 209 A 60 ASP B 149 ASP^? 14.91 O15 C8E B 209 A 175 TYR B 138 TYR^? 18.52 O18 C8E A 209 coo 46.10 28.27 19.27 45.48 26.99 20.84 75.25 -49.35 -42.08 74.13 -47.63 -42.56 coo 56.42 28.06 12.93 55.01 27.92 14.50 79.48 -42.39 -33.32 81.04 -41.48 -34.38 coo 45.02 22.04 15.38 46.16 24.00 13.76 69.87 -51.92 -34.99 68.26 -54.21 -34.65 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 6 3 # 6 A 49 GLU B 194 GLU.? 2.86 C13 C8E B 210s A 60 ASP B 45 ASP.? -3.07 CA CA B 208s A 175 TYR B 155 TYR^? 7.60 C13 C8E B 209 coo 46.10 28.27 19.27 45.48 26.99 20.84 97.88 -33.97 -28.78 99.62 -34.16 -27.58 coo 56.42 28.06 12.93 55.01 27.92 14.50 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo 45.02 22.04 15.38 46.16 24.00 13.76 92.02 -31.30 -32.58 89.26 -31.61 -33.00 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 7 3 # 7 A 49 GLU C 70 GLU^? -2.71 CA CA C 208s A 60 ASP C 61 ASP~? 12.61 CA CA C 208 A 175 TYR C 109 TYR^? 10.73 CA CA C 208 coo 46.10 28.27 19.27 45.48 26.99 20.84 27.73 -42.94 -10.42 26.74 -44.79 -10.37 coo 56.42 28.06 12.93 55.01 27.92 14.50 16.71 -46.53 -3.05 15.59 -48.22 -3.69 coo 45.02 22.04 15.38 46.16 24.00 13.76 28.40 -39.89 -5.18 28.52 -40.13 -2.40 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 8 3 # 8 A 49 GLU C 194 GLU.? 3.24 O15 C8E C 209s A 60 ASP C 45 ASP.? 3.27 CA CA C 208s A 175 TYR C 155 TYR^? 7.32 C13 C8E C 210 coo 46.10 28.27 19.27 45.48 26.99 20.84 36.17 -59.59 -12.28 34.91 -60.51 -10.83 coo 56.42 28.06 12.93 55.01 27.92 14.50 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo 45.02 22.04 15.38 46.16 24.00 13.76 41.26 -55.52 -15.76 41.81 -54.24 -18.13 1a50_c03 source 1a50 TRYPTOPHAN SYNTHASE : 8 hits 1a50_c03 naa= 3 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 1 3 # 1 142 TRP A 59 TRP~? 6.21 CA CA A 208 223 ASP A 45 ASP.? -2.96 CA CA A 208s 258 LYS A 188 LYS~? 10.77 C20 C8E A 210 coo 127.19 33.46 26.14 126.78 36.79 28.15 71.67 -80.29 -29.02 69.69 -82.14 -31.86 coo 126.95 41.66 23.38 128.48 40.72 24.51 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo 138.83 37.95 25.17 133.50 36.37 26.52 68.32 -80.18 -18.11 71.95 -84.24 -15.84 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 2 3 # 2 142 TRP A 59 TRP~? 6.21 CA CA A 208 223 ASP A 52 ASP.? 15.11 CA CA A 208 258 LYS A 188 LYS~? 10.77 C20 C8E A 210 coo 127.19 33.46 26.14 126.78 36.79 28.15 71.67 -80.29 -29.02 69.69 -82.14 -31.86 coo 126.95 41.66 23.38 128.48 40.72 24.51 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo 138.83 37.95 25.17 133.50 36.37 26.52 68.32 -80.18 -18.11 71.95 -84.24 -15.84 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 3 3 # 3 142 TRP A 59 TRP~? 6.21 CA CA A 208 223 ASP A 61 ASP~? 12.37 CA CA A 208 258 LYS A 67 LYS~? 13.30 CA CA A 208 coo 127.19 33.46 26.14 126.78 36.79 28.15 71.67 -80.29 -29.02 69.69 -82.14 -31.86 coo 126.95 41.66 23.38 128.48 40.72 24.51 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo 138.83 37.95 25.17 133.50 36.37 26.52 73.21 -82.07 -40.14 71.59 -78.49 -41.85 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 4 3 # 4 142 TRP A 71 TRP^? 11.26 CA CA A 208 223 ASP A 45 ASP.? -2.96 CA CA A 208s 258 LYS A 63 LYS~? 3.96 CA CA A 208 coo 127.19 33.46 26.14 126.78 36.79 28.15 63.94 -74.90 -35.16 60.97 -73.12 -33.30 coo 126.95 41.66 23.38 128.48 40.72 24.51 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo 138.83 37.95 25.17 133.50 36.37 26.52 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 5 3 # 5 142 TRP B 59 TRP~? 6.11 CA CA B 208 223 ASP B 45 ASP.? -3.07 CA CA B 208s 258 LYS B 188 LYS~? 9.67 C16 C8E B 210 coo 127.19 33.46 26.14 126.78 36.79 28.15 95.08 -26.15 -12.40 94.38 -22.43 -11.38 coo 126.95 41.66 23.38 128.48 40.72 24.51 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo 138.83 37.95 25.17 133.50 36.37 26.52 102.16 -28.74 -21.10 106.15 -31.37 -17.86 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 6 3 # 6 142 TRP B 59 TRP~? 6.11 CA CA B 208 223 ASP B 61 ASP~? 12.48 CA CA B 208 258 LYS B 67 LYS~? 18.13 CA CA B 208 coo 127.19 33.46 26.14 126.78 36.79 28.15 95.08 -26.15 -12.40 94.38 -22.43 -11.38 coo 126.95 41.66 23.38 128.48 40.72 24.51 98.68 -27.22 -4.60 99.30 -29.23 -4.23 coo 138.83 37.95 25.17 133.50 36.37 26.52 89.12 -21.41 -4.23 87.66 -21.56 1.71 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 7 3 # 7 142 TRP C 59 TRP~? 6.20 CA CA C 208 223 ASP C 45 ASP.? 3.27 CA CA C 208s 258 LYS C 188 LYS~? 9.02 C16 C8E C 209 coo 127.19 33.46 26.14 126.78 36.79 28.15 24.77 -46.37 -6.57 25.55 -42.98 -4.73 coo 126.95 41.66 23.38 128.48 40.72 24.51 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo 138.83 37.95 25.17 133.50 36.37 26.52 31.07 -55.82 -4.30 26.58 -58.21 -2.57 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 8 3 # 8 142 TRP C 59 TRP~? 6.20 CA CA C 208 223 ASP C 61 ASP~? 12.61 CA CA C 208 258 LYS C 67 LYS.? 18.71 CA CA C 208 coo 127.19 33.46 26.14 126.78 36.79 28.15 24.77 -46.37 -6.57 25.55 -42.98 -4.73 coo 126.95 41.66 23.38 128.48 40.72 24.51 16.71 -46.53 -3.05 15.59 -48.22 -3.69 coo 138.83 37.95 25.17 133.50 36.37 26.52 20.04 -36.06 -6.98 16.11 -31.17 -7.78 1aam_c01 source 1aam ASPARTATE AMINOTRANSFERASE : 8 hits 1aam_c01 naa= 3 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 1 3 # 1 33 ASP A 49 ASP.? -3.00 CA CA A 208s 187 GLU A 64 GLU~? 12.36 CA CA A 208 229 LYS A 67 LYS~? 13.30 CA CA A 208 coo -52.57 56.60 47.75 -51.52 54.87 46.95 75.72 -77.89 -27.98 74.67 -77.10 -29.65 coo -45.08 48.37 46.81 -46.53 49.74 45.96 79.25 -82.11 -37.14 78.75 -80.37 -38.23 coo -47.40 44.36 48.48 -50.80 49.18 46.20 73.21 -82.07 -40.14 71.59 -78.49 -41.85 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 2 3 # 2 33 ASP A 80 ASP^? 12.60 C1 C8E A 210 187 GLU A 93 GLU^? 23.51 C1 C8E A 210 229 LYS A 84 LYS.? 23.11 C2 C8E C 209 coo -52.57 56.60 47.75 -51.52 54.87 46.95 58.12 -52.30 -15.93 59.10 -53.68 -17.13 coo -45.08 48.37 46.81 -46.53 49.74 45.96 64.33 -40.66 -16.04 62.38 -40.13 -16.70 coo -47.40 44.36 48.48 -50.80 49.18 46.20 61.58 -41.74 -11.00 58.66 -39.80 -16.04 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 3 3 # 3 33 ASP A 111 ASP.? 17.05 CA CA A 208 187 GLU A 165 GLU^? 21.76 CA CA A 208 229 LYS A 171 LYS^? 22.02 O21 C8E A 209 coo -52.57 56.60 47.75 -51.52 54.87 46.95 65.36 -83.80 -40.24 66.17 -85.36 -41.35 coo -45.08 48.37 46.81 -46.53 49.74 45.96 55.17 -82.77 -39.51 54.39 -80.85 -40.05 coo -47.40 44.36 48.48 -50.80 49.18 46.20 51.77 -85.30 -36.11 51.41 -79.16 -37.75 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 4 3 # 4 33 ASP A 114 ASP.? 22.11 CA CA A 208 187 GLU A 64 GLU~? 12.36 CA CA A 208 229 LYS A 63 LYS~? 3.96 CA CA A 208 coo -52.57 56.60 47.75 -51.52 54.87 46.95 71.50 -87.46 -45.26 70.62 -89.18 -46.15 coo -45.08 48.37 46.81 -46.53 49.74 45.96 79.25 -82.11 -37.14 78.75 -80.37 -38.23 coo -47.40 44.36 48.48 -50.80 49.18 46.20 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 5 3 # 5 33 ASP A 149 ASP^? 14.85 C1 C8E A 210 187 GLU A 93 GLU^? 23.51 C1 C8E A 210 229 LYS A 84 LYS.? 23.11 C2 C8E C 209 coo -52.57 56.60 47.75 -51.52 54.87 46.95 66.40 -51.17 -20.74 65.06 -51.90 -19.38 coo -45.08 48.37 46.81 -46.53 49.74 45.96 64.33 -40.66 -16.04 62.38 -40.13 -16.70 coo -47.40 44.36 48.48 -50.80 49.18 46.20 61.58 -41.74 -11.00 58.66 -39.80 -16.04 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 6 3 # 6 33 ASP B 111 ASP.? 16.97 CA CA B 208 187 GLU B 164 GLU^? 19.99 CA CA B 208 229 LYS B 171 LYS^? 22.17 C20 C8E B 209 coo -52.57 56.60 47.75 -51.52 54.87 46.95 89.21 -14.92 -8.80 89.40 -13.99 -6.98 coo -45.08 48.37 46.81 -46.53 49.74 45.96 94.70 -10.70 -16.52 96.59 -9.81 -16.07 coo -47.40 44.36 48.48 -50.80 49.18 46.20 90.66 -6.85 -20.43 84.87 -8.89 -21.63 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 7 3 # 7 33 ASP B 111 ASP.? 16.97 CA CA B 208 187 GLU B 165 GLU^? 20.64 CA CA B 208 229 LYS B 171 LYS^? 22.17 C20 C8E B 209 coo -52.57 56.60 47.75 -51.52 54.87 46.95 89.21 -14.92 -8.80 89.40 -13.99 -6.98 coo -45.08 48.37 46.81 -46.53 49.74 45.96 88.15 -8.84 -16.79 86.14 -9.46 -16.74 coo -47.40 44.36 48.48 -50.80 49.18 46.20 90.66 -6.85 -20.43 84.87 -8.89 -21.63 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 8 3 # 8 33 ASP B 149 ASP^? 14.91 O15 C8E B 209 187 GLU B 93 GLU^? 27.23 O15 C8E B 209 229 LYS B 84 LYS.? 25.86 O15 C8E B 209 coo -52.57 56.60 47.75 -51.52 54.87 46.95 79.48 -42.39 -33.32 81.04 -41.48 -34.38 coo -45.08 48.37 46.81 -46.53 49.74 45.96 75.25 -49.35 -42.08 74.13 -47.63 -42.56 coo -47.40 44.36 48.48 -50.80 49.18 46.20 79.44 -47.69 -46.65 75.97 -44.45 -44.18 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 9 3 # 9 33 ASP C 80 ASP^? 16.43 C13 C8E C 210 187 GLU C 93 GLU^? 26.90 C13 C8E C 210 229 LYS C 84 LYS.? 25.24 O21 C8E A 209 coo -52.57 56.60 47.75 -51.52 54.87 46.95 47.10 -57.14 -28.79 45.64 -55.94 -27.77 coo -45.08 48.37 46.81 -46.53 49.74 45.96 45.29 -60.19 -41.07 45.99 -58.52 -39.91 coo -47.40 44.36 48.48 -50.80 49.18 46.20 49.01 -63.83 -38.44 48.10 -58.01 -38.38 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 10 3 # 10 33 ASP C 111 ASP.? 17.21 CA CA C 208 187 GLU C 164 GLU^? 20.06 CA CA C 208 229 LYS C 171 LYS^? 21.29 O21 C8E C 210 coo -52.57 56.60 47.75 -51.52 54.87 46.95 27.11 -33.17 -3.90 25.73 -31.94 -3.00 coo -45.08 48.37 46.81 -46.53 49.74 45.96 34.72 -37.11 1.76 34.46 -37.46 3.82 coo -47.40 44.36 48.48 -50.80 49.18 46.20 40.39 -33.45 0.65 41.79 -31.81 -5.33 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 11 3 # 11 33 ASP C 111 ASP.? 17.21 CA CA C 208 187 GLU C 165 GLU^? 20.98 CA CA C 208 229 LYS C 171 LYS^? 21.29 O21 C8E C 210 coo -52.57 56.60 47.75 -51.52 54.87 46.95 27.11 -33.17 -3.90 25.73 -31.94 -3.00 coo -45.08 48.37 46.81 -46.53 49.74 45.96 36.32 -31.59 -2.15 36.97 -31.00 -4.08 coo -47.40 44.36 48.48 -50.80 49.18 46.20 40.39 -33.45 0.65 41.79 -31.81 -5.33 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 12 3 # 12 33 ASP C 149 ASP^? 16.02 C16 C8E C 210 187 GLU C 93 GLU^? 26.90 C13 C8E C 210 229 LYS C 84 LYS.? 25.24 O21 C8E A 209 coo -52.57 56.60 47.75 -51.52 54.87 46.95 38.72 -55.19 -32.44 40.02 -55.93 -30.97 coo -45.08 48.37 46.81 -46.53 49.74 45.96 45.29 -60.19 -41.07 45.99 -58.52 -39.91 coo -47.40 44.36 48.48 -50.80 49.18 46.20 49.01 -63.83 -38.44 48.10 -58.01 -38.38 1ald_c00 source 1ald ALDOLASE A (E.C.4.1.2.13) : 12 hits 1ald_c00 naa= 3 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 61 ASP~? 12.37 CA CA A 208 214 ASP A 153 ASP^? 8.28 C1 C8E A 210 289 ASP A 49 ASP.? -3.00 CA CA A 208s coo -0.62 65.95 29.97 0.31 67.47 31.05 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo 26.86 59.76 46.36 25.42 58.23 45.92 63.37 -61.81 -16.17 62.75 -59.91 -16.84 coo 9.42 68.07 30.27 7.35 68.27 30.10 75.72 -77.89 -27.98 74.67 -77.10 -29.65 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP A 80 ASP^? 12.60 C1 C8E A 210 214 ASP A 49 ASP.? -3.00 CA CA A 208s 289 ASP A 153 ASP^? 8.28 C1 C8E A 210 coo -0.62 65.95 29.97 0.31 67.47 31.05 58.12 -52.30 -15.93 59.10 -53.68 -17.13 coo 26.86 59.76 46.36 25.42 58.23 45.92 75.72 -77.89 -27.98 74.67 -77.10 -29.65 coo 9.42 68.07 30.27 7.35 68.27 30.10 63.37 -61.81 -16.17 62.75 -59.91 -16.84 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 3 # 3 179 ASP A 80 ASP^? 12.60 C1 C8E A 210 214 ASP A 180 ASP.? 14.47 O15 C8E A 210 289 ASP A 153 ASP^? 8.28 C1 C8E A 210 coo -0.62 65.95 29.97 0.31 67.47 31.05 58.12 -52.30 -15.93 59.10 -53.68 -17.13 coo 26.86 59.76 46.36 25.42 58.23 45.92 55.45 -86.10 -15.44 53.65 -85.04 -15.38 coo 9.42 68.07 30.27 7.35 68.27 30.10 63.37 -61.81 -16.17 62.75 -59.91 -16.84 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 4 3 # 4 179 ASP A 114 ASP.? 22.11 CA CA A 208 214 ASP A 180 ASP.? 14.47 O15 C8E A 210 289 ASP A 111 ASP.? 17.05 CA CA A 208 coo -0.62 65.95 29.97 0.31 67.47 31.05 71.50 -87.46 -45.26 70.62 -89.18 -46.15 coo 26.86 59.76 46.36 25.42 58.23 45.92 55.45 -86.10 -15.44 53.65 -85.04 -15.38 coo 9.42 68.07 30.27 7.35 68.27 30.10 65.36 -83.80 -40.24 66.17 -85.36 -41.35 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 5 3 # 5 179 ASP B 61 ASP~? 12.48 CA CA B 208 214 ASP B 153 ASP^? 9.57 O15 C8E B 209 289 ASP B 49 ASP.? -3.05 CA CA B 208s coo -0.62 65.95 29.97 0.31 67.47 31.05 98.68 -27.22 -4.60 99.30 -29.23 -4.23 coo 26.86 59.76 46.36 25.42 58.23 45.92 89.74 -36.17 -33.46 87.76 -36.55 -34.22 coo 9.42 68.07 30.27 7.35 68.27 30.10 94.52 -28.97 -11.62 93.03 -30.41 -11.73 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 6 3 # 6 179 ASP B 80 ASP^? 15.94 O15 C8E B 209 214 ASP B 49 ASP.? -3.05 CA CA B 208s 289 ASP B 153 ASP^? 9.57 O15 C8E B 209 coo -0.62 65.95 29.97 0.31 67.47 31.05 82.56 -37.87 -41.00 82.97 -37.16 -39.06 coo 26.86 59.76 46.36 25.42 58.23 45.92 94.52 -28.97 -11.62 93.03 -30.41 -11.73 coo 9.42 68.07 30.27 7.35 68.27 30.10 89.74 -36.17 -33.46 87.76 -36.55 -34.22 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 7 3 # 7 179 ASP B 80 ASP^? 15.94 O15 C8E B 209 214 ASP B 180 ASP.? 10.93 C4 C8E B 210 289 ASP B 153 ASP^? 9.57 O15 C8E B 209 coo -0.62 65.95 29.97 0.31 67.47 31.05 82.56 -37.87 -41.00 82.97 -37.16 -39.06 coo 26.86 59.76 46.36 25.42 58.23 45.92 106.50 -18.19 -29.27 105.54 -17.21 -30.85 coo 9.42 68.07 30.27 7.35 68.27 30.10 89.74 -36.17 -33.46 87.76 -36.55 -34.22 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 8 3 # 8 179 ASP B 80 ASP^? 15.94 O15 C8E B 209 214 ASP B 185 ASP~? 11.63 O21 C8E B 210 289 ASP B 153 ASP^? 9.57 O15 C8E B 209 coo -0.62 65.95 29.97 0.31 67.47 31.05 82.56 -37.87 -41.00 82.97 -37.16 -39.06 coo 26.86 59.76 46.36 25.42 58.23 45.92 106.30 -23.80 -20.43 108.26 -24.54 -20.08 coo 9.42 68.07 30.27 7.35 68.27 30.10 89.74 -36.17 -33.46 87.76 -36.55 -34.22 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 9 3 # 9 179 ASP B 114 ASP.? 22.07 CA CA B 208 214 ASP B 180 ASP.? 10.93 C4 C8E B 210 289 ASP B 111 ASP.? 16.97 CA CA B 208 coo -0.62 65.95 29.97 0.31 67.47 31.05 88.69 -13.97 -0.41 89.97 -12.27 -0.12 coo 26.86 59.76 46.36 25.42 58.23 45.92 106.50 -18.19 -29.27 105.54 -17.21 -30.85 coo 9.42 68.07 30.27 7.35 68.27 30.10 89.21 -14.92 -8.80 89.40 -13.99 -6.98 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 10 3 # 10 179 ASP C 49 ASP.? -2.87 CA CA C 208s 214 ASP C 80 ASP^? 16.43 C13 C8E C 210 289 ASP C 45 ASP.? 3.27 CA CA C 208s coo -0.62 65.95 29.97 0.31 67.47 31.05 22.13 -48.50 -9.42 23.00 -46.66 -10.00 coo 26.86 59.76 46.36 25.42 58.23 45.92 47.10 -57.14 -28.79 45.64 -55.94 -27.77 coo 9.42 68.07 30.27 7.35 68.27 30.10 28.98 -48.61 -14.39 27.54 -48.99 -12.93 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 11 3 # 11 179 ASP C 61 ASP~? 12.61 CA CA C 208 214 ASP C 153 ASP^? 9.83 C13 C8E C 210 289 ASP C 49 ASP.? -2.87 CA CA C 208s coo -0.62 65.95 29.97 0.31 67.47 31.05 16.71 -46.53 -3.05 15.59 -48.22 -3.69 coo 26.86 59.76 46.36 25.42 58.23 45.92 40.09 -57.62 -20.90 41.26 -57.13 -22.61 coo 9.42 68.07 30.27 7.35 68.27 30.10 22.13 -48.50 -9.42 23.00 -46.66 -10.00 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 12 3 # 12 179 ASP C 80 ASP^? 16.43 C13 C8E C 210 214 ASP C 49 ASP.? -2.87 CA CA C 208s 289 ASP C 153 ASP^? 9.83 C13 C8E C 210 coo -0.62 65.95 29.97 0.31 67.47 31.05 47.10 -57.14 -28.79 45.64 -55.94 -27.77 coo 26.86 59.76 46.36 25.42 58.23 45.92 22.13 -48.50 -9.42 23.00 -46.66 -10.00 coo 9.42 68.07 30.27 7.35 68.27 30.10 40.09 -57.62 -20.90 41.26 -57.13 -22.61 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 13 3 # 13 179 ASP C 80 ASP^? 16.43 C13 C8E C 210 214 ASP C 180 ASP.? 12.29 C5 C8E C 209 289 ASP C 153 ASP^? 9.83 C13 C8E C 210 coo -0.62 65.95 29.97 0.31 67.47 31.05 47.10 -57.14 -28.79 45.64 -55.94 -27.77 coo 26.86 59.76 46.36 25.42 58.23 45.92 42.24 -54.49 3.97 44.24 -53.90 3.82 coo 9.42 68.07 30.27 7.35 68.27 30.10 40.09 -57.62 -20.90 41.26 -57.13 -22.61 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 14 3 # 14 179 ASP C 80 ASP^? 16.43 C13 C8E C 210 214 ASP C 185 ASP~? 11.81 O21 C8E C 209 289 ASP C 153 ASP^? 9.83 C13 C8E C 210 coo -0.62 65.95 29.97 0.31 67.47 31.05 47.10 -57.14 -28.79 45.64 -55.94 -27.77 coo 26.86 59.76 46.36 25.42 58.23 45.92 31.89 -54.53 1.93 31.11 -55.91 3.29 coo 9.42 68.07 30.27 7.35 68.27 30.10 40.09 -57.62 -20.90 41.26 -57.13 -22.61 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 15 3 # 15 179 ASP C 185 ASP~? 11.81 O21 C8E C 209 214 ASP A 80 ASP^? 12.60 C1 C8E A 210 289 ASP C 180 ASP.? 12.29 C5 C8E C 209 coo -0.62 65.95 29.97 0.31 67.47 31.05 31.89 -54.53 1.93 31.11 -55.91 3.29 coo 26.86 59.76 46.36 25.42 58.23 45.92 58.12 -52.30 -15.93 59.10 -53.68 -17.13 coo 9.42 68.07 30.27 7.35 68.27 30.10 42.24 -54.49 3.97 44.24 -53.90 3.82 1amy_c01 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 15 hits 1amy_c01 naa= 3 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 185 ASP~? 11.73 O21 C8E A 210 204 GLU A 184 GLU~? 7.72 C16 C8E A 210 289 ASP A 180 ASP.? 14.47 O15 C8E A 210 coo -0.62 65.95 29.97 0.31 67.47 31.05 65.81 -86.27 -18.22 66.54 -87.64 -16.78 coo 4.34 62.44 32.05 4.22 64.48 32.53 63.73 -84.37 -12.45 63.45 -82.45 -11.70 coo 9.42 68.07 30.27 7.35 68.27 30.10 55.45 -86.10 -15.44 53.65 -85.04 -15.38 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP B 111 ASP.? 16.97 CA CA B 208 204 GLU B 113 GLU.? 20.51 CA CA B 208 289 ASP B 167 ASP.? 22.72 CA CA B 208 coo -0.62 65.95 29.97 0.31 67.47 31.05 89.21 -14.92 -8.80 89.40 -13.99 -6.98 coo 4.34 62.44 32.05 4.22 64.48 32.53 86.78 -12.34 -3.10 88.60 -11.66 -4.00 coo 9.42 68.07 30.27 7.35 68.27 30.10 88.92 -5.85 -9.56 88.92 -7.42 -8.19 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 3 # 3 179 ASP B 185 ASP~? 11.63 O21 C8E B 210 204 GLU B 184 GLU~? 8.45 C14 C8E B 210 289 ASP B 180 ASP.? 10.93 C4 C8E B 210 coo -0.62 65.95 29.97 0.31 67.47 31.05 106.30 -23.80 -20.43 108.26 -24.54 -20.08 coo 4.34 62.44 32.05 4.22 64.48 32.53 107.80 -26.84 -26.43 109.06 -28.52 -26.54 coo 9.42 68.07 30.27 7.35 68.27 30.10 106.50 -18.19 -29.27 105.54 -17.21 -30.85 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 4 3 # 4 179 ASP C 45 ASP.? 3.27 CA CA C 208s 204 GLU C 70 GLU^? -2.71 CA CA C 208s 289 ASP C 49 ASP.? -2.87 CA CA C 208s coo -0.62 65.95 29.97 0.31 67.47 31.05 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo 4.34 62.44 32.05 4.22 64.48 32.53 27.73 -42.94 -10.42 26.74 -44.79 -10.37 coo 9.42 68.07 30.27 7.35 68.27 30.10 22.13 -48.50 -9.42 23.00 -46.66 -10.00 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 5 3 # 5 179 ASP C 49 ASP.? -2.87 CA CA C 208s 204 GLU C 70 GLU^? -2.71 CA CA C 208s 289 ASP C 45 ASP.? 3.27 CA CA C 208s coo -0.62 65.95 29.97 0.31 67.47 31.05 22.13 -48.50 -9.42 23.00 -46.66 -10.00 coo 4.34 62.44 32.05 4.22 64.48 32.53 27.73 -42.94 -10.42 26.74 -44.79 -10.37 coo 9.42 68.07 30.27 7.35 68.27 30.10 28.98 -48.61 -14.39 27.54 -48.99 -12.93 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 6 3 # 6 179 ASP C 61 ASP~? 12.61 CA CA C 208 204 GLU C 64 GLU~? 12.03 CA CA C 208 289 ASP C 49 ASP.? -2.87 CA CA C 208s coo -0.62 65.95 29.97 0.31 67.47 31.05 16.71 -46.53 -3.05 15.59 -48.22 -3.69 coo 4.34 62.44 32.05 4.22 64.48 32.53 16.47 -41.84 -8.31 14.60 -42.35 -9.15 coo 9.42 68.07 30.27 7.35 68.27 30.10 22.13 -48.50 -9.42 23.00 -46.66 -10.00 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 7 3 # 7 179 ASP C 111 ASP.? 17.21 CA CA C 208 204 GLU C 113 GLU.? 20.72 CA CA C 208 289 ASP C 167 ASP.? 25.18 CA CA C 208 coo -0.62 65.95 29.97 0.31 67.47 31.05 27.11 -33.17 -3.90 25.73 -31.94 -3.00 coo 4.34 62.44 32.05 4.22 64.48 32.53 22.93 -28.02 -2.65 24.78 -28.62 -1.78 coo 9.42 68.07 30.27 7.35 68.27 30.10 31.39 -27.44 2.08 30.34 -25.78 1.31 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 8 3 # 8 179 ASP C 166 ASP.? 24.81 CA CA C 208 204 GLU C 165 GLU^? 20.98 CA CA C 208 289 ASP C 111 ASP.? 17.21 CA CA C 208 coo -0.62 65.95 29.97 0.31 67.47 31.05 35.75 -30.25 2.83 35.54 -31.07 4.76 coo 4.34 62.44 32.05 4.22 64.48 32.53 36.32 -31.59 -2.15 36.97 -31.00 -4.08 coo 9.42 68.07 30.27 7.35 68.27 30.10 27.11 -33.17 -3.90 25.73 -31.94 -3.00 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 9 3 # 9 179 ASP C 167 ASP.? 25.18 CA CA C 208 204 GLU C 165 GLU^? 20.98 CA CA C 208 289 ASP C 111 ASP.? 17.21 CA CA C 208 coo -0.62 65.95 29.97 0.31 67.47 31.05 31.39 -27.44 2.08 30.34 -25.78 1.31 coo 4.34 62.44 32.05 4.22 64.48 32.53 36.32 -31.59 -2.15 36.97 -31.00 -4.08 coo 9.42 68.07 30.27 7.35 68.27 30.10 27.11 -33.17 -3.90 25.73 -31.94 -3.00 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 10 3 # 10 179 ASP C 185 ASP~? 11.81 O21 C8E C 209 204 GLU C 184 GLU~? 7.93 C14 C8E C 209 289 ASP C 180 ASP.? 12.29 C5 C8E C 209 coo -0.62 65.95 29.97 0.31 67.47 31.05 31.89 -54.53 1.93 31.11 -55.91 3.29 coo 4.34 62.44 32.05 4.22 64.48 32.53 35.72 -59.91 1.24 36.69 -61.13 -0.21 coo 9.42 68.07 30.27 7.35 68.27 30.10 42.24 -54.49 3.97 44.24 -53.90 3.82 1amy_c05 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 10 hits 1amy_c05 naa= 3 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 48 ASP.? 7.38 CA CA A 208 227 GLU A 64 GLU~? 12.36 CA CA A 208 289 ASP A 52 ASP.? 15.11 CA CA A 208 coo -0.62 65.95 29.97 0.31 67.47 31.05 72.05 -78.20 -23.17 73.82 -77.79 -22.11 coo 3.96 55.76 41.24 4.83 57.69 41.17 79.25 -82.11 -37.14 78.75 -80.37 -38.23 coo 9.42 68.07 30.27 7.35 68.27 30.10 76.18 -86.89 -22.52 75.57 -87.62 -20.65 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP A 48 ASP.? 7.38 CA CA A 208 227 GLU A 184 GLU~? 7.72 C16 C8E A 210 289 ASP A 52 ASP.? 15.11 CA CA A 208 coo -0.62 65.95 29.97 0.31 67.47 31.05 72.05 -78.20 -23.17 73.82 -77.79 -22.11 coo 3.96 55.76 41.24 4.83 57.69 41.17 63.73 -84.37 -12.45 63.45 -82.45 -11.70 coo 9.42 68.07 30.27 7.35 68.27 30.10 76.18 -86.89 -22.52 75.57 -87.62 -20.65 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 3 # 3 179 ASP A 52 ASP.? 15.11 CA CA A 208 227 GLU A 64 GLU~? 12.36 CA CA A 208 289 ASP A 48 ASP.? 7.38 CA CA A 208 coo -0.62 65.95 29.97 0.31 67.47 31.05 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo 3.96 55.76 41.24 4.83 57.69 41.17 79.25 -82.11 -37.14 78.75 -80.37 -38.23 coo 9.42 68.07 30.27 7.35 68.27 30.10 72.05 -78.20 -23.17 73.82 -77.79 -22.11 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 4 3 # 4 179 ASP A 52 ASP.? 15.11 CA CA A 208 227 GLU A 70 GLU^? -2.69 CA CA A 208s 289 ASP A 185 ASP~? 11.73 O21 C8E A 210 coo -0.62 65.95 29.97 0.31 67.47 31.05 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo 3.96 55.76 41.24 4.83 57.69 41.17 68.79 -75.79 -31.87 70.14 -76.30 -30.27 coo 9.42 68.07 30.27 7.35 68.27 30.10 65.81 -86.27 -18.22 66.54 -87.64 -16.78 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 5 3 # 5 179 ASP A 180 ASP.? 14.47 O15 C8E A 210 227 GLU A 164 GLU^? 19.19 O21 C8E A 210 289 ASP A 185 ASP~? 11.73 O21 C8E A 210 coo -0.62 65.95 29.97 0.31 67.47 31.05 55.45 -86.10 -15.44 53.65 -85.04 -15.38 coo 3.96 55.76 41.24 4.83 57.69 41.17 57.65 -86.15 -32.10 58.08 -88.26 -31.94 coo 9.42 68.07 30.27 7.35 68.27 30.10 65.81 -86.27 -18.22 66.54 -87.64 -16.78 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 6 3 # 6 179 ASP A 185 ASP~? 11.73 O21 C8E A 210 227 GLU A 70 GLU^? -2.69 CA CA A 208s 289 ASP A 52 ASP.? 15.11 CA CA A 208 coo -0.62 65.95 29.97 0.31 67.47 31.05 65.81 -86.27 -18.22 66.54 -87.64 -16.78 coo 3.96 55.76 41.24 4.83 57.69 41.17 68.79 -75.79 -31.87 70.14 -76.30 -30.27 coo 9.42 68.07 30.27 7.35 68.27 30.10 76.18 -86.89 -22.52 75.57 -87.62 -20.65 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 7 3 # 7 179 ASP A 185 ASP~? 11.73 O21 C8E A 210 227 GLU A 164 GLU^? 19.19 O21 C8E A 210 289 ASP A 48 ASP.? 7.38 CA CA A 208 coo -0.62 65.95 29.97 0.31 67.47 31.05 65.81 -86.27 -18.22 66.54 -87.64 -16.78 coo 3.96 55.76 41.24 4.83 57.69 41.17 57.65 -86.15 -32.10 58.08 -88.26 -31.94 coo 9.42 68.07 30.27 7.35 68.27 30.10 72.05 -78.20 -23.17 73.82 -77.79 -22.11 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 8 3 # 8 179 ASP A 185 ASP~? 11.73 O21 C8E A 210 227 GLU A 164 GLU^? 19.19 O21 C8E A 210 289 ASP A 180 ASP.? 14.47 O15 C8E A 210 coo -0.62 65.95 29.97 0.31 67.47 31.05 65.81 -86.27 -18.22 66.54 -87.64 -16.78 coo 3.96 55.76 41.24 4.83 57.69 41.17 57.65 -86.15 -32.10 58.08 -88.26 -31.94 coo 9.42 68.07 30.27 7.35 68.27 30.10 55.45 -86.10 -15.44 53.65 -85.04 -15.38 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 9 3 # 9 179 ASP A 185 ASP~? 11.73 O21 C8E A 210 227 GLU A 194 GLU.? 3.11 C17 C8E A 210s 289 ASP A 180 ASP.? 14.47 O15 C8E A 210 coo -0.62 65.95 29.97 0.31 67.47 31.05 65.81 -86.27 -18.22 66.54 -87.64 -16.78 coo 3.96 55.76 41.24 4.83 57.69 41.17 66.12 -70.72 -14.05 67.03 -72.48 -13.31 coo 9.42 68.07 30.27 7.35 68.27 30.10 55.45 -86.10 -15.44 53.65 -85.04 -15.38 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 10 3 # 10 179 ASP B 48 ASP.? 7.20 CA CA B 208 227 GLU B 64 GLU~? 12.78 CA CA B 208 289 ASP B 52 ASP.? 15.59 CA CA B 208 coo -0.62 65.95 29.97 0.31 67.47 31.05 97.60 -30.12 -16.68 98.20 -32.01 -15.99 coo 3.96 55.76 41.24 4.83 57.69 41.17 92.75 -26.79 -1.73 90.87 -27.74 -1.56 coo 9.42 68.07 30.27 7.35 68.27 30.10 105.61 -28.95 -11.53 106.78 -28.70 -9.81 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 11 3 # 11 179 ASP B 52 ASP.? 15.59 CA CA B 208 227 GLU B 64 GLU~? 12.78 CA CA B 208 289 ASP B 48 ASP.? 7.20 CA CA B 208 coo -0.62 65.95 29.97 0.31 67.47 31.05 105.61 -28.95 -11.53 106.78 -28.70 -9.81 coo 3.96 55.76 41.24 4.83 57.69 41.17 92.75 -26.79 -1.73 90.87 -27.74 -1.56 coo 9.42 68.07 30.27 7.35 68.27 30.10 97.60 -30.12 -16.68 98.20 -32.01 -15.99 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 12 3 # 12 179 ASP B 52 ASP.? 15.59 CA CA B 208 227 GLU B 70 GLU^? -2.58 CA CA B 208s 289 ASP B 185 ASP~? 11.63 O21 C8E B 210 coo -0.62 65.95 29.97 0.31 67.47 31.05 105.61 -28.95 -11.53 106.78 -28.70 -9.81 coo 3.96 55.76 41.24 4.83 57.69 41.17 89.83 -24.96 -14.47 91.03 -26.69 -14.39 coo 9.42 68.07 30.27 7.35 68.27 30.10 106.30 -23.80 -20.43 108.26 -24.54 -20.08 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 13 3 # 13 179 ASP B 185 ASP~? 11.63 O21 C8E B 210 227 GLU B 70 GLU^? -2.58 CA CA B 208s 289 ASP B 52 ASP.? 15.59 CA CA B 208 coo -0.62 65.95 29.97 0.31 67.47 31.05 106.30 -23.80 -20.43 108.26 -24.54 -20.08 coo 3.96 55.76 41.24 4.83 57.69 41.17 89.83 -24.96 -14.47 91.03 -26.69 -14.39 coo 9.42 68.07 30.27 7.35 68.27 30.10 105.61 -28.95 -11.53 106.78 -28.70 -9.81 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 14 3 # 14 179 ASP B 185 ASP~? 11.63 O21 C8E B 210 227 GLU B 194 GLU.? 2.86 C13 C8E B 210s 289 ASP B 180 ASP.? 10.93 C4 C8E B 210 coo -0.62 65.95 29.97 0.31 67.47 31.05 106.30 -23.80 -20.43 108.26 -24.54 -20.08 coo 3.96 55.76 41.24 4.83 57.69 41.17 97.88 -33.97 -28.78 99.62 -34.16 -27.58 coo 9.42 68.07 30.27 7.35 68.27 30.10 106.50 -18.19 -29.27 105.54 -17.21 -30.85 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 15 3 # 15 179 ASP C 48 ASP.? 7.17 CA CA C 208 227 GLU C 64 GLU~? 12.03 CA CA C 208 289 ASP C 52 ASP.? 15.77 CA CA C 208 coo -0.62 65.95 29.97 0.31 67.47 31.05 26.68 -52.06 -7.74 25.46 -53.53 -8.54 coo 3.96 55.76 41.24 4.83 57.69 41.17 16.47 -41.84 -8.31 14.60 -42.35 -9.15 coo 9.42 68.07 30.27 7.35 68.27 30.10 21.29 -54.58 -0.38 20.26 -54.47 1.43 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 16 3 # 16 179 ASP C 48 ASP.? 7.17 CA CA C 208 227 GLU C 184 GLU~? 7.93 C14 C8E C 209 289 ASP C 52 ASP.? 15.77 CA CA C 208 coo -0.62 65.95 29.97 0.31 67.47 31.05 26.68 -52.06 -7.74 25.46 -53.53 -8.54 coo 3.96 55.76 41.24 4.83 57.69 41.17 35.72 -59.91 1.24 36.69 -61.13 -0.21 coo 9.42 68.07 30.27 7.35 68.27 30.10 21.29 -54.58 -0.38 20.26 -54.47 1.43 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 17 3 # 17 179 ASP C 52 ASP.? 15.77 CA CA C 208 227 GLU C 70 GLU^? -2.71 CA CA C 208s 289 ASP C 185 ASP~? 11.81 O21 C8E C 209 coo -0.62 65.95 29.97 0.31 67.47 31.05 21.29 -54.58 -0.38 20.26 -54.47 1.43 coo 3.96 55.76 41.24 4.83 57.69 41.17 27.73 -42.94 -10.42 26.74 -44.79 -10.37 coo 9.42 68.07 30.27 7.35 68.27 30.10 31.89 -54.53 1.93 31.11 -55.91 3.29 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 18 3 # 18 179 ASP C 185 ASP~? 11.81 O21 C8E C 209 227 GLU C 70 GLU^? -2.71 CA CA C 208s 289 ASP C 52 ASP.? 15.77 CA CA C 208 coo -0.62 65.95 29.97 0.31 67.47 31.05 31.89 -54.53 1.93 31.11 -55.91 3.29 coo 3.96 55.76 41.24 4.83 57.69 41.17 27.73 -42.94 -10.42 26.74 -44.79 -10.37 coo 9.42 68.07 30.27 7.35 68.27 30.10 21.29 -54.58 -0.38 20.26 -54.47 1.43 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 19 3 # 19 179 ASP C 185 ASP~? 11.81 O21 C8E C 209 227 GLU C 164 GLU^? 20.06 CA CA C 208 289 ASP C 180 ASP.? 12.29 C5 C8E C 209 coo -0.62 65.95 29.97 0.31 67.47 31.05 31.89 -54.53 1.93 31.11 -55.91 3.29 coo 3.96 55.76 41.24 4.83 57.69 41.17 34.72 -37.11 1.76 34.46 -37.46 3.82 coo 9.42 68.07 30.27 7.35 68.27 30.10 42.24 -54.49 3.97 44.24 -53.90 3.82 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 20 3 # 20 179 ASP C 185 ASP~? 11.81 O21 C8E C 209 227 GLU C 194 GLU.? 3.24 O15 C8E C 209s 289 ASP C 180 ASP.? 12.29 C5 C8E C 209 coo -0.62 65.95 29.97 0.31 67.47 31.05 31.89 -54.53 1.93 31.11 -55.91 3.29 coo 3.96 55.76 41.24 4.83 57.69 41.17 36.17 -59.59 -12.28 34.91 -60.51 -10.83 coo 9.42 68.07 30.27 7.35 68.27 30.10 42.24 -54.49 3.97 44.24 -53.90 3.82 1amy_c06 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 20 hits 1amy_c06 naa= 3 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 1 3 # 1 A 194 SER A 5 SER^? 24.40 C2 C8E C 209 A 292 ASP A 153 ASP^? 8.28 C1 C8E A 210 A 322 HIS A 0 HIS.? 19.31 C20 C8E C 210 coo 36.34 32.23 39.60 36.43 34.62 39.93 55.35 -42.73 -25.42 56.65 -41.65 -23.68 coo 19.73 19.18 41.39 21.50 18.65 40.34 63.37 -61.81 -16.17 62.75 -59.91 -16.84 coo 41.69 45.14 46.60 41.78 47.19 46.18 44.54 -33.06 -16.20 42.49 -32.93 -16.64 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 2 3 # 2 A 194 SER C 124 SER^? 11.72 O21 C8E C 210 A 292 ASP C 52 ASP.? 15.77 CA CA C 208 A 322 HIS A 0 HIS.? 19.31 C20 C8E C 210 coo 36.34 32.23 39.60 36.43 34.62 39.93 40.05 -45.29 -8.01 42.09 -44.13 -7.44 coo 19.73 19.18 41.39 21.50 18.65 40.34 21.29 -54.58 -0.38 20.26 -54.47 1.43 coo 41.69 45.14 46.60 41.78 47.19 46.18 44.54 -33.06 -16.20 42.49 -32.93 -16.64 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 3 3 # 3 A 194 SER C 125 SER^? 7.77 O21 C8E C 209 A 292 ASP C 52 ASP.? 15.77 CA CA C 208 A 322 HIS A 0 HIS.? 19.31 C20 C8E C 210 coo 36.34 32.23 39.60 36.43 34.62 39.93 41.72 -48.67 -8.69 41.33 -51.09 -8.33 coo 19.73 19.18 41.39 21.50 18.65 40.34 21.29 -54.58 -0.38 20.26 -54.47 1.43 coo 41.69 45.14 46.60 41.78 47.19 46.18 44.54 -33.06 -16.20 42.49 -32.93 -16.64 1aql_c02 source 1aql BILE-SALT ACTIVATED LIPASE : 3 hits 1aql_c02 naa= 3 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 1 3 # 1 B 194 SER A 5 SER^? 24.40 C2 C8E C 209 B 292 ASP A 153 ASP^? 8.28 C1 C8E A 210 B 322 HIS A 0 HIS.? 19.31 C20 C8E C 210 coo 35.42 71.28 22.94 36.24 69.06 22.37 55.35 -42.73 -25.42 56.65 -41.65 -23.68 coo 24.74 78.07 5.59 24.32 79.03 7.46 63.37 -61.81 -16.17 62.75 -59.91 -16.84 coo 48.81 64.16 26.34 49.30 62.16 26.73 44.54 -33.06 -16.20 42.49 -32.93 -16.64 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 2 3 # 2 B 194 SER C 106 SER^? 9.17 O21 C8E C 210 B 292 ASP C 52 ASP.? 15.77 CA CA C 208 B 322 HIS A 0 HIS.? 19.31 C20 C8E C 210 coo 35.42 71.28 22.94 36.24 69.06 22.37 38.19 -43.96 -11.39 38.81 -41.96 -12.55 coo 24.74 78.07 5.59 24.32 79.03 7.46 21.29 -54.58 -0.38 20.26 -54.47 1.43 coo 48.81 64.16 26.34 49.30 62.16 26.73 44.54 -33.06 -16.20 42.49 -32.93 -16.64 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 3 3 # 3 B 194 SER C 106 SER^? 9.17 O21 C8E C 210 B 292 ASP C 61 ASP~? 12.61 CA CA C 208 B 322 HIS A 0 HIS.? 19.31 C20 C8E C 210 coo 35.42 71.28 22.94 36.24 69.06 22.37 38.19 -43.96 -11.39 38.81 -41.96 -12.55 coo 24.74 78.07 5.59 24.32 79.03 7.46 16.71 -46.53 -3.05 15.59 -48.22 -3.69 coo 48.81 64.16 26.34 49.30 62.16 26.73 44.54 -33.06 -16.20 42.49 -32.93 -16.64 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 4 3 # 4 B 194 SER C 124 SER^? 11.72 O21 C8E C 210 B 292 ASP C 52 ASP.? 15.77 CA CA C 208 B 322 HIS A 0 HIS.? 19.31 C20 C8E C 210 coo 35.42 71.28 22.94 36.24 69.06 22.37 40.05 -45.29 -8.01 42.09 -44.13 -7.44 coo 24.74 78.07 5.59 24.32 79.03 7.46 21.29 -54.58 -0.38 20.26 -54.47 1.43 coo 48.81 64.16 26.34 49.30 62.16 26.73 44.54 -33.06 -16.20 42.49 -32.93 -16.64 1aql_c03 source 1aql BILE-SALT ACTIVATED LIPASE : 4 hits 1aql_c03 naa= 3 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 1 3 # 1 B 325 ARG A 200 ARG^? 11.17 C17 C8E A 209 B 342 ASP A 153 ASP^? 8.28 C1 C8E A 210 B 531 ARG A 135 ARG^? 21.29 C1 C8E A 210 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 65.38 -54.68 -25.12 63.65 -56.91 -23.89 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 63.37 -61.81 -16.17 62.75 -59.91 -16.84 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 62.45 -46.81 -18.85 61.41 -44.79 -20.90 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 2 3 # 2 B 325 ARG B 200 ARG^? 11.34 O15 C8E B 209 B 342 ASP B 153 ASP^? 9.57 O15 C8E B 209 B 531 ARG B 135 ARG^? 22.88 O15 C8E B 209 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 78.82 -37.69 -29.59 80.99 -36.13 -31.14 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 89.74 -36.17 -33.46 87.76 -36.55 -34.22 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 77.46 -42.45 -38.74 74.50 -42.61 -39.42 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 3 3 # 3 B 325 ARG C 200 ARG^? 12.04 C16 C8E C 210 B 342 ASP C 153 ASP^? 9.83 C13 C8E C 210 B 531 ARG C 135 ARG^? 23.87 C16 C8E C 210 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 37.62 -50.12 -29.23 39.44 -51.00 -26.91 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 40.09 -57.62 -20.90 41.26 -57.13 -22.61 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 44.01 -56.05 -34.91 45.01 -54.65 -37.44 1asy_c00 source 1asy TRANSFER RIBONUCLEIC ACID (TRNAASP) : 3 hits 1asy_c00 naa= 3 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 1 3 # 1 A 325 ARG A 200 ARG^? 11.17 C17 C8E A 209 A 342 ASP A 153 ASP^? 8.28 C1 C8E A 210 A 531 ARG A 135 ARG^? 21.29 C1 C8E A 210 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 65.38 -54.68 -25.12 63.65 -56.91 -23.89 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 63.37 -61.81 -16.17 62.75 -59.91 -16.84 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 62.45 -46.81 -18.85 61.41 -44.79 -20.90 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 2 3 # 2 A 325 ARG B 200 ARG^? 11.34 O15 C8E B 209 A 342 ASP B 153 ASP^? 9.57 O15 C8E B 209 A 531 ARG B 135 ARG^? 22.88 O15 C8E B 209 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 78.82 -37.69 -29.59 80.99 -36.13 -31.14 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 89.74 -36.17 -33.46 87.76 -36.55 -34.22 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 77.46 -42.45 -38.74 74.50 -42.61 -39.42 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 3 3 # 3 A 325 ARG C 200 ARG^? 12.04 C16 C8E C 210 A 342 ASP C 153 ASP^? 9.83 C13 C8E C 210 A 531 ARG C 135 ARG^? 23.87 C16 C8E C 210 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 37.62 -50.12 -29.23 39.44 -51.00 -26.91 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 40.09 -57.62 -20.90 41.26 -57.13 -22.61 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 44.01 -56.05 -34.91 45.01 -54.65 -37.44 1asy_c01 source 1asy TRANSFER RIBONUCLEIC ACID (TRNAASP) : 3 hits 1asy_c01 naa= 3 ULMN 3 1ax4_c04 TRYPTOPHANASE user 1 3 # 1 A 130 PHE A 12 PHE^? 6.66 C16 C8E A 209 A 223 ASP A 45 ASP.? -2.96 CA CA A 208s A 265 LYS A 188 LYS~? 10.77 C20 C8E A 210 coo 39.74 52.86 65.74 41.15 55.14 66.52 71.82 -60.62 -24.43 72.20 -63.22 -23.50 coo 30.70 47.50 67.53 29.83 49.47 67.39 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo 19.99 54.53 64.11 20.55 58.78 68.33 68.32 -80.18 -18.11 71.95 -84.24 -15.84 ULMN 3 1ax4_c04 TRYPTOPHANASE user 2 3 # 2 A 130 PHE A 68 PHE.? 12.64 CA CA A 208 A 223 ASP A 49 ASP.? -3.00 CA CA A 208s A 265 LYS A 188 LYS~? 10.77 C20 C8E A 210 coo 39.74 52.86 65.74 41.15 55.14 66.52 69.51 -83.16 -37.04 69.32 -85.92 -37.33 coo 30.70 47.50 67.53 29.83 49.47 67.39 75.72 -77.89 -27.98 74.67 -77.10 -29.65 coo 19.99 54.53 64.11 20.55 58.78 68.33 68.32 -80.18 -18.11 71.95 -84.24 -15.84 ULMN 3 1ax4_c04 TRYPTOPHANASE user 3 3 # 3 A 130 PHE A 105 PHE^? 4.85 O21 C8E A 209 A 223 ASP A 45 ASP.? -2.96 CA CA A 208s A 265 LYS A 63 LYS~? 3.96 CA CA A 208 coo 39.74 52.86 65.74 41.15 55.14 66.52 61.29 -71.83 -24.77 63.18 -73.65 -25.72 coo 30.70 47.50 67.53 29.83 49.47 67.39 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo 19.99 54.53 64.11 20.55 58.78 68.33 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 1ax4_c04 TRYPTOPHANASE user 4 3 # 4 A 130 PHE A 105 PHE^? 4.85 O21 C8E A 209 A 223 ASP A 48 ASP.? 7.38 CA CA A 208 A 265 LYS A 63 LYS~? 3.96 CA CA A 208 coo 39.74 52.86 65.74 41.15 55.14 66.52 61.29 -71.83 -24.77 63.18 -73.65 -25.72 coo 30.70 47.50 67.53 29.83 49.47 67.39 72.05 -78.20 -23.17 73.82 -77.79 -22.11 coo 19.99 54.53 64.11 20.55 58.78 68.33 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 1ax4_c04 TRYPTOPHANASE user 5 3 # 5 A 130 PHE B 12 PHE^? 7.11 C16 C8E B 209 A 223 ASP B 45 ASP.? -3.07 CA CA B 208s A 265 LYS B 188 LYS~? 9.67 C16 C8E B 210 coo 39.74 52.86 65.74 41.15 55.14 66.52 84.38 -39.21 -23.20 86.71 -38.33 -21.97 coo 30.70 47.50 67.53 29.83 49.47 67.39 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo 19.99 54.53 64.11 20.55 58.78 68.33 102.16 -28.74 -21.10 106.15 -31.37 -17.86 ULMN 3 1ax4_c04 TRYPTOPHANASE user 6 3 # 6 A 130 PHE B 16 PHE^? 10.76 C16 C8E B 209 A 223 ASP B 45 ASP.? -3.07 CA CA B 208s A 265 LYS B 63 LYS~? 3.79 CA CA B 208 coo 39.74 52.86 65.74 41.15 55.14 66.52 80.83 -36.54 -19.88 82.09 -38.77 -18.74 coo 30.70 47.50 67.53 29.83 49.47 67.39 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo 19.99 54.53 64.11 20.55 58.78 68.33 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1ax4_c04 TRYPTOPHANASE user 7 3 # 7 A 130 PHE B 68 PHE.? 12.45 CA CA B 208 A 223 ASP B 49 ASP.? -3.05 CA CA B 208s A 265 LYS B 188 LYS~? 9.67 C16 C8E B 210 coo 39.74 52.86 65.74 41.15 55.14 66.52 91.51 -19.54 -8.10 93.32 -17.88 -6.80 coo 30.70 47.50 67.53 29.83 49.47 67.39 94.52 -28.97 -11.62 93.03 -30.41 -11.73 coo 19.99 54.53 64.11 20.55 58.78 68.33 102.16 -28.74 -21.10 106.15 -31.37 -17.86 ULMN 3 1ax4_c04 TRYPTOPHANASE user 8 3 # 8 A 130 PHE B 105 PHE^? 5.21 C20 C8E B 209 A 223 ASP B 45 ASP.? -3.07 CA CA B 208s A 265 LYS B 63 LYS~? 3.79 CA CA B 208 coo 39.74 52.86 65.74 41.15 55.14 66.52 90.70 -25.26 -25.77 91.65 -25.28 -23.14 coo 30.70 47.50 67.53 29.83 49.47 67.39 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo 19.99 54.53 64.11 20.55 58.78 68.33 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1ax4_c04 TRYPTOPHANASE user 9 3 # 9 A 130 PHE B 105 PHE^? 5.21 C20 C8E B 209 A 223 ASP B 48 ASP.? 7.20 CA CA B 208 A 265 LYS B 63 LYS~? 3.79 CA CA B 208 coo 39.74 52.86 65.74 41.15 55.14 66.52 90.70 -25.26 -25.77 91.65 -25.28 -23.14 coo 30.70 47.50 67.53 29.83 49.47 67.39 97.60 -30.12 -16.68 98.20 -32.01 -15.99 coo 19.99 54.53 64.11 20.55 58.78 68.33 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1ax4_c04 TRYPTOPHANASE user 10 3 # 10 A 130 PHE B 160 PHE^? 5.74 O21 C8E B 210 A 223 ASP B 48 ASP.? 7.20 CA CA B 208 A 265 LYS B 63 LYS~? 3.79 CA CA B 208 coo 39.74 52.86 65.74 41.15 55.14 66.52 97.82 -21.95 -26.27 98.06 -24.71 -26.08 coo 30.70 47.50 67.53 29.83 49.47 67.39 97.60 -30.12 -16.68 98.20 -32.01 -15.99 coo 19.99 54.53 64.11 20.55 58.78 68.33 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1ax4_c04 TRYPTOPHANASE user 11 3 # 11 A 130 PHE C 12 PHE^? 6.93 C16 C8E C 210 A 223 ASP C 45 ASP.? 3.27 CA CA C 208s A 265 LYS C 188 LYS~? 9.02 C16 C8E C 209 coo 39.74 52.86 65.74 41.15 55.14 66.52 30.57 -52.31 -25.04 29.52 -53.06 -22.58 coo 30.70 47.50 67.53 29.83 49.47 67.39 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo 19.99 54.53 64.11 20.55 58.78 68.33 31.07 -55.82 -4.30 26.58 -58.21 -2.57 ULMN 3 1ax4_c04 TRYPTOPHANASE user 12 3 # 12 A 130 PHE C 68 PHE.? 11.96 CA CA C 208 A 223 ASP C 49 ASP.? -2.87 CA CA C 208s A 265 LYS C 188 LYS~? 9.02 C16 C8E C 209 coo 39.74 52.86 65.74 41.15 55.14 66.52 23.80 -38.52 -4.60 23.26 -38.36 -1.88 coo 30.70 47.50 67.53 29.83 49.47 67.39 22.13 -48.50 -9.42 23.00 -46.66 -10.00 coo 19.99 54.53 64.11 20.55 58.78 68.33 31.07 -55.82 -4.30 26.58 -58.21 -2.57 ULMN 3 1ax4_c04 TRYPTOPHANASE user 13 3 # 13 A 130 PHE C 105 PHE^? -4.13 O21 C8E C 210s A 223 ASP C 45 ASP.? 3.27 CA CA C 208s A 265 LYS C 63 LYS~? 4.21 CA CA C 208 coo 39.74 52.86 65.74 41.15 55.14 66.52 37.70 -47.93 -11.88 35.28 -47.45 -10.64 coo 30.70 47.50 67.53 29.83 49.47 67.39 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo 19.99 54.53 64.11 20.55 58.78 68.33 20.98 -41.61 -5.49 23.04 -43.67 -10.44 ULMN 3 1ax4_c04 TRYPTOPHANASE user 14 3 # 14 A 130 PHE C 105 PHE^? -4.13 O21 C8E C 210s A 223 ASP C 48 ASP.? 7.17 CA CA C 208 A 265 LYS C 63 LYS~? 4.21 CA CA C 208 coo 39.74 52.86 65.74 41.15 55.14 66.52 37.70 -47.93 -11.88 35.28 -47.45 -10.64 coo 30.70 47.50 67.53 29.83 49.47 67.39 26.68 -52.06 -7.74 25.46 -53.53 -8.54 coo 19.99 54.53 64.11 20.55 58.78 68.33 20.98 -41.61 -5.49 23.04 -43.67 -10.44 1ax4_c04 source 1ax4 TRYPTOPHANASE : 14 hits 1ax4_c04 naa= 3 ULMN 3 1ax4_c05 TRYPTOPHANASE user 1 3 # 1 B 130 PHE A 12 PHE^? 6.66 C16 C8E A 209 B 223 ASP A 45 ASP.? -2.96 CA CA A 208s B 265 LYS A 188 LYS~? 10.77 C20 C8E A 210 coo 7.48 54.94 99.62 7.67 52.27 100.42 71.82 -60.62 -24.43 72.20 -63.22 -23.50 coo 10.43 61.66 91.81 9.80 60.04 90.61 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo 5.43 58.06 80.08 8.57 53.00 79.37 68.32 -80.18 -18.11 71.95 -84.24 -15.84 ULMN 3 1ax4_c05 TRYPTOPHANASE user 2 3 # 2 B 130 PHE A 68 PHE.? 12.64 CA CA A 208 B 223 ASP A 49 ASP.? -3.00 CA CA A 208s B 265 LYS A 188 LYS~? 10.77 C20 C8E A 210 coo 7.48 54.94 99.62 7.67 52.27 100.42 69.51 -83.16 -37.04 69.32 -85.92 -37.33 coo 10.43 61.66 91.81 9.80 60.04 90.61 75.72 -77.89 -27.98 74.67 -77.10 -29.65 coo 5.43 58.06 80.08 8.57 53.00 79.37 68.32 -80.18 -18.11 71.95 -84.24 -15.84 ULMN 3 1ax4_c05 TRYPTOPHANASE user 3 3 # 3 B 130 PHE A 105 PHE^? 4.85 O21 C8E A 209 B 223 ASP A 45 ASP.? -2.96 CA CA A 208s B 265 LYS A 63 LYS~? 3.96 CA CA A 208 coo 7.48 54.94 99.62 7.67 52.27 100.42 61.29 -71.83 -24.77 63.18 -73.65 -25.72 coo 10.43 61.66 91.81 9.80 60.04 90.61 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo 5.43 58.06 80.08 8.57 53.00 79.37 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 1ax4_c05 TRYPTOPHANASE user 4 3 # 4 B 130 PHE A 105 PHE^? 4.85 O21 C8E A 209 B 223 ASP A 48 ASP.? 7.38 CA CA A 208 B 265 LYS A 63 LYS~? 3.96 CA CA A 208 coo 7.48 54.94 99.62 7.67 52.27 100.42 61.29 -71.83 -24.77 63.18 -73.65 -25.72 coo 10.43 61.66 91.81 9.80 60.04 90.61 72.05 -78.20 -23.17 73.82 -77.79 -22.11 coo 5.43 58.06 80.08 8.57 53.00 79.37 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 1ax4_c05 TRYPTOPHANASE user 5 3 # 5 B 130 PHE B 12 PHE^? 7.11 C16 C8E B 209 B 223 ASP B 45 ASP.? -3.07 CA CA B 208s B 265 LYS B 188 LYS~? 9.67 C16 C8E B 210 coo 7.48 54.94 99.62 7.67 52.27 100.42 84.38 -39.21 -23.20 86.71 -38.33 -21.97 coo 10.43 61.66 91.81 9.80 60.04 90.61 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo 5.43 58.06 80.08 8.57 53.00 79.37 102.16 -28.74 -21.10 106.15 -31.37 -17.86 ULMN 3 1ax4_c05 TRYPTOPHANASE user 6 3 # 6 B 130 PHE B 16 PHE^? 10.76 C16 C8E B 209 B 223 ASP B 45 ASP.? -3.07 CA CA B 208s B 265 LYS B 63 LYS~? 3.79 CA CA B 208 coo 7.48 54.94 99.62 7.67 52.27 100.42 80.83 -36.54 -19.88 82.09 -38.77 -18.74 coo 10.43 61.66 91.81 9.80 60.04 90.61 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo 5.43 58.06 80.08 8.57 53.00 79.37 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1ax4_c05 TRYPTOPHANASE user 7 3 # 7 B 130 PHE B 68 PHE.? 12.45 CA CA B 208 B 223 ASP B 49 ASP.? -3.05 CA CA B 208s B 265 LYS B 188 LYS~? 9.67 C16 C8E B 210 coo 7.48 54.94 99.62 7.67 52.27 100.42 91.51 -19.54 -8.10 93.32 -17.88 -6.80 coo 10.43 61.66 91.81 9.80 60.04 90.61 94.52 -28.97 -11.62 93.03 -30.41 -11.73 coo 5.43 58.06 80.08 8.57 53.00 79.37 102.16 -28.74 -21.10 106.15 -31.37 -17.86 ULMN 3 1ax4_c05 TRYPTOPHANASE user 8 3 # 8 B 130 PHE B 105 PHE^? 5.21 C20 C8E B 209 B 223 ASP B 45 ASP.? -3.07 CA CA B 208s B 265 LYS B 63 LYS~? 3.79 CA CA B 208 coo 7.48 54.94 99.62 7.67 52.27 100.42 90.70 -25.26 -25.77 91.65 -25.28 -23.14 coo 10.43 61.66 91.81 9.80 60.04 90.61 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo 5.43 58.06 80.08 8.57 53.00 79.37 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1ax4_c05 TRYPTOPHANASE user 9 3 # 9 B 130 PHE B 105 PHE^? 5.21 C20 C8E B 209 B 223 ASP B 48 ASP.? 7.20 CA CA B 208 B 265 LYS B 63 LYS~? 3.79 CA CA B 208 coo 7.48 54.94 99.62 7.67 52.27 100.42 90.70 -25.26 -25.77 91.65 -25.28 -23.14 coo 10.43 61.66 91.81 9.80 60.04 90.61 97.60 -30.12 -16.68 98.20 -32.01 -15.99 coo 5.43 58.06 80.08 8.57 53.00 79.37 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1ax4_c05 TRYPTOPHANASE user 10 3 # 10 B 130 PHE B 160 PHE^? 5.74 O21 C8E B 210 B 223 ASP B 48 ASP.? 7.20 CA CA B 208 B 265 LYS B 63 LYS~? 3.79 CA CA B 208 coo 7.48 54.94 99.62 7.67 52.27 100.42 97.82 -21.95 -26.27 98.06 -24.71 -26.08 coo 10.43 61.66 91.81 9.80 60.04 90.61 97.60 -30.12 -16.68 98.20 -32.01 -15.99 coo 5.43 58.06 80.08 8.57 53.00 79.37 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1ax4_c05 TRYPTOPHANASE user 11 3 # 11 B 130 PHE C 12 PHE^? 6.93 C16 C8E C 210 B 223 ASP C 45 ASP.? 3.27 CA CA C 208s B 265 LYS C 188 LYS~? 9.02 C16 C8E C 209 coo 7.48 54.94 99.62 7.67 52.27 100.42 30.57 -52.31 -25.04 29.52 -53.06 -22.58 coo 10.43 61.66 91.81 9.80 60.04 90.61 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo 5.43 58.06 80.08 8.57 53.00 79.37 31.07 -55.82 -4.30 26.58 -58.21 -2.57 ULMN 3 1ax4_c05 TRYPTOPHANASE user 12 3 # 12 B 130 PHE C 68 PHE.? 11.96 CA CA C 208 B 223 ASP C 49 ASP.? -2.87 CA CA C 208s B 265 LYS C 188 LYS~? 9.02 C16 C8E C 209 coo 7.48 54.94 99.62 7.67 52.27 100.42 23.80 -38.52 -4.60 23.26 -38.36 -1.88 coo 10.43 61.66 91.81 9.80 60.04 90.61 22.13 -48.50 -9.42 23.00 -46.66 -10.00 coo 5.43 58.06 80.08 8.57 53.00 79.37 31.07 -55.82 -4.30 26.58 -58.21 -2.57 ULMN 3 1ax4_c05 TRYPTOPHANASE user 13 3 # 13 B 130 PHE C 105 PHE^? -4.13 O21 C8E C 210s B 223 ASP C 45 ASP.? 3.27 CA CA C 208s B 265 LYS C 63 LYS~? 4.21 CA CA C 208 coo 7.48 54.94 99.62 7.67 52.27 100.42 37.70 -47.93 -11.88 35.28 -47.45 -10.64 coo 10.43 61.66 91.81 9.80 60.04 90.61 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo 5.43 58.06 80.08 8.57 53.00 79.37 20.98 -41.61 -5.49 23.04 -43.67 -10.44 ULMN 3 1ax4_c05 TRYPTOPHANASE user 14 3 # 14 B 130 PHE C 105 PHE^? -4.13 O21 C8E C 210s B 223 ASP C 48 ASP.? 7.17 CA CA C 208 B 265 LYS C 63 LYS~? 4.21 CA CA C 208 coo 7.48 54.94 99.62 7.67 52.27 100.42 37.70 -47.93 -11.88 35.28 -47.45 -10.64 coo 10.43 61.66 91.81 9.80 60.04 90.61 26.68 -52.06 -7.74 25.46 -53.53 -8.54 coo 5.43 58.06 80.08 8.57 53.00 79.37 20.98 -41.61 -5.49 23.04 -43.67 -10.44 1ax4_c05 source 1ax4 TRYPTOPHANASE : 14 hits 1ax4_c05 naa= 3 ULMN 3 1ax4_c06 TRYPTOPHANASE user 1 3 # 1 C 130 PHE A 12 PHE^? 6.66 C16 C8E A 209 C 223 ASP A 45 ASP.? -2.96 CA CA A 208s C 265 LYS A 188 LYS~? 10.77 C20 C8E A 210 coo -6.55 73.45 23.60 -6.77 71.48 21.66 71.82 -60.62 -24.43 72.20 -63.22 -23.50 coo -9.52 75.74 33.62 -8.85 73.74 33.93 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo -4.44 67.20 42.32 -7.50 62.41 40.49 68.32 -80.18 -18.11 71.95 -84.24 -15.84 ULMN 3 1ax4_c06 TRYPTOPHANASE user 2 3 # 2 C 130 PHE A 68 PHE.? 12.64 CA CA A 208 C 223 ASP A 49 ASP.? -3.00 CA CA A 208s C 265 LYS A 188 LYS~? 10.77 C20 C8E A 210 coo -6.55 73.45 23.60 -6.77 71.48 21.66 69.51 -83.16 -37.04 69.32 -85.92 -37.33 coo -9.52 75.74 33.62 -8.85 73.74 33.93 75.72 -77.89 -27.98 74.67 -77.10 -29.65 coo -4.44 67.20 42.32 -7.50 62.41 40.49 68.32 -80.18 -18.11 71.95 -84.24 -15.84 ULMN 3 1ax4_c06 TRYPTOPHANASE user 3 3 # 3 C 130 PHE A 105 PHE^? 4.85 O21 C8E A 209 C 223 ASP A 45 ASP.? -2.96 CA CA A 208s C 265 LYS A 63 LYS~? 3.96 CA CA A 208 coo -6.55 73.45 23.60 -6.77 71.48 21.66 61.29 -71.83 -24.77 63.18 -73.65 -25.72 coo -9.52 75.74 33.62 -8.85 73.74 33.93 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo -4.44 67.20 42.32 -7.50 62.41 40.49 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 1ax4_c06 TRYPTOPHANASE user 4 3 # 4 C 130 PHE A 105 PHE^? 4.85 O21 C8E A 209 C 223 ASP A 48 ASP.? 7.38 CA CA A 208 C 265 LYS A 63 LYS~? 3.96 CA CA A 208 coo -6.55 73.45 23.60 -6.77 71.48 21.66 61.29 -71.83 -24.77 63.18 -73.65 -25.72 coo -9.52 75.74 33.62 -8.85 73.74 33.93 72.05 -78.20 -23.17 73.82 -77.79 -22.11 coo -4.44 67.20 42.32 -7.50 62.41 40.49 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 1ax4_c06 TRYPTOPHANASE user 5 3 # 5 C 130 PHE B 12 PHE^? 7.11 C16 C8E B 209 C 223 ASP B 45 ASP.? -3.07 CA CA B 208s C 265 LYS B 188 LYS~? 9.67 C16 C8E B 210 coo -6.55 73.45 23.60 -6.77 71.48 21.66 84.38 -39.21 -23.20 86.71 -38.33 -21.97 coo -9.52 75.74 33.62 -8.85 73.74 33.93 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo -4.44 67.20 42.32 -7.50 62.41 40.49 102.16 -28.74 -21.10 106.15 -31.37 -17.86 ULMN 3 1ax4_c06 TRYPTOPHANASE user 6 3 # 6 C 130 PHE B 68 PHE.? 12.45 CA CA B 208 C 223 ASP B 49 ASP.? -3.05 CA CA B 208s C 265 LYS B 188 LYS~? 9.67 C16 C8E B 210 coo -6.55 73.45 23.60 -6.77 71.48 21.66 91.51 -19.54 -8.10 93.32 -17.88 -6.80 coo -9.52 75.74 33.62 -8.85 73.74 33.93 94.52 -28.97 -11.62 93.03 -30.41 -11.73 coo -4.44 67.20 42.32 -7.50 62.41 40.49 102.16 -28.74 -21.10 106.15 -31.37 -17.86 ULMN 3 1ax4_c06 TRYPTOPHANASE user 7 3 # 7 C 130 PHE B 105 PHE^? 5.21 C20 C8E B 209 C 223 ASP B 45 ASP.? -3.07 CA CA B 208s C 265 LYS B 63 LYS~? 3.79 CA CA B 208 coo -6.55 73.45 23.60 -6.77 71.48 21.66 90.70 -25.26 -25.77 91.65 -25.28 -23.14 coo -9.52 75.74 33.62 -8.85 73.74 33.93 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo -4.44 67.20 42.32 -7.50 62.41 40.49 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1ax4_c06 TRYPTOPHANASE user 8 3 # 8 C 130 PHE B 105 PHE^? 5.21 C20 C8E B 209 C 223 ASP B 48 ASP.? 7.20 CA CA B 208 C 265 LYS B 63 LYS~? 3.79 CA CA B 208 coo -6.55 73.45 23.60 -6.77 71.48 21.66 90.70 -25.26 -25.77 91.65 -25.28 -23.14 coo -9.52 75.74 33.62 -8.85 73.74 33.93 97.60 -30.12 -16.68 98.20 -32.01 -15.99 coo -4.44 67.20 42.32 -7.50 62.41 40.49 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1ax4_c06 TRYPTOPHANASE user 9 3 # 9 C 130 PHE B 160 PHE^? 5.74 O21 C8E B 210 C 223 ASP B 48 ASP.? 7.20 CA CA B 208 C 265 LYS B 63 LYS~? 3.79 CA CA B 208 coo -6.55 73.45 23.60 -6.77 71.48 21.66 97.82 -21.95 -26.27 98.06 -24.71 -26.08 coo -9.52 75.74 33.62 -8.85 73.74 33.93 97.60 -30.12 -16.68 98.20 -32.01 -15.99 coo -4.44 67.20 42.32 -7.50 62.41 40.49 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1ax4_c06 TRYPTOPHANASE user 10 3 # 10 C 130 PHE C 12 PHE^? 6.93 C16 C8E C 210 C 223 ASP C 45 ASP.? 3.27 CA CA C 208s C 265 LYS C 188 LYS~? 9.02 C16 C8E C 209 coo -6.55 73.45 23.60 -6.77 71.48 21.66 30.57 -52.31 -25.04 29.52 -53.06 -22.58 coo -9.52 75.74 33.62 -8.85 73.74 33.93 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo -4.44 67.20 42.32 -7.50 62.41 40.49 31.07 -55.82 -4.30 26.58 -58.21 -2.57 ULMN 3 1ax4_c06 TRYPTOPHANASE user 11 3 # 11 C 130 PHE C 68 PHE.? 11.96 CA CA C 208 C 223 ASP C 49 ASP.? -2.87 CA CA C 208s C 265 LYS C 188 LYS~? 9.02 C16 C8E C 209 coo -6.55 73.45 23.60 -6.77 71.48 21.66 23.80 -38.52 -4.60 23.26 -38.36 -1.88 coo -9.52 75.74 33.62 -8.85 73.74 33.93 22.13 -48.50 -9.42 23.00 -46.66 -10.00 coo -4.44 67.20 42.32 -7.50 62.41 40.49 31.07 -55.82 -4.30 26.58 -58.21 -2.57 ULMN 3 1ax4_c06 TRYPTOPHANASE user 12 3 # 12 C 130 PHE C 105 PHE^? -4.13 O21 C8E C 210s C 223 ASP C 45 ASP.? 3.27 CA CA C 208s C 265 LYS C 63 LYS~? 4.21 CA CA C 208 coo -6.55 73.45 23.60 -6.77 71.48 21.66 37.70 -47.93 -11.88 35.28 -47.45 -10.64 coo -9.52 75.74 33.62 -8.85 73.74 33.93 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo -4.44 67.20 42.32 -7.50 62.41 40.49 20.98 -41.61 -5.49 23.04 -43.67 -10.44 ULMN 3 1ax4_c06 TRYPTOPHANASE user 13 3 # 13 C 130 PHE C 105 PHE^? -4.13 O21 C8E C 210s C 223 ASP C 48 ASP.? 7.17 CA CA C 208 C 265 LYS C 63 LYS~? 4.21 CA CA C 208 coo -6.55 73.45 23.60 -6.77 71.48 21.66 37.70 -47.93 -11.88 35.28 -47.45 -10.64 coo -9.52 75.74 33.62 -8.85 73.74 33.93 26.68 -52.06 -7.74 25.46 -53.53 -8.54 coo -4.44 67.20 42.32 -7.50 62.41 40.49 20.98 -41.61 -5.49 23.04 -43.67 -10.44 1ax4_c06 source 1ax4 TRYPTOPHANASE : 13 hits 1ax4_c06 naa= 3 ULMN 3 1ax4_c07 TRYPTOPHANASE user 1 3 # 1 D 130 PHE A 12 PHE^? 6.66 C16 C8E A 209 D 223 ASP A 45 ASP.? -2.96 CA CA A 208s D 265 LYS A 188 LYS~? 10.77 C20 C8E A 210 coo -38.60 55.38 52.70 -40.06 57.72 53.04 71.82 -60.62 -24.43 72.20 -63.22 -23.50 coo -29.46 51.67 48.51 -28.63 53.31 49.56 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo -18.87 56.53 54.79 -19.47 62.22 53.03 68.32 -80.18 -18.11 71.95 -84.24 -15.84 ULMN 3 1ax4_c07 TRYPTOPHANASE user 2 3 # 2 D 130 PHE A 68 PHE.? 12.64 CA CA A 208 D 223 ASP A 49 ASP.? -3.00 CA CA A 208s D 265 LYS A 188 LYS~? 10.77 C20 C8E A 210 coo -38.60 55.38 52.70 -40.06 57.72 53.04 69.51 -83.16 -37.04 69.32 -85.92 -37.33 coo -29.46 51.67 48.51 -28.63 53.31 49.56 75.72 -77.89 -27.98 74.67 -77.10 -29.65 coo -18.87 56.53 54.79 -19.47 62.22 53.03 68.32 -80.18 -18.11 71.95 -84.24 -15.84 ULMN 3 1ax4_c07 TRYPTOPHANASE user 3 3 # 3 D 130 PHE A 105 PHE^? 4.85 O21 C8E A 209 D 223 ASP A 45 ASP.? -2.96 CA CA A 208s D 265 LYS A 63 LYS~? 3.96 CA CA A 208 coo -38.60 55.38 52.70 -40.06 57.72 53.04 61.29 -71.83 -24.77 63.18 -73.65 -25.72 coo -29.46 51.67 48.51 -28.63 53.31 49.56 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo -18.87 56.53 54.79 -19.47 62.22 53.03 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 1ax4_c07 TRYPTOPHANASE user 4 3 # 4 D 130 PHE A 105 PHE^? 4.85 O21 C8E A 209 D 223 ASP A 48 ASP.? 7.38 CA CA A 208 D 265 LYS A 63 LYS~? 3.96 CA CA A 208 coo -38.60 55.38 52.70 -40.06 57.72 53.04 61.29 -71.83 -24.77 63.18 -73.65 -25.72 coo -29.46 51.67 48.51 -28.63 53.31 49.56 72.05 -78.20 -23.17 73.82 -77.79 -22.11 coo -18.87 56.53 54.79 -19.47 62.22 53.03 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 1ax4_c07 TRYPTOPHANASE user 5 3 # 5 D 130 PHE B 12 PHE^? 7.11 C16 C8E B 209 D 223 ASP B 45 ASP.? -3.07 CA CA B 208s D 265 LYS B 188 LYS~? 9.67 C16 C8E B 210 coo -38.60 55.38 52.70 -40.06 57.72 53.04 84.38 -39.21 -23.20 86.71 -38.33 -21.97 coo -29.46 51.67 48.51 -28.63 53.31 49.56 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo -18.87 56.53 54.79 -19.47 62.22 53.03 102.16 -28.74 -21.10 106.15 -31.37 -17.86 ULMN 3 1ax4_c07 TRYPTOPHANASE user 6 3 # 6 D 130 PHE B 16 PHE^? 10.76 C16 C8E B 209 D 223 ASP B 45 ASP.? -3.07 CA CA B 208s D 265 LYS B 63 LYS~? 3.79 CA CA B 208 coo -38.60 55.38 52.70 -40.06 57.72 53.04 80.83 -36.54 -19.88 82.09 -38.77 -18.74 coo -29.46 51.67 48.51 -28.63 53.31 49.56 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo -18.87 56.53 54.79 -19.47 62.22 53.03 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1ax4_c07 TRYPTOPHANASE user 7 3 # 7 D 130 PHE B 68 PHE.? 12.45 CA CA B 208 D 223 ASP B 49 ASP.? -3.05 CA CA B 208s D 265 LYS B 188 LYS~? 9.67 C16 C8E B 210 coo -38.60 55.38 52.70 -40.06 57.72 53.04 91.51 -19.54 -8.10 93.32 -17.88 -6.80 coo -29.46 51.67 48.51 -28.63 53.31 49.56 94.52 -28.97 -11.62 93.03 -30.41 -11.73 coo -18.87 56.53 54.79 -19.47 62.22 53.03 102.16 -28.74 -21.10 106.15 -31.37 -17.86 ULMN 3 1ax4_c07 TRYPTOPHANASE user 8 3 # 8 D 130 PHE B 105 PHE^? 5.21 C20 C8E B 209 D 223 ASP B 45 ASP.? -3.07 CA CA B 208s D 265 LYS B 63 LYS~? 3.79 CA CA B 208 coo -38.60 55.38 52.70 -40.06 57.72 53.04 90.70 -25.26 -25.77 91.65 -25.28 -23.14 coo -29.46 51.67 48.51 -28.63 53.31 49.56 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo -18.87 56.53 54.79 -19.47 62.22 53.03 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1ax4_c07 TRYPTOPHANASE user 9 3 # 9 D 130 PHE B 105 PHE^? 5.21 C20 C8E B 209 D 223 ASP B 48 ASP.? 7.20 CA CA B 208 D 265 LYS B 63 LYS~? 3.79 CA CA B 208 coo -38.60 55.38 52.70 -40.06 57.72 53.04 90.70 -25.26 -25.77 91.65 -25.28 -23.14 coo -29.46 51.67 48.51 -28.63 53.31 49.56 97.60 -30.12 -16.68 98.20 -32.01 -15.99 coo -18.87 56.53 54.79 -19.47 62.22 53.03 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1ax4_c07 TRYPTOPHANASE user 10 3 # 10 D 130 PHE B 160 PHE^? 5.74 O21 C8E B 210 D 223 ASP B 48 ASP.? 7.20 CA CA B 208 D 265 LYS B 63 LYS~? 3.79 CA CA B 208 coo -38.60 55.38 52.70 -40.06 57.72 53.04 97.82 -21.95 -26.27 98.06 -24.71 -26.08 coo -29.46 51.67 48.51 -28.63 53.31 49.56 97.60 -30.12 -16.68 98.20 -32.01 -15.99 coo -18.87 56.53 54.79 -19.47 62.22 53.03 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1ax4_c07 TRYPTOPHANASE user 11 3 # 11 D 130 PHE C 12 PHE^? 6.93 C16 C8E C 210 D 223 ASP C 45 ASP.? 3.27 CA CA C 208s D 265 LYS C 188 LYS~? 9.02 C16 C8E C 209 coo -38.60 55.38 52.70 -40.06 57.72 53.04 30.57 -52.31 -25.04 29.52 -53.06 -22.58 coo -29.46 51.67 48.51 -28.63 53.31 49.56 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo -18.87 56.53 54.79 -19.47 62.22 53.03 31.07 -55.82 -4.30 26.58 -58.21 -2.57 ULMN 3 1ax4_c07 TRYPTOPHANASE user 12 3 # 12 D 130 PHE C 68 PHE.? 11.96 CA CA C 208 D 223 ASP C 49 ASP.? -2.87 CA CA C 208s D 265 LYS C 188 LYS~? 9.02 C16 C8E C 209 coo -38.60 55.38 52.70 -40.06 57.72 53.04 23.80 -38.52 -4.60 23.26 -38.36 -1.88 coo -29.46 51.67 48.51 -28.63 53.31 49.56 22.13 -48.50 -9.42 23.00 -46.66 -10.00 coo -18.87 56.53 54.79 -19.47 62.22 53.03 31.07 -55.82 -4.30 26.58 -58.21 -2.57 ULMN 3 1ax4_c07 TRYPTOPHANASE user 13 3 # 13 D 130 PHE C 105 PHE^? -4.13 O21 C8E C 210s D 223 ASP C 45 ASP.? 3.27 CA CA C 208s D 265 LYS C 63 LYS~? 4.21 CA CA C 208 coo -38.60 55.38 52.70 -40.06 57.72 53.04 37.70 -47.93 -11.88 35.28 -47.45 -10.64 coo -29.46 51.67 48.51 -28.63 53.31 49.56 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo -18.87 56.53 54.79 -19.47 62.22 53.03 20.98 -41.61 -5.49 23.04 -43.67 -10.44 ULMN 3 1ax4_c07 TRYPTOPHANASE user 14 3 # 14 D 130 PHE C 105 PHE^? -4.13 O21 C8E C 210s D 223 ASP C 48 ASP.? 7.17 CA CA C 208 D 265 LYS C 63 LYS~? 4.21 CA CA C 208 coo -38.60 55.38 52.70 -40.06 57.72 53.04 37.70 -47.93 -11.88 35.28 -47.45 -10.64 coo -29.46 51.67 48.51 -28.63 53.31 49.56 26.68 -52.06 -7.74 25.46 -53.53 -8.54 coo -18.87 56.53 54.79 -19.47 62.22 53.03 20.98 -41.61 -5.49 23.04 -43.67 -10.44 1ax4_c07 source 1ax4 TRYPTOPHANASE : 14 hits 1ax4_c07 naa= 3 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 1 3 # 1 A 140 TRP A 59 TRP~? 6.21 CA CA A 208 A 222 ASP A 45 ASP.? -2.96 CA CA A 208s A 258 LYS A 188 LYS~? 10.77 C20 C8E A 210 coo 89.83 15.40 0.01 90.61 18.86 1.71 71.67 -80.29 -29.02 69.69 -82.14 -31.86 coo 82.92 20.43 2.47 84.82 20.45 1.55 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 68.32 -80.18 -18.11 71.95 -84.24 -15.84 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 2 3 # 2 A 140 TRP A 71 TRP^? 11.26 CA CA A 208 A 222 ASP A 45 ASP.? -2.96 CA CA A 208s A 258 LYS A 63 LYS~? 3.96 CA CA A 208 coo 89.83 15.40 0.01 90.61 18.86 1.71 63.94 -74.90 -35.16 60.97 -73.12 -33.30 coo 82.92 20.43 2.47 84.82 20.45 1.55 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 3 3 # 3 A 140 TRP B 59 TRP~? 6.11 CA CA B 208 A 222 ASP B 45 ASP.? -3.07 CA CA B 208s A 258 LYS B 188 LYS~? 9.67 C16 C8E B 210 coo 89.83 15.40 0.01 90.61 18.86 1.71 95.08 -26.15 -12.40 94.38 -22.43 -11.38 coo 82.92 20.43 2.47 84.82 20.45 1.55 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 102.16 -28.74 -21.10 106.15 -31.37 -17.86 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 4 3 # 4 A 140 TRP C 59 TRP~? 6.20 CA CA C 208 A 222 ASP C 45 ASP.? 3.27 CA CA C 208s A 258 LYS C 188 LYS~? 9.02 C16 C8E C 209 coo 89.83 15.40 0.01 90.61 18.86 1.71 24.77 -46.37 -6.57 25.55 -42.98 -4.73 coo 82.92 20.43 2.47 84.82 20.45 1.55 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 31.07 -55.82 -4.30 26.58 -58.21 -2.57 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 5 3 # 5 A 140 TRP C 59 TRP~? 6.20 CA CA C 208 A 222 ASP C 61 ASP~? 12.61 CA CA C 208 A 258 LYS C 67 LYS.? 18.71 CA CA C 208 coo 89.83 15.40 0.01 90.61 18.86 1.71 24.77 -46.37 -6.57 25.55 -42.98 -4.73 coo 82.92 20.43 2.47 84.82 20.45 1.55 16.71 -46.53 -3.05 15.59 -48.22 -3.69 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 20.04 -36.06 -6.98 16.11 -31.17 -7.78 1ay4_c02 source 1ay4 AROMATIC AMINO ACID AMINOTRANSFERASE : 5 hits 1ay4_c02 naa= 3 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 1 3 # 1 B 140 TRP A 59 TRP~? 6.21 CA CA A 208 B 222 ASP A 45 ASP.? -2.96 CA CA A 208s B 258 LYS A 188 LYS~? 10.77 C20 C8E A 210 coo 103.45 44.39 16.20 102.66 41.02 14.32 71.67 -80.29 -29.02 69.69 -82.14 -31.86 coo 110.10 38.66 15.58 108.40 39.41 14.53 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo 107.51 45.54 4.76 105.41 44.51 10.25 68.32 -80.18 -18.11 71.95 -84.24 -15.84 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 2 3 # 2 B 140 TRP A 59 TRP~? 6.21 CA CA A 208 B 222 ASP A 52 ASP.? 15.11 CA CA A 208 B 258 LYS A 188 LYS~? 10.77 C20 C8E A 210 coo 103.45 44.39 16.20 102.66 41.02 14.32 71.67 -80.29 -29.02 69.69 -82.14 -31.86 coo 110.10 38.66 15.58 108.40 39.41 14.53 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo 107.51 45.54 4.76 105.41 44.51 10.25 68.32 -80.18 -18.11 71.95 -84.24 -15.84 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 3 3 # 3 B 140 TRP A 59 TRP~? 6.21 CA CA A 208 B 222 ASP A 61 ASP~? 12.37 CA CA A 208 B 258 LYS A 67 LYS~? 13.30 CA CA A 208 coo 103.45 44.39 16.20 102.66 41.02 14.32 71.67 -80.29 -29.02 69.69 -82.14 -31.86 coo 110.10 38.66 15.58 108.40 39.41 14.53 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo 107.51 45.54 4.76 105.41 44.51 10.25 73.21 -82.07 -40.14 71.59 -78.49 -41.85 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 4 3 # 4 B 140 TRP A 71 TRP^? 11.26 CA CA A 208 B 222 ASP A 45 ASP.? -2.96 CA CA A 208s B 258 LYS A 63 LYS~? 3.96 CA CA A 208 coo 103.45 44.39 16.20 102.66 41.02 14.32 63.94 -74.90 -35.16 60.97 -73.12 -33.30 coo 110.10 38.66 15.58 108.40 39.41 14.53 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo 107.51 45.54 4.76 105.41 44.51 10.25 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 5 3 # 5 B 140 TRP B 59 TRP~? 6.11 CA CA B 208 B 222 ASP B 45 ASP.? -3.07 CA CA B 208s B 258 LYS B 188 LYS~? 9.67 C16 C8E B 210 coo 103.45 44.39 16.20 102.66 41.02 14.32 95.08 -26.15 -12.40 94.38 -22.43 -11.38 coo 110.10 38.66 15.58 108.40 39.41 14.53 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo 107.51 45.54 4.76 105.41 44.51 10.25 102.16 -28.74 -21.10 106.15 -31.37 -17.86 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 6 3 # 6 B 140 TRP B 59 TRP~? 6.11 CA CA B 208 B 222 ASP B 61 ASP~? 12.48 CA CA B 208 B 258 LYS B 67 LYS~? 18.13 CA CA B 208 coo 103.45 44.39 16.20 102.66 41.02 14.32 95.08 -26.15 -12.40 94.38 -22.43 -11.38 coo 110.10 38.66 15.58 108.40 39.41 14.53 98.68 -27.22 -4.60 99.30 -29.23 -4.23 coo 107.51 45.54 4.76 105.41 44.51 10.25 89.12 -21.41 -4.23 87.66 -21.56 1.71 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 7 3 # 7 B 140 TRP C 59 TRP~? 6.20 CA CA C 208 B 222 ASP C 45 ASP.? 3.27 CA CA C 208s B 258 LYS C 188 LYS~? 9.02 C16 C8E C 209 coo 103.45 44.39 16.20 102.66 41.02 14.32 24.77 -46.37 -6.57 25.55 -42.98 -4.73 coo 110.10 38.66 15.58 108.40 39.41 14.53 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo 107.51 45.54 4.76 105.41 44.51 10.25 31.07 -55.82 -4.30 26.58 -58.21 -2.57 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 8 3 # 8 B 140 TRP C 59 TRP~? 6.20 CA CA C 208 B 222 ASP C 61 ASP~? 12.61 CA CA C 208 B 258 LYS C 67 LYS.? 18.71 CA CA C 208 coo 103.45 44.39 16.20 102.66 41.02 14.32 24.77 -46.37 -6.57 25.55 -42.98 -4.73 coo 110.10 38.66 15.58 108.40 39.41 14.53 16.71 -46.53 -3.05 15.59 -48.22 -3.69 coo 107.51 45.54 4.76 105.41 44.51 10.25 20.04 -36.06 -6.98 16.11 -31.17 -7.78 1ay4_c03 source 1ay4 AROMATIC AMINO ACID AMINOTRANSFERASE : 8 hits 1ay4_c03 naa= 3 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 1 3 # 1 A 85 HIS B 0 HIS.? 33.03 C1 C8E B 210 A 171 ARG B 36 ARG^? 17.08 O15 C8E B 209 A 190 LYS B 3 LYS^? 35.51 O15 C8E B 209 coo 22.59 2.26 43.22 21.17 3.47 42.27 70.48 -35.36 -55.71 72.36 -34.80 -54.96 coo 13.63 3.81 28.83 14.49 2.91 31.59 77.67 -37.50 -38.51 79.47 -39.58 -37.24 coo 24.97 7.47 37.69 21.24 10.69 35.89 68.65 -39.32 -48.24 67.06 -43.09 -50.47 1azy_c00 source 1azy THYMIDINE PHOSPHORYLASE : 1 hits 1azy_c00 naa= 3 ULMN 3 1azy_c01 THYMIDINE PHOSPHORYLASE user 1 3 # 1 B 85 HIS B 0 HIS.? 33.03 C1 C8E B 210 B 171 ARG B 36 ARG^? 17.08 O15 C8E B 209 B 190 LYS B 3 LYS^? 35.51 O15 C8E B 209 coo -6.44 4.86 -3.45 -5.03 5.97 -2.36 70.48 -35.36 -55.71 72.36 -34.80 -54.96 coo 2.83 4.83 10.84 1.96 4.32 7.97 77.67 -37.50 -38.51 79.47 -39.58 -37.24 coo -8.96 9.04 2.88 -5.39 12.11 5.08 68.65 -39.32 -48.24 67.06 -43.09 -50.47 1azy_c01 source 1azy THYMIDINE PHOSPHORYLASE : 1 hits 1azy_c01 naa= 3 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 1 3 # 1 A 109 ASP A 153 ASP^? 8.28 C1 C8E A 210 A 182 GLU A 194 GLU.? 3.11 C17 C8E A 210s A 286 ASN A 103 ASN^? 6.31 O21 C8E A 209 coo 26.03 44.66 108.90 25.67 42.61 108.82 63.37 -61.81 -16.17 62.75 -59.91 -16.84 coo 18.06 44.02 105.38 18.08 45.37 107.03 66.12 -70.72 -14.05 67.03 -72.48 -13.31 coo 25.47 38.28 112.06 27.26 39.30 111.54 58.51 -66.15 -21.33 59.95 -66.28 -22.87 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 2 3 # 2 A 109 ASP B 153 ASP^? 9.57 O15 C8E B 209 A 182 GLU B 194 GLU.? 2.86 C13 C8E B 210s A 286 ASN B 103 ASN^? 6.73 O21 C8E B 209 coo 26.03 44.66 108.90 25.67 42.61 108.82 89.74 -36.17 -33.46 87.76 -36.55 -34.22 coo 18.06 44.02 105.38 18.08 45.37 107.03 97.88 -33.97 -28.78 99.62 -34.16 -27.58 coo 25.47 38.28 112.06 27.26 39.30 111.54 88.46 -28.09 -32.02 87.63 -28.23 -30.06 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 3 3 # 3 A 109 ASP C 153 ASP^? 9.83 C13 C8E C 210 A 182 GLU C 194 GLU.? 3.24 O15 C8E C 209s A 286 ASN C 103 ASN^? 6.32 C20 C8E C 210 coo 26.03 44.66 108.90 25.67 42.61 108.82 40.09 -57.62 -20.90 41.26 -57.13 -22.61 coo 18.06 44.02 105.38 18.08 45.37 107.03 36.17 -59.59 -12.28 34.91 -60.51 -10.83 coo 25.47 38.28 112.06 27.26 39.30 111.54 42.54 -50.86 -16.42 40.88 -49.65 -16.80 1b57_c00 source 1b57 FRUCTOSE-BISPHOSPHATE ALDOLASE II : 3 hits 1b57_c00 naa= 3 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 1 3 # 1 B 109 ASP A 153 ASP^? 8.28 C1 C8E A 210 B 182 GLU A 194 GLU.? 3.11 C17 C8E A 210s B 286 ASN A 103 ASN^? 6.31 O21 C8E A 209 coo 13.82 69.26 132.27 11.87 70.14 132.51 63.37 -61.81 -16.17 62.75 -59.91 -16.84 coo 8.74 63.05 136.42 9.87 62.19 134.79 66.12 -70.72 -14.05 67.03 -72.48 -13.31 coo 8.26 72.60 129.22 10.14 73.45 129.80 58.51 -66.15 -21.33 59.95 -66.28 -22.87 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 2 3 # 2 B 109 ASP B 153 ASP^? 9.57 O15 C8E B 209 B 182 GLU B 194 GLU.? 2.86 C13 C8E B 210s B 286 ASN B 103 ASN^? 6.73 O21 C8E B 209 coo 13.82 69.26 132.27 11.87 70.14 132.51 89.74 -36.17 -33.46 87.76 -36.55 -34.22 coo 8.74 63.05 136.42 9.87 62.19 134.79 97.88 -33.97 -28.78 99.62 -34.16 -27.58 coo 8.26 72.60 129.22 10.14 73.45 129.80 88.46 -28.09 -32.02 87.63 -28.23 -30.06 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 3 3 # 3 B 109 ASP C 153 ASP^? 9.83 C13 C8E C 210 B 182 GLU C 194 GLU.? 3.24 O15 C8E C 209s B 286 ASN C 103 ASN^? 6.32 C20 C8E C 210 coo 13.82 69.26 132.27 11.87 70.14 132.51 40.09 -57.62 -20.90 41.26 -57.13 -22.61 coo 8.74 63.05 136.42 9.87 62.19 134.79 36.17 -59.59 -12.28 34.91 -60.51 -10.83 coo 8.26 72.60 129.22 10.14 73.45 129.80 42.54 -50.86 -16.42 40.88 -49.65 -16.80 1b57_c01 source 1b57 FRUCTOSE-BISPHOSPHATE ALDOLASE II : 3 hits 1b57_c01 naa= 3 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 1 3 # 1 A 88 PHE A 68 PHE.? 12.64 CA CA A 208 A 159 ASP A 114 ASP.? 22.11 CA CA A 208 A 188 LYS A 119 LYS.? 17.79 CA CA A 208 coo 13.91 34.58 14.67 12.95 36.00 12.47 69.51 -83.16 -37.04 69.32 -85.92 -37.33 coo 20.97 28.40 16.26 20.19 30.15 15.34 71.50 -87.46 -45.26 70.62 -89.18 -46.15 coo 22.55 41.65 15.60 18.92 37.20 14.63 60.88 -84.29 -40.26 61.29 -87.76 -35.50 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 2 3 # 2 A 88 PHE A 105 PHE^? 4.85 O21 C8E A 209 A 159 ASP A 45 ASP.? -2.96 CA CA A 208s A 188 LYS A 188 LYS~? 10.77 C20 C8E A 210 coo 13.91 34.58 14.67 12.95 36.00 12.47 61.29 -71.83 -24.77 63.18 -73.65 -25.72 coo 20.97 28.40 16.26 20.19 30.15 15.34 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo 22.55 41.65 15.60 18.92 37.20 14.63 68.32 -80.18 -18.11 71.95 -84.24 -15.84 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 3 3 # 3 A 88 PHE A 160 PHE^? 5.84 O21 C8E A 210 A 159 ASP A 180 ASP.? 14.47 O15 C8E A 210 A 188 LYS A 188 LYS~? 10.77 C20 C8E A 210 coo 13.91 34.58 14.67 12.95 36.00 12.47 59.20 -78.65 -21.19 61.28 -77.31 -20.00 coo 20.97 28.40 16.26 20.19 30.15 15.34 55.45 -86.10 -15.44 53.65 -85.04 -15.38 coo 22.55 41.65 15.60 18.92 37.20 14.63 68.32 -80.18 -18.11 71.95 -84.24 -15.84 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 4 3 # 4 A 88 PHE A 189 PHE~? 8.72 CA CA A 208 A 159 ASP A 45 ASP.? -2.96 CA CA A 208s A 188 LYS A 63 LYS~? 3.96 CA CA A 208 coo 13.91 34.58 14.67 12.95 36.00 12.47 68.20 -82.10 -23.88 68.92 -82.62 -26.53 coo 20.97 28.40 16.26 20.19 30.15 15.34 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo 22.55 41.65 15.60 18.92 37.20 14.63 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 5 3 # 5 A 88 PHE A 189 PHE~? 8.72 CA CA A 208 A 159 ASP A 52 ASP.? 15.11 CA CA A 208 A 188 LYS A 63 LYS~? 3.96 CA CA A 208 coo 13.91 34.58 14.67 12.95 36.00 12.47 68.20 -82.10 -23.88 68.92 -82.62 -26.53 coo 20.97 28.40 16.26 20.19 30.15 15.34 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo 22.55 41.65 15.60 18.92 37.20 14.63 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 6 3 # 6 A 88 PHE B 16 PHE^? 10.76 C16 C8E B 209 A 159 ASP B 45 ASP.? -3.07 CA CA B 208s A 188 LYS B 198 LYS^? 12.15 O15 C8E B 209 coo 13.91 34.58 14.67 12.95 36.00 12.47 80.83 -36.54 -19.88 82.09 -38.77 -18.74 coo 20.97 28.40 16.26 20.19 30.15 15.34 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo 22.55 41.65 15.60 18.92 37.20 14.63 85.01 -40.11 -29.09 83.85 -38.63 -34.53 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 7 3 # 7 A 88 PHE B 68 PHE.? 12.45 CA CA B 208 A 159 ASP B 114 ASP.? 22.07 CA CA B 208 A 188 LYS B 119 LYS.? 18.40 CA CA B 208 coo 13.91 34.58 14.67 12.95 36.00 12.47 91.51 -19.54 -8.10 93.32 -17.88 -6.80 coo 20.97 28.40 16.26 20.19 30.15 15.34 88.69 -13.97 -0.41 89.97 -12.27 -0.12 coo 22.55 41.65 15.60 18.92 37.20 14.63 89.22 -11.21 -11.71 95.34 -11.17 -12.31 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 8 3 # 8 A 88 PHE B 105 PHE^? 5.21 C20 C8E B 209 A 159 ASP B 45 ASP.? -3.07 CA CA B 208s A 188 LYS B 188 LYS~? 9.67 C16 C8E B 210 coo 13.91 34.58 14.67 12.95 36.00 12.47 90.70 -25.26 -25.77 91.65 -25.28 -23.14 coo 20.97 28.40 16.26 20.19 30.15 15.34 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo 22.55 41.65 15.60 18.92 37.20 14.63 102.16 -28.74 -21.10 106.15 -31.37 -17.86 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 9 3 # 9 A 88 PHE B 160 PHE^? 5.74 O21 C8E B 210 A 159 ASP B 180 ASP.? 10.93 C4 C8E B 210 A 188 LYS B 188 LYS~? 9.67 C16 C8E B 210 coo 13.91 34.58 14.67 12.95 36.00 12.47 97.82 -21.95 -26.27 98.06 -24.71 -26.08 coo 20.97 28.40 16.26 20.19 30.15 15.34 106.50 -18.19 -29.27 105.54 -17.21 -30.85 coo 22.55 41.65 15.60 18.92 37.20 14.63 102.16 -28.74 -21.10 106.15 -31.37 -17.86 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 10 3 # 10 A 88 PHE B 189 PHE~? 8.56 CA CA B 208 A 159 ASP B 45 ASP.? -3.07 CA CA B 208s A 188 LYS B 63 LYS~? 3.79 CA CA B 208 coo 13.91 34.58 14.67 12.95 36.00 12.47 99.55 -24.92 -16.99 98.05 -23.95 -14.81 coo 20.97 28.40 16.26 20.19 30.15 15.34 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo 22.55 41.65 15.60 18.92 37.20 14.63 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 11 3 # 11 A 88 PHE B 189 PHE~? 8.56 CA CA B 208 A 159 ASP B 52 ASP.? 15.59 CA CA B 208 A 188 LYS B 63 LYS~? 3.79 CA CA B 208 coo 13.91 34.58 14.67 12.95 36.00 12.47 99.55 -24.92 -16.99 98.05 -23.95 -14.81 coo 20.97 28.40 16.26 20.19 30.15 15.34 105.61 -28.95 -11.53 106.78 -28.70 -9.81 coo 22.55 41.65 15.60 18.92 37.20 14.63 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 12 3 # 12 A 88 PHE C 16 PHE^? 10.45 C16 C8E C 210 A 159 ASP C 45 ASP.? 3.27 CA CA C 208s A 188 LYS C 198 LYS^? 12.94 C13 C8E C 210 coo 13.91 34.58 14.67 12.95 36.00 12.47 29.17 -47.03 -25.43 27.11 -48.90 -25.82 coo 20.97 28.40 16.26 20.19 30.15 15.34 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo 22.55 41.65 15.60 18.92 37.20 14.63 35.43 -55.44 -26.10 41.10 -55.85 -26.89 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 13 3 # 13 A 88 PHE C 68 PHE.? 11.96 CA CA C 208 A 159 ASP C 114 ASP.? 22.22 CA CA C 208 A 188 LYS C 119 LYS.? 22.44 CA CA C 208 coo 13.91 34.58 14.67 12.95 36.00 12.47 23.80 -38.52 -4.60 23.26 -38.36 -1.88 coo 20.97 28.40 16.26 20.19 30.15 15.34 19.39 -30.14 -1.59 19.46 -28.98 0.18 coo 22.55 41.65 15.60 18.92 37.20 14.63 30.81 -32.05 -1.80 31.88 -31.87 3.92 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 14 3 # 14 A 88 PHE C 105 PHE^? -4.13 O21 C8E C 210s A 159 ASP C 45 ASP.? 3.27 CA CA C 208s A 188 LYS C 188 LYS~? 9.02 C16 C8E C 209 coo 13.91 34.58 14.67 12.95 36.00 12.47 37.70 -47.93 -11.88 35.28 -47.45 -10.64 coo 20.97 28.40 16.26 20.19 30.15 15.34 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo 22.55 41.65 15.60 18.92 37.20 14.63 31.07 -55.82 -4.30 26.58 -58.21 -2.57 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 15 3 # 15 A 88 PHE C 160 PHE^? 5.66 O21 C8E C 209 A 159 ASP C 180 ASP.? 12.29 C5 C8E C 209 A 188 LYS C 188 LYS~? 9.02 C16 C8E C 209 coo 13.91 34.58 14.67 12.95 36.00 12.47 38.86 -50.43 -4.43 37.56 -52.24 -6.09 coo 20.97 28.40 16.26 20.19 30.15 15.34 42.24 -54.49 3.97 44.24 -53.90 3.82 coo 22.55 41.65 15.60 18.92 37.20 14.63 31.07 -55.82 -4.30 26.58 -58.21 -2.57 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 16 3 # 16 A 88 PHE C 189 PHE~? 9.03 CA CA C 208 A 159 ASP C 45 ASP.? 3.27 CA CA C 208s A 188 LYS C 63 LYS~? 4.21 CA CA C 208 coo 13.91 34.58 14.67 12.95 36.00 12.47 29.10 -50.14 -3.03 27.67 -47.71 -3.13 coo 20.97 28.40 16.26 20.19 30.15 15.34 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo 22.55 41.65 15.60 18.92 37.20 14.63 20.98 -41.61 -5.49 23.04 -43.67 -10.44 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 17 3 # 17 A 88 PHE C 189 PHE~? 9.03 CA CA C 208 A 159 ASP C 52 ASP.? 15.77 CA CA C 208 A 188 LYS C 63 LYS~? 4.21 CA CA C 208 coo 13.91 34.58 14.67 12.95 36.00 12.47 29.10 -50.14 -3.03 27.67 -47.71 -3.13 coo 20.97 28.40 16.26 20.19 30.15 15.34 21.29 -54.58 -0.38 20.26 -54.47 1.43 coo 22.55 41.65 15.60 18.92 37.20 14.63 20.98 -41.61 -5.49 23.04 -43.67 -10.44 1b9h_c02 source 1b9h 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHASE : 17 hits 1b9h_c02 naa= 3 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 A 137 ARG A 162 ARG^? 10.87 O21 C8E A 210 A 141 THR A 161 THR^? 14.36 O21 C8E A 210 A 235 ASP A 111 ASP.? 17.05 CA CA A 208 coo 6.21 93.81 36.58 4.58 96.33 37.17 60.16 -83.54 -27.36 63.31 -83.18 -27.03 coo 6.80 92.87 28.33 4.91 92.74 27.40 54.89 -79.58 -24.95 52.94 -78.87 -25.32 coo 12.98 90.36 47.57 11.26 89.62 46.62 65.36 -83.80 -40.24 66.17 -85.36 -41.35 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 A 137 ARG B 162 ARG^? 16.35 O21 C8E B 210 A 141 THR B 161 THR^? 13.87 C2 C8E B 210 A 235 ASP B 111 ASP.? 16.97 CA CA B 208 coo 6.21 93.81 36.58 4.58 96.33 37.17 96.21 -15.01 -19.71 98.63 -13.28 -19.03 coo 6.80 92.87 28.33 4.91 92.74 27.40 95.26 -16.61 -26.72 94.31 -15.20 -28.05 coo 12.98 90.36 47.57 11.26 89.62 46.62 89.21 -14.92 -8.80 89.40 -13.99 -6.98 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 A 137 ARG C 162 ARG^? 16.00 O21 C8E C 209 A 141 THR C 161 THR^? 14.40 O21 C8E C 209 A 235 ASP C 111 ASP.? 17.21 CA CA C 208 coo 6.21 93.81 36.58 4.58 96.33 37.17 35.66 -43.15 0.12 35.66 -43.03 3.18 coo 6.80 92.87 28.33 4.91 92.74 27.40 41.89 -45.49 -3.13 43.84 -44.64 -3.41 coo 12.98 90.36 47.57 11.26 89.62 46.62 27.11 -33.17 -3.90 25.73 -31.94 -3.00 1bd3_c00 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 3 hits 1bd3_c00 naa= 3 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 D 137 ARG A 162 ARG^? 10.87 O21 C8E A 210 D 141 THR A 161 THR^? 14.36 O21 C8E A 210 D 235 ASP A 111 ASP.? 17.05 CA CA A 208 coo -8.33 92.80 100.06 -7.71 95.33 98.44 60.16 -83.54 -27.36 63.31 -83.18 -27.03 coo -9.24 93.49 108.77 -7.37 94.21 109.61 54.89 -79.58 -24.95 52.94 -78.87 -25.32 coo -14.64 87.74 89.51 -12.89 87.43 90.65 65.36 -83.80 -40.24 66.17 -85.36 -41.35 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 D 137 ARG B 162 ARG^? 16.35 O21 C8E B 210 D 141 THR B 161 THR^? 13.87 C2 C8E B 210 D 235 ASP B 111 ASP.? 16.97 CA CA B 208 coo -8.33 92.80 100.06 -7.71 95.33 98.44 96.21 -15.01 -19.71 98.63 -13.28 -19.03 coo -9.24 93.49 108.77 -7.37 94.21 109.61 95.26 -16.61 -26.72 94.31 -15.20 -28.05 coo -14.64 87.74 89.51 -12.89 87.43 90.65 89.21 -14.92 -8.80 89.40 -13.99 -6.98 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 D 137 ARG C 162 ARG^? 16.00 O21 C8E C 209 D 141 THR C 161 THR^? 14.40 O21 C8E C 209 D 235 ASP C 111 ASP.? 17.21 CA CA C 208 coo -8.33 92.80 100.06 -7.71 95.33 98.44 35.66 -43.15 0.12 35.66 -43.03 3.18 coo -9.24 93.49 108.77 -7.37 94.21 109.61 41.89 -45.49 -3.13 43.84 -44.64 -3.41 coo -14.64 87.74 89.51 -12.89 87.43 90.65 27.11 -33.17 -3.90 25.73 -31.94 -3.00 1bd3_c01 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 3 hits 1bd3_c01 naa= 3 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 C 137 ARG A 162 ARG^? 10.87 O21 C8E A 210 C 141 THR A 161 THR^? 14.36 O21 C8E A 210 C 235 ASP A 111 ASP.? 17.05 CA CA A 208 coo -5.79 67.26 36.83 -4.57 64.58 37.74 60.16 -83.54 -27.36 63.31 -83.18 -27.03 coo -6.81 68.31 28.28 -4.82 68.47 27.57 54.89 -79.58 -24.95 52.94 -78.87 -25.32 coo -13.01 70.96 47.58 -11.44 71.65 46.34 65.36 -83.80 -40.24 66.17 -85.36 -41.35 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 C 137 ARG B 162 ARG^? 16.35 O21 C8E B 210 C 141 THR B 161 THR^? 13.87 C2 C8E B 210 C 235 ASP B 111 ASP.? 16.97 CA CA B 208 coo -5.79 67.26 36.83 -4.57 64.58 37.74 96.21 -15.01 -19.71 98.63 -13.28 -19.03 coo -6.81 68.31 28.28 -4.82 68.47 27.57 95.26 -16.61 -26.72 94.31 -15.20 -28.05 coo -13.01 70.96 47.58 -11.44 71.65 46.34 89.21 -14.92 -8.80 89.40 -13.99 -6.98 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 C 137 ARG B 162 ARG^? 16.35 O21 C8E B 210 C 141 THR B 161 THR^? 13.87 C2 C8E B 210 C 235 ASP B 167 ASP.? 22.72 CA CA B 208 coo -5.79 67.26 36.83 -4.57 64.58 37.74 96.21 -15.01 -19.71 98.63 -13.28 -19.03 coo -6.81 68.31 28.28 -4.82 68.47 27.57 95.26 -16.61 -26.72 94.31 -15.20 -28.05 coo -13.01 70.96 47.58 -11.44 71.65 46.34 88.92 -5.85 -9.56 88.92 -7.42 -8.19 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 C 137 ARG C 162 ARG^? 16.00 O21 C8E C 209 C 141 THR C 161 THR^? 14.40 O21 C8E C 209 C 235 ASP C 111 ASP.? 17.21 CA CA C 208 coo -5.79 67.26 36.83 -4.57 64.58 37.74 35.66 -43.15 0.12 35.66 -43.03 3.18 coo -6.81 68.31 28.28 -4.82 68.47 27.57 41.89 -45.49 -3.13 43.84 -44.64 -3.41 coo -13.01 70.96 47.58 -11.44 71.65 46.34 27.11 -33.17 -3.90 25.73 -31.94 -3.00 1bd3_c02 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 4 hits 1bd3_c02 naa= 3 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 B 137 ARG B 162 ARG^? 16.35 O21 C8E B 210 B 141 THR B 161 THR^? 13.87 C2 C8E B 210 B 235 ASP B 167 ASP.? 22.72 CA CA B 208 coo 8.13 67.41 100.27 7.18 68.35 97.45 96.21 -15.01 -19.71 98.63 -13.28 -19.03 coo 8.28 67.78 108.81 6.22 67.65 109.43 95.26 -16.61 -26.72 94.31 -15.20 -28.05 coo 14.55 73.52 89.47 12.81 73.95 90.56 88.92 -5.85 -9.56 88.92 -7.42 -8.19 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 B 137 ARG C 162 ARG^? 16.00 O21 C8E C 209 B 141 THR C 161 THR^? 14.40 O21 C8E C 209 B 235 ASP C 111 ASP.? 17.21 CA CA C 208 coo 8.13 67.41 100.27 7.18 68.35 97.45 35.66 -43.15 0.12 35.66 -43.03 3.18 coo 8.28 67.78 108.81 6.22 67.65 109.43 41.89 -45.49 -3.13 43.84 -44.64 -3.41 coo 14.55 73.52 89.47 12.81 73.95 90.56 27.11 -33.17 -3.90 25.73 -31.94 -3.00 1bd3_c03 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 2 hits 1bd3_c03 naa= 3 ULMN 3 1bf2_c00 ISOAMYLASE user 1 3 # 1 375 ASP A 111 ASP.? 17.05 CA CA A 208 435 GLU A 113 GLU.? 20.24 CA CA A 208 510 ASP A 167 ASP.? 22.50 CA CA A 208 coo 88.62 69.90 41.16 89.05 70.67 43.04 65.36 -83.80 -40.24 66.17 -85.36 -41.35 coo 89.52 76.11 40.17 89.01 75.16 41.97 67.94 -85.82 -46.11 66.40 -86.46 -44.83 coo 84.89 77.60 46.67 85.63 75.79 46.03 58.25 -87.45 -44.58 60.23 -87.13 -43.88 ULMN 3 1bf2_c00 ISOAMYLASE user 2 3 # 2 375 ASP A 185 ASP~? 11.73 O21 C8E A 210 435 GLU A 184 GLU~? 7.72 C16 C8E A 210 510 ASP A 180 ASP.? 14.47 O15 C8E A 210 coo 88.62 69.90 41.16 89.05 70.67 43.04 65.81 -86.27 -18.22 66.54 -87.64 -16.78 coo 89.52 76.11 40.17 89.01 75.16 41.97 63.73 -84.37 -12.45 63.45 -82.45 -11.70 coo 84.89 77.60 46.67 85.63 75.79 46.03 55.45 -86.10 -15.44 53.65 -85.04 -15.38 ULMN 3 1bf2_c00 ISOAMYLASE user 3 3 # 3 375 ASP B 111 ASP.? 16.97 CA CA B 208 435 GLU B 113 GLU.? 20.51 CA CA B 208 510 ASP B 167 ASP.? 22.72 CA CA B 208 coo 88.62 69.90 41.16 89.05 70.67 43.04 89.21 -14.92 -8.80 89.40 -13.99 -6.98 coo 89.52 76.11 40.17 89.01 75.16 41.97 86.78 -12.34 -3.10 88.60 -11.66 -4.00 coo 84.89 77.60 46.67 85.63 75.79 46.03 88.92 -5.85 -9.56 88.92 -7.42 -8.19 ULMN 3 1bf2_c00 ISOAMYLASE user 4 3 # 4 375 ASP B 166 ASP.? 24.17 CA CA B 208 435 GLU B 165 GLU^? 20.64 CA CA B 208 510 ASP B 111 ASP.? 16.97 CA CA B 208 coo 88.62 69.90 41.16 89.05 70.67 43.04 91.14 -5.33 -14.11 93.17 -5.00 -14.63 coo 89.52 76.11 40.17 89.01 75.16 41.97 88.15 -8.84 -16.79 86.14 -9.46 -16.74 coo 84.89 77.60 46.67 85.63 75.79 46.03 89.21 -14.92 -8.80 89.40 -13.99 -6.98 ULMN 3 1bf2_c00 ISOAMYLASE user 5 3 # 5 375 ASP B 167 ASP.? 22.72 CA CA B 208 435 GLU B 165 GLU^? 20.64 CA CA B 208 510 ASP B 111 ASP.? 16.97 CA CA B 208 coo 88.62 69.90 41.16 89.05 70.67 43.04 88.92 -5.85 -9.56 88.92 -7.42 -8.19 coo 89.52 76.11 40.17 89.01 75.16 41.97 88.15 -8.84 -16.79 86.14 -9.46 -16.74 coo 84.89 77.60 46.67 85.63 75.79 46.03 89.21 -14.92 -8.80 89.40 -13.99 -6.98 ULMN 3 1bf2_c00 ISOAMYLASE user 6 3 # 6 375 ASP B 185 ASP~? 11.63 O21 C8E B 210 435 GLU B 184 GLU~? 8.45 C14 C8E B 210 510 ASP B 180 ASP.? 10.93 C4 C8E B 210 coo 88.62 69.90 41.16 89.05 70.67 43.04 106.30 -23.80 -20.43 108.26 -24.54 -20.08 coo 89.52 76.11 40.17 89.01 75.16 41.97 107.80 -26.84 -26.43 109.06 -28.52 -26.54 coo 84.89 77.60 46.67 85.63 75.79 46.03 106.50 -18.19 -29.27 105.54 -17.21 -30.85 ULMN 3 1bf2_c00 ISOAMYLASE user 7 3 # 7 375 ASP C 45 ASP.? 3.27 CA CA C 208s 435 GLU C 70 GLU^? -2.71 CA CA C 208s 510 ASP C 49 ASP.? -2.87 CA CA C 208s coo 88.62 69.90 41.16 89.05 70.67 43.04 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo 89.52 76.11 40.17 89.01 75.16 41.97 27.73 -42.94 -10.42 26.74 -44.79 -10.37 coo 84.89 77.60 46.67 85.63 75.79 46.03 22.13 -48.50 -9.42 23.00 -46.66 -10.00 ULMN 3 1bf2_c00 ISOAMYLASE user 8 3 # 8 375 ASP C 49 ASP.? -2.87 CA CA C 208s 435 GLU C 70 GLU^? -2.71 CA CA C 208s 510 ASP C 45 ASP.? 3.27 CA CA C 208s coo 88.62 69.90 41.16 89.05 70.67 43.04 22.13 -48.50 -9.42 23.00 -46.66 -10.00 coo 89.52 76.11 40.17 89.01 75.16 41.97 27.73 -42.94 -10.42 26.74 -44.79 -10.37 coo 84.89 77.60 46.67 85.63 75.79 46.03 28.98 -48.61 -14.39 27.54 -48.99 -12.93 ULMN 3 1bf2_c00 ISOAMYLASE user 9 3 # 9 375 ASP C 61 ASP~? 12.61 CA CA C 208 435 GLU C 64 GLU~? 12.03 CA CA C 208 510 ASP C 49 ASP.? -2.87 CA CA C 208s coo 88.62 69.90 41.16 89.05 70.67 43.04 16.71 -46.53 -3.05 15.59 -48.22 -3.69 coo 89.52 76.11 40.17 89.01 75.16 41.97 16.47 -41.84 -8.31 14.60 -42.35 -9.15 coo 84.89 77.60 46.67 85.63 75.79 46.03 22.13 -48.50 -9.42 23.00 -46.66 -10.00 ULMN 3 1bf2_c00 ISOAMYLASE user 10 3 # 10 375 ASP C 111 ASP.? 17.21 CA CA C 208 435 GLU C 113 GLU.? 20.72 CA CA C 208 510 ASP C 167 ASP.? 25.18 CA CA C 208 coo 88.62 69.90 41.16 89.05 70.67 43.04 27.11 -33.17 -3.90 25.73 -31.94 -3.00 coo 89.52 76.11 40.17 89.01 75.16 41.97 22.93 -28.02 -2.65 24.78 -28.62 -1.78 coo 84.89 77.60 46.67 85.63 75.79 46.03 31.39 -27.44 2.08 30.34 -25.78 1.31 ULMN 3 1bf2_c00 ISOAMYLASE user 11 3 # 11 375 ASP C 166 ASP.? 24.81 CA CA C 208 435 GLU C 165 GLU^? 20.98 CA CA C 208 510 ASP C 111 ASP.? 17.21 CA CA C 208 coo 88.62 69.90 41.16 89.05 70.67 43.04 35.75 -30.25 2.83 35.54 -31.07 4.76 coo 89.52 76.11 40.17 89.01 75.16 41.97 36.32 -31.59 -2.15 36.97 -31.00 -4.08 coo 84.89 77.60 46.67 85.63 75.79 46.03 27.11 -33.17 -3.90 25.73 -31.94 -3.00 ULMN 3 1bf2_c00 ISOAMYLASE user 12 3 # 12 375 ASP C 167 ASP.? 25.18 CA CA C 208 435 GLU C 165 GLU^? 20.98 CA CA C 208 510 ASP C 111 ASP.? 17.21 CA CA C 208 coo 88.62 69.90 41.16 89.05 70.67 43.04 31.39 -27.44 2.08 30.34 -25.78 1.31 coo 89.52 76.11 40.17 89.01 75.16 41.97 36.32 -31.59 -2.15 36.97 -31.00 -4.08 coo 84.89 77.60 46.67 85.63 75.79 46.03 27.11 -33.17 -3.90 25.73 -31.94 -3.00 ULMN 3 1bf2_c00 ISOAMYLASE user 13 3 # 13 375 ASP C 185 ASP~? 11.81 O21 C8E C 209 435 GLU C 184 GLU~? 7.93 C14 C8E C 209 510 ASP C 180 ASP.? 12.29 C5 C8E C 209 coo 88.62 69.90 41.16 89.05 70.67 43.04 31.89 -54.53 1.93 31.11 -55.91 3.29 coo 89.52 76.11 40.17 89.01 75.16 41.97 35.72 -59.91 1.24 36.69 -61.13 -0.21 coo 84.89 77.60 46.67 85.63 75.79 46.03 42.24 -54.49 3.97 44.24 -53.90 3.82 1bf2_c00 source 1bf2 ISOAMYLASE : 13 hits 1bf2_c00 naa= 3 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 1 3 # 1 A 382 ARG A 135 ARG^? 21.29 C1 C8E A 210 A 451 GLU A 25 GLU^? 22.98 C2 C8E C 209 A 540 GLU A 93 GLU^? 23.51 C1 C8E A 210 coo 79.04 80.20 80.81 79.58 81.40 83.63 62.45 -46.81 -18.85 61.41 -44.79 -20.90 coo 81.34 87.29 87.22 82.36 86.09 88.61 56.22 -40.62 -18.58 57.98 -41.28 -19.55 coo 79.94 80.46 88.84 81.11 81.36 87.27 64.33 -40.66 -16.04 62.38 -40.13 -16.70 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 2 3 # 2 A 382 ARG B 135 ARG^? 22.88 O15 C8E B 209 A 451 GLU B 25 GLU^? 27.65 O15 C8E B 209 A 540 GLU B 93 GLU^? 27.23 O15 C8E B 209 coo 79.04 80.20 80.81 79.58 81.40 83.63 77.46 -42.45 -38.74 74.50 -42.61 -39.42 coo 81.34 87.29 87.22 82.36 86.09 88.61 73.50 -42.12 -45.68 71.97 -42.23 -44.24 coo 79.94 80.46 88.84 81.11 81.36 87.27 75.25 -49.35 -42.08 74.13 -47.63 -42.56 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 3 3 # 3 A 382 ARG B 135 ARG^? 22.88 O15 C8E B 209 A 451 GLU B 93 GLU^? 27.23 O15 C8E B 209 A 540 GLU B 25 GLU^? 27.65 O15 C8E B 209 coo 79.04 80.20 80.81 79.58 81.40 83.63 77.46 -42.45 -38.74 74.50 -42.61 -39.42 coo 81.34 87.29 87.22 82.36 86.09 88.61 75.25 -49.35 -42.08 74.13 -47.63 -42.56 coo 79.94 80.46 88.84 81.11 81.36 87.27 73.50 -42.12 -45.68 71.97 -42.23 -44.24 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 4 3 # 4 A 382 ARG C 135 ARG^? 23.87 C16 C8E C 210 A 451 GLU C 25 GLU.? 26.72 O21 C8E A 209 A 540 GLU C 93 GLU^? 26.90 C13 C8E C 210 coo 79.04 80.20 80.81 79.58 81.40 83.63 44.01 -56.05 -34.91 45.01 -54.65 -37.44 coo 81.34 87.29 87.22 82.36 86.09 88.61 50.80 -55.81 -38.99 49.16 -55.90 -40.32 coo 79.94 80.46 88.84 81.11 81.36 87.27 45.29 -60.19 -41.07 45.99 -58.52 -39.91 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 5 3 # 5 A 382 ARG C 162 ARG^? 16.00 O21 C8E C 209 A 451 GLU C 165 GLU^? 20.98 CA CA C 208 A 540 GLU C 164 GLU^? 20.06 CA CA C 208 coo 79.04 80.20 80.81 79.58 81.40 83.63 35.66 -43.15 0.12 35.66 -43.03 3.18 coo 81.34 87.29 87.22 82.36 86.09 88.61 36.32 -31.59 -2.15 36.97 -31.00 -4.08 coo 79.94 80.46 88.84 81.11 81.36 87.27 34.72 -37.11 1.76 34.46 -37.46 3.82 1bhg_c04 source 1bhg BETA-GLUCURONIDASE : 5 hits 1bhg_c04 naa= 3 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 1 3 # 1 B 382 ARG A 135 ARG^? 21.29 C1 C8E A 210 B 451 GLU A 25 GLU^? 22.98 C2 C8E C 209 B 540 GLU A 93 GLU^? 23.51 C1 C8E A 210 coo 82.21 41.07 119.14 83.95 40.66 116.59 62.45 -46.81 -18.85 61.41 -44.79 -20.90 coo 86.52 35.28 112.74 87.08 36.38 110.99 56.22 -40.62 -18.58 57.98 -41.28 -19.55 coo 83.38 41.19 112.55 85.47 40.59 112.72 64.33 -40.66 -16.04 62.38 -40.13 -16.70 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 2 3 # 2 B 382 ARG B 135 ARG^? 22.88 O15 C8E B 209 B 451 GLU B 25 GLU^? 27.65 O15 C8E B 209 B 540 GLU B 93 GLU^? 27.23 O15 C8E B 209 coo 82.21 41.07 119.14 83.95 40.66 116.59 77.46 -42.45 -38.74 74.50 -42.61 -39.42 coo 86.52 35.28 112.74 87.08 36.38 110.99 73.50 -42.12 -45.68 71.97 -42.23 -44.24 coo 83.38 41.19 112.55 85.47 40.59 112.72 75.25 -49.35 -42.08 74.13 -47.63 -42.56 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 3 3 # 3 B 382 ARG B 135 ARG^? 22.88 O15 C8E B 209 B 451 GLU B 93 GLU^? 27.23 O15 C8E B 209 B 540 GLU B 25 GLU^? 27.65 O15 C8E B 209 coo 82.21 41.07 119.14 83.95 40.66 116.59 77.46 -42.45 -38.74 74.50 -42.61 -39.42 coo 86.52 35.28 112.74 87.08 36.38 110.99 75.25 -49.35 -42.08 74.13 -47.63 -42.56 coo 83.38 41.19 112.55 85.47 40.59 112.72 73.50 -42.12 -45.68 71.97 -42.23 -44.24 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 4 3 # 4 B 382 ARG B 162 ARG^? 16.35 O21 C8E B 210 B 451 GLU B 165 GLU^? 20.64 CA CA B 208 B 540 GLU B 164 GLU^? 19.99 CA CA B 208 coo 82.21 41.07 119.14 83.95 40.66 116.59 96.21 -15.01 -19.71 98.63 -13.28 -19.03 coo 86.52 35.28 112.74 87.08 36.38 110.99 88.15 -8.84 -16.79 86.14 -9.46 -16.74 coo 83.38 41.19 112.55 85.47 40.59 112.72 94.70 -10.70 -16.52 96.59 -9.81 -16.07 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 5 3 # 5 B 382 ARG C 135 ARG^? 23.87 C16 C8E C 210 B 451 GLU C 25 GLU.? 26.72 O21 C8E A 209 B 540 GLU C 93 GLU^? 26.90 C13 C8E C 210 coo 82.21 41.07 119.14 83.95 40.66 116.59 44.01 -56.05 -34.91 45.01 -54.65 -37.44 coo 86.52 35.28 112.74 87.08 36.38 110.99 50.80 -55.81 -38.99 49.16 -55.90 -40.32 coo 83.38 41.19 112.55 85.47 40.59 112.72 45.29 -60.19 -41.07 45.99 -58.52 -39.91 1bhg_c05 source 1bhg BETA-GLUCURONIDASE : 5 hits 1bhg_c05 naa= 3 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 1 3 # 1 118 ARG A 36 ARG^? 15.77 C1 C8E A 210 183 LYS A 3 LYS^? 24.80 C20 C8E C 210 317 ARG C 200 ARG^? 12.04 C16 C8E C 210 coo 76.57 109.19 73.41 73.86 110.26 72.16 59.00 -50.13 -20.90 61.68 -51.06 -19.88 coo 82.09 117.51 66.37 80.60 114.32 71.44 52.63 -38.57 -20.93 53.13 -33.95 -19.17 coo 65.21 120.62 58.76 63.62 123.14 59.66 37.62 -50.12 -29.23 39.44 -51.00 -26.91 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 2 3 # 2 118 ARG A 135 ARG^? 21.29 C1 C8E A 210 183 LYS A 3 LYS^? 24.80 C20 C8E C 210 317 ARG C 36 ARG^? 17.98 C16 C8E C 210 coo 76.57 109.19 73.41 73.86 110.26 72.16 62.45 -46.81 -18.85 61.41 -44.79 -20.90 coo 82.09 117.51 66.37 80.60 114.32 71.44 52.63 -38.57 -20.93 53.13 -33.95 -19.17 coo 65.21 120.62 58.76 63.62 123.14 59.66 45.58 -52.92 -31.76 43.11 -54.70 -31.56 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 3 3 # 3 118 ARG A 135 ARG^? 21.29 C1 C8E A 210 183 LYS A 3 LYS^? 24.80 C20 C8E C 210 317 ARG C 101 ARG^? 13.82 C13 C8E C 210 coo 76.57 109.19 73.41 73.86 110.26 72.16 62.45 -46.81 -18.85 61.41 -44.79 -20.90 coo 82.09 117.51 66.37 80.60 114.32 71.44 52.63 -38.57 -20.93 53.13 -33.95 -19.17 coo 65.21 120.62 58.76 63.62 123.14 59.66 44.39 -56.56 -21.66 44.87 -57.05 -24.63 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 4 3 # 4 118 ARG C 36 ARG^? 17.98 C16 C8E C 210 183 LYS C 3 LYS.? 29.42 O21 C8E A 209 317 ARG A 200 ARG^? 11.17 C17 C8E A 209 coo 76.57 109.19 73.41 73.86 110.26 72.16 45.58 -52.92 -31.76 43.11 -54.70 -31.56 coo 82.09 117.51 66.37 80.60 114.32 71.44 54.64 -52.54 -41.89 51.76 -56.14 -46.37 coo 65.21 120.62 58.76 63.62 123.14 59.66 65.38 -54.68 -25.12 63.65 -56.91 -23.89 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 5 3 # 5 118 ARG C 135 ARG^? 23.87 C16 C8E C 210 183 LYS C 3 LYS.? 29.42 O21 C8E A 209 317 ARG A 200 ARG^? 11.17 C17 C8E A 209 coo 76.57 109.19 73.41 73.86 110.26 72.16 44.01 -56.05 -34.91 45.01 -54.65 -37.44 coo 82.09 117.51 66.37 80.60 114.32 71.44 54.64 -52.54 -41.89 51.76 -56.14 -46.37 coo 65.21 120.62 58.76 63.62 123.14 59.66 65.38 -54.68 -25.12 63.65 -56.91 -23.89 1bib_c00 source 1bib BIRA BIFUNCTIONAL PROTEIN (ACTS AS BIOTIN OPER: 5 hits 1bib_c00 naa= 3 ULMN 3 1bjo_c00 PHOSPHOSERINE AMINOTRANSFERASE user 1 3 # 1 A 102 TRP A 59 TRP~? 6.21 CA CA A 208 A 174 ASP A 45 ASP.? -2.96 CA CA A 208s A 198 LYS A 188 LYS~? 10.77 C20 C8E A 210 coo 21.59 67.76 35.19 19.10 64.95 36.34 71.67 -80.29 -29.02 69.69 -82.14 -31.86 coo 19.39 73.14 39.98 19.70 71.07 40.14 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo 27.94 65.10 43.55 24.20 64.94 40.01 68.32 -80.18 -18.11 71.95 -84.24 -15.84 ULMN 3 1bjo_c00 PHOSPHOSERINE AMINOTRANSFERASE user 2 3 # 2 A 102 TRP A 59 TRP~? 6.21 CA CA A 208 A 174 ASP A 61 ASP~? 12.37 CA CA A 208 A 198 LYS A 67 LYS~? 13.30 CA CA A 208 coo 21.59 67.76 35.19 19.10 64.95 36.34 71.67 -80.29 -29.02 69.69 -82.14 -31.86 coo 19.39 73.14 39.98 19.70 71.07 40.14 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo 27.94 65.10 43.55 24.20 64.94 40.01 73.21 -82.07 -40.14 71.59 -78.49 -41.85 ULMN 3 1bjo_c00 PHOSPHOSERINE AMINOTRANSFERASE user 3 3 # 3 A 102 TRP B 59 TRP~? 6.11 CA CA B 208 A 174 ASP B 45 ASP.? -3.07 CA CA B 208s A 198 LYS B 188 LYS~? 9.67 C16 C8E B 210 coo 21.59 67.76 35.19 19.10 64.95 36.34 95.08 -26.15 -12.40 94.38 -22.43 -11.38 coo 19.39 73.14 39.98 19.70 71.07 40.14 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo 27.94 65.10 43.55 24.20 64.94 40.01 102.16 -28.74 -21.10 106.15 -31.37 -17.86 ULMN 3 1bjo_c00 PHOSPHOSERINE AMINOTRANSFERASE user 4 3 # 4 A 102 TRP B 59 TRP~? 6.11 CA CA B 208 A 174 ASP B 61 ASP~? 12.48 CA CA B 208 A 198 LYS B 67 LYS~? 18.13 CA CA B 208 coo 21.59 67.76 35.19 19.10 64.95 36.34 95.08 -26.15 -12.40 94.38 -22.43 -11.38 coo 19.39 73.14 39.98 19.70 71.07 40.14 98.68 -27.22 -4.60 99.30 -29.23 -4.23 coo 27.94 65.10 43.55 24.20 64.94 40.01 89.12 -21.41 -4.23 87.66 -21.56 1.71 ULMN 3 1bjo_c00 PHOSPHOSERINE AMINOTRANSFERASE user 5 3 # 5 A 102 TRP C 59 TRP~? 6.20 CA CA C 208 A 174 ASP C 45 ASP.? 3.27 CA CA C 208s A 198 LYS C 188 LYS~? 9.02 C16 C8E C 209 coo 21.59 67.76 35.19 19.10 64.95 36.34 24.77 -46.37 -6.57 25.55 -42.98 -4.73 coo 19.39 73.14 39.98 19.70 71.07 40.14 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo 27.94 65.10 43.55 24.20 64.94 40.01 31.07 -55.82 -4.30 26.58 -58.21 -2.57 ULMN 3 1bjo_c00 PHOSPHOSERINE AMINOTRANSFERASE user 6 3 # 6 A 102 TRP C 59 TRP~? 6.20 CA CA C 208 A 174 ASP C 61 ASP~? 12.61 CA CA C 208 A 198 LYS C 67 LYS.? 18.71 CA CA C 208 coo 21.59 67.76 35.19 19.10 64.95 36.34 24.77 -46.37 -6.57 25.55 -42.98 -4.73 coo 19.39 73.14 39.98 19.70 71.07 40.14 16.71 -46.53 -3.05 15.59 -48.22 -3.69 coo 27.94 65.10 43.55 24.20 64.94 40.01 20.04 -36.06 -6.98 16.11 -31.17 -7.78 1bjo_c00 source 1bjo PHOSPHOSERINE AMINOTRANSFERASE : 6 hits 1bjo_c00 naa= 3 ULMN 3 1bqc_c01 BETA-MANNANASE user 1 3 # 1 A 50 ARG B 162 ARG^? 16.35 O21 C8E B 210 A 128 GLU B 165 GLU^? 20.64 CA CA B 208 A 225 GLU B 164 GLU^? 19.99 CA CA B 208 coo 38.56 19.11 14.83 37.12 21.00 16.76 96.21 -15.01 -19.71 98.63 -13.28 -19.03 coo 36.48 24.43 22.02 36.86 26.34 21.13 88.15 -8.84 -16.79 86.14 -9.46 -16.74 coo 40.16 23.71 17.01 38.52 24.96 17.40 94.70 -10.70 -16.52 96.59 -9.81 -16.07 1bqc_c01 source 1bqc BETA-MANNANASE : 1 hits 1bqc_c01 naa= 3 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 1 3 # 1 A 109 PHE A 105 PHE^? 4.85 O21 C8E A 209 A 205 ASP A 49 ASP.? -3.00 CA CA A 208s A 236 LYS A 188 LYS~? 10.77 C20 C8E A 210 coo 4.14 2.10 36.34 6.69 3.08 36.92 61.29 -71.83 -24.77 63.18 -73.65 -25.72 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 75.72 -77.89 -27.98 74.67 -77.10 -29.65 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 68.32 -80.18 -18.11 71.95 -84.24 -15.84 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 2 3 # 2 A 109 PHE B 105 PHE^? 5.21 C20 C8E B 209 A 205 ASP B 49 ASP.? -3.05 CA CA B 208s A 236 LYS B 188 LYS~? 9.67 C16 C8E B 210 coo 4.14 2.10 36.34 6.69 3.08 36.92 90.70 -25.26 -25.77 91.65 -25.28 -23.14 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 94.52 -28.97 -11.62 93.03 -30.41 -11.73 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 102.16 -28.74 -21.10 106.15 -31.37 -17.86 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 3 3 # 3 A 109 PHE C 4 PHE^? 24.78 O18 C8E A 209 A 205 ASP C 80 ASP^? 16.43 C13 C8E C 210 A 236 LYS C 84 LYS.? 25.24 O21 C8E A 209 coo 4.14 2.10 36.34 6.69 3.08 36.92 55.69 -49.63 -37.86 57.79 -50.73 -36.33 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 47.10 -57.14 -28.79 45.64 -55.94 -27.77 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 49.01 -63.83 -38.44 48.10 -58.01 -38.38 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 4 3 # 4 A 109 PHE C 105 PHE^? -4.13 O21 C8E C 210s A 205 ASP C 49 ASP.? -2.87 CA CA C 208s A 236 LYS C 188 LYS~? 9.02 C16 C8E C 209 coo 4.14 2.10 36.34 6.69 3.08 36.92 37.70 -47.93 -11.88 35.28 -47.45 -10.64 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 22.13 -48.50 -9.42 23.00 -46.66 -10.00 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 31.07 -55.82 -4.30 26.58 -58.21 -2.57 1bs0_c01 source 1bs0 8-AMINO-7-OXONANOATE SYNTHASE : 4 hits 1bs0_c01 naa= 3 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 1 3 # 1 A 50 GLN A 19 GLN^? 15.77 C17 C8E A 209 A 91 LEU A 20 LEU^? 19.65 O18 C8E A 209 A 133 GLU A 7 GLU^? 19.52 C17 C8E A 209 coo 43.58 43.67 66.73 42.32 42.78 68.15 61.68 -53.90 -25.59 60.40 -53.32 -23.97 coo 38.58 45.09 70.44 38.28 45.21 72.59 57.38 -52.91 -29.60 57.55 -52.15 -31.57 coo 44.05 36.87 70.65 43.15 38.64 69.97 61.29 -47.52 -25.12 61.48 -48.69 -23.33 1bs4_c00 source 1bs4 PEPTIDE DEFORMYLASE : 1 hits 1bs4_c00 naa= 3 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 1 3 # 1 B 550 GLN A 19 GLN^? 15.77 C17 C8E A 209 B 591 LEU A 20 LEU^? 19.65 O18 C8E A 209 B 633 GLU A 7 GLU^? 19.52 C17 C8E A 209 coo 88.06 44.34 57.19 89.06 45.53 55.74 61.68 -53.90 -25.59 60.40 -53.32 -23.97 coo 86.70 48.66 52.61 87.15 48.69 50.51 57.38 -52.91 -29.60 57.55 -52.15 -31.57 coo 95.42 44.52 54.43 93.46 45.31 54.70 61.29 -47.52 -25.12 61.48 -48.69 -23.33 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 2 3 # 2 B 550 GLN B 19 GLN^? 14.72 O15 C8E B 209 B 591 LEU B 20 LEU^? 20.07 C16 C8E B 209 B 633 GLU B 7 GLU^? 19.70 O15 C8E B 209 coo 88.06 44.34 57.19 89.06 45.53 55.74 77.54 -34.58 -33.49 79.23 -35.13 -34.67 coo 86.70 48.66 52.61 87.15 48.69 50.51 73.38 -31.17 -33.46 71.23 -31.17 -33.54 coo 95.42 44.52 54.43 93.46 45.31 54.70 73.39 -38.66 -35.65 75.17 -39.55 -36.49 1bs4_c01 source 1bs4 PEPTIDE DEFORMYLASE : 2 hits 1bs4_c01 naa= 3 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 1 3 # 1 C1050 GLN A 19 GLN^? 15.77 C17 C8E A 209 C1091 LEU A 20 LEU^? 19.65 O18 C8E A 209 C1133 GLU A 7 GLU^? 19.52 C17 C8E A 209 coo 68.29 34.44 43.03 66.67 34.74 44.37 61.68 -53.90 -25.59 60.40 -53.32 -23.97 coo 65.83 38.95 47.05 65.46 38.90 49.20 57.38 -52.91 -29.60 57.55 -52.15 -31.57 coo 63.14 29.39 46.25 63.84 31.31 45.74 61.29 -47.52 -25.12 61.48 -48.69 -23.33 1bs4_c02 source 1bs4 PEPTIDE DEFORMYLASE : 1 hits 1bs4_c02 naa= 3 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 1 3 # 1 A 50 GLN C 127 GLN^? 6.69 C11 C8E C 209 A 91 LEU C 128 LEU^? 5.70 C1 C8E C 209 A 133 GLU C 194 GLU.? 3.24 O15 C8E C 209s coo 38.23 53.34 67.59 38.84 53.87 69.56 42.39 -53.01 -11.20 40.42 -53.72 -11.54 coo 35.40 53.22 73.30 35.37 54.87 74.74 47.85 -56.39 -13.76 49.16 -57.76 -14.88 coo 45.08 56.04 70.60 43.15 55.19 70.77 36.17 -59.59 -12.28 34.91 -60.51 -10.83 1bsj_c00 source 1bsj PEPTIDE DEFORMYLASE : 1 hits 1bsj_c00 naa= 3 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 1 3 # 1 A 325 ASP A 166 ASP.? 23.45 CA CA A 208 A 354 GLU A 164 GLU^? 19.19 O21 C8E A 210 A 421 ASP A 111 ASP.? 17.05 CA CA A 208 coo 31.05 49.37 64.51 31.97 51.11 63.85 55.95 -88.25 -40.15 55.99 -89.39 -38.36 coo 29.07 50.42 58.36 29.02 52.18 59.49 57.65 -86.15 -32.10 58.08 -88.26 -31.94 coo 30.82 59.76 58.47 31.12 59.02 60.40 65.36 -83.80 -40.24 66.17 -85.36 -41.35 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 2 3 # 2 A 325 ASP A 166 ASP.? 23.45 CA CA A 208 A 354 GLU A 165 GLU^? 21.76 CA CA A 208 A 421 ASP A 111 ASP.? 17.05 CA CA A 208 coo 31.05 49.37 64.51 31.97 51.11 63.85 55.95 -88.25 -40.15 55.99 -89.39 -38.36 coo 29.07 50.42 58.36 29.02 52.18 59.49 55.17 -82.77 -39.51 54.39 -80.85 -40.05 coo 30.82 59.76 58.47 31.12 59.02 60.40 65.36 -83.80 -40.24 66.17 -85.36 -41.35 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 3 3 # 3 A 325 ASP A 185 ASP~? 11.73 O21 C8E A 210 A 354 GLU A 184 GLU~? 7.72 C16 C8E A 210 A 421 ASP A 180 ASP.? 14.47 O15 C8E A 210 coo 31.05 49.37 64.51 31.97 51.11 63.85 65.81 -86.27 -18.22 66.54 -87.64 -16.78 coo 29.07 50.42 58.36 29.02 52.18 59.49 63.73 -84.37 -12.45 63.45 -82.45 -11.70 coo 30.82 59.76 58.47 31.12 59.02 60.40 55.45 -86.10 -15.44 53.65 -85.04 -15.38 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 4 3 # 4 A 325 ASP B 166 ASP.? 24.17 CA CA B 208 A 354 GLU B 164 GLU^? 19.99 CA CA B 208 A 421 ASP B 111 ASP.? 16.97 CA CA B 208 coo 31.05 49.37 64.51 31.97 51.11 63.85 91.14 -5.33 -14.11 93.17 -5.00 -14.63 coo 29.07 50.42 58.36 29.02 52.18 59.49 94.70 -10.70 -16.52 96.59 -9.81 -16.07 coo 30.82 59.76 58.47 31.12 59.02 60.40 89.21 -14.92 -8.80 89.40 -13.99 -6.98 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 5 3 # 5 A 325 ASP B 166 ASP.? 24.17 CA CA B 208 A 354 GLU B 165 GLU^? 20.64 CA CA B 208 A 421 ASP B 111 ASP.? 16.97 CA CA B 208 coo 31.05 49.37 64.51 31.97 51.11 63.85 91.14 -5.33 -14.11 93.17 -5.00 -14.63 coo 29.07 50.42 58.36 29.02 52.18 59.49 88.15 -8.84 -16.79 86.14 -9.46 -16.74 coo 30.82 59.76 58.47 31.12 59.02 60.40 89.21 -14.92 -8.80 89.40 -13.99 -6.98 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 6 3 # 6 A 325 ASP B 185 ASP~? 11.63 O21 C8E B 210 A 354 GLU B 184 GLU~? 8.45 C14 C8E B 210 A 421 ASP B 180 ASP.? 10.93 C4 C8E B 210 coo 31.05 49.37 64.51 31.97 51.11 63.85 106.30 -23.80 -20.43 108.26 -24.54 -20.08 coo 29.07 50.42 58.36 29.02 52.18 59.49 107.80 -26.84 -26.43 109.06 -28.52 -26.54 coo 30.82 59.76 58.47 31.12 59.02 60.40 106.50 -18.19 -29.27 105.54 -17.21 -30.85 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 7 3 # 7 A 325 ASP C 166 ASP.? 24.81 CA CA C 208 A 354 GLU C 164 GLU^? 20.06 CA CA C 208 A 421 ASP C 111 ASP.? 17.21 CA CA C 208 coo 31.05 49.37 64.51 31.97 51.11 63.85 35.75 -30.25 2.83 35.54 -31.07 4.76 coo 29.07 50.42 58.36 29.02 52.18 59.49 34.72 -37.11 1.76 34.46 -37.46 3.82 coo 30.82 59.76 58.47 31.12 59.02 60.40 27.11 -33.17 -3.90 25.73 -31.94 -3.00 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 8 3 # 8 A 325 ASP C 166 ASP.? 24.81 CA CA C 208 A 354 GLU C 165 GLU^? 20.98 CA CA C 208 A 421 ASP C 111 ASP.? 17.21 CA CA C 208 coo 31.05 49.37 64.51 31.97 51.11 63.85 35.75 -30.25 2.83 35.54 -31.07 4.76 coo 29.07 50.42 58.36 29.02 52.18 59.49 36.32 -31.59 -2.15 36.97 -31.00 -4.08 coo 30.82 59.76 58.47 31.12 59.02 60.40 27.11 -33.17 -3.90 25.73 -31.94 -3.00 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 9 3 # 9 A 325 ASP C 185 ASP~? 11.81 O21 C8E C 209 A 354 GLU C 184 GLU~? 7.93 C14 C8E C 209 A 421 ASP C 180 ASP.? 12.29 C5 C8E C 209 coo 31.05 49.37 64.51 31.97 51.11 63.85 31.89 -54.53 1.93 31.11 -55.91 3.29 coo 29.07 50.42 58.36 29.02 52.18 59.49 35.72 -59.91 1.24 36.69 -61.13 -0.21 coo 30.82 59.76 58.47 31.12 59.02 60.40 42.24 -54.49 3.97 44.24 -53.90 3.82 1bvz_c08 source 1bvz ALPHA-AMYLASE II : 9 hits 1bvz_c08 naa= 3 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 1 3 # 1 B 325 ASP A 166 ASP.? 23.45 CA CA A 208 B 354 GLU A 164 GLU^? 19.19 O21 C8E A 210 B 421 ASP A 111 ASP.? 17.05 CA CA A 208 coo 25.90 8.19 53.87 25.36 6.97 52.29 55.95 -88.25 -40.15 55.99 -89.39 -38.36 coo 27.87 10.66 47.95 27.82 8.60 48.27 57.65 -86.15 -32.10 58.08 -88.26 -31.94 coo 26.02 1.87 43.38 25.90 1.97 45.49 65.36 -83.80 -40.24 66.17 -85.36 -41.35 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 2 3 # 2 B 325 ASP A 166 ASP.? 23.45 CA CA A 208 B 354 GLU A 165 GLU^? 21.76 CA CA A 208 B 421 ASP A 111 ASP.? 17.05 CA CA A 208 coo 25.90 8.19 53.87 25.36 6.97 52.29 55.95 -88.25 -40.15 55.99 -89.39 -38.36 coo 27.87 10.66 47.95 27.82 8.60 48.27 55.17 -82.77 -39.51 54.39 -80.85 -40.05 coo 26.02 1.87 43.38 25.90 1.97 45.49 65.36 -83.80 -40.24 66.17 -85.36 -41.35 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 3 3 # 3 B 325 ASP A 185 ASP~? 11.73 O21 C8E A 210 B 354 GLU A 184 GLU~? 7.72 C16 C8E A 210 B 421 ASP A 180 ASP.? 14.47 O15 C8E A 210 coo 25.90 8.19 53.87 25.36 6.97 52.29 65.81 -86.27 -18.22 66.54 -87.64 -16.78 coo 27.87 10.66 47.95 27.82 8.60 48.27 63.73 -84.37 -12.45 63.45 -82.45 -11.70 coo 26.02 1.87 43.38 25.90 1.97 45.49 55.45 -86.10 -15.44 53.65 -85.04 -15.38 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 4 3 # 4 B 325 ASP B 166 ASP.? 24.17 CA CA B 208 B 354 GLU B 164 GLU^? 19.99 CA CA B 208 B 421 ASP B 111 ASP.? 16.97 CA CA B 208 coo 25.90 8.19 53.87 25.36 6.97 52.29 91.14 -5.33 -14.11 93.17 -5.00 -14.63 coo 27.87 10.66 47.95 27.82 8.60 48.27 94.70 -10.70 -16.52 96.59 -9.81 -16.07 coo 26.02 1.87 43.38 25.90 1.97 45.49 89.21 -14.92 -8.80 89.40 -13.99 -6.98 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 5 3 # 5 B 325 ASP B 166 ASP.? 24.17 CA CA B 208 B 354 GLU B 165 GLU^? 20.64 CA CA B 208 B 421 ASP B 111 ASP.? 16.97 CA CA B 208 coo 25.90 8.19 53.87 25.36 6.97 52.29 91.14 -5.33 -14.11 93.17 -5.00 -14.63 coo 27.87 10.66 47.95 27.82 8.60 48.27 88.15 -8.84 -16.79 86.14 -9.46 -16.74 coo 26.02 1.87 43.38 25.90 1.97 45.49 89.21 -14.92 -8.80 89.40 -13.99 -6.98 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 6 3 # 6 B 325 ASP B 185 ASP~? 11.63 O21 C8E B 210 B 354 GLU B 184 GLU~? 8.45 C14 C8E B 210 B 421 ASP B 180 ASP.? 10.93 C4 C8E B 210 coo 25.90 8.19 53.87 25.36 6.97 52.29 106.30 -23.80 -20.43 108.26 -24.54 -20.08 coo 27.87 10.66 47.95 27.82 8.60 48.27 107.80 -26.84 -26.43 109.06 -28.52 -26.54 coo 26.02 1.87 43.38 25.90 1.97 45.49 106.50 -18.19 -29.27 105.54 -17.21 -30.85 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 7 3 # 7 B 325 ASP C 166 ASP.? 24.81 CA CA C 208 B 354 GLU C 164 GLU^? 20.06 CA CA C 208 B 421 ASP C 111 ASP.? 17.21 CA CA C 208 coo 25.90 8.19 53.87 25.36 6.97 52.29 35.75 -30.25 2.83 35.54 -31.07 4.76 coo 27.87 10.66 47.95 27.82 8.60 48.27 34.72 -37.11 1.76 34.46 -37.46 3.82 coo 26.02 1.87 43.38 25.90 1.97 45.49 27.11 -33.17 -3.90 25.73 -31.94 -3.00 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 8 3 # 8 B 325 ASP C 166 ASP.? 24.81 CA CA C 208 B 354 GLU C 165 GLU^? 20.98 CA CA C 208 B 421 ASP C 111 ASP.? 17.21 CA CA C 208 coo 25.90 8.19 53.87 25.36 6.97 52.29 35.75 -30.25 2.83 35.54 -31.07 4.76 coo 27.87 10.66 47.95 27.82 8.60 48.27 36.32 -31.59 -2.15 36.97 -31.00 -4.08 coo 26.02 1.87 43.38 25.90 1.97 45.49 27.11 -33.17 -3.90 25.73 -31.94 -3.00 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 9 3 # 9 B 325 ASP C 185 ASP~? 11.81 O21 C8E C 209 B 354 GLU C 184 GLU~? 7.93 C14 C8E C 209 B 421 ASP C 180 ASP.? 12.29 C5 C8E C 209 coo 25.90 8.19 53.87 25.36 6.97 52.29 31.89 -54.53 1.93 31.11 -55.91 3.29 coo 27.87 10.66 47.95 27.82 8.60 48.27 35.72 -59.91 1.24 36.69 -61.13 -0.21 coo 26.02 1.87 43.38 25.90 1.97 45.49 42.24 -54.49 3.97 44.24 -53.90 3.82 1bvz_c09 source 1bvz ALPHA-AMYLASE II : 9 hits 1bvz_c09 naa= 3 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 1 3 # 1 229 ASP A 48 ASP.? 7.38 CA CA A 208 264 GLU A 164 GLU^? 19.19 O21 C8E A 210 328 ASP A 185 ASP~? 11.73 O21 C8E A 210 coo 45.62 80.42 43.69 45.65 82.01 45.07 72.05 -78.20 -23.17 73.82 -77.79 -22.11 coo 59.69 92.71 39.85 58.53 92.03 41.47 57.65 -86.15 -32.10 58.08 -88.26 -31.94 coo 45.39 90.72 40.63 45.07 89.14 41.90 65.81 -86.27 -18.22 66.54 -87.64 -16.78 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 2 3 # 2 229 ASP A 49 ASP.? -3.00 CA CA A 208s 264 GLU A 184 GLU~? 7.72 C16 C8E A 210 328 ASP A 52 ASP.? 15.11 CA CA A 208 coo 45.62 80.42 43.69 45.65 82.01 45.07 75.72 -77.89 -27.98 74.67 -77.10 -29.65 coo 59.69 92.71 39.85 58.53 92.03 41.47 63.73 -84.37 -12.45 63.45 -82.45 -11.70 coo 45.39 90.72 40.63 45.07 89.14 41.90 76.18 -86.89 -22.52 75.57 -87.62 -20.65 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 3 3 # 3 229 ASP A 52 ASP.? 15.11 CA CA A 208 264 GLU A 164 GLU^? 19.19 O21 C8E A 210 328 ASP A 185 ASP~? 11.73 O21 C8E A 210 coo 45.62 80.42 43.69 45.65 82.01 45.07 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo 59.69 92.71 39.85 58.53 92.03 41.47 57.65 -86.15 -32.10 58.08 -88.26 -31.94 coo 45.39 90.72 40.63 45.07 89.14 41.90 65.81 -86.27 -18.22 66.54 -87.64 -16.78 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 4 3 # 4 229 ASP A 52 ASP.? 15.11 CA CA A 208 264 GLU A 194 GLU.? 3.11 C17 C8E A 210s 328 ASP A 48 ASP.? 7.38 CA CA A 208 coo 45.62 80.42 43.69 45.65 82.01 45.07 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo 59.69 92.71 39.85 58.53 92.03 41.47 66.12 -70.72 -14.05 67.03 -72.48 -13.31 coo 45.39 90.72 40.63 45.07 89.14 41.90 72.05 -78.20 -23.17 73.82 -77.79 -22.11 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 5 3 # 5 229 ASP A 52 ASP.? 15.11 CA CA A 208 264 GLU A 194 GLU.? 3.11 C17 C8E A 210s 328 ASP A 185 ASP~? 11.73 O21 C8E A 210 coo 45.62 80.42 43.69 45.65 82.01 45.07 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo 59.69 92.71 39.85 58.53 92.03 41.47 66.12 -70.72 -14.05 67.03 -72.48 -13.31 coo 45.39 90.72 40.63 45.07 89.14 41.90 65.81 -86.27 -18.22 66.54 -87.64 -16.78 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 6 3 # 6 229 ASP A 180 ASP.? 14.47 O15 C8E A 210 264 GLU A 194 GLU.? 3.11 C17 C8E A 210s 328 ASP A 185 ASP~? 11.73 O21 C8E A 210 coo 45.62 80.42 43.69 45.65 82.01 45.07 55.45 -86.10 -15.44 53.65 -85.04 -15.38 coo 59.69 92.71 39.85 58.53 92.03 41.47 66.12 -70.72 -14.05 67.03 -72.48 -13.31 coo 45.39 90.72 40.63 45.07 89.14 41.90 65.81 -86.27 -18.22 66.54 -87.64 -16.78 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 7 3 # 7 229 ASP A 185 ASP~? 11.73 O21 C8E A 210 264 GLU A 70 GLU^? -2.69 CA CA A 208s 328 ASP A 52 ASP.? 15.11 CA CA A 208 coo 45.62 80.42 43.69 45.65 82.01 45.07 65.81 -86.27 -18.22 66.54 -87.64 -16.78 coo 59.69 92.71 39.85 58.53 92.03 41.47 68.79 -75.79 -31.87 70.14 -76.30 -30.27 coo 45.39 90.72 40.63 45.07 89.14 41.90 76.18 -86.89 -22.52 75.57 -87.62 -20.65 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 8 3 # 8 229 ASP B 49 ASP.? -3.05 CA CA B 208s 264 GLU B 184 GLU~? 8.45 C14 C8E B 210 328 ASP B 52 ASP.? 15.59 CA CA B 208 coo 45.62 80.42 43.69 45.65 82.01 45.07 94.52 -28.97 -11.62 93.03 -30.41 -11.73 coo 59.69 92.71 39.85 58.53 92.03 41.47 107.80 -26.84 -26.43 109.06 -28.52 -26.54 coo 45.39 90.72 40.63 45.07 89.14 41.90 105.61 -28.95 -11.53 106.78 -28.70 -9.81 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 9 3 # 9 229 ASP B 52 ASP.? 15.59 CA CA B 208 264 GLU B 194 GLU.? 2.86 C13 C8E B 210s 328 ASP B 48 ASP.? 7.20 CA CA B 208 coo 45.62 80.42 43.69 45.65 82.01 45.07 105.61 -28.95 -11.53 106.78 -28.70 -9.81 coo 59.69 92.71 39.85 58.53 92.03 41.47 97.88 -33.97 -28.78 99.62 -34.16 -27.58 coo 45.39 90.72 40.63 45.07 89.14 41.90 97.60 -30.12 -16.68 98.20 -32.01 -15.99 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 10 3 # 10 229 ASP B 52 ASP.? 15.59 CA CA B 208 264 GLU B 194 GLU.? 2.86 C13 C8E B 210s 328 ASP B 185 ASP~? 11.63 O21 C8E B 210 coo 45.62 80.42 43.69 45.65 82.01 45.07 105.61 -28.95 -11.53 106.78 -28.70 -9.81 coo 59.69 92.71 39.85 58.53 92.03 41.47 97.88 -33.97 -28.78 99.62 -34.16 -27.58 coo 45.39 90.72 40.63 45.07 89.14 41.90 106.30 -23.80 -20.43 108.26 -24.54 -20.08 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 11 3 # 11 229 ASP B 180 ASP.? 10.93 C4 C8E B 210 264 GLU B 194 GLU.? 2.86 C13 C8E B 210s 328 ASP B 185 ASP~? 11.63 O21 C8E B 210 coo 45.62 80.42 43.69 45.65 82.01 45.07 106.50 -18.19 -29.27 105.54 -17.21 -30.85 coo 59.69 92.71 39.85 58.53 92.03 41.47 97.88 -33.97 -28.78 99.62 -34.16 -27.58 coo 45.39 90.72 40.63 45.07 89.14 41.90 106.30 -23.80 -20.43 108.26 -24.54 -20.08 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 12 3 # 12 229 ASP C 49 ASP.? -2.87 CA CA C 208s 264 GLU C 184 GLU~? 7.93 C14 C8E C 209 328 ASP C 52 ASP.? 15.77 CA CA C 208 coo 45.62 80.42 43.69 45.65 82.01 45.07 22.13 -48.50 -9.42 23.00 -46.66 -10.00 coo 59.69 92.71 39.85 58.53 92.03 41.47 35.72 -59.91 1.24 36.69 -61.13 -0.21 coo 45.39 90.72 40.63 45.07 89.14 41.90 21.29 -54.58 -0.38 20.26 -54.47 1.43 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 13 3 # 13 229 ASP C 52 ASP.? 15.77 CA CA C 208 264 GLU C 194 GLU.? 3.24 O15 C8E C 209s 328 ASP C 48 ASP.? 7.17 CA CA C 208 coo 45.62 80.42 43.69 45.65 82.01 45.07 21.29 -54.58 -0.38 20.26 -54.47 1.43 coo 59.69 92.71 39.85 58.53 92.03 41.47 36.17 -59.59 -12.28 34.91 -60.51 -10.83 coo 45.39 90.72 40.63 45.07 89.14 41.90 26.68 -52.06 -7.74 25.46 -53.53 -8.54 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 14 3 # 14 229 ASP C 52 ASP.? 15.77 CA CA C 208 264 GLU C 194 GLU.? 3.24 O15 C8E C 209s 328 ASP C 185 ASP~? 11.81 O21 C8E C 209 coo 45.62 80.42 43.69 45.65 82.01 45.07 21.29 -54.58 -0.38 20.26 -54.47 1.43 coo 59.69 92.71 39.85 58.53 92.03 41.47 36.17 -59.59 -12.28 34.91 -60.51 -10.83 coo 45.39 90.72 40.63 45.07 89.14 41.90 31.89 -54.53 1.93 31.11 -55.91 3.29 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 15 3 # 15 229 ASP C 153 ASP^? 9.83 C13 C8E C 210 264 GLU C 93 GLU^? 26.90 C13 C8E C 210 328 ASP C 80 ASP^? 16.43 C13 C8E C 210 coo 45.62 80.42 43.69 45.65 82.01 45.07 40.09 -57.62 -20.90 41.26 -57.13 -22.61 coo 59.69 92.71 39.85 58.53 92.03 41.47 45.29 -60.19 -41.07 45.99 -58.52 -39.91 coo 45.39 90.72 40.63 45.07 89.14 41.90 47.10 -57.14 -28.79 45.64 -55.94 -27.77 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 16 3 # 16 229 ASP C 180 ASP.? 12.29 C5 C8E C 209 264 GLU C 194 GLU.? 3.24 O15 C8E C 209s 328 ASP C 185 ASP~? 11.81 O21 C8E C 209 coo 45.62 80.42 43.69 45.65 82.01 45.07 42.24 -54.49 3.97 44.24 -53.90 3.82 coo 59.69 92.71 39.85 58.53 92.03 41.47 36.17 -59.59 -12.28 34.91 -60.51 -10.83 coo 45.39 90.72 40.63 45.07 89.14 41.90 31.89 -54.53 1.93 31.11 -55.91 3.29 1cdg_c00 source 1cdg CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.C.2.4.1.19: 16 hits 1cdg_c00 naa= 3 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 1 3 # 1 A 198 GLY A 14 GLY.? -3.37 O18 C8E A 209s A 228 SER A 44 SER.? -2.67 O21 C8E A 209s A 549 ASP A 45 ASP.? -2.96 CA CA A 208s coo 43.62 -9.31 54.06 43.04 -9.29 54.58 69.00 -64.43 -23.63 69.02 -63.91 -24.27 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 67.29 -68.39 -28.17 66.32 -69.65 -26.34 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 70.45 -71.75 -27.39 71.06 -73.65 -26.89 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 2 3 # 2 A 198 GLY A 38 GLY^? 17.41 C17 C8E A 209 A 228 SER A 78 SER^? 13.83 C1 C8E A 210 A 549 ASP A 80 ASP^? 12.60 C1 C8E A 210 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 56.17 -54.24 -23.69 55.70 -54.84 -23.39 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 55.97 -57.73 -19.67 57.70 -56.10 -19.98 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 58.12 -52.30 -15.93 59.10 -53.68 -17.13 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 3 3 # 3 A 198 GLY A 107 GLY^? 8.81 O21 C8E A 209 A 228 SER A 44 SER.? -2.67 O21 C8E A 209s A 549 ASP A 45 ASP.? -2.96 CA CA A 208s coo 43.62 -9.31 54.06 43.04 -9.29 54.58 62.40 -74.29 -30.50 61.92 -74.87 -30.13 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 67.29 -68.39 -28.17 66.32 -69.65 -26.34 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 70.45 -71.75 -27.39 71.06 -73.65 -26.89 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 4 3 # 4 A 198 GLY B 14 GLY.? -3.42 C16 C8E B 209s A 228 SER B 44 SER.? -2.63 C20 C8E B 209s A 549 ASP B 45 ASP.? -3.07 CA CA B 208s coo 43.62 -9.31 54.06 43.04 -9.29 54.58 87.36 -35.68 -24.06 86.56 -35.48 -24.06 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 86.51 -29.99 -20.81 88.33 -29.21 -22.26 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 90.60 -30.65 -18.50 91.26 -30.99 -16.60 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 5 3 # 5 A 198 GLY B 38 GLY^? 17.30 O15 C8E B 209 A 228 SER B 78 SER^? 13.33 O15 C8E B 209 A 549 ASP B 80 ASP^? 15.94 O15 C8E B 209 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 78.31 -32.08 -37.28 78.82 -31.54 -37.56 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 83.33 -32.12 -37.91 83.81 -34.26 -36.79 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 82.56 -37.87 -41.00 82.97 -37.16 -39.06 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 6 3 # 6 A 198 GLY B 107 GLY^? 8.76 C20 C8E B 209 A 228 SER B 44 SER.? -2.63 C20 C8E B 209s A 549 ASP B 45 ASP.? -3.07 CA CA B 208s coo 43.62 -9.31 54.06 43.04 -9.29 54.58 88.75 -22.32 -20.64 89.23 -21.73 -20.93 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 86.51 -29.99 -20.81 88.33 -29.21 -22.26 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 90.60 -30.65 -18.50 91.26 -30.99 -16.60 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 7 3 # 7 A 198 GLY B 108 GLY^? 8.97 CA CA B 208 A 228 SER B 69 SER^? 12.05 CA CA B 208 A 549 ASP B 111 ASP.? 16.97 CA CA B 208 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 90.48 -20.92 -17.58 89.78 -21.35 -17.37 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 86.53 -22.01 -10.29 84.57 -20.83 -9.39 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 89.21 -14.92 -8.80 89.40 -13.99 -6.98 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 8 3 # 8 A 198 GLY C 38 GLY^? 17.56 C19 C8E C 210 A 228 SER C 78 SER^? 13.93 C13 C8E C 210 A 549 ASP C 80 ASP^? 16.43 C13 C8E C 210 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 47.08 -49.08 -27.59 47.53 -49.11 -26.94 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 46.95 -52.32 -23.90 45.02 -53.63 -24.63 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 47.10 -57.14 -28.79 45.64 -55.94 -27.77 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 9 3 # 9 A 198 GLY C 107 GLY^? 7.61 O21 C8E C 210 A 228 SER C 44 SER.? -2.60 O21 C8E C 210s A 549 ASP C 45 ASP.? 3.27 CA CA C 208s coo 43.62 -9.31 54.06 43.04 -9.29 54.58 34.65 -42.83 -10.66 35.11 -42.76 -9.95 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 31.95 -46.42 -17.08 33.26 -47.96 -15.73 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 28.98 -48.61 -14.39 27.54 -48.99 -12.93 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 10 3 # 10 A 198 GLY C 108 GLY^? 9.19 CA CA C 208 A 228 SER C 69 SER^? 11.34 CA CA C 208 A 549 ASP C 111 ASP.? 17.21 CA CA C 208 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 32.28 -41.91 -7.84 31.99 -41.73 -8.59 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 25.63 -37.12 -10.07 26.01 -35.64 -11.95 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 27.11 -33.17 -3.90 25.73 -31.94 -3.00 1cjy_c00 source 1cjy CYTOSOLIC PHOSPHOLIPASE A2 : 10 hits 1cjy_c00 naa= 3 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 1 3 # 1 B1198 GLY A 14 GLY.? -3.37 O18 C8E A 209s B1228 SER A 44 SER.? -2.67 O21 C8E A 209s B1549 ASP A 45 ASP.? -2.96 CA CA A 208s coo 126.34 72.75 125.66 125.95 73.27 126.11 69.00 -64.43 -23.63 69.02 -63.91 -24.27 coo 131.65 74.68 129.41 130.31 72.73 128.82 67.29 -68.39 -28.17 66.32 -69.65 -26.34 coo 134.72 69.43 130.42 133.03 70.65 130.08 70.45 -71.75 -27.39 71.06 -73.65 -26.89 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 2 3 # 2 B1198 GLY A 38 GLY^? 17.41 C17 C8E A 209 B1228 SER A 78 SER^? 13.83 C1 C8E A 210 B1549 ASP A 80 ASP^? 12.60 C1 C8E A 210 coo 126.34 72.75 125.66 125.95 73.27 126.11 56.17 -54.24 -23.69 55.70 -54.84 -23.39 coo 131.65 74.68 129.41 130.31 72.73 128.82 55.97 -57.73 -19.67 57.70 -56.10 -19.98 coo 134.72 69.43 130.42 133.03 70.65 130.08 58.12 -52.30 -15.93 59.10 -53.68 -17.13 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 3 3 # 3 B1198 GLY A 107 GLY^? 8.81 O21 C8E A 209 B1228 SER A 44 SER.? -2.67 O21 C8E A 209s B1549 ASP A 45 ASP.? -2.96 CA CA A 208s coo 126.34 72.75 125.66 125.95 73.27 126.11 62.40 -74.29 -30.50 61.92 -74.87 -30.13 coo 131.65 74.68 129.41 130.31 72.73 128.82 67.29 -68.39 -28.17 66.32 -69.65 -26.34 coo 134.72 69.43 130.42 133.03 70.65 130.08 70.45 -71.75 -27.39 71.06 -73.65 -26.89 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 4 3 # 4 B1198 GLY A 108 GLY^? 9.22 CA CA A 208 B1228 SER A 69 SER^? 11.97 CA CA A 208 B1549 ASP A 111 ASP.? 17.05 CA CA A 208 coo 126.34 72.75 125.66 125.95 73.27 126.11 63.77 -77.60 -31.68 64.12 -76.93 -32.11 coo 131.65 74.68 129.41 130.31 72.73 128.82 69.09 -77.26 -37.91 68.86 -76.80 -40.31 coo 134.72 69.43 130.42 133.03 70.65 130.08 65.36 -83.80 -40.24 66.17 -85.36 -41.35 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 5 3 # 5 B1198 GLY B 107 GLY^? 8.76 C20 C8E B 209 B1228 SER B 44 SER.? -2.63 C20 C8E B 209s B1549 ASP B 45 ASP.? -3.07 CA CA B 208s coo 126.34 72.75 125.66 125.95 73.27 126.11 88.75 -22.32 -20.64 89.23 -21.73 -20.93 coo 131.65 74.68 129.41 130.31 72.73 128.82 86.51 -29.99 -20.81 88.33 -29.21 -22.26 coo 134.72 69.43 130.42 133.03 70.65 130.08 90.60 -30.65 -18.50 91.26 -30.99 -16.60 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 6 3 # 6 B1198 GLY B 108 GLY^? 8.97 CA CA B 208 B1228 SER B 69 SER^? 12.05 CA CA B 208 B1549 ASP B 111 ASP.? 16.97 CA CA B 208 coo 126.34 72.75 125.66 125.95 73.27 126.11 90.48 -20.92 -17.58 89.78 -21.35 -17.37 coo 131.65 74.68 129.41 130.31 72.73 128.82 86.53 -22.01 -10.29 84.57 -20.83 -9.39 coo 134.72 69.43 130.42 133.03 70.65 130.08 89.21 -14.92 -8.80 89.40 -13.99 -6.98 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 7 3 # 7 B1198 GLY C 107 GLY^? 7.61 O21 C8E C 210 B1228 SER C 44 SER.? -2.60 O21 C8E C 210s B1549 ASP C 45 ASP.? 3.27 CA CA C 208s coo 126.34 72.75 125.66 125.95 73.27 126.11 34.65 -42.83 -10.66 35.11 -42.76 -9.95 coo 131.65 74.68 129.41 130.31 72.73 128.82 31.95 -46.42 -17.08 33.26 -47.96 -15.73 coo 134.72 69.43 130.42 133.03 70.65 130.08 28.98 -48.61 -14.39 27.54 -48.99 -12.93 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 8 3 # 8 B1198 GLY C 108 GLY^? 9.19 CA CA C 208 B1228 SER C 69 SER^? 11.34 CA CA C 208 B1549 ASP C 111 ASP.? 17.21 CA CA C 208 coo 126.34 72.75 125.66 125.95 73.27 126.11 32.28 -41.91 -7.84 31.99 -41.73 -8.59 coo 131.65 74.68 129.41 130.31 72.73 128.82 25.63 -37.12 -10.07 26.01 -35.64 -11.95 coo 134.72 69.43 130.42 133.03 70.65 130.08 27.11 -33.17 -3.90 25.73 -31.94 -3.00 1cjy_c01 source 1cjy CYTOSOLIC PHOSPHOLIPASE A2 : 8 hits 1cjy_c01 naa= 3 ULMN 3 1cns_c00 CHITINASE user 1 3 # 1 A 67 GLU A 7 GLU^? 19.52 C17 C8E A 209 A 89 GLU A 93 GLU^? 23.51 C1 C8E A 210 A 120 SER A 145 SER^? 27.15 C1 C8E A 210 coo -24.35 9.53 67.64 -25.07 11.29 68.60 61.29 -47.52 -25.12 61.48 -48.69 -23.33 coo -31.18 6.91 75.60 -32.39 8.51 74.91 64.33 -40.66 -16.04 62.38 -40.13 -16.70 coo -34.73 8.57 68.21 -33.63 9.08 70.28 64.96 -39.73 -25.95 63.25 -39.86 -24.22 ULMN 3 1cns_c00 CHITINASE user 2 3 # 2 A 67 GLU A 25 GLU^? 22.98 C2 C8E C 209 A 89 GLU A 7 GLU^? 19.52 C17 C8E A 209 A 120 SER A 145 SER^? 27.15 C1 C8E A 210 coo -24.35 9.53 67.64 -25.07 11.29 68.60 56.22 -40.62 -18.58 57.98 -41.28 -19.55 coo -31.18 6.91 75.60 -32.39 8.51 74.91 61.29 -47.52 -25.12 61.48 -48.69 -23.33 coo -34.73 8.57 68.21 -33.63 9.08 70.28 64.96 -39.73 -25.95 63.25 -39.86 -24.22 ULMN 3 1cns_c00 CHITINASE user 3 3 # 3 A 67 GLU A 93 GLU^? 23.51 C1 C8E A 210 A 89 GLU A 7 GLU^? 19.52 C17 C8E A 209 A 120 SER A 145 SER^? 27.15 C1 C8E A 210 coo -24.35 9.53 67.64 -25.07 11.29 68.60 64.33 -40.66 -16.04 62.38 -40.13 -16.70 coo -31.18 6.91 75.60 -32.39 8.51 74.91 61.29 -47.52 -25.12 61.48 -48.69 -23.33 coo -34.73 8.57 68.21 -33.63 9.08 70.28 64.96 -39.73 -25.95 63.25 -39.86 -24.22 ULMN 3 1cns_c00 CHITINASE user 4 3 # 4 A 67 GLU B 7 GLU^? 19.70 O15 C8E B 209 A 89 GLU B 93 GLU^? 27.23 O15 C8E B 209 A 120 SER B 145 SER^? 27.20 O18 C8E A 209 coo -24.35 9.53 67.64 -25.07 11.29 68.60 73.39 -38.66 -35.65 75.17 -39.55 -36.49 coo -31.18 6.91 75.60 -32.39 8.51 74.91 75.25 -49.35 -42.08 74.13 -47.63 -42.56 coo -34.73 8.57 68.21 -33.63 9.08 70.28 67.49 -45.58 -36.35 68.68 -44.91 -38.37 ULMN 3 1cns_c00 CHITINASE user 5 3 # 5 A 67 GLU B 25 GLU^? 27.65 O15 C8E B 209 A 89 GLU B 7 GLU^? 19.70 O15 C8E B 209 A 120 SER B 145 SER^? 27.20 O18 C8E A 209 coo -24.35 9.53 67.64 -25.07 11.29 68.60 73.50 -42.12 -45.68 71.97 -42.23 -44.24 coo -31.18 6.91 75.60 -32.39 8.51 74.91 73.39 -38.66 -35.65 75.17 -39.55 -36.49 coo -34.73 8.57 68.21 -33.63 9.08 70.28 67.49 -45.58 -36.35 68.68 -44.91 -38.37 ULMN 3 1cns_c00 CHITINASE user 6 3 # 6 A 67 GLU B 93 GLU^? 27.23 O15 C8E B 209 A 89 GLU B 7 GLU^? 19.70 O15 C8E B 209 A 120 SER B 145 SER^? 27.20 O18 C8E A 209 coo -24.35 9.53 67.64 -25.07 11.29 68.60 75.25 -49.35 -42.08 74.13 -47.63 -42.56 coo -31.18 6.91 75.60 -32.39 8.51 74.91 73.39 -38.66 -35.65 75.17 -39.55 -36.49 coo -34.73 8.57 68.21 -33.63 9.08 70.28 67.49 -45.58 -36.35 68.68 -44.91 -38.37 ULMN 3 1cns_c00 CHITINASE user 7 3 # 7 A 67 GLU C 7 GLU^? 20.56 C16 C8E C 210 A 89 GLU C 93 GLU^? 26.90 C13 C8E C 210 A 120 SER C 145 SER^? 28.85 C16 C8E C 210 coo -24.35 9.53 67.64 -25.07 11.29 68.60 43.33 -49.69 -35.12 43.56 -51.77 -34.52 coo -31.18 6.91 75.60 -32.39 8.51 74.91 45.29 -60.19 -41.07 45.99 -58.52 -39.91 coo -34.73 8.57 68.21 -33.63 9.08 70.28 41.87 -50.77 -43.64 43.47 -52.56 -43.92 ULMN 3 1cns_c00 CHITINASE user 8 3 # 8 A 67 GLU C 25 GLU.? 26.72 O21 C8E A 209 A 89 GLU C 7 GLU^? 20.56 C16 C8E C 210 A 120 SER C 145 SER^? 28.85 C16 C8E C 210 coo -24.35 9.53 67.64 -25.07 11.29 68.60 50.80 -55.81 -38.99 49.16 -55.90 -40.32 coo -31.18 6.91 75.60 -32.39 8.51 74.91 43.33 -49.69 -35.12 43.56 -51.77 -34.52 coo -34.73 8.57 68.21 -33.63 9.08 70.28 41.87 -50.77 -43.64 43.47 -52.56 -43.92 ULMN 3 1cns_c00 CHITINASE user 9 3 # 9 A 67 GLU C 93 GLU^? 26.90 C13 C8E C 210 A 89 GLU C 7 GLU^? 20.56 C16 C8E C 210 A 120 SER C 145 SER^? 28.85 C16 C8E C 210 coo -24.35 9.53 67.64 -25.07 11.29 68.60 45.29 -60.19 -41.07 45.99 -58.52 -39.91 coo -31.18 6.91 75.60 -32.39 8.51 74.91 43.33 -49.69 -35.12 43.56 -51.77 -34.52 coo -34.73 8.57 68.21 -33.63 9.08 70.28 41.87 -50.77 -43.64 43.47 -52.56 -43.92 1cns_c00 source 1cns CHITINASE : 9 hits 1cns_c00 naa= 3 ULMN 3 1cns_c01 CHITINASE user 1 3 # 1 B 67 GLU A 25 GLU^? 22.98 C2 C8E C 209 B 89 GLU A 7 GLU^? 19.52 C17 C8E A 209 B 120 SER A 145 SER^? 27.15 C1 C8E A 210 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 56.22 -40.62 -18.58 57.98 -41.28 -19.55 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 61.29 -47.52 -25.12 61.48 -48.69 -23.33 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 64.96 -39.73 -25.95 63.25 -39.86 -24.22 ULMN 3 1cns_c01 CHITINASE user 2 3 # 2 B 67 GLU A 93 GLU^? 23.51 C1 C8E A 210 B 89 GLU A 7 GLU^? 19.52 C17 C8E A 209 B 120 SER A 145 SER^? 27.15 C1 C8E A 210 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 64.33 -40.66 -16.04 62.38 -40.13 -16.70 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 61.29 -47.52 -25.12 61.48 -48.69 -23.33 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 64.96 -39.73 -25.95 63.25 -39.86 -24.22 ULMN 3 1cns_c01 CHITINASE user 3 3 # 3 B 67 GLU B 7 GLU^? 19.70 O15 C8E B 209 B 89 GLU B 93 GLU^? 27.23 O15 C8E B 209 B 120 SER B 145 SER^? 27.20 O18 C8E A 209 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 73.39 -38.66 -35.65 75.17 -39.55 -36.49 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 75.25 -49.35 -42.08 74.13 -47.63 -42.56 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 67.49 -45.58 -36.35 68.68 -44.91 -38.37 ULMN 3 1cns_c01 CHITINASE user 4 3 # 4 B 67 GLU B 25 GLU^? 27.65 O15 C8E B 209 B 89 GLU B 7 GLU^? 19.70 O15 C8E B 209 B 120 SER B 145 SER^? 27.20 O18 C8E A 209 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 73.50 -42.12 -45.68 71.97 -42.23 -44.24 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 73.39 -38.66 -35.65 75.17 -39.55 -36.49 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 67.49 -45.58 -36.35 68.68 -44.91 -38.37 ULMN 3 1cns_c01 CHITINASE user 5 3 # 5 B 67 GLU B 93 GLU^? 27.23 O15 C8E B 209 B 89 GLU B 7 GLU^? 19.70 O15 C8E B 209 B 120 SER B 145 SER^? 27.20 O18 C8E A 209 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 75.25 -49.35 -42.08 74.13 -47.63 -42.56 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 73.39 -38.66 -35.65 75.17 -39.55 -36.49 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 67.49 -45.58 -36.35 68.68 -44.91 -38.37 ULMN 3 1cns_c01 CHITINASE user 6 3 # 6 B 67 GLU C 25 GLU.? 26.72 O21 C8E A 209 B 89 GLU C 7 GLU^? 20.56 C16 C8E C 210 B 120 SER C 145 SER^? 28.85 C16 C8E C 210 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 50.80 -55.81 -38.99 49.16 -55.90 -40.32 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 43.33 -49.69 -35.12 43.56 -51.77 -34.52 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 41.87 -50.77 -43.64 43.47 -52.56 -43.92 ULMN 3 1cns_c01 CHITINASE user 7 3 # 7 B 67 GLU C 93 GLU^? 26.90 C13 C8E C 210 B 89 GLU C 7 GLU^? 20.56 C16 C8E C 210 B 120 SER C 5 SER^? 28.64 C16 C8E C 210 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 45.29 -60.19 -41.07 45.99 -58.52 -39.91 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 43.33 -49.69 -35.12 43.56 -51.77 -34.52 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 50.03 -48.53 -38.83 49.40 -50.39 -40.21 ULMN 3 1cns_c01 CHITINASE user 8 3 # 8 B 67 GLU C 93 GLU^? 26.90 C13 C8E C 210 B 89 GLU C 7 GLU^? 20.56 C16 C8E C 210 B 120 SER C 145 SER^? 28.85 C16 C8E C 210 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 45.29 -60.19 -41.07 45.99 -58.52 -39.91 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 43.33 -49.69 -35.12 43.56 -51.77 -34.52 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 41.87 -50.77 -43.64 43.47 -52.56 -43.92 1cns_c01 source 1cns CHITINASE : 8 hits 1cns_c01 naa= 3 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 101 TYR A 97 TYR^? 11.99 C1 C8E A 210 A 173 ASP A 149 ASP^? 14.85 C1 C8E A 210 C 48 ARG A 101 ARG^? 8.92 C1 C8E A 210 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 61.97 -51.46 -14.47 63.57 -52.89 -16.21 coo 24.35 4.55 25.11 25.94 3.23 25.53 66.40 -51.17 -20.74 65.06 -51.90 -19.38 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 59.10 -60.12 -16.06 60.30 -57.41 -15.78 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 101 TYR A 109 TYR^? 10.85 CA CA A 208 A 173 ASP A 111 ASP.? 17.05 CA CA A 208 C 48 ARG A 162 ARG^? 10.87 O21 C8E A 210 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo 24.35 4.55 25.11 25.94 3.23 25.53 65.36 -83.80 -40.24 66.17 -85.36 -41.35 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 60.16 -83.54 -27.36 63.31 -83.18 -27.03 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 101 TYR B 109 TYR^? 10.54 CA CA B 208 A 173 ASP B 111 ASP.? 16.97 CA CA B 208 C 48 ARG B 162 ARG^? 16.35 O21 C8E B 210 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo 24.35 4.55 25.11 25.94 3.23 25.53 89.21 -14.92 -8.80 89.40 -13.99 -6.98 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 96.21 -15.01 -19.71 98.63 -13.28 -19.03 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 101 TYR C 109 TYR^? 10.73 CA CA C 208 A 173 ASP C 111 ASP.? 17.21 CA CA C 208 C 48 ARG C 162 ARG^? 16.00 O21 C8E C 209 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo 24.35 4.55 25.11 25.94 3.23 25.53 27.11 -33.17 -3.90 25.73 -31.94 -3.00 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 35.66 -43.15 0.12 35.66 -43.03 3.18 1cs1_c00 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 4 hits 1cs1_c00 naa= 3 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 48 ARG A 101 ARG^? 8.92 C1 C8E A 210 C 101 TYR A 97 TYR^? 11.99 C1 C8E A 210 C 173 ASP A 149 ASP^? 14.85 C1 C8E A 210 coo 32.27 5.62 48.15 31.93 6.48 51.06 59.10 -60.12 -16.06 60.30 -57.41 -15.78 coo 29.64 3.64 57.39 31.22 5.14 55.65 61.97 -51.46 -14.47 63.57 -52.89 -16.21 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 66.40 -51.17 -20.74 65.06 -51.90 -19.38 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 48 ARG A 162 ARG^? 10.87 O21 C8E A 210 C 101 TYR A 109 TYR^? 10.85 CA CA A 208 C 173 ASP A 111 ASP.? 17.05 CA CA A 208 coo 32.27 5.62 48.15 31.93 6.48 51.06 60.16 -83.54 -27.36 63.31 -83.18 -27.03 coo 29.64 3.64 57.39 31.22 5.14 55.65 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 65.36 -83.80 -40.24 66.17 -85.36 -41.35 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 48 ARG B 101 ARG^? 13.86 O15 C8E B 209 C 101 TYR B 97 TYR^? 16.46 O15 C8E B 209 C 173 ASP B 149 ASP^? 14.91 O15 C8E B 209 coo 32.27 5.62 48.15 31.93 6.48 51.06 87.52 -34.18 -37.50 85.80 -36.55 -38.16 coo 29.64 3.64 57.39 31.22 5.14 55.65 83.74 -41.85 -39.80 83.62 -41.42 -37.05 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 79.48 -42.39 -33.32 81.04 -41.48 -34.38 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 48 ARG B 162 ARG^? 16.35 O21 C8E B 210 C 101 TYR B 109 TYR^? 10.54 CA CA B 208 C 173 ASP B 111 ASP.? 16.97 CA CA B 208 coo 32.27 5.62 48.15 31.93 6.48 51.06 96.21 -15.01 -19.71 98.63 -13.28 -19.03 coo 29.64 3.64 57.39 31.22 5.14 55.65 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 89.21 -14.92 -8.80 89.40 -13.99 -6.98 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 A 48 ARG C 101 ARG^? 13.82 C13 C8E C 210 C 101 TYR C 97 TYR^? 17.03 C13 C8E C 210 C 173 ASP C 149 ASP^? 16.02 C16 C8E C 210 coo 32.27 5.62 48.15 31.93 6.48 51.06 44.39 -56.56 -21.66 44.87 -57.05 -24.63 coo 29.64 3.64 57.39 31.22 5.14 55.65 44.42 -59.94 -30.24 42.23 -58.45 -29.40 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 38.72 -55.19 -32.44 40.02 -55.93 -30.97 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 A 48 ARG C 162 ARG^? 16.00 O21 C8E C 209 C 101 TYR C 109 TYR^? 10.73 CA CA C 208 C 173 ASP C 111 ASP.? 17.21 CA CA C 208 coo 32.27 5.62 48.15 31.93 6.48 51.06 35.66 -43.15 0.12 35.66 -43.03 3.18 coo 29.64 3.64 57.39 31.22 5.14 55.65 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 27.11 -33.17 -3.90 25.73 -31.94 -3.00 1cs1_c01 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 6 hits 1cs1_c01 naa= 3 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 48 ARG A 101 ARG^? 8.92 C1 C8E A 210 D 101 TYR A 97 TYR^? 11.99 C1 C8E A 210 D 173 ASP A 149 ASP^? 14.85 C1 C8E A 210 coo 69.08 8.58 32.60 69.70 10.81 30.58 59.10 -60.12 -16.06 60.30 -57.41 -15.78 coo 71.77 11.86 24.26 70.23 12.22 26.56 61.97 -51.46 -14.47 63.57 -52.89 -16.21 coo 71.60 6.14 19.25 70.26 6.87 20.69 66.40 -51.17 -20.74 65.06 -51.90 -19.38 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 48 ARG A 162 ARG^? 10.87 O21 C8E A 210 D 101 TYR A 109 TYR^? 10.85 CA CA A 208 D 173 ASP A 111 ASP.? 17.05 CA CA A 208 coo 69.08 8.58 32.60 69.70 10.81 30.58 60.16 -83.54 -27.36 63.31 -83.18 -27.03 coo 71.77 11.86 24.26 70.23 12.22 26.56 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo 71.60 6.14 19.25 70.26 6.87 20.69 65.36 -83.80 -40.24 66.17 -85.36 -41.35 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 48 ARG B 101 ARG^? 13.86 O15 C8E B 209 D 101 TYR B 97 TYR^? 16.46 O15 C8E B 209 D 173 ASP B 149 ASP^? 14.91 O15 C8E B 209 coo 69.08 8.58 32.60 69.70 10.81 30.58 87.52 -34.18 -37.50 85.80 -36.55 -38.16 coo 71.77 11.86 24.26 70.23 12.22 26.56 83.74 -41.85 -39.80 83.62 -41.42 -37.05 coo 71.60 6.14 19.25 70.26 6.87 20.69 79.48 -42.39 -33.32 81.04 -41.48 -34.38 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 48 ARG B 162 ARG^? 16.35 O21 C8E B 210 D 101 TYR B 109 TYR^? 10.54 CA CA B 208 D 173 ASP B 111 ASP.? 16.97 CA CA B 208 coo 69.08 8.58 32.60 69.70 10.81 30.58 96.21 -15.01 -19.71 98.63 -13.28 -19.03 coo 71.77 11.86 24.26 70.23 12.22 26.56 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo 71.60 6.14 19.25 70.26 6.87 20.69 89.21 -14.92 -8.80 89.40 -13.99 -6.98 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 48 ARG C 101 ARG^? 13.82 C13 C8E C 210 D 101 TYR C 97 TYR^? 17.03 C13 C8E C 210 D 173 ASP C 149 ASP^? 16.02 C16 C8E C 210 coo 69.08 8.58 32.60 69.70 10.81 30.58 44.39 -56.56 -21.66 44.87 -57.05 -24.63 coo 71.77 11.86 24.26 70.23 12.22 26.56 44.42 -59.94 -30.24 42.23 -58.45 -29.40 coo 71.60 6.14 19.25 70.26 6.87 20.69 38.72 -55.19 -32.44 40.02 -55.93 -30.97 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 B 48 ARG C 162 ARG^? 16.00 O21 C8E C 209 D 101 TYR C 109 TYR^? 10.73 CA CA C 208 D 173 ASP C 111 ASP.? 17.21 CA CA C 208 coo 69.08 8.58 32.60 69.70 10.81 30.58 35.66 -43.15 0.12 35.66 -43.03 3.18 coo 71.77 11.86 24.26 70.23 12.22 26.56 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo 71.60 6.14 19.25 70.26 6.87 20.69 27.11 -33.17 -3.90 25.73 -31.94 -3.00 1cs1_c02 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 6 hits 1cs1_c02 naa= 3 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 101 TYR A 97 TYR^? 11.99 C1 C8E A 210 B 173 ASP A 149 ASP^? 14.85 C1 C8E A 210 D 48 ARG A 101 ARG^? 8.92 C1 C8E A 210 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 61.97 -51.46 -14.47 63.57 -52.89 -16.21 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 66.40 -51.17 -20.74 65.06 -51.90 -19.38 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 59.10 -60.12 -16.06 60.30 -57.41 -15.78 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 101 TYR A 109 TYR^? 10.85 CA CA A 208 B 173 ASP A 111 ASP.? 17.05 CA CA A 208 D 48 ARG A 162 ARG^? 10.87 O21 C8E A 210 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 65.36 -83.80 -40.24 66.17 -85.36 -41.35 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 60.16 -83.54 -27.36 63.31 -83.18 -27.03 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 101 TYR B 97 TYR^? 16.46 O15 C8E B 209 B 173 ASP B 149 ASP^? 14.91 O15 C8E B 209 D 48 ARG B 101 ARG^? 13.86 O15 C8E B 209 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 83.74 -41.85 -39.80 83.62 -41.42 -37.05 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 79.48 -42.39 -33.32 81.04 -41.48 -34.38 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 87.52 -34.18 -37.50 85.80 -36.55 -38.16 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 101 TYR B 109 TYR^? 10.54 CA CA B 208 B 173 ASP B 111 ASP.? 16.97 CA CA B 208 D 48 ARG B 162 ARG^? 16.35 O21 C8E B 210 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 89.21 -14.92 -8.80 89.40 -13.99 -6.98 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 96.21 -15.01 -19.71 98.63 -13.28 -19.03 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 101 TYR C 97 TYR^? 17.03 C13 C8E C 210 B 173 ASP C 149 ASP^? 16.02 C16 C8E C 210 D 48 ARG C 101 ARG^? 13.82 C13 C8E C 210 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 44.42 -59.94 -30.24 42.23 -58.45 -29.40 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 38.72 -55.19 -32.44 40.02 -55.93 -30.97 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 44.39 -56.56 -21.66 44.87 -57.05 -24.63 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 B 101 TYR C 109 TYR^? 10.73 CA CA C 208 B 173 ASP C 111 ASP.? 17.21 CA CA C 208 D 48 ARG C 162 ARG^? 16.00 O21 C8E C 209 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 27.11 -33.17 -3.90 25.73 -31.94 -3.00 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 35.66 -43.15 0.12 35.66 -43.03 3.18 1cs1_c03 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 6 hits 1cs1_c03 naa= 3 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 1 3 # 1 313 ASP A 26 ASP.? 24.86 C2 C8E C 209 315 GLU A 25 GLU^? 22.98 C2 C8E C 209 390 TYR A 83 TYR^? -19.24 C2 C8E C 209s coo 32.46 99.13 19.34 30.94 100.38 20.07 53.70 -37.11 -16.05 55.72 -36.42 -15.97 coo 32.04 94.22 18.23 30.57 94.75 16.88 56.22 -40.62 -18.58 57.98 -41.28 -19.55 coo 21.10 94.74 18.36 23.09 96.71 18.59 59.25 -44.27 -7.74 58.41 -42.23 -6.03 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 2 3 # 2 313 ASP A 45 ASP.? -2.96 CA CA A 208s 315 GLU A 70 GLU^? -2.69 CA CA A 208s 390 TYR A 51 TYR.? 9.92 O21 C8E A 210 coo 32.46 99.13 19.34 30.94 100.38 20.07 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo 32.04 94.22 18.23 30.57 94.75 16.88 68.79 -75.79 -31.87 70.14 -76.30 -30.27 coo 21.10 94.74 18.36 23.09 96.71 18.59 71.70 -83.21 -22.40 69.97 -85.02 -21.17 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 3 3 # 3 313 ASP A 114 ASP.? 22.11 CA CA A 208 315 GLU A 113 GLU.? 20.24 CA CA A 208 390 TYR A 109 TYR^? 10.85 CA CA A 208 coo 32.46 99.13 19.34 30.94 100.38 20.07 71.50 -87.46 -45.26 70.62 -89.18 -46.15 coo 32.04 94.22 18.23 30.57 94.75 16.88 67.94 -85.82 -46.11 66.40 -86.46 -44.83 coo 21.10 94.74 18.36 23.09 96.71 18.59 66.11 -81.19 -34.21 65.29 -83.76 -33.55 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 4 3 # 4 313 ASP A 166 ASP.? 23.45 CA CA A 208 315 GLU A 165 GLU^? 21.76 CA CA A 208 390 TYR A 109 TYR^? 10.85 CA CA A 208 coo 32.46 99.13 19.34 30.94 100.38 20.07 55.95 -88.25 -40.15 55.99 -89.39 -38.36 coo 32.04 94.22 18.23 30.57 94.75 16.88 55.17 -82.77 -39.51 54.39 -80.85 -40.05 coo 21.10 94.74 18.36 23.09 96.71 18.59 66.11 -81.19 -34.21 65.29 -83.76 -33.55 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 5 3 # 5 313 ASP B 26 ASP.? 33.07 O15 C8E B 209 315 GLU B 25 GLU^? 27.65 O15 C8E B 209 390 TYR B 83 TYR^? 23.90 C1 C8E B 209 coo 32.46 99.13 19.34 30.94 100.38 20.07 71.92 -43.11 -51.36 71.95 -45.06 -50.50 coo 32.04 94.22 18.23 30.57 94.75 16.88 73.50 -42.12 -45.68 71.97 -42.23 -44.24 coo 21.10 94.74 18.36 23.09 96.71 18.59 84.86 -45.84 -46.52 87.07 -46.60 -44.97 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 6 3 # 6 313 ASP B 45 ASP.? -3.07 CA CA B 208s 315 GLU B 70 GLU^? -2.58 CA CA B 208s 390 TYR B 51 TYR.? 9.95 O21 C8E B 210 coo 32.46 99.13 19.34 30.94 100.38 20.07 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo 32.04 94.22 18.23 30.57 94.75 16.88 89.83 -24.96 -14.47 91.03 -26.69 -14.39 coo 21.10 94.74 18.36 23.09 96.71 18.59 102.03 -27.53 -15.19 104.12 -26.16 -16.40 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 7 3 # 7 313 ASP C 26 ASP.? 24.60 O21 C8E A 209 315 GLU C 25 GLU.? 26.72 O21 C8E A 209 390 TYR C 83 TYR^? 19.88 O21 C8E A 209 coo 32.46 99.13 19.34 30.94 100.38 20.07 55.55 -58.08 -41.98 53.84 -58.94 -42.96 coo 32.04 94.22 18.23 30.57 94.75 16.88 50.80 -55.81 -38.99 49.16 -55.90 -40.32 coo 21.10 94.74 18.36 23.09 96.71 18.59 49.20 -66.70 -34.88 49.82 -68.82 -36.60 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 8 3 # 8 313 ASP C 45 ASP.? 3.27 CA CA C 208s 315 GLU C 70 GLU^? -2.71 CA CA C 208s 390 TYR C 51 TYR.? 10.04 O21 C8E C 209 coo 32.46 99.13 19.34 30.94 100.38 20.07 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo 32.04 94.22 18.23 30.57 94.75 16.88 27.73 -42.94 -10.42 26.74 -44.79 -10.37 coo 21.10 94.74 18.36 23.09 96.71 18.59 26.09 -52.62 -2.60 27.54 -53.38 -0.32 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 9 3 # 9 313 ASP C 61 ASP~? 12.61 CA CA C 208 315 GLU C 64 GLU~? 12.03 CA CA C 208 390 TYR C 109 TYR^? 10.73 CA CA C 208 coo 32.46 99.13 19.34 30.94 100.38 20.07 16.71 -46.53 -3.05 15.59 -48.22 -3.69 coo 32.04 94.22 18.23 30.57 94.75 16.88 16.47 -41.84 -8.31 14.60 -42.35 -9.15 coo 21.10 94.74 18.36 23.09 96.71 18.59 28.40 -39.89 -5.18 28.52 -40.13 -2.40 1ctn_c00 source 1ctn CHITINASE A (E.C.3.2.1.14) (PH 5.5, 4 DEGREES : 9 hits 1ctn_c00 naa= 3 ULMN 3 1cwy_c00 AMYLOMALTASE user 1 3 # 1 A 293 ASP A 45 ASP.? -2.96 CA CA A 208s A 340 GLU A 70 GLU^? -2.69 CA CA A 208s A 395 ASP A 49 ASP.? -3.00 CA CA A 208s coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 68.79 -75.79 -31.87 70.14 -76.30 -30.27 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 75.72 -77.89 -27.98 74.67 -77.10 -29.65 ULMN 3 1cwy_c00 AMYLOMALTASE user 2 3 # 2 A 293 ASP A 111 ASP.? 17.05 CA CA A 208 A 340 GLU A 113 GLU.? 20.24 CA CA A 208 A 395 ASP A 167 ASP.? 22.50 CA CA A 208 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 65.36 -83.80 -40.24 66.17 -85.36 -41.35 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 67.94 -85.82 -46.11 66.40 -86.46 -44.83 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 58.25 -87.45 -44.58 60.23 -87.13 -43.88 ULMN 3 1cwy_c00 AMYLOMALTASE user 3 3 # 3 A 293 ASP A 166 ASP.? 23.45 CA CA A 208 A 340 GLU A 165 GLU^? 21.76 CA CA A 208 A 395 ASP A 111 ASP.? 17.05 CA CA A 208 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 55.95 -88.25 -40.15 55.99 -89.39 -38.36 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 55.17 -82.77 -39.51 54.39 -80.85 -40.05 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 65.36 -83.80 -40.24 66.17 -85.36 -41.35 ULMN 3 1cwy_c00 AMYLOMALTASE user 4 3 # 4 A 293 ASP A 185 ASP~? 11.73 O21 C8E A 210 A 340 GLU A 184 GLU~? 7.72 C16 C8E A 210 A 395 ASP A 180 ASP.? 14.47 O15 C8E A 210 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 65.81 -86.27 -18.22 66.54 -87.64 -16.78 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 63.73 -84.37 -12.45 63.45 -82.45 -11.70 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 55.45 -86.10 -15.44 53.65 -85.04 -15.38 ULMN 3 1cwy_c00 AMYLOMALTASE user 5 3 # 5 A 293 ASP B 49 ASP.? -3.05 CA CA B 208s A 340 GLU B 70 GLU^? -2.58 CA CA B 208s A 395 ASP B 45 ASP.? -3.07 CA CA B 208s coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 94.52 -28.97 -11.62 93.03 -30.41 -11.73 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 89.83 -24.96 -14.47 91.03 -26.69 -14.39 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 90.60 -30.65 -18.50 91.26 -30.99 -16.60 ULMN 3 1cwy_c00 AMYLOMALTASE user 6 3 # 6 A 293 ASP B 61 ASP~? 12.48 CA CA B 208 A 340 GLU B 64 GLU~? 12.78 CA CA B 208 A 395 ASP B 49 ASP.? -3.05 CA CA B 208s coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 98.68 -27.22 -4.60 99.30 -29.23 -4.23 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 92.75 -26.79 -1.73 90.87 -27.74 -1.56 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 94.52 -28.97 -11.62 93.03 -30.41 -11.73 ULMN 3 1cwy_c00 AMYLOMALTASE user 7 3 # 7 A 293 ASP B 111 ASP.? 16.97 CA CA B 208 A 340 GLU B 113 GLU.? 20.51 CA CA B 208 A 395 ASP B 167 ASP.? 22.72 CA CA B 208 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 89.21 -14.92 -8.80 89.40 -13.99 -6.98 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 86.78 -12.34 -3.10 88.60 -11.66 -4.00 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 88.92 -5.85 -9.56 88.92 -7.42 -8.19 ULMN 3 1cwy_c00 AMYLOMALTASE user 8 3 # 8 A 293 ASP B 166 ASP.? 24.17 CA CA B 208 A 340 GLU B 164 GLU^? 19.99 CA CA B 208 A 395 ASP B 111 ASP.? 16.97 CA CA B 208 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 91.14 -5.33 -14.11 93.17 -5.00 -14.63 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 94.70 -10.70 -16.52 96.59 -9.81 -16.07 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 89.21 -14.92 -8.80 89.40 -13.99 -6.98 ULMN 3 1cwy_c00 AMYLOMALTASE user 9 3 # 9 A 293 ASP B 166 ASP.? 24.17 CA CA B 208 A 340 GLU B 165 GLU^? 20.64 CA CA B 208 A 395 ASP B 111 ASP.? 16.97 CA CA B 208 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 91.14 -5.33 -14.11 93.17 -5.00 -14.63 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 88.15 -8.84 -16.79 86.14 -9.46 -16.74 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 89.21 -14.92 -8.80 89.40 -13.99 -6.98 ULMN 3 1cwy_c00 AMYLOMALTASE user 10 3 # 10 A 293 ASP B 185 ASP~? 11.63 O21 C8E B 210 A 340 GLU B 184 GLU~? 8.45 C14 C8E B 210 A 395 ASP B 180 ASP.? 10.93 C4 C8E B 210 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 106.30 -23.80 -20.43 108.26 -24.54 -20.08 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 107.80 -26.84 -26.43 109.06 -28.52 -26.54 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 106.50 -18.19 -29.27 105.54 -17.21 -30.85 ULMN 3 1cwy_c00 AMYLOMALTASE user 11 3 # 11 A 293 ASP C 45 ASP.? 3.27 CA CA C 208s A 340 GLU C 70 GLU^? -2.71 CA CA C 208s A 395 ASP C 49 ASP.? -2.87 CA CA C 208s coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 27.73 -42.94 -10.42 26.74 -44.79 -10.37 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 22.13 -48.50 -9.42 23.00 -46.66 -10.00 ULMN 3 1cwy_c00 AMYLOMALTASE user 12 3 # 12 A 293 ASP C 61 ASP~? 12.61 CA CA C 208 A 340 GLU C 64 GLU~? 12.03 CA CA C 208 A 395 ASP C 49 ASP.? -2.87 CA CA C 208s coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 16.71 -46.53 -3.05 15.59 -48.22 -3.69 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 16.47 -41.84 -8.31 14.60 -42.35 -9.15 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 22.13 -48.50 -9.42 23.00 -46.66 -10.00 ULMN 3 1cwy_c00 AMYLOMALTASE user 13 3 # 13 A 293 ASP C 111 ASP.? 17.21 CA CA C 208 A 340 GLU C 113 GLU.? 20.72 CA CA C 208 A 395 ASP C 167 ASP.? 25.18 CA CA C 208 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 27.11 -33.17 -3.90 25.73 -31.94 -3.00 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 22.93 -28.02 -2.65 24.78 -28.62 -1.78 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 31.39 -27.44 2.08 30.34 -25.78 1.31 ULMN 3 1cwy_c00 AMYLOMALTASE user 14 3 # 14 A 293 ASP C 166 ASP.? 24.81 CA CA C 208 A 340 GLU C 164 GLU^? 20.06 CA CA C 208 A 395 ASP C 111 ASP.? 17.21 CA CA C 208 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 35.75 -30.25 2.83 35.54 -31.07 4.76 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 34.72 -37.11 1.76 34.46 -37.46 3.82 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 27.11 -33.17 -3.90 25.73 -31.94 -3.00 ULMN 3 1cwy_c00 AMYLOMALTASE user 15 3 # 15 A 293 ASP C 166 ASP.? 24.81 CA CA C 208 A 340 GLU C 165 GLU^? 20.98 CA CA C 208 A 395 ASP C 111 ASP.? 17.21 CA CA C 208 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 35.75 -30.25 2.83 35.54 -31.07 4.76 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 36.32 -31.59 -2.15 36.97 -31.00 -4.08 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 27.11 -33.17 -3.90 25.73 -31.94 -3.00 ULMN 3 1cwy_c00 AMYLOMALTASE user 16 3 # 16 A 293 ASP C 185 ASP~? 11.81 O21 C8E C 209 A 340 GLU C 184 GLU~? 7.93 C14 C8E C 209 A 395 ASP C 180 ASP.? 12.29 C5 C8E C 209 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 31.89 -54.53 1.93 31.11 -55.91 3.29 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 35.72 -59.91 1.24 36.69 -61.13 -0.21 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 42.24 -54.49 3.97 44.24 -53.90 3.82 1cwy_c00 source 1cwy AMYLOMALTASE : 16 hits 1cwy_c00 naa= 3 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 1 3 # 1 A 138 TRP A 59 TRP~? 6.21 CA CA A 208 A 243 ASP A 45 ASP.? -2.96 CA CA A 208s A 272 LYS A 188 LYS~? 10.77 C20 C8E A 210 coo 18.21 54.75 18.05 19.91 55.17 21.59 71.67 -80.29 -29.02 69.69 -82.14 -31.86 coo 16.93 55.67 9.65 17.16 54.23 11.19 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo 14.13 45.79 13.40 14.25 49.41 18.30 68.32 -80.18 -18.11 71.95 -84.24 -15.84 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 2 3 # 2 A 138 TRP A 59 TRP~? 6.21 CA CA A 208 A 243 ASP A 52 ASP.? 15.11 CA CA A 208 A 272 LYS A 188 LYS~? 10.77 C20 C8E A 210 coo 18.21 54.75 18.05 19.91 55.17 21.59 71.67 -80.29 -29.02 69.69 -82.14 -31.86 coo 16.93 55.67 9.65 17.16 54.23 11.19 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo 14.13 45.79 13.40 14.25 49.41 18.30 68.32 -80.18 -18.11 71.95 -84.24 -15.84 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 3 3 # 3 A 138 TRP A 59 TRP~? 6.21 CA CA A 208 A 243 ASP A 61 ASP~? 12.37 CA CA A 208 A 272 LYS A 67 LYS~? 13.30 CA CA A 208 coo 18.21 54.75 18.05 19.91 55.17 21.59 71.67 -80.29 -29.02 69.69 -82.14 -31.86 coo 16.93 55.67 9.65 17.16 54.23 11.19 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo 14.13 45.79 13.40 14.25 49.41 18.30 73.21 -82.07 -40.14 71.59 -78.49 -41.85 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 4 3 # 4 A 138 TRP A 71 TRP^? 11.26 CA CA A 208 A 243 ASP A 111 ASP.? 17.05 CA CA A 208 A 272 LYS A 63 LYS~? 3.96 CA CA A 208 coo 18.21 54.75 18.05 19.91 55.17 21.59 63.94 -74.90 -35.16 60.97 -73.12 -33.30 coo 16.93 55.67 9.65 17.16 54.23 11.19 65.36 -83.80 -40.24 66.17 -85.36 -41.35 coo 14.13 45.79 13.40 14.25 49.41 18.30 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 5 3 # 5 A 138 TRP B 59 TRP~? 6.11 CA CA B 208 A 243 ASP B 45 ASP.? -3.07 CA CA B 208s A 272 LYS B 188 LYS~? 9.67 C16 C8E B 210 coo 18.21 54.75 18.05 19.91 55.17 21.59 95.08 -26.15 -12.40 94.38 -22.43 -11.38 coo 16.93 55.67 9.65 17.16 54.23 11.19 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo 14.13 45.79 13.40 14.25 49.41 18.30 102.16 -28.74 -21.10 106.15 -31.37 -17.86 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 6 3 # 6 A 138 TRP B 59 TRP~? 6.11 CA CA B 208 A 243 ASP B 61 ASP~? 12.48 CA CA B 208 A 272 LYS B 67 LYS~? 18.13 CA CA B 208 coo 18.21 54.75 18.05 19.91 55.17 21.59 95.08 -26.15 -12.40 94.38 -22.43 -11.38 coo 16.93 55.67 9.65 17.16 54.23 11.19 98.68 -27.22 -4.60 99.30 -29.23 -4.23 coo 14.13 45.79 13.40 14.25 49.41 18.30 89.12 -21.41 -4.23 87.66 -21.56 1.71 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 7 3 # 7 A 138 TRP B 71 TRP^? 11.25 CA CA B 208 A 243 ASP B 111 ASP.? 16.97 CA CA B 208 A 272 LYS B 63 LYS~? 3.79 CA CA B 208 coo 18.21 54.75 18.05 19.91 55.17 21.59 86.05 -20.83 -16.48 85.77 -20.27 -20.38 coo 16.93 55.67 9.65 17.16 54.23 11.19 89.21 -14.92 -8.80 89.40 -13.99 -6.98 coo 14.13 45.79 13.40 14.25 49.41 18.30 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 8 3 # 8 A 138 TRP C 59 TRP~? 6.20 CA CA C 208 A 243 ASP C 45 ASP.? 3.27 CA CA C 208s A 272 LYS C 188 LYS~? 9.02 C16 C8E C 209 coo 18.21 54.75 18.05 19.91 55.17 21.59 24.77 -46.37 -6.57 25.55 -42.98 -4.73 coo 16.93 55.67 9.65 17.16 54.23 11.19 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo 14.13 45.79 13.40 14.25 49.41 18.30 31.07 -55.82 -4.30 26.58 -58.21 -2.57 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 9 3 # 9 A 138 TRP C 59 TRP~? 6.20 CA CA C 208 A 243 ASP C 61 ASP~? 12.61 CA CA C 208 A 272 LYS C 67 LYS.? 18.71 CA CA C 208 coo 18.21 54.75 18.05 19.91 55.17 21.59 24.77 -46.37 -6.57 25.55 -42.98 -4.73 coo 16.93 55.67 9.65 17.16 54.23 11.19 16.71 -46.53 -3.05 15.59 -48.22 -3.69 coo 14.13 45.79 13.40 14.25 49.41 18.30 20.04 -36.06 -6.98 16.11 -31.17 -7.78 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 10 3 # 10 A 138 TRP C 71 TRP^? 10.96 O21 C8E C 210 A 243 ASP C 111 ASP.? 17.21 CA CA C 208 A 272 LYS C 63 LYS~? 4.21 CA CA C 208 coo 18.21 54.75 18.05 19.91 55.17 21.59 31.84 -38.56 -11.03 35.57 -39.45 -11.85 coo 16.93 55.67 9.65 17.16 54.23 11.19 27.11 -33.17 -3.90 25.73 -31.94 -3.00 coo 14.13 45.79 13.40 14.25 49.41 18.30 20.98 -41.61 -5.49 23.04 -43.67 -10.44 1d7r_c01 source 1d7r 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYRUVATE) : 10 hits 1d7r_c01 naa= 3 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 1 3 # 1 A 173 TYR A 138 TYR^? 19.17 C16 C8E B 209 A 243 ASP B 80 ASP^? 15.94 O15 C8E B 209 A 272 LYS B 84 LYS.? 25.86 O15 C8E B 209 coo 2.03 68.31 21.46 0.66 68.36 23.90 70.50 -38.06 -22.60 71.93 -35.69 -22.96 coo 16.93 55.67 9.65 17.16 54.23 11.19 82.56 -37.87 -41.00 82.97 -37.16 -39.06 coo 14.13 45.79 13.40 14.25 49.41 18.30 79.44 -47.69 -46.65 75.97 -44.45 -44.18 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 2 3 # 2 A 173 TYR A 183 TYR~? 7.18 C16 C8E A 210 A 243 ASP A 61 ASP~? 12.37 CA CA A 208 A 272 LYS A 67 LYS~? 13.30 CA CA A 208 coo 2.03 68.31 21.46 0.66 68.36 23.90 59.65 -81.82 -15.52 59.58 -79.01 -15.74 coo 16.93 55.67 9.65 17.16 54.23 11.19 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo 14.13 45.79 13.40 14.25 49.41 18.30 73.21 -82.07 -40.14 71.59 -78.49 -41.85 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 3 3 # 3 A 173 TYR A 205 TYR^? 30.20 C20 C8E C 210 A 243 ASP B 26 ASP.? 33.07 O15 C8E B 209 A 272 LYS B 84 LYS.? 25.86 O15 C8E B 209 coo 2.03 68.31 21.46 0.66 68.36 23.90 57.96 -40.35 -31.16 56.81 -38.18 -32.51 coo 16.93 55.67 9.65 17.16 54.23 11.19 71.92 -43.11 -51.36 71.95 -45.06 -50.50 coo 14.13 45.79 13.40 14.25 49.41 18.30 79.44 -47.69 -46.65 75.97 -44.45 -44.18 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 4 3 # 4 A 173 TYR A 205 TYR^? 30.20 C20 C8E C 210 A 243 ASP C 26 ASP.? 24.60 O21 C8E A 209 A 272 LYS C 84 LYS.? 25.24 O21 C8E A 209 coo 2.03 68.31 21.46 0.66 68.36 23.90 57.96 -40.35 -31.16 56.81 -38.18 -32.51 coo 16.93 55.67 9.65 17.16 54.23 11.19 55.55 -58.08 -41.98 53.84 -58.94 -42.96 coo 14.13 45.79 13.40 14.25 49.41 18.30 49.01 -63.83 -38.44 48.10 -58.01 -38.38 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 5 3 # 5 A 173 TYR B 138 TYR^? 18.52 O18 C8E A 209 A 243 ASP A 80 ASP^? 12.60 C1 C8E A 210 A 272 LYS A 84 LYS.? 23.11 C2 C8E C 209 coo 2.03 68.31 21.46 0.66 68.36 23.90 69.87 -51.92 -34.99 68.26 -54.21 -34.65 coo 16.93 55.67 9.65 17.16 54.23 11.19 58.12 -52.30 -15.93 59.10 -53.68 -17.13 coo 14.13 45.79 13.40 14.25 49.41 18.30 61.58 -41.74 -11.00 58.66 -39.80 -16.04 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 6 3 # 6 A 173 TYR B 183 TYR~? 7.74 O12 C8E B 210 A 243 ASP B 61 ASP~? 12.48 CA CA B 208 A 272 LYS B 67 LYS~? 18.13 CA CA B 208 coo 2.03 68.31 21.46 0.66 68.36 23.90 104.05 -23.05 -28.11 101.72 -24.25 -29.01 coo 16.93 55.67 9.65 17.16 54.23 11.19 98.68 -27.22 -4.60 99.30 -29.23 -4.23 coo 14.13 45.79 13.40 14.25 49.41 18.30 89.12 -21.41 -4.23 87.66 -21.56 1.71 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 7 3 # 7 A 173 TYR B 205 TYR^? 31.23 O15 C8E B 209 A 243 ASP A 26 ASP.? 24.86 C2 C8E C 209 A 272 LYS A 84 LYS.? 23.11 C2 C8E C 209 coo 2.03 68.31 21.46 0.66 68.36 23.90 63.66 -38.04 -37.77 60.98 -37.67 -38.58 coo 16.93 55.67 9.65 17.16 54.23 11.19 53.70 -37.11 -16.05 55.72 -36.42 -15.97 coo 14.13 45.79 13.40 14.25 49.41 18.30 61.58 -41.74 -11.00 58.66 -39.80 -16.04 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 8 3 # 8 A 173 TYR C 83 TYR^? 19.88 O21 C8E A 209 A 243 ASP A 45 ASP.? -2.96 CA CA A 208s A 272 LYS A 188 LYS~? 10.77 C20 C8E A 210 coo 2.03 68.31 21.46 0.66 68.36 23.90 49.20 -66.70 -34.88 49.82 -68.82 -36.60 coo 16.93 55.67 9.65 17.16 54.23 11.19 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo 14.13 45.79 13.40 14.25 49.41 18.30 68.32 -80.18 -18.11 71.95 -84.24 -15.84 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 9 3 # 9 A 173 TYR C 97 TYR^? 17.03 C13 C8E C 210 A 243 ASP A 80 ASP^? 12.60 C1 C8E A 210 A 272 LYS A 198 LYS^? 12.09 C1 C8E A 210 coo 2.03 68.31 21.46 0.66 68.36 23.90 44.42 -59.94 -30.24 42.23 -58.45 -29.40 coo 16.93 55.67 9.65 17.16 54.23 11.19 58.12 -52.30 -15.93 59.10 -53.68 -17.13 coo 14.13 45.79 13.40 14.25 49.41 18.30 68.28 -58.05 -20.21 63.11 -55.44 -18.88 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 10 3 # 10 A 173 TYR C 155 TYR^? 7.32 C13 C8E C 210 A 243 ASP A 26 ASP.? 24.86 C2 C8E C 209 A 272 LYS A 84 LYS.? 23.11 C2 C8E C 209 coo 2.03 68.31 21.46 0.66 68.36 23.90 41.26 -55.52 -15.76 41.81 -54.24 -18.13 coo 16.93 55.67 9.65 17.16 54.23 11.19 53.70 -37.11 -16.05 55.72 -36.42 -15.97 coo 14.13 45.79 13.40 14.25 49.41 18.30 61.58 -41.74 -11.00 58.66 -39.80 -16.04 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 11 3 # 11 A 173 TYR C 183 TYR~? 7.45 C14 C8E C 209 A 243 ASP A 80 ASP^? 12.60 C1 C8E A 210 A 272 LYS A 84 LYS.? 23.11 C2 C8E C 209 coo 2.03 68.31 21.46 0.66 68.36 23.90 39.42 -55.89 -0.59 40.02 -55.54 -3.26 coo 16.93 55.67 9.65 17.16 54.23 11.19 58.12 -52.30 -15.93 59.10 -53.68 -17.13 coo 14.13 45.79 13.40 14.25 49.41 18.30 61.58 -41.74 -11.00 58.66 -39.80 -16.04 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 12 3 # 12 A 173 TYR C 183 TYR~? 7.45 C14 C8E C 209 A 243 ASP C 61 ASP~? 12.61 CA CA C 208 A 272 LYS C 67 LYS.? 18.71 CA CA C 208 coo 2.03 68.31 21.46 0.66 68.36 23.90 39.42 -55.89 -0.59 40.02 -55.54 -3.26 coo 16.93 55.67 9.65 17.16 54.23 11.19 16.71 -46.53 -3.05 15.59 -48.22 -3.69 coo 14.13 45.79 13.40 14.25 49.41 18.30 20.04 -36.06 -6.98 16.11 -31.17 -7.78 1d7r_c02 source 1d7r 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYRUVATE) : 12 hits 1d7r_c02 naa= 3 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 1 3 # 1 A 145 LYS A 84 LYS.? 23.11 C2 C8E C 209 A 177 GLU A 25 GLU^? 22.98 C2 C8E C 209 A 201 LEU A 82 LEU^? 16.79 C1 C8E A 210 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 61.58 -41.74 -11.00 58.66 -39.80 -16.04 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 56.22 -40.62 -18.58 57.98 -41.28 -19.55 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 59.00 -46.86 -14.13 59.29 -47.61 -16.11 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 2 3 # 2 A 145 LYS A 119 LYS.? 17.79 CA CA A 208 A 177 GLU A 113 GLU.? 20.24 CA CA A 208 A 201 LEU A 116 LEU.? 16.15 CA CA A 208 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 60.88 -84.29 -40.26 61.29 -87.76 -35.50 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 67.94 -85.82 -46.11 66.40 -86.46 -44.83 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 66.94 -87.97 -38.60 66.23 -87.58 -36.63 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 3 3 # 3 A 145 LYS B 119 LYS.? 18.40 CA CA B 208 A 177 GLU B 113 GLU.? 20.51 CA CA B 208 A 201 LEU B 116 LEU.? 16.00 CA CA B 208 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 89.22 -11.21 -11.71 95.34 -11.17 -12.31 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 86.78 -12.34 -3.10 88.60 -11.66 -4.00 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 93.01 -14.13 -7.42 94.62 -14.92 -8.59 1daa_c00 source 1daa D-AMINO ACID AMINOTRANSFERASE : 3 hits 1daa_c00 naa= 3 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 1 3 # 1 B 145 LYS A 119 LYS.? 17.79 CA CA A 208 B 177 GLU A 113 GLU.? 20.24 CA CA A 208 B 201 LEU A 116 LEU.? 16.15 CA CA A 208 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 60.88 -84.29 -40.26 61.29 -87.76 -35.50 coo 27.00 6.35 51.01 26.30 4.53 50.18 67.94 -85.82 -46.11 66.40 -86.46 -44.83 coo 23.74 1.68 49.50 22.87 -0.24 49.97 66.94 -87.97 -38.60 66.23 -87.58 -36.63 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 2 3 # 2 B 145 LYS B 119 LYS.? 18.40 CA CA B 208 B 177 GLU B 113 GLU.? 20.51 CA CA B 208 B 201 LEU B 116 LEU.? 16.00 CA CA B 208 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 89.22 -11.21 -11.71 95.34 -11.17 -12.31 coo 27.00 6.35 51.01 26.30 4.53 50.18 86.78 -12.34 -3.10 88.60 -11.66 -4.00 coo 23.74 1.68 49.50 22.87 -0.24 49.97 93.01 -14.13 -7.42 94.62 -14.92 -8.59 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 3 3 # 3 B 145 LYS C 119 LYS.? 22.44 CA CA C 208 B 177 GLU C 113 GLU.? 20.72 CA CA C 208 B 201 LEU C 116 LEU.? 16.14 CA CA C 208 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 30.81 -32.05 -1.80 31.88 -31.87 3.92 coo 27.00 6.35 51.01 26.30 4.53 50.18 22.93 -28.02 -2.65 24.78 -28.62 -1.78 coo 23.74 1.68 49.50 22.87 -0.24 49.97 25.74 -33.77 -0.35 25.49 -35.13 -2.07 1daa_c01 source 1daa D-AMINO ACID AMINOTRANSFERASE : 3 hits 1daa_c01 naa= 3 ULMN 3 1db3_c01 GDP-MANNOSE 4,6-DEHYDRATASE user 1 3 # 1 A 132 THR A 191 THR.? -4.98 C19 C8E A 209s A 156 TYR A 51 TYR.? 9.92 O21 C8E A 210 A 160 LYS A 188 LYS~? 10.77 C20 C8E A 210 coo 10.50 56.87 17.73 11.24 57.93 19.43 67.24 -74.39 -22.77 69.05 -73.78 -23.78 coo 11.64 63.07 23.95 11.76 62.47 21.20 71.70 -83.21 -22.40 69.97 -85.02 -21.17 coo 5.78 61.30 21.65 8.04 62.89 17.54 68.32 -80.18 -18.11 71.95 -84.24 -15.84 ULMN 3 1db3_c01 GDP-MANNOSE 4,6-DEHYDRATASE user 2 3 # 2 A 132 THR B 191 THR.? -5.05 O18 C8E B 209s A 156 TYR B 51 TYR.? 9.95 O21 C8E B 210 A 160 LYS B 188 LYS~? 9.67 C16 C8E B 210 coo 10.50 56.87 17.73 11.24 57.93 19.43 94.88 -29.06 -21.80 94.27 -29.66 -19.85 coo 11.64 63.07 23.95 11.76 62.47 21.20 102.03 -27.53 -15.19 104.12 -26.16 -16.40 coo 5.78 61.30 21.65 8.04 62.89 17.54 102.16 -28.74 -21.10 106.15 -31.37 -17.86 ULMN 3 1db3_c01 GDP-MANNOSE 4,6-DEHYDRATASE user 3 3 # 3 A 132 THR C 191 THR.? 5.18 C20 C8E C 209s A 156 TYR C 51 TYR.? 10.04 O21 C8E C 209 A 160 LYS C 188 LYS~? 9.02 C16 C8E C 209 coo 10.50 56.87 17.73 11.24 57.93 19.43 32.16 -51.72 -10.15 30.14 -51.15 -10.71 coo 11.64 63.07 23.95 11.76 62.47 21.20 26.09 -52.62 -2.60 27.54 -53.38 -0.32 coo 5.78 61.30 21.65 8.04 62.89 17.54 31.07 -55.82 -4.30 26.58 -58.21 -2.57 1db3_c01 source 1db3 GDP-MANNOSE 4,6-DEHYDRATASE : 3 hits 1db3_c01 naa= 3 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 A 57 GLU A 165 GLU^? 21.76 CA CA A 208 A 226 THR A 191 THR.? -4.98 C19 C8E A 209s A 229 LYS A 188 LYS~? 10.77 C20 C8E A 210 coo 9.66 102.78 70.07 9.79 101.18 71.42 55.17 -82.77 -39.51 54.39 -80.85 -40.05 coo 7.24 97.46 49.60 8.11 95.69 48.80 67.24 -74.39 -22.77 69.05 -73.78 -23.78 coo 10.53 97.56 43.71 9.33 93.71 47.17 68.32 -80.18 -18.11 71.95 -84.24 -15.84 1dfo_c04 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 1 hits 1dfo_c04 naa= 3 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 B 57 GLU A 165 GLU^? 21.76 CA CA A 208 B 226 THR A 191 THR.? -4.98 C19 C8E A 209s B 229 LYS A 188 LYS~? 10.77 C20 C8E A 210 coo 15.90 87.61 49.61 13.92 86.96 49.36 55.17 -82.77 -39.51 54.39 -80.85 -40.05 coo 20.74 95.78 68.68 19.29 96.84 69.83 67.24 -74.39 -22.77 69.05 -73.78 -23.78 coo 22.32 101.61 71.64 17.89 98.63 71.55 68.32 -80.18 -18.11 71.95 -84.24 -15.84 1dfo_c05 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 1 hits 1dfo_c05 naa= 3 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 C 57 GLU A 165 GLU^? 21.76 CA CA A 208 C 226 THR A 191 THR.? -4.98 C19 C8E A 209s C 229 LYS A 188 LYS~? 10.77 C20 C8E A 210 coo 5.43 40.40 61.63 4.27 41.99 60.90 55.17 -82.77 -39.51 54.39 -80.85 -40.05 coo 22.16 45.88 73.63 23.23 47.70 73.25 67.24 -74.39 -22.77 69.05 -73.78 -23.78 coo 28.90 45.91 73.55 25.22 49.72 72.97 68.32 -80.18 -18.11 71.95 -84.24 -15.84 1dfo_c06 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 1 hits 1dfo_c06 naa= 3 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 D 57 GLU A 165 GLU^? 21.76 CA CA A 208 D 226 THR A 191 THR.? -4.98 C19 C8E A 209s D 229 LYS A 188 LYS~? 10.77 C20 C8E A 210 coo 26.07 55.89 66.14 25.33 56.50 68.01 55.17 -82.77 -39.51 54.39 -80.85 -40.05 coo 11.79 47.62 52.67 10.10 46.51 53.39 67.24 -74.39 -22.77 69.05 -73.78 -23.78 coo 10.05 41.79 49.80 7.94 44.71 53.76 68.32 -80.18 -18.11 71.95 -84.24 -15.84 1dfo_c07 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 1 hits 1dfo_c07 naa= 3 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 A 133 TYR A 13 TYR^? 6.88 C17 C8E A 209 A 138 ARG A 101 ARG^? 8.92 C1 C8E A 210 A 161 LYS A 198 LYS^? 12.09 C1 C8E A 210 coo 29.03 88.95 86.80 28.09 90.57 84.75 65.07 -60.93 -23.01 63.35 -61.54 -20.90 coo 23.31 93.18 82.88 23.00 93.71 79.86 59.10 -60.12 -16.06 60.30 -57.41 -15.78 coo 33.83 91.15 88.62 31.07 91.06 83.02 68.28 -58.05 -20.21 63.11 -55.44 -18.88 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 2 3 # 2 A 133 TYR B 13 TYR^? 6.78 O15 C8E B 209 A 138 ARG B 101 ARG^? 13.86 O15 C8E B 209 A 161 LYS B 198 LYS^? 12.15 O15 C8E B 209 coo 29.03 88.95 86.80 28.09 90.57 84.75 84.65 -34.92 -28.70 86.28 -34.17 -30.84 coo 23.31 93.18 82.88 23.00 93.71 79.86 87.52 -34.18 -37.50 85.80 -36.55 -38.16 coo 33.83 91.15 88.62 31.07 91.06 83.02 85.01 -40.11 -29.09 83.85 -38.63 -34.53 1dhp_c00 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 2 hits 1dhp_c00 naa= 3 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 B 133 TYR A 13 TYR^? 6.88 C17 C8E A 209 B 138 ARG A 101 ARG^? 8.92 C1 C8E A 210 B 161 LYS A 198 LYS^? 12.09 C1 C8E A 210 coo 4.62 122.69 99.88 5.46 122.82 97.24 65.07 -60.93 -23.01 63.35 -61.54 -20.90 coo 10.44 122.27 94.08 11.02 123.87 91.53 59.10 -60.12 -16.06 60.30 -57.41 -15.78 coo -0.17 119.75 99.65 2.51 123.83 95.70 68.28 -58.05 -20.21 63.11 -55.44 -18.88 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 2 3 # 2 B 133 TYR B 13 TYR^? 6.78 O15 C8E B 209 B 138 ARG B 101 ARG^? 13.86 O15 C8E B 209 B 161 LYS B 198 LYS^? 12.15 O15 C8E B 209 coo 4.62 122.69 99.88 5.46 122.82 97.24 84.65 -34.92 -28.70 86.28 -34.17 -30.84 coo 10.44 122.27 94.08 11.02 123.87 91.53 87.52 -34.18 -37.50 85.80 -36.55 -38.16 coo -0.17 119.75 99.65 2.51 123.83 95.70 85.01 -40.11 -29.09 83.85 -38.63 -34.53 1dhp_c01 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 2 hits 1dhp_c01 naa= 3 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 A 44 THR A 58 THR~? 10.52 CA CA A 208 A 45 THR A 57 THR.? 15.79 CA CA A 208 A 161 LYS A 67 LYS~? 13.30 CA CA A 208 coo 26.16 88.25 79.16 25.22 89.47 80.71 76.40 -85.04 -26.81 78.11 -83.80 -26.40 coo 27.73 89.90 76.08 29.24 91.46 75.95 78.12 -88.42 -27.00 77.65 -90.24 -28.10 coo 33.83 91.15 88.62 31.07 91.06 83.02 73.21 -82.07 -40.14 71.59 -78.49 -41.85 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 2 3 # 2 A 44 THR A 58 THR~? 10.52 CA CA A 208 A 45 THR A 57 THR.? 15.79 CA CA A 208 A 161 LYS A 188 LYS~? 10.77 C20 C8E A 210 coo 26.16 88.25 79.16 25.22 89.47 80.71 76.40 -85.04 -26.81 78.11 -83.80 -26.40 coo 27.73 89.90 76.08 29.24 91.46 75.95 78.12 -88.42 -27.00 77.65 -90.24 -28.10 coo 33.83 91.15 88.62 31.07 91.06 83.02 68.32 -80.18 -18.11 71.95 -84.24 -15.84 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 3 3 # 3 A 44 THR B 58 THR~? 10.41 CA CA B 208 A 45 THR B 57 THR.? 15.82 CA CA B 208 A 161 LYS B 67 LYS~? 18.13 CA CA B 208 coo 26.16 88.25 79.16 25.22 89.47 80.71 100.65 -27.90 -8.43 100.12 -29.92 -7.97 coo 27.73 89.90 76.08 29.24 91.46 75.95 103.33 -27.21 -5.87 103.96 -25.48 -4.75 coo 33.83 91.15 88.62 31.07 91.06 83.02 89.12 -21.41 -4.23 87.66 -21.56 1.71 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 4 3 # 4 A 44 THR B 58 THR~? 10.41 CA CA B 208 A 45 THR B 57 THR.? 15.82 CA CA B 208 A 161 LYS B 188 LYS~? 9.67 C16 C8E B 210 coo 26.16 88.25 79.16 25.22 89.47 80.71 100.65 -27.90 -8.43 100.12 -29.92 -7.97 coo 27.73 89.90 76.08 29.24 91.46 75.95 103.33 -27.21 -5.87 103.96 -25.48 -4.75 coo 33.83 91.15 88.62 31.07 91.06 83.02 102.16 -28.74 -21.10 106.15 -31.37 -17.86 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 5 3 # 5 A 44 THR C 58 THR~? 10.65 CA CA C 208 A 45 THR C 57 THR.? 15.66 CA CA C 208 A 161 LYS C 67 LYS.? 18.71 CA CA C 208 coo 26.16 88.25 79.16 25.22 89.47 80.71 19.91 -49.60 -2.59 18.80 -50.74 -4.02 coo 27.73 89.90 76.08 29.24 91.46 75.95 17.34 -49.58 0.14 17.08 -48.15 1.75 coo 33.83 91.15 88.62 31.07 91.06 83.02 20.04 -36.06 -6.98 16.11 -31.17 -7.78 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 6 3 # 6 A 44 THR C 58 THR~? 10.65 CA CA C 208 A 45 THR C 57 THR.? 15.66 CA CA C 208 A 161 LYS C 188 LYS~? 9.02 C16 C8E C 209 coo 26.16 88.25 79.16 25.22 89.47 80.71 19.91 -49.60 -2.59 18.80 -50.74 -4.02 coo 27.73 89.90 76.08 29.24 91.46 75.95 17.34 -49.58 0.14 17.08 -48.15 1.75 coo 33.83 91.15 88.62 31.07 91.06 83.02 31.07 -55.82 -4.30 26.58 -58.21 -2.57 1dhp_c02 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 6 hits 1dhp_c02 naa= 3 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 B 44 THR A 58 THR~? 10.52 CA CA A 208 B 45 THR A 57 THR.? 15.79 CA CA A 208 B 161 LYS A 67 LYS~? 13.30 CA CA A 208 coo 7.39 128.28 94.56 8.34 126.36 94.79 76.40 -85.04 -26.81 78.11 -83.80 -26.40 coo 5.75 129.25 91.25 4.29 128.16 90.07 78.12 -88.42 -27.00 77.65 -90.24 -28.10 coo -0.17 119.75 99.65 2.51 123.83 95.70 73.21 -82.07 -40.14 71.59 -78.49 -41.85 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 2 3 # 2 B 44 THR A 58 THR~? 10.52 CA CA A 208 B 45 THR A 57 THR.? 15.79 CA CA A 208 B 161 LYS A 188 LYS~? 10.77 C20 C8E A 210 coo 7.39 128.28 94.56 8.34 126.36 94.79 76.40 -85.04 -26.81 78.11 -83.80 -26.40 coo 5.75 129.25 91.25 4.29 128.16 90.07 78.12 -88.42 -27.00 77.65 -90.24 -28.10 coo -0.17 119.75 99.65 2.51 123.83 95.70 68.32 -80.18 -18.11 71.95 -84.24 -15.84 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 3 3 # 3 B 44 THR B 58 THR~? 10.41 CA CA B 208 B 45 THR B 57 THR.? 15.82 CA CA B 208 B 161 LYS B 67 LYS~? 18.13 CA CA B 208 coo 7.39 128.28 94.56 8.34 126.36 94.79 100.65 -27.90 -8.43 100.12 -29.92 -7.97 coo 5.75 129.25 91.25 4.29 128.16 90.07 103.33 -27.21 -5.87 103.96 -25.48 -4.75 coo -0.17 119.75 99.65 2.51 123.83 95.70 89.12 -21.41 -4.23 87.66 -21.56 1.71 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 4 3 # 4 B 44 THR B 58 THR~? 10.41 CA CA B 208 B 45 THR B 57 THR.? 15.82 CA CA B 208 B 161 LYS B 188 LYS~? 9.67 C16 C8E B 210 coo 7.39 128.28 94.56 8.34 126.36 94.79 100.65 -27.90 -8.43 100.12 -29.92 -7.97 coo 5.75 129.25 91.25 4.29 128.16 90.07 103.33 -27.21 -5.87 103.96 -25.48 -4.75 coo -0.17 119.75 99.65 2.51 123.83 95.70 102.16 -28.74 -21.10 106.15 -31.37 -17.86 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 5 3 # 5 B 44 THR C 58 THR~? 10.65 CA CA C 208 B 45 THR C 57 THR.? 15.66 CA CA C 208 B 161 LYS C 67 LYS.? 18.71 CA CA C 208 coo 7.39 128.28 94.56 8.34 126.36 94.79 19.91 -49.60 -2.59 18.80 -50.74 -4.02 coo 5.75 129.25 91.25 4.29 128.16 90.07 17.34 -49.58 0.14 17.08 -48.15 1.75 coo -0.17 119.75 99.65 2.51 123.83 95.70 20.04 -36.06 -6.98 16.11 -31.17 -7.78 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 6 3 # 6 B 44 THR C 58 THR~? 10.65 CA CA C 208 B 45 THR C 57 THR.? 15.66 CA CA C 208 B 161 LYS C 188 LYS~? 9.02 C16 C8E C 209 coo 7.39 128.28 94.56 8.34 126.36 94.79 19.91 -49.60 -2.59 18.80 -50.74 -4.02 coo 5.75 129.25 91.25 4.29 128.16 90.07 17.34 -49.58 0.14 17.08 -48.15 1.75 coo -0.17 119.75 99.65 2.51 123.83 95.70 31.07 -55.82 -4.30 26.58 -58.21 -2.57 1dhp_c03 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 6 hits 1dhp_c03 naa= 3 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 1 3 # 1 146 TYR A 13 TYR^? 6.88 C17 C8E A 209 150 LYS A 198 LYS^? 12.09 C1 C8E A 210 186 ASN A 126 ASN^? 12.66 O21 C8E A 209 coo 32.88 50.55 24.33 31.89 51.78 26.65 65.07 -60.93 -23.01 63.35 -61.54 -20.90 coo 27.04 52.42 22.30 26.88 49.99 27.00 68.28 -58.05 -20.21 63.11 -55.44 -18.88 coo 36.98 50.30 37.29 35.85 50.29 35.50 53.38 -70.73 -21.66 52.86 -71.17 -23.66 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 2 3 # 2 146 TYR A 83 TYR^? -19.24 C2 C8E C 209s 150 LYS A 84 LYS.? 23.11 C2 C8E C 209 186 ASN C 126 ASN^? 12.17 C20 C8E C 210 coo 32.88 50.55 24.33 31.89 51.78 26.65 59.25 -44.27 -7.74 58.41 -42.23 -6.03 coo 27.04 52.42 22.30 26.88 49.99 27.00 61.58 -41.74 -11.00 58.66 -39.80 -16.04 coo 36.98 50.30 37.29 35.85 50.29 35.50 46.00 -48.72 -10.75 45.75 -46.60 -10.82 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 3 3 # 3 146 TYR B 13 TYR^? 6.78 O15 C8E B 209 150 LYS B 198 LYS^? 12.15 O15 C8E B 209 186 ASN B 126 ASN^? 11.28 C1 C8E B 210 coo 32.88 50.55 24.33 31.89 51.78 26.65 84.65 -34.92 -28.70 86.28 -34.17 -30.84 coo 27.04 52.42 22.30 26.88 49.99 27.00 85.01 -40.11 -29.09 83.85 -38.63 -34.53 coo 36.98 50.30 37.29 35.85 50.29 35.50 90.80 -21.61 -33.24 89.51 -20.33 -32.18 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 4 3 # 4 146 TYR C 13 TYR^? 7.82 C16 C8E C 210 150 LYS C 198 LYS^? 12.94 C13 C8E C 210 186 ASN C 126 ASN^? 12.17 C20 C8E C 210 coo 32.88 50.55 24.33 31.89 51.78 26.65 37.24 -51.70 -23.13 39.21 -53.16 -21.84 coo 27.04 52.42 22.30 26.88 49.99 27.00 35.43 -55.44 -26.10 41.10 -55.85 -26.89 coo 36.98 50.30 37.29 35.85 50.29 35.50 46.00 -48.72 -10.75 45.75 -46.60 -10.82 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 5 3 # 5 146 TYR C 83 TYR^? 19.88 O21 C8E A 209 150 LYS C 84 LYS.? 25.24 O21 C8E A 209 186 ASN A 126 ASN^? 12.66 O21 C8E A 209 coo 32.88 50.55 24.33 31.89 51.78 26.65 49.20 -66.70 -34.88 49.82 -68.82 -36.60 coo 27.04 52.42 22.30 26.88 49.99 27.00 49.01 -63.83 -38.44 48.10 -58.01 -38.38 coo 36.98 50.30 37.29 35.85 50.29 35.50 53.38 -70.73 -21.66 52.86 -71.17 -23.66 1dhr_c00 source 1dhr DIHYDROPTERIDINE REDUCTASE (DHPR) (E.C.1.6.99.: 5 hits 1dhr_c00 naa= 3 ULMN 3 1do8_c00 MALIC ENZYME user 1 3 # 1 A 112 TYR A 109 TYR^? 10.85 CA CA A 208 A 183 LYS A 63 LYS~? 3.96 CA CA A 208 A 278 ASP A 49 ASP.? -3.00 CA CA A 208s coo 19.43 18.53 42.32 17.66 18.80 40.15 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo 21.92 15.80 36.19 17.64 19.44 36.35 73.63 -82.49 -34.44 73.43 -77.00 -32.37 coo 15.46 19.03 31.40 15.01 18.25 33.31 75.72 -77.89 -27.98 74.67 -77.10 -29.65 ULMN 3 1do8_c00 MALIC ENZYME user 2 3 # 2 A 112 TYR A 109 TYR^? 10.85 CA CA A 208 A 183 LYS A 63 LYS~? 3.96 CA CA A 208 A 278 ASP A 61 ASP~? 12.37 CA CA A 208 coo 19.43 18.53 42.32 17.66 18.80 40.15 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo 21.92 15.80 36.19 17.64 19.44 36.35 73.63 -82.49 -34.44 73.43 -77.00 -32.37 coo 15.46 19.03 31.40 15.01 18.25 33.31 78.34 -85.42 -30.67 80.16 -84.92 -29.71 ULMN 3 1do8_c00 MALIC ENZYME user 3 3 # 3 A 112 TYR B 13 TYR^? 6.78 O15 C8E B 209 A 183 LYS B 198 LYS^? 12.15 O15 C8E B 209 A 278 ASP B 149 ASP^? 14.91 O15 C8E B 209 coo 19.43 18.53 42.32 17.66 18.80 40.15 84.65 -34.92 -28.70 86.28 -34.17 -30.84 coo 21.92 15.80 36.19 17.64 19.44 36.35 85.01 -40.11 -29.09 83.85 -38.63 -34.53 coo 15.46 19.03 31.40 15.01 18.25 33.31 79.48 -42.39 -33.32 81.04 -41.48 -34.38 ULMN 3 1do8_c00 MALIC ENZYME user 4 3 # 4 A 112 TYR B 109 TYR^? 10.54 CA CA B 208 A 183 LYS B 63 LYS~? 3.79 CA CA B 208 A 278 ASP B 49 ASP.? -3.05 CA CA B 208s coo 19.43 18.53 42.32 17.66 18.80 40.15 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo 21.92 15.80 36.19 17.64 19.44 36.35 93.18 -23.71 -7.17 90.77 -27.85 -10.83 coo 15.46 19.03 31.40 15.01 18.25 33.31 94.52 -28.97 -11.62 93.03 -30.41 -11.73 ULMN 3 1do8_c00 MALIC ENZYME user 5 3 # 5 A 112 TYR B 109 TYR^? 10.54 CA CA B 208 A 183 LYS B 63 LYS~? 3.79 CA CA B 208 A 278 ASP B 61 ASP~? 12.48 CA CA B 208 coo 19.43 18.53 42.32 17.66 18.80 40.15 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo 21.92 15.80 36.19 17.64 19.44 36.35 93.18 -23.71 -7.17 90.77 -27.85 -10.83 coo 15.46 19.03 31.40 15.01 18.25 33.31 98.68 -27.22 -4.60 99.30 -29.23 -4.23 ULMN 3 1do8_c00 MALIC ENZYME user 6 3 # 6 A 112 TYR C 109 TYR^? 10.73 CA CA C 208 A 183 LYS C 63 LYS~? 4.21 CA CA C 208 A 278 ASP C 49 ASP.? -2.87 CA CA C 208s coo 19.43 18.53 42.32 17.66 18.80 40.15 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo 21.92 15.80 36.19 17.64 19.44 36.35 20.98 -41.61 -5.49 23.04 -43.67 -10.44 coo 15.46 19.03 31.40 15.01 18.25 33.31 22.13 -48.50 -9.42 23.00 -46.66 -10.00 1do8_c00 source 1do8 MALIC ENZYME : 6 hits 1do8_c00 naa= 3 ULMN 3 1do8_c01 MALIC ENZYME user 1 3 # 1 B 112 TYR A 109 TYR^? 10.85 CA CA A 208 B 183 LYS A 63 LYS~? 3.96 CA CA A 208 B 278 ASP A 49 ASP.? -3.00 CA CA A 208s coo 58.62 15.99 58.34 60.98 14.60 58.93 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo 60.11 10.60 53.63 62.59 10.74 58.67 73.63 -82.49 -34.44 73.43 -77.00 -32.37 coo 66.50 7.32 58.45 66.26 9.42 58.23 75.72 -77.89 -27.98 74.67 -77.10 -29.65 ULMN 3 1do8_c01 MALIC ENZYME user 2 3 # 2 B 112 TYR A 109 TYR^? 10.85 CA CA A 208 B 183 LYS A 63 LYS~? 3.96 CA CA A 208 B 278 ASP A 61 ASP~? 12.37 CA CA A 208 coo 58.62 15.99 58.34 60.98 14.60 58.93 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo 60.11 10.60 53.63 62.59 10.74 58.67 73.63 -82.49 -34.44 73.43 -77.00 -32.37 coo 66.50 7.32 58.45 66.26 9.42 58.23 78.34 -85.42 -30.67 80.16 -84.92 -29.71 ULMN 3 1do8_c01 MALIC ENZYME user 3 3 # 3 B 112 TYR B 109 TYR^? 10.54 CA CA B 208 B 183 LYS B 63 LYS~? 3.79 CA CA B 208 B 278 ASP B 49 ASP.? -3.05 CA CA B 208s coo 58.62 15.99 58.34 60.98 14.60 58.93 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo 60.11 10.60 53.63 62.59 10.74 58.67 93.18 -23.71 -7.17 90.77 -27.85 -10.83 coo 66.50 7.32 58.45 66.26 9.42 58.23 94.52 -28.97 -11.62 93.03 -30.41 -11.73 ULMN 3 1do8_c01 MALIC ENZYME user 4 3 # 4 B 112 TYR B 109 TYR^? 10.54 CA CA B 208 B 183 LYS B 63 LYS~? 3.79 CA CA B 208 B 278 ASP B 61 ASP~? 12.48 CA CA B 208 coo 58.62 15.99 58.34 60.98 14.60 58.93 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo 60.11 10.60 53.63 62.59 10.74 58.67 93.18 -23.71 -7.17 90.77 -27.85 -10.83 coo 66.50 7.32 58.45 66.26 9.42 58.23 98.68 -27.22 -4.60 99.30 -29.23 -4.23 ULMN 3 1do8_c01 MALIC ENZYME user 5 3 # 5 B 112 TYR C 109 TYR^? 10.73 CA CA C 208 B 183 LYS C 63 LYS~? 4.21 CA CA C 208 B 278 ASP C 49 ASP.? -2.87 CA CA C 208s coo 58.62 15.99 58.34 60.98 14.60 58.93 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo 60.11 10.60 53.63 62.59 10.74 58.67 20.98 -41.61 -5.49 23.04 -43.67 -10.44 coo 66.50 7.32 58.45 66.26 9.42 58.23 22.13 -48.50 -9.42 23.00 -46.66 -10.00 ULMN 3 1do8_c01 MALIC ENZYME user 6 3 # 6 B 112 TYR C 109 TYR^? 10.73 CA CA C 208 B 183 LYS C 63 LYS~? 4.21 CA CA C 208 B 278 ASP C 61 ASP~? 12.61 CA CA C 208 coo 58.62 15.99 58.34 60.98 14.60 58.93 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo 60.11 10.60 53.63 62.59 10.74 58.67 20.98 -41.61 -5.49 23.04 -43.67 -10.44 coo 66.50 7.32 58.45 66.26 9.42 58.23 16.71 -46.53 -3.05 15.59 -48.22 -3.69 1do8_c01 source 1do8 MALIC ENZYME : 6 hits 1do8_c01 naa= 3 ULMN 3 1do8_c02 MALIC ENZYME user 1 3 # 1 C 112 TYR A 109 TYR^? 10.85 CA CA A 208 C 183 LYS A 63 LYS~? 3.96 CA CA A 208 C 278 ASP A 49 ASP.? -3.00 CA CA A 208s coo 76.02 -16.57 8.89 78.24 -15.17 9.87 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 73.63 -82.49 -34.44 73.43 -77.00 -32.37 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 75.72 -77.89 -27.98 74.67 -77.10 -29.65 ULMN 3 1do8_c02 MALIC ENZYME user 2 3 # 2 C 112 TYR A 109 TYR^? 10.85 CA CA A 208 C 183 LYS A 63 LYS~? 3.96 CA CA A 208 C 278 ASP A 61 ASP~? 12.37 CA CA A 208 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 73.63 -82.49 -34.44 73.43 -77.00 -32.37 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 78.34 -85.42 -30.67 80.16 -84.92 -29.71 ULMN 3 1do8_c02 MALIC ENZYME user 3 3 # 3 C 112 TYR B 13 TYR^? 6.78 O15 C8E B 209 C 183 LYS B 198 LYS^? 12.15 O15 C8E B 209 C 278 ASP B 149 ASP^? 14.91 O15 C8E B 209 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 84.65 -34.92 -28.70 86.28 -34.17 -30.84 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 85.01 -40.11 -29.09 83.85 -38.63 -34.53 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 79.48 -42.39 -33.32 81.04 -41.48 -34.38 ULMN 3 1do8_c02 MALIC ENZYME user 4 3 # 4 C 112 TYR B 109 TYR^? 10.54 CA CA B 208 C 183 LYS B 63 LYS~? 3.79 CA CA B 208 C 278 ASP B 49 ASP.? -3.05 CA CA B 208s coo 76.02 -16.57 8.89 78.24 -15.17 9.87 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 93.18 -23.71 -7.17 90.77 -27.85 -10.83 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 94.52 -28.97 -11.62 93.03 -30.41 -11.73 ULMN 3 1do8_c02 MALIC ENZYME user 5 3 # 5 C 112 TYR B 109 TYR^? 10.54 CA CA B 208 C 183 LYS B 63 LYS~? 3.79 CA CA B 208 C 278 ASP B 61 ASP~? 12.48 CA CA B 208 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 93.18 -23.71 -7.17 90.77 -27.85 -10.83 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 98.68 -27.22 -4.60 99.30 -29.23 -4.23 ULMN 3 1do8_c02 MALIC ENZYME user 6 3 # 6 C 112 TYR C 109 TYR^? 10.73 CA CA C 208 C 183 LYS C 63 LYS~? 4.21 CA CA C 208 C 278 ASP C 49 ASP.? -2.87 CA CA C 208s coo 76.02 -16.57 8.89 78.24 -15.17 9.87 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 20.98 -41.61 -5.49 23.04 -43.67 -10.44 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 22.13 -48.50 -9.42 23.00 -46.66 -10.00 1do8_c02 source 1do8 MALIC ENZYME : 6 hits 1do8_c02 naa= 3 ULMN 3 1do8_c03 MALIC ENZYME user 1 3 # 1 D 112 TYR A 109 TYR^? 10.85 CA CA A 208 D 183 LYS A 63 LYS~? 3.96 CA CA A 208 D 278 ASP A 49 ASP.? -3.00 CA CA A 208s coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 73.63 -82.49 -34.44 73.43 -77.00 -32.37 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 75.72 -77.89 -27.98 74.67 -77.10 -29.65 ULMN 3 1do8_c03 MALIC ENZYME user 2 3 # 2 D 112 TYR A 109 TYR^? 10.85 CA CA A 208 D 183 LYS A 63 LYS~? 3.96 CA CA A 208 D 278 ASP A 61 ASP~? 12.37 CA CA A 208 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 73.63 -82.49 -34.44 73.43 -77.00 -32.37 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 78.34 -85.42 -30.67 80.16 -84.92 -29.71 ULMN 3 1do8_c03 MALIC ENZYME user 3 3 # 3 D 112 TYR B 13 TYR^? 6.78 O15 C8E B 209 D 183 LYS B 198 LYS^? 12.15 O15 C8E B 209 D 278 ASP B 149 ASP^? 14.91 O15 C8E B 209 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 84.65 -34.92 -28.70 86.28 -34.17 -30.84 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 85.01 -40.11 -29.09 83.85 -38.63 -34.53 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 79.48 -42.39 -33.32 81.04 -41.48 -34.38 ULMN 3 1do8_c03 MALIC ENZYME user 4 3 # 4 D 112 TYR B 109 TYR^? 10.54 CA CA B 208 D 183 LYS B 63 LYS~? 3.79 CA CA B 208 D 278 ASP B 49 ASP.? -3.05 CA CA B 208s coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 93.18 -23.71 -7.17 90.77 -27.85 -10.83 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 94.52 -28.97 -11.62 93.03 -30.41 -11.73 ULMN 3 1do8_c03 MALIC ENZYME user 5 3 # 5 D 112 TYR B 109 TYR^? 10.54 CA CA B 208 D 183 LYS B 63 LYS~? 3.79 CA CA B 208 D 278 ASP B 61 ASP~? 12.48 CA CA B 208 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 93.18 -23.71 -7.17 90.77 -27.85 -10.83 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 98.68 -27.22 -4.60 99.30 -29.23 -4.23 ULMN 3 1do8_c03 MALIC ENZYME user 6 3 # 6 D 112 TYR C 109 TYR^? 10.73 CA CA C 208 D 183 LYS C 63 LYS~? 4.21 CA CA C 208 D 278 ASP C 49 ASP.? -2.87 CA CA C 208s coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 20.98 -41.61 -5.49 23.04 -43.67 -10.44 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 22.13 -48.50 -9.42 23.00 -46.66 -10.00 ULMN 3 1do8_c03 MALIC ENZYME user 7 3 # 7 D 112 TYR C 109 TYR^? 10.73 CA CA C 208 D 183 LYS C 63 LYS~? 4.21 CA CA C 208 D 278 ASP C 61 ASP~? 12.61 CA CA C 208 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 20.98 -41.61 -5.49 23.04 -43.67 -10.44 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 16.71 -46.53 -3.05 15.59 -48.22 -3.69 1do8_c03 source 1do8 MALIC ENZYME : 7 hits 1do8_c03 naa= 3 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 1 3 # 1 A 16 TYR A 51 TYR.? 9.92 O21 C8E A 210 A 40 ASP A 45 ASP.? -2.96 CA CA A 208s A 103 ASP A 49 ASP.? -3.00 CA CA A 208s coo 3.86 -20.80 85.74 4.58 -18.11 85.73 71.70 -83.21 -22.40 69.97 -85.02 -21.17 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 75.72 -77.89 -27.98 74.67 -77.10 -29.65 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 2 3 # 2 A 16 TYR A 51 TYR.? 9.92 O21 C8E A 210 A 40 ASP A 61 ASP~? 12.37 CA CA A 208 A 103 ASP A 49 ASP.? -3.00 CA CA A 208s coo 3.86 -20.80 85.74 4.58 -18.11 85.73 71.70 -83.21 -22.40 69.97 -85.02 -21.17 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 75.72 -77.89 -27.98 74.67 -77.10 -29.65 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 3 3 # 3 A 16 TYR A 51 TYR.? 9.92 O21 C8E A 210 A 40 ASP A 61 ASP~? 12.37 CA CA A 208 A 103 ASP A 52 ASP.? 15.11 CA CA A 208 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 71.70 -83.21 -22.40 69.97 -85.02 -21.17 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 76.18 -86.89 -22.52 75.57 -87.62 -20.65 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 4 3 # 4 A 16 TYR B 51 TYR.? 9.95 O21 C8E B 210 A 40 ASP B 45 ASP.? -3.07 CA CA B 208s A 103 ASP B 48 ASP.? 7.20 CA CA B 208 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 102.03 -27.53 -15.19 104.12 -26.16 -16.40 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 97.60 -30.12 -16.68 98.20 -32.01 -15.99 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 5 3 # 5 A 16 TYR B 51 TYR.? 9.95 O21 C8E B 210 A 40 ASP B 45 ASP.? -3.07 CA CA B 208s A 103 ASP B 49 ASP.? -3.05 CA CA B 208s coo 3.86 -20.80 85.74 4.58 -18.11 85.73 102.03 -27.53 -15.19 104.12 -26.16 -16.40 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 94.52 -28.97 -11.62 93.03 -30.41 -11.73 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 6 3 # 6 A 16 TYR B 51 TYR.? 9.95 O21 C8E B 210 A 40 ASP B 61 ASP~? 12.48 CA CA B 208 A 103 ASP B 49 ASP.? -3.05 CA CA B 208s coo 3.86 -20.80 85.74 4.58 -18.11 85.73 102.03 -27.53 -15.19 104.12 -26.16 -16.40 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 98.68 -27.22 -4.60 99.30 -29.23 -4.23 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 94.52 -28.97 -11.62 93.03 -30.41 -11.73 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 7 3 # 7 A 16 TYR B 51 TYR.? 9.95 O21 C8E B 210 A 40 ASP B 61 ASP~? 12.48 CA CA B 208 A 103 ASP B 52 ASP.? 15.59 CA CA B 208 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 102.03 -27.53 -15.19 104.12 -26.16 -16.40 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 98.68 -27.22 -4.60 99.30 -29.23 -4.23 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 105.61 -28.95 -11.53 106.78 -28.70 -9.81 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 8 3 # 8 A 16 TYR C 51 TYR.? 10.04 O21 C8E C 209 A 40 ASP C 45 ASP.? 3.27 CA CA C 208s A 103 ASP C 48 ASP.? 7.17 CA CA C 208 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 26.09 -52.62 -2.60 27.54 -53.38 -0.32 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 26.68 -52.06 -7.74 25.46 -53.53 -8.54 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 9 3 # 9 A 16 TYR C 51 TYR.? 10.04 O21 C8E C 209 A 40 ASP C 45 ASP.? 3.27 CA CA C 208s A 103 ASP C 49 ASP.? -2.87 CA CA C 208s coo 3.86 -20.80 85.74 4.58 -18.11 85.73 26.09 -52.62 -2.60 27.54 -53.38 -0.32 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 22.13 -48.50 -9.42 23.00 -46.66 -10.00 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 10 3 # 10 A 16 TYR C 51 TYR.? 10.04 O21 C8E C 209 A 40 ASP C 61 ASP~? 12.61 CA CA C 208 A 103 ASP C 49 ASP.? -2.87 CA CA C 208s coo 3.86 -20.80 85.74 4.58 -18.11 85.73 26.09 -52.62 -2.60 27.54 -53.38 -0.32 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 16.71 -46.53 -3.05 15.59 -48.22 -3.69 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 22.13 -48.50 -9.42 23.00 -46.66 -10.00 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 11 3 # 11 A 16 TYR C 51 TYR.? 10.04 O21 C8E C 209 A 40 ASP C 61 ASP~? 12.61 CA CA C 208 A 103 ASP C 52 ASP.? 15.77 CA CA C 208 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 26.09 -52.62 -2.60 27.54 -53.38 -0.32 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 16.71 -46.53 -3.05 15.59 -48.22 -3.69 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 21.29 -54.58 -0.38 20.26 -54.47 1.43 1e3v_c02 source 1e3v STEROID DELTA-ISOMERASE : 11 hits 1e3v_c02 naa= 3 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 1 3 # 1 B 16 TYR A 51 TYR.? 9.92 O21 C8E A 210 B 40 ASP A 45 ASP.? -2.96 CA CA A 208s B 103 ASP A 49 ASP.? -3.00 CA CA A 208s coo 4.95 -16.38 58.56 5.78 -19.05 58.68 71.70 -83.21 -22.40 69.97 -85.02 -21.17 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 75.72 -77.89 -27.98 74.67 -77.10 -29.65 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 2 3 # 2 B 16 TYR A 51 TYR.? 9.92 O21 C8E A 210 B 40 ASP A 61 ASP~? 12.37 CA CA A 208 B 103 ASP A 49 ASP.? -3.00 CA CA A 208s coo 4.95 -16.38 58.56 5.78 -19.05 58.68 71.70 -83.21 -22.40 69.97 -85.02 -21.17 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 75.72 -77.89 -27.98 74.67 -77.10 -29.65 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 3 3 # 3 B 16 TYR A 51 TYR.? 9.92 O21 C8E A 210 B 40 ASP A 61 ASP~? 12.37 CA CA A 208 B 103 ASP A 52 ASP.? 15.11 CA CA A 208 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 71.70 -83.21 -22.40 69.97 -85.02 -21.17 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 76.18 -86.89 -22.52 75.57 -87.62 -20.65 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 4 3 # 4 B 16 TYR B 51 TYR.? 9.95 O21 C8E B 210 B 40 ASP B 45 ASP.? -3.07 CA CA B 208s B 103 ASP B 48 ASP.? 7.20 CA CA B 208 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 102.03 -27.53 -15.19 104.12 -26.16 -16.40 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 97.60 -30.12 -16.68 98.20 -32.01 -15.99 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 5 3 # 5 B 16 TYR B 51 TYR.? 9.95 O21 C8E B 210 B 40 ASP B 45 ASP.? -3.07 CA CA B 208s B 103 ASP B 49 ASP.? -3.05 CA CA B 208s coo 4.95 -16.38 58.56 5.78 -19.05 58.68 102.03 -27.53 -15.19 104.12 -26.16 -16.40 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 94.52 -28.97 -11.62 93.03 -30.41 -11.73 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 6 3 # 6 B 16 TYR B 51 TYR.? 9.95 O21 C8E B 210 B 40 ASP B 61 ASP~? 12.48 CA CA B 208 B 103 ASP B 49 ASP.? -3.05 CA CA B 208s coo 4.95 -16.38 58.56 5.78 -19.05 58.68 102.03 -27.53 -15.19 104.12 -26.16 -16.40 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 98.68 -27.22 -4.60 99.30 -29.23 -4.23 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 94.52 -28.97 -11.62 93.03 -30.41 -11.73 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 7 3 # 7 B 16 TYR B 51 TYR.? 9.95 O21 C8E B 210 B 40 ASP B 61 ASP~? 12.48 CA CA B 208 B 103 ASP B 52 ASP.? 15.59 CA CA B 208 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 102.03 -27.53 -15.19 104.12 -26.16 -16.40 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 98.68 -27.22 -4.60 99.30 -29.23 -4.23 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 105.61 -28.95 -11.53 106.78 -28.70 -9.81 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 8 3 # 8 B 16 TYR C 51 TYR.? 10.04 O21 C8E C 209 B 40 ASP C 45 ASP.? 3.27 CA CA C 208s B 103 ASP C 48 ASP.? 7.17 CA CA C 208 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 26.09 -52.62 -2.60 27.54 -53.38 -0.32 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 26.68 -52.06 -7.74 25.46 -53.53 -8.54 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 9 3 # 9 B 16 TYR C 51 TYR.? 10.04 O21 C8E C 209 B 40 ASP C 45 ASP.? 3.27 CA CA C 208s B 103 ASP C 49 ASP.? -2.87 CA CA C 208s coo 4.95 -16.38 58.56 5.78 -19.05 58.68 26.09 -52.62 -2.60 27.54 -53.38 -0.32 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 22.13 -48.50 -9.42 23.00 -46.66 -10.00 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 10 3 # 10 B 16 TYR C 51 TYR.? 10.04 O21 C8E C 209 B 40 ASP C 61 ASP~? 12.61 CA CA C 208 B 103 ASP C 49 ASP.? -2.87 CA CA C 208s coo 4.95 -16.38 58.56 5.78 -19.05 58.68 26.09 -52.62 -2.60 27.54 -53.38 -0.32 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 16.71 -46.53 -3.05 15.59 -48.22 -3.69 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 22.13 -48.50 -9.42 23.00 -46.66 -10.00 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 11 3 # 11 B 16 TYR C 51 TYR.? 10.04 O21 C8E C 209 B 40 ASP C 61 ASP~? 12.61 CA CA C 208 B 103 ASP C 52 ASP.? 15.77 CA CA C 208 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 26.09 -52.62 -2.60 27.54 -53.38 -0.32 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 16.71 -46.53 -3.05 15.59 -48.22 -3.69 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 21.29 -54.58 -0.38 20.26 -54.47 1.43 1e3v_c03 source 1e3v STEROID DELTA-ISOMERASE : 11 hits 1e3v_c03 naa= 3 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 1 3 # 1 A 205 LYS A 63 LYS~? 3.96 CA CA A 208 A 207 LYS A 67 LYS~? 13.30 CA CA A 208 A 366 ASP A 61 ASP~? 12.37 CA CA A 208 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 73.63 -82.49 -34.44 73.43 -77.00 -32.37 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 73.21 -82.07 -40.14 71.59 -78.49 -41.85 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 78.34 -85.42 -30.67 80.16 -84.92 -29.71 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 2 3 # 2 A 205 LYS A 67 LYS~? 13.30 CA CA A 208 A 207 LYS A 63 LYS~? 3.96 CA CA A 208 A 366 ASP A 111 ASP.? 17.05 CA CA A 208 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 73.21 -82.07 -40.14 71.59 -78.49 -41.85 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 73.63 -82.49 -34.44 73.43 -77.00 -32.37 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 65.36 -83.80 -40.24 66.17 -85.36 -41.35 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 3 3 # 3 A 205 LYS A 67 LYS~? 13.30 CA CA A 208 A 207 LYS A 63 LYS~? 3.96 CA CA A 208 A 366 ASP A 114 ASP.? 22.11 CA CA A 208 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 73.21 -82.07 -40.14 71.59 -78.49 -41.85 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 73.63 -82.49 -34.44 73.43 -77.00 -32.37 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 71.50 -87.46 -45.26 70.62 -89.18 -46.15 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 4 3 # 4 A 205 LYS B 63 LYS~? 3.79 CA CA B 208 A 207 LYS B 67 LYS~? 18.13 CA CA B 208 A 366 ASP B 49 ASP.? -3.05 CA CA B 208s coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 93.18 -23.71 -7.17 90.77 -27.85 -10.83 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 89.12 -21.41 -4.23 87.66 -21.56 1.71 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 94.52 -28.97 -11.62 93.03 -30.41 -11.73 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 5 3 # 5 A 205 LYS B 63 LYS~? 3.79 CA CA B 208 A 207 LYS B 67 LYS~? 18.13 CA CA B 208 A 366 ASP B 61 ASP~? 12.48 CA CA B 208 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 93.18 -23.71 -7.17 90.77 -27.85 -10.83 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 89.12 -21.41 -4.23 87.66 -21.56 1.71 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 98.68 -27.22 -4.60 99.30 -29.23 -4.23 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 6 3 # 6 A 205 LYS B 67 LYS~? 18.13 CA CA B 208 A 207 LYS B 63 LYS~? 3.79 CA CA B 208 A 366 ASP B 111 ASP.? 16.97 CA CA B 208 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 89.12 -21.41 -4.23 87.66 -21.56 1.71 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 93.18 -23.71 -7.17 90.77 -27.85 -10.83 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 89.21 -14.92 -8.80 89.40 -13.99 -6.98 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 7 3 # 7 A 205 LYS C 63 LYS~? 4.21 CA CA C 208 A 207 LYS C 67 LYS.? 18.71 CA CA C 208 A 366 ASP C 61 ASP~? 12.61 CA CA C 208 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 20.98 -41.61 -5.49 23.04 -43.67 -10.44 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 20.04 -36.06 -6.98 16.11 -31.17 -7.78 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 16.71 -46.53 -3.05 15.59 -48.22 -3.69 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 8 3 # 8 A 205 LYS C 67 LYS.? 18.71 CA CA C 208 A 207 LYS C 63 LYS~? 4.21 CA CA C 208 A 366 ASP C 111 ASP.? 17.21 CA CA C 208 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 20.04 -36.06 -6.98 16.11 -31.17 -7.78 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 20.98 -41.61 -5.49 23.04 -43.67 -10.44 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 27.11 -33.17 -3.90 25.73 -31.94 -3.00 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 9 3 # 9 A 205 LYS C 67 LYS.? 18.71 CA CA C 208 A 207 LYS C 63 LYS~? 4.21 CA CA C 208 A 366 ASP C 114 ASP.? 22.22 CA CA C 208 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 20.04 -36.06 -6.98 16.11 -31.17 -7.78 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 20.98 -41.61 -5.49 23.04 -43.67 -10.44 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 19.39 -30.14 -1.59 19.46 -28.98 0.18 1ec9_c04 source 1ec9 GLUCARATE DEHYDRATASE : 9 hits 1ec9_c04 naa= 3 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 1 3 # 1 B 205 LYS A 63 LYS~? 3.96 CA CA A 208 B 207 LYS A 67 LYS~? 13.30 CA CA A 208 B 366 ASP A 61 ASP~? 12.37 CA CA A 208 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 73.63 -82.49 -34.44 73.43 -77.00 -32.37 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 73.21 -82.07 -40.14 71.59 -78.49 -41.85 coo -11.13 25.71 4.86 -10.82 24.43 3.24 78.34 -85.42 -30.67 80.16 -84.92 -29.71 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 2 3 # 2 B 205 LYS A 67 LYS~? 13.30 CA CA A 208 B 207 LYS A 63 LYS~? 3.96 CA CA A 208 B 366 ASP A 111 ASP.? 17.05 CA CA A 208 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 73.21 -82.07 -40.14 71.59 -78.49 -41.85 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 73.63 -82.49 -34.44 73.43 -77.00 -32.37 coo -11.13 25.71 4.86 -10.82 24.43 3.24 65.36 -83.80 -40.24 66.17 -85.36 -41.35 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 3 3 # 3 B 205 LYS A 67 LYS~? 13.30 CA CA A 208 B 207 LYS A 63 LYS~? 3.96 CA CA A 208 B 366 ASP A 114 ASP.? 22.11 CA CA A 208 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 73.21 -82.07 -40.14 71.59 -78.49 -41.85 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 73.63 -82.49 -34.44 73.43 -77.00 -32.37 coo -11.13 25.71 4.86 -10.82 24.43 3.24 71.50 -87.46 -45.26 70.62 -89.18 -46.15 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 4 3 # 4 B 205 LYS B 63 LYS~? 3.79 CA CA B 208 B 207 LYS B 67 LYS~? 18.13 CA CA B 208 B 366 ASP B 49 ASP.? -3.05 CA CA B 208s coo -11.45 28.09 -2.93 -13.20 23.63 1.17 93.18 -23.71 -7.17 90.77 -27.85 -10.83 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 89.12 -21.41 -4.23 87.66 -21.56 1.71 coo -11.13 25.71 4.86 -10.82 24.43 3.24 94.52 -28.97 -11.62 93.03 -30.41 -11.73 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 5 3 # 5 B 205 LYS B 63 LYS~? 3.79 CA CA B 208 B 207 LYS B 67 LYS~? 18.13 CA CA B 208 B 366 ASP B 61 ASP~? 12.48 CA CA B 208 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 93.18 -23.71 -7.17 90.77 -27.85 -10.83 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 89.12 -21.41 -4.23 87.66 -21.56 1.71 coo -11.13 25.71 4.86 -10.82 24.43 3.24 98.68 -27.22 -4.60 99.30 -29.23 -4.23 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 6 3 # 6 B 205 LYS B 67 LYS~? 18.13 CA CA B 208 B 207 LYS B 63 LYS~? 3.79 CA CA B 208 B 366 ASP B 111 ASP.? 16.97 CA CA B 208 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 89.12 -21.41 -4.23 87.66 -21.56 1.71 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 93.18 -23.71 -7.17 90.77 -27.85 -10.83 coo -11.13 25.71 4.86 -10.82 24.43 3.24 89.21 -14.92 -8.80 89.40 -13.99 -6.98 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 7 3 # 7 B 205 LYS C 63 LYS~? 4.21 CA CA C 208 B 207 LYS C 67 LYS.? 18.71 CA CA C 208 B 366 ASP C 61 ASP~? 12.61 CA CA C 208 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 20.98 -41.61 -5.49 23.04 -43.67 -10.44 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 20.04 -36.06 -6.98 16.11 -31.17 -7.78 coo -11.13 25.71 4.86 -10.82 24.43 3.24 16.71 -46.53 -3.05 15.59 -48.22 -3.69 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 8 3 # 8 B 205 LYS C 67 LYS.? 18.71 CA CA C 208 B 207 LYS C 63 LYS~? 4.21 CA CA C 208 B 366 ASP C 111 ASP.? 17.21 CA CA C 208 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 20.04 -36.06 -6.98 16.11 -31.17 -7.78 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 20.98 -41.61 -5.49 23.04 -43.67 -10.44 coo -11.13 25.71 4.86 -10.82 24.43 3.24 27.11 -33.17 -3.90 25.73 -31.94 -3.00 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 9 3 # 9 B 205 LYS C 67 LYS.? 18.71 CA CA C 208 B 207 LYS C 63 LYS~? 4.21 CA CA C 208 B 366 ASP C 114 ASP.? 22.22 CA CA C 208 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 20.04 -36.06 -6.98 16.11 -31.17 -7.78 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 20.98 -41.61 -5.49 23.04 -43.67 -10.44 coo -11.13 25.71 4.86 -10.82 24.43 3.24 19.39 -30.14 -1.59 19.46 -28.98 0.18 1ec9_c05 source 1ec9 GLUCARATE DEHYDRATASE : 9 hits 1ec9_c05 naa= 3 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 1 3 # 1 C 205 LYS A 63 LYS~? 3.96 CA CA A 208 C 207 LYS A 67 LYS~? 13.30 CA CA A 208 C 366 ASP A 61 ASP~? 12.37 CA CA A 208 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 73.63 -82.49 -34.44 73.43 -77.00 -32.37 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 73.21 -82.07 -40.14 71.59 -78.49 -41.85 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 78.34 -85.42 -30.67 80.16 -84.92 -29.71 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 2 3 # 2 C 205 LYS A 67 LYS~? 13.30 CA CA A 208 C 207 LYS A 63 LYS~? 3.96 CA CA A 208 C 366 ASP A 111 ASP.? 17.05 CA CA A 208 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 73.21 -82.07 -40.14 71.59 -78.49 -41.85 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 73.63 -82.49 -34.44 73.43 -77.00 -32.37 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 65.36 -83.80 -40.24 66.17 -85.36 -41.35 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 3 3 # 3 C 205 LYS A 67 LYS~? 13.30 CA CA A 208 C 207 LYS A 63 LYS~? 3.96 CA CA A 208 C 366 ASP A 114 ASP.? 22.11 CA CA A 208 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 73.21 -82.07 -40.14 71.59 -78.49 -41.85 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 73.63 -82.49 -34.44 73.43 -77.00 -32.37 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 71.50 -87.46 -45.26 70.62 -89.18 -46.15 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 4 3 # 4 C 205 LYS B 63 LYS~? 3.79 CA CA B 208 C 207 LYS B 67 LYS~? 18.13 CA CA B 208 C 366 ASP B 49 ASP.? -3.05 CA CA B 208s coo 15.57 11.65 -23.50 16.31 5.98 -20.68 93.18 -23.71 -7.17 90.77 -27.85 -10.83 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 89.12 -21.41 -4.23 87.66 -21.56 1.71 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 94.52 -28.97 -11.62 93.03 -30.41 -11.73 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 5 3 # 5 C 205 LYS B 63 LYS~? 3.79 CA CA B 208 C 207 LYS B 67 LYS~? 18.13 CA CA B 208 C 366 ASP B 61 ASP~? 12.48 CA CA B 208 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 93.18 -23.71 -7.17 90.77 -27.85 -10.83 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 89.12 -21.41 -4.23 87.66 -21.56 1.71 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 98.68 -27.22 -4.60 99.30 -29.23 -4.23 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 6 3 # 6 C 205 LYS B 67 LYS~? 18.13 CA CA B 208 C 207 LYS B 63 LYS~? 3.79 CA CA B 208 C 366 ASP B 111 ASP.? 16.97 CA CA B 208 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 89.12 -21.41 -4.23 87.66 -21.56 1.71 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 93.18 -23.71 -7.17 90.77 -27.85 -10.83 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 89.21 -14.92 -8.80 89.40 -13.99 -6.98 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 7 3 # 7 C 205 LYS C 63 LYS~? 4.21 CA CA C 208 C 207 LYS C 67 LYS.? 18.71 CA CA C 208 C 366 ASP C 61 ASP~? 12.61 CA CA C 208 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 20.98 -41.61 -5.49 23.04 -43.67 -10.44 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 20.04 -36.06 -6.98 16.11 -31.17 -7.78 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 16.71 -46.53 -3.05 15.59 -48.22 -3.69 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 8 3 # 8 C 205 LYS C 67 LYS.? 18.71 CA CA C 208 C 207 LYS C 63 LYS~? 4.21 CA CA C 208 C 366 ASP C 111 ASP.? 17.21 CA CA C 208 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 20.04 -36.06 -6.98 16.11 -31.17 -7.78 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 20.98 -41.61 -5.49 23.04 -43.67 -10.44 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 27.11 -33.17 -3.90 25.73 -31.94 -3.00 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 9 3 # 9 C 205 LYS C 67 LYS.? 18.71 CA CA C 208 C 207 LYS C 63 LYS~? 4.21 CA CA C 208 C 366 ASP C 114 ASP.? 22.22 CA CA C 208 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 20.04 -36.06 -6.98 16.11 -31.17 -7.78 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 20.98 -41.61 -5.49 23.04 -43.67 -10.44 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 19.39 -30.14 -1.59 19.46 -28.98 0.18 1ec9_c06 source 1ec9 GLUCARATE DEHYDRATASE : 9 hits 1ec9_c06 naa= 3 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 1 3 # 1 D 205 LYS A 63 LYS~? 3.96 CA CA A 208 D 207 LYS A 67 LYS~? 13.30 CA CA A 208 D 366 ASP A 61 ASP~? 12.37 CA CA A 208 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 73.63 -82.49 -34.44 73.43 -77.00 -32.37 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 73.21 -82.07 -40.14 71.59 -78.49 -41.85 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 78.34 -85.42 -30.67 80.16 -84.92 -29.71 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 2 3 # 2 D 205 LYS A 67 LYS~? 13.30 CA CA A 208 D 207 LYS A 63 LYS~? 3.96 CA CA A 208 D 366 ASP A 111 ASP.? 17.05 CA CA A 208 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 73.21 -82.07 -40.14 71.59 -78.49 -41.85 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 73.63 -82.49 -34.44 73.43 -77.00 -32.37 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 65.36 -83.80 -40.24 66.17 -85.36 -41.35 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 3 3 # 3 D 205 LYS A 67 LYS~? 13.30 CA CA A 208 D 207 LYS A 63 LYS~? 3.96 CA CA A 208 D 366 ASP A 114 ASP.? 22.11 CA CA A 208 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 73.21 -82.07 -40.14 71.59 -78.49 -41.85 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 73.63 -82.49 -34.44 73.43 -77.00 -32.37 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 71.50 -87.46 -45.26 70.62 -89.18 -46.15 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 4 3 # 4 D 205 LYS B 63 LYS~? 3.79 CA CA B 208 D 207 LYS B 67 LYS~? 18.13 CA CA B 208 D 366 ASP B 49 ASP.? -3.05 CA CA B 208s coo 11.00 -13.38 25.10 13.14 -7.87 22.68 93.18 -23.71 -7.17 90.77 -27.85 -10.83 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 89.12 -21.41 -4.23 87.66 -21.56 1.71 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 94.52 -28.97 -11.62 93.03 -30.41 -11.73 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 5 3 # 5 D 205 LYS B 63 LYS~? 3.79 CA CA B 208 D 207 LYS B 67 LYS~? 18.13 CA CA B 208 D 366 ASP B 61 ASP~? 12.48 CA CA B 208 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 93.18 -23.71 -7.17 90.77 -27.85 -10.83 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 89.12 -21.41 -4.23 87.66 -21.56 1.71 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 98.68 -27.22 -4.60 99.30 -29.23 -4.23 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 6 3 # 6 D 205 LYS B 67 LYS~? 18.13 CA CA B 208 D 207 LYS B 63 LYS~? 3.79 CA CA B 208 D 366 ASP B 111 ASP.? 16.97 CA CA B 208 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 89.12 -21.41 -4.23 87.66 -21.56 1.71 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 93.18 -23.71 -7.17 90.77 -27.85 -10.83 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 89.21 -14.92 -8.80 89.40 -13.99 -6.98 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 7 3 # 7 D 205 LYS C 63 LYS~? 4.21 CA CA C 208 D 207 LYS C 67 LYS.? 18.71 CA CA C 208 D 366 ASP C 61 ASP~? 12.61 CA CA C 208 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 20.98 -41.61 -5.49 23.04 -43.67 -10.44 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 20.04 -36.06 -6.98 16.11 -31.17 -7.78 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 16.71 -46.53 -3.05 15.59 -48.22 -3.69 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 8 3 # 8 D 205 LYS C 67 LYS.? 18.71 CA CA C 208 D 207 LYS C 63 LYS~? 4.21 CA CA C 208 D 366 ASP C 111 ASP.? 17.21 CA CA C 208 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 20.04 -36.06 -6.98 16.11 -31.17 -7.78 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 20.98 -41.61 -5.49 23.04 -43.67 -10.44 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 27.11 -33.17 -3.90 25.73 -31.94 -3.00 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 9 3 # 9 D 205 LYS C 67 LYS.? 18.71 CA CA C 208 D 207 LYS C 63 LYS~? 4.21 CA CA C 208 D 366 ASP C 114 ASP.? 22.22 CA CA C 208 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 20.04 -36.06 -6.98 16.11 -31.17 -7.78 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 20.98 -41.61 -5.49 23.04 -43.67 -10.44 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 19.39 -30.14 -1.59 19.46 -28.98 0.18 1ec9_c07 source 1ec9 GLUCARATE DEHYDRATASE : 9 hits 1ec9_c07 naa= 3 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 1 3 # 1 A 229 ALA A 8 ALA^? 20.71 O18 C8E A 209 A 257 ALA A 10 ALA^? 16.05 O18 C8E A 209 A 328 ASP A 149 ASP^? 14.85 C1 C8E A 210 coo 39.84 24.12 8.44 38.50 24.23 9.11 61.58 -49.53 -29.33 61.65 -49.30 -30.88 coo 43.22 26.73 5.37 41.81 27.09 5.79 67.31 -53.72 -29.40 67.90 -53.34 -30.78 coo 38.17 34.10 6.67 37.72 32.06 6.84 66.40 -51.17 -20.74 65.06 -51.90 -19.38 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 2 3 # 2 A 229 ALA A 8 ALA^? 20.71 O18 C8E A 209 A 257 ALA A 21 ALA^? 19.23 C17 C8E A 209 A 328 ASP A 149 ASP^? 14.85 C1 C8E A 210 coo 39.84 24.12 8.44 38.50 24.23 9.11 61.58 -49.53 -29.33 61.65 -49.30 -30.88 coo 43.22 26.73 5.37 41.81 27.09 5.79 56.59 -50.97 -25.51 57.52 -51.00 -24.26 coo 38.17 34.10 6.67 37.72 32.06 6.84 66.40 -51.17 -20.74 65.06 -51.90 -19.38 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 3 3 # 3 A 229 ALA A 8 ALA^? 20.71 O18 C8E A 209 A 257 ALA A 203 ALA^? 24.35 C17 C8E A 209 A 328 ASP A 149 ASP^? 14.85 C1 C8E A 210 coo 39.84 24.12 8.44 38.50 24.23 9.11 61.58 -49.53 -29.33 61.65 -49.30 -30.88 coo 43.22 26.73 5.37 41.81 27.09 5.79 64.54 -44.79 -28.25 64.77 -44.19 -29.63 coo 38.17 34.10 6.67 37.72 32.06 6.84 66.40 -51.17 -20.74 65.06 -51.90 -19.38 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 4 3 # 4 A 229 ALA A 10 ALA^? 16.05 O18 C8E A 209 A 257 ALA A 8 ALA^? 20.71 O18 C8E A 209 A 328 ASP A 149 ASP^? 14.85 C1 C8E A 210 coo 39.84 24.12 8.44 38.50 24.23 9.11 67.31 -53.72 -29.40 67.90 -53.34 -30.78 coo 43.22 26.73 5.37 41.81 27.09 5.79 61.58 -49.53 -29.33 61.65 -49.30 -30.88 coo 38.17 34.10 6.67 37.72 32.06 6.84 66.40 -51.17 -20.74 65.06 -51.90 -19.38 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 5 3 # 5 A 229 ALA A 21 ALA^? 19.23 C17 C8E A 209 A 257 ALA A 8 ALA^? 20.71 O18 C8E A 209 A 328 ASP A 149 ASP^? 14.85 C1 C8E A 210 coo 39.84 24.12 8.44 38.50 24.23 9.11 56.59 -50.97 -25.51 57.52 -51.00 -24.26 coo 43.22 26.73 5.37 41.81 27.09 5.79 61.58 -49.53 -29.33 61.65 -49.30 -30.88 coo 38.17 34.10 6.67 37.72 32.06 6.84 66.40 -51.17 -20.74 65.06 -51.90 -19.38 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 6 3 # 6 A 229 ALA A 137 ALA^? 23.51 C1 C8E A 210 A 257 ALA A 136 ALA^? 18.84 C1 C8E A 209 A 328 ASP A 149 ASP^? 14.85 C1 C8E A 210 coo 39.84 24.12 8.44 38.50 24.23 9.11 66.42 -42.01 -20.39 64.95 -41.78 -20.29 coo 43.22 26.73 5.37 41.81 27.09 5.79 67.89 -44.74 -18.16 69.42 -44.83 -18.22 coo 38.17 34.10 6.67 37.72 32.06 6.84 66.40 -51.17 -20.74 65.06 -51.90 -19.38 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 7 3 # 7 A 229 ALA A 203 ALA^? 24.35 C17 C8E A 209 A 257 ALA A 8 ALA^? 20.71 O18 C8E A 209 A 328 ASP A 149 ASP^? 14.85 C1 C8E A 210 coo 39.84 24.12 8.44 38.50 24.23 9.11 64.54 -44.79 -28.25 64.77 -44.19 -29.63 coo 43.22 26.73 5.37 41.81 27.09 5.79 61.58 -49.53 -29.33 61.65 -49.30 -30.88 coo 38.17 34.10 6.67 37.72 32.06 6.84 66.40 -51.17 -20.74 65.06 -51.90 -19.38 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 8 3 # 8 A 229 ALA A 204 ALA^? 24.86 C17 C8E A 209 A 257 ALA A 8 ALA^? 20.71 O18 C8E A 209 A 328 ASP A 149 ASP^? 14.85 C1 C8E A 210 coo 39.84 24.12 8.44 38.50 24.23 9.11 61.22 -43.46 -27.01 60.98 -43.47 -25.53 coo 43.22 26.73 5.37 41.81 27.09 5.79 61.58 -49.53 -29.33 61.65 -49.30 -30.88 coo 38.17 34.10 6.67 37.72 32.06 6.84 66.40 -51.17 -20.74 65.06 -51.90 -19.38 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 9 3 # 9 A 229 ALA A 204 ALA^? 24.86 C17 C8E A 209 A 257 ALA A 203 ALA^? 24.35 C17 C8E A 209 A 328 ASP A 149 ASP^? 14.85 C1 C8E A 210 coo 39.84 24.12 8.44 38.50 24.23 9.11 61.22 -43.46 -27.01 60.98 -43.47 -25.53 coo 43.22 26.73 5.37 41.81 27.09 5.79 64.54 -44.79 -28.25 64.77 -44.19 -29.63 coo 38.17 34.10 6.67 37.72 32.06 6.84 66.40 -51.17 -20.74 65.06 -51.90 -19.38 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 10 3 # 10 A 229 ALA B 8 ALA^? 20.90 C16 C8E B 209 A 257 ALA B 10 ALA^? 16.31 C16 C8E B 209 A 328 ASP B 149 ASP^? 14.91 O15 C8E B 209 coo 39.84 24.12 8.44 38.50 24.23 9.11 71.81 -36.32 -32.47 70.60 -35.68 -31.80 coo 43.22 26.73 5.37 41.81 27.09 5.79 75.45 -37.67 -26.46 74.31 -37.81 -25.41 coo 38.17 34.10 6.67 37.72 32.06 6.84 79.48 -42.39 -33.32 81.04 -41.48 -34.38 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 11 3 # 11 A 229 ALA B 8 ALA^? 20.90 C16 C8E B 209 A 257 ALA B 21 ALA^? 19.24 O15 C8E B 209 A 328 ASP B 149 ASP^? 14.91 O15 C8E B 209 coo 39.84 24.12 8.44 38.50 24.23 9.11 71.81 -36.32 -32.47 70.60 -35.68 -31.80 coo 43.22 26.73 5.37 41.81 27.09 5.79 74.65 -33.46 -37.41 75.65 -34.62 -37.46 coo 38.17 34.10 6.67 37.72 32.06 6.84 79.48 -42.39 -33.32 81.04 -41.48 -34.38 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 12 3 # 12 A 229 ALA B 8 ALA^? 20.90 C16 C8E B 209 A 257 ALA B 203 ALA^? 24.58 O15 C8E B 209 A 328 ASP B 149 ASP^? 14.91 O15 C8E B 209 coo 39.84 24.12 8.44 38.50 24.23 9.11 71.81 -36.32 -32.47 70.60 -35.68 -31.80 coo 43.22 26.73 5.37 41.81 27.09 5.79 69.42 -41.50 -32.95 68.05 -41.38 -32.31 coo 38.17 34.10 6.67 37.72 32.06 6.84 79.48 -42.39 -33.32 81.04 -41.48 -34.38 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 13 3 # 13 A 229 ALA B 10 ALA^? 16.31 C16 C8E B 209 A 257 ALA B 8 ALA^? 20.90 C16 C8E B 209 A 328 ASP B 149 ASP^? 14.91 O15 C8E B 209 coo 39.84 24.12 8.44 38.50 24.23 9.11 75.45 -37.67 -26.46 74.31 -37.81 -25.41 coo 43.22 26.73 5.37 41.81 27.09 5.79 71.81 -36.32 -32.47 70.60 -35.68 -31.80 coo 38.17 34.10 6.67 37.72 32.06 6.84 79.48 -42.39 -33.32 81.04 -41.48 -34.38 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 14 3 # 14 A 229 ALA B 21 ALA^? 19.24 O15 C8E B 209 A 257 ALA B 8 ALA^? 20.90 C16 C8E B 209 A 328 ASP B 149 ASP^? 14.91 O15 C8E B 209 coo 39.84 24.12 8.44 38.50 24.23 9.11 74.65 -33.46 -37.41 75.65 -34.62 -37.46 coo 43.22 26.73 5.37 41.81 27.09 5.79 71.81 -36.32 -32.47 70.60 -35.68 -31.80 coo 38.17 34.10 6.67 37.72 32.06 6.84 79.48 -42.39 -33.32 81.04 -41.48 -34.38 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 15 3 # 15 A 229 ALA B 203 ALA^? 24.58 O15 C8E B 209 A 257 ALA B 8 ALA^? 20.90 C16 C8E B 209 A 328 ASP B 149 ASP^? 14.91 O15 C8E B 209 coo 39.84 24.12 8.44 38.50 24.23 9.11 69.42 -41.50 -32.95 68.05 -41.38 -32.31 coo 43.22 26.73 5.37 41.81 27.09 5.79 71.81 -36.32 -32.47 70.60 -35.68 -31.80 coo 38.17 34.10 6.67 37.72 32.06 6.84 79.48 -42.39 -33.32 81.04 -41.48 -34.38 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 16 3 # 16 A 229 ALA B 204 ALA^? 24.79 O15 C8E B 209 A 257 ALA B 8 ALA^? 20.90 C16 C8E B 209 A 328 ASP B 149 ASP^? 14.91 O15 C8E B 209 coo 39.84 24.12 8.44 38.50 24.23 9.11 69.10 -40.47 -36.57 70.05 -40.95 -37.62 coo 43.22 26.73 5.37 41.81 27.09 5.79 71.81 -36.32 -32.47 70.60 -35.68 -31.80 coo 38.17 34.10 6.67 37.72 32.06 6.84 79.48 -42.39 -33.32 81.04 -41.48 -34.38 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 17 3 # 17 A 229 ALA B 204 ALA^? 24.79 O15 C8E B 209 A 257 ALA B 203 ALA^? 24.58 O15 C8E B 209 A 328 ASP B 149 ASP^? 14.91 O15 C8E B 209 coo 39.84 24.12 8.44 38.50 24.23 9.11 69.10 -40.47 -36.57 70.05 -40.95 -37.62 coo 43.22 26.73 5.37 41.81 27.09 5.79 69.42 -41.50 -32.95 68.05 -41.38 -32.31 coo 38.17 34.10 6.67 37.72 32.06 6.84 79.48 -42.39 -33.32 81.04 -41.48 -34.38 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 18 3 # 18 A 229 ALA C 8 ALA^? 21.06 C19 C8E C 210 A 257 ALA C 10 ALA^? 16.38 C16 C8E C 210 A 328 ASP C 149 ASP^? 16.02 C16 C8E C 210 coo 39.84 24.12 8.44 38.50 24.23 9.11 41.60 -45.69 -34.21 41.31 -44.27 -34.65 coo 43.22 26.73 5.37 41.81 27.09 5.79 35.38 -46.95 -31.32 34.79 -45.75 -31.96 coo 38.17 34.10 6.67 37.72 32.06 6.84 38.72 -55.19 -32.44 40.02 -55.93 -30.97 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 19 3 # 19 A 229 ALA C 8 ALA^? 21.06 C19 C8E C 210 A 257 ALA C 203 ALA^? 24.88 C16 C8E C 210 A 328 ASP C 149 ASP^? 16.02 C16 C8E C 210 coo 39.84 24.12 8.44 38.50 24.23 9.11 41.60 -45.69 -34.21 41.31 -44.27 -34.65 coo 43.22 26.73 5.37 41.81 27.09 5.79 40.30 -47.76 -39.37 39.98 -46.52 -40.19 coo 38.17 34.10 6.67 37.72 32.06 6.84 38.72 -55.19 -32.44 40.02 -55.93 -30.97 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 20 3 # 20 A 229 ALA C 10 ALA^? 16.38 C16 C8E C 210 A 257 ALA C 8 ALA^? 21.06 C19 C8E C 210 A 328 ASP C 149 ASP^? 16.02 C16 C8E C 210 coo 39.84 24.12 8.44 38.50 24.23 9.11 35.38 -46.95 -31.32 34.79 -45.75 -31.96 coo 43.22 26.73 5.37 41.81 27.09 5.79 41.60 -45.69 -34.21 41.31 -44.27 -34.65 coo 38.17 34.10 6.67 37.72 32.06 6.84 38.72 -55.19 -32.44 40.02 -55.93 -30.97 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 21 3 # 21 A 229 ALA C 21 ALA^? 19.73 C19 C8E C 210 A 257 ALA C 8 ALA^? 21.06 C19 C8E C 210 A 328 ASP C 149 ASP^? 16.02 C16 C8E C 210 coo 39.84 24.12 8.44 38.50 24.23 9.11 46.78 -47.73 -31.34 46.03 -49.05 -31.56 coo 43.22 26.73 5.37 41.81 27.09 5.79 41.60 -45.69 -34.21 41.31 -44.27 -34.65 coo 38.17 34.10 6.67 37.72 32.06 6.84 38.72 -55.19 -32.44 40.02 -55.93 -30.97 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 22 3 # 22 A 229 ALA C 95 ALA^? 24.19 C13 C8E C 210 A 257 ALA C 136 ALA^? 23.08 C16 C8E C 210 A 328 ASP C 149 ASP^? 16.02 C16 C8E C 210 coo 39.84 24.12 8.44 38.50 24.23 9.11 44.22 -62.46 -36.43 45.39 -61.49 -36.49 coo 43.22 26.73 5.37 41.81 27.09 5.79 39.69 -58.64 -38.49 38.27 -59.07 -38.64 coo 38.17 34.10 6.67 37.72 32.06 6.84 38.72 -55.19 -32.44 40.02 -55.93 -30.97 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 23 3 # 23 A 229 ALA C 136 ALA^? 23.08 C16 C8E C 210 A 257 ALA C 95 ALA^? 24.19 C13 C8E C 210 A 328 ASP C 80 ASP^? 16.43 C13 C8E C 210 coo 39.84 24.12 8.44 38.50 24.23 9.11 39.69 -58.64 -38.49 38.27 -59.07 -38.64 coo 43.22 26.73 5.37 41.81 27.09 5.79 44.22 -62.46 -36.43 45.39 -61.49 -36.49 coo 38.17 34.10 6.67 37.72 32.06 6.84 47.10 -57.14 -28.79 45.64 -55.94 -27.77 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 24 3 # 24 A 229 ALA C 137 ALA^? 25.83 C16 C8E C 210 A 257 ALA C 136 ALA^? 23.08 C16 C8E C 210 A 328 ASP C 149 ASP^? 16.02 C16 C8E C 210 coo 39.84 24.12 8.44 38.50 24.23 9.11 41.11 -56.22 -41.00 42.54 -55.78 -40.81 coo 43.22 26.73 5.37 41.81 27.09 5.79 39.69 -58.64 -38.49 38.27 -59.07 -38.64 coo 38.17 34.10 6.67 37.72 32.06 6.84 38.72 -55.19 -32.44 40.02 -55.93 -30.97 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 25 3 # 25 A 229 ALA C 203 ALA^? 24.88 C16 C8E C 210 A 257 ALA C 8 ALA^? 21.06 C19 C8E C 210 A 328 ASP C 149 ASP^? 16.02 C16 C8E C 210 coo 39.84 24.12 8.44 38.50 24.23 9.11 40.30 -47.76 -39.37 39.98 -46.52 -40.19 coo 43.22 26.73 5.37 41.81 27.09 5.79 41.60 -45.69 -34.21 41.31 -44.27 -34.65 coo 38.17 34.10 6.67 37.72 32.06 6.84 38.72 -55.19 -32.44 40.02 -55.93 -30.97 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 26 3 # 26 A 229 ALA C 204 ALA^? 25.35 C16 C8E C 210 A 257 ALA C 8 ALA^? 21.06 C19 C8E C 210 A 328 ASP C 149 ASP^? 16.02 C16 C8E C 210 coo 39.84 24.12 8.44 38.50 24.23 9.11 44.01 -48.39 -39.77 44.55 -49.75 -39.34 coo 43.22 26.73 5.37 41.81 27.09 5.79 41.60 -45.69 -34.21 41.31 -44.27 -34.65 coo 38.17 34.10 6.67 37.72 32.06 6.84 38.72 -55.19 -32.44 40.02 -55.93 -30.97 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 27 3 # 27 A 229 ALA C 204 ALA^? 25.35 C16 C8E C 210 A 257 ALA C 203 ALA^? 24.88 C16 C8E C 210 A 328 ASP C 149 ASP^? 16.02 C16 C8E C 210 coo 39.84 24.12 8.44 38.50 24.23 9.11 44.01 -48.39 -39.77 44.55 -49.75 -39.34 coo 43.22 26.73 5.37 41.81 27.09 5.79 40.30 -47.76 -39.37 39.98 -46.52 -40.19 coo 38.17 34.10 6.67 37.72 32.06 6.84 38.72 -55.19 -32.44 40.02 -55.93 -30.97 1eo7_c00 source 1eo7 CYCLODEXTRIN GLYCOSYLTRANSFERASE : 27 hits 1eo7_c00 naa= 3 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 A 116 SER A 69 SER^? 11.97 CA CA A 208 A 140 TYR A 109 TYR^? 10.85 CA CA A 208 A 144 LYS A 63 LYS~? 3.96 CA CA A 208 coo 34.67 35.79 48.83 33.57 37.88 49.47 69.09 -77.26 -37.91 68.86 -76.80 -40.31 coo 29.60 38.99 53.89 30.10 37.88 51.36 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo 32.73 32.94 54.42 29.29 32.83 50.35 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 A 116 SER B 69 SER^? 12.05 CA CA B 208 A 140 TYR B 109 TYR^? 10.54 CA CA B 208 A 144 LYS B 63 LYS~? 3.79 CA CA B 208 coo 34.67 35.79 48.83 33.57 37.88 49.47 86.53 -22.01 -10.29 84.57 -20.83 -9.39 coo 29.60 38.99 53.89 30.10 37.88 51.36 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo 32.73 32.94 54.42 29.29 32.83 50.35 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 A 116 SER C 69 SER^? 11.34 CA CA C 208 A 140 TYR C 109 TYR^? 10.73 CA CA C 208 A 144 LYS C 63 LYS~? 4.21 CA CA C 208 coo 34.67 35.79 48.83 33.57 37.88 49.47 25.63 -37.12 -10.07 26.01 -35.64 -11.95 coo 29.60 38.99 53.89 30.10 37.88 51.36 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo 32.73 32.94 54.42 29.29 32.83 50.35 20.98 -41.61 -5.49 23.04 -43.67 -10.44 1eq2_c00 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 3 hits 1eq2_c00 naa= 3 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 B 116 SER A 69 SER^? 11.97 CA CA A 208 B 140 TYR A 109 TYR^? 10.85 CA CA A 208 B 144 LYS A 63 LYS~? 3.96 CA CA A 208 coo 30.90 35.65 89.60 29.85 37.72 88.83 69.09 -77.26 -37.91 68.86 -76.80 -40.31 coo 24.43 38.83 86.53 27.07 38.03 86.12 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo 25.13 32.62 89.49 27.74 32.61 84.91 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 B 116 SER B 69 SER^? 12.05 CA CA B 208 B 140 TYR B 109 TYR^? 10.54 CA CA B 208 B 144 LYS B 63 LYS~? 3.79 CA CA B 208 coo 30.90 35.65 89.60 29.85 37.72 88.83 86.53 -22.01 -10.29 84.57 -20.83 -9.39 coo 24.43 38.83 86.53 27.07 38.03 86.12 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo 25.13 32.62 89.49 27.74 32.61 84.91 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 B 116 SER C 69 SER^? 11.34 CA CA C 208 B 140 TYR C 109 TYR^? 10.73 CA CA C 208 B 144 LYS C 63 LYS~? 4.21 CA CA C 208 coo 30.90 35.65 89.60 29.85 37.72 88.83 25.63 -37.12 -10.07 26.01 -35.64 -11.95 coo 24.43 38.83 86.53 27.07 38.03 86.12 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo 25.13 32.62 89.49 27.74 32.61 84.91 20.98 -41.61 -5.49 23.04 -43.67 -10.44 1eq2_c01 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 3 hits 1eq2_c01 naa= 3 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 C 116 SER A 69 SER^? 11.97 CA CA A 208 C 140 TYR A 109 TYR^? 10.85 CA CA A 208 C 144 LYS A 63 LYS~? 3.96 CA CA A 208 coo -8.96 33.70 98.81 -8.96 35.77 97.56 69.09 -77.26 -37.91 68.86 -76.80 -40.31 coo -8.28 37.01 91.79 -6.99 36.16 94.13 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo -10.48 30.66 93.19 -5.27 31.07 94.32 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 C 116 SER B 69 SER^? 12.05 CA CA B 208 C 140 TYR B 109 TYR^? 10.54 CA CA B 208 C 144 LYS B 63 LYS~? 3.79 CA CA B 208 coo -8.96 33.70 98.81 -8.96 35.77 97.56 86.53 -22.01 -10.29 84.57 -20.83 -9.39 coo -8.28 37.01 91.79 -6.99 36.16 94.13 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo -10.48 30.66 93.19 -5.27 31.07 94.32 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 C 116 SER C 69 SER^? 11.34 CA CA C 208 C 140 TYR C 109 TYR^? 10.73 CA CA C 208 C 144 LYS C 63 LYS~? 4.21 CA CA C 208 coo -8.96 33.70 98.81 -8.96 35.77 97.56 25.63 -37.12 -10.07 26.01 -35.64 -11.95 coo -8.28 37.01 91.79 -6.99 36.16 94.13 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo -10.48 30.66 93.19 -5.27 31.07 94.32 20.98 -41.61 -5.49 23.04 -43.67 -10.44 1eq2_c02 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 3 hits 1eq2_c02 naa= 3 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 D 116 SER A 69 SER^? 11.97 CA CA A 208 D 140 TYR A 109 TYR^? 10.85 CA CA A 208 D 144 LYS A 63 LYS~? 3.96 CA CA A 208 coo -29.80 31.30 63.54 -28.79 33.52 63.37 69.09 -77.26 -37.91 68.86 -76.80 -40.31 coo -23.30 35.33 62.20 -25.10 34.24 64.06 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo -24.76 28.82 60.31 -24.27 29.01 65.58 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 D 116 SER B 69 SER^? 12.05 CA CA B 208 D 140 TYR B 109 TYR^? 10.54 CA CA B 208 D 144 LYS B 63 LYS~? 3.79 CA CA B 208 coo -29.80 31.30 63.54 -28.79 33.52 63.37 86.53 -22.01 -10.29 84.57 -20.83 -9.39 coo -23.30 35.33 62.20 -25.10 34.24 64.06 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo -24.76 28.82 60.31 -24.27 29.01 65.58 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 D 116 SER C 69 SER^? 11.34 CA CA C 208 D 140 TYR C 109 TYR^? 10.73 CA CA C 208 D 144 LYS C 63 LYS~? 4.21 CA CA C 208 coo -29.80 31.30 63.54 -28.79 33.52 63.37 25.63 -37.12 -10.07 26.01 -35.64 -11.95 coo -23.30 35.33 62.20 -25.10 34.24 64.06 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo -24.76 28.82 60.31 -24.27 29.01 65.58 20.98 -41.61 -5.49 23.04 -43.67 -10.44 1eq2_c03 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 3 hits 1eq2_c03 naa= 3 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 E 116 SER A 69 SER^? 11.97 CA CA A 208 E 140 TYR A 109 TYR^? 10.85 CA CA A 208 E 144 LYS A 63 LYS~? 3.96 CA CA A 208 coo -3.01 32.72 32.71 -2.80 34.91 33.79 69.09 -77.26 -37.91 68.86 -76.80 -40.31 coo 0.04 36.70 38.68 -2.21 35.46 37.50 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo 1.93 30.52 36.31 -2.84 30.18 38.54 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 E 116 SER B 69 SER^? 12.05 CA CA B 208 E 140 TYR B 109 TYR^? 10.54 CA CA B 208 E 144 LYS B 63 LYS~? 3.79 CA CA B 208 coo -3.01 32.72 32.71 -2.80 34.91 33.79 86.53 -22.01 -10.29 84.57 -20.83 -9.39 coo 0.04 36.70 38.68 -2.21 35.46 37.50 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo 1.93 30.52 36.31 -2.84 30.18 38.54 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 E 116 SER C 69 SER^? 11.34 CA CA C 208 E 140 TYR C 109 TYR^? 10.73 CA CA C 208 E 144 LYS C 63 LYS~? 4.21 CA CA C 208 coo -3.01 32.72 32.71 -2.80 34.91 33.79 25.63 -37.12 -10.07 26.01 -35.64 -11.95 coo 0.04 36.70 38.68 -2.21 35.46 37.50 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo 1.93 30.52 36.31 -2.84 30.18 38.54 20.98 -41.61 -5.49 23.04 -43.67 -10.44 1eq2_c04 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 3 hits 1eq2_c04 naa= 3 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 F 116 SER A 69 SER^? 11.97 CA CA A 208 F 140 TYR A 109 TYR^? 10.85 CA CA A 208 F 144 LYS A 63 LYS~? 3.96 CA CA A 208 coo 55.30 92.46 56.72 55.15 90.39 55.38 69.09 -77.26 -37.91 68.86 -76.80 -40.31 coo 54.49 89.31 49.65 53.35 90.16 52.06 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo 56.78 95.62 51.15 51.59 95.31 52.37 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 F 116 SER B 69 SER^? 12.05 CA CA B 208 F 140 TYR B 109 TYR^? 10.54 CA CA B 208 F 144 LYS B 63 LYS~? 3.79 CA CA B 208 coo 55.30 92.46 56.72 55.15 90.39 55.38 86.53 -22.01 -10.29 84.57 -20.83 -9.39 coo 54.49 89.31 49.65 53.35 90.16 52.06 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo 56.78 95.62 51.15 51.59 95.31 52.37 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 F 116 SER C 69 SER^? 11.34 CA CA C 208 F 140 TYR C 109 TYR^? 10.73 CA CA C 208 F 144 LYS C 63 LYS~? 4.21 CA CA C 208 coo 55.30 92.46 56.72 55.15 90.39 55.38 25.63 -37.12 -10.07 26.01 -35.64 -11.95 coo 54.49 89.31 49.65 53.35 90.16 52.06 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo 56.78 95.62 51.15 51.59 95.31 52.37 20.98 -41.61 -5.49 23.04 -43.67 -10.44 1eq2_c05 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 3 hits 1eq2_c05 naa= 3 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 G 116 SER A 69 SER^? 11.97 CA CA A 208 G 140 TYR A 109 TYR^? 10.85 CA CA A 208 G 144 LYS A 63 LYS~? 3.96 CA CA A 208 coo 76.25 95.63 21.56 75.29 93.40 21.36 69.09 -77.26 -37.91 68.86 -76.80 -40.31 coo 69.78 91.62 20.06 71.51 92.68 22.02 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo 71.19 98.21 18.32 70.69 97.75 23.67 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 G 116 SER B 69 SER^? 12.05 CA CA B 208 G 140 TYR B 109 TYR^? 10.54 CA CA B 208 G 144 LYS B 63 LYS~? 3.79 CA CA B 208 coo 76.25 95.63 21.56 75.29 93.40 21.36 86.53 -22.01 -10.29 84.57 -20.83 -9.39 coo 69.78 91.62 20.06 71.51 92.68 22.02 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo 71.19 98.21 18.32 70.69 97.75 23.67 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 G 116 SER C 69 SER^? 11.34 CA CA C 208 G 140 TYR C 109 TYR^? 10.73 CA CA C 208 G 144 LYS C 63 LYS~? 4.21 CA CA C 208 coo 76.25 95.63 21.56 75.29 93.40 21.36 25.63 -37.12 -10.07 26.01 -35.64 -11.95 coo 69.78 91.62 20.06 71.51 92.68 22.02 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo 71.19 98.21 18.32 70.69 97.75 23.67 20.98 -41.61 -5.49 23.04 -43.67 -10.44 1eq2_c06 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 3 hits 1eq2_c06 naa= 3 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 H 116 SER A 69 SER^? 11.97 CA CA A 208 H 140 TYR A 109 TYR^? 10.85 CA CA A 208 H 144 LYS A 63 LYS~? 3.96 CA CA A 208 coo 15.45 90.62 47.70 16.55 88.57 46.97 69.09 -77.26 -37.91 68.86 -76.80 -40.31 coo 21.92 87.58 44.67 19.30 88.41 44.23 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo 21.26 93.70 47.67 18.47 93.68 43.08 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 H 116 SER B 69 SER^? 12.05 CA CA B 208 H 140 TYR B 109 TYR^? 10.54 CA CA B 208 H 144 LYS B 63 LYS~? 3.79 CA CA B 208 coo 15.45 90.62 47.70 16.55 88.57 46.97 86.53 -22.01 -10.29 84.57 -20.83 -9.39 coo 21.92 87.58 44.67 19.30 88.41 44.23 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo 21.26 93.70 47.67 18.47 93.68 43.08 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 H 116 SER C 69 SER^? 11.34 CA CA C 208 H 140 TYR C 109 TYR^? 10.73 CA CA C 208 H 144 LYS C 63 LYS~? 4.21 CA CA C 208 coo 15.45 90.62 47.70 16.55 88.57 46.97 25.63 -37.12 -10.07 26.01 -35.64 -11.95 coo 21.92 87.58 44.67 19.30 88.41 44.23 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo 21.26 93.70 47.67 18.47 93.68 43.08 20.98 -41.61 -5.49 23.04 -43.67 -10.44 1eq2_c07 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 3 hits 1eq2_c07 naa= 3 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 I 116 SER A 69 SER^? 11.97 CA CA A 208 I 140 TYR A 109 TYR^? 10.85 CA CA A 208 I 144 LYS A 63 LYS~? 3.96 CA CA A 208 coo 11.78 90.82 7.18 12.84 88.72 7.93 69.09 -77.26 -37.91 68.86 -76.80 -40.31 coo 16.78 87.76 12.19 16.39 88.69 9.59 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo 13.67 93.83 12.65 17.08 93.94 8.58 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 I 116 SER B 69 SER^? 12.05 CA CA B 208 I 140 TYR B 109 TYR^? 10.54 CA CA B 208 I 144 LYS B 63 LYS~? 3.79 CA CA B 208 coo 11.78 90.82 7.18 12.84 88.72 7.93 86.53 -22.01 -10.29 84.57 -20.83 -9.39 coo 16.78 87.76 12.19 16.39 88.69 9.59 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo 13.67 93.83 12.65 17.08 93.94 8.58 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 I 116 SER C 69 SER^? 11.34 CA CA C 208 I 140 TYR C 109 TYR^? 10.73 CA CA C 208 I 144 LYS C 63 LYS~? 4.21 CA CA C 208 coo 11.78 90.82 7.18 12.84 88.72 7.93 25.63 -37.12 -10.07 26.01 -35.64 -11.95 coo 16.78 87.76 12.19 16.39 88.69 9.59 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo 13.67 93.83 12.65 17.08 93.94 8.58 20.98 -41.61 -5.49 23.04 -43.67 -10.44 1eq2_c08 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 3 hits 1eq2_c08 naa= 3 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 J 116 SER A 69 SER^? 11.97 CA CA A 208 J 140 TYR A 109 TYR^? 10.85 CA CA A 208 J 144 LYS A 63 LYS~? 3.96 CA CA A 208 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 69.09 -77.26 -37.91 68.86 -76.80 -40.31 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 J 116 SER B 69 SER^? 12.05 CA CA B 208 J 140 TYR B 109 TYR^? 10.54 CA CA B 208 J 144 LYS B 63 LYS~? 3.79 CA CA B 208 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 86.53 -22.01 -10.29 84.57 -20.83 -9.39 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 J 116 SER C 69 SER^? 11.34 CA CA C 208 J 140 TYR C 109 TYR^? 10.73 CA CA C 208 J 144 LYS C 63 LYS~? 4.21 CA CA C 208 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 25.63 -37.12 -10.07 26.01 -35.64 -11.95 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 20.98 -41.61 -5.49 23.04 -43.67 -10.44 1eq2_c09 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 3 hits 1eq2_c09 naa= 3 ULMN 3 1euu_c00 SIALIDASE user 1 3 # 1 92 ASP A 48 ASP.? 7.38 CA CA A 208 260 GLU A 70 GLU^? -2.69 CA CA A 208s 370 TYR A 109 TYR^? 10.85 CA CA A 208 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 72.05 -78.20 -23.17 73.82 -77.79 -22.11 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 68.79 -75.79 -31.87 70.14 -76.30 -30.27 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 66.11 -81.19 -34.21 65.29 -83.76 -33.55 ULMN 3 1euu_c00 SIALIDASE user 2 3 # 2 92 ASP B 48 ASP.? 7.20 CA CA B 208 260 GLU B 70 GLU^? -2.58 CA CA B 208s 370 TYR B 109 TYR^? 10.54 CA CA B 208 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 97.60 -30.12 -16.68 98.20 -32.01 -15.99 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 89.83 -24.96 -14.47 91.03 -26.69 -14.39 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 91.74 -19.55 -12.92 94.01 -17.92 -12.82 ULMN 3 1euu_c00 SIALIDASE user 3 3 # 3 92 ASP C 48 ASP.? 7.17 CA CA C 208 260 GLU C 70 GLU^? -2.71 CA CA C 208s 370 TYR C 109 TYR^? 10.73 CA CA C 208 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 26.68 -52.06 -7.74 25.46 -53.53 -8.54 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 27.73 -42.94 -10.42 26.74 -44.79 -10.37 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 28.40 -39.89 -5.18 28.52 -40.13 -2.40 1euu_c00 source 1euu SIALIDASE : 3 hits 1euu_c00 naa= 3 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 1 3 # 1 A 34 GLU A 184 GLU~? 7.72 C16 C8E A 210 A 260 ARG A 162 ARG^? 10.87 O21 C8E A 210 A 270 LYS A 188 LYS~? 10.77 C20 C8E A 210 coo 50.99 29.43 12.86 52.11 29.45 14.65 63.73 -84.37 -12.45 63.45 -82.45 -11.70 coo 39.80 27.50 22.98 42.20 26.56 21.34 60.16 -83.54 -27.36 63.31 -83.18 -27.03 coo 48.83 21.70 19.50 47.44 24.99 15.25 68.32 -80.18 -18.11 71.95 -84.24 -15.84 1euy_c00 source 1euy GLUTAMINYL-TRNA SYNTHETASE : 1 hits 1euy_c00 naa= 3 ULMN 3 1eyi_c00 FRUCTOSE-1,6-BISPHOSPHATASE user 1 3 # 1 A 68 ASP A 48 ASP.? 7.38 CA CA A 208 A 74 ASP A 45 ASP.? -2.96 CA CA A 208s A 98 GLU A 70 GLU^? -2.69 CA CA A 208s coo 17.19 9.05 25.28 15.77 9.98 26.53 72.05 -78.20 -23.17 73.82 -77.79 -22.11 coo 15.99 8.54 17.36 14.96 7.80 19.05 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo 16.31 12.85 18.11 16.71 11.79 19.90 68.79 -75.79 -31.87 70.14 -76.30 -30.27 ULMN 3 1eyi_c00 FRUCTOSE-1,6-BISPHOSPHATASE user 2 3 # 2 A 68 ASP A 49 ASP.? -3.00 CA CA A 208s A 74 ASP A 45 ASP.? -2.96 CA CA A 208s A 98 GLU A 70 GLU^? -2.69 CA CA A 208s coo 17.19 9.05 25.28 15.77 9.98 26.53 75.72 -77.89 -27.98 74.67 -77.10 -29.65 coo 15.99 8.54 17.36 14.96 7.80 19.05 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo 16.31 12.85 18.11 16.71 11.79 19.90 68.79 -75.79 -31.87 70.14 -76.30 -30.27 ULMN 3 1eyi_c00 FRUCTOSE-1,6-BISPHOSPHATASE user 3 3 # 3 A 68 ASP A 111 ASP.? 17.05 CA CA A 208 A 74 ASP A 114 ASP.? 22.11 CA CA A 208 A 98 GLU A 113 GLU.? 20.24 CA CA A 208 coo 17.19 9.05 25.28 15.77 9.98 26.53 65.36 -83.80 -40.24 66.17 -85.36 -41.35 coo 15.99 8.54 17.36 14.96 7.80 19.05 71.50 -87.46 -45.26 70.62 -89.18 -46.15 coo 16.31 12.85 18.11 16.71 11.79 19.90 67.94 -85.82 -46.11 66.40 -86.46 -44.83 ULMN 3 1eyi_c00 FRUCTOSE-1,6-BISPHOSPHATASE user 4 3 # 4 A 68 ASP B 111 ASP.? 16.97 CA CA B 208 A 74 ASP B 114 ASP.? 22.07 CA CA B 208 A 98 GLU B 113 GLU.? 20.51 CA CA B 208 coo 17.19 9.05 25.28 15.77 9.98 26.53 89.21 -14.92 -8.80 89.40 -13.99 -6.98 coo 15.99 8.54 17.36 14.96 7.80 19.05 88.69 -13.97 -0.41 89.97 -12.27 -0.12 coo 16.31 12.85 18.11 16.71 11.79 19.90 86.78 -12.34 -3.10 88.60 -11.66 -4.00 ULMN 3 1eyi_c00 FRUCTOSE-1,6-BISPHOSPHATASE user 5 3 # 5 A 68 ASP C 111 ASP.? 17.21 CA CA C 208 A 74 ASP C 114 ASP.? 22.22 CA CA C 208 A 98 GLU C 113 GLU.? 20.72 CA CA C 208 coo 17.19 9.05 25.28 15.77 9.98 26.53 27.11 -33.17 -3.90 25.73 -31.94 -3.00 coo 15.99 8.54 17.36 14.96 7.80 19.05 19.39 -30.14 -1.59 19.46 -28.98 0.18 coo 16.31 12.85 18.11 16.71 11.79 19.90 22.93 -28.02 -2.65 24.78 -28.62 -1.78 1eyi_c00 source 1eyi FRUCTOSE-1,6-BISPHOSPHATASE : 5 hits 1eyi_c00 naa= 3 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 A 112 PHE A 105 PHE^? 4.85 O21 C8E A 209 A 210 ASP A 45 ASP.? -2.96 CA CA A 208s A 244 LYS A 188 LYS~? 10.77 C20 C8E A 210 coo 9.23 46.77 25.11 11.48 48.39 24.76 61.29 -71.83 -24.77 63.18 -73.65 -25.72 coo 10.51 37.86 19.71 9.07 39.38 20.04 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo -1.20 42.34 17.67 3.19 45.13 19.06 68.32 -80.18 -18.11 71.95 -84.24 -15.84 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 A 112 PHE A 189 PHE~? 8.72 CA CA A 208 A 210 ASP A 45 ASP.? -2.96 CA CA A 208s A 244 LYS A 63 LYS~? 3.96 CA CA A 208 coo 9.23 46.77 25.11 11.48 48.39 24.76 68.20 -82.10 -23.88 68.92 -82.62 -26.53 coo 10.51 37.86 19.71 9.07 39.38 20.04 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo -1.20 42.34 17.67 3.19 45.13 19.06 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 A 112 PHE A 189 PHE~? 8.72 CA CA A 208 A 210 ASP A 52 ASP.? 15.11 CA CA A 208 A 244 LYS A 63 LYS~? 3.96 CA CA A 208 coo 9.23 46.77 25.11 11.48 48.39 24.76 68.20 -82.10 -23.88 68.92 -82.62 -26.53 coo 10.51 37.86 19.71 9.07 39.38 20.04 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo -1.20 42.34 17.67 3.19 45.13 19.06 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 A 112 PHE B 105 PHE^? 5.21 C20 C8E B 209 A 210 ASP B 45 ASP.? -3.07 CA CA B 208s A 244 LYS B 188 LYS~? 9.67 C16 C8E B 210 coo 9.23 46.77 25.11 11.48 48.39 24.76 90.70 -25.26 -25.77 91.65 -25.28 -23.14 coo 10.51 37.86 19.71 9.07 39.38 20.04 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo -1.20 42.34 17.67 3.19 45.13 19.06 102.16 -28.74 -21.10 106.15 -31.37 -17.86 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 5 3 # 5 A 112 PHE B 189 PHE~? 8.56 CA CA B 208 A 210 ASP B 45 ASP.? -3.07 CA CA B 208s A 244 LYS B 63 LYS~? 3.79 CA CA B 208 coo 9.23 46.77 25.11 11.48 48.39 24.76 99.55 -24.92 -16.99 98.05 -23.95 -14.81 coo 10.51 37.86 19.71 9.07 39.38 20.04 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo -1.20 42.34 17.67 3.19 45.13 19.06 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 6 3 # 6 A 112 PHE B 189 PHE~? 8.56 CA CA B 208 A 210 ASP B 52 ASP.? 15.59 CA CA B 208 A 244 LYS B 63 LYS~? 3.79 CA CA B 208 coo 9.23 46.77 25.11 11.48 48.39 24.76 99.55 -24.92 -16.99 98.05 -23.95 -14.81 coo 10.51 37.86 19.71 9.07 39.38 20.04 105.61 -28.95 -11.53 106.78 -28.70 -9.81 coo -1.20 42.34 17.67 3.19 45.13 19.06 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 7 3 # 7 A 112 PHE C 105 PHE^? -4.13 O21 C8E C 210s A 210 ASP C 45 ASP.? 3.27 CA CA C 208s A 244 LYS C 188 LYS~? 9.02 C16 C8E C 209 coo 9.23 46.77 25.11 11.48 48.39 24.76 37.70 -47.93 -11.88 35.28 -47.45 -10.64 coo 10.51 37.86 19.71 9.07 39.38 20.04 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo -1.20 42.34 17.67 3.19 45.13 19.06 31.07 -55.82 -4.30 26.58 -58.21 -2.57 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 8 3 # 8 A 112 PHE C 189 PHE~? 9.03 CA CA C 208 A 210 ASP C 45 ASP.? 3.27 CA CA C 208s A 244 LYS C 63 LYS~? 4.21 CA CA C 208 coo 9.23 46.77 25.11 11.48 48.39 24.76 29.10 -50.14 -3.03 27.67 -47.71 -3.13 coo 10.51 37.86 19.71 9.07 39.38 20.04 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo -1.20 42.34 17.67 3.19 45.13 19.06 20.98 -41.61 -5.49 23.04 -43.67 -10.44 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 9 3 # 9 A 112 PHE C 189 PHE~? 9.03 CA CA C 208 A 210 ASP C 52 ASP.? 15.77 CA CA C 208 A 244 LYS C 63 LYS~? 4.21 CA CA C 208 coo 9.23 46.77 25.11 11.48 48.39 24.76 29.10 -50.14 -3.03 27.67 -47.71 -3.13 coo 10.51 37.86 19.71 9.07 39.38 20.04 21.29 -54.58 -0.38 20.26 -54.47 1.43 coo -1.20 42.34 17.67 3.19 45.13 19.06 20.98 -41.61 -5.49 23.04 -43.67 -10.44 1fc4_c02 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 9 hits 1fc4_c02 naa= 3 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 B 112 PHE A 105 PHE^? 4.85 O21 C8E A 209 B 210 ASP A 45 ASP.? -2.96 CA CA A 208s B 244 LYS A 188 LYS~? 10.77 C20 C8E A 210 coo 8.76 47.85 34.91 11.08 46.36 35.41 61.29 -71.83 -24.77 63.18 -73.65 -25.72 coo 9.06 56.85 40.30 7.71 55.27 39.90 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo -2.38 51.82 41.62 2.07 49.19 40.42 68.32 -80.18 -18.11 71.95 -84.24 -15.84 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 B 112 PHE A 189 PHE~? 8.72 CA CA A 208 B 210 ASP A 45 ASP.? -2.96 CA CA A 208s B 244 LYS A 63 LYS~? 3.96 CA CA A 208 coo 8.76 47.85 34.91 11.08 46.36 35.41 68.20 -82.10 -23.88 68.92 -82.62 -26.53 coo 9.06 56.85 40.30 7.71 55.27 39.90 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo -2.38 51.82 41.62 2.07 49.19 40.42 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 B 112 PHE A 189 PHE~? 8.72 CA CA A 208 B 210 ASP A 52 ASP.? 15.11 CA CA A 208 B 244 LYS A 63 LYS~? 3.96 CA CA A 208 coo 8.76 47.85 34.91 11.08 46.36 35.41 68.20 -82.10 -23.88 68.92 -82.62 -26.53 coo 9.06 56.85 40.30 7.71 55.27 39.90 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo -2.38 51.82 41.62 2.07 49.19 40.42 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 B 112 PHE B 105 PHE^? 5.21 C20 C8E B 209 B 210 ASP B 45 ASP.? -3.07 CA CA B 208s B 244 LYS B 188 LYS~? 9.67 C16 C8E B 210 coo 8.76 47.85 34.91 11.08 46.36 35.41 90.70 -25.26 -25.77 91.65 -25.28 -23.14 coo 9.06 56.85 40.30 7.71 55.27 39.90 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo -2.38 51.82 41.62 2.07 49.19 40.42 102.16 -28.74 -21.10 106.15 -31.37 -17.86 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 5 3 # 5 B 112 PHE B 189 PHE~? 8.56 CA CA B 208 B 210 ASP B 45 ASP.? -3.07 CA CA B 208s B 244 LYS B 63 LYS~? 3.79 CA CA B 208 coo 8.76 47.85 34.91 11.08 46.36 35.41 99.55 -24.92 -16.99 98.05 -23.95 -14.81 coo 9.06 56.85 40.30 7.71 55.27 39.90 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo -2.38 51.82 41.62 2.07 49.19 40.42 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 6 3 # 6 B 112 PHE B 189 PHE~? 8.56 CA CA B 208 B 210 ASP B 52 ASP.? 15.59 CA CA B 208 B 244 LYS B 63 LYS~? 3.79 CA CA B 208 coo 8.76 47.85 34.91 11.08 46.36 35.41 99.55 -24.92 -16.99 98.05 -23.95 -14.81 coo 9.06 56.85 40.30 7.71 55.27 39.90 105.61 -28.95 -11.53 106.78 -28.70 -9.81 coo -2.38 51.82 41.62 2.07 49.19 40.42 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 7 3 # 7 B 112 PHE C 105 PHE^? -4.13 O21 C8E C 210s B 210 ASP C 45 ASP.? 3.27 CA CA C 208s B 244 LYS C 188 LYS~? 9.02 C16 C8E C 209 coo 8.76 47.85 34.91 11.08 46.36 35.41 37.70 -47.93 -11.88 35.28 -47.45 -10.64 coo 9.06 56.85 40.30 7.71 55.27 39.90 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo -2.38 51.82 41.62 2.07 49.19 40.42 31.07 -55.82 -4.30 26.58 -58.21 -2.57 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 8 3 # 8 B 112 PHE C 189 PHE~? 9.03 CA CA C 208 B 210 ASP C 45 ASP.? 3.27 CA CA C 208s B 244 LYS C 63 LYS~? 4.21 CA CA C 208 coo 8.76 47.85 34.91 11.08 46.36 35.41 29.10 -50.14 -3.03 27.67 -47.71 -3.13 coo 9.06 56.85 40.30 7.71 55.27 39.90 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo -2.38 51.82 41.62 2.07 49.19 40.42 20.98 -41.61 -5.49 23.04 -43.67 -10.44 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 9 3 # 9 B 112 PHE C 189 PHE~? 9.03 CA CA C 208 B 210 ASP C 52 ASP.? 15.77 CA CA C 208 B 244 LYS C 63 LYS~? 4.21 CA CA C 208 coo 8.76 47.85 34.91 11.08 46.36 35.41 29.10 -50.14 -3.03 27.67 -47.71 -3.13 coo 9.06 56.85 40.30 7.71 55.27 39.90 21.29 -54.58 -0.38 20.26 -54.47 1.43 coo -2.38 51.82 41.62 2.07 49.19 40.42 20.98 -41.61 -5.49 23.04 -43.67 -10.44 1fc4_c03 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 9 hits 1fc4_c03 naa= 3 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 A 137 TYR B 83 TYR^? 23.90 C1 C8E B 209 A 142 LEU B 132 LEU^? 15.23 C3 C8E B 209 A 165 LYS B 84 LYS.? 25.86 O15 C8E B 209 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 84.86 -45.84 -46.52 87.07 -46.60 -44.97 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 89.72 -42.61 -38.67 91.33 -43.84 -37.88 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 79.44 -47.69 -46.65 75.97 -44.45 -44.18 1fdy_c00 source 1fdy N-ACETYLNEURAMINATE LYASE : 1 hits 1fdy_c00 naa= 3 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 B 137 TYR B 83 TYR^? 23.90 C1 C8E B 209 B 142 LEU B 132 LEU^? 15.23 C3 C8E B 209 B 165 LYS B 84 LYS.? 25.86 O15 C8E B 209 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 84.86 -45.84 -46.52 87.07 -46.60 -44.97 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 89.72 -42.61 -38.67 91.33 -43.84 -37.88 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 79.44 -47.69 -46.65 75.97 -44.45 -44.18 1fdy_c01 source 1fdy N-ACETYLNEURAMINATE LYASE : 1 hits 1fdy_c01 naa= 3 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 C 137 TYR B 83 TYR^? 23.90 C1 C8E B 209 C 142 LEU B 132 LEU^? 15.23 C3 C8E B 209 C 165 LYS B 84 LYS.? 25.86 O15 C8E B 209 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 84.86 -45.84 -46.52 87.07 -46.60 -44.97 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 89.72 -42.61 -38.67 91.33 -43.84 -37.88 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 79.44 -47.69 -46.65 75.97 -44.45 -44.18 1fdy_c02 source 1fdy N-ACETYLNEURAMINATE LYASE : 1 hits 1fdy_c02 naa= 3 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 D 137 TYR B 83 TYR^? 23.90 C1 C8E B 209 D 142 LEU B 132 LEU^? 15.23 C3 C8E B 209 D 165 LYS B 84 LYS.? 25.86 O15 C8E B 209 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 84.86 -45.84 -46.52 87.07 -46.60 -44.97 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 89.72 -42.61 -38.67 91.33 -43.84 -37.88 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 79.44 -47.69 -46.65 75.97 -44.45 -44.18 1fdy_c03 source 1fdy N-ACETYLNEURAMINATE LYASE : 1 hits 1fdy_c03 naa= 3 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 A 47 SER A 44 SER.? -2.67 O21 C8E A 209s A 48 THR A 43 THR^? 9.02 O18 C8E A 209 A 165 LYS A 198 LYS^? 12.09 C1 C8E A 210 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 67.29 -68.39 -28.17 66.32 -69.65 -26.34 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 66.48 -65.68 -30.63 67.85 -65.90 -32.25 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 68.28 -58.05 -20.21 63.11 -55.44 -18.88 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 A 47 SER A 174 SER^? 15.95 O21 C8E A 210 A 48 THR A 161 THR^? 14.36 O21 C8E A 210 A 165 LYS A 171 LYS^? 22.02 O21 C8E A 209 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 52.92 -84.93 -25.72 55.12 -85.87 -26.20 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 54.89 -79.58 -24.95 52.94 -78.87 -25.32 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 51.77 -85.30 -36.11 51.41 -79.16 -37.75 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 A 47 SER A 175 SER^? 15.77 O21 C8E A 210 A 48 THR A 161 THR^? 14.36 O21 C8E A 210 A 165 LYS A 171 LYS^? 22.02 O21 C8E A 209 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 53.84 -83.01 -22.59 51.54 -82.77 -21.91 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 54.89 -79.58 -24.95 52.94 -78.87 -25.32 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 51.77 -85.30 -36.11 51.41 -79.16 -37.75 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 A 47 SER B 44 SER.? -2.63 C20 C8E B 209s A 48 THR B 43 THR^? 8.90 C19 C8E B 209 A 165 LYS B 198 LYS^? 12.15 O15 C8E B 209 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 86.51 -29.99 -20.81 88.33 -29.21 -22.26 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 82.82 -29.73 -21.27 81.56 -30.56 -19.69 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 85.01 -40.11 -29.09 83.85 -38.63 -34.53 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 A 47 SER B 175 SER^? 13.23 C2 C8E B 210 A 48 THR B 161 THR^? 13.87 C2 C8E B 210 A 165 LYS B 171 LYS^? 22.17 C20 C8E B 209 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 99.30 -14.92 -27.12 99.42 -13.98 -29.34 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 95.26 -16.61 -26.72 94.31 -15.20 -28.05 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 90.66 -6.85 -20.43 84.87 -8.89 -21.63 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 A 47 SER C 44 SER.? -2.60 O21 C8E C 210s A 48 THR C 43 THR^? 8.54 C17 C8E C 210 A 165 LYS C 198 LYS^? 12.94 C13 C8E C 210 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 31.95 -46.42 -17.08 33.26 -47.96 -15.73 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 32.76 -44.26 -20.08 30.65 -44.02 -20.37 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 35.43 -55.44 -26.10 41.10 -55.85 -26.89 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 7 3 # 7 A 47 SER C 175 SER^? 14.60 C3 C8E C 209 A 48 THR C 161 THR^? 14.40 O21 C8E C 209 A 165 LYS C 171 LYS^? 21.29 O21 C8E C 210 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 42.43 -46.97 0.86 44.90 -47.21 0.95 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 41.89 -45.49 -3.13 43.84 -44.64 -3.41 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 40.39 -33.45 0.65 41.79 -31.81 -5.33 1fdy_c04 source 1fdy N-ACETYLNEURAMINATE LYASE : 7 hits 1fdy_c04 naa= 3 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 B 47 SER A 44 SER.? -2.67 O21 C8E A 209s B 48 THR A 43 THR^? 9.02 O18 C8E A 209 B 165 LYS A 198 LYS^? 12.09 C1 C8E A 210 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 67.29 -68.39 -28.17 66.32 -69.65 -26.34 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 66.48 -65.68 -30.63 67.85 -65.90 -32.25 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 68.28 -58.05 -20.21 63.11 -55.44 -18.88 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 B 47 SER A 174 SER^? 15.95 O21 C8E A 210 B 48 THR A 161 THR^? 14.36 O21 C8E A 210 B 165 LYS A 171 LYS^? 22.02 O21 C8E A 209 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 52.92 -84.93 -25.72 55.12 -85.87 -26.20 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 54.89 -79.58 -24.95 52.94 -78.87 -25.32 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 51.77 -85.30 -36.11 51.41 -79.16 -37.75 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 B 47 SER A 175 SER^? 15.77 O21 C8E A 210 B 48 THR A 161 THR^? 14.36 O21 C8E A 210 B 165 LYS A 171 LYS^? 22.02 O21 C8E A 209 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 53.84 -83.01 -22.59 51.54 -82.77 -21.91 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 54.89 -79.58 -24.95 52.94 -78.87 -25.32 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 51.77 -85.30 -36.11 51.41 -79.16 -37.75 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 B 47 SER B 44 SER.? -2.63 C20 C8E B 209s B 48 THR B 43 THR^? 8.90 C19 C8E B 209 B 165 LYS B 198 LYS^? 12.15 O15 C8E B 209 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 86.51 -29.99 -20.81 88.33 -29.21 -22.26 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 82.82 -29.73 -21.27 81.56 -30.56 -19.69 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 85.01 -40.11 -29.09 83.85 -38.63 -34.53 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 B 47 SER B 175 SER^? 13.23 C2 C8E B 210 B 48 THR B 161 THR^? 13.87 C2 C8E B 210 B 165 LYS B 171 LYS^? 22.17 C20 C8E B 209 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 99.30 -14.92 -27.12 99.42 -13.98 -29.34 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 95.26 -16.61 -26.72 94.31 -15.20 -28.05 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 90.66 -6.85 -20.43 84.87 -8.89 -21.63 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 B 47 SER C 44 SER.? -2.60 O21 C8E C 210s B 48 THR C 43 THR^? 8.54 C17 C8E C 210 B 165 LYS C 198 LYS^? 12.94 C13 C8E C 210 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 31.95 -46.42 -17.08 33.26 -47.96 -15.73 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 32.76 -44.26 -20.08 30.65 -44.02 -20.37 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 35.43 -55.44 -26.10 41.10 -55.85 -26.89 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 7 3 # 7 B 47 SER C 175 SER^? 14.60 C3 C8E C 209 B 48 THR C 161 THR^? 14.40 O21 C8E C 209 B 165 LYS C 171 LYS^? 21.29 O21 C8E C 210 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 42.43 -46.97 0.86 44.90 -47.21 0.95 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 41.89 -45.49 -3.13 43.84 -44.64 -3.41 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 40.39 -33.45 0.65 41.79 -31.81 -5.33 1fdy_c05 source 1fdy N-ACETYLNEURAMINATE LYASE : 7 hits 1fdy_c05 naa= 3 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 C 47 SER A 44 SER.? -2.67 O21 C8E A 209s C 48 THR A 43 THR^? 9.02 O18 C8E A 209 C 165 LYS A 198 LYS^? 12.09 C1 C8E A 210 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 67.29 -68.39 -28.17 66.32 -69.65 -26.34 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 66.48 -65.68 -30.63 67.85 -65.90 -32.25 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 68.28 -58.05 -20.21 63.11 -55.44 -18.88 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 C 47 SER A 174 SER^? 15.95 O21 C8E A 210 C 48 THR A 161 THR^? 14.36 O21 C8E A 210 C 165 LYS A 171 LYS^? 22.02 O21 C8E A 209 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 52.92 -84.93 -25.72 55.12 -85.87 -26.20 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 54.89 -79.58 -24.95 52.94 -78.87 -25.32 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 51.77 -85.30 -36.11 51.41 -79.16 -37.75 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 C 47 SER A 175 SER^? 15.77 O21 C8E A 210 C 48 THR A 161 THR^? 14.36 O21 C8E A 210 C 165 LYS A 171 LYS^? 22.02 O21 C8E A 209 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 53.84 -83.01 -22.59 51.54 -82.77 -21.91 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 54.89 -79.58 -24.95 52.94 -78.87 -25.32 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 51.77 -85.30 -36.11 51.41 -79.16 -37.75 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 C 47 SER B 44 SER.? -2.63 C20 C8E B 209s C 48 THR B 43 THR^? 8.90 C19 C8E B 209 C 165 LYS B 198 LYS^? 12.15 O15 C8E B 209 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 86.51 -29.99 -20.81 88.33 -29.21 -22.26 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 82.82 -29.73 -21.27 81.56 -30.56 -19.69 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 85.01 -40.11 -29.09 83.85 -38.63 -34.53 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 C 47 SER B 175 SER^? 13.23 C2 C8E B 210 C 48 THR B 161 THR^? 13.87 C2 C8E B 210 C 165 LYS B 171 LYS^? 22.17 C20 C8E B 209 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 99.30 -14.92 -27.12 99.42 -13.98 -29.34 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 95.26 -16.61 -26.72 94.31 -15.20 -28.05 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 90.66 -6.85 -20.43 84.87 -8.89 -21.63 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 C 47 SER C 44 SER.? -2.60 O21 C8E C 210s C 48 THR C 43 THR^? 8.54 C17 C8E C 210 C 165 LYS C 198 LYS^? 12.94 C13 C8E C 210 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 31.95 -46.42 -17.08 33.26 -47.96 -15.73 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 32.76 -44.26 -20.08 30.65 -44.02 -20.37 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 35.43 -55.44 -26.10 41.10 -55.85 -26.89 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 7 3 # 7 C 47 SER C 175 SER^? 14.60 C3 C8E C 209 C 48 THR C 161 THR^? 14.40 O21 C8E C 209 C 165 LYS C 171 LYS^? 21.29 O21 C8E C 210 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 42.43 -46.97 0.86 44.90 -47.21 0.95 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 41.89 -45.49 -3.13 43.84 -44.64 -3.41 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 40.39 -33.45 0.65 41.79 -31.81 -5.33 1fdy_c06 source 1fdy N-ACETYLNEURAMINATE LYASE : 7 hits 1fdy_c06 naa= 3 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 D 47 SER A 44 SER.? -2.67 O21 C8E A 209s D 48 THR A 43 THR^? 9.02 O18 C8E A 209 D 165 LYS A 198 LYS^? 12.09 C1 C8E A 210 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 67.29 -68.39 -28.17 66.32 -69.65 -26.34 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 66.48 -65.68 -30.63 67.85 -65.90 -32.25 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 68.28 -58.05 -20.21 63.11 -55.44 -18.88 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 D 47 SER A 124 SER^? 11.39 O21 C8E A 209 D 48 THR A 161 THR^? 14.36 O21 C8E A 210 D 165 LYS A 188 LYS~? 10.77 C20 C8E A 210 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 57.35 -75.30 -26.04 56.15 -74.57 -27.97 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 54.89 -79.58 -24.95 52.94 -78.87 -25.32 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 68.32 -80.18 -18.11 71.95 -84.24 -15.84 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 D 47 SER A 175 SER^? 15.77 O21 C8E A 210 D 48 THR A 161 THR^? 14.36 O21 C8E A 210 D 165 LYS A 171 LYS^? 22.02 O21 C8E A 209 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 53.84 -83.01 -22.59 51.54 -82.77 -21.91 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 54.89 -79.58 -24.95 52.94 -78.87 -25.32 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 51.77 -85.30 -36.11 51.41 -79.16 -37.75 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 D 47 SER B 44 SER.? -2.63 C20 C8E B 209s D 48 THR B 43 THR^? 8.90 C19 C8E B 209 D 165 LYS B 198 LYS^? 12.15 O15 C8E B 209 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 86.51 -29.99 -20.81 88.33 -29.21 -22.26 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 82.82 -29.73 -21.27 81.56 -30.56 -19.69 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 85.01 -40.11 -29.09 83.85 -38.63 -34.53 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 D 47 SER B 124 SER^? 12.13 C20 C8E B 209 D 48 THR B 161 THR^? 13.87 C2 C8E B 210 D 165 LYS B 171 LYS^? 22.17 C20 C8E B 209 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 91.65 -20.05 -26.20 89.80 -18.42 -26.25 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 95.26 -16.61 -26.72 94.31 -15.20 -28.05 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 90.66 -6.85 -20.43 84.87 -8.89 -21.63 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 D 47 SER B 175 SER^? 13.23 C2 C8E B 210 D 48 THR B 161 THR^? 13.87 C2 C8E B 210 D 165 LYS B 171 LYS^? 22.17 C20 C8E B 209 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 99.30 -14.92 -27.12 99.42 -13.98 -29.34 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 95.26 -16.61 -26.72 94.31 -15.20 -28.05 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 90.66 -6.85 -20.43 84.87 -8.89 -21.63 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 7 3 # 7 D 47 SER C 44 SER.? -2.60 O21 C8E C 210s D 48 THR C 43 THR^? 8.54 C17 C8E C 210 D 165 LYS C 198 LYS^? 12.94 C13 C8E C 210 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 31.95 -46.42 -17.08 33.26 -47.96 -15.73 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 32.76 -44.26 -20.08 30.65 -44.02 -20.37 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 35.43 -55.44 -26.10 41.10 -55.85 -26.89 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 8 3 # 8 D 47 SER C 124 SER^? 11.72 O21 C8E C 210 D 48 THR C 161 THR^? 14.40 O21 C8E C 209 D 165 LYS C 188 LYS~? 9.02 C16 C8E C 209 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 40.05 -45.29 -8.01 42.09 -44.13 -7.44 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 41.89 -45.49 -3.13 43.84 -44.64 -3.41 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 31.07 -55.82 -4.30 26.58 -58.21 -2.57 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 9 3 # 9 D 47 SER C 175 SER^? 14.60 C3 C8E C 209 D 48 THR C 161 THR^? 14.40 O21 C8E C 209 D 165 LYS C 171 LYS^? 21.29 O21 C8E C 210 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 42.43 -46.97 0.86 44.90 -47.21 0.95 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 41.89 -45.49 -3.13 43.84 -44.64 -3.41 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 40.39 -33.45 0.65 41.79 -31.81 -5.33 1fdy_c07 source 1fdy N-ACETYLNEURAMINATE LYASE : 9 hits 1fdy_c07 naa= 3 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 1 3 # 1 A 45 ARG A 135 ARG^? 21.29 C1 C8E A 210 A 136 GLU A 25 GLU^? 22.98 C2 C8E C 209 A 246 GLU A 93 GLU^? 23.51 C1 C8E A 210 coo 13.48 30.30 107.06 11.75 30.99 109.44 62.45 -46.81 -18.85 61.41 -44.79 -20.90 coo 9.46 32.37 115.82 8.50 34.20 115.47 56.22 -40.62 -18.58 57.98 -41.28 -19.55 coo 11.99 34.33 109.92 10.08 34.19 110.77 64.33 -40.66 -16.04 62.38 -40.13 -16.70 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 2 3 # 2 A 45 ARG B 162 ARG^? 16.35 O21 C8E B 210 A 136 GLU B 165 GLU^? 20.64 CA CA B 208 A 246 GLU B 164 GLU^? 19.99 CA CA B 208 coo 13.48 30.30 107.06 11.75 30.99 109.44 96.21 -15.01 -19.71 98.63 -13.28 -19.03 coo 9.46 32.37 115.82 8.50 34.20 115.47 88.15 -8.84 -16.79 86.14 -9.46 -16.74 coo 11.99 34.33 109.92 10.08 34.19 110.77 94.70 -10.70 -16.52 96.59 -9.81 -16.07 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 3 3 # 3 A 45 ARG C 162 ARG^? 16.00 O21 C8E C 209 A 136 GLU C 165 GLU^? 20.98 CA CA C 208 A 246 GLU C 164 GLU^? 20.06 CA CA C 208 coo 13.48 30.30 107.06 11.75 30.99 109.44 35.66 -43.15 0.12 35.66 -43.03 3.18 coo 9.46 32.37 115.82 8.50 34.20 115.47 36.32 -31.59 -2.15 36.97 -31.00 -4.08 coo 11.99 34.33 109.92 10.08 34.19 110.77 34.72 -37.11 1.76 34.46 -37.46 3.82 1fhl_c00 source 1fhl BETA-1,4-GALACTANASE : 3 hits 1fhl_c00 naa= 3 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 1 3 # 1 A 45 ARG A 135 ARG^? 21.29 C1 C8E A 210 A 136 GLU A 25 GLU^? 22.98 C2 C8E C 209 A 246 GLU A 93 GLU^? 23.51 C1 C8E A 210 coo 13.94 29.84 106.80 11.67 30.40 108.79 62.45 -46.81 -18.85 61.41 -44.79 -20.90 coo 9.52 31.97 115.23 8.45 33.74 114.72 56.22 -40.62 -18.58 57.98 -41.28 -19.55 coo 11.92 33.82 109.35 10.10 33.50 110.39 64.33 -40.66 -16.04 62.38 -40.13 -16.70 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 2 3 # 2 A 45 ARG B 162 ARG^? 16.35 O21 C8E B 210 A 136 GLU B 165 GLU^? 20.64 CA CA B 208 A 246 GLU B 164 GLU^? 19.99 CA CA B 208 coo 13.94 29.84 106.80 11.67 30.40 108.79 96.21 -15.01 -19.71 98.63 -13.28 -19.03 coo 9.52 31.97 115.23 8.45 33.74 114.72 88.15 -8.84 -16.79 86.14 -9.46 -16.74 coo 11.92 33.82 109.35 10.10 33.50 110.39 94.70 -10.70 -16.52 96.59 -9.81 -16.07 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 3 3 # 3 A 45 ARG C 162 ARG^? 16.00 O21 C8E C 209 A 136 GLU C 165 GLU^? 20.98 CA CA C 208 A 246 GLU C 164 GLU^? 20.06 CA CA C 208 coo 13.94 29.84 106.80 11.67 30.40 108.79 35.66 -43.15 0.12 35.66 -43.03 3.18 coo 9.52 31.97 115.23 8.45 33.74 114.72 36.32 -31.59 -2.15 36.97 -31.00 -4.08 coo 11.92 33.82 109.35 10.10 33.50 110.39 34.72 -37.11 1.76 34.46 -37.46 3.82 1fob_c00 source 1fob BETA-1,4-GALACTANASE : 3 hits 1fob_c00 naa= 3 ULMN 3 1foh_c00 PHENOL HYDROXYLASE user 1 3 # 1 A 54 ASP A 80 ASP^? 12.60 C1 C8E A 210 A 281 ARG A 36 ARG^? 15.77 C1 C8E A 210 A 289 TYR C 102 TYR^? 9.73 C2 C8E C 209 coo 54.86 40.00 47.23 55.57 38.60 48.67 58.12 -52.30 -15.93 59.10 -53.68 -17.13 coo 52.08 40.18 50.14 50.83 38.93 47.73 59.00 -50.13 -20.90 61.68 -51.06 -19.88 coo 57.82 31.70 50.73 57.94 34.00 49.17 48.50 -51.08 -15.65 48.91 -50.66 -12.96 ULMN 3 1foh_c00 PHENOL HYDROXYLASE user 2 3 # 2 A 54 ASP A 149 ASP^? 14.85 C1 C8E A 210 A 281 ARG A 200 ARG^? 11.17 C17 C8E A 209 A 289 TYR A 97 TYR^? 11.99 C1 C8E A 210 coo 54.86 40.00 47.23 55.57 38.60 48.67 66.40 -51.17 -20.74 65.06 -51.90 -19.38 coo 52.08 40.18 50.14 50.83 38.93 47.73 65.38 -54.68 -25.12 63.65 -56.91 -23.89 coo 57.82 31.70 50.73 57.94 34.00 49.17 61.97 -51.46 -14.47 63.57 -52.89 -16.21 ULMN 3 1foh_c00 PHENOL HYDROXYLASE user 3 3 # 3 A 54 ASP A 153 ASP^? 8.28 C1 C8E A 210 A 281 ARG A 101 ARG^? 8.92 C1 C8E A 210 A 289 TYR A 97 TYR^? 11.99 C1 C8E A 210 coo 54.86 40.00 47.23 55.57 38.60 48.67 63.37 -61.81 -16.17 62.75 -59.91 -16.84 coo 52.08 40.18 50.14 50.83 38.93 47.73 59.10 -60.12 -16.06 60.30 -57.41 -15.78 coo 57.82 31.70 50.73 57.94 34.00 49.17 61.97 -51.46 -14.47 63.57 -52.89 -16.21 ULMN 3 1foh_c00 PHENOL HYDROXYLASE user 4 3 # 4 A 54 ASP B 153 ASP^? 9.57 O15 C8E B 209 A 281 ARG B 101 ARG^? 13.86 O15 C8E B 209 A 289 TYR B 97 TYR^? 16.46 O15 C8E B 209 coo 54.86 40.00 47.23 55.57 38.60 48.67 89.74 -36.17 -33.46 87.76 -36.55 -34.22 coo 52.08 40.18 50.14 50.83 38.93 47.73 87.52 -34.18 -37.50 85.80 -36.55 -38.16 coo 57.82 31.70 50.73 57.94 34.00 49.17 83.74 -41.85 -39.80 83.62 -41.42 -37.05 ULMN 3 1foh_c00 PHENOL HYDROXYLASE user 5 3 # 5 A 54 ASP C 153 ASP^? 9.83 C13 C8E C 210 A 281 ARG C 101 ARG^? 13.82 C13 C8E C 210 A 289 TYR C 97 TYR^? 17.03 C13 C8E C 210 coo 54.86 40.00 47.23 55.57 38.60 48.67 40.09 -57.62 -20.90 41.26 -57.13 -22.61 coo 52.08 40.18 50.14 50.83 38.93 47.73 44.39 -56.56 -21.66 44.87 -57.05 -24.63 coo 57.82 31.70 50.73 57.94 34.00 49.17 44.42 -59.94 -30.24 42.23 -58.45 -29.40 1foh_c00 source 1foh PHENOL HYDROXYLASE : 5 hits 1foh_c00 naa= 3 ULMN 3 1foh_c01 PHENOL HYDROXYLASE user 1 3 # 1 B 54 ASP A 80 ASP^? 12.60 C1 C8E A 210 B 281 ARG A 36 ARG^? 15.77 C1 C8E A 210 B 289 TYR C 102 TYR^? 9.73 C2 C8E C 209 coo 90.56 80.24 98.04 90.36 81.53 96.34 58.12 -52.30 -15.93 59.10 -53.68 -17.13 coo 86.62 80.67 97.51 87.37 82.00 100.10 59.00 -50.13 -20.90 61.68 -51.06 -19.88 coo 91.83 88.28 92.88 92.60 85.93 94.14 48.50 -51.08 -15.65 48.91 -50.66 -12.96 ULMN 3 1foh_c01 PHENOL HYDROXYLASE user 2 3 # 2 B 54 ASP A 149 ASP^? 14.85 C1 C8E A 210 B 281 ARG A 200 ARG^? 11.17 C17 C8E A 209 B 289 TYR A 97 TYR^? 11.99 C1 C8E A 210 coo 90.56 80.24 98.04 90.36 81.53 96.34 66.40 -51.17 -20.74 65.06 -51.90 -19.38 coo 86.62 80.67 97.51 87.37 82.00 100.10 65.38 -54.68 -25.12 63.65 -56.91 -23.89 coo 91.83 88.28 92.88 92.60 85.93 94.14 61.97 -51.46 -14.47 63.57 -52.89 -16.21 ULMN 3 1foh_c01 PHENOL HYDROXYLASE user 3 3 # 3 B 54 ASP A 153 ASP^? 8.28 C1 C8E A 210 B 281 ARG A 101 ARG^? 8.92 C1 C8E A 210 B 289 TYR A 97 TYR^? 11.99 C1 C8E A 210 coo 90.56 80.24 98.04 90.36 81.53 96.34 63.37 -61.81 -16.17 62.75 -59.91 -16.84 coo 86.62 80.67 97.51 87.37 82.00 100.10 59.10 -60.12 -16.06 60.30 -57.41 -15.78 coo 91.83 88.28 92.88 92.60 85.93 94.14 61.97 -51.46 -14.47 63.57 -52.89 -16.21 ULMN 3 1foh_c01 PHENOL HYDROXYLASE user 4 3 # 4 B 54 ASP B 153 ASP^? 9.57 O15 C8E B 209 B 281 ARG B 101 ARG^? 13.86 O15 C8E B 209 B 289 TYR B 97 TYR^? 16.46 O15 C8E B 209 coo 90.56 80.24 98.04 90.36 81.53 96.34 89.74 -36.17 -33.46 87.76 -36.55 -34.22 coo 86.62 80.67 97.51 87.37 82.00 100.10 87.52 -34.18 -37.50 85.80 -36.55 -38.16 coo 91.83 88.28 92.88 92.60 85.93 94.14 83.74 -41.85 -39.80 83.62 -41.42 -37.05 ULMN 3 1foh_c01 PHENOL HYDROXYLASE user 5 3 # 5 B 54 ASP C 153 ASP^? 9.83 C13 C8E C 210 B 281 ARG C 101 ARG^? 13.82 C13 C8E C 210 B 289 TYR C 97 TYR^? 17.03 C13 C8E C 210 coo 90.56 80.24 98.04 90.36 81.53 96.34 40.09 -57.62 -20.90 41.26 -57.13 -22.61 coo 86.62 80.67 97.51 87.37 82.00 100.10 44.39 -56.56 -21.66 44.87 -57.05 -24.63 coo 91.83 88.28 92.88 92.60 85.93 94.14 44.42 -59.94 -30.24 42.23 -58.45 -29.40 1foh_c01 source 1foh PHENOL HYDROXYLASE : 5 hits 1foh_c01 naa= 3 ULMN 3 1foh_c02 PHENOL HYDROXYLASE user 1 3 # 1 C 54 ASP A 80 ASP^? 12.60 C1 C8E A 210 C 281 ARG A 36 ARG^? 15.77 C1 C8E A 210 C 289 TYR C 102 TYR^? 9.73 C2 C8E C 209 coo 42.34 76.83 49.10 43.06 78.59 50.01 58.12 -52.30 -15.93 59.10 -53.68 -17.13 coo 46.12 77.15 48.13 44.44 77.61 45.70 59.00 -50.13 -20.90 61.68 -51.06 -19.88 coo 42.69 86.18 51.69 41.59 83.63 51.54 48.50 -51.08 -15.65 48.91 -50.66 -12.96 ULMN 3 1foh_c02 PHENOL HYDROXYLASE user 2 3 # 2 C 54 ASP A 153 ASP^? 8.28 C1 C8E A 210 C 281 ARG A 101 ARG^? 8.92 C1 C8E A 210 C 289 TYR A 97 TYR^? 11.99 C1 C8E A 210 coo 42.34 76.83 49.10 43.06 78.59 50.01 63.37 -61.81 -16.17 62.75 -59.91 -16.84 coo 46.12 77.15 48.13 44.44 77.61 45.70 59.10 -60.12 -16.06 60.30 -57.41 -15.78 coo 42.69 86.18 51.69 41.59 83.63 51.54 61.97 -51.46 -14.47 63.57 -52.89 -16.21 ULMN 3 1foh_c02 PHENOL HYDROXYLASE user 3 3 # 3 C 54 ASP B 153 ASP^? 9.57 O15 C8E B 209 C 281 ARG B 101 ARG^? 13.86 O15 C8E B 209 C 289 TYR B 97 TYR^? 16.46 O15 C8E B 209 coo 42.34 76.83 49.10 43.06 78.59 50.01 89.74 -36.17 -33.46 87.76 -36.55 -34.22 coo 46.12 77.15 48.13 44.44 77.61 45.70 87.52 -34.18 -37.50 85.80 -36.55 -38.16 coo 42.69 86.18 51.69 41.59 83.63 51.54 83.74 -41.85 -39.80 83.62 -41.42 -37.05 ULMN 3 1foh_c02 PHENOL HYDROXYLASE user 4 3 # 4 C 54 ASP C 153 ASP^? 9.83 C13 C8E C 210 C 281 ARG C 101 ARG^? 13.82 C13 C8E C 210 C 289 TYR C 97 TYR^? 17.03 C13 C8E C 210 coo 42.34 76.83 49.10 43.06 78.59 50.01 40.09 -57.62 -20.90 41.26 -57.13 -22.61 coo 46.12 77.15 48.13 44.44 77.61 45.70 44.39 -56.56 -21.66 44.87 -57.05 -24.63 coo 42.69 86.18 51.69 41.59 83.63 51.54 44.42 -59.94 -30.24 42.23 -58.45 -29.40 1foh_c02 source 1foh PHENOL HYDROXYLASE : 4 hits 1foh_c02 naa= 3 ULMN 3 1foh_c03 PHENOL HYDROXYLASE user 1 3 # 1 D 54 ASP A 80 ASP^? 12.60 C1 C8E A 210 D 281 ARG A 36 ARG^? 15.77 C1 C8E A 210 D 289 TYR C 102 TYR^? 9.73 C2 C8E C 209 coo 75.05 45.80 106.18 74.73 43.88 105.51 58.12 -52.30 -15.93 59.10 -53.68 -17.13 coo 78.52 44.93 104.78 78.72 44.49 107.76 59.00 -50.13 -20.90 61.68 -51.06 -19.88 coo 72.35 36.51 104.82 72.00 39.20 105.46 48.50 -51.08 -15.65 48.91 -50.66 -12.96 ULMN 3 1foh_c03 PHENOL HYDROXYLASE user 2 3 # 2 D 54 ASP A 153 ASP^? 8.28 C1 C8E A 210 D 281 ARG A 101 ARG^? 8.92 C1 C8E A 210 D 289 TYR A 97 TYR^? 11.99 C1 C8E A 210 coo 75.05 45.80 106.18 74.73 43.88 105.51 63.37 -61.81 -16.17 62.75 -59.91 -16.84 coo 78.52 44.93 104.78 78.72 44.49 107.76 59.10 -60.12 -16.06 60.30 -57.41 -15.78 coo 72.35 36.51 104.82 72.00 39.20 105.46 61.97 -51.46 -14.47 63.57 -52.89 -16.21 ULMN 3 1foh_c03 PHENOL HYDROXYLASE user 3 3 # 3 D 54 ASP B 153 ASP^? 9.57 O15 C8E B 209 D 281 ARG B 101 ARG^? 13.86 O15 C8E B 209 D 289 TYR B 97 TYR^? 16.46 O15 C8E B 209 coo 75.05 45.80 106.18 74.73 43.88 105.51 89.74 -36.17 -33.46 87.76 -36.55 -34.22 coo 78.52 44.93 104.78 78.72 44.49 107.76 87.52 -34.18 -37.50 85.80 -36.55 -38.16 coo 72.35 36.51 104.82 72.00 39.20 105.46 83.74 -41.85 -39.80 83.62 -41.42 -37.05 ULMN 3 1foh_c03 PHENOL HYDROXYLASE user 4 3 # 4 D 54 ASP C 153 ASP^? 9.83 C13 C8E C 210 D 281 ARG C 101 ARG^? 13.82 C13 C8E C 210 D 289 TYR C 97 TYR^? 17.03 C13 C8E C 210 coo 75.05 45.80 106.18 74.73 43.88 105.51 40.09 -57.62 -20.90 41.26 -57.13 -22.61 coo 78.52 44.93 104.78 78.72 44.49 107.76 44.39 -56.56 -21.66 44.87 -57.05 -24.63 coo 72.35 36.51 104.82 72.00 39.20 105.46 44.42 -59.94 -30.24 42.23 -58.45 -29.40 1foh_c03 source 1foh PHENOL HYDROXYLASE : 4 hits 1foh_c03 naa= 3 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 1 3 # 1 A 317 GLU A 194 GLU.? 3.11 C17 C8E A 210s A 319 ASP A 153 ASP^? 8.28 C1 C8E A 210 A 359 ARG A 101 ARG^? 8.92 C1 C8E A 210 coo 14.41 12.40 16.42 12.92 13.74 15.71 66.12 -70.72 -14.05 67.03 -72.48 -13.31 coo 12.25 13.04 23.85 11.56 15.02 23.93 63.37 -61.81 -16.17 62.75 -59.91 -16.84 coo 10.89 14.95 28.28 12.39 12.53 29.31 59.10 -60.12 -16.06 60.30 -57.41 -15.78 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 2 3 # 2 A 317 GLU B 194 GLU.? 2.86 C13 C8E B 210s A 319 ASP B 153 ASP^? 9.57 O15 C8E B 209 A 359 ARG B 101 ARG^? 13.86 O15 C8E B 209 coo 14.41 12.40 16.42 12.92 13.74 15.71 97.88 -33.97 -28.78 99.62 -34.16 -27.58 coo 12.25 13.04 23.85 11.56 15.02 23.93 89.74 -36.17 -33.46 87.76 -36.55 -34.22 coo 10.89 14.95 28.28 12.39 12.53 29.31 87.52 -34.18 -37.50 85.80 -36.55 -38.16 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 3 3 # 3 A 317 GLU C 194 GLU.? 3.24 O15 C8E C 209s A 319 ASP C 153 ASP^? 9.83 C13 C8E C 210 A 359 ARG C 101 ARG^? 13.82 C13 C8E C 210 coo 14.41 12.40 16.42 12.92 13.74 15.71 36.17 -59.59 -12.28 34.91 -60.51 -10.83 coo 12.25 13.04 23.85 11.56 15.02 23.93 40.09 -57.62 -20.90 41.26 -57.13 -22.61 coo 10.89 14.95 28.28 12.39 12.53 29.31 44.39 -56.56 -21.66 44.87 -57.05 -24.63 1fr8_c00 source 1fr8 BETA 1,4 GALACTOSYLTRANSFERASE : 3 hits 1fr8_c00 naa= 3 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 1 3 # 1 A 314 TRP A 59 TRP~? 6.21 CA CA A 208 A 317 GLU A 70 GLU^? -2.69 CA CA A 208s A 365 ARG A 162 ARG^? 10.87 O21 C8E A 210 coo 79.91 26.87 38.77 78.95 23.18 37.81 71.67 -80.29 -29.02 69.69 -82.14 -31.86 coo 85.55 26.30 41.25 85.59 24.97 39.65 68.79 -75.79 -31.87 70.14 -76.30 -30.27 coo 83.47 25.30 27.10 83.44 27.82 25.29 60.16 -83.54 -27.36 63.31 -83.18 -27.03 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 2 3 # 2 A 314 TRP A 71 TRP^? 11.26 CA CA A 208 A 317 GLU A 70 GLU^? -2.69 CA CA A 208s A 365 ARG A 162 ARG^? 10.87 O21 C8E A 210 coo 79.91 26.87 38.77 78.95 23.18 37.81 63.94 -74.90 -35.16 60.97 -73.12 -33.30 coo 85.55 26.30 41.25 85.59 24.97 39.65 68.79 -75.79 -31.87 70.14 -76.30 -30.27 coo 83.47 25.30 27.10 83.44 27.82 25.29 60.16 -83.54 -27.36 63.31 -83.18 -27.03 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 3 3 # 3 A 314 TRP B 59 TRP~? 6.11 CA CA B 208 A 317 GLU B 70 GLU^? -2.58 CA CA B 208s A 365 ARG B 162 ARG^? 16.35 O21 C8E B 210 coo 79.91 26.87 38.77 78.95 23.18 37.81 95.08 -26.15 -12.40 94.38 -22.43 -11.38 coo 85.55 26.30 41.25 85.59 24.97 39.65 89.83 -24.96 -14.47 91.03 -26.69 -14.39 coo 83.47 25.30 27.10 83.44 27.82 25.29 96.21 -15.01 -19.71 98.63 -13.28 -19.03 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 4 3 # 4 A 314 TRP B 71 TRP^? 11.25 CA CA B 208 A 317 GLU B 70 GLU^? -2.58 CA CA B 208s A 365 ARG B 162 ARG^? 16.35 O21 C8E B 210 coo 79.91 26.87 38.77 78.95 23.18 37.81 86.05 -20.83 -16.48 85.77 -20.27 -20.38 coo 85.55 26.30 41.25 85.59 24.97 39.65 89.83 -24.96 -14.47 91.03 -26.69 -14.39 coo 83.47 25.30 27.10 83.44 27.82 25.29 96.21 -15.01 -19.71 98.63 -13.28 -19.03 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 5 3 # 5 A 314 TRP C 59 TRP~? 6.20 CA CA C 208 A 317 GLU C 70 GLU^? -2.71 CA CA C 208s A 365 ARG C 162 ARG^? 16.00 O21 C8E C 209 coo 79.91 26.87 38.77 78.95 23.18 37.81 24.77 -46.37 -6.57 25.55 -42.98 -4.73 coo 85.55 26.30 41.25 85.59 24.97 39.65 27.73 -42.94 -10.42 26.74 -44.79 -10.37 coo 83.47 25.30 27.10 83.44 27.82 25.29 35.66 -43.15 0.12 35.66 -43.03 3.18 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 6 3 # 6 A 314 TRP C 71 TRP^? 10.96 O21 C8E C 210 A 317 GLU C 70 GLU^? -2.71 CA CA C 208s A 365 ARG C 162 ARG^? 16.00 O21 C8E C 209 coo 79.91 26.87 38.77 78.95 23.18 37.81 31.84 -38.56 -11.03 35.57 -39.45 -11.85 coo 85.55 26.30 41.25 85.59 24.97 39.65 27.73 -42.94 -10.42 26.74 -44.79 -10.37 coo 83.47 25.30 27.10 83.44 27.82 25.29 35.66 -43.15 0.12 35.66 -43.03 3.18 1g8o_c01 source 1g8o N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALACTOSYLTRA: 6 hits 1g8o_c01 naa= 3 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 1 3 # 1 A 36 GLU A 70 GLU^? -2.69 CA CA A 208s A 47 ASP A 61 ASP~? 12.37 CA CA A 208 A 161 TYR A 109 TYR^? 10.85 CA CA A 208 coo 37.12 18.35 73.76 37.09 16.69 72.44 68.79 -75.79 -31.87 70.14 -76.30 -30.27 coo 29.81 8.06 73.13 30.21 10.11 72.95 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo 37.29 15.56 67.90 37.37 13.79 70.08 66.11 -81.19 -34.21 65.29 -83.76 -33.55 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 2 3 # 2 A 36 GLU B 70 GLU^? -2.58 CA CA B 208s A 47 ASP B 61 ASP~? 12.48 CA CA B 208 A 161 TYR B 109 TYR^? 10.54 CA CA B 208 coo 37.12 18.35 73.76 37.09 16.69 72.44 89.83 -24.96 -14.47 91.03 -26.69 -14.39 coo 29.81 8.06 73.13 30.21 10.11 72.95 98.68 -27.22 -4.60 99.30 -29.23 -4.23 coo 37.29 15.56 67.90 37.37 13.79 70.08 91.74 -19.55 -12.92 94.01 -17.92 -12.82 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 3 3 # 3 A 36 GLU C 70 GLU^? -2.71 CA CA C 208s A 47 ASP C 61 ASP~? 12.61 CA CA C 208 A 161 TYR C 109 TYR^? 10.73 CA CA C 208 coo 37.12 18.35 73.76 37.09 16.69 72.44 27.73 -42.94 -10.42 26.74 -44.79 -10.37 coo 29.81 8.06 73.13 30.21 10.11 72.95 16.71 -46.53 -3.05 15.59 -48.22 -3.69 coo 37.29 15.56 67.90 37.37 13.79 70.08 28.40 -39.89 -5.18 28.52 -40.13 -2.40 1geq_c02 source 1geq TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT : 3 hits 1geq_c02 naa= 3 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 1 3 # 1 B 36 GLU A 70 GLU^? -2.69 CA CA A 208s B 47 ASP A 61 ASP~? 12.37 CA CA A 208 B 161 TYR A 109 TYR^? 10.85 CA CA A 208 coo 53.87 35.49 53.22 55.44 35.72 54.61 68.79 -75.79 -31.87 70.14 -76.30 -30.27 coo 63.47 43.65 53.95 61.45 43.07 54.06 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo 56.38 35.81 59.19 58.25 35.77 57.10 66.11 -81.19 -34.21 65.29 -83.76 -33.55 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 2 3 # 2 B 36 GLU B 70 GLU^? -2.58 CA CA B 208s B 47 ASP B 61 ASP~? 12.48 CA CA B 208 B 161 TYR B 109 TYR^? 10.54 CA CA B 208 coo 53.87 35.49 53.22 55.44 35.72 54.61 89.83 -24.96 -14.47 91.03 -26.69 -14.39 coo 63.47 43.65 53.95 61.45 43.07 54.06 98.68 -27.22 -4.60 99.30 -29.23 -4.23 coo 56.38 35.81 59.19 58.25 35.77 57.10 91.74 -19.55 -12.92 94.01 -17.92 -12.82 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 3 3 # 3 B 36 GLU C 70 GLU^? -2.71 CA CA C 208s B 47 ASP C 61 ASP~? 12.61 CA CA C 208 B 161 TYR C 109 TYR^? 10.73 CA CA C 208 coo 53.87 35.49 53.22 55.44 35.72 54.61 27.73 -42.94 -10.42 26.74 -44.79 -10.37 coo 63.47 43.65 53.95 61.45 43.07 54.06 16.71 -46.53 -3.05 15.59 -48.22 -3.69 coo 56.38 35.81 59.19 58.25 35.77 57.10 28.40 -39.89 -5.18 28.52 -40.13 -2.40 1geq_c03 source 1geq TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT : 3 hits 1geq_c03 naa= 3 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 A 189 PHE A 98 PHE^? 10.84 C1 C8E A 210 A 298 ASP A 80 ASP^? 12.60 C1 C8E A 210 A 329 LYS A 84 LYS.? 23.11 C2 C8E C 209 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 58.55 -53.78 -9.03 56.20 -52.58 -8.10 coo 2.59 0.29 25.55 4.65 0.18 25.07 58.12 -52.30 -15.93 59.10 -53.68 -17.13 coo 12.42 6.10 23.27 9.95 1.57 20.16 61.58 -41.74 -11.00 58.66 -39.80 -16.04 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 A 189 PHE A 105 PHE^? 4.85 O21 C8E A 209 A 298 ASP A 45 ASP.? -2.96 CA CA A 208s A 329 LYS A 188 LYS~? 10.77 C20 C8E A 210 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 61.29 -71.83 -24.77 63.18 -73.65 -25.72 coo 2.59 0.29 25.55 4.65 0.18 25.07 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo 12.42 6.10 23.27 9.95 1.57 20.16 68.32 -80.18 -18.11 71.95 -84.24 -15.84 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 A 189 PHE A 189 PHE~? 8.72 CA CA A 208 A 298 ASP A 52 ASP.? 15.11 CA CA A 208 A 329 LYS A 63 LYS~? 3.96 CA CA A 208 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 68.20 -82.10 -23.88 68.92 -82.62 -26.53 coo 2.59 0.29 25.55 4.65 0.18 25.07 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo 12.42 6.10 23.27 9.95 1.57 20.16 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 A 189 PHE B 98 PHE^? 18.60 C8 C8E B 210 A 298 ASP B 80 ASP^? 15.94 O15 C8E B 209 A 329 LYS B 84 LYS.? 25.86 O15 C8E B 209 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 88.93 -40.28 -43.85 88.97 -39.56 -46.61 coo 2.59 0.29 25.55 4.65 0.18 25.07 82.56 -37.87 -41.00 82.97 -37.16 -39.06 coo 12.42 6.10 23.27 9.95 1.57 20.16 79.44 -47.69 -46.65 75.97 -44.45 -44.18 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 A 189 PHE B 105 PHE^? 5.21 C20 C8E B 209 A 298 ASP B 45 ASP.? -3.07 CA CA B 208s A 329 LYS B 188 LYS~? 9.67 C16 C8E B 210 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 90.70 -25.26 -25.77 91.65 -25.28 -23.14 coo 2.59 0.29 25.55 4.65 0.18 25.07 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo 12.42 6.10 23.27 9.95 1.57 20.16 102.16 -28.74 -21.10 106.15 -31.37 -17.86 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 A 189 PHE B 189 PHE~? 8.56 CA CA B 208 A 298 ASP B 45 ASP.? -3.07 CA CA B 208s A 329 LYS B 63 LYS~? 3.79 CA CA B 208 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 99.55 -24.92 -16.99 98.05 -23.95 -14.81 coo 2.59 0.29 25.55 4.65 0.18 25.07 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo 12.42 6.10 23.27 9.95 1.57 20.16 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 7 3 # 7 A 189 PHE C 98 PHE^? 16.93 O21 C8E A 209 A 298 ASP C 80 ASP^? 16.43 C13 C8E C 210 A 329 LYS C 84 LYS.? 25.24 O21 C8E A 209 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 48.24 -64.04 -26.66 50.81 -64.73 -27.68 coo 2.59 0.29 25.55 4.65 0.18 25.07 47.10 -57.14 -28.79 45.64 -55.94 -27.77 coo 12.42 6.10 23.27 9.95 1.57 20.16 49.01 -63.83 -38.44 48.10 -58.01 -38.38 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 8 3 # 8 A 189 PHE C 105 PHE^? -4.13 O21 C8E C 210s A 298 ASP C 45 ASP.? 3.27 CA CA C 208s A 329 LYS C 188 LYS~? 9.02 C16 C8E C 209 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 37.70 -47.93 -11.88 35.28 -47.45 -10.64 coo 2.59 0.29 25.55 4.65 0.18 25.07 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo 12.42 6.10 23.27 9.95 1.57 20.16 31.07 -55.82 -4.30 26.58 -58.21 -2.57 1gtx_c00 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 8 hits 1gtx_c00 naa= 3 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 B 189 PHE A 98 PHE^? 10.84 C1 C8E A 210 B 298 ASP A 80 ASP^? 12.60 C1 C8E A 210 B 329 LYS A 84 LYS.? 23.11 C2 C8E C 209 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 58.55 -53.78 -9.03 56.20 -52.58 -8.10 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 58.12 -52.30 -15.93 59.10 -53.68 -17.13 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 61.58 -41.74 -11.00 58.66 -39.80 -16.04 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 B 189 PHE A 105 PHE^? 4.85 O21 C8E A 209 B 298 ASP A 45 ASP.? -2.96 CA CA A 208s B 329 LYS A 188 LYS~? 10.77 C20 C8E A 210 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 61.29 -71.83 -24.77 63.18 -73.65 -25.72 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 68.32 -80.18 -18.11 71.95 -84.24 -15.84 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 B 189 PHE A 189 PHE~? 8.72 CA CA A 208 B 298 ASP A 52 ASP.? 15.11 CA CA A 208 B 329 LYS A 63 LYS~? 3.96 CA CA A 208 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 68.20 -82.10 -23.88 68.92 -82.62 -26.53 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 B 189 PHE B 98 PHE^? 18.60 C8 C8E B 210 B 298 ASP B 80 ASP^? 15.94 O15 C8E B 209 B 329 LYS B 84 LYS.? 25.86 O15 C8E B 209 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 88.93 -40.28 -43.85 88.97 -39.56 -46.61 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 82.56 -37.87 -41.00 82.97 -37.16 -39.06 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 79.44 -47.69 -46.65 75.97 -44.45 -44.18 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 B 189 PHE B 105 PHE^? 5.21 C20 C8E B 209 B 298 ASP B 45 ASP.? -3.07 CA CA B 208s B 329 LYS B 188 LYS~? 9.67 C16 C8E B 210 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 90.70 -25.26 -25.77 91.65 -25.28 -23.14 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 102.16 -28.74 -21.10 106.15 -31.37 -17.86 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 B 189 PHE B 189 PHE~? 8.56 CA CA B 208 B 298 ASP B 45 ASP.? -3.07 CA CA B 208s B 329 LYS B 63 LYS~? 3.79 CA CA B 208 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 99.55 -24.92 -16.99 98.05 -23.95 -14.81 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 7 3 # 7 B 189 PHE C 98 PHE^? 16.93 O21 C8E A 209 B 298 ASP C 80 ASP^? 16.43 C13 C8E C 210 B 329 LYS C 84 LYS.? 25.24 O21 C8E A 209 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 48.24 -64.04 -26.66 50.81 -64.73 -27.68 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 47.10 -57.14 -28.79 45.64 -55.94 -27.77 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 49.01 -63.83 -38.44 48.10 -58.01 -38.38 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 8 3 # 8 B 189 PHE C 105 PHE^? -4.13 O21 C8E C 210s B 298 ASP C 45 ASP.? 3.27 CA CA C 208s B 329 LYS C 188 LYS~? 9.02 C16 C8E C 209 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 37.70 -47.93 -11.88 35.28 -47.45 -10.64 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 31.07 -55.82 -4.30 26.58 -58.21 -2.57 1gtx_c01 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 8 hits 1gtx_c01 naa= 3 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 C 189 PHE A 98 PHE^? 10.84 C1 C8E A 210 C 298 ASP A 80 ASP^? 12.60 C1 C8E A 210 C 329 LYS A 84 LYS.? 23.11 C2 C8E C 209 coo 17.41 60.57 64.39 18.40 58.12 65.34 58.55 -53.78 -9.03 56.20 -52.58 -8.10 coo 24.10 66.43 63.33 24.18 64.30 63.40 58.12 -52.30 -15.93 59.10 -53.68 -17.13 coo 27.64 56.61 58.17 22.18 57.92 60.36 61.58 -41.74 -11.00 58.66 -39.80 -16.04 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 C 189 PHE A 105 PHE^? 4.85 O21 C8E A 209 C 298 ASP A 45 ASP.? -2.96 CA CA A 208s C 329 LYS A 188 LYS~? 10.77 C20 C8E A 210 coo 17.41 60.57 64.39 18.40 58.12 65.34 61.29 -71.83 -24.77 63.18 -73.65 -25.72 coo 24.10 66.43 63.33 24.18 64.30 63.40 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo 27.64 56.61 58.17 22.18 57.92 60.36 68.32 -80.18 -18.11 71.95 -84.24 -15.84 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 C 189 PHE A 189 PHE~? 8.72 CA CA A 208 C 298 ASP A 52 ASP.? 15.11 CA CA A 208 C 329 LYS A 63 LYS~? 3.96 CA CA A 208 coo 17.41 60.57 64.39 18.40 58.12 65.34 68.20 -82.10 -23.88 68.92 -82.62 -26.53 coo 24.10 66.43 63.33 24.18 64.30 63.40 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo 27.64 56.61 58.17 22.18 57.92 60.36 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 C 189 PHE B 98 PHE^? 18.60 C8 C8E B 210 C 298 ASP B 80 ASP^? 15.94 O15 C8E B 209 C 329 LYS B 84 LYS.? 25.86 O15 C8E B 209 coo 17.41 60.57 64.39 18.40 58.12 65.34 88.93 -40.28 -43.85 88.97 -39.56 -46.61 coo 24.10 66.43 63.33 24.18 64.30 63.40 82.56 -37.87 -41.00 82.97 -37.16 -39.06 coo 27.64 56.61 58.17 22.18 57.92 60.36 79.44 -47.69 -46.65 75.97 -44.45 -44.18 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 C 189 PHE B 105 PHE^? 5.21 C20 C8E B 209 C 298 ASP B 45 ASP.? -3.07 CA CA B 208s C 329 LYS B 188 LYS~? 9.67 C16 C8E B 210 coo 17.41 60.57 64.39 18.40 58.12 65.34 90.70 -25.26 -25.77 91.65 -25.28 -23.14 coo 24.10 66.43 63.33 24.18 64.30 63.40 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo 27.64 56.61 58.17 22.18 57.92 60.36 102.16 -28.74 -21.10 106.15 -31.37 -17.86 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 C 189 PHE B 189 PHE~? 8.56 CA CA B 208 C 298 ASP B 45 ASP.? -3.07 CA CA B 208s C 329 LYS B 63 LYS~? 3.79 CA CA B 208 coo 17.41 60.57 64.39 18.40 58.12 65.34 99.55 -24.92 -16.99 98.05 -23.95 -14.81 coo 24.10 66.43 63.33 24.18 64.30 63.40 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo 27.64 56.61 58.17 22.18 57.92 60.36 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 7 3 # 7 C 189 PHE C 98 PHE^? 16.93 O21 C8E A 209 C 298 ASP C 80 ASP^? 16.43 C13 C8E C 210 C 329 LYS C 84 LYS.? 25.24 O21 C8E A 209 coo 17.41 60.57 64.39 18.40 58.12 65.34 48.24 -64.04 -26.66 50.81 -64.73 -27.68 coo 24.10 66.43 63.33 24.18 64.30 63.40 47.10 -57.14 -28.79 45.64 -55.94 -27.77 coo 27.64 56.61 58.17 22.18 57.92 60.36 49.01 -63.83 -38.44 48.10 -58.01 -38.38 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 8 3 # 8 C 189 PHE C 105 PHE^? -4.13 O21 C8E C 210s C 298 ASP C 45 ASP.? 3.27 CA CA C 208s C 329 LYS C 188 LYS~? 9.02 C16 C8E C 209 coo 17.41 60.57 64.39 18.40 58.12 65.34 37.70 -47.93 -11.88 35.28 -47.45 -10.64 coo 24.10 66.43 63.33 24.18 64.30 63.40 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo 27.64 56.61 58.17 22.18 57.92 60.36 31.07 -55.82 -4.30 26.58 -58.21 -2.57 1gtx_c02 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 8 hits 1gtx_c02 naa= 3 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 D 189 PHE A 98 PHE^? 10.84 C1 C8E A 210 D 298 ASP A 80 ASP^? 12.60 C1 C8E A 210 D 329 LYS A 84 LYS.? 23.11 C2 C8E C 209 coo 35.44 53.35 83.81 35.65 54.53 81.28 58.55 -53.78 -9.03 56.20 -52.58 -8.10 coo 29.72 46.46 83.60 30.79 47.36 81.99 58.12 -52.30 -15.93 59.10 -53.68 -17.13 coo 36.89 44.91 74.55 37.33 48.94 79.01 61.58 -41.74 -11.00 58.66 -39.80 -16.04 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 D 189 PHE A 105 PHE^? 4.85 O21 C8E A 209 D 298 ASP A 45 ASP.? -2.96 CA CA A 208s D 329 LYS A 188 LYS~? 10.77 C20 C8E A 210 coo 35.44 53.35 83.81 35.65 54.53 81.28 61.29 -71.83 -24.77 63.18 -73.65 -25.72 coo 29.72 46.46 83.60 30.79 47.36 81.99 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo 36.89 44.91 74.55 37.33 48.94 79.01 68.32 -80.18 -18.11 71.95 -84.24 -15.84 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 D 189 PHE A 189 PHE~? 8.72 CA CA A 208 D 298 ASP A 52 ASP.? 15.11 CA CA A 208 D 329 LYS A 63 LYS~? 3.96 CA CA A 208 coo 35.44 53.35 83.81 35.65 54.53 81.28 68.20 -82.10 -23.88 68.92 -82.62 -26.53 coo 29.72 46.46 83.60 30.79 47.36 81.99 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo 36.89 44.91 74.55 37.33 48.94 79.01 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 D 189 PHE B 98 PHE^? 18.60 C8 C8E B 210 D 298 ASP B 80 ASP^? 15.94 O15 C8E B 209 D 329 LYS B 84 LYS.? 25.86 O15 C8E B 209 coo 35.44 53.35 83.81 35.65 54.53 81.28 88.93 -40.28 -43.85 88.97 -39.56 -46.61 coo 29.72 46.46 83.60 30.79 47.36 81.99 82.56 -37.87 -41.00 82.97 -37.16 -39.06 coo 36.89 44.91 74.55 37.33 48.94 79.01 79.44 -47.69 -46.65 75.97 -44.45 -44.18 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 D 189 PHE B 105 PHE^? 5.21 C20 C8E B 209 D 298 ASP B 45 ASP.? -3.07 CA CA B 208s D 329 LYS B 188 LYS~? 9.67 C16 C8E B 210 coo 35.44 53.35 83.81 35.65 54.53 81.28 90.70 -25.26 -25.77 91.65 -25.28 -23.14 coo 29.72 46.46 83.60 30.79 47.36 81.99 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo 36.89 44.91 74.55 37.33 48.94 79.01 102.16 -28.74 -21.10 106.15 -31.37 -17.86 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 D 189 PHE B 189 PHE~? 8.56 CA CA B 208 D 298 ASP B 45 ASP.? -3.07 CA CA B 208s D 329 LYS B 63 LYS~? 3.79 CA CA B 208 coo 35.44 53.35 83.81 35.65 54.53 81.28 99.55 -24.92 -16.99 98.05 -23.95 -14.81 coo 29.72 46.46 83.60 30.79 47.36 81.99 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo 36.89 44.91 74.55 37.33 48.94 79.01 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 7 3 # 7 D 189 PHE C 98 PHE^? 16.93 O21 C8E A 209 D 298 ASP C 80 ASP^? 16.43 C13 C8E C 210 D 329 LYS C 84 LYS.? 25.24 O21 C8E A 209 coo 35.44 53.35 83.81 35.65 54.53 81.28 48.24 -64.04 -26.66 50.81 -64.73 -27.68 coo 29.72 46.46 83.60 30.79 47.36 81.99 47.10 -57.14 -28.79 45.64 -55.94 -27.77 coo 36.89 44.91 74.55 37.33 48.94 79.01 49.01 -63.83 -38.44 48.10 -58.01 -38.38 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 8 3 # 8 D 189 PHE C 105 PHE^? -4.13 O21 C8E C 210s D 298 ASP C 45 ASP.? 3.27 CA CA C 208s D 329 LYS C 188 LYS~? 9.02 C16 C8E C 209 coo 35.44 53.35 83.81 35.65 54.53 81.28 37.70 -47.93 -11.88 35.28 -47.45 -10.64 coo 29.72 46.46 83.60 30.79 47.36 81.99 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo 36.89 44.91 74.55 37.33 48.94 79.01 31.07 -55.82 -4.30 26.58 -58.21 -2.57 1gtx_c03 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 8 hits 1gtx_c03 naa= 3 ULMN 3 1gz6_c00 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 3 # 1 A 151 SER A 69 SER^? 11.97 CA CA A 208 A 164 TYR A 109 TYR^? 10.85 CA CA A 208 A 168 LYS A 63 LYS~? 3.96 CA CA A 208 coo 32.37 52.40 49.35 31.32 53.88 47.74 69.09 -77.26 -37.91 68.86 -76.80 -40.31 coo 29.69 55.04 42.83 31.98 53.56 43.49 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo 26.96 50.99 47.03 31.03 48.83 44.33 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 1gz6_c00 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 2 3 # 2 A 151 SER A 86 SER.? 26.41 C2 C8E C 209 A 164 TYR A 83 TYR^? -19.24 C2 C8E C 209s A 168 LYS A 84 LYS.? 23.11 C2 C8E C 209 coo 32.37 52.40 49.35 31.32 53.88 47.74 63.25 -36.36 -7.87 60.84 -35.97 -7.64 coo 29.69 55.04 42.83 31.98 53.56 43.49 59.25 -44.27 -7.74 58.41 -42.23 -6.03 coo 26.96 50.99 47.03 31.03 48.83 44.33 61.58 -41.74 -11.00 58.66 -39.80 -16.04 ULMN 3 1gz6_c00 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 3 3 # 3 A 151 SER B 69 SER^? 12.05 CA CA B 208 A 164 TYR B 109 TYR^? 10.54 CA CA B 208 A 168 LYS B 63 LYS~? 3.79 CA CA B 208 coo 32.37 52.40 49.35 31.32 53.88 47.74 86.53 -22.01 -10.29 84.57 -20.83 -9.39 coo 29.69 55.04 42.83 31.98 53.56 43.49 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo 26.96 50.99 47.03 31.03 48.83 44.33 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1gz6_c00 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 4 3 # 4 A 151 SER C 69 SER^? 11.34 CA CA C 208 A 164 TYR C 109 TYR^? 10.73 CA CA C 208 A 168 LYS C 63 LYS~? 4.21 CA CA C 208 coo 32.37 52.40 49.35 31.32 53.88 47.74 25.63 -37.12 -10.07 26.01 -35.64 -11.95 coo 29.69 55.04 42.83 31.98 53.56 43.49 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo 26.96 50.99 47.03 31.03 48.83 44.33 20.98 -41.61 -5.49 23.04 -43.67 -10.44 1gz6_c00 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 4 hits 1gz6_c00 naa= 3 ULMN 3 1gz6_c01 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 3 # 1 B 151 SER A 69 SER^? 11.97 CA CA A 208 B 164 TYR A 109 TYR^? 10.85 CA CA A 208 B 168 LYS A 63 LYS~? 3.96 CA CA A 208 coo 13.08 50.93 56.67 13.12 48.99 55.27 69.09 -77.26 -37.91 68.86 -76.80 -40.31 coo 11.52 46.03 51.32 10.06 47.90 52.76 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo 15.72 50.86 51.22 10.77 52.35 51.39 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 1gz6_c01 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 2 3 # 2 B 151 SER A 86 SER.? 26.41 C2 C8E C 209 B 164 TYR A 83 TYR^? -19.24 C2 C8E C 209s B 168 LYS A 84 LYS.? 23.11 C2 C8E C 209 coo 13.08 50.93 56.67 13.12 48.99 55.27 63.25 -36.36 -7.87 60.84 -35.97 -7.64 coo 11.52 46.03 51.32 10.06 47.90 52.76 59.25 -44.27 -7.74 58.41 -42.23 -6.03 coo 15.72 50.86 51.22 10.77 52.35 51.39 61.58 -41.74 -11.00 58.66 -39.80 -16.04 ULMN 3 1gz6_c01 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 3 3 # 3 B 151 SER B 69 SER^? 12.05 CA CA B 208 B 164 TYR B 109 TYR^? 10.54 CA CA B 208 B 168 LYS B 63 LYS~? 3.79 CA CA B 208 coo 13.08 50.93 56.67 13.12 48.99 55.27 86.53 -22.01 -10.29 84.57 -20.83 -9.39 coo 11.52 46.03 51.32 10.06 47.90 52.76 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo 15.72 50.86 51.22 10.77 52.35 51.39 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1gz6_c01 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 4 3 # 4 B 151 SER C 69 SER^? 11.34 CA CA C 208 B 164 TYR C 109 TYR^? 10.73 CA CA C 208 B 168 LYS C 63 LYS~? 4.21 CA CA C 208 coo 13.08 50.93 56.67 13.12 48.99 55.27 25.63 -37.12 -10.07 26.01 -35.64 -11.95 coo 11.52 46.03 51.32 10.06 47.90 52.76 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo 15.72 50.86 51.22 10.77 52.35 51.39 20.98 -41.61 -5.49 23.04 -43.67 -10.44 1gz6_c01 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 4 hits 1gz6_c01 naa= 3 ULMN 3 1gz6_c02 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 3 # 1 C 151 SER A 69 SER^? 11.97 CA CA A 208 C 164 TYR A 109 TYR^? 10.85 CA CA A 208 C 168 LYS A 63 LYS~? 3.96 CA CA A 208 coo 11.22 34.38 82.32 11.07 36.29 83.78 69.09 -77.26 -37.91 68.86 -76.80 -40.31 coo 8.83 39.27 87.38 7.60 37.43 85.69 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo 12.98 34.46 88.14 8.11 32.96 87.14 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 1gz6_c02 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 2 3 # 2 C 151 SER A 86 SER.? 26.41 C2 C8E C 209 C 164 TYR A 83 TYR^? -19.24 C2 C8E C 209s C 168 LYS A 84 LYS.? 23.11 C2 C8E C 209 coo 11.22 34.38 82.32 11.07 36.29 83.78 63.25 -36.36 -7.87 60.84 -35.97 -7.64 coo 8.83 39.27 87.38 7.60 37.43 85.69 59.25 -44.27 -7.74 58.41 -42.23 -6.03 coo 12.98 34.46 88.14 8.11 32.96 87.14 61.58 -41.74 -11.00 58.66 -39.80 -16.04 ULMN 3 1gz6_c02 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 3 3 # 3 C 151 SER B 69 SER^? 12.05 CA CA B 208 C 164 TYR B 109 TYR^? 10.54 CA CA B 208 C 168 LYS B 63 LYS~? 3.79 CA CA B 208 coo 11.22 34.38 82.32 11.07 36.29 83.78 86.53 -22.01 -10.29 84.57 -20.83 -9.39 coo 8.83 39.27 87.38 7.60 37.43 85.69 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo 12.98 34.46 88.14 8.11 32.96 87.14 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1gz6_c02 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 4 3 # 4 C 151 SER C 69 SER^? 11.34 CA CA C 208 C 164 TYR C 109 TYR^? 10.73 CA CA C 208 C 168 LYS C 63 LYS~? 4.21 CA CA C 208 coo 11.22 34.38 82.32 11.07 36.29 83.78 25.63 -37.12 -10.07 26.01 -35.64 -11.95 coo 8.83 39.27 87.38 7.60 37.43 85.69 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo 12.98 34.46 88.14 8.11 32.96 87.14 20.98 -41.61 -5.49 23.04 -43.67 -10.44 1gz6_c02 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 4 hits 1gz6_c02 naa= 3 ULMN 3 1gz6_c03 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 3 # 1 D 151 SER A 69 SER^? 11.97 CA CA A 208 D 164 TYR A 109 TYR^? 10.85 CA CA A 208 D 168 LYS A 63 LYS~? 3.96 CA CA A 208 coo 29.15 32.90 92.57 27.86 31.44 94.02 69.09 -77.26 -37.91 68.86 -76.80 -40.31 coo 25.49 30.28 98.59 27.88 31.73 98.26 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo 23.46 34.31 94.02 27.08 36.46 97.29 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 1gz6_c03 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 2 3 # 2 D 151 SER A 86 SER.? 26.41 C2 C8E C 209 D 164 TYR A 83 TYR^? -19.24 C2 C8E C 209s D 168 LYS A 84 LYS.? 23.11 C2 C8E C 209 coo 29.15 32.90 92.57 27.86 31.44 94.02 63.25 -36.36 -7.87 60.84 -35.97 -7.64 coo 25.49 30.28 98.59 27.88 31.73 98.26 59.25 -44.27 -7.74 58.41 -42.23 -6.03 coo 23.46 34.31 94.02 27.08 36.46 97.29 61.58 -41.74 -11.00 58.66 -39.80 -16.04 ULMN 3 1gz6_c03 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 3 3 # 3 D 151 SER B 69 SER^? 12.05 CA CA B 208 D 164 TYR B 109 TYR^? 10.54 CA CA B 208 D 168 LYS B 63 LYS~? 3.79 CA CA B 208 coo 29.15 32.90 92.57 27.86 31.44 94.02 86.53 -22.01 -10.29 84.57 -20.83 -9.39 coo 25.49 30.28 98.59 27.88 31.73 98.26 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo 23.46 34.31 94.02 27.08 36.46 97.29 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1gz6_c03 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 4 3 # 4 D 151 SER C 69 SER^? 11.34 CA CA C 208 D 164 TYR C 109 TYR^? 10.73 CA CA C 208 D 168 LYS C 63 LYS~? 4.21 CA CA C 208 coo 29.15 32.90 92.57 27.86 31.44 94.02 25.63 -37.12 -10.07 26.01 -35.64 -11.95 coo 25.49 30.28 98.59 27.88 31.73 98.26 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo 23.46 34.31 94.02 27.08 36.46 97.29 20.98 -41.61 -5.49 23.04 -43.67 -10.44 1gz6_c03 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 4 hits 1gz6_c03 naa= 3 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 1 3 # 1 A 271 GLN A 19 GLN^? 15.77 C17 C8E A 209 A 296 GLU A 7 GLU^? 19.52 C17 C8E A 209 A 383 TYR A 97 TYR^? 11.99 C1 C8E A 210 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 61.68 -53.90 -25.59 60.40 -53.32 -23.97 coo 40.93 4.45 2.36 38.91 3.75 2.26 61.29 -47.52 -25.12 61.48 -48.69 -23.33 coo 30.54 7.22 6.23 31.38 5.79 3.97 61.97 -51.46 -14.47 63.57 -52.89 -16.21 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 2 3 # 2 A 271 GLN A 192 GLN.? 2.85 O21 C8E A 210s A 296 GLU A 194 GLU.? 3.11 C17 C8E A 210s A 383 TYR A 13 TYR^? 6.88 C17 C8E A 209 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 62.30 -73.12 -20.03 63.16 -74.67 -18.84 coo 40.93 4.45 2.36 38.91 3.75 2.26 66.12 -70.72 -14.05 67.03 -72.48 -13.31 coo 30.54 7.22 6.23 31.38 5.79 3.97 65.07 -60.93 -23.01 63.35 -61.54 -20.90 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 3 3 # 3 A 271 GLN A 192 GLN.? 2.85 O21 C8E A 210s A 296 GLU A 194 GLU.? 3.11 C17 C8E A 210s A 383 TYR A 183 TYR~? 7.18 C16 C8E A 210 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 62.30 -73.12 -20.03 63.16 -74.67 -18.84 coo 40.93 4.45 2.36 38.91 3.75 2.26 66.12 -70.72 -14.05 67.03 -72.48 -13.31 coo 30.54 7.22 6.23 31.38 5.79 3.97 59.65 -81.82 -15.52 59.58 -79.01 -15.74 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 4 3 # 4 A 271 GLN B 19 GLN^? 14.72 O15 C8E B 209 A 296 GLU B 7 GLU^? 19.70 O15 C8E B 209 A 383 TYR A 138 TYR^? 19.17 C16 C8E B 209 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 77.54 -34.58 -33.49 79.23 -35.13 -34.67 coo 40.93 4.45 2.36 38.91 3.75 2.26 73.39 -38.66 -35.65 75.17 -39.55 -36.49 coo 30.54 7.22 6.23 31.38 5.79 3.97 70.50 -38.06 -22.60 71.93 -35.69 -22.96 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 5 3 # 5 A 271 GLN B 19 GLN^? 14.72 O15 C8E B 209 A 296 GLU B 7 GLU^? 19.70 O15 C8E B 209 A 383 TYR B 97 TYR^? 16.46 O15 C8E B 209 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 77.54 -34.58 -33.49 79.23 -35.13 -34.67 coo 40.93 4.45 2.36 38.91 3.75 2.26 73.39 -38.66 -35.65 75.17 -39.55 -36.49 coo 30.54 7.22 6.23 31.38 5.79 3.97 83.74 -41.85 -39.80 83.62 -41.42 -37.05 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 6 3 # 6 A 271 GLN B 192 GLN.? 2.71 C20 C8E B 210s A 296 GLU B 194 GLU.? 2.86 C13 C8E B 210s A 383 TYR B 13 TYR^? 6.78 O15 C8E B 209 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 94.96 -27.39 -27.11 96.91 -27.71 -26.40 coo 40.93 4.45 2.36 38.91 3.75 2.26 97.88 -33.97 -28.78 99.62 -34.16 -27.58 coo 30.54 7.22 6.23 31.38 5.79 3.97 84.65 -34.92 -28.70 86.28 -34.17 -30.84 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 7 3 # 7 A 271 GLN B 192 GLN.? 2.71 C20 C8E B 210s A 296 GLU B 194 GLU.? 2.86 C13 C8E B 210s A 383 TYR B 183 TYR~? 7.74 O12 C8E B 210 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 94.96 -27.39 -27.11 96.91 -27.71 -26.40 coo 40.93 4.45 2.36 38.91 3.75 2.26 97.88 -33.97 -28.78 99.62 -34.16 -27.58 coo 30.54 7.22 6.23 31.38 5.79 3.97 104.05 -23.05 -28.11 101.72 -24.25 -29.01 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 8 3 # 8 A 271 GLN C 19 GLN^? 15.24 C19 C8E C 210 A 296 GLU C 7 GLU^? 20.56 C16 C8E C 210 A 383 TYR C 97 TYR^? 17.03 C13 C8E C 210 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 42.90 -48.48 -28.27 43.27 -50.57 -28.10 coo 40.93 4.45 2.36 38.91 3.75 2.26 43.33 -49.69 -35.12 43.56 -51.77 -34.52 coo 30.54 7.22 6.23 31.38 5.79 3.97 44.42 -59.94 -30.24 42.23 -58.45 -29.40 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 9 3 # 9 A 271 GLN C 192 GLN.? 2.81 O21 C8E C 209s A 296 GLU C 194 GLU.? 3.24 O15 C8E C 209s A 383 TYR C 183 TYR~? 7.45 C14 C8E C 209 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 37.88 -52.49 -10.10 36.97 -53.88 -8.75 coo 40.93 4.45 2.36 38.91 3.75 2.26 36.17 -59.59 -12.28 34.91 -60.51 -10.83 coo 30.54 7.22 6.23 31.38 5.79 3.97 39.42 -55.89 -0.59 40.02 -55.54 -3.26 1h19_c00 source 1h19 LEUKOTRIENE A-4 HYDROLASE : 9 hits 1h19_c00 naa= 3 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 1 3 # 1 A 50 ASP A 26 ASP.? 24.86 C2 C8E C 209 A 327 GLU B 164 GLU^? 19.99 CA CA B 208 A 339 ARG B 162 ARG^? 16.35 O21 C8E B 210 coo 85.81 57.99 116.01 86.03 55.86 115.89 53.70 -37.11 -16.05 55.72 -36.42 -15.97 coo 75.11 41.01 160.30 76.65 40.06 161.41 94.70 -10.70 -16.52 96.59 -9.81 -16.07 coo 82.23 40.35 159.87 85.09 40.67 161.01 96.21 -15.01 -19.71 98.63 -13.28 -19.03 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 2 3 # 2 A 50 ASP A 52 ASP.? 15.11 CA CA A 208 A 327 GLU B 7 GLU^? 19.70 O15 C8E B 209 A 339 ARG B 135 ARG^? 22.88 O15 C8E B 209 coo 85.81 57.99 116.01 86.03 55.86 115.89 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo 75.11 41.01 160.30 76.65 40.06 161.41 73.39 -38.66 -35.65 75.17 -39.55 -36.49 coo 82.23 40.35 159.87 85.09 40.67 161.01 77.46 -42.45 -38.74 74.50 -42.61 -39.42 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 3 3 # 3 A 50 ASP A 52 ASP.? 15.11 CA CA A 208 A 327 GLU B 25 GLU^? 27.65 O15 C8E B 209 A 339 ARG B 135 ARG^? 22.88 O15 C8E B 209 coo 85.81 57.99 116.01 86.03 55.86 115.89 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo 75.11 41.01 160.30 76.65 40.06 161.41 73.50 -42.12 -45.68 71.97 -42.23 -44.24 coo 82.23 40.35 159.87 85.09 40.67 161.01 77.46 -42.45 -38.74 74.50 -42.61 -39.42 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 4 3 # 4 A 50 ASP A 61 ASP~? 12.37 CA CA A 208 A 327 GLU B 7 GLU^? 19.70 O15 C8E B 209 A 339 ARG B 36 ARG^? 17.08 O15 C8E B 209 coo 85.81 57.99 116.01 86.03 55.86 115.89 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo 75.11 41.01 160.30 76.65 40.06 161.41 73.39 -38.66 -35.65 75.17 -39.55 -36.49 coo 82.23 40.35 159.87 85.09 40.67 161.01 77.67 -37.50 -38.51 79.47 -39.58 -37.24 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 5 3 # 5 A 50 ASP A 61 ASP~? 12.37 CA CA A 208 A 327 GLU B 7 GLU^? 19.70 O15 C8E B 209 A 339 ARG B 200 ARG^? 11.34 O15 C8E B 209 coo 85.81 57.99 116.01 86.03 55.86 115.89 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo 75.11 41.01 160.30 76.65 40.06 161.41 73.39 -38.66 -35.65 75.17 -39.55 -36.49 coo 82.23 40.35 159.87 85.09 40.67 161.01 78.82 -37.69 -29.59 80.99 -36.13 -31.14 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 6 3 # 6 A 50 ASP A 114 ASP.? 22.11 CA CA A 208 A 327 GLU B 7 GLU^? 19.70 O15 C8E B 209 A 339 ARG B 135 ARG^? 22.88 O15 C8E B 209 coo 85.81 57.99 116.01 86.03 55.86 115.89 71.50 -87.46 -45.26 70.62 -89.18 -46.15 coo 75.11 41.01 160.30 76.65 40.06 161.41 73.39 -38.66 -35.65 75.17 -39.55 -36.49 coo 82.23 40.35 159.87 85.09 40.67 161.01 77.46 -42.45 -38.74 74.50 -42.61 -39.42 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 7 3 # 7 A 50 ASP A 149 ASP^? 14.85 C1 C8E A 210 A 327 GLU B 164 GLU^? 19.99 CA CA B 208 A 339 ARG B 162 ARG^? 16.35 O21 C8E B 210 coo 85.81 57.99 116.01 86.03 55.86 115.89 66.40 -51.17 -20.74 65.06 -51.90 -19.38 coo 75.11 41.01 160.30 76.65 40.06 161.41 94.70 -10.70 -16.52 96.59 -9.81 -16.07 coo 82.23 40.35 159.87 85.09 40.67 161.01 96.21 -15.01 -19.71 98.63 -13.28 -19.03 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 8 3 # 8 A 50 ASP A 166 ASP.? 23.45 CA CA A 208 A 327 GLU B 25 GLU^? 27.65 O15 C8E B 209 A 339 ARG B 206 ARG^? 34.91 O15 C8E B 209 coo 85.81 57.99 116.01 86.03 55.86 115.89 55.95 -88.25 -40.15 55.99 -89.39 -38.36 coo 75.11 41.01 160.30 76.65 40.06 161.41 73.50 -42.12 -45.68 71.97 -42.23 -44.24 coo 82.23 40.35 159.87 85.09 40.67 161.01 66.21 -41.62 -44.73 64.06 -41.49 -46.91 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 9 3 # 9 A 50 ASP A 167 ASP.? 22.50 CA CA A 208 A 327 GLU B 25 GLU^? 27.65 O15 C8E B 209 A 339 ARG B 135 ARG^? 22.88 O15 C8E B 209 coo 85.81 57.99 116.01 86.03 55.86 115.89 58.25 -87.45 -44.58 60.23 -87.13 -43.88 coo 75.11 41.01 160.30 76.65 40.06 161.41 73.50 -42.12 -45.68 71.97 -42.23 -44.24 coo 82.23 40.35 159.87 85.09 40.67 161.01 77.46 -42.45 -38.74 74.50 -42.61 -39.42 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 10 3 # 10 A 50 ASP A 167 ASP.? 22.50 CA CA A 208 A 327 GLU B 25 GLU^? 27.65 O15 C8E B 209 A 339 ARG B 206 ARG^? 34.91 O15 C8E B 209 coo 85.81 57.99 116.01 86.03 55.86 115.89 58.25 -87.45 -44.58 60.23 -87.13 -43.88 coo 75.11 41.01 160.30 76.65 40.06 161.41 73.50 -42.12 -45.68 71.97 -42.23 -44.24 coo 82.23 40.35 159.87 85.09 40.67 161.01 66.21 -41.62 -44.73 64.06 -41.49 -46.91 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 11 3 # 11 A 50 ASP B 26 ASP.? 33.07 O15 C8E B 209 A 327 GLU A 164 GLU^? 19.19 O21 C8E A 210 A 339 ARG A 162 ARG^? 10.87 O21 C8E A 210 coo 85.81 57.99 116.01 86.03 55.86 115.89 71.92 -43.11 -51.36 71.95 -45.06 -50.50 coo 75.11 41.01 160.30 76.65 40.06 161.41 57.65 -86.15 -32.10 58.08 -88.26 -31.94 coo 82.23 40.35 159.87 85.09 40.67 161.01 60.16 -83.54 -27.36 63.31 -83.18 -27.03 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 12 3 # 12 A 50 ASP B 52 ASP.? 15.59 CA CA B 208 A 327 GLU A 7 GLU^? 19.52 C17 C8E A 209 A 339 ARG A 135 ARG^? 21.29 C1 C8E A 210 coo 85.81 57.99 116.01 86.03 55.86 115.89 105.61 -28.95 -11.53 106.78 -28.70 -9.81 coo 75.11 41.01 160.30 76.65 40.06 161.41 61.29 -47.52 -25.12 61.48 -48.69 -23.33 coo 82.23 40.35 159.87 85.09 40.67 161.01 62.45 -46.81 -18.85 61.41 -44.79 -20.90 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 13 3 # 13 A 50 ASP B 61 ASP~? 12.48 CA CA B 208 A 327 GLU A 7 GLU^? 19.52 C17 C8E A 209 A 339 ARG A 36 ARG^? 15.77 C1 C8E A 210 coo 85.81 57.99 116.01 86.03 55.86 115.89 98.68 -27.22 -4.60 99.30 -29.23 -4.23 coo 75.11 41.01 160.30 76.65 40.06 161.41 61.29 -47.52 -25.12 61.48 -48.69 -23.33 coo 82.23 40.35 159.87 85.09 40.67 161.01 59.00 -50.13 -20.90 61.68 -51.06 -19.88 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 14 3 # 14 A 50 ASP B 61 ASP~? 12.48 CA CA B 208 A 327 GLU A 7 GLU^? 19.52 C17 C8E A 209 A 339 ARG A 200 ARG^? 11.17 C17 C8E A 209 coo 85.81 57.99 116.01 86.03 55.86 115.89 98.68 -27.22 -4.60 99.30 -29.23 -4.23 coo 75.11 41.01 160.30 76.65 40.06 161.41 61.29 -47.52 -25.12 61.48 -48.69 -23.33 coo 82.23 40.35 159.87 85.09 40.67 161.01 65.38 -54.68 -25.12 63.65 -56.91 -23.89 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 15 3 # 15 A 50 ASP B 61 ASP~? 12.48 CA CA B 208 A 327 GLU A 25 GLU^? 22.98 C2 C8E C 209 A 339 ARG A 206 ARG^? 26.36 C2 C8E C 209 coo 85.81 57.99 116.01 86.03 55.86 115.89 98.68 -27.22 -4.60 99.30 -29.23 -4.23 coo 75.11 41.01 160.30 76.65 40.06 161.41 56.22 -40.62 -18.58 57.98 -41.28 -19.55 coo 82.23 40.35 159.87 85.09 40.67 161.01 56.35 -36.42 -23.90 57.63 -37.98 -21.56 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 16 3 # 16 A 50 ASP B 114 ASP.? 22.07 CA CA B 208 A 327 GLU A 7 GLU^? 19.52 C17 C8E A 209 A 339 ARG A 135 ARG^? 21.29 C1 C8E A 210 coo 85.81 57.99 116.01 86.03 55.86 115.89 88.69 -13.97 -0.41 89.97 -12.27 -0.12 coo 75.11 41.01 160.30 76.65 40.06 161.41 61.29 -47.52 -25.12 61.48 -48.69 -23.33 coo 82.23 40.35 159.87 85.09 40.67 161.01 62.45 -46.81 -18.85 61.41 -44.79 -20.90 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 17 3 # 17 A 50 ASP B 149 ASP^? 14.91 O15 C8E B 209 A 327 GLU A 164 GLU^? 19.19 O21 C8E A 210 A 339 ARG A 162 ARG^? 10.87 O21 C8E A 210 coo 85.81 57.99 116.01 86.03 55.86 115.89 79.48 -42.39 -33.32 81.04 -41.48 -34.38 coo 75.11 41.01 160.30 76.65 40.06 161.41 57.65 -86.15 -32.10 58.08 -88.26 -31.94 coo 82.23 40.35 159.87 85.09 40.67 161.01 60.16 -83.54 -27.36 63.31 -83.18 -27.03 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 18 3 # 18 A 50 ASP B 166 ASP.? 24.17 CA CA B 208 A 327 GLU A 25 GLU^? 22.98 C2 C8E C 209 A 339 ARG A 206 ARG^? 26.36 C2 C8E C 209 coo 85.81 57.99 116.01 86.03 55.86 115.89 91.14 -5.33 -14.11 93.17 -5.00 -14.63 coo 75.11 41.01 160.30 76.65 40.06 161.41 56.22 -40.62 -18.58 57.98 -41.28 -19.55 coo 82.23 40.35 159.87 85.09 40.67 161.01 56.35 -36.42 -23.90 57.63 -37.98 -21.56 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 19 3 # 19 A 50 ASP B 167 ASP.? 22.72 CA CA B 208 A 327 GLU A 25 GLU^? 22.98 C2 C8E C 209 A 339 ARG A 206 ARG^? 26.36 C2 C8E C 209 coo 85.81 57.99 116.01 86.03 55.86 115.89 88.92 -5.85 -9.56 88.92 -7.42 -8.19 coo 75.11 41.01 160.30 76.65 40.06 161.41 56.22 -40.62 -18.58 57.98 -41.28 -19.55 coo 82.23 40.35 159.87 85.09 40.67 161.01 56.35 -36.42 -23.90 57.63 -37.98 -21.56 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 20 3 # 20 A 50 ASP C 45 ASP.? 3.27 CA CA C 208s A 327 GLU A 164 GLU^? 19.19 O21 C8E A 210 A 339 ARG A 162 ARG^? 10.87 O21 C8E A 210 coo 85.81 57.99 116.01 86.03 55.86 115.89 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo 75.11 41.01 160.30 76.65 40.06 161.41 57.65 -86.15 -32.10 58.08 -88.26 -31.94 coo 82.23 40.35 159.87 85.09 40.67 161.01 60.16 -83.54 -27.36 63.31 -83.18 -27.03 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 21 3 # 21 A 50 ASP C 52 ASP.? 15.77 CA CA C 208 A 327 GLU A 7 GLU^? 19.52 C17 C8E A 209 A 339 ARG A 135 ARG^? 21.29 C1 C8E A 210 coo 85.81 57.99 116.01 86.03 55.86 115.89 21.29 -54.58 -0.38 20.26 -54.47 1.43 coo 75.11 41.01 160.30 76.65 40.06 161.41 61.29 -47.52 -25.12 61.48 -48.69 -23.33 coo 82.23 40.35 159.87 85.09 40.67 161.01 62.45 -46.81 -18.85 61.41 -44.79 -20.90 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 22 3 # 22 A 50 ASP C 52 ASP.? 15.77 CA CA C 208 A 327 GLU A 93 GLU^? 23.51 C1 C8E A 210 A 339 ARG A 135 ARG^? 21.29 C1 C8E A 210 coo 85.81 57.99 116.01 86.03 55.86 115.89 21.29 -54.58 -0.38 20.26 -54.47 1.43 coo 75.11 41.01 160.30 76.65 40.06 161.41 64.33 -40.66 -16.04 62.38 -40.13 -16.70 coo 82.23 40.35 159.87 85.09 40.67 161.01 62.45 -46.81 -18.85 61.41 -44.79 -20.90 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 23 3 # 23 A 50 ASP C 61 ASP~? 12.61 CA CA C 208 A 327 GLU A 7 GLU^? 19.52 C17 C8E A 209 A 339 ARG A 36 ARG^? 15.77 C1 C8E A 210 coo 85.81 57.99 116.01 86.03 55.86 115.89 16.71 -46.53 -3.05 15.59 -48.22 -3.69 coo 75.11 41.01 160.30 76.65 40.06 161.41 61.29 -47.52 -25.12 61.48 -48.69 -23.33 coo 82.23 40.35 159.87 85.09 40.67 161.01 59.00 -50.13 -20.90 61.68 -51.06 -19.88 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 24 3 # 24 A 50 ASP C 61 ASP~? 12.61 CA CA C 208 A 327 GLU A 7 GLU^? 19.52 C17 C8E A 209 A 339 ARG A 135 ARG^? 21.29 C1 C8E A 210 coo 85.81 57.99 116.01 86.03 55.86 115.89 16.71 -46.53 -3.05 15.59 -48.22 -3.69 coo 75.11 41.01 160.30 76.65 40.06 161.41 61.29 -47.52 -25.12 61.48 -48.69 -23.33 coo 82.23 40.35 159.87 85.09 40.67 161.01 62.45 -46.81 -18.85 61.41 -44.79 -20.90 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 25 3 # 25 A 50 ASP C 61 ASP~? 12.61 CA CA C 208 A 327 GLU A 93 GLU^? 23.51 C1 C8E A 210 A 339 ARG A 135 ARG^? 21.29 C1 C8E A 210 coo 85.81 57.99 116.01 86.03 55.86 115.89 16.71 -46.53 -3.05 15.59 -48.22 -3.69 coo 75.11 41.01 160.30 76.65 40.06 161.41 64.33 -40.66 -16.04 62.38 -40.13 -16.70 coo 82.23 40.35 159.87 85.09 40.67 161.01 62.45 -46.81 -18.85 61.41 -44.79 -20.90 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 26 3 # 26 A 50 ASP C 114 ASP.? 22.22 CA CA C 208 A 327 GLU A 93 GLU^? 23.51 C1 C8E A 210 A 339 ARG A 135 ARG^? 21.29 C1 C8E A 210 coo 85.81 57.99 116.01 86.03 55.86 115.89 19.39 -30.14 -1.59 19.46 -28.98 0.18 coo 75.11 41.01 160.30 76.65 40.06 161.41 64.33 -40.66 -16.04 62.38 -40.13 -16.70 coo 82.23 40.35 159.87 85.09 40.67 161.01 62.45 -46.81 -18.85 61.41 -44.79 -20.90 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 27 3 # 27 A 50 ASP C 180 ASP.? 12.29 C5 C8E C 209 A 327 GLU A 164 GLU^? 19.19 O21 C8E A 210 A 339 ARG A 162 ARG^? 10.87 O21 C8E A 210 coo 85.81 57.99 116.01 86.03 55.86 115.89 42.24 -54.49 3.97 44.24 -53.90 3.82 coo 75.11 41.01 160.30 76.65 40.06 161.41 57.65 -86.15 -32.10 58.08 -88.26 -31.94 coo 82.23 40.35 159.87 85.09 40.67 161.01 60.16 -83.54 -27.36 63.31 -83.18 -27.03 1hto_c00 source 1hto GLUTAMINE SYNTHETASE : 27 hits 1hto_c00 naa= 3 ULMN 3 1hy3_c00 ESTROGEN SULFOTRANSFERASE user 1 3 # 1 A 47 LYS B 3 LYS^? 35.51 O15 C8E B 209 A 107 HIS B 0 HIS.? 33.03 C1 C8E B 210 A 137 SER B 5 SER^? 27.72 O15 C8E B 209 coo 5.11 -0.55 31.43 1.36 1.90 33.24 68.65 -39.32 -48.24 67.06 -43.09 -50.47 coo 6.14 -0.73 24.01 6.05 0.83 25.40 70.48 -35.36 -55.71 72.36 -34.80 -54.96 coo 1.06 -1.40 35.67 2.72 0.28 35.10 68.96 -37.45 -41.77 69.21 -39.86 -42.14 1hy3_c00 source 1hy3 ESTROGEN SULFOTRANSFERASE : 1 hits 1hy3_c00 naa= 3 ULMN 3 1hy3_c01 ESTROGEN SULFOTRANSFERASE user 1 3 # 1 B 47 LYS B 3 LYS^? 35.51 O15 C8E B 209 B 107 HIS B 0 HIS.? 33.03 C1 C8E B 210 B 137 SER B 5 SER^? 27.72 O15 C8E B 209 coo -20.15 -16.49 60.11 -21.92 -14.52 56.18 68.65 -39.32 -48.24 67.06 -43.09 -50.47 coo -23.43 -14.78 66.71 -24.10 -15.65 64.93 70.48 -35.36 -55.71 72.36 -34.80 -54.96 coo -17.90 -14.30 55.11 -19.49 -15.96 55.90 68.96 -37.45 -41.77 69.21 -39.86 -42.14 1hy3_c01 source 1hy3 ESTROGEN SULFOTRANSFERASE : 1 hits 1hy3_c01 naa= 3 ULMN 3 1i29_c03 CSDB user 1 3 # 1 A 128 VAL A 22 VAL^? 19.55 C2 C8E C 209 A 200 ASP C 80 ASP^? 16.43 C13 C8E C 210 A 226 LYS C 84 LYS.? 25.24 O21 C8E A 209 coo 19.13 38.05 1.41 19.72 38.80 -0.53 54.15 -48.28 -24.50 51.93 -48.23 -24.31 coo 24.51 43.28 11.18 25.17 44.50 9.58 47.10 -57.14 -28.79 45.64 -55.94 -27.77 coo 34.47 51.09 7.19 28.58 51.18 7.53 49.01 -63.83 -38.44 48.10 -58.01 -38.38 ULMN 3 1i29_c03 CSDB user 2 3 # 2 A 128 VAL A 22 VAL^? 19.55 C2 C8E C 209 A 200 ASP C 80 ASP^? 16.43 C13 C8E C 210 A 226 LYS C 198 LYS^? 12.94 C13 C8E C 210 coo 19.13 38.05 1.41 19.72 38.80 -0.53 54.15 -48.28 -24.50 51.93 -48.23 -24.31 coo 24.51 43.28 11.18 25.17 44.50 9.58 47.10 -57.14 -28.79 45.64 -55.94 -27.77 coo 34.47 51.09 7.19 28.58 51.18 7.53 35.43 -55.44 -26.10 41.10 -55.85 -26.89 ULMN 3 1i29_c03 CSDB user 3 3 # 3 A 128 VAL A 39 VAL^? 15.36 O21 C8E A 209 A 200 ASP A 80 ASP^? 12.60 C1 C8E A 210 A 226 LYS A 84 LYS.? 23.11 C2 C8E C 209 coo 19.13 38.05 1.41 19.72 38.80 -0.53 56.65 -57.17 -25.99 55.61 -57.72 -27.81 coo 24.51 43.28 11.18 25.17 44.50 9.58 58.12 -52.30 -15.93 59.10 -53.68 -17.13 coo 34.47 51.09 7.19 28.58 51.18 7.53 61.58 -41.74 -11.00 58.66 -39.80 -16.04 ULMN 3 1i29_c03 CSDB user 4 3 # 4 A 128 VAL A 39 VAL^? 15.36 O21 C8E A 209 A 200 ASP A 149 ASP^? 14.85 C1 C8E A 210 A 226 LYS A 84 LYS.? 23.11 C2 C8E C 209 coo 19.13 38.05 1.41 19.72 38.80 -0.53 56.65 -57.17 -25.99 55.61 -57.72 -27.81 coo 24.51 43.28 11.18 25.17 44.50 9.58 66.40 -51.17 -20.74 65.06 -51.90 -19.38 coo 34.47 51.09 7.19 28.58 51.18 7.53 61.58 -41.74 -11.00 58.66 -39.80 -16.04 ULMN 3 1i29_c03 CSDB user 5 3 # 5 A 128 VAL A 152 VAL^? 5.71 C2 C8E A 209 A 200 ASP A 80 ASP^? 12.60 C1 C8E A 210 A 226 LYS A 84 LYS.? 23.11 C2 C8E C 209 coo 19.13 38.05 1.41 19.72 38.80 -0.53 67.24 -59.51 -14.71 68.94 -60.40 -13.59 coo 24.51 43.28 11.18 25.17 44.50 9.58 58.12 -52.30 -15.93 59.10 -53.68 -17.13 coo 34.47 51.09 7.19 28.58 51.18 7.53 61.58 -41.74 -11.00 58.66 -39.80 -16.04 ULMN 3 1i29_c03 CSDB user 6 3 # 6 A 128 VAL A 152 VAL^? 5.71 C2 C8E A 209 A 200 ASP A 149 ASP^? 14.85 C1 C8E A 210 A 226 LYS A 84 LYS.? 23.11 C2 C8E C 209 coo 19.13 38.05 1.41 19.72 38.80 -0.53 67.24 -59.51 -14.71 68.94 -60.40 -13.59 coo 24.51 43.28 11.18 25.17 44.50 9.58 66.40 -51.17 -20.74 65.06 -51.90 -19.38 coo 34.47 51.09 7.19 28.58 51.18 7.53 61.58 -41.74 -11.00 58.66 -39.80 -16.04 ULMN 3 1i29_c03 CSDB user 7 3 # 7 A 128 VAL A 190 VAL~? 4.63 O21 C8E A 210 A 200 ASP A 49 ASP.? -3.00 CA CA A 208s A 226 LYS A 67 LYS~? 13.30 CA CA A 208 coo 19.13 38.05 1.41 19.72 38.80 -0.53 65.92 -77.91 -22.89 63.79 -78.15 -23.56 coo 24.51 43.28 11.18 25.17 44.50 9.58 75.72 -77.89 -27.98 74.67 -77.10 -29.65 coo 34.47 51.09 7.19 28.58 51.18 7.53 73.21 -82.07 -40.14 71.59 -78.49 -41.85 ULMN 3 1i29_c03 CSDB user 8 3 # 8 A 128 VAL B 6 VAL^? 25.37 O15 C8E B 209 A 200 ASP B 80 ASP^? 15.94 O15 C8E B 209 A 226 LYS B 198 LYS^? 12.15 O15 C8E B 209 coo 19.13 38.05 1.41 19.72 38.80 -0.53 69.31 -35.26 -38.72 68.34 -33.48 -38.01 coo 24.51 43.28 11.18 25.17 44.50 9.58 82.56 -37.87 -41.00 82.97 -37.16 -39.06 coo 34.47 51.09 7.19 28.58 51.18 7.53 85.01 -40.11 -29.09 83.85 -38.63 -34.53 ULMN 3 1i29_c03 CSDB user 9 3 # 9 A 128 VAL B 39 VAL^? 15.93 C20 C8E B 209 A 200 ASP B 80 ASP^? 15.94 O15 C8E B 209 A 226 LYS B 84 LYS.? 25.86 O15 C8E B 209 coo 19.13 38.05 1.41 19.72 38.80 -0.53 78.58 -29.46 -34.61 77.54 -27.66 -34.03 coo 24.51 43.28 11.18 25.17 44.50 9.58 82.56 -37.87 -41.00 82.97 -37.16 -39.06 coo 34.47 51.09 7.19 28.58 51.18 7.53 79.44 -47.69 -46.65 75.97 -44.45 -44.18 ULMN 3 1i29_c03 CSDB user 10 3 # 10 A 128 VAL B 39 VAL^? 15.93 C20 C8E B 209 A 200 ASP B 149 ASP^? 14.91 O15 C8E B 209 A 226 LYS B 84 LYS.? 25.86 O15 C8E B 209 coo 19.13 38.05 1.41 19.72 38.80 -0.53 78.58 -29.46 -34.61 77.54 -27.66 -34.03 coo 24.51 43.28 11.18 25.17 44.50 9.58 79.48 -42.39 -33.32 81.04 -41.48 -34.38 coo 34.47 51.09 7.19 28.58 51.18 7.53 79.44 -47.69 -46.65 75.97 -44.45 -44.18 ULMN 3 1i29_c03 CSDB user 11 3 # 11 A 128 VAL B 75 VAL^? 10.73 C20 C8E B 209 A 200 ASP B 45 ASP.? -3.07 CA CA B 208s A 226 LYS B 188 LYS~? 9.67 C16 C8E B 210 coo 19.13 38.05 1.41 19.72 38.80 -0.53 82.95 -26.54 -29.63 81.51 -24.87 -29.78 coo 24.51 43.28 11.18 25.17 44.50 9.58 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo 34.47 51.09 7.19 28.58 51.18 7.53 102.16 -28.74 -21.10 106.15 -31.37 -17.86 ULMN 3 1i29_c03 CSDB user 12 3 # 12 A 128 VAL B 186 VAL~? 7.56 O21 C8E B 210 A 200 ASP B 49 ASP.? -3.05 CA CA B 208s A 226 LYS B 67 LYS~? 18.13 CA CA B 208 coo 19.13 38.05 1.41 19.72 38.80 -0.53 102.03 -23.25 -21.93 101.21 -21.29 -22.72 coo 24.51 43.28 11.18 25.17 44.50 9.58 94.52 -28.97 -11.62 93.03 -30.41 -11.73 coo 34.47 51.09 7.19 28.58 51.18 7.53 89.12 -21.41 -4.23 87.66 -21.56 1.71 ULMN 3 1i29_c03 CSDB user 13 3 # 13 A 128 VAL C 6 VAL^? 25.62 C19 C8E C 210 A 200 ASP C 80 ASP^? 16.43 C13 C8E C 210 A 226 LYS C 198 LYS^? 12.94 C13 C8E C 210 coo 19.13 38.05 1.41 19.72 38.80 -0.53 48.09 -46.15 -36.64 47.69 -44.03 -36.90 coo 24.51 43.28 11.18 25.17 44.50 9.58 47.10 -57.14 -28.79 45.64 -55.94 -27.77 coo 34.47 51.09 7.19 28.58 51.18 7.53 35.43 -55.44 -26.10 41.10 -55.85 -26.89 ULMN 3 1i29_c03 CSDB user 14 3 # 14 A 128 VAL C 39 VAL^? 15.77 C20 C8E C 210 A 200 ASP C 80 ASP^? 16.43 C13 C8E C 210 A 226 LYS C 84 LYS.? 25.24 O21 C8E A 209 coo 19.13 38.05 1.41 19.72 38.80 -0.53 45.59 -46.48 -25.31 46.87 -44.90 -24.49 coo 24.51 43.28 11.18 25.17 44.50 9.58 47.10 -57.14 -28.79 45.64 -55.94 -27.77 coo 34.47 51.09 7.19 28.58 51.18 7.53 49.01 -63.83 -38.44 48.10 -58.01 -38.38 ULMN 3 1i29_c03 CSDB user 15 3 # 15 A 128 VAL C 39 VAL^? 15.77 C20 C8E C 210 A 200 ASP C 149 ASP^? 16.02 C16 C8E C 210 A 226 LYS C 84 LYS.? 25.24 O21 C8E A 209 coo 19.13 38.05 1.41 19.72 38.80 -0.53 45.59 -46.48 -25.31 46.87 -44.90 -24.49 coo 24.51 43.28 11.18 25.17 44.50 9.58 38.72 -55.19 -32.44 40.02 -55.93 -30.97 coo 34.47 51.09 7.19 28.58 51.18 7.53 49.01 -63.83 -38.44 48.10 -58.01 -38.38 ULMN 3 1i29_c03 CSDB user 16 3 # 16 A 128 VAL C 75 VAL^? 10.43 C20 C8E C 210 A 200 ASP C 45 ASP.? 3.27 CA CA C 208s A 226 LYS C 188 LYS~? 9.02 C16 C8E C 209 coo 19.13 38.05 1.41 19.72 38.80 -0.53 41.88 -45.41 -19.23 42.87 -43.46 -19.44 coo 24.51 43.28 11.18 25.17 44.50 9.58 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo 34.47 51.09 7.19 28.58 51.18 7.53 31.07 -55.82 -4.30 26.58 -58.21 -2.57 ULMN 3 1i29_c03 CSDB user 17 3 # 17 A 128 VAL C 100 VAL^? 11.61 C1 C8E C 209 A 200 ASP A 80 ASP^? 12.60 C1 C8E A 210 A 226 LYS A 198 LYS^? 12.09 C1 C8E A 210 coo 19.13 38.05 1.41 19.72 38.80 -0.53 48.42 -57.82 -21.21 50.38 -57.25 -20.38 coo 24.51 43.28 11.18 25.17 44.50 9.58 58.12 -52.30 -15.93 59.10 -53.68 -17.13 coo 34.47 51.09 7.19 28.58 51.18 7.53 68.28 -58.05 -20.21 63.11 -55.44 -18.88 ULMN 3 1i29_c03 CSDB user 18 3 # 18 A 128 VAL C 152 VAL^? 9.85 C13 C8E C 210 A 200 ASP C 80 ASP^? 16.43 C13 C8E C 210 A 226 LYS C 84 LYS.? 25.24 O21 C8E A 209 coo 19.13 38.05 1.41 19.72 38.80 -0.53 37.53 -60.45 -23.70 36.18 -62.01 -23.03 coo 24.51 43.28 11.18 25.17 44.50 9.58 47.10 -57.14 -28.79 45.64 -55.94 -27.77 coo 34.47 51.09 7.19 28.58 51.18 7.53 49.01 -63.83 -38.44 48.10 -58.01 -38.38 ULMN 3 1i29_c03 CSDB user 19 3 # 19 A 128 VAL C 190 VAL~? 4.79 O21 C8E C 209 A 200 ASP C 49 ASP.? -2.87 CA CA C 208s A 226 LYS C 67 LYS.? 18.71 CA CA C 208 coo 19.13 38.05 1.41 19.72 38.80 -0.53 32.42 -50.64 -6.54 34.20 -49.46 -6.05 coo 24.51 43.28 11.18 25.17 44.50 9.58 22.13 -48.50 -9.42 23.00 -46.66 -10.00 coo 34.47 51.09 7.19 28.58 51.18 7.53 20.04 -36.06 -6.98 16.11 -31.17 -7.78 1i29_c03 source 1i29 CSDB : 19 hits 1i29_c03 naa= 3 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 1 3 # 1 A 14 LYS B 67 LYS~? 18.13 CA CA B 208 A 74 LYS B 63 LYS~? 3.79 CA CA B 208 A 165 GLU B 164 GLU^? 19.99 CA CA B 208 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 89.12 -21.41 -4.23 87.66 -21.56 1.71 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 93.18 -23.71 -7.17 90.77 -27.85 -10.83 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 94.70 -10.70 -16.52 96.59 -9.81 -16.07 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 2 3 # 2 A 14 LYS C 67 LYS.? 18.71 CA CA C 208 A 74 LYS C 63 LYS~? 4.21 CA CA C 208 A 165 GLU C 164 GLU^? 20.06 CA CA C 208 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 20.04 -36.06 -6.98 16.11 -31.17 -7.78 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 20.98 -41.61 -5.49 23.04 -43.67 -10.44 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 34.72 -37.11 1.76 34.46 -37.46 3.82 1idt_c00 source 1idt MINOR FMN-DEPENDENT NITROREDUCTASE : 2 hits 1idt_c00 naa= 3 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 1 3 # 1 B 14 LYS B 67 LYS~? 18.13 CA CA B 208 B 74 LYS B 63 LYS~? 3.79 CA CA B 208 B 165 GLU B 164 GLU^? 19.99 CA CA B 208 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 89.12 -21.41 -4.23 87.66 -21.56 1.71 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 93.18 -23.71 -7.17 90.77 -27.85 -10.83 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 94.70 -10.70 -16.52 96.59 -9.81 -16.07 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 2 3 # 2 B 14 LYS C 67 LYS.? 18.71 CA CA C 208 B 74 LYS C 63 LYS~? 4.21 CA CA C 208 B 165 GLU C 164 GLU^? 20.06 CA CA C 208 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 20.04 -36.06 -6.98 16.11 -31.17 -7.78 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 20.98 -41.61 -5.49 23.04 -43.67 -10.44 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 34.72 -37.11 1.76 34.46 -37.46 3.82 1idt_c01 source 1idt MINOR FMN-DEPENDENT NITROREDUCTASE : 2 hits 1idt_c01 naa= 3 ULMN 3 1ig8_c00 HEXOKINASE PII user 1 3 # 1 A 158 SER A 44 SER.? -2.67 O21 C8E A 209s A 173 ARG A 200 ARG^? 11.17 C17 C8E A 209 A 211 ASP A 45 ASP.? -2.96 CA CA A 208s coo 22.72 76.24 0.23 24.60 76.86 -1.25 67.29 -68.39 -28.17 66.32 -69.65 -26.34 coo 18.77 77.82 11.69 20.55 80.22 10.73 65.38 -54.68 -25.12 63.65 -56.91 -23.89 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 70.45 -71.75 -27.39 71.06 -73.65 -26.89 ULMN 3 1ig8_c00 HEXOKINASE PII user 2 3 # 2 A 158 SER B 44 SER.? -2.63 C20 C8E B 209s A 173 ARG B 200 ARG^? 11.34 O15 C8E B 209 A 211 ASP B 45 ASP.? -3.07 CA CA B 208s coo 22.72 76.24 0.23 24.60 76.86 -1.25 86.51 -29.99 -20.81 88.33 -29.21 -22.26 coo 18.77 77.82 11.69 20.55 80.22 10.73 78.82 -37.69 -29.59 80.99 -36.13 -31.14 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 90.60 -30.65 -18.50 91.26 -30.99 -16.60 ULMN 3 1ig8_c00 HEXOKINASE PII user 3 3 # 3 A 158 SER C 44 SER.? -2.60 O21 C8E C 210s A 173 ARG C 200 ARG^? 12.04 C16 C8E C 210 A 211 ASP C 45 ASP.? 3.27 CA CA C 208s coo 22.72 76.24 0.23 24.60 76.86 -1.25 31.95 -46.42 -17.08 33.26 -47.96 -15.73 coo 18.77 77.82 11.69 20.55 80.22 10.73 37.62 -50.12 -29.23 39.44 -51.00 -26.91 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 28.98 -48.61 -14.39 27.54 -48.99 -12.93 ULMN 3 1ig8_c00 HEXOKINASE PII user 4 3 # 4 A 158 SER C 78 SER^? 13.93 C13 C8E C 210 A 173 ARG A 36 ARG^? 15.77 C1 C8E A 210 A 211 ASP C 80 ASP^? 16.43 C13 C8E C 210 coo 22.72 76.24 0.23 24.60 76.86 -1.25 46.95 -52.32 -23.90 45.02 -53.63 -24.63 coo 18.77 77.82 11.69 20.55 80.22 10.73 59.00 -50.13 -20.90 61.68 -51.06 -19.88 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 47.10 -57.14 -28.79 45.64 -55.94 -27.77 1ig8_c00 source 1ig8 HEXOKINASE PII : 4 hits 1ig8_c00 naa= 3 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 1 3 # 1 54 ASP B 49 ASP.? -3.05 CA CA B 208s 158 THR B 58 THR~? 10.41 CA CA B 208 317 ASP B 185 ASP~? 11.63 O21 C8E B 210 coo -2.63 8.40 35.07 -3.66 9.81 36.17 94.52 -28.97 -11.62 93.03 -30.41 -11.73 coo -5.30 12.75 41.86 -4.34 13.05 39.99 100.65 -27.90 -8.43 100.12 -29.92 -7.97 coo -12.63 17.64 33.66 -10.65 17.90 34.40 106.30 -23.80 -20.43 108.26 -24.54 -20.08 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 2 3 # 2 54 ASP B 49 ASP.? -3.05 CA CA B 208s 158 THR B 191 THR.? -5.05 O18 C8E B 209s 317 ASP B 185 ASP~? 11.63 O21 C8E B 210 coo -2.63 8.40 35.07 -3.66 9.81 36.17 94.52 -28.97 -11.62 93.03 -30.41 -11.73 coo -5.30 12.75 41.86 -4.34 13.05 39.99 94.88 -29.06 -21.80 94.27 -29.66 -19.85 coo -12.63 17.64 33.66 -10.65 17.90 34.40 106.30 -23.80 -20.43 108.26 -24.54 -20.08 1inp_c02 source 1inp INOSITOL POLYPHOSPHATE 1-PHOSPHATASE (1-PTASE): 2 hits 1inp_c02 naa= 3 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 1 3 # 1 A 202 ASP A 26 ASP.? 24.86 C2 C8E C 209 A 204 GLU A 25 GLU^? 22.98 C2 C8E C 209 A 279 TYR A 83 TYR^? -19.24 C2 C8E C 209s coo 5.85 5.60 30.32 5.00 7.49 29.88 53.70 -37.11 -16.05 55.72 -36.42 -15.97 coo 7.79 1.83 27.81 9.08 3.25 26.92 56.22 -40.62 -18.58 57.98 -41.28 -19.55 coo 8.22 7.77 18.64 7.58 8.47 21.28 59.25 -44.27 -7.74 58.41 -42.23 -6.03 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 2 3 # 2 A 202 ASP A 45 ASP.? -2.96 CA CA A 208s A 204 GLU A 70 GLU^? -2.69 CA CA A 208s A 279 TYR A 51 TYR.? 9.92 O21 C8E A 210 coo 5.85 5.60 30.32 5.00 7.49 29.88 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo 7.79 1.83 27.81 9.08 3.25 26.92 68.79 -75.79 -31.87 70.14 -76.30 -30.27 coo 8.22 7.77 18.64 7.58 8.47 21.28 71.70 -83.21 -22.40 69.97 -85.02 -21.17 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 3 3 # 3 A 202 ASP A 114 ASP.? 22.11 CA CA A 208 A 204 GLU A 113 GLU.? 20.24 CA CA A 208 A 279 TYR A 109 TYR^? 10.85 CA CA A 208 coo 5.85 5.60 30.32 5.00 7.49 29.88 71.50 -87.46 -45.26 70.62 -89.18 -46.15 coo 7.79 1.83 27.81 9.08 3.25 26.92 67.94 -85.82 -46.11 66.40 -86.46 -44.83 coo 8.22 7.77 18.64 7.58 8.47 21.28 66.11 -81.19 -34.21 65.29 -83.76 -33.55 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 4 3 # 4 A 202 ASP A 166 ASP.? 23.45 CA CA A 208 A 204 GLU A 165 GLU^? 21.76 CA CA A 208 A 279 TYR A 109 TYR^? 10.85 CA CA A 208 coo 5.85 5.60 30.32 5.00 7.49 29.88 55.95 -88.25 -40.15 55.99 -89.39 -38.36 coo 7.79 1.83 27.81 9.08 3.25 26.92 55.17 -82.77 -39.51 54.39 -80.85 -40.05 coo 8.22 7.77 18.64 7.58 8.47 21.28 66.11 -81.19 -34.21 65.29 -83.76 -33.55 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 5 3 # 5 A 202 ASP B 26 ASP.? 33.07 O15 C8E B 209 A 204 GLU B 25 GLU^? 27.65 O15 C8E B 209 A 279 TYR B 83 TYR^? 23.90 C1 C8E B 209 coo 5.85 5.60 30.32 5.00 7.49 29.88 71.92 -43.11 -51.36 71.95 -45.06 -50.50 coo 7.79 1.83 27.81 9.08 3.25 26.92 73.50 -42.12 -45.68 71.97 -42.23 -44.24 coo 8.22 7.77 18.64 7.58 8.47 21.28 84.86 -45.84 -46.52 87.07 -46.60 -44.97 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 6 3 # 6 A 202 ASP C 26 ASP.? 24.60 O21 C8E A 209 A 204 GLU C 25 GLU.? 26.72 O21 C8E A 209 A 279 TYR C 83 TYR^? 19.88 O21 C8E A 209 coo 5.85 5.60 30.32 5.00 7.49 29.88 55.55 -58.08 -41.98 53.84 -58.94 -42.96 coo 7.79 1.83 27.81 9.08 3.25 26.92 50.80 -55.81 -38.99 49.16 -55.90 -40.32 coo 8.22 7.77 18.64 7.58 8.47 21.28 49.20 -66.70 -34.88 49.82 -68.82 -36.60 1itx_c00 source 1itx GLYCOSYL HYDROLASE : 6 hits 1itx_c00 naa= 3 ULMN 3 1j7g_c00 D-TYROSYL-TRNA(TYR) DEACYLASE user 1 3 # 1 A 78 GLN B 73 GLN^? 10.80 C20 C8E B 209 A 79 PHE B 41 PHE^? 11.29 C20 C8E B 209 A 80 THR B 43 THR^? 8.90 C19 C8E B 209 coo 18.18 6.97 -1.14 17.20 5.70 -2.56 83.87 -24.06 -23.73 82.10 -22.98 -24.12 coo 24.87 4.39 -2.11 26.74 2.89 -0.67 78.91 -27.63 -25.83 79.60 -26.32 -23.43 coo 21.26 8.65 -4.24 19.54 7.67 -5.04 82.82 -29.73 -21.27 81.56 -30.56 -19.69 ULMN 3 1j7g_c00 D-TYROSYL-TRNA(TYR) DEACYLASE user 2 3 # 2 A 78 GLN C 73 GLN^? 10.77 C20 C8E C 210 A 79 PHE C 41 PHE^? 11.26 C20 C8E C 210 A 80 THR C 43 THR^? 8.54 C17 C8E C 210 coo 18.18 6.97 -1.14 17.20 5.70 -2.56 37.52 -41.93 -15.99 38.52 -40.23 -16.76 coo 24.87 4.39 -2.11 26.74 2.89 -0.67 38.53 -42.08 -22.17 36.81 -40.66 -20.50 coo 21.26 8.65 -4.24 19.54 7.67 -5.04 32.76 -44.26 -20.08 30.65 -44.02 -20.37 1j7g_c00 source 1j7g D-TYROSYL-TRNA(TYR) DEACYLASE : 2 hits 1j7g_c00 naa= 3 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 1 3 # 1 A 396 ARG A 36 ARG^? 15.77 C1 C8E A 210 A 581 ARG A 101 ARG^? 8.92 C1 C8E A 210 A 713 ARG A 200 ARG^? 11.17 C17 C8E A 209 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 59.00 -50.13 -20.90 61.68 -51.06 -19.88 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 59.10 -60.12 -16.06 60.30 -57.41 -15.78 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 65.38 -54.68 -25.12 63.65 -56.91 -23.89 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 2 3 # 2 A 396 ARG A 36 ARG^? 15.77 C1 C8E A 210 A 581 ARG A 200 ARG^? 11.17 C17 C8E A 209 A 713 ARG A 101 ARG^? 8.92 C1 C8E A 210 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 59.00 -50.13 -20.90 61.68 -51.06 -19.88 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 65.38 -54.68 -25.12 63.65 -56.91 -23.89 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 59.10 -60.12 -16.06 60.30 -57.41 -15.78 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 3 3 # 3 A 396 ARG B 36 ARG^? 17.08 O15 C8E B 209 A 581 ARG B 101 ARG^? 13.86 O15 C8E B 209 A 713 ARG B 200 ARG^? 11.34 O15 C8E B 209 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 77.67 -37.50 -38.51 79.47 -39.58 -37.24 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 87.52 -34.18 -37.50 85.80 -36.55 -38.16 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 78.82 -37.69 -29.59 80.99 -36.13 -31.14 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 4 3 # 4 A 396 ARG B 36 ARG^? 17.08 O15 C8E B 209 A 581 ARG B 200 ARG^? 11.34 O15 C8E B 209 A 713 ARG B 101 ARG^? 13.86 O15 C8E B 209 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 77.67 -37.50 -38.51 79.47 -39.58 -37.24 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 78.82 -37.69 -29.59 80.99 -36.13 -31.14 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 87.52 -34.18 -37.50 85.80 -36.55 -38.16 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 5 3 # 5 A 396 ARG C 36 ARG^? 17.98 C16 C8E C 210 A 581 ARG C 101 ARG^? 13.82 C13 C8E C 210 A 713 ARG C 200 ARG^? 12.04 C16 C8E C 210 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 45.58 -52.92 -31.76 43.11 -54.70 -31.56 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 44.39 -56.56 -21.66 44.87 -57.05 -24.63 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 37.62 -50.12 -29.23 39.44 -51.00 -26.91 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 6 3 # 6 A 396 ARG C 36 ARG^? 17.98 C16 C8E C 210 A 581 ARG C 200 ARG^? 12.04 C16 C8E C 210 A 713 ARG C 101 ARG^? 13.82 C13 C8E C 210 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 45.58 -52.92 -31.76 43.11 -54.70 -31.56 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 37.62 -50.12 -29.23 39.44 -51.00 -26.91 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 44.39 -56.56 -21.66 44.87 -57.05 -24.63 1jqn_c01 source 1jqn PHOSPHOENOLPYRUVATE CARBOXYLASE : 6 hits 1jqn_c01 naa= 3 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 1 3 # 1 A 55 ASP A 48 ASP.? 7.38 CA CA A 208 A 58 ASP A 49 ASP.? -3.00 CA CA A 208s A 424 GLU A 70 GLU^? -2.69 CA CA A 208s coo 58.42 47.76 20.67 58.01 49.10 19.12 72.05 -78.20 -23.17 73.82 -77.79 -22.11 coo 58.59 41.80 18.81 58.94 43.89 18.94 75.72 -77.89 -27.98 74.67 -77.10 -29.65 coo 52.85 46.34 13.34 54.09 44.97 14.42 68.79 -75.79 -31.87 70.14 -76.30 -30.27 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 2 3 # 2 A 55 ASP A 49 ASP.? -3.00 CA CA A 208s A 58 ASP A 48 ASP.? 7.38 CA CA A 208 A 424 GLU A 70 GLU^? -2.69 CA CA A 208s coo 58.42 47.76 20.67 58.01 49.10 19.12 75.72 -77.89 -27.98 74.67 -77.10 -29.65 coo 58.59 41.80 18.81 58.94 43.89 18.94 72.05 -78.20 -23.17 73.82 -77.79 -22.11 coo 52.85 46.34 13.34 54.09 44.97 14.42 68.79 -75.79 -31.87 70.14 -76.30 -30.27 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 3 3 # 3 A 55 ASP C 48 ASP.? 7.17 CA CA C 208 A 58 ASP C 49 ASP.? -2.87 CA CA C 208s A 424 GLU C 70 GLU^? -2.71 CA CA C 208s coo 58.42 47.76 20.67 58.01 49.10 19.12 26.68 -52.06 -7.74 25.46 -53.53 -8.54 coo 58.59 41.80 18.81 58.94 43.89 18.94 22.13 -48.50 -9.42 23.00 -46.66 -10.00 coo 52.85 46.34 13.34 54.09 44.97 14.42 27.73 -42.94 -10.42 26.74 -44.79 -10.37 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 4 3 # 4 A 55 ASP C 49 ASP.? -2.87 CA CA C 208s A 58 ASP C 48 ASP.? 7.17 CA CA C 208 A 424 GLU C 70 GLU^? -2.71 CA CA C 208s coo 58.42 47.76 20.67 58.01 49.10 19.12 22.13 -48.50 -9.42 23.00 -46.66 -10.00 coo 58.59 41.80 18.81 58.94 43.89 18.94 26.68 -52.06 -7.74 25.46 -53.53 -8.54 coo 52.85 46.34 13.34 54.09 44.97 14.42 27.73 -42.94 -10.42 26.74 -44.79 -10.37 1js4_c00 source 1js4 ENDO-EXOCELLULASE E4 : 4 hits 1js4_c00 naa= 3 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 1 3 # 1 B 55 ASP A 48 ASP.? 7.38 CA CA A 208 B 58 ASP A 49 ASP.? -3.00 CA CA A 208s B 424 GLU A 70 GLU^? -2.69 CA CA A 208s coo 112.10 61.46 19.99 111.82 60.65 18.07 72.05 -78.20 -23.17 73.82 -77.79 -22.11 coo 117.85 63.62 21.08 115.96 63.25 20.18 75.72 -77.89 -27.98 74.67 -77.10 -29.65 coo 118.47 57.23 15.57 119.32 58.77 16.73 68.79 -75.79 -31.87 70.14 -76.30 -30.27 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 2 3 # 2 B 55 ASP A 49 ASP.? -3.00 CA CA A 208s B 58 ASP A 48 ASP.? 7.38 CA CA A 208 B 424 GLU A 70 GLU^? -2.69 CA CA A 208s coo 112.10 61.46 19.99 111.82 60.65 18.07 75.72 -77.89 -27.98 74.67 -77.10 -29.65 coo 117.85 63.62 21.08 115.96 63.25 20.18 72.05 -78.20 -23.17 73.82 -77.79 -22.11 coo 118.47 57.23 15.57 119.32 58.77 16.73 68.79 -75.79 -31.87 70.14 -76.30 -30.27 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 3 3 # 3 B 55 ASP B 45 ASP.? -3.07 CA CA B 208s B 58 ASP B 48 ASP.? 7.20 CA CA B 208 B 424 GLU B 70 GLU^? -2.58 CA CA B 208s coo 112.10 61.46 19.99 111.82 60.65 18.07 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo 117.85 63.62 21.08 115.96 63.25 20.18 97.60 -30.12 -16.68 98.20 -32.01 -15.99 coo 118.47 57.23 15.57 119.32 58.77 16.73 89.83 -24.96 -14.47 91.03 -26.69 -14.39 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 4 3 # 4 B 55 ASP B 45 ASP.? -3.07 CA CA B 208s B 58 ASP B 49 ASP.? -3.05 CA CA B 208s B 424 GLU B 70 GLU^? -2.58 CA CA B 208s coo 112.10 61.46 19.99 111.82 60.65 18.07 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo 117.85 63.62 21.08 115.96 63.25 20.18 94.52 -28.97 -11.62 93.03 -30.41 -11.73 coo 118.47 57.23 15.57 119.32 58.77 16.73 89.83 -24.96 -14.47 91.03 -26.69 -14.39 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 5 3 # 5 B 55 ASP B 48 ASP.? 7.20 CA CA B 208 B 58 ASP B 45 ASP.? -3.07 CA CA B 208s B 424 GLU B 70 GLU^? -2.58 CA CA B 208s coo 112.10 61.46 19.99 111.82 60.65 18.07 97.60 -30.12 -16.68 98.20 -32.01 -15.99 coo 117.85 63.62 21.08 115.96 63.25 20.18 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo 118.47 57.23 15.57 119.32 58.77 16.73 89.83 -24.96 -14.47 91.03 -26.69 -14.39 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 6 3 # 6 B 55 ASP B 48 ASP.? 7.20 CA CA B 208 B 58 ASP B 49 ASP.? -3.05 CA CA B 208s B 424 GLU B 70 GLU^? -2.58 CA CA B 208s coo 112.10 61.46 19.99 111.82 60.65 18.07 97.60 -30.12 -16.68 98.20 -32.01 -15.99 coo 117.85 63.62 21.08 115.96 63.25 20.18 94.52 -28.97 -11.62 93.03 -30.41 -11.73 coo 118.47 57.23 15.57 119.32 58.77 16.73 89.83 -24.96 -14.47 91.03 -26.69 -14.39 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 7 3 # 7 B 55 ASP B 166 ASP.? 24.17 CA CA B 208 B 58 ASP B 167 ASP.? 22.72 CA CA B 208 B 424 GLU B 164 GLU^? 19.99 CA CA B 208 coo 112.10 61.46 19.99 111.82 60.65 18.07 91.14 -5.33 -14.11 93.17 -5.00 -14.63 coo 117.85 63.62 21.08 115.96 63.25 20.18 88.92 -5.85 -9.56 88.92 -7.42 -8.19 coo 118.47 57.23 15.57 119.32 58.77 16.73 94.70 -10.70 -16.52 96.59 -9.81 -16.07 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 8 3 # 8 B 55 ASP B 167 ASP.? 22.72 CA CA B 208 B 58 ASP B 166 ASP.? 24.17 CA CA B 208 B 424 GLU B 164 GLU^? 19.99 CA CA B 208 coo 112.10 61.46 19.99 111.82 60.65 18.07 88.92 -5.85 -9.56 88.92 -7.42 -8.19 coo 117.85 63.62 21.08 115.96 63.25 20.18 91.14 -5.33 -14.11 93.17 -5.00 -14.63 coo 118.47 57.23 15.57 119.32 58.77 16.73 94.70 -10.70 -16.52 96.59 -9.81 -16.07 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 9 3 # 9 B 55 ASP C 45 ASP.? 3.27 CA CA C 208s B 58 ASP C 48 ASP.? 7.17 CA CA C 208 B 424 GLU C 70 GLU^? -2.71 CA CA C 208s coo 112.10 61.46 19.99 111.82 60.65 18.07 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo 117.85 63.62 21.08 115.96 63.25 20.18 26.68 -52.06 -7.74 25.46 -53.53 -8.54 coo 118.47 57.23 15.57 119.32 58.77 16.73 27.73 -42.94 -10.42 26.74 -44.79 -10.37 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 10 3 # 10 B 55 ASP C 48 ASP.? 7.17 CA CA C 208 B 58 ASP C 45 ASP.? 3.27 CA CA C 208s B 424 GLU C 70 GLU^? -2.71 CA CA C 208s coo 112.10 61.46 19.99 111.82 60.65 18.07 26.68 -52.06 -7.74 25.46 -53.53 -8.54 coo 117.85 63.62 21.08 115.96 63.25 20.18 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo 118.47 57.23 15.57 119.32 58.77 16.73 27.73 -42.94 -10.42 26.74 -44.79 -10.37 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 11 3 # 11 B 55 ASP C 48 ASP.? 7.17 CA CA C 208 B 58 ASP C 49 ASP.? -2.87 CA CA C 208s B 424 GLU C 70 GLU^? -2.71 CA CA C 208s coo 112.10 61.46 19.99 111.82 60.65 18.07 26.68 -52.06 -7.74 25.46 -53.53 -8.54 coo 117.85 63.62 21.08 115.96 63.25 20.18 22.13 -48.50 -9.42 23.00 -46.66 -10.00 coo 118.47 57.23 15.57 119.32 58.77 16.73 27.73 -42.94 -10.42 26.74 -44.79 -10.37 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 12 3 # 12 B 55 ASP C 49 ASP.? -2.87 CA CA C 208s B 58 ASP C 48 ASP.? 7.17 CA CA C 208 B 424 GLU C 70 GLU^? -2.71 CA CA C 208s coo 112.10 61.46 19.99 111.82 60.65 18.07 22.13 -48.50 -9.42 23.00 -46.66 -10.00 coo 117.85 63.62 21.08 115.96 63.25 20.18 26.68 -52.06 -7.74 25.46 -53.53 -8.54 coo 118.47 57.23 15.57 119.32 58.77 16.73 27.73 -42.94 -10.42 26.74 -44.79 -10.37 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 13 3 # 13 B 55 ASP C 166 ASP.? 24.81 CA CA C 208 B 58 ASP C 167 ASP.? 25.18 CA CA C 208 B 424 GLU C 164 GLU^? 20.06 CA CA C 208 coo 112.10 61.46 19.99 111.82 60.65 18.07 35.75 -30.25 2.83 35.54 -31.07 4.76 coo 117.85 63.62 21.08 115.96 63.25 20.18 31.39 -27.44 2.08 30.34 -25.78 1.31 coo 118.47 57.23 15.57 119.32 58.77 16.73 34.72 -37.11 1.76 34.46 -37.46 3.82 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 14 3 # 14 B 55 ASP C 167 ASP.? 25.18 CA CA C 208 B 58 ASP C 166 ASP.? 24.81 CA CA C 208 B 424 GLU C 164 GLU^? 20.06 CA CA C 208 coo 112.10 61.46 19.99 111.82 60.65 18.07 31.39 -27.44 2.08 30.34 -25.78 1.31 coo 117.85 63.62 21.08 115.96 63.25 20.18 35.75 -30.25 2.83 35.54 -31.07 4.76 coo 118.47 57.23 15.57 119.32 58.77 16.73 34.72 -37.11 1.76 34.46 -37.46 3.82 1js4_c01 source 1js4 ENDO-EXOCELLULASE E4 : 14 hits 1js4_c01 naa= 3 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 A 2 GLU A 70 GLU^? -2.69 CA CA A 208s A 56 LYS A 63 LYS~? 3.96 CA CA A 208 A 258 ARG A 162 ARG^? 10.87 O21 C8E A 210 coo 42.33 1.56 26.99 42.38 2.91 28.66 68.79 -75.79 -31.87 70.14 -76.30 -30.27 coo 38.45 -0.44 19.89 37.36 0.90 25.90 73.63 -82.49 -34.44 73.43 -77.00 -32.37 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 60.16 -83.54 -27.36 63.31 -83.18 -27.03 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 A 2 GLU B 93 GLU^? 27.23 O15 C8E B 209 A 56 LYS B 84 LYS.? 25.86 O15 C8E B 209 A 258 ARG B 206 ARG^? 34.91 O15 C8E B 209 coo 42.33 1.56 26.99 42.38 2.91 28.66 75.25 -49.35 -42.08 74.13 -47.63 -42.56 coo 38.45 -0.44 19.89 37.36 0.90 25.90 79.44 -47.69 -46.65 75.97 -44.45 -44.18 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 66.21 -41.62 -44.73 64.06 -41.49 -46.91 1k82_c00 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 2 hits 1k82_c00 naa= 3 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 B 2 GLU A 70 GLU^? -2.69 CA CA A 208s B 56 LYS A 63 LYS~? 3.96 CA CA A 208 B 258 ARG A 162 ARG^? 10.87 O21 C8E A 210 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 68.79 -75.79 -31.87 70.14 -76.30 -30.27 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 73.63 -82.49 -34.44 73.43 -77.00 -32.37 coo 2.64 1.83 34.81 1.56 1.13 32.02 60.16 -83.54 -27.36 63.31 -83.18 -27.03 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 B 2 GLU B 70 GLU^? -2.58 CA CA B 208s B 56 LYS B 63 LYS~? 3.79 CA CA B 208 B 258 ARG B 162 ARG^? 16.35 O21 C8E B 210 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 89.83 -24.96 -14.47 91.03 -26.69 -14.39 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 93.18 -23.71 -7.17 90.77 -27.85 -10.83 coo 2.64 1.83 34.81 1.56 1.13 32.02 96.21 -15.01 -19.71 98.63 -13.28 -19.03 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 B 2 GLU B 93 GLU^? 27.23 O15 C8E B 209 B 56 LYS B 84 LYS.? 25.86 O15 C8E B 209 B 258 ARG B 206 ARG^? 34.91 O15 C8E B 209 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 75.25 -49.35 -42.08 74.13 -47.63 -42.56 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 79.44 -47.69 -46.65 75.97 -44.45 -44.18 coo 2.64 1.83 34.81 1.56 1.13 32.02 66.21 -41.62 -44.73 64.06 -41.49 -46.91 1k82_c01 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 3 hits 1k82_c01 naa= 3 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 C 2 GLU A 70 GLU^? -2.69 CA CA A 208s C 56 LYS A 63 LYS~? 3.96 CA CA A 208 C 258 ARG A 162 ARG^? 10.87 O21 C8E A 210 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 68.79 -75.79 -31.87 70.14 -76.30 -30.27 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 73.63 -82.49 -34.44 73.43 -77.00 -32.37 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 60.16 -83.54 -27.36 63.31 -83.18 -27.03 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 C 2 GLU B 70 GLU^? -2.58 CA CA B 208s C 56 LYS B 63 LYS~? 3.79 CA CA B 208 C 258 ARG B 162 ARG^? 16.35 O21 C8E B 210 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 89.83 -24.96 -14.47 91.03 -26.69 -14.39 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 93.18 -23.71 -7.17 90.77 -27.85 -10.83 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 96.21 -15.01 -19.71 98.63 -13.28 -19.03 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 C 2 GLU B 93 GLU^? 27.23 O15 C8E B 209 C 56 LYS B 84 LYS.? 25.86 O15 C8E B 209 C 258 ARG B 206 ARG^? 34.91 O15 C8E B 209 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 75.25 -49.35 -42.08 74.13 -47.63 -42.56 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 79.44 -47.69 -46.65 75.97 -44.45 -44.18 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 66.21 -41.62 -44.73 64.06 -41.49 -46.91 1k82_c02 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 3 hits 1k82_c02 naa= 3 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 D 2 GLU A 70 GLU^? -2.69 CA CA A 208s D 56 LYS A 63 LYS~? 3.96 CA CA A 208 D 258 ARG A 162 ARG^? 10.87 O21 C8E A 210 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 68.79 -75.79 -31.87 70.14 -76.30 -30.27 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 73.63 -82.49 -34.44 73.43 -77.00 -32.37 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 60.16 -83.54 -27.36 63.31 -83.18 -27.03 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 D 2 GLU B 70 GLU^? -2.58 CA CA B 208s D 56 LYS B 63 LYS~? 3.79 CA CA B 208 D 258 ARG B 162 ARG^? 16.35 O21 C8E B 210 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 89.83 -24.96 -14.47 91.03 -26.69 -14.39 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 93.18 -23.71 -7.17 90.77 -27.85 -10.83 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 96.21 -15.01 -19.71 98.63 -13.28 -19.03 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 D 2 GLU B 93 GLU^? 27.23 O15 C8E B 209 D 56 LYS B 84 LYS.? 25.86 O15 C8E B 209 D 258 ARG B 206 ARG^? 34.91 O15 C8E B 209 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 75.25 -49.35 -42.08 74.13 -47.63 -42.56 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 79.44 -47.69 -46.65 75.97 -44.45 -44.18 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 66.21 -41.62 -44.73 64.06 -41.49 -46.91 1k82_c03 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 3 hits 1k82_c03 naa= 3 ULMN 3 1kim_c00 THYMIDINE KINASE user 1 3 # 1 A 83 GLU A 7 GLU^? 19.52 C17 C8E A 209 A 163 ARG A 36 ARG^? 15.77 C1 C8E A 210 A 222 ARG A 200 ARG^? 11.17 C17 C8E A 209 coo 51.27 81.34 48.31 51.67 80.79 50.28 61.29 -47.52 -25.12 61.48 -48.69 -23.33 coo 48.06 78.22 50.94 48.51 78.27 53.98 59.00 -50.13 -20.90 61.68 -51.06 -19.88 coo 54.85 84.16 52.60 54.26 81.23 53.34 65.38 -54.68 -25.12 63.65 -56.91 -23.89 ULMN 3 1kim_c00 THYMIDINE KINASE user 2 3 # 2 A 83 GLU A 7 GLU^? 19.52 C17 C8E A 209 A 163 ARG A 135 ARG^? 21.29 C1 C8E A 210 A 222 ARG A 200 ARG^? 11.17 C17 C8E A 209 coo 51.27 81.34 48.31 51.67 80.79 50.28 61.29 -47.52 -25.12 61.48 -48.69 -23.33 coo 48.06 78.22 50.94 48.51 78.27 53.98 62.45 -46.81 -18.85 61.41 -44.79 -20.90 coo 54.85 84.16 52.60 54.26 81.23 53.34 65.38 -54.68 -25.12 63.65 -56.91 -23.89 ULMN 3 1kim_c00 THYMIDINE KINASE user 3 3 # 3 A 83 GLU B 7 GLU^? 19.70 O15 C8E B 209 A 163 ARG B 36 ARG^? 17.08 O15 C8E B 209 A 222 ARG B 200 ARG^? 11.34 O15 C8E B 209 coo 51.27 81.34 48.31 51.67 80.79 50.28 73.39 -38.66 -35.65 75.17 -39.55 -36.49 coo 48.06 78.22 50.94 48.51 78.27 53.98 77.67 -37.50 -38.51 79.47 -39.58 -37.24 coo 54.85 84.16 52.60 54.26 81.23 53.34 78.82 -37.69 -29.59 80.99 -36.13 -31.14 ULMN 3 1kim_c00 THYMIDINE KINASE user 4 3 # 4 A 83 GLU B 7 GLU^? 19.70 O15 C8E B 209 A 163 ARG B 135 ARG^? 22.88 O15 C8E B 209 A 222 ARG B 200 ARG^? 11.34 O15 C8E B 209 coo 51.27 81.34 48.31 51.67 80.79 50.28 73.39 -38.66 -35.65 75.17 -39.55 -36.49 coo 48.06 78.22 50.94 48.51 78.27 53.98 77.46 -42.45 -38.74 74.50 -42.61 -39.42 coo 54.85 84.16 52.60 54.26 81.23 53.34 78.82 -37.69 -29.59 80.99 -36.13 -31.14 ULMN 3 1kim_c00 THYMIDINE KINASE user 5 3 # 5 A 83 GLU C 7 GLU^? 20.56 C16 C8E C 210 A 163 ARG C 36 ARG^? 17.98 C16 C8E C 210 A 222 ARG C 200 ARG^? 12.04 C16 C8E C 210 coo 51.27 81.34 48.31 51.67 80.79 50.28 43.33 -49.69 -35.12 43.56 -51.77 -34.52 coo 48.06 78.22 50.94 48.51 78.27 53.98 45.58 -52.92 -31.76 43.11 -54.70 -31.56 coo 54.85 84.16 52.60 54.26 81.23 53.34 37.62 -50.12 -29.23 39.44 -51.00 -26.91 ULMN 3 1kim_c00 THYMIDINE KINASE user 6 3 # 6 A 83 GLU C 7 GLU^? 20.56 C16 C8E C 210 A 163 ARG C 135 ARG^? 23.87 C16 C8E C 210 A 222 ARG C 200 ARG^? 12.04 C16 C8E C 210 coo 51.27 81.34 48.31 51.67 80.79 50.28 43.33 -49.69 -35.12 43.56 -51.77 -34.52 coo 48.06 78.22 50.94 48.51 78.27 53.98 44.01 -56.05 -34.91 45.01 -54.65 -37.44 coo 54.85 84.16 52.60 54.26 81.23 53.34 37.62 -50.12 -29.23 39.44 -51.00 -26.91 1kim_c00 source 1kim THYMIDINE KINASE : 6 hits 1kim_c00 naa= 3 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 A 14 LYS B 67 LYS~? 18.13 CA CA B 208 A 74 LYS B 63 LYS~? 3.79 CA CA B 208 A 165 GLU B 164 GLU^? 19.99 CA CA B 208 coo 24.97 5.82 58.78 26.79 1.97 55.46 89.12 -21.41 -4.23 87.66 -21.56 1.71 coo 19.46 3.44 61.93 23.95 1.12 60.13 93.18 -23.71 -7.17 90.77 -27.85 -10.83 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 94.70 -10.70 -16.52 96.59 -9.81 -16.07 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 A 14 LYS C 67 LYS.? 18.71 CA CA C 208 A 74 LYS C 63 LYS~? 4.21 CA CA C 208 A 165 GLU C 164 GLU^? 20.06 CA CA C 208 coo 24.97 5.82 58.78 26.79 1.97 55.46 20.04 -36.06 -6.98 16.11 -31.17 -7.78 coo 19.46 3.44 61.93 23.95 1.12 60.13 20.98 -41.61 -5.49 23.04 -43.67 -10.44 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 34.72 -37.11 1.76 34.46 -37.46 3.82 1kqc_c00 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 2 hits 1kqc_c00 naa= 3 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 B 14 LYS B 67 LYS~? 18.13 CA CA B 208 B 74 LYS B 63 LYS~? 3.79 CA CA B 208 B 165 GLU B 164 GLU^? 19.99 CA CA B 208 coo 4.84 5.09 23.75 3.30 1.39 27.48 89.12 -21.41 -4.23 87.66 -21.56 1.71 coo 10.43 2.88 20.75 5.72 0.41 23.95 93.18 -23.71 -7.17 90.77 -27.85 -10.83 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 94.70 -10.70 -16.52 96.59 -9.81 -16.07 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 B 14 LYS C 67 LYS.? 18.71 CA CA C 208 B 74 LYS C 63 LYS~? 4.21 CA CA C 208 B 165 GLU C 164 GLU^? 20.06 CA CA C 208 coo 4.84 5.09 23.75 3.30 1.39 27.48 20.04 -36.06 -6.98 16.11 -31.17 -7.78 coo 10.43 2.88 20.75 5.72 0.41 23.95 20.98 -41.61 -5.49 23.04 -43.67 -10.44 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 34.72 -37.11 1.76 34.46 -37.46 3.82 1kqc_c01 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 2 hits 1kqc_c01 naa= 3 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 C 14 LYS B 67 LYS~? 18.13 CA CA B 208 C 74 LYS B 63 LYS~? 3.79 CA CA B 208 C 165 GLU B 164 GLU^? 19.99 CA CA B 208 coo 17.59 37.25 25.80 19.64 34.15 21.60 89.12 -21.41 -4.23 87.66 -21.56 1.71 coo 12.29 34.52 28.11 16.84 32.47 25.43 93.18 -23.71 -7.17 90.77 -27.85 -10.83 coo 12.06 27.10 15.56 13.23 27.02 13.80 94.70 -10.70 -16.52 96.59 -9.81 -16.07 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 C 14 LYS C 67 LYS.? 18.71 CA CA C 208 C 74 LYS C 63 LYS~? 4.21 CA CA C 208 C 165 GLU C 164 GLU^? 20.06 CA CA C 208 coo 17.59 37.25 25.80 19.64 34.15 21.60 20.04 -36.06 -6.98 16.11 -31.17 -7.78 coo 12.29 34.52 28.11 16.84 32.47 25.43 20.98 -41.61 -5.49 23.04 -43.67 -10.44 coo 12.06 27.10 15.56 13.23 27.02 13.80 34.72 -37.11 1.76 34.46 -37.46 3.82 1kqc_c02 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 2 hits 1kqc_c02 naa= 3 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 D 14 LYS B 67 LYS~? 18.13 CA CA B 208 D 74 LYS B 63 LYS~? 3.79 CA CA B 208 D 165 GLU B 164 GLU^? 19.99 CA CA B 208 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 89.12 -21.41 -4.23 87.66 -21.56 1.71 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 93.18 -23.71 -7.17 90.77 -27.85 -10.83 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 94.70 -10.70 -16.52 96.59 -9.81 -16.07 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 D 14 LYS C 67 LYS.? 18.71 CA CA C 208 D 74 LYS C 63 LYS~? 4.21 CA CA C 208 D 165 GLU C 164 GLU^? 20.06 CA CA C 208 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 20.04 -36.06 -6.98 16.11 -31.17 -7.78 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 20.98 -41.61 -5.49 23.04 -43.67 -10.44 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 34.72 -37.11 1.76 34.46 -37.46 3.82 1kqc_c03 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 2 hits 1kqc_c03 naa= 3 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 1 3 # 1 255 ASP A 111 ASP.? 17.05 CA CA A 208 262 LYS A 63 LYS~? 3.96 CA CA A 208 336 ARG A 162 ARG^? 10.87 O21 C8E A 210 coo 61.88 50.78 12.96 63.84 50.60 13.71 65.36 -83.80 -40.24 66.17 -85.36 -41.35 coo 63.59 44.40 18.32 63.20 49.74 17.95 73.63 -82.49 -34.44 73.43 -77.00 -32.37 coo 72.60 57.42 15.86 71.61 56.68 18.70 60.16 -83.54 -27.36 63.31 -83.18 -27.03 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 2 3 # 2 255 ASP B 111 ASP.? 16.97 CA CA B 208 262 LYS B 63 LYS~? 3.79 CA CA B 208 336 ARG B 162 ARG^? 16.35 O21 C8E B 210 coo 61.88 50.78 12.96 63.84 50.60 13.71 89.21 -14.92 -8.80 89.40 -13.99 -6.98 coo 63.59 44.40 18.32 63.20 49.74 17.95 93.18 -23.71 -7.17 90.77 -27.85 -10.83 coo 72.60 57.42 15.86 71.61 56.68 18.70 96.21 -15.01 -19.71 98.63 -13.28 -19.03 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 3 3 # 3 255 ASP C 48 ASP.? 7.17 CA CA C 208 262 LYS C 188 LYS~? 9.02 C16 C8E C 209 336 ARG C 162 ARG^? 16.00 O21 C8E C 209 coo 61.88 50.78 12.96 63.84 50.60 13.71 26.68 -52.06 -7.74 25.46 -53.53 -8.54 coo 63.59 44.40 18.32 63.20 49.74 17.95 31.07 -55.82 -4.30 26.58 -58.21 -2.57 coo 72.60 57.42 15.86 71.61 56.68 18.70 35.66 -43.15 0.12 35.66 -43.03 3.18 1lam_c00 source 1lam LEUCINE AMINOPEPTIDASE : 3 hits 1lam_c00 naa= 3 ULMN 3 1lij_c01 ADENOSINE KINASE user 1 3 # 1 A 316 ALA A 46 ALA.? 6.64 CA CA A 208 A 317 GLY A 72 GLY^? 7.13 O21 C8E A 209 A 318 ASP A 45 ASP.? -2.96 CA CA A 208s coo 144.15 17.54 -4.21 144.96 16.79 -5.26 66.69 -74.67 -27.61 65.67 -75.06 -28.70 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 64.73 -71.23 -30.71 64.86 -70.64 -31.29 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 70.45 -71.75 -27.39 71.06 -73.65 -26.89 ULMN 3 1lij_c01 ADENOSINE KINASE user 2 3 # 2 A 316 ALA A 136 ALA^? 18.84 C1 C8E A 209 A 317 GLY A 148 GLY^? 17.63 C1 C8E A 209 A 318 ASP A 149 ASP^? 14.85 C1 C8E A 210 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 67.89 -44.74 -18.16 69.42 -44.83 -18.22 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 69.03 -47.69 -21.86 68.24 -47.54 -21.53 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 66.40 -51.17 -20.74 65.06 -51.90 -19.38 ULMN 3 1lij_c01 ADENOSINE KINASE user 3 3 # 3 A 316 ALA B 46 ALA.? 6.22 CA CA B 208 A 317 GLY B 72 GLY^? 7.04 C20 C8E B 209 A 318 ASP B 45 ASP.? -3.07 CA CA B 208s coo 144.15 17.54 -4.21 144.96 16.79 -5.26 91.46 -26.30 -19.06 90.82 -24.97 -18.73 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 86.64 -25.55 -20.04 85.82 -25.67 -19.86 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 90.60 -30.65 -18.50 91.26 -30.99 -16.60 ULMN 3 1lij_c01 ADENOSINE KINASE user 4 3 # 4 A 316 ALA B 136 ALA^? 22.19 O15 C8E B 209 A 317 GLY B 148 GLY^? 19.08 O15 C8E B 209 A 318 ASP B 149 ASP^? 14.91 O15 C8E B 209 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 76.87 -47.95 -36.51 77.18 -48.96 -35.45 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 76.61 -45.51 -32.17 76.71 -45.21 -33.00 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 79.48 -42.39 -33.32 81.04 -41.48 -34.38 ULMN 3 1lij_c01 ADENOSINE KINASE user 5 3 # 5 A 316 ALA C 46 ALA.? 6.35 CA CA C 208 A 317 GLY C 72 GLY^? 6.51 O21 C8E C 210 A 318 ASP C 45 ASP.? 3.27 CA CA C 208s coo 144.15 17.54 -4.21 144.96 16.79 -5.26 31.22 -46.48 -10.69 31.43 -45.03 -10.31 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 32.98 -43.26 -14.24 32.91 -42.76 -14.86 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 28.98 -48.61 -14.39 27.54 -48.99 -12.93 ULMN 3 1lij_c01 ADENOSINE KINASE user 6 3 # 6 A 316 ALA C 136 ALA^? 23.08 C16 C8E C 210 A 317 GLY C 148 GLY^? 19.87 C16 C8E C 210 A 318 ASP C 149 ASP^? 16.02 C16 C8E C 210 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 39.69 -58.64 -38.49 38.27 -59.07 -38.64 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 36.86 -55.05 -36.49 37.69 -55.22 -36.43 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 38.72 -55.19 -32.44 40.02 -55.93 -30.97 1lij_c01 source 1lij ADENOSINE KINASE : 6 hits 1lij_c01 naa= 3 ULMN 3 1lio_c01 ADENOSINE KINASE user 1 3 # 1 A 316 ALA A 46 ALA.? 6.64 CA CA A 208 A 317 GLY A 72 GLY^? 7.13 O21 C8E A 209 A 318 ASP A 45 ASP.? -2.96 CA CA A 208s coo 27.04 23.54 41.85 25.72 24.19 42.18 66.69 -74.67 -27.61 65.67 -75.06 -28.70 coo 27.87 23.16 38.17 28.43 22.97 38.87 64.73 -71.23 -30.71 64.86 -70.64 -31.29 coo 32.11 22.71 40.58 33.42 24.22 39.78 70.45 -71.75 -27.39 71.06 -73.65 -26.89 ULMN 3 1lio_c01 ADENOSINE KINASE user 2 3 # 2 A 316 ALA A 136 ALA^? 18.84 C1 C8E A 209 A 317 GLY A 148 GLY^? 17.63 C1 C8E A 209 A 318 ASP A 149 ASP^? 14.85 C1 C8E A 210 coo 27.04 23.54 41.85 25.72 24.19 42.18 67.89 -44.74 -18.16 69.42 -44.83 -18.22 coo 27.87 23.16 38.17 28.43 22.97 38.87 69.03 -47.69 -21.86 68.24 -47.54 -21.53 coo 32.11 22.71 40.58 33.42 24.22 39.78 66.40 -51.17 -20.74 65.06 -51.90 -19.38 ULMN 3 1lio_c01 ADENOSINE KINASE user 3 3 # 3 A 316 ALA B 46 ALA.? 6.22 CA CA B 208 A 317 GLY B 72 GLY^? 7.04 C20 C8E B 209 A 318 ASP B 45 ASP.? -3.07 CA CA B 208s coo 27.04 23.54 41.85 25.72 24.19 42.18 91.46 -26.30 -19.06 90.82 -24.97 -18.73 coo 27.87 23.16 38.17 28.43 22.97 38.87 86.64 -25.55 -20.04 85.82 -25.67 -19.86 coo 32.11 22.71 40.58 33.42 24.22 39.78 90.60 -30.65 -18.50 91.26 -30.99 -16.60 ULMN 3 1lio_c01 ADENOSINE KINASE user 4 3 # 4 A 316 ALA B 136 ALA^? 22.19 O15 C8E B 209 A 317 GLY B 148 GLY^? 19.08 O15 C8E B 209 A 318 ASP B 149 ASP^? 14.91 O15 C8E B 209 coo 27.04 23.54 41.85 25.72 24.19 42.18 76.87 -47.95 -36.51 77.18 -48.96 -35.45 coo 27.87 23.16 38.17 28.43 22.97 38.87 76.61 -45.51 -32.17 76.71 -45.21 -33.00 coo 32.11 22.71 40.58 33.42 24.22 39.78 79.48 -42.39 -33.32 81.04 -41.48 -34.38 ULMN 3 1lio_c01 ADENOSINE KINASE user 5 3 # 5 A 316 ALA C 46 ALA.? 6.35 CA CA C 208 A 317 GLY C 72 GLY^? 6.51 O21 C8E C 210 A 318 ASP C 45 ASP.? 3.27 CA CA C 208s coo 27.04 23.54 41.85 25.72 24.19 42.18 31.22 -46.48 -10.69 31.43 -45.03 -10.31 coo 27.87 23.16 38.17 28.43 22.97 38.87 32.98 -43.26 -14.24 32.91 -42.76 -14.86 coo 32.11 22.71 40.58 33.42 24.22 39.78 28.98 -48.61 -14.39 27.54 -48.99 -12.93 ULMN 3 1lio_c01 ADENOSINE KINASE user 6 3 # 6 A 316 ALA C 136 ALA^? 23.08 C16 C8E C 210 A 317 GLY C 148 GLY^? 19.87 C16 C8E C 210 A 318 ASP C 149 ASP^? 16.02 C16 C8E C 210 coo 27.04 23.54 41.85 25.72 24.19 42.18 39.69 -58.64 -38.49 38.27 -59.07 -38.64 coo 27.87 23.16 38.17 28.43 22.97 38.87 36.86 -55.05 -36.49 37.69 -55.22 -36.43 coo 32.11 22.71 40.58 33.42 24.22 39.78 38.72 -55.19 -32.44 40.02 -55.93 -30.97 1lio_c01 source 1lio ADENOSINE KINASE : 6 hits 1lio_c01 naa= 3 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 45 ASP.? -2.96 CA CA A 208s A 295 GLU A 70 GLU^? -2.69 CA CA A 208s A 369 ASP A 49 ASP.? -3.00 CA CA A 208s coo 11.74 38.14 80.19 10.63 36.40 80.65 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo 16.11 33.72 80.99 14.10 33.54 81.63 68.79 -75.79 -31.87 70.14 -76.30 -30.27 coo 12.19 31.08 87.29 11.13 32.66 86.38 75.72 -77.89 -27.98 74.67 -77.10 -29.65 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP A 49 ASP.? -3.00 CA CA A 208s A 295 GLU A 70 GLU^? -2.69 CA CA A 208s A 369 ASP A 45 ASP.? -2.96 CA CA A 208s coo 11.74 38.14 80.19 10.63 36.40 80.65 75.72 -77.89 -27.98 74.67 -77.10 -29.65 coo 16.11 33.72 80.99 14.10 33.54 81.63 68.79 -75.79 -31.87 70.14 -76.30 -30.27 coo 12.19 31.08 87.29 11.13 32.66 86.38 70.45 -71.75 -27.39 71.06 -73.65 -26.89 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 3 3 # 3 A 241 ASP A 185 ASP~? 11.73 O21 C8E A 210 A 295 GLU A 184 GLU~? 7.72 C16 C8E A 210 A 369 ASP A 180 ASP.? 14.47 O15 C8E A 210 coo 11.74 38.14 80.19 10.63 36.40 80.65 65.81 -86.27 -18.22 66.54 -87.64 -16.78 coo 16.11 33.72 80.99 14.10 33.54 81.63 63.73 -84.37 -12.45 63.45 -82.45 -11.70 coo 12.19 31.08 87.29 11.13 32.66 86.38 55.45 -86.10 -15.44 53.65 -85.04 -15.38 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 4 3 # 4 A 241 ASP B 45 ASP.? -3.07 CA CA B 208s A 295 GLU B 70 GLU^? -2.58 CA CA B 208s A 369 ASP B 49 ASP.? -3.05 CA CA B 208s coo 11.74 38.14 80.19 10.63 36.40 80.65 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo 16.11 33.72 80.99 14.10 33.54 81.63 89.83 -24.96 -14.47 91.03 -26.69 -14.39 coo 12.19 31.08 87.29 11.13 32.66 86.38 94.52 -28.97 -11.62 93.03 -30.41 -11.73 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 5 3 # 5 A 241 ASP B 49 ASP.? -3.05 CA CA B 208s A 295 GLU B 70 GLU^? -2.58 CA CA B 208s A 369 ASP B 45 ASP.? -3.07 CA CA B 208s coo 11.74 38.14 80.19 10.63 36.40 80.65 94.52 -28.97 -11.62 93.03 -30.41 -11.73 coo 16.11 33.72 80.99 14.10 33.54 81.63 89.83 -24.96 -14.47 91.03 -26.69 -14.39 coo 12.19 31.08 87.29 11.13 32.66 86.38 90.60 -30.65 -18.50 91.26 -30.99 -16.60 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 6 3 # 6 A 241 ASP B 111 ASP.? 16.97 CA CA B 208 A 295 GLU B 113 GLU.? 20.51 CA CA B 208 A 369 ASP B 167 ASP.? 22.72 CA CA B 208 coo 11.74 38.14 80.19 10.63 36.40 80.65 89.21 -14.92 -8.80 89.40 -13.99 -6.98 coo 16.11 33.72 80.99 14.10 33.54 81.63 86.78 -12.34 -3.10 88.60 -11.66 -4.00 coo 12.19 31.08 87.29 11.13 32.66 86.38 88.92 -5.85 -9.56 88.92 -7.42 -8.19 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 7 3 # 7 A 241 ASP B 185 ASP~? 11.63 O21 C8E B 210 A 295 GLU B 184 GLU~? 8.45 C14 C8E B 210 A 369 ASP B 180 ASP.? 10.93 C4 C8E B 210 coo 11.74 38.14 80.19 10.63 36.40 80.65 106.30 -23.80 -20.43 108.26 -24.54 -20.08 coo 16.11 33.72 80.99 14.10 33.54 81.63 107.80 -26.84 -26.43 109.06 -28.52 -26.54 coo 12.19 31.08 87.29 11.13 32.66 86.38 106.50 -18.19 -29.27 105.54 -17.21 -30.85 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 8 3 # 8 A 241 ASP C 45 ASP.? 3.27 CA CA C 208s A 295 GLU C 70 GLU^? -2.71 CA CA C 208s A 369 ASP C 49 ASP.? -2.87 CA CA C 208s coo 11.74 38.14 80.19 10.63 36.40 80.65 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo 16.11 33.72 80.99 14.10 33.54 81.63 27.73 -42.94 -10.42 26.74 -44.79 -10.37 coo 12.19 31.08 87.29 11.13 32.66 86.38 22.13 -48.50 -9.42 23.00 -46.66 -10.00 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 9 3 # 9 A 241 ASP C 49 ASP.? -2.87 CA CA C 208s A 295 GLU C 70 GLU^? -2.71 CA CA C 208s A 369 ASP C 45 ASP.? 3.27 CA CA C 208s coo 11.74 38.14 80.19 10.63 36.40 80.65 22.13 -48.50 -9.42 23.00 -46.66 -10.00 coo 16.11 33.72 80.99 14.10 33.54 81.63 27.73 -42.94 -10.42 26.74 -44.79 -10.37 coo 12.19 31.08 87.29 11.13 32.66 86.38 28.98 -48.61 -14.39 27.54 -48.99 -12.93 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 10 3 # 10 A 241 ASP C 61 ASP~? 12.61 CA CA C 208 A 295 GLU C 64 GLU~? 12.03 CA CA C 208 A 369 ASP C 49 ASP.? -2.87 CA CA C 208s coo 11.74 38.14 80.19 10.63 36.40 80.65 16.71 -46.53 -3.05 15.59 -48.22 -3.69 coo 16.11 33.72 80.99 14.10 33.54 81.63 16.47 -41.84 -8.31 14.60 -42.35 -9.15 coo 12.19 31.08 87.29 11.13 32.66 86.38 22.13 -48.50 -9.42 23.00 -46.66 -10.00 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 11 3 # 11 A 241 ASP C 111 ASP.? 17.21 CA CA C 208 A 295 GLU C 113 GLU.? 20.72 CA CA C 208 A 369 ASP C 167 ASP.? 25.18 CA CA C 208 coo 11.74 38.14 80.19 10.63 36.40 80.65 27.11 -33.17 -3.90 25.73 -31.94 -3.00 coo 16.11 33.72 80.99 14.10 33.54 81.63 22.93 -28.02 -2.65 24.78 -28.62 -1.78 coo 12.19 31.08 87.29 11.13 32.66 86.38 31.39 -27.44 2.08 30.34 -25.78 1.31 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 12 3 # 12 A 241 ASP C 166 ASP.? 24.81 CA CA C 208 A 295 GLU C 165 GLU^? 20.98 CA CA C 208 A 369 ASP C 111 ASP.? 17.21 CA CA C 208 coo 11.74 38.14 80.19 10.63 36.40 80.65 35.75 -30.25 2.83 35.54 -31.07 4.76 coo 16.11 33.72 80.99 14.10 33.54 81.63 36.32 -31.59 -2.15 36.97 -31.00 -4.08 coo 12.19 31.08 87.29 11.13 32.66 86.38 27.11 -33.17 -3.90 25.73 -31.94 -3.00 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 13 3 # 13 A 241 ASP C 167 ASP.? 25.18 CA CA C 208 A 295 GLU C 165 GLU^? 20.98 CA CA C 208 A 369 ASP C 111 ASP.? 17.21 CA CA C 208 coo 11.74 38.14 80.19 10.63 36.40 80.65 31.39 -27.44 2.08 30.34 -25.78 1.31 coo 16.11 33.72 80.99 14.10 33.54 81.63 36.32 -31.59 -2.15 36.97 -31.00 -4.08 coo 12.19 31.08 87.29 11.13 32.66 86.38 27.11 -33.17 -3.90 25.73 -31.94 -3.00 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 14 3 # 14 A 241 ASP C 185 ASP~? 11.81 O21 C8E C 209 A 295 GLU C 184 GLU~? 7.93 C14 C8E C 209 A 369 ASP C 180 ASP.? 12.29 C5 C8E C 209 coo 11.74 38.14 80.19 10.63 36.40 80.65 31.89 -54.53 1.93 31.11 -55.91 3.29 coo 16.11 33.72 80.99 14.10 33.54 81.63 35.72 -59.91 1.24 36.69 -61.13 -0.21 coo 12.19 31.08 87.29 11.13 32.66 86.38 42.24 -54.49 3.97 44.24 -53.90 3.82 1m53_c03 source 1m53 ISOMALTULOSE SYNTHASE : 14 hits 1m53_c03 naa= 3 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 48 ASP.? 7.38 CA CA A 208 A 265 GLU A 164 GLU^? 19.19 O21 C8E A 210 A 369 ASP A 185 ASP~? 11.73 O21 C8E A 210 coo 11.74 38.14 80.19 10.63 36.40 80.65 72.05 -78.20 -23.17 73.82 -77.79 -22.11 coo 17.36 23.57 72.04 18.68 21.92 71.98 57.65 -86.15 -32.10 58.08 -88.26 -31.94 coo 12.19 31.08 87.29 11.13 32.66 86.38 65.81 -86.27 -18.22 66.54 -87.64 -16.78 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP A 52 ASP.? 15.11 CA CA A 208 A 265 GLU A 64 GLU~? 12.36 CA CA A 208 A 369 ASP A 48 ASP.? 7.38 CA CA A 208 coo 11.74 38.14 80.19 10.63 36.40 80.65 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo 17.36 23.57 72.04 18.68 21.92 71.98 79.25 -82.11 -37.14 78.75 -80.37 -38.23 coo 12.19 31.08 87.29 11.13 32.66 86.38 72.05 -78.20 -23.17 73.82 -77.79 -22.11 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 3 3 # 3 A 241 ASP A 52 ASP.? 15.11 CA CA A 208 A 265 GLU A 70 GLU^? -2.69 CA CA A 208s A 369 ASP A 185 ASP~? 11.73 O21 C8E A 210 coo 11.74 38.14 80.19 10.63 36.40 80.65 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo 17.36 23.57 72.04 18.68 21.92 71.98 68.79 -75.79 -31.87 70.14 -76.30 -30.27 coo 12.19 31.08 87.29 11.13 32.66 86.38 65.81 -86.27 -18.22 66.54 -87.64 -16.78 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 4 3 # 4 A 241 ASP A 180 ASP.? 14.47 O15 C8E A 210 A 265 GLU A 164 GLU^? 19.19 O21 C8E A 210 A 369 ASP A 185 ASP~? 11.73 O21 C8E A 210 coo 11.74 38.14 80.19 10.63 36.40 80.65 55.45 -86.10 -15.44 53.65 -85.04 -15.38 coo 17.36 23.57 72.04 18.68 21.92 71.98 57.65 -86.15 -32.10 58.08 -88.26 -31.94 coo 12.19 31.08 87.29 11.13 32.66 86.38 65.81 -86.27 -18.22 66.54 -87.64 -16.78 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 5 3 # 5 A 241 ASP A 180 ASP.? 14.47 O15 C8E A 210 A 265 GLU A 194 GLU.? 3.11 C17 C8E A 210s A 369 ASP A 185 ASP~? 11.73 O21 C8E A 210 coo 11.74 38.14 80.19 10.63 36.40 80.65 55.45 -86.10 -15.44 53.65 -85.04 -15.38 coo 17.36 23.57 72.04 18.68 21.92 71.98 66.12 -70.72 -14.05 67.03 -72.48 -13.31 coo 12.19 31.08 87.29 11.13 32.66 86.38 65.81 -86.27 -18.22 66.54 -87.64 -16.78 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 6 3 # 6 A 241 ASP A 185 ASP~? 11.73 O21 C8E A 210 A 265 GLU A 70 GLU^? -2.69 CA CA A 208s A 369 ASP A 52 ASP.? 15.11 CA CA A 208 coo 11.74 38.14 80.19 10.63 36.40 80.65 65.81 -86.27 -18.22 66.54 -87.64 -16.78 coo 17.36 23.57 72.04 18.68 21.92 71.98 68.79 -75.79 -31.87 70.14 -76.30 -30.27 coo 12.19 31.08 87.29 11.13 32.66 86.38 76.18 -86.89 -22.52 75.57 -87.62 -20.65 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 7 3 # 7 A 241 ASP A 185 ASP~? 11.73 O21 C8E A 210 A 265 GLU A 164 GLU^? 19.19 O21 C8E A 210 A 369 ASP A 48 ASP.? 7.38 CA CA A 208 coo 11.74 38.14 80.19 10.63 36.40 80.65 65.81 -86.27 -18.22 66.54 -87.64 -16.78 coo 17.36 23.57 72.04 18.68 21.92 71.98 57.65 -86.15 -32.10 58.08 -88.26 -31.94 coo 12.19 31.08 87.29 11.13 32.66 86.38 72.05 -78.20 -23.17 73.82 -77.79 -22.11 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 8 3 # 8 A 241 ASP A 185 ASP~? 11.73 O21 C8E A 210 A 265 GLU A 164 GLU^? 19.19 O21 C8E A 210 A 369 ASP A 180 ASP.? 14.47 O15 C8E A 210 coo 11.74 38.14 80.19 10.63 36.40 80.65 65.81 -86.27 -18.22 66.54 -87.64 -16.78 coo 17.36 23.57 72.04 18.68 21.92 71.98 57.65 -86.15 -32.10 58.08 -88.26 -31.94 coo 12.19 31.08 87.29 11.13 32.66 86.38 55.45 -86.10 -15.44 53.65 -85.04 -15.38 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 9 3 # 9 A 241 ASP A 185 ASP~? 11.73 O21 C8E A 210 A 265 GLU A 194 GLU.? 3.11 C17 C8E A 210s A 369 ASP A 180 ASP.? 14.47 O15 C8E A 210 coo 11.74 38.14 80.19 10.63 36.40 80.65 65.81 -86.27 -18.22 66.54 -87.64 -16.78 coo 17.36 23.57 72.04 18.68 21.92 71.98 66.12 -70.72 -14.05 67.03 -72.48 -13.31 coo 12.19 31.08 87.29 11.13 32.66 86.38 55.45 -86.10 -15.44 53.65 -85.04 -15.38 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 10 3 # 10 A 241 ASP B 48 ASP.? 7.20 CA CA B 208 A 265 GLU B 64 GLU~? 12.78 CA CA B 208 A 369 ASP B 52 ASP.? 15.59 CA CA B 208 coo 11.74 38.14 80.19 10.63 36.40 80.65 97.60 -30.12 -16.68 98.20 -32.01 -15.99 coo 17.36 23.57 72.04 18.68 21.92 71.98 92.75 -26.79 -1.73 90.87 -27.74 -1.56 coo 12.19 31.08 87.29 11.13 32.66 86.38 105.61 -28.95 -11.53 106.78 -28.70 -9.81 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 11 3 # 11 A 241 ASP B 49 ASP.? -3.05 CA CA B 208s A 265 GLU B 194 GLU.? 2.86 C13 C8E B 210s A 369 ASP B 52 ASP.? 15.59 CA CA B 208 coo 11.74 38.14 80.19 10.63 36.40 80.65 94.52 -28.97 -11.62 93.03 -30.41 -11.73 coo 17.36 23.57 72.04 18.68 21.92 71.98 97.88 -33.97 -28.78 99.62 -34.16 -27.58 coo 12.19 31.08 87.29 11.13 32.66 86.38 105.61 -28.95 -11.53 106.78 -28.70 -9.81 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 12 3 # 12 A 241 ASP B 52 ASP.? 15.59 CA CA B 208 A 265 GLU B 64 GLU~? 12.78 CA CA B 208 A 369 ASP B 48 ASP.? 7.20 CA CA B 208 coo 11.74 38.14 80.19 10.63 36.40 80.65 105.61 -28.95 -11.53 106.78 -28.70 -9.81 coo 17.36 23.57 72.04 18.68 21.92 71.98 92.75 -26.79 -1.73 90.87 -27.74 -1.56 coo 12.19 31.08 87.29 11.13 32.66 86.38 97.60 -30.12 -16.68 98.20 -32.01 -15.99 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 13 3 # 13 A 241 ASP B 52 ASP.? 15.59 CA CA B 208 A 265 GLU B 70 GLU^? -2.58 CA CA B 208s A 369 ASP B 185 ASP~? 11.63 O21 C8E B 210 coo 11.74 38.14 80.19 10.63 36.40 80.65 105.61 -28.95 -11.53 106.78 -28.70 -9.81 coo 17.36 23.57 72.04 18.68 21.92 71.98 89.83 -24.96 -14.47 91.03 -26.69 -14.39 coo 12.19 31.08 87.29 11.13 32.66 86.38 106.30 -23.80 -20.43 108.26 -24.54 -20.08 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 14 3 # 14 A 241 ASP B 52 ASP.? 15.59 CA CA B 208 A 265 GLU B 194 GLU.? 2.86 C13 C8E B 210s A 369 ASP B 49 ASP.? -3.05 CA CA B 208s coo 11.74 38.14 80.19 10.63 36.40 80.65 105.61 -28.95 -11.53 106.78 -28.70 -9.81 coo 17.36 23.57 72.04 18.68 21.92 71.98 97.88 -33.97 -28.78 99.62 -34.16 -27.58 coo 12.19 31.08 87.29 11.13 32.66 86.38 94.52 -28.97 -11.62 93.03 -30.41 -11.73 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 15 3 # 15 A 241 ASP B 180 ASP.? 10.93 C4 C8E B 210 A 265 GLU B 164 GLU^? 19.99 CA CA B 208 A 369 ASP B 185 ASP~? 11.63 O21 C8E B 210 coo 11.74 38.14 80.19 10.63 36.40 80.65 106.50 -18.19 -29.27 105.54 -17.21 -30.85 coo 17.36 23.57 72.04 18.68 21.92 71.98 94.70 -10.70 -16.52 96.59 -9.81 -16.07 coo 12.19 31.08 87.29 11.13 32.66 86.38 106.30 -23.80 -20.43 108.26 -24.54 -20.08 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 16 3 # 16 A 241 ASP B 185 ASP~? 11.63 O21 C8E B 210 A 265 GLU B 70 GLU^? -2.58 CA CA B 208s A 369 ASP B 52 ASP.? 15.59 CA CA B 208 coo 11.74 38.14 80.19 10.63 36.40 80.65 106.30 -23.80 -20.43 108.26 -24.54 -20.08 coo 17.36 23.57 72.04 18.68 21.92 71.98 89.83 -24.96 -14.47 91.03 -26.69 -14.39 coo 12.19 31.08 87.29 11.13 32.66 86.38 105.61 -28.95 -11.53 106.78 -28.70 -9.81 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 17 3 # 17 A 241 ASP B 185 ASP~? 11.63 O21 C8E B 210 A 265 GLU B 164 GLU^? 19.99 CA CA B 208 A 369 ASP B 48 ASP.? 7.20 CA CA B 208 coo 11.74 38.14 80.19 10.63 36.40 80.65 106.30 -23.80 -20.43 108.26 -24.54 -20.08 coo 17.36 23.57 72.04 18.68 21.92 71.98 94.70 -10.70 -16.52 96.59 -9.81 -16.07 coo 12.19 31.08 87.29 11.13 32.66 86.38 97.60 -30.12 -16.68 98.20 -32.01 -15.99 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 18 3 # 18 A 241 ASP B 185 ASP~? 11.63 O21 C8E B 210 A 265 GLU B 164 GLU^? 19.99 CA CA B 208 A 369 ASP B 180 ASP.? 10.93 C4 C8E B 210 coo 11.74 38.14 80.19 10.63 36.40 80.65 106.30 -23.80 -20.43 108.26 -24.54 -20.08 coo 17.36 23.57 72.04 18.68 21.92 71.98 94.70 -10.70 -16.52 96.59 -9.81 -16.07 coo 12.19 31.08 87.29 11.13 32.66 86.38 106.50 -18.19 -29.27 105.54 -17.21 -30.85 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 19 3 # 19 A 241 ASP B 185 ASP~? 11.63 O21 C8E B 210 A 265 GLU B 194 GLU.? 2.86 C13 C8E B 210s A 369 ASP B 52 ASP.? 15.59 CA CA B 208 coo 11.74 38.14 80.19 10.63 36.40 80.65 106.30 -23.80 -20.43 108.26 -24.54 -20.08 coo 17.36 23.57 72.04 18.68 21.92 71.98 97.88 -33.97 -28.78 99.62 -34.16 -27.58 coo 12.19 31.08 87.29 11.13 32.66 86.38 105.61 -28.95 -11.53 106.78 -28.70 -9.81 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 20 3 # 20 A 241 ASP B 185 ASP~? 11.63 O21 C8E B 210 A 265 GLU B 194 GLU.? 2.86 C13 C8E B 210s A 369 ASP B 180 ASP.? 10.93 C4 C8E B 210 coo 11.74 38.14 80.19 10.63 36.40 80.65 106.30 -23.80 -20.43 108.26 -24.54 -20.08 coo 17.36 23.57 72.04 18.68 21.92 71.98 97.88 -33.97 -28.78 99.62 -34.16 -27.58 coo 12.19 31.08 87.29 11.13 32.66 86.38 106.50 -18.19 -29.27 105.54 -17.21 -30.85 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 21 3 # 21 A 241 ASP C 48 ASP.? 7.17 CA CA C 208 A 265 GLU C 164 GLU^? 20.06 CA CA C 208 A 369 ASP C 185 ASP~? 11.81 O21 C8E C 209 coo 11.74 38.14 80.19 10.63 36.40 80.65 26.68 -52.06 -7.74 25.46 -53.53 -8.54 coo 17.36 23.57 72.04 18.68 21.92 71.98 34.72 -37.11 1.76 34.46 -37.46 3.82 coo 12.19 31.08 87.29 11.13 32.66 86.38 31.89 -54.53 1.93 31.11 -55.91 3.29 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 22 3 # 22 A 241 ASP C 49 ASP.? -2.87 CA CA C 208s A 265 GLU C 194 GLU.? 3.24 O15 C8E C 209s A 369 ASP C 52 ASP.? 15.77 CA CA C 208 coo 11.74 38.14 80.19 10.63 36.40 80.65 22.13 -48.50 -9.42 23.00 -46.66 -10.00 coo 17.36 23.57 72.04 18.68 21.92 71.98 36.17 -59.59 -12.28 34.91 -60.51 -10.83 coo 12.19 31.08 87.29 11.13 32.66 86.38 21.29 -54.58 -0.38 20.26 -54.47 1.43 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 23 3 # 23 A 241 ASP C 52 ASP.? 15.77 CA CA C 208 A 265 GLU C 70 GLU^? -2.71 CA CA C 208s A 369 ASP C 185 ASP~? 11.81 O21 C8E C 209 coo 11.74 38.14 80.19 10.63 36.40 80.65 21.29 -54.58 -0.38 20.26 -54.47 1.43 coo 17.36 23.57 72.04 18.68 21.92 71.98 27.73 -42.94 -10.42 26.74 -44.79 -10.37 coo 12.19 31.08 87.29 11.13 32.66 86.38 31.89 -54.53 1.93 31.11 -55.91 3.29 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 24 3 # 24 A 241 ASP C 180 ASP.? 12.29 C5 C8E C 209 A 265 GLU C 164 GLU^? 20.06 CA CA C 208 A 369 ASP C 185 ASP~? 11.81 O21 C8E C 209 coo 11.74 38.14 80.19 10.63 36.40 80.65 42.24 -54.49 3.97 44.24 -53.90 3.82 coo 17.36 23.57 72.04 18.68 21.92 71.98 34.72 -37.11 1.76 34.46 -37.46 3.82 coo 12.19 31.08 87.29 11.13 32.66 86.38 31.89 -54.53 1.93 31.11 -55.91 3.29 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 25 3 # 25 A 241 ASP C 185 ASP~? 11.81 O21 C8E C 209 A 265 GLU C 70 GLU^? -2.71 CA CA C 208s A 369 ASP C 52 ASP.? 15.77 CA CA C 208 coo 11.74 38.14 80.19 10.63 36.40 80.65 31.89 -54.53 1.93 31.11 -55.91 3.29 coo 17.36 23.57 72.04 18.68 21.92 71.98 27.73 -42.94 -10.42 26.74 -44.79 -10.37 coo 12.19 31.08 87.29 11.13 32.66 86.38 21.29 -54.58 -0.38 20.26 -54.47 1.43 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 26 3 # 26 A 241 ASP C 185 ASP~? 11.81 O21 C8E C 209 A 265 GLU C 164 GLU^? 20.06 CA CA C 208 A 369 ASP C 48 ASP.? 7.17 CA CA C 208 coo 11.74 38.14 80.19 10.63 36.40 80.65 31.89 -54.53 1.93 31.11 -55.91 3.29 coo 17.36 23.57 72.04 18.68 21.92 71.98 34.72 -37.11 1.76 34.46 -37.46 3.82 coo 12.19 31.08 87.29 11.13 32.66 86.38 26.68 -52.06 -7.74 25.46 -53.53 -8.54 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 27 3 # 27 A 241 ASP C 185 ASP~? 11.81 O21 C8E C 209 A 265 GLU C 164 GLU^? 20.06 CA CA C 208 A 369 ASP C 180 ASP.? 12.29 C5 C8E C 209 coo 11.74 38.14 80.19 10.63 36.40 80.65 31.89 -54.53 1.93 31.11 -55.91 3.29 coo 17.36 23.57 72.04 18.68 21.92 71.98 34.72 -37.11 1.76 34.46 -37.46 3.82 coo 12.19 31.08 87.29 11.13 32.66 86.38 42.24 -54.49 3.97 44.24 -53.90 3.82 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 28 3 # 28 A 241 ASP C 185 ASP~? 11.81 O21 C8E C 209 A 265 GLU C 194 GLU.? 3.24 O15 C8E C 209s A 369 ASP C 52 ASP.? 15.77 CA CA C 208 coo 11.74 38.14 80.19 10.63 36.40 80.65 31.89 -54.53 1.93 31.11 -55.91 3.29 coo 17.36 23.57 72.04 18.68 21.92 71.98 36.17 -59.59 -12.28 34.91 -60.51 -10.83 coo 12.19 31.08 87.29 11.13 32.66 86.38 21.29 -54.58 -0.38 20.26 -54.47 1.43 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 29 3 # 29 A 241 ASP C 185 ASP~? 11.81 O21 C8E C 209 A 265 GLU C 194 GLU.? 3.24 O15 C8E C 209s A 369 ASP C 180 ASP.? 12.29 C5 C8E C 209 coo 11.74 38.14 80.19 10.63 36.40 80.65 31.89 -54.53 1.93 31.11 -55.91 3.29 coo 17.36 23.57 72.04 18.68 21.92 71.98 36.17 -59.59 -12.28 34.91 -60.51 -10.83 coo 12.19 31.08 87.29 11.13 32.66 86.38 42.24 -54.49 3.97 44.24 -53.90 3.82 1m53_c05 source 1m53 ISOMALTULOSE SYNTHASE : 29 hits 1m53_c05 naa= 3 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 149 ASP^? 14.85 C1 C8E A 210 A 279 GLU B 7 GLU^? 19.70 O15 C8E B 209 A 369 ASP A 80 ASP^? 12.60 C1 C8E A 210 coo 11.74 38.14 80.19 10.63 36.40 80.65 66.40 -51.17 -20.74 65.06 -51.90 -19.38 coo 16.54 46.37 63.94 14.77 45.79 62.95 73.39 -38.66 -35.65 75.17 -39.55 -36.49 coo 12.19 31.08 87.29 11.13 32.66 86.38 58.12 -52.30 -15.93 59.10 -53.68 -17.13 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP B 49 ASP.? -3.05 CA CA B 208s A 279 GLU B 113 GLU.? 20.51 CA CA B 208 A 369 ASP B 52 ASP.? 15.59 CA CA B 208 coo 11.74 38.14 80.19 10.63 36.40 80.65 94.52 -28.97 -11.62 93.03 -30.41 -11.73 coo 16.54 46.37 63.94 14.77 45.79 62.95 86.78 -12.34 -3.10 88.60 -11.66 -4.00 coo 12.19 31.08 87.29 11.13 32.66 86.38 105.61 -28.95 -11.53 106.78 -28.70 -9.81 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 3 3 # 3 A 241 ASP B 61 ASP~? 12.48 CA CA B 208 A 279 GLU B 113 GLU.? 20.51 CA CA B 208 A 369 ASP B 52 ASP.? 15.59 CA CA B 208 coo 11.74 38.14 80.19 10.63 36.40 80.65 98.68 -27.22 -4.60 99.30 -29.23 -4.23 coo 16.54 46.37 63.94 14.77 45.79 62.95 86.78 -12.34 -3.10 88.60 -11.66 -4.00 coo 12.19 31.08 87.29 11.13 32.66 86.38 105.61 -28.95 -11.53 106.78 -28.70 -9.81 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 4 3 # 4 A 241 ASP B 149 ASP^? 14.91 O15 C8E B 209 A 279 GLU A 7 GLU^? 19.52 C17 C8E A 209 A 369 ASP B 80 ASP^? 15.94 O15 C8E B 209 coo 11.74 38.14 80.19 10.63 36.40 80.65 79.48 -42.39 -33.32 81.04 -41.48 -34.38 coo 16.54 46.37 63.94 14.77 45.79 62.95 61.29 -47.52 -25.12 61.48 -48.69 -23.33 coo 12.19 31.08 87.29 11.13 32.66 86.38 82.56 -37.87 -41.00 82.97 -37.16 -39.06 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 5 3 # 5 A 241 ASP C 61 ASP~? 12.61 CA CA C 208 A 279 GLU C 113 GLU.? 20.72 CA CA C 208 A 369 ASP C 52 ASP.? 15.77 CA CA C 208 coo 11.74 38.14 80.19 10.63 36.40 80.65 16.71 -46.53 -3.05 15.59 -48.22 -3.69 coo 16.54 46.37 63.94 14.77 45.79 62.95 22.93 -28.02 -2.65 24.78 -28.62 -1.78 coo 12.19 31.08 87.29 11.13 32.66 86.38 21.29 -54.58 -0.38 20.26 -54.47 1.43 1m53_c06 source 1m53 ISOMALTULOSE SYNTHASE : 5 hits 1m53_c06 naa= 3 ULMN 3 1mbb_c00 URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYuser 1 3 # 1 159 ARG A 36 ARG^? 15.77 C1 C8E A 210 229 SER A 5 SER^? 24.40 C2 C8E C 209 325 GLU A 7 GLU^? 19.52 C17 C8E A 209 coo 2.54 15.84 18.57 3.24 17.85 16.30 59.00 -50.13 -20.90 61.68 -51.06 -19.88 coo 10.17 13.48 15.92 9.61 15.76 15.27 55.35 -42.73 -25.42 56.65 -41.65 -23.68 coo 5.42 13.04 19.75 5.74 13.81 17.79 61.29 -47.52 -25.12 61.48 -48.69 -23.33 ULMN 3 1mbb_c00 URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYuser 2 3 # 2 159 ARG A 162 ARG^? 10.87 O21 C8E A 210 229 SER A 172 SER^? 21.14 O21 C8E A 210 325 GLU A 164 GLU^? 19.19 O21 C8E A 210 coo 2.54 15.84 18.57 3.24 17.85 16.30 60.16 -83.54 -27.36 63.31 -83.18 -27.03 coo 10.17 13.48 15.92 9.61 15.76 15.27 52.39 -86.47 -32.61 53.25 -88.25 -31.26 coo 5.42 13.04 19.75 5.74 13.81 17.79 57.65 -86.15 -32.10 58.08 -88.26 -31.94 ULMN 3 1mbb_c00 URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYuser 3 3 # 3 159 ARG A 162 ARG^? 10.87 O21 C8E A 210 229 SER A 174 SER^? 15.95 O21 C8E A 210 325 GLU A 164 GLU^? 19.19 O21 C8E A 210 coo 2.54 15.84 18.57 3.24 17.85 16.30 60.16 -83.54 -27.36 63.31 -83.18 -27.03 coo 10.17 13.48 15.92 9.61 15.76 15.27 52.92 -84.93 -25.72 55.12 -85.87 -26.20 coo 5.42 13.04 19.75 5.74 13.81 17.79 57.65 -86.15 -32.10 58.08 -88.26 -31.94 ULMN 3 1mbb_c00 URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYuser 4 3 # 4 159 ARG B 36 ARG^? 17.08 O15 C8E B 209 229 SER B 5 SER^? 27.72 O15 C8E B 209 325 GLU B 7 GLU^? 19.70 O15 C8E B 209 coo 2.54 15.84 18.57 3.24 17.85 16.30 77.67 -37.50 -38.51 79.47 -39.58 -37.24 coo 10.17 13.48 15.92 9.61 15.76 15.27 68.96 -37.45 -41.77 69.21 -39.86 -42.14 coo 5.42 13.04 19.75 5.74 13.81 17.79 73.39 -38.66 -35.65 75.17 -39.55 -36.49 ULMN 3 1mbb_c00 URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYuser 5 3 # 5 159 ARG B 162 ARG^? 16.35 O21 C8E B 210 229 SER B 172 SER^? 21.23 O21 C8E B 210 325 GLU B 164 GLU^? 19.99 CA CA B 208 coo 2.54 15.84 18.57 3.24 17.85 16.30 96.21 -15.01 -19.71 98.63 -13.28 -19.03 coo 10.17 13.48 15.92 9.61 15.76 15.27 94.19 -7.30 -21.74 95.99 -8.03 -20.24 coo 5.42 13.04 19.75 5.74 13.81 17.79 94.70 -10.70 -16.52 96.59 -9.81 -16.07 ULMN 3 1mbb_c00 URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYuser 6 3 # 6 159 ARG C 36 ARG^? 17.98 C16 C8E C 210 229 SER C 5 SER^? 28.64 C16 C8E C 210 325 GLU C 7 GLU^? 20.56 C16 C8E C 210 coo 2.54 15.84 18.57 3.24 17.85 16.30 45.58 -52.92 -31.76 43.11 -54.70 -31.56 coo 10.17 13.48 15.92 9.61 15.76 15.27 50.03 -48.53 -38.83 49.40 -50.39 -40.21 coo 5.42 13.04 19.75 5.74 13.81 17.79 43.33 -49.69 -35.12 43.56 -51.77 -34.52 1mbb_c00 source 1mbb URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYLGLUCOSAMI: 6 hits 1mbb_c00 naa= 3 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 1 3 # 1 164 LYS A 63 LYS~? 3.96 CA CA A 208 166 LYS A 67 LYS~? 13.30 CA CA A 208 324 SER A 125 SER^? 8.08 O21 C8E A 210 coo 25.93 8.11 25.51 26.40 7.80 19.66 73.63 -82.49 -34.44 73.43 -77.00 -32.37 coo 27.27 1.43 25.09 29.18 5.25 22.89 73.21 -82.07 -40.14 71.59 -78.49 -41.85 coo 46.32 14.55 19.93 45.95 12.72 21.27 56.95 -73.80 -22.57 57.82 -74.32 -20.36 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 2 3 # 2 164 LYS A 63 LYS~? 3.96 CA CA A 208 166 LYS A 67 LYS~? 13.30 CA CA A 208 324 SER A 172 SER^? 21.14 O21 C8E A 210 coo 25.93 8.11 25.51 26.40 7.80 19.66 73.63 -82.49 -34.44 73.43 -77.00 -32.37 coo 27.27 1.43 25.09 29.18 5.25 22.89 73.21 -82.07 -40.14 71.59 -78.49 -41.85 coo 46.32 14.55 19.93 45.95 12.72 21.27 52.39 -86.47 -32.61 53.25 -88.25 -31.26 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 3 3 # 3 164 LYS A 63 LYS~? 3.96 CA CA A 208 166 LYS A 67 LYS~? 13.30 CA CA A 208 324 SER A 174 SER^? 15.95 O21 C8E A 210 coo 25.93 8.11 25.51 26.40 7.80 19.66 73.63 -82.49 -34.44 73.43 -77.00 -32.37 coo 27.27 1.43 25.09 29.18 5.25 22.89 73.21 -82.07 -40.14 71.59 -78.49 -41.85 coo 46.32 14.55 19.93 45.95 12.72 21.27 52.92 -84.93 -25.72 55.12 -85.87 -26.20 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 4 3 # 4 164 LYS A 67 LYS~? 13.30 CA CA A 208 166 LYS A 63 LYS~? 3.96 CA CA A 208 324 SER A 168 SER.? 28.11 CA CA A 208 coo 25.93 8.11 25.51 26.40 7.80 19.66 73.21 -82.07 -40.14 71.59 -78.49 -41.85 coo 27.27 1.43 25.09 29.18 5.25 22.89 73.63 -82.49 -34.44 73.43 -77.00 -32.37 coo 46.32 14.55 19.93 45.95 12.72 21.27 53.74 -87.86 -44.66 54.17 -90.24 -44.48 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 5 3 # 5 164 LYS B 63 LYS~? 3.79 CA CA B 208 166 LYS B 67 LYS~? 18.13 CA CA B 208 324 SER B 125 SER^? 8.02 O21 C8E B 210 coo 25.93 8.11 25.51 26.40 7.80 19.66 93.18 -23.71 -7.17 90.77 -27.85 -10.83 coo 27.27 1.43 25.09 29.18 5.25 22.89 89.12 -21.41 -4.23 87.66 -21.56 1.71 coo 46.32 14.55 19.93 45.95 12.72 21.27 92.94 -22.19 -29.04 94.91 -23.58 -29.43 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 6 3 # 6 164 LYS B 63 LYS~? 3.79 CA CA B 208 166 LYS B 67 LYS~? 18.13 CA CA B 208 324 SER B 172 SER^? 21.23 O21 C8E B 210 coo 25.93 8.11 25.51 26.40 7.80 19.66 93.18 -23.71 -7.17 90.77 -27.85 -10.83 coo 27.27 1.43 25.09 29.18 5.25 22.89 89.12 -21.41 -4.23 87.66 -21.56 1.71 coo 46.32 14.55 19.93 45.95 12.72 21.27 94.19 -7.30 -21.74 95.99 -8.03 -20.24 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 7 3 # 7 164 LYS B 63 LYS~? 3.79 CA CA B 208 166 LYS B 67 LYS~? 18.13 CA CA B 208 324 SER B 174 SER^? 16.18 O21 C8E B 210 coo 25.93 8.11 25.51 26.40 7.80 19.66 93.18 -23.71 -7.17 90.77 -27.85 -10.83 coo 27.27 1.43 25.09 29.18 5.25 22.89 89.12 -21.41 -4.23 87.66 -21.56 1.71 coo 46.32 14.55 19.93 45.95 12.72 21.27 98.48 -11.85 -25.05 98.67 -12.65 -22.71 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 8 3 # 8 164 LYS B 67 LYS~? 18.13 CA CA B 208 166 LYS B 63 LYS~? 3.79 CA CA B 208 324 SER B 168 SER.? 28.34 CA CA B 208 coo 25.93 8.11 25.51 26.40 7.80 19.66 89.12 -21.41 -4.23 87.66 -21.56 1.71 coo 27.27 1.43 25.09 29.18 5.25 22.89 93.18 -23.71 -7.17 90.77 -27.85 -10.83 coo 46.32 14.55 19.93 45.95 12.72 21.27 87.65 -2.97 -12.63 88.84 -1.07 -11.63 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 9 3 # 9 164 LYS B 67 LYS~? 18.13 CA CA B 208 166 LYS B 63 LYS~? 3.79 CA CA B 208 324 SER B 172 SER^? 21.23 O21 C8E B 210 coo 25.93 8.11 25.51 26.40 7.80 19.66 89.12 -21.41 -4.23 87.66 -21.56 1.71 coo 27.27 1.43 25.09 29.18 5.25 22.89 93.18 -23.71 -7.17 90.77 -27.85 -10.83 coo 46.32 14.55 19.93 45.95 12.72 21.27 94.19 -7.30 -21.74 95.99 -8.03 -20.24 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 10 3 # 10 164 LYS C 63 LYS~? 4.21 CA CA C 208 166 LYS C 67 LYS.? 18.71 CA CA C 208 324 SER C 125 SER^? 7.77 O21 C8E C 209 coo 25.93 8.11 25.51 26.40 7.80 19.66 20.98 -41.61 -5.49 23.04 -43.67 -10.44 coo 27.27 1.43 25.09 29.18 5.25 22.89 20.04 -36.06 -6.98 16.11 -31.17 -7.78 coo 46.32 14.55 19.93 45.95 12.72 21.27 41.72 -48.67 -8.69 41.33 -51.09 -8.33 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 11 3 # 11 164 LYS C 63 LYS~? 4.21 CA CA C 208 166 LYS C 67 LYS.? 18.71 CA CA C 208 324 SER C 172 SER^? 21.08 O21 C8E C 209 coo 25.93 8.11 25.51 26.40 7.80 19.66 20.98 -41.61 -5.49 23.04 -43.67 -10.44 coo 27.27 1.43 25.09 29.18 5.25 22.89 20.04 -36.06 -6.98 16.11 -31.17 -7.78 coo 46.32 14.55 19.93 45.95 12.72 21.27 41.00 -36.60 2.65 39.03 -37.50 3.67 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 12 3 # 12 164 LYS C 63 LYS~? 4.21 CA CA C 208 166 LYS C 67 LYS.? 18.71 CA CA C 208 324 SER C 174 SER^? 16.15 O21 C8E C 209 coo 25.93 8.11 25.51 26.40 7.80 19.66 20.98 -41.61 -5.49 23.04 -43.67 -10.44 coo 27.27 1.43 25.09 29.18 5.25 22.89 20.04 -36.06 -6.98 16.11 -31.17 -7.78 coo 46.32 14.55 19.93 45.95 12.72 21.27 41.96 -43.62 2.49 39.55 -43.47 2.68 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 13 3 # 13 164 LYS C 67 LYS.? 18.71 CA CA C 208 166 LYS C 63 LYS~? 4.21 CA CA C 208 324 SER C 168 SER.? 28.61 CA CA C 208 coo 25.93 8.11 25.51 26.40 7.80 19.66 20.04 -36.06 -6.98 16.11 -31.17 -7.78 coo 27.27 1.43 25.09 29.18 5.25 22.89 20.98 -41.61 -5.49 23.04 -43.67 -10.44 coo 46.32 14.55 19.93 45.95 12.72 21.27 35.58 -25.74 2.02 35.23 -25.15 4.34 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 14 3 # 14 164 LYS C 67 LYS.? 18.71 CA CA C 208 166 LYS C 63 LYS~? 4.21 CA CA C 208 324 SER C 172 SER^? 21.08 O21 C8E C 209 coo 25.93 8.11 25.51 26.40 7.80 19.66 20.04 -36.06 -6.98 16.11 -31.17 -7.78 coo 27.27 1.43 25.09 29.18 5.25 22.89 20.98 -41.61 -5.49 23.04 -43.67 -10.44 coo 46.32 14.55 19.93 45.95 12.72 21.27 41.00 -36.60 2.65 39.03 -37.50 3.67 1mdr_c01 source 1mdr MANDELATE RACEMASE (E.C.5.1.2.2) : 14 hits 1mdr_c01 naa= 3 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 1 3 # 1 A 465 GLY A 9 GLY^? 17.25 C17 C8E A 209 A 501 ASP A 45 ASP.? -2.96 CA CA A 208s B 367 TYR B 83 TYR^? 23.90 C1 C8E B 209 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 64.71 -51.29 -28.16 64.32 -51.77 -28.65 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 84.86 -45.84 -46.52 87.07 -46.60 -44.97 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 2 3 # 2 A 465 GLY A 9 GLY^? 17.25 C17 C8E A 209 A 501 ASP A 45 ASP.? -2.96 CA CA A 208s B 367 TYR C 155 TYR^? 7.32 C13 C8E C 210 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 64.71 -51.29 -28.16 64.32 -51.77 -28.65 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 41.26 -55.52 -15.76 41.81 -54.24 -18.13 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 3 3 # 3 A 465 GLY A 11 GLY^? 12.60 O18 C8E A 209 A 501 ASP A 49 ASP.? -3.00 CA CA A 208s B 367 TYR B 83 TYR^? 23.90 C1 C8E B 209 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 69.81 -55.88 -27.59 69.20 -56.35 -27.77 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 75.72 -77.89 -27.98 74.67 -77.10 -29.65 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 84.86 -45.84 -46.52 87.07 -46.60 -44.97 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 4 3 # 4 A 465 GLY A 11 GLY^? 12.60 O18 C8E A 209 A 501 ASP A 49 ASP.? -3.00 CA CA A 208s B 367 TYR C 97 TYR^? 17.03 C13 C8E C 210 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 69.81 -55.88 -27.59 69.20 -56.35 -27.77 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 75.72 -77.89 -27.98 74.67 -77.10 -29.65 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 44.42 -59.94 -30.24 42.23 -58.45 -29.40 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 5 3 # 5 A 465 GLY A 11 GLY^? 12.60 O18 C8E A 209 A 501 ASP C 80 ASP^? 16.43 C13 C8E C 210 B 367 TYR A 51 TYR.? 9.92 O21 C8E A 210 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 69.81 -55.88 -27.59 69.20 -56.35 -27.77 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 47.10 -57.14 -28.79 45.64 -55.94 -27.77 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 71.70 -83.21 -22.40 69.97 -85.02 -21.17 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 6 3 # 6 A 465 GLY A 14 GLY.? -3.37 O18 C8E A 209s A 501 ASP A 185 ASP~? 11.73 O21 C8E A 210 B 367 TYR C 97 TYR^? 17.03 C13 C8E C 210 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 69.00 -64.43 -23.63 69.02 -63.91 -24.27 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 65.81 -86.27 -18.22 66.54 -87.64 -16.78 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 44.42 -59.94 -30.24 42.23 -58.45 -29.40 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 7 3 # 7 A 465 GLY A 14 GLY.? -3.37 O18 C8E A 209s A 501 ASP C 26 ASP.? 24.60 O21 C8E A 209 B 367 TYR A 83 TYR^? -19.24 C2 C8E C 209s coo 4.40 25.46 -23.33 5.00 25.87 -23.68 69.00 -64.43 -23.63 69.02 -63.91 -24.27 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 55.55 -58.08 -41.98 53.84 -58.94 -42.96 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 59.25 -44.27 -7.74 58.41 -42.23 -6.03 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 8 3 # 8 A 465 GLY A 17 GLY^? 10.84 O18 C8E A 209 A 501 ASP A 49 ASP.? -3.00 CA CA A 208s B 367 TYR B 83 TYR^? 23.90 C1 C8E B 209 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 66.16 -59.55 -30.47 66.70 -58.93 -30.18 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 75.72 -77.89 -27.98 74.67 -77.10 -29.65 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 84.86 -45.84 -46.52 87.07 -46.60 -44.97 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 9 3 # 9 A 465 GLY A 17 GLY^? 10.84 O18 C8E A 209 A 501 ASP A 49 ASP.? -3.00 CA CA A 208s B 367 TYR B 97 TYR^? 16.46 O15 C8E B 209 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 66.16 -59.55 -30.47 66.70 -58.93 -30.18 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 75.72 -77.89 -27.98 74.67 -77.10 -29.65 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 83.74 -41.85 -39.80 83.62 -41.42 -37.05 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 10 3 # 10 A 465 GLY A 17 GLY^? 10.84 O18 C8E A 209 A 501 ASP B 149 ASP^? 14.91 O15 C8E B 209 B 367 TYR C 205 TYR^? 27.50 C19 C8E C 210 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 66.16 -59.55 -30.47 66.70 -58.93 -30.18 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 79.48 -42.39 -33.32 81.04 -41.48 -34.38 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 44.79 -44.04 -41.24 42.28 -43.19 -40.34 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 11 3 # 11 A 465 GLY A 18 GLY^? 13.28 O18 C8E A 209 A 501 ASP A 48 ASP.? 7.38 CA CA A 208 B 367 TYR C 154 TYR^? -5.05 C10 C8E C 209s coo 4.40 25.46 -23.33 5.00 25.87 -23.68 64.23 -56.43 -29.63 63.79 -57.08 -29.36 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 72.05 -78.20 -23.17 73.82 -77.79 -22.11 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 40.20 -61.77 -15.26 39.91 -62.08 -12.52 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 12 3 # 12 A 465 GLY A 18 GLY^? 13.28 O18 C8E A 209 A 501 ASP A 49 ASP.? -3.00 CA CA A 208s B 367 TYR B 83 TYR^? 23.90 C1 C8E B 209 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 64.23 -56.43 -29.63 63.79 -57.08 -29.36 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 75.72 -77.89 -27.98 74.67 -77.10 -29.65 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 84.86 -45.84 -46.52 87.07 -46.60 -44.97 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 13 3 # 13 A 465 GLY A 18 GLY^? 13.28 O18 C8E A 209 A 501 ASP A 49 ASP.? -3.00 CA CA A 208s B 367 TYR B 97 TYR^? 16.46 O15 C8E B 209 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 64.23 -56.43 -29.63 63.79 -57.08 -29.36 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 75.72 -77.89 -27.98 74.67 -77.10 -29.65 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 83.74 -41.85 -39.80 83.62 -41.42 -37.05 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 14 3 # 14 A 465 GLY A 18 GLY^? 13.28 O18 C8E A 209 A 501 ASP B 149 ASP^? 14.91 O15 C8E B 209 B 367 TYR C 205 TYR^? 27.50 C19 C8E C 210 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 64.23 -56.43 -29.63 63.79 -57.08 -29.36 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 79.48 -42.39 -33.32 81.04 -41.48 -34.38 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 44.79 -44.04 -41.24 42.28 -43.19 -40.34 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 15 3 # 15 A 465 GLY A 34 GLY^? 16.97 C2 C8E C 209 A 501 ASP C 153 ASP^? 9.83 C13 C8E C 210 B 367 TYR B 205 TYR^? 31.23 O15 C8E B 209 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 55.45 -44.86 -14.56 55.21 -45.43 -13.93 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 40.09 -57.62 -20.90 41.26 -57.13 -22.61 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 63.66 -38.04 -37.77 60.98 -37.67 -38.58 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 16 3 # 16 A 465 GLY A 40 GLY^? 12.19 O21 C8E A 209 A 501 ASP C 149 ASP^? 16.02 C16 C8E C 210 B 367 TYR A 183 TYR~? 7.18 C16 C8E A 210 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 59.98 -58.78 -26.79 59.34 -59.26 -26.97 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 38.72 -55.19 -32.44 40.02 -55.93 -30.97 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 59.65 -81.82 -15.52 59.58 -79.01 -15.74 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 17 3 # 17 A 465 GLY A 60 GLY~? 6.96 CA CA A 208 A 501 ASP A 166 ASP.? 23.45 CA CA A 208 B 367 TYR A 154 TYR^? -3.93 C5 C8E A 210s coo 4.40 25.46 -23.33 5.00 25.87 -23.68 76.07 -81.13 -30.14 75.99 -81.96 -30.16 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 55.95 -88.25 -40.15 55.99 -89.39 -38.36 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 63.59 -66.74 -11.40 63.46 -69.45 -10.84 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 18 3 # 18 A 465 GLY A 72 GLY^? 7.13 O21 C8E A 209 A 501 ASP A 180 ASP.? 14.47 O15 C8E A 210 B 367 TYR A 97 TYR^? 11.99 C1 C8E A 210 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 64.73 -71.23 -30.71 64.86 -70.64 -31.29 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 55.45 -86.10 -15.44 53.65 -85.04 -15.38 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 61.97 -51.46 -14.47 63.57 -52.89 -16.21 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 19 3 # 19 A 465 GLY A 89 GLY.? 22.69 CA CA B 208 A 501 ASP B 45 ASP.? -3.07 CA CA B 208s B 367 TYR A 205 TYR^? 30.20 C20 C8E C 210 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 70.25 -34.57 -9.81 70.82 -35.19 -9.83 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 57.96 -40.35 -31.16 56.81 -38.18 -32.51 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 20 3 # 20 A 465 GLY A 99 GLY^? 9.17 C1 C8E A 210 A 501 ASP C 180 ASP.? 12.29 C5 C8E C 209 B 367 TYR A 183 TYR~? 7.18 C16 C8E A 210 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 57.59 -56.25 -12.88 58.07 -56.78 -12.60 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 42.24 -54.49 3.97 44.24 -53.90 3.82 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 59.65 -81.82 -15.52 59.58 -79.01 -15.74 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 21 3 # 21 A 465 GLY A 129 GLY^? 7.87 C1 C8E A 210 A 501 ASP A 185 ASP~? 11.73 O21 C8E A 210 B 367 TYR B 138 TYR^? 18.52 O18 C8E A 209 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 58.31 -64.58 -14.62 57.65 -64.21 -14.49 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 65.81 -86.27 -18.22 66.54 -87.64 -16.78 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 69.87 -51.92 -34.99 68.26 -54.21 -34.65 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 22 3 # 22 A 465 GLY A 129 GLY^? 7.87 C1 C8E A 210 A 501 ASP C 153 ASP^? 9.83 C13 C8E C 210 B 367 TYR A 109 TYR^? 10.85 CA CA A 208 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 58.31 -64.58 -14.62 57.65 -64.21 -14.49 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 40.09 -57.62 -20.90 41.26 -57.13 -22.61 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 66.11 -81.19 -34.21 65.29 -83.76 -33.55 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 23 3 # 23 A 465 GLY A 131 GLY^? 5.02 C1 C8E A 210 A 501 ASP A 26 ASP.? 24.86 C2 C8E C 209 B 367 TYR C 83 TYR^? 19.88 O21 C8E A 209 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 62.01 -59.19 -12.67 61.45 -58.82 -12.27 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 53.70 -37.11 -16.05 55.72 -36.42 -15.97 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 49.20 -66.70 -34.88 49.82 -68.82 -36.60 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 24 3 # 24 A 465 GLY A 131 GLY^? 5.02 C1 C8E A 210 A 501 ASP C 80 ASP^? 16.43 C13 C8E C 210 B 367 TYR A 51 TYR.? 9.92 O21 C8E A 210 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 62.01 -59.19 -12.67 61.45 -58.82 -12.27 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 47.10 -57.14 -28.79 45.64 -55.94 -27.77 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 71.70 -83.21 -22.40 69.97 -85.02 -21.17 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 25 3 # 25 A 465 GLY A 133 GLY^? 10.29 C1 C8E A 210 A 501 ASP A 45 ASP.? -2.96 CA CA A 208s B 367 TYR B 205 TYR^? 31.23 O15 C8E B 209 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 65.83 -53.45 -13.52 65.37 -53.02 -13.01 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 63.66 -38.04 -37.77 60.98 -37.67 -38.58 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 26 3 # 26 A 465 GLY A 151 GLY^? 9.44 C2 C8E A 209 A 501 ASP A 26 ASP.? 24.86 C2 C8E C 209 B 367 TYR C 83 TYR^? 19.88 O21 C8E A 209 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 67.42 -55.91 -15.92 67.92 -56.29 -16.40 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 53.70 -37.11 -16.05 55.72 -36.42 -15.97 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 49.20 -66.70 -34.88 49.82 -68.82 -36.60 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 27 3 # 27 A 465 GLY A 151 GLY^? 9.44 C2 C8E A 209 A 501 ASP A 48 ASP.? 7.38 CA CA A 208 B 367 TYR C 154 TYR^? -5.05 C10 C8E C 209s coo 4.40 25.46 -23.33 5.00 25.87 -23.68 67.42 -55.91 -15.92 67.92 -56.29 -16.40 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 72.05 -78.20 -23.17 73.82 -77.79 -22.11 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 40.20 -61.77 -15.26 39.91 -62.08 -12.52 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 28 3 # 28 A 465 GLY A 151 GLY^? 9.44 C2 C8E A 209 A 501 ASP C 80 ASP^? 16.43 C13 C8E C 210 B 367 TYR A 51 TYR.? 9.92 O21 C8E A 210 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 67.42 -55.91 -15.92 67.92 -56.29 -16.40 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 47.10 -57.14 -28.79 45.64 -55.94 -27.77 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 71.70 -83.21 -22.40 69.97 -85.02 -21.17 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 29 3 # 29 A 465 GLY A 182 GLY~? 12.38 O21 C8E A 210 A 501 ASP A 61 ASP~? 12.37 CA CA A 208 B 367 TYR A 102 TYR^? 9.25 C1 C8E C 209 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 61.11 -87.58 -17.26 60.59 -87.05 -16.97 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 52.54 -63.26 -18.57 51.08 -62.17 -16.42 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 30 3 # 30 A 465 GLY A 202 GLY^? 20.08 C17 C8E A 209 A 501 ASP A 26 ASP.? 24.86 C2 C8E C 209 B 367 TYR C 83 TYR^? 19.88 O21 C8E A 209 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 66.56 -47.95 -27.86 66.94 -47.39 -27.39 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 53.70 -37.11 -16.05 55.72 -36.42 -15.97 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 49.20 -66.70 -34.88 49.82 -68.82 -36.60 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 31 3 # 31 A 465 GLY A 202 GLY^? 20.08 C17 C8E A 209 A 501 ASP A 45 ASP.? -2.96 CA CA A 208s B 367 TYR B 83 TYR^? 23.90 C1 C8E B 209 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 66.56 -47.95 -27.86 66.94 -47.39 -27.39 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 84.86 -45.84 -46.52 87.07 -46.60 -44.97 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 32 3 # 32 A 465 GLY A 202 GLY^? 20.08 C17 C8E A 209 A 501 ASP A 45 ASP.? -2.96 CA CA A 208s B 367 TYR C 155 TYR^? 7.32 C13 C8E C 210 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 66.56 -47.95 -27.86 66.94 -47.39 -27.39 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 41.26 -55.52 -15.76 41.81 -54.24 -18.13 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 33 3 # 33 A 465 GLY A 202 GLY^? 20.08 C17 C8E A 209 A 501 ASP B 80 ASP^? 15.94 O15 C8E B 209 B 367 TYR C 205 TYR^? 27.50 C19 C8E C 210 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 66.56 -47.95 -27.86 66.94 -47.39 -27.39 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 82.56 -37.87 -41.00 82.97 -37.16 -39.06 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 44.79 -44.04 -41.24 42.28 -43.19 -40.34 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 34 3 # 34 A 465 GLY B 9 GLY^? 17.41 C16 C8E B 209 A 501 ASP B 45 ASP.? -3.07 CA CA B 208s B 367 TYR A 83 TYR^? -19.24 C2 C8E C 209s coo 4.40 25.46 -23.33 5.00 25.87 -23.68 74.15 -37.97 -30.01 74.20 -37.18 -29.91 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 59.25 -44.27 -7.74 58.41 -42.23 -6.03 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 35 3 # 35 A 465 GLY B 11 GLY^? 12.70 C16 C8E B 209 A 501 ASP B 49 ASP.? -3.05 CA CA B 208s B 367 TYR A 83 TYR^? -19.24 C2 C8E C 209s coo 4.40 25.46 -23.33 5.00 25.87 -23.68 78.59 -39.04 -24.96 78.74 -38.24 -25.03 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 94.52 -28.97 -11.62 93.03 -30.41 -11.73 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 59.25 -44.27 -7.74 58.41 -42.23 -6.03 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 36 3 # 36 A 465 GLY B 17 GLY^? 11.57 C19 C8E B 209 A 501 ASP B 48 ASP.? 7.20 CA CA B 208 B 367 TYR B 83 TYR^? 23.90 C1 C8E B 209 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 78.40 -33.46 -24.16 78.51 -34.26 -24.36 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 97.60 -30.12 -16.68 98.20 -32.01 -15.99 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 84.86 -45.84 -46.52 87.07 -46.60 -44.97 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 37 3 # 37 A 465 GLY B 17 GLY^? 11.57 C19 C8E B 209 A 501 ASP B 49 ASP.? -3.05 CA CA B 208s B 367 TYR A 83 TYR^? -19.24 C2 C8E C 209s coo 4.40 25.46 -23.33 5.00 25.87 -23.68 78.40 -33.46 -24.16 78.51 -34.26 -24.36 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 94.52 -28.97 -11.62 93.03 -30.41 -11.73 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 59.25 -44.27 -7.74 58.41 -42.23 -6.03 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 38 3 # 38 A 465 GLY B 18 GLY^? 13.41 C16 C8E B 209 A 501 ASP B 49 ASP.? -3.05 CA CA B 208s B 367 TYR A 83 TYR^? -19.24 C2 C8E C 209s coo 4.40 25.46 -23.33 5.00 25.87 -23.68 77.02 -34.15 -27.57 77.48 -33.52 -27.66 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 94.52 -28.97 -11.62 93.03 -30.41 -11.73 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 59.25 -44.27 -7.74 58.41 -42.23 -6.03 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 39 3 # 39 A 465 GLY B 50 GLY.? 7.39 CA CA B 208 A 501 ASP B 114 ASP.? 22.07 CA CA B 208 B 367 TYR B 102 TYR^? 9.00 C1 C8E B 210 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 98.40 -30.11 -10.96 98.47 -30.73 -11.53 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 88.69 -13.97 -0.41 89.97 -12.27 -0.12 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 88.26 -25.14 -37.39 89.63 -22.79 -36.84 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 40 3 # 40 A 465 GLY B 60 GLY~? 7.13 CA CA B 208 A 501 ASP B 166 ASP.? 24.17 CA CA B 208 B 367 TYR B 154 TYR^? 5.13 C1 C8E B 209s coo 4.40 25.46 -23.33 5.00 25.87 -23.68 95.52 -28.35 -8.17 96.08 -27.79 -7.92 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 91.14 -5.33 -14.11 93.17 -5.00 -14.63 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 96.51 -35.71 -33.91 98.87 -34.53 -33.06 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 41 3 # 41 A 465 GLY B 72 GLY^? 7.04 C20 C8E B 209 A 501 ASP B 52 ASP.? 15.59 CA CA B 208 B 367 TYR B 97 TYR^? 16.46 O15 C8E B 209 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 86.64 -25.55 -20.04 85.82 -25.67 -19.86 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 105.61 -28.95 -11.53 106.78 -28.70 -9.81 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 83.74 -41.85 -39.80 83.62 -41.42 -37.05 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 42 3 # 42 A 465 GLY B 129 GLY^? 8.67 C1 C8E B 210 A 501 ASP B 185 ASP~? 11.63 O21 C8E B 210 B 367 TYR A 138 TYR^? 19.17 C16 C8E B 209 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 92.24 -31.68 -37.02 91.94 -31.53 -37.72 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 106.30 -23.80 -20.43 108.26 -24.54 -20.08 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 70.50 -38.06 -22.60 71.93 -35.69 -22.96 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 43 3 # 43 A 465 GLY B 133 GLY^? 15.21 O15 C8E B 209 A 501 ASP B 45 ASP.? -3.07 CA CA B 208s B 367 TYR A 205 TYR^? 30.20 C20 C8E C 210 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 86.08 -43.87 -36.38 86.09 -44.05 -37.22 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 57.96 -40.35 -31.16 56.81 -38.18 -32.51 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 44 3 # 44 A 465 GLY B 202 GLY^? 20.20 O15 C8E B 209 A 501 ASP B 45 ASP.? -3.07 CA CA B 208s B 367 TYR A 83 TYR^? -19.24 C2 C8E C 209s coo 4.40 25.46 -23.33 5.00 25.87 -23.68 72.27 -41.27 -30.46 72.24 -42.05 -30.66 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 59.25 -44.27 -7.74 58.41 -42.23 -6.03 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 45 3 # 45 A 465 GLY C 11 GLY^? 12.79 C16 C8E C 210 A 501 ASP C 49 ASP.? -2.87 CA CA C 208s B 367 TYR A 102 TYR^? 9.25 C1 C8E C 209 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 32.80 -49.06 -29.57 33.28 -48.67 -28.99 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 22.13 -48.50 -9.42 23.00 -46.66 -10.00 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 52.54 -63.26 -18.57 51.08 -62.17 -16.42 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 46 3 # 46 A 465 GLY C 15 GLY.? 5.81 C16 C8E C 210 A 501 ASP C 52 ASP.? 15.77 CA CA C 208 B 367 TYR A 102 TYR^? 9.25 C1 C8E C 209 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 30.97 -48.94 -21.56 31.55 -49.29 -22.18 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 21.29 -54.58 -0.38 20.26 -54.47 1.43 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 52.54 -63.26 -18.57 51.08 -62.17 -16.42 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 47 3 # 47 A 465 GLY C 17 GLY^? 11.43 C19 C8E C 210 A 501 ASP A 26 ASP.? 24.86 C2 C8E C 209 B 367 TYR C 83 TYR^? 19.88 O21 C8E A 209 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 34.61 -45.03 -25.87 34.39 -45.63 -26.41 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 53.70 -37.11 -16.05 55.72 -36.42 -15.97 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 49.20 -66.70 -34.88 49.82 -68.82 -36.60 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 48 3 # 48 A 465 GLY C 17 GLY^? 11.43 C19 C8E C 210 A 501 ASP C 48 ASP.? 7.17 CA CA C 208 B 367 TYR C 83 TYR^? 19.88 O21 C8E A 209 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 34.61 -45.03 -25.87 34.39 -45.63 -26.41 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 26.68 -52.06 -7.74 25.46 -53.53 -8.54 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 49.20 -66.70 -34.88 49.82 -68.82 -36.60 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 49 3 # 49 A 465 GLY C 17 GLY^? 11.43 C19 C8E C 210 A 501 ASP C 49 ASP.? -2.87 CA CA C 208s B 367 TYR A 102 TYR^? 9.25 C1 C8E C 209 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 34.61 -45.03 -25.87 34.39 -45.63 -26.41 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 22.13 -48.50 -9.42 23.00 -46.66 -10.00 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 52.54 -63.26 -18.57 51.08 -62.17 -16.42 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 50 3 # 50 A 465 GLY C 18 GLY^? 13.60 C19 C8E C 210 A 501 ASP C 48 ASP.? 7.17 CA CA C 208 B 367 TYR A 97 TYR^? 11.99 C1 C8E A 210 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 37.51 -45.80 -28.16 37.81 -45.75 -27.39 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 26.68 -52.06 -7.74 25.46 -53.53 -8.54 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 61.97 -51.46 -14.47 63.57 -52.89 -16.21 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 51 3 # 51 A 465 GLY C 34 GLY^? 20.14 O21 C8E A 209 A 501 ASP A 80 ASP^? 12.60 C1 C8E A 210 B 367 TYR A 109 TYR^? 10.85 CA CA A 208 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 52.44 -58.67 -35.04 52.34 -59.13 -34.28 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 58.12 -52.30 -15.93 59.10 -53.68 -17.13 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 66.11 -81.19 -34.21 65.29 -83.76 -33.55 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 52 3 # 52 A 465 GLY C 40 GLY^? 12.46 C19 C8E C 210 A 501 ASP C 48 ASP.? 7.17 CA CA C 208 B 367 TYR A 155 TYR^? 8.43 C17 C8E A 209 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 41.84 -46.53 -24.70 42.24 -46.19 -24.08 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 26.68 -52.06 -7.74 25.46 -53.53 -8.54 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 60.87 -66.67 -17.05 60.42 -64.37 -18.53 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 53 3 # 53 A 465 GLY C 50 GLY.? 8.32 CA CA C 208 A 501 ASP C 114 ASP.? 22.22 CA CA C 208 B 367 TYR C 102 TYR^? 9.73 C2 C8E C 209 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 21.11 -51.78 -6.22 21.90 -51.63 -6.15 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 19.39 -30.14 -1.59 19.46 -28.98 0.18 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 48.50 -51.08 -15.65 48.91 -50.66 -12.96 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 54 3 # 54 A 465 GLY C 54 GLY.? 17.14 CA CA C 208 A 501 ASP C 114 ASP.? 22.22 CA CA C 208 B 367 TYR C 155 TYR^? 7.32 C13 C8E C 210 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 20.40 -51.33 4.37 20.14 -50.80 3.78 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 19.39 -30.14 -1.59 19.46 -28.98 0.18 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 41.26 -55.52 -15.76 41.81 -54.24 -18.13 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 55 3 # 55 A 465 GLY C 72 GLY^? 6.51 O21 C8E C 210 A 501 ASP C 52 ASP.? 15.77 CA CA C 208 B 367 TYR A 102 TYR^? 9.25 C1 C8E C 209 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 32.98 -43.26 -14.24 32.91 -42.76 -14.86 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 21.29 -54.58 -0.38 20.26 -54.47 1.43 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 52.54 -63.26 -18.57 51.08 -62.17 -16.42 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 56 3 # 56 A 465 GLY C 72 GLY^? 6.51 O21 C8E C 210 A 501 ASP C 52 ASP.? 15.77 CA CA C 208 B 367 TYR C 97 TYR^? 17.03 C13 C8E C 210 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 32.98 -43.26 -14.24 32.91 -42.76 -14.86 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 21.29 -54.58 -0.38 20.26 -54.47 1.43 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 44.42 -59.94 -30.24 42.23 -58.45 -29.40 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 57 3 # 57 A 465 GLY C 107 GLY^? 7.61 O21 C8E C 210 A 501 ASP C 52 ASP.? 15.77 CA CA C 208 B 367 TYR A 102 TYR^? 9.25 C1 C8E C 209 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 34.65 -42.83 -10.66 35.11 -42.76 -9.95 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 21.29 -54.58 -0.38 20.26 -54.47 1.43 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 52.54 -63.26 -18.57 51.08 -62.17 -16.42 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 58 3 # 58 A 465 GLY C 107 GLY^? 7.61 O21 C8E C 210 A 501 ASP C 52 ASP.? 15.77 CA CA C 208 B 367 TYR C 97 TYR^? 17.03 C13 C8E C 210 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 34.65 -42.83 -10.66 35.11 -42.76 -9.95 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 21.29 -54.58 -0.38 20.26 -54.47 1.43 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 44.42 -59.94 -30.24 42.23 -58.45 -29.40 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 59 3 # 59 A 465 GLY C 129 GLY^? 8.32 C1 C8E C 209 A 501 ASP C 180 ASP.? 12.29 C5 C8E C 209 B 367 TYR A 183 TYR~? 7.18 C16 C8E A 210 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 44.60 -57.45 -16.86 45.41 -57.44 -17.05 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 42.24 -54.49 3.97 44.24 -53.90 3.82 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 59.65 -81.82 -15.52 59.58 -79.01 -15.74 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 60 3 # 60 A 465 GLY C 131 GLY^? 12.25 C13 C8E C 210 A 501 ASP C 26 ASP.? 24.60 O21 C8E A 209 B 367 TYR A 83 TYR^? -19.24 C2 C8E C 209s coo 4.40 25.46 -23.33 5.00 25.87 -23.68 43.06 -60.72 -22.58 43.75 -61.01 -22.74 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 55.55 -58.08 -41.98 53.84 -58.94 -42.96 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 59.25 -44.27 -7.74 58.41 -42.23 -6.03 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 61 3 # 61 A 465 GLY C 131 GLY^? 12.25 C13 C8E C 210 A 501 ASP C 26 ASP.? 24.60 O21 C8E A 209 B 367 TYR A 183 TYR~? 7.18 C16 C8E A 210 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 43.06 -60.72 -22.58 43.75 -61.01 -22.74 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 55.55 -58.08 -41.98 53.84 -58.94 -42.96 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 59.65 -81.82 -15.52 59.58 -79.01 -15.74 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 62 3 # 62 A 465 GLY C 151 GLY^? 12.60 C13 C8E C 210 A 501 ASP C 48 ASP.? 7.17 CA CA C 208 B 367 TYR A 97 TYR^? 11.99 C1 C8E A 210 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 37.96 -59.28 -27.29 37.21 -59.08 -27.12 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 26.68 -52.06 -7.74 25.46 -53.53 -8.54 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 61.97 -51.46 -14.47 63.57 -52.89 -16.21 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 63 3 # 63 A 465 GLY C 151 GLY^? 12.60 C13 C8E C 210 A 501 ASP C 48 ASP.? 7.17 CA CA C 208 B 367 TYR A 155 TYR^? 8.43 C17 C8E A 209 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 37.96 -59.28 -27.29 37.21 -59.08 -27.12 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 26.68 -52.06 -7.74 25.46 -53.53 -8.54 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 60.87 -66.67 -17.05 60.42 -64.37 -18.53 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 64 3 # 64 A 465 GLY C 179 GLY.? 9.08 C5 C8E C 209 A 501 ASP C 45 ASP.? 3.27 CA CA C 208s B 367 TYR A 155 TYR^? 8.43 C17 C8E A 209 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 42.35 -58.77 1.88 43.04 -58.32 2.32 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 60.87 -66.67 -17.05 60.42 -64.37 -18.53 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 65 3 # 65 A 465 GLY C 182 GLY~? 12.84 O21 C8E C 209 A 501 ASP C 49 ASP.? -2.87 CA CA C 208s B 367 TYR A 83 TYR^? -19.24 C2 C8E C 209s coo 4.40 25.46 -23.33 5.00 25.87 -23.68 36.73 -53.96 4.63 37.26 -54.38 4.27 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 22.13 -48.50 -9.42 23.00 -46.66 -10.00 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 59.25 -44.27 -7.74 58.41 -42.23 -6.03 1mro_c00 source 1mro METHYL-COENZYME M REDUCTASE : 65 hits 1mro_c00 naa= 3 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 1 3 # 1 D 465 GLY A 9 GLY^? 17.25 C17 C8E A 209 D 501 ASP A 45 ASP.? -2.96 CA CA A 208s E 367 TYR B 83 TYR^? 23.90 C1 C8E B 209 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 64.71 -51.29 -28.16 64.32 -51.77 -28.65 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 84.86 -45.84 -46.52 87.07 -46.60 -44.97 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 2 3 # 2 D 465 GLY A 9 GLY^? 17.25 C17 C8E A 209 D 501 ASP A 45 ASP.? -2.96 CA CA A 208s E 367 TYR C 155 TYR^? 7.32 C13 C8E C 210 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 64.71 -51.29 -28.16 64.32 -51.77 -28.65 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 41.26 -55.52 -15.76 41.81 -54.24 -18.13 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 3 3 # 3 D 465 GLY A 11 GLY^? 12.60 O18 C8E A 209 D 501 ASP A 49 ASP.? -3.00 CA CA A 208s E 367 TYR B 83 TYR^? 23.90 C1 C8E B 209 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 69.81 -55.88 -27.59 69.20 -56.35 -27.77 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 75.72 -77.89 -27.98 74.67 -77.10 -29.65 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 84.86 -45.84 -46.52 87.07 -46.60 -44.97 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 4 3 # 4 D 465 GLY A 11 GLY^? 12.60 O18 C8E A 209 D 501 ASP A 49 ASP.? -3.00 CA CA A 208s E 367 TYR C 97 TYR^? 17.03 C13 C8E C 210 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 69.81 -55.88 -27.59 69.20 -56.35 -27.77 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 75.72 -77.89 -27.98 74.67 -77.10 -29.65 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 44.42 -59.94 -30.24 42.23 -58.45 -29.40 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 5 3 # 5 D 465 GLY A 11 GLY^? 12.60 O18 C8E A 209 D 501 ASP C 80 ASP^? 16.43 C13 C8E C 210 E 367 TYR A 51 TYR.? 9.92 O21 C8E A 210 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 69.81 -55.88 -27.59 69.20 -56.35 -27.77 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 47.10 -57.14 -28.79 45.64 -55.94 -27.77 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 71.70 -83.21 -22.40 69.97 -85.02 -21.17 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 6 3 # 6 D 465 GLY A 14 GLY.? -3.37 O18 C8E A 209s D 501 ASP A 185 ASP~? 11.73 O21 C8E A 210 E 367 TYR C 97 TYR^? 17.03 C13 C8E C 210 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 69.00 -64.43 -23.63 69.02 -63.91 -24.27 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 65.81 -86.27 -18.22 66.54 -87.64 -16.78 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 44.42 -59.94 -30.24 42.23 -58.45 -29.40 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 7 3 # 7 D 465 GLY A 14 GLY.? -3.37 O18 C8E A 209s D 501 ASP C 26 ASP.? 24.60 O21 C8E A 209 E 367 TYR A 83 TYR^? -19.24 C2 C8E C 209s coo 21.60 60.44 -42.77 21.61 59.72 -42.40 69.00 -64.43 -23.63 69.02 -63.91 -24.27 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 55.55 -58.08 -41.98 53.84 -58.94 -42.96 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 59.25 -44.27 -7.74 58.41 -42.23 -6.03 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 8 3 # 8 D 465 GLY A 17 GLY^? 10.84 O18 C8E A 209 D 501 ASP A 49 ASP.? -3.00 CA CA A 208s E 367 TYR B 83 TYR^? 23.90 C1 C8E B 209 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 66.16 -59.55 -30.47 66.70 -58.93 -30.18 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 75.72 -77.89 -27.98 74.67 -77.10 -29.65 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 84.86 -45.84 -46.52 87.07 -46.60 -44.97 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 9 3 # 9 D 465 GLY A 17 GLY^? 10.84 O18 C8E A 209 D 501 ASP A 49 ASP.? -3.00 CA CA A 208s E 367 TYR B 97 TYR^? 16.46 O15 C8E B 209 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 66.16 -59.55 -30.47 66.70 -58.93 -30.18 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 75.72 -77.89 -27.98 74.67 -77.10 -29.65 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 83.74 -41.85 -39.80 83.62 -41.42 -37.05 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 10 3 # 10 D 465 GLY A 17 GLY^? 10.84 O18 C8E A 209 D 501 ASP B 149 ASP^? 14.91 O15 C8E B 209 E 367 TYR C 205 TYR^? 27.50 C19 C8E C 210 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 66.16 -59.55 -30.47 66.70 -58.93 -30.18 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 79.48 -42.39 -33.32 81.04 -41.48 -34.38 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 44.79 -44.04 -41.24 42.28 -43.19 -40.34 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 11 3 # 11 D 465 GLY A 18 GLY^? 13.28 O18 C8E A 209 D 501 ASP A 48 ASP.? 7.38 CA CA A 208 E 367 TYR C 154 TYR^? -5.05 C10 C8E C 209s coo 21.60 60.44 -42.77 21.61 59.72 -42.40 64.23 -56.43 -29.63 63.79 -57.08 -29.36 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 72.05 -78.20 -23.17 73.82 -77.79 -22.11 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 40.20 -61.77 -15.26 39.91 -62.08 -12.52 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 12 3 # 12 D 465 GLY A 18 GLY^? 13.28 O18 C8E A 209 D 501 ASP A 49 ASP.? -3.00 CA CA A 208s E 367 TYR B 83 TYR^? 23.90 C1 C8E B 209 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 64.23 -56.43 -29.63 63.79 -57.08 -29.36 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 75.72 -77.89 -27.98 74.67 -77.10 -29.65 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 84.86 -45.84 -46.52 87.07 -46.60 -44.97 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 13 3 # 13 D 465 GLY A 18 GLY^? 13.28 O18 C8E A 209 D 501 ASP A 49 ASP.? -3.00 CA CA A 208s E 367 TYR B 97 TYR^? 16.46 O15 C8E B 209 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 64.23 -56.43 -29.63 63.79 -57.08 -29.36 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 75.72 -77.89 -27.98 74.67 -77.10 -29.65 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 83.74 -41.85 -39.80 83.62 -41.42 -37.05 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 14 3 # 14 D 465 GLY A 18 GLY^? 13.28 O18 C8E A 209 D 501 ASP B 149 ASP^? 14.91 O15 C8E B 209 E 367 TYR C 205 TYR^? 27.50 C19 C8E C 210 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 64.23 -56.43 -29.63 63.79 -57.08 -29.36 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 79.48 -42.39 -33.32 81.04 -41.48 -34.38 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 44.79 -44.04 -41.24 42.28 -43.19 -40.34 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 15 3 # 15 D 465 GLY A 34 GLY^? 16.97 C2 C8E C 209 D 501 ASP C 153 ASP^? 9.83 C13 C8E C 210 E 367 TYR B 205 TYR^? 31.23 O15 C8E B 209 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 55.45 -44.86 -14.56 55.21 -45.43 -13.93 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 40.09 -57.62 -20.90 41.26 -57.13 -22.61 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 63.66 -38.04 -37.77 60.98 -37.67 -38.58 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 16 3 # 16 D 465 GLY A 40 GLY^? 12.19 O21 C8E A 209 D 501 ASP C 149 ASP^? 16.02 C16 C8E C 210 E 367 TYR A 183 TYR~? 7.18 C16 C8E A 210 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 59.98 -58.78 -26.79 59.34 -59.26 -26.97 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 38.72 -55.19 -32.44 40.02 -55.93 -30.97 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 59.65 -81.82 -15.52 59.58 -79.01 -15.74 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 17 3 # 17 D 465 GLY A 60 GLY~? 6.96 CA CA A 208 D 501 ASP A 166 ASP.? 23.45 CA CA A 208 E 367 TYR A 154 TYR^? -3.93 C5 C8E A 210s coo 21.60 60.44 -42.77 21.61 59.72 -42.40 76.07 -81.13 -30.14 75.99 -81.96 -30.16 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 55.95 -88.25 -40.15 55.99 -89.39 -38.36 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 63.59 -66.74 -11.40 63.46 -69.45 -10.84 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 18 3 # 18 D 465 GLY A 72 GLY^? 7.13 O21 C8E A 209 D 501 ASP A 180 ASP.? 14.47 O15 C8E A 210 E 367 TYR A 97 TYR^? 11.99 C1 C8E A 210 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 64.73 -71.23 -30.71 64.86 -70.64 -31.29 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 55.45 -86.10 -15.44 53.65 -85.04 -15.38 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 61.97 -51.46 -14.47 63.57 -52.89 -16.21 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 19 3 # 19 D 465 GLY A 89 GLY.? 22.69 CA CA B 208 D 501 ASP B 45 ASP.? -3.07 CA CA B 208s E 367 TYR A 205 TYR^? 30.20 C20 C8E C 210 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 70.25 -34.57 -9.81 70.82 -35.19 -9.83 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 57.96 -40.35 -31.16 56.81 -38.18 -32.51 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 20 3 # 20 D 465 GLY A 99 GLY^? 9.17 C1 C8E A 210 D 501 ASP C 180 ASP.? 12.29 C5 C8E C 209 E 367 TYR A 183 TYR~? 7.18 C16 C8E A 210 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 57.59 -56.25 -12.88 58.07 -56.78 -12.60 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 42.24 -54.49 3.97 44.24 -53.90 3.82 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 59.65 -81.82 -15.52 59.58 -79.01 -15.74 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 21 3 # 21 D 465 GLY A 129 GLY^? 7.87 C1 C8E A 210 D 501 ASP A 185 ASP~? 11.73 O21 C8E A 210 E 367 TYR B 138 TYR^? 18.52 O18 C8E A 209 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 58.31 -64.58 -14.62 57.65 -64.21 -14.49 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 65.81 -86.27 -18.22 66.54 -87.64 -16.78 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 69.87 -51.92 -34.99 68.26 -54.21 -34.65 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 22 3 # 22 D 465 GLY A 129 GLY^? 7.87 C1 C8E A 210 D 501 ASP C 153 ASP^? 9.83 C13 C8E C 210 E 367 TYR A 109 TYR^? 10.85 CA CA A 208 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 58.31 -64.58 -14.62 57.65 -64.21 -14.49 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 40.09 -57.62 -20.90 41.26 -57.13 -22.61 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 66.11 -81.19 -34.21 65.29 -83.76 -33.55 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 23 3 # 23 D 465 GLY A 131 GLY^? 5.02 C1 C8E A 210 D 501 ASP A 26 ASP.? 24.86 C2 C8E C 209 E 367 TYR C 83 TYR^? 19.88 O21 C8E A 209 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 62.01 -59.19 -12.67 61.45 -58.82 -12.27 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 53.70 -37.11 -16.05 55.72 -36.42 -15.97 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 49.20 -66.70 -34.88 49.82 -68.82 -36.60 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 24 3 # 24 D 465 GLY A 131 GLY^? 5.02 C1 C8E A 210 D 501 ASP C 80 ASP^? 16.43 C13 C8E C 210 E 367 TYR A 51 TYR.? 9.92 O21 C8E A 210 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 62.01 -59.19 -12.67 61.45 -58.82 -12.27 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 47.10 -57.14 -28.79 45.64 -55.94 -27.77 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 71.70 -83.21 -22.40 69.97 -85.02 -21.17 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 25 3 # 25 D 465 GLY A 133 GLY^? 10.29 C1 C8E A 210 D 501 ASP A 45 ASP.? -2.96 CA CA A 208s E 367 TYR B 205 TYR^? 31.23 O15 C8E B 209 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 65.83 -53.45 -13.52 65.37 -53.02 -13.01 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 63.66 -38.04 -37.77 60.98 -37.67 -38.58 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 26 3 # 26 D 465 GLY A 151 GLY^? 9.44 C2 C8E A 209 D 501 ASP A 26 ASP.? 24.86 C2 C8E C 209 E 367 TYR C 83 TYR^? 19.88 O21 C8E A 209 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 67.42 -55.91 -15.92 67.92 -56.29 -16.40 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 53.70 -37.11 -16.05 55.72 -36.42 -15.97 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 49.20 -66.70 -34.88 49.82 -68.82 -36.60 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 27 3 # 27 D 465 GLY A 151 GLY^? 9.44 C2 C8E A 209 D 501 ASP A 48 ASP.? 7.38 CA CA A 208 E 367 TYR C 154 TYR^? -5.05 C10 C8E C 209s coo 21.60 60.44 -42.77 21.61 59.72 -42.40 67.42 -55.91 -15.92 67.92 -56.29 -16.40 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 72.05 -78.20 -23.17 73.82 -77.79 -22.11 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 40.20 -61.77 -15.26 39.91 -62.08 -12.52 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 28 3 # 28 D 465 GLY A 151 GLY^? 9.44 C2 C8E A 209 D 501 ASP C 80 ASP^? 16.43 C13 C8E C 210 E 367 TYR A 51 TYR.? 9.92 O21 C8E A 210 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 67.42 -55.91 -15.92 67.92 -56.29 -16.40 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 47.10 -57.14 -28.79 45.64 -55.94 -27.77 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 71.70 -83.21 -22.40 69.97 -85.02 -21.17 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 29 3 # 29 D 465 GLY A 182 GLY~? 12.38 O21 C8E A 210 D 501 ASP A 61 ASP~? 12.37 CA CA A 208 E 367 TYR A 102 TYR^? 9.25 C1 C8E C 209 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 61.11 -87.58 -17.26 60.59 -87.05 -16.97 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 52.54 -63.26 -18.57 51.08 -62.17 -16.42 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 30 3 # 30 D 465 GLY A 202 GLY^? 20.08 C17 C8E A 209 D 501 ASP A 26 ASP.? 24.86 C2 C8E C 209 E 367 TYR C 83 TYR^? 19.88 O21 C8E A 209 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 66.56 -47.95 -27.86 66.94 -47.39 -27.39 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 53.70 -37.11 -16.05 55.72 -36.42 -15.97 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 49.20 -66.70 -34.88 49.82 -68.82 -36.60 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 31 3 # 31 D 465 GLY A 202 GLY^? 20.08 C17 C8E A 209 D 501 ASP A 45 ASP.? -2.96 CA CA A 208s E 367 TYR B 83 TYR^? 23.90 C1 C8E B 209 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 66.56 -47.95 -27.86 66.94 -47.39 -27.39 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 84.86 -45.84 -46.52 87.07 -46.60 -44.97 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 32 3 # 32 D 465 GLY A 202 GLY^? 20.08 C17 C8E A 209 D 501 ASP A 45 ASP.? -2.96 CA CA A 208s E 367 TYR C 155 TYR^? 7.32 C13 C8E C 210 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 66.56 -47.95 -27.86 66.94 -47.39 -27.39 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 41.26 -55.52 -15.76 41.81 -54.24 -18.13 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 33 3 # 33 D 465 GLY A 202 GLY^? 20.08 C17 C8E A 209 D 501 ASP B 80 ASP^? 15.94 O15 C8E B 209 E 367 TYR C 205 TYR^? 27.50 C19 C8E C 210 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 66.56 -47.95 -27.86 66.94 -47.39 -27.39 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 82.56 -37.87 -41.00 82.97 -37.16 -39.06 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 44.79 -44.04 -41.24 42.28 -43.19 -40.34 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 34 3 # 34 D 465 GLY B 9 GLY^? 17.41 C16 C8E B 209 D 501 ASP B 45 ASP.? -3.07 CA CA B 208s E 367 TYR A 83 TYR^? -19.24 C2 C8E C 209s coo 21.60 60.44 -42.77 21.61 59.72 -42.40 74.15 -37.97 -30.01 74.20 -37.18 -29.91 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 59.25 -44.27 -7.74 58.41 -42.23 -6.03 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 35 3 # 35 D 465 GLY B 11 GLY^? 12.70 C16 C8E B 209 D 501 ASP B 49 ASP.? -3.05 CA CA B 208s E 367 TYR A 83 TYR^? -19.24 C2 C8E C 209s coo 21.60 60.44 -42.77 21.61 59.72 -42.40 78.59 -39.04 -24.96 78.74 -38.24 -25.03 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 94.52 -28.97 -11.62 93.03 -30.41 -11.73 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 59.25 -44.27 -7.74 58.41 -42.23 -6.03 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 36 3 # 36 D 465 GLY B 17 GLY^? 11.57 C19 C8E B 209 D 501 ASP B 48 ASP.? 7.20 CA CA B 208 E 367 TYR B 83 TYR^? 23.90 C1 C8E B 209 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 78.40 -33.46 -24.16 78.51 -34.26 -24.36 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 97.60 -30.12 -16.68 98.20 -32.01 -15.99 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 84.86 -45.84 -46.52 87.07 -46.60 -44.97 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 37 3 # 37 D 465 GLY B 17 GLY^? 11.57 C19 C8E B 209 D 501 ASP B 49 ASP.? -3.05 CA CA B 208s E 367 TYR A 83 TYR^? -19.24 C2 C8E C 209s coo 21.60 60.44 -42.77 21.61 59.72 -42.40 78.40 -33.46 -24.16 78.51 -34.26 -24.36 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 94.52 -28.97 -11.62 93.03 -30.41 -11.73 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 59.25 -44.27 -7.74 58.41 -42.23 -6.03 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 38 3 # 38 D 465 GLY B 18 GLY^? 13.41 C16 C8E B 209 D 501 ASP B 49 ASP.? -3.05 CA CA B 208s E 367 TYR A 83 TYR^? -19.24 C2 C8E C 209s coo 21.60 60.44 -42.77 21.61 59.72 -42.40 77.02 -34.15 -27.57 77.48 -33.52 -27.66 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 94.52 -28.97 -11.62 93.03 -30.41 -11.73 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 59.25 -44.27 -7.74 58.41 -42.23 -6.03 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 39 3 # 39 D 465 GLY B 50 GLY.? 7.39 CA CA B 208 D 501 ASP B 114 ASP.? 22.07 CA CA B 208 E 367 TYR B 102 TYR^? 9.00 C1 C8E B 210 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 98.40 -30.11 -10.96 98.47 -30.73 -11.53 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 88.69 -13.97 -0.41 89.97 -12.27 -0.12 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 88.26 -25.14 -37.39 89.63 -22.79 -36.84 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 40 3 # 40 D 465 GLY B 60 GLY~? 7.13 CA CA B 208 D 501 ASP B 166 ASP.? 24.17 CA CA B 208 E 367 TYR B 154 TYR^? 5.13 C1 C8E B 209s coo 21.60 60.44 -42.77 21.61 59.72 -42.40 95.52 -28.35 -8.17 96.08 -27.79 -7.92 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 91.14 -5.33 -14.11 93.17 -5.00 -14.63 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 96.51 -35.71 -33.91 98.87 -34.53 -33.06 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 41 3 # 41 D 465 GLY B 72 GLY^? 7.04 C20 C8E B 209 D 501 ASP B 52 ASP.? 15.59 CA CA B 208 E 367 TYR B 97 TYR^? 16.46 O15 C8E B 209 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 86.64 -25.55 -20.04 85.82 -25.67 -19.86 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 105.61 -28.95 -11.53 106.78 -28.70 -9.81 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 83.74 -41.85 -39.80 83.62 -41.42 -37.05 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 42 3 # 42 D 465 GLY B 129 GLY^? 8.67 C1 C8E B 210 D 501 ASP B 185 ASP~? 11.63 O21 C8E B 210 E 367 TYR A 138 TYR^? 19.17 C16 C8E B 209 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 92.24 -31.68 -37.02 91.94 -31.53 -37.72 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 106.30 -23.80 -20.43 108.26 -24.54 -20.08 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 70.50 -38.06 -22.60 71.93 -35.69 -22.96 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 43 3 # 43 D 465 GLY B 133 GLY^? 15.21 O15 C8E B 209 D 501 ASP B 45 ASP.? -3.07 CA CA B 208s E 367 TYR A 205 TYR^? 30.20 C20 C8E C 210 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 86.08 -43.87 -36.38 86.09 -44.05 -37.22 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 57.96 -40.35 -31.16 56.81 -38.18 -32.51 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 44 3 # 44 D 465 GLY B 202 GLY^? 20.20 O15 C8E B 209 D 501 ASP B 45 ASP.? -3.07 CA CA B 208s E 367 TYR A 83 TYR^? -19.24 C2 C8E C 209s coo 21.60 60.44 -42.77 21.61 59.72 -42.40 72.27 -41.27 -30.46 72.24 -42.05 -30.66 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 59.25 -44.27 -7.74 58.41 -42.23 -6.03 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 45 3 # 45 D 465 GLY C 11 GLY^? 12.79 C16 C8E C 210 D 501 ASP C 49 ASP.? -2.87 CA CA C 208s E 367 TYR A 102 TYR^? 9.25 C1 C8E C 209 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 32.80 -49.06 -29.57 33.28 -48.67 -28.99 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 22.13 -48.50 -9.42 23.00 -46.66 -10.00 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 52.54 -63.26 -18.57 51.08 -62.17 -16.42 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 46 3 # 46 D 465 GLY C 15 GLY.? 5.81 C16 C8E C 210 D 501 ASP C 52 ASP.? 15.77 CA CA C 208 E 367 TYR A 102 TYR^? 9.25 C1 C8E C 209 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 30.97 -48.94 -21.56 31.55 -49.29 -22.18 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 21.29 -54.58 -0.38 20.26 -54.47 1.43 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 52.54 -63.26 -18.57 51.08 -62.17 -16.42 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 47 3 # 47 D 465 GLY C 17 GLY^? 11.43 C19 C8E C 210 D 501 ASP A 26 ASP.? 24.86 C2 C8E C 209 E 367 TYR C 83 TYR^? 19.88 O21 C8E A 209 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 34.61 -45.03 -25.87 34.39 -45.63 -26.41 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 53.70 -37.11 -16.05 55.72 -36.42 -15.97 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 49.20 -66.70 -34.88 49.82 -68.82 -36.60 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 48 3 # 48 D 465 GLY C 17 GLY^? 11.43 C19 C8E C 210 D 501 ASP C 48 ASP.? 7.17 CA CA C 208 E 367 TYR C 83 TYR^? 19.88 O21 C8E A 209 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 34.61 -45.03 -25.87 34.39 -45.63 -26.41 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 26.68 -52.06 -7.74 25.46 -53.53 -8.54 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 49.20 -66.70 -34.88 49.82 -68.82 -36.60 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 49 3 # 49 D 465 GLY C 17 GLY^? 11.43 C19 C8E C 210 D 501 ASP C 49 ASP.? -2.87 CA CA C 208s E 367 TYR A 102 TYR^? 9.25 C1 C8E C 209 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 34.61 -45.03 -25.87 34.39 -45.63 -26.41 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 22.13 -48.50 -9.42 23.00 -46.66 -10.00 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 52.54 -63.26 -18.57 51.08 -62.17 -16.42 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 50 3 # 50 D 465 GLY C 18 GLY^? 13.60 C19 C8E C 210 D 501 ASP C 48 ASP.? 7.17 CA CA C 208 E 367 TYR A 97 TYR^? 11.99 C1 C8E A 210 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 37.51 -45.80 -28.16 37.81 -45.75 -27.39 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 26.68 -52.06 -7.74 25.46 -53.53 -8.54 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 61.97 -51.46 -14.47 63.57 -52.89 -16.21 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 51 3 # 51 D 465 GLY C 30 GLY.? 17.86 O21 C8E A 209 D 501 ASP A 166 ASP.? 23.45 CA CA A 208 E 367 TYR C 138 TYR^? 29.21 C16 C8E C 210 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 60.02 -66.08 -40.59 59.62 -65.42 -40.45 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 55.95 -88.25 -40.15 55.99 -89.39 -38.36 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 37.44 -55.85 -45.58 34.94 -55.10 -46.63 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 52 3 # 52 D 465 GLY C 30 GLY.? 17.86 O21 C8E A 209 D 501 ASP A 167 ASP.? 22.50 CA CA A 208 E 367 TYR C 138 TYR^? 29.21 C16 C8E C 210 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 60.02 -66.08 -40.59 59.62 -65.42 -40.45 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 58.25 -87.45 -44.58 60.23 -87.13 -43.88 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 37.44 -55.85 -45.58 34.94 -55.10 -46.63 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 53 3 # 53 D 465 GLY C 34 GLY^? 20.14 O21 C8E A 209 D 501 ASP A 80 ASP^? 12.60 C1 C8E A 210 E 367 TYR A 109 TYR^? 10.85 CA CA A 208 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 52.44 -58.67 -35.04 52.34 -59.13 -34.28 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 58.12 -52.30 -15.93 59.10 -53.68 -17.13 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 66.11 -81.19 -34.21 65.29 -83.76 -33.55 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 54 3 # 54 D 465 GLY C 40 GLY^? 12.46 C19 C8E C 210 D 501 ASP C 48 ASP.? 7.17 CA CA C 208 E 367 TYR A 155 TYR^? 8.43 C17 C8E A 209 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 41.84 -46.53 -24.70 42.24 -46.19 -24.08 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 26.68 -52.06 -7.74 25.46 -53.53 -8.54 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 60.87 -66.67 -17.05 60.42 -64.37 -18.53 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 55 3 # 55 D 465 GLY C 50 GLY.? 8.32 CA CA C 208 D 501 ASP C 114 ASP.? 22.22 CA CA C 208 E 367 TYR C 102 TYR^? 9.73 C2 C8E C 209 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 21.11 -51.78 -6.22 21.90 -51.63 -6.15 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 19.39 -30.14 -1.59 19.46 -28.98 0.18 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 48.50 -51.08 -15.65 48.91 -50.66 -12.96 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 56 3 # 56 D 465 GLY C 72 GLY^? 6.51 O21 C8E C 210 D 501 ASP C 52 ASP.? 15.77 CA CA C 208 E 367 TYR A 102 TYR^? 9.25 C1 C8E C 209 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 32.98 -43.26 -14.24 32.91 -42.76 -14.86 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 21.29 -54.58 -0.38 20.26 -54.47 1.43 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 52.54 -63.26 -18.57 51.08 -62.17 -16.42 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 57 3 # 57 D 465 GLY C 72 GLY^? 6.51 O21 C8E C 210 D 501 ASP C 52 ASP.? 15.77 CA CA C 208 E 367 TYR C 97 TYR^? 17.03 C13 C8E C 210 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 32.98 -43.26 -14.24 32.91 -42.76 -14.86 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 21.29 -54.58 -0.38 20.26 -54.47 1.43 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 44.42 -59.94 -30.24 42.23 -58.45 -29.40 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 58 3 # 58 D 465 GLY C 107 GLY^? 7.61 O21 C8E C 210 D 501 ASP C 52 ASP.? 15.77 CA CA C 208 E 367 TYR A 102 TYR^? 9.25 C1 C8E C 209 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 34.65 -42.83 -10.66 35.11 -42.76 -9.95 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 21.29 -54.58 -0.38 20.26 -54.47 1.43 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 52.54 -63.26 -18.57 51.08 -62.17 -16.42 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 59 3 # 59 D 465 GLY C 107 GLY^? 7.61 O21 C8E C 210 D 501 ASP C 52 ASP.? 15.77 CA CA C 208 E 367 TYR C 97 TYR^? 17.03 C13 C8E C 210 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 34.65 -42.83 -10.66 35.11 -42.76 -9.95 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 21.29 -54.58 -0.38 20.26 -54.47 1.43 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 44.42 -59.94 -30.24 42.23 -58.45 -29.40 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 60 3 # 60 D 465 GLY C 129 GLY^? 8.32 C1 C8E C 209 D 501 ASP C 180 ASP.? 12.29 C5 C8E C 209 E 367 TYR A 183 TYR~? 7.18 C16 C8E A 210 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 44.60 -57.45 -16.86 45.41 -57.44 -17.05 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 42.24 -54.49 3.97 44.24 -53.90 3.82 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 59.65 -81.82 -15.52 59.58 -79.01 -15.74 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 61 3 # 61 D 465 GLY C 131 GLY^? 12.25 C13 C8E C 210 D 501 ASP C 26 ASP.? 24.60 O21 C8E A 209 E 367 TYR A 83 TYR^? -19.24 C2 C8E C 209s coo 21.60 60.44 -42.77 21.61 59.72 -42.40 43.06 -60.72 -22.58 43.75 -61.01 -22.74 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 55.55 -58.08 -41.98 53.84 -58.94 -42.96 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 59.25 -44.27 -7.74 58.41 -42.23 -6.03 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 62 3 # 62 D 465 GLY C 131 GLY^? 12.25 C13 C8E C 210 D 501 ASP C 26 ASP.? 24.60 O21 C8E A 209 E 367 TYR A 183 TYR~? 7.18 C16 C8E A 210 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 43.06 -60.72 -22.58 43.75 -61.01 -22.74 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 55.55 -58.08 -41.98 53.84 -58.94 -42.96 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 59.65 -81.82 -15.52 59.58 -79.01 -15.74 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 63 3 # 63 D 465 GLY C 151 GLY^? 12.60 C13 C8E C 210 D 501 ASP C 48 ASP.? 7.17 CA CA C 208 E 367 TYR A 97 TYR^? 11.99 C1 C8E A 210 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 37.96 -59.28 -27.29 37.21 -59.08 -27.12 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 26.68 -52.06 -7.74 25.46 -53.53 -8.54 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 61.97 -51.46 -14.47 63.57 -52.89 -16.21 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 64 3 # 64 D 465 GLY C 151 GLY^? 12.60 C13 C8E C 210 D 501 ASP C 48 ASP.? 7.17 CA CA C 208 E 367 TYR A 155 TYR^? 8.43 C17 C8E A 209 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 37.96 -59.28 -27.29 37.21 -59.08 -27.12 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 26.68 -52.06 -7.74 25.46 -53.53 -8.54 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 60.87 -66.67 -17.05 60.42 -64.37 -18.53 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 65 3 # 65 D 465 GLY C 179 GLY.? 9.08 C5 C8E C 209 D 501 ASP C 45 ASP.? 3.27 CA CA C 208s E 367 TYR A 155 TYR^? 8.43 C17 C8E A 209 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 42.35 -58.77 1.88 43.04 -58.32 2.32 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 60.87 -66.67 -17.05 60.42 -64.37 -18.53 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 66 3 # 66 D 465 GLY C 182 GLY~? 12.84 O21 C8E C 209 D 501 ASP C 49 ASP.? -2.87 CA CA C 208s E 367 TYR A 83 TYR^? -19.24 C2 C8E C 209s coo 21.60 60.44 -42.77 21.61 59.72 -42.40 36.73 -53.96 4.63 37.26 -54.38 4.27 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 22.13 -48.50 -9.42 23.00 -46.66 -10.00 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 59.25 -44.27 -7.74 58.41 -42.23 -6.03 1mro_c01 source 1mro METHYL-COENZYME M REDUCTASE : 66 hits 1mro_c01 naa= 3 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 1 3 # 1 A 50 ASP A 111 ASP.? 17.05 CA CA A 208 A 55 TYR A 109 TYR^? 10.85 CA CA A 208 A 84 LYS A 63 LYS~? 3.96 CA CA A 208 coo 11.09 42.89 24.44 11.32 42.06 22.49 65.36 -83.80 -40.24 66.17 -85.36 -41.35 coo 4.60 40.33 20.42 7.25 39.50 20.05 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo 9.71 44.83 15.47 10.13 41.43 19.93 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 2 3 # 2 A 50 ASP A 111 ASP.? 17.05 CA CA A 208 A 55 TYR A 109 TYR^? 10.85 CA CA A 208 A 84 LYS A 67 LYS~? 13.30 CA CA A 208 coo 11.09 42.89 24.44 11.32 42.06 22.49 65.36 -83.80 -40.24 66.17 -85.36 -41.35 coo 4.60 40.33 20.42 7.25 39.50 20.05 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo 9.71 44.83 15.47 10.13 41.43 19.93 73.21 -82.07 -40.14 71.59 -78.49 -41.85 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 3 3 # 3 A 50 ASP B 111 ASP.? 16.97 CA CA B 208 A 55 TYR B 109 TYR^? 10.54 CA CA B 208 A 84 LYS B 63 LYS~? 3.79 CA CA B 208 coo 11.09 42.89 24.44 11.32 42.06 22.49 89.21 -14.92 -8.80 89.40 -13.99 -6.98 coo 4.60 40.33 20.42 7.25 39.50 20.05 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo 9.71 44.83 15.47 10.13 41.43 19.93 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 4 3 # 4 A 50 ASP B 111 ASP.? 16.97 CA CA B 208 A 55 TYR B 109 TYR^? 10.54 CA CA B 208 A 84 LYS B 67 LYS~? 18.13 CA CA B 208 coo 11.09 42.89 24.44 11.32 42.06 22.49 89.21 -14.92 -8.80 89.40 -13.99 -6.98 coo 4.60 40.33 20.42 7.25 39.50 20.05 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo 9.71 44.83 15.47 10.13 41.43 19.93 89.12 -21.41 -4.23 87.66 -21.56 1.71 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 5 3 # 5 A 50 ASP C 111 ASP.? 17.21 CA CA C 208 A 55 TYR C 109 TYR^? 10.73 CA CA C 208 A 84 LYS C 63 LYS~? 4.21 CA CA C 208 coo 11.09 42.89 24.44 11.32 42.06 22.49 27.11 -33.17 -3.90 25.73 -31.94 -3.00 coo 4.60 40.33 20.42 7.25 39.50 20.05 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo 9.71 44.83 15.47 10.13 41.43 19.93 20.98 -41.61 -5.49 23.04 -43.67 -10.44 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 6 3 # 6 A 50 ASP C 111 ASP.? 17.21 CA CA C 208 A 55 TYR C 109 TYR^? 10.73 CA CA C 208 A 84 LYS C 67 LYS.? 18.71 CA CA C 208 coo 11.09 42.89 24.44 11.32 42.06 22.49 27.11 -33.17 -3.90 25.73 -31.94 -3.00 coo 4.60 40.33 20.42 7.25 39.50 20.05 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo 9.71 44.83 15.47 10.13 41.43 19.93 20.04 -36.06 -6.98 16.11 -31.17 -7.78 1mrq_c02 source 1mrq ALDO-KETO REDUCTASE FAMILY 1 MEMBER C1 : 6 hits 1mrq_c02 naa= 3 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 1 3 # 1 A 167 LYS A 63 LYS~? 3.96 CA CA A 208 A 169 LYS A 67 LYS~? 13.30 CA CA A 208 A 327 GLU A 70 GLU^? -2.69 CA CA A 208s coo 20.73 15.53 25.54 22.09 15.64 19.40 73.63 -82.49 -34.44 73.43 -77.00 -32.37 coo 24.31 10.25 23.71 29.02 12.05 20.75 73.21 -82.07 -40.14 71.59 -78.49 -41.85 coo 21.86 20.40 18.59 22.12 18.33 18.33 68.79 -75.79 -31.87 70.14 -76.30 -30.27 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 2 3 # 2 A 167 LYS A 67 LYS~? 13.30 CA CA A 208 A 169 LYS A 63 LYS~? 3.96 CA CA A 208 A 327 GLU A 113 GLU.? 20.24 CA CA A 208 coo 20.73 15.53 25.54 22.09 15.64 19.40 73.21 -82.07 -40.14 71.59 -78.49 -41.85 coo 24.31 10.25 23.71 29.02 12.05 20.75 73.63 -82.49 -34.44 73.43 -77.00 -32.37 coo 21.86 20.40 18.59 22.12 18.33 18.33 67.94 -85.82 -46.11 66.40 -86.46 -44.83 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 3 3 # 3 A 167 LYS B 63 LYS~? 3.79 CA CA B 208 A 169 LYS B 67 LYS~? 18.13 CA CA B 208 A 327 GLU B 70 GLU^? -2.58 CA CA B 208s coo 20.73 15.53 25.54 22.09 15.64 19.40 93.18 -23.71 -7.17 90.77 -27.85 -10.83 coo 24.31 10.25 23.71 29.02 12.05 20.75 89.12 -21.41 -4.23 87.66 -21.56 1.71 coo 21.86 20.40 18.59 22.12 18.33 18.33 89.83 -24.96 -14.47 91.03 -26.69 -14.39 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 4 3 # 4 A 167 LYS C 63 LYS~? 4.21 CA CA C 208 A 169 LYS C 67 LYS.? 18.71 CA CA C 208 A 327 GLU C 70 GLU^? -2.71 CA CA C 208s coo 20.73 15.53 25.54 22.09 15.64 19.40 20.98 -41.61 -5.49 23.04 -43.67 -10.44 coo 24.31 10.25 23.71 29.02 12.05 20.75 20.04 -36.06 -6.98 16.11 -31.17 -7.78 coo 21.86 20.40 18.59 22.12 18.33 18.33 27.73 -42.94 -10.42 26.74 -44.79 -10.37 1muc_c00 source 1muc MUCONATE LACTONIZING ENZYME : 4 hits 1muc_c00 naa= 3 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 1 3 # 1 B 167 LYS A 63 LYS~? 3.96 CA CA A 208 B 169 LYS A 67 LYS~? 13.30 CA CA A 208 B 327 GLU A 70 GLU^? -2.69 CA CA A 208s coo 25.79 1.90 -25.69 27.00 2.59 -19.56 73.63 -82.49 -34.44 73.43 -77.00 -32.37 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 73.21 -82.07 -40.14 71.59 -78.49 -41.85 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 68.79 -75.79 -31.87 70.14 -76.30 -30.27 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 2 3 # 2 B 167 LYS A 67 LYS~? 13.30 CA CA A 208 B 169 LYS A 63 LYS~? 3.96 CA CA A 208 B 327 GLU A 113 GLU.? 20.24 CA CA A 208 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 73.21 -82.07 -40.14 71.59 -78.49 -41.85 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 73.63 -82.49 -34.44 73.43 -77.00 -32.37 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 67.94 -85.82 -46.11 66.40 -86.46 -44.83 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 3 3 # 3 B 167 LYS B 63 LYS~? 3.79 CA CA B 208 B 169 LYS B 67 LYS~? 18.13 CA CA B 208 B 327 GLU B 70 GLU^? -2.58 CA CA B 208s coo 25.79 1.90 -25.69 27.00 2.59 -19.56 93.18 -23.71 -7.17 90.77 -27.85 -10.83 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 89.12 -21.41 -4.23 87.66 -21.56 1.71 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 89.83 -24.96 -14.47 91.03 -26.69 -14.39 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 4 3 # 4 B 167 LYS C 63 LYS~? 4.21 CA CA C 208 B 169 LYS C 67 LYS.? 18.71 CA CA C 208 B 327 GLU C 70 GLU^? -2.71 CA CA C 208s coo 25.79 1.90 -25.69 27.00 2.59 -19.56 20.98 -41.61 -5.49 23.04 -43.67 -10.44 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 20.04 -36.06 -6.98 16.11 -31.17 -7.78 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 27.73 -42.94 -10.42 26.74 -44.79 -10.37 1muc_c01 source 1muc MUCONATE LACTONIZING ENZYME : 4 hits 1muc_c01 naa= 3 ULMN 3 1myr_c00 MYROSINASE user 1 3 # 1 187 GLN B 157 GLN.? -3.32 O12 C8E B 210s 328 ASN B 187 ASN~? -3.44 O21 C8E B 210s 409 GLU B 184 GLU~? 8.45 C14 C8E B 210 coo 45.09 114.33 52.30 45.59 116.18 51.29 100.90 -28.16 -30.62 102.98 -28.51 -30.67 coo 41.10 116.46 52.80 42.09 116.00 54.64 101.97 -26.81 -25.28 100.76 -28.02 -26.55 coo 42.69 118.64 56.27 44.58 118.34 55.45 107.80 -26.84 -26.43 109.06 -28.52 -26.54 1myr_c00 source 1myr MYROSINASE : 1 hits 1myr_c00 naa= 3 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 1 3 # 1 A 99 ARG A 36 ARG^? 15.77 C1 C8E A 210 A 101 ASP A 80 ASP^? 12.60 C1 C8E A 210 A 132 ASP A 149 ASP^? 14.85 C1 C8E A 210 coo 11.61 22.83 17.30 14.06 21.71 15.78 59.00 -50.13 -20.90 61.68 -51.06 -19.88 coo 11.37 24.94 11.48 12.48 24.45 13.28 58.12 -52.30 -15.93 59.10 -53.68 -17.13 coo 16.14 18.17 13.37 15.92 19.81 14.71 66.40 -51.17 -20.74 65.06 -51.90 -19.38 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 2 3 # 2 A 99 ARG A 135 ARG^? 21.29 C1 C8E A 210 A 101 ASP A 80 ASP^? 12.60 C1 C8E A 210 A 132 ASP A 149 ASP^? 14.85 C1 C8E A 210 coo 11.61 22.83 17.30 14.06 21.71 15.78 62.45 -46.81 -18.85 61.41 -44.79 -20.90 coo 11.37 24.94 11.48 12.48 24.45 13.28 58.12 -52.30 -15.93 59.10 -53.68 -17.13 coo 16.14 18.17 13.37 15.92 19.81 14.71 66.40 -51.17 -20.74 65.06 -51.90 -19.38 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 3 3 # 3 A 99 ARG A 135 ARG^? 21.29 C1 C8E A 210 A 101 ASP A 149 ASP^? 14.85 C1 C8E A 210 A 132 ASP A 80 ASP^? 12.60 C1 C8E A 210 coo 11.61 22.83 17.30 14.06 21.71 15.78 62.45 -46.81 -18.85 61.41 -44.79 -20.90 coo 11.37 24.94 11.48 12.48 24.45 13.28 66.40 -51.17 -20.74 65.06 -51.90 -19.38 coo 16.14 18.17 13.37 15.92 19.81 14.71 58.12 -52.30 -15.93 59.10 -53.68 -17.13 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 4 3 # 4 A 99 ARG B 36 ARG^? 17.08 O15 C8E B 209 A 101 ASP B 80 ASP^? 15.94 O15 C8E B 209 A 132 ASP B 149 ASP^? 14.91 O15 C8E B 209 coo 11.61 22.83 17.30 14.06 21.71 15.78 77.67 -37.50 -38.51 79.47 -39.58 -37.24 coo 11.37 24.94 11.48 12.48 24.45 13.28 82.56 -37.87 -41.00 82.97 -37.16 -39.06 coo 16.14 18.17 13.37 15.92 19.81 14.71 79.48 -42.39 -33.32 81.04 -41.48 -34.38 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 5 3 # 5 A 99 ARG B 135 ARG^? 22.88 O15 C8E B 209 A 101 ASP B 80 ASP^? 15.94 O15 C8E B 209 A 132 ASP B 149 ASP^? 14.91 O15 C8E B 209 coo 11.61 22.83 17.30 14.06 21.71 15.78 77.46 -42.45 -38.74 74.50 -42.61 -39.42 coo 11.37 24.94 11.48 12.48 24.45 13.28 82.56 -37.87 -41.00 82.97 -37.16 -39.06 coo 16.14 18.17 13.37 15.92 19.81 14.71 79.48 -42.39 -33.32 81.04 -41.48 -34.38 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 6 3 # 6 A 99 ARG B 135 ARG^? 22.88 O15 C8E B 209 A 101 ASP B 149 ASP^? 14.91 O15 C8E B 209 A 132 ASP B 80 ASP^? 15.94 O15 C8E B 209 coo 11.61 22.83 17.30 14.06 21.71 15.78 77.46 -42.45 -38.74 74.50 -42.61 -39.42 coo 11.37 24.94 11.48 12.48 24.45 13.28 79.48 -42.39 -33.32 81.04 -41.48 -34.38 coo 16.14 18.17 13.37 15.92 19.81 14.71 82.56 -37.87 -41.00 82.97 -37.16 -39.06 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 7 3 # 7 A 99 ARG C 36 ARG^? 17.98 C16 C8E C 210 A 101 ASP C 80 ASP^? 16.43 C13 C8E C 210 A 132 ASP C 149 ASP^? 16.02 C16 C8E C 210 coo 11.61 22.83 17.30 14.06 21.71 15.78 45.58 -52.92 -31.76 43.11 -54.70 -31.56 coo 11.37 24.94 11.48 12.48 24.45 13.28 47.10 -57.14 -28.79 45.64 -55.94 -27.77 coo 16.14 18.17 13.37 15.92 19.81 14.71 38.72 -55.19 -32.44 40.02 -55.93 -30.97 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 8 3 # 8 A 99 ARG C 135 ARG^? 23.87 C16 C8E C 210 A 101 ASP C 80 ASP^? 16.43 C13 C8E C 210 A 132 ASP C 149 ASP^? 16.02 C16 C8E C 210 coo 11.61 22.83 17.30 14.06 21.71 15.78 44.01 -56.05 -34.91 45.01 -54.65 -37.44 coo 11.37 24.94 11.48 12.48 24.45 13.28 47.10 -57.14 -28.79 45.64 -55.94 -27.77 coo 16.14 18.17 13.37 15.92 19.81 14.71 38.72 -55.19 -32.44 40.02 -55.93 -30.97 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 9 3 # 9 A 99 ARG C 135 ARG^? 23.87 C16 C8E C 210 A 101 ASP C 149 ASP^? 16.02 C16 C8E C 210 A 132 ASP C 80 ASP^? 16.43 C13 C8E C 210 coo 11.61 22.83 17.30 14.06 21.71 15.78 44.01 -56.05 -34.91 45.01 -54.65 -37.44 coo 11.37 24.94 11.48 12.48 24.45 13.28 38.72 -55.19 -32.44 40.02 -55.93 -30.97 coo 16.14 18.17 13.37 15.92 19.81 14.71 47.10 -57.14 -28.79 45.64 -55.94 -27.77 1nu3_c00 source 1nu3 LIMONENE-1,2-EPOXIDE HYDROLASE : 9 hits 1nu3_c00 naa= 3 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 1 3 # 1 B 99 ARG A 36 ARG^? 15.77 C1 C8E A 210 B 101 ASP A 80 ASP^? 12.60 C1 C8E A 210 B 132 ASP A 149 ASP^? 14.85 C1 C8E A 210 coo 11.61 3.43 18.38 9.11 4.29 16.86 59.00 -50.13 -20.90 61.68 -51.06 -19.88 coo 11.74 0.51 12.98 10.75 1.32 14.67 58.12 -52.30 -15.93 59.10 -53.68 -17.13 coo 6.93 7.52 14.08 7.18 6.08 15.65 66.40 -51.17 -20.74 65.06 -51.90 -19.38 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 2 3 # 2 B 99 ARG A 135 ARG^? 21.29 C1 C8E A 210 B 101 ASP A 80 ASP^? 12.60 C1 C8E A 210 B 132 ASP A 149 ASP^? 14.85 C1 C8E A 210 coo 11.61 3.43 18.38 9.11 4.29 16.86 62.45 -46.81 -18.85 61.41 -44.79 -20.90 coo 11.74 0.51 12.98 10.75 1.32 14.67 58.12 -52.30 -15.93 59.10 -53.68 -17.13 coo 6.93 7.52 14.08 7.18 6.08 15.65 66.40 -51.17 -20.74 65.06 -51.90 -19.38 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 3 3 # 3 B 99 ARG A 135 ARG^? 21.29 C1 C8E A 210 B 101 ASP A 149 ASP^? 14.85 C1 C8E A 210 B 132 ASP A 80 ASP^? 12.60 C1 C8E A 210 coo 11.61 3.43 18.38 9.11 4.29 16.86 62.45 -46.81 -18.85 61.41 -44.79 -20.90 coo 11.74 0.51 12.98 10.75 1.32 14.67 66.40 -51.17 -20.74 65.06 -51.90 -19.38 coo 6.93 7.52 14.08 7.18 6.08 15.65 58.12 -52.30 -15.93 59.10 -53.68 -17.13 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 4 3 # 4 B 99 ARG B 36 ARG^? 17.08 O15 C8E B 209 B 101 ASP B 80 ASP^? 15.94 O15 C8E B 209 B 132 ASP B 149 ASP^? 14.91 O15 C8E B 209 coo 11.61 3.43 18.38 9.11 4.29 16.86 77.67 -37.50 -38.51 79.47 -39.58 -37.24 coo 11.74 0.51 12.98 10.75 1.32 14.67 82.56 -37.87 -41.00 82.97 -37.16 -39.06 coo 6.93 7.52 14.08 7.18 6.08 15.65 79.48 -42.39 -33.32 81.04 -41.48 -34.38 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 5 3 # 5 B 99 ARG B 101 ARG^? 13.86 O15 C8E B 209 B 101 ASP B 153 ASP^? 9.57 O15 C8E B 209 B 132 ASP B 80 ASP^? 15.94 O15 C8E B 209 coo 11.61 3.43 18.38 9.11 4.29 16.86 87.52 -34.18 -37.50 85.80 -36.55 -38.16 coo 11.74 0.51 12.98 10.75 1.32 14.67 89.74 -36.17 -33.46 87.76 -36.55 -34.22 coo 6.93 7.52 14.08 7.18 6.08 15.65 82.56 -37.87 -41.00 82.97 -37.16 -39.06 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 6 3 # 6 B 99 ARG B 135 ARG^? 22.88 O15 C8E B 209 B 101 ASP B 80 ASP^? 15.94 O15 C8E B 209 B 132 ASP B 149 ASP^? 14.91 O15 C8E B 209 coo 11.61 3.43 18.38 9.11 4.29 16.86 77.46 -42.45 -38.74 74.50 -42.61 -39.42 coo 11.74 0.51 12.98 10.75 1.32 14.67 82.56 -37.87 -41.00 82.97 -37.16 -39.06 coo 6.93 7.52 14.08 7.18 6.08 15.65 79.48 -42.39 -33.32 81.04 -41.48 -34.38 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 7 3 # 7 B 99 ARG B 135 ARG^? 22.88 O15 C8E B 209 B 101 ASP B 149 ASP^? 14.91 O15 C8E B 209 B 132 ASP B 80 ASP^? 15.94 O15 C8E B 209 coo 11.61 3.43 18.38 9.11 4.29 16.86 77.46 -42.45 -38.74 74.50 -42.61 -39.42 coo 11.74 0.51 12.98 10.75 1.32 14.67 79.48 -42.39 -33.32 81.04 -41.48 -34.38 coo 6.93 7.52 14.08 7.18 6.08 15.65 82.56 -37.87 -41.00 82.97 -37.16 -39.06 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 8 3 # 8 B 99 ARG C 36 ARG^? 17.98 C16 C8E C 210 B 101 ASP C 80 ASP^? 16.43 C13 C8E C 210 B 132 ASP C 149 ASP^? 16.02 C16 C8E C 210 coo 11.61 3.43 18.38 9.11 4.29 16.86 45.58 -52.92 -31.76 43.11 -54.70 -31.56 coo 11.74 0.51 12.98 10.75 1.32 14.67 47.10 -57.14 -28.79 45.64 -55.94 -27.77 coo 6.93 7.52 14.08 7.18 6.08 15.65 38.72 -55.19 -32.44 40.02 -55.93 -30.97 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 9 3 # 9 B 99 ARG C 101 ARG^? 13.82 C13 C8E C 210 B 101 ASP C 153 ASP^? 9.83 C13 C8E C 210 B 132 ASP C 80 ASP^? 16.43 C13 C8E C 210 coo 11.61 3.43 18.38 9.11 4.29 16.86 44.39 -56.56 -21.66 44.87 -57.05 -24.63 coo 11.74 0.51 12.98 10.75 1.32 14.67 40.09 -57.62 -20.90 41.26 -57.13 -22.61 coo 6.93 7.52 14.08 7.18 6.08 15.65 47.10 -57.14 -28.79 45.64 -55.94 -27.77 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 10 3 # 10 B 99 ARG C 135 ARG^? 23.87 C16 C8E C 210 B 101 ASP C 80 ASP^? 16.43 C13 C8E C 210 B 132 ASP C 149 ASP^? 16.02 C16 C8E C 210 coo 11.61 3.43 18.38 9.11 4.29 16.86 44.01 -56.05 -34.91 45.01 -54.65 -37.44 coo 11.74 0.51 12.98 10.75 1.32 14.67 47.10 -57.14 -28.79 45.64 -55.94 -27.77 coo 6.93 7.52 14.08 7.18 6.08 15.65 38.72 -55.19 -32.44 40.02 -55.93 -30.97 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 11 3 # 11 B 99 ARG C 135 ARG^? 23.87 C16 C8E C 210 B 101 ASP C 149 ASP^? 16.02 C16 C8E C 210 B 132 ASP C 80 ASP^? 16.43 C13 C8E C 210 coo 11.61 3.43 18.38 9.11 4.29 16.86 44.01 -56.05 -34.91 45.01 -54.65 -37.44 coo 11.74 0.51 12.98 10.75 1.32 14.67 38.72 -55.19 -32.44 40.02 -55.93 -30.97 coo 6.93 7.52 14.08 7.18 6.08 15.65 47.10 -57.14 -28.79 45.64 -55.94 -27.77 1nu3_c01 source 1nu3 LIMONENE-1,2-EPOXIDE HYDROLASE : 11 hits 1nu3_c01 naa= 3 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 1 3 # 1 A 99 ARG A 36 ARG^? 15.77 C1 C8E A 210 A 101 ASP A 80 ASP^? 12.60 C1 C8E A 210 A 132 ASP A 149 ASP^? 14.85 C1 C8E A 210 coo 11.50 22.77 17.24 14.00 21.62 15.86 59.00 -50.13 -20.90 61.68 -51.06 -19.88 coo 11.19 25.00 11.76 12.16 24.45 13.59 58.12 -52.30 -15.93 59.10 -53.68 -17.13 coo 16.04 18.11 13.43 15.88 19.70 14.83 66.40 -51.17 -20.74 65.06 -51.90 -19.38 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 2 3 # 2 A 99 ARG A 135 ARG^? 21.29 C1 C8E A 210 A 101 ASP A 80 ASP^? 12.60 C1 C8E A 210 A 132 ASP A 149 ASP^? 14.85 C1 C8E A 210 coo 11.50 22.77 17.24 14.00 21.62 15.86 62.45 -46.81 -18.85 61.41 -44.79 -20.90 coo 11.19 25.00 11.76 12.16 24.45 13.59 58.12 -52.30 -15.93 59.10 -53.68 -17.13 coo 16.04 18.11 13.43 15.88 19.70 14.83 66.40 -51.17 -20.74 65.06 -51.90 -19.38 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 3 3 # 3 A 99 ARG A 135 ARG^? 21.29 C1 C8E A 210 A 101 ASP A 149 ASP^? 14.85 C1 C8E A 210 A 132 ASP A 80 ASP^? 12.60 C1 C8E A 210 coo 11.50 22.77 17.24 14.00 21.62 15.86 62.45 -46.81 -18.85 61.41 -44.79 -20.90 coo 11.19 25.00 11.76 12.16 24.45 13.59 66.40 -51.17 -20.74 65.06 -51.90 -19.38 coo 16.04 18.11 13.43 15.88 19.70 14.83 58.12 -52.30 -15.93 59.10 -53.68 -17.13 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 4 3 # 4 A 99 ARG B 36 ARG^? 17.08 O15 C8E B 209 A 101 ASP B 80 ASP^? 15.94 O15 C8E B 209 A 132 ASP B 149 ASP^? 14.91 O15 C8E B 209 coo 11.50 22.77 17.24 14.00 21.62 15.86 77.67 -37.50 -38.51 79.47 -39.58 -37.24 coo 11.19 25.00 11.76 12.16 24.45 13.59 82.56 -37.87 -41.00 82.97 -37.16 -39.06 coo 16.04 18.11 13.43 15.88 19.70 14.83 79.48 -42.39 -33.32 81.04 -41.48 -34.38 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 5 3 # 5 A 99 ARG B 101 ARG^? 13.86 O15 C8E B 209 A 101 ASP B 153 ASP^? 9.57 O15 C8E B 209 A 132 ASP B 80 ASP^? 15.94 O15 C8E B 209 coo 11.50 22.77 17.24 14.00 21.62 15.86 87.52 -34.18 -37.50 85.80 -36.55 -38.16 coo 11.19 25.00 11.76 12.16 24.45 13.59 89.74 -36.17 -33.46 87.76 -36.55 -34.22 coo 16.04 18.11 13.43 15.88 19.70 14.83 82.56 -37.87 -41.00 82.97 -37.16 -39.06 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 6 3 # 6 A 99 ARG B 135 ARG^? 22.88 O15 C8E B 209 A 101 ASP B 80 ASP^? 15.94 O15 C8E B 209 A 132 ASP B 149 ASP^? 14.91 O15 C8E B 209 coo 11.50 22.77 17.24 14.00 21.62 15.86 77.46 -42.45 -38.74 74.50 -42.61 -39.42 coo 11.19 25.00 11.76 12.16 24.45 13.59 82.56 -37.87 -41.00 82.97 -37.16 -39.06 coo 16.04 18.11 13.43 15.88 19.70 14.83 79.48 -42.39 -33.32 81.04 -41.48 -34.38 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 7 3 # 7 A 99 ARG B 135 ARG^? 22.88 O15 C8E B 209 A 101 ASP B 149 ASP^? 14.91 O15 C8E B 209 A 132 ASP B 80 ASP^? 15.94 O15 C8E B 209 coo 11.50 22.77 17.24 14.00 21.62 15.86 77.46 -42.45 -38.74 74.50 -42.61 -39.42 coo 11.19 25.00 11.76 12.16 24.45 13.59 79.48 -42.39 -33.32 81.04 -41.48 -34.38 coo 16.04 18.11 13.43 15.88 19.70 14.83 82.56 -37.87 -41.00 82.97 -37.16 -39.06 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 8 3 # 8 A 99 ARG C 36 ARG^? 17.98 C16 C8E C 210 A 101 ASP C 80 ASP^? 16.43 C13 C8E C 210 A 132 ASP C 149 ASP^? 16.02 C16 C8E C 210 coo 11.50 22.77 17.24 14.00 21.62 15.86 45.58 -52.92 -31.76 43.11 -54.70 -31.56 coo 11.19 25.00 11.76 12.16 24.45 13.59 47.10 -57.14 -28.79 45.64 -55.94 -27.77 coo 16.04 18.11 13.43 15.88 19.70 14.83 38.72 -55.19 -32.44 40.02 -55.93 -30.97 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 9 3 # 9 A 99 ARG C 101 ARG^? 13.82 C13 C8E C 210 A 101 ASP C 153 ASP^? 9.83 C13 C8E C 210 A 132 ASP C 80 ASP^? 16.43 C13 C8E C 210 coo 11.50 22.77 17.24 14.00 21.62 15.86 44.39 -56.56 -21.66 44.87 -57.05 -24.63 coo 11.19 25.00 11.76 12.16 24.45 13.59 40.09 -57.62 -20.90 41.26 -57.13 -22.61 coo 16.04 18.11 13.43 15.88 19.70 14.83 47.10 -57.14 -28.79 45.64 -55.94 -27.77 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 10 3 # 10 A 99 ARG C 135 ARG^? 23.87 C16 C8E C 210 A 101 ASP C 80 ASP^? 16.43 C13 C8E C 210 A 132 ASP C 149 ASP^? 16.02 C16 C8E C 210 coo 11.50 22.77 17.24 14.00 21.62 15.86 44.01 -56.05 -34.91 45.01 -54.65 -37.44 coo 11.19 25.00 11.76 12.16 24.45 13.59 47.10 -57.14 -28.79 45.64 -55.94 -27.77 coo 16.04 18.11 13.43 15.88 19.70 14.83 38.72 -55.19 -32.44 40.02 -55.93 -30.97 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 11 3 # 11 A 99 ARG C 135 ARG^? 23.87 C16 C8E C 210 A 101 ASP C 149 ASP^? 16.02 C16 C8E C 210 A 132 ASP C 80 ASP^? 16.43 C13 C8E C 210 coo 11.50 22.77 17.24 14.00 21.62 15.86 44.01 -56.05 -34.91 45.01 -54.65 -37.44 coo 11.19 25.00 11.76 12.16 24.45 13.59 38.72 -55.19 -32.44 40.02 -55.93 -30.97 coo 16.04 18.11 13.43 15.88 19.70 14.83 47.10 -57.14 -28.79 45.64 -55.94 -27.77 1nww_c02 source 1nww LIMONENE-1,2-EPOXIDE HYDROLASE : 11 hits 1nww_c02 naa= 3 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 1 3 # 1 B 99 ARG A 36 ARG^? 15.77 C1 C8E A 210 B 101 ASP A 80 ASP^? 12.60 C1 C8E A 210 B 132 ASP A 149 ASP^? 14.85 C1 C8E A 210 coo 11.48 3.09 18.25 9.01 4.07 16.77 59.00 -50.13 -20.90 61.68 -51.06 -19.88 coo 11.83 0.33 13.01 10.88 1.04 14.81 58.12 -52.30 -15.93 59.10 -53.68 -17.13 coo 6.85 7.33 14.07 7.10 5.88 15.60 66.40 -51.17 -20.74 65.06 -51.90 -19.38 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 2 3 # 2 B 99 ARG A 135 ARG^? 21.29 C1 C8E A 210 B 101 ASP A 80 ASP^? 12.60 C1 C8E A 210 B 132 ASP A 149 ASP^? 14.85 C1 C8E A 210 coo 11.48 3.09 18.25 9.01 4.07 16.77 62.45 -46.81 -18.85 61.41 -44.79 -20.90 coo 11.83 0.33 13.01 10.88 1.04 14.81 58.12 -52.30 -15.93 59.10 -53.68 -17.13 coo 6.85 7.33 14.07 7.10 5.88 15.60 66.40 -51.17 -20.74 65.06 -51.90 -19.38 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 3 3 # 3 B 99 ARG A 135 ARG^? 21.29 C1 C8E A 210 B 101 ASP A 149 ASP^? 14.85 C1 C8E A 210 B 132 ASP A 80 ASP^? 12.60 C1 C8E A 210 coo 11.48 3.09 18.25 9.01 4.07 16.77 62.45 -46.81 -18.85 61.41 -44.79 -20.90 coo 11.83 0.33 13.01 10.88 1.04 14.81 66.40 -51.17 -20.74 65.06 -51.90 -19.38 coo 6.85 7.33 14.07 7.10 5.88 15.60 58.12 -52.30 -15.93 59.10 -53.68 -17.13 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 4 3 # 4 B 99 ARG B 36 ARG^? 17.08 O15 C8E B 209 B 101 ASP B 80 ASP^? 15.94 O15 C8E B 209 B 132 ASP B 149 ASP^? 14.91 O15 C8E B 209 coo 11.48 3.09 18.25 9.01 4.07 16.77 77.67 -37.50 -38.51 79.47 -39.58 -37.24 coo 11.83 0.33 13.01 10.88 1.04 14.81 82.56 -37.87 -41.00 82.97 -37.16 -39.06 coo 6.85 7.33 14.07 7.10 5.88 15.60 79.48 -42.39 -33.32 81.04 -41.48 -34.38 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 5 3 # 5 B 99 ARG B 101 ARG^? 13.86 O15 C8E B 209 B 101 ASP B 153 ASP^? 9.57 O15 C8E B 209 B 132 ASP B 80 ASP^? 15.94 O15 C8E B 209 coo 11.48 3.09 18.25 9.01 4.07 16.77 87.52 -34.18 -37.50 85.80 -36.55 -38.16 coo 11.83 0.33 13.01 10.88 1.04 14.81 89.74 -36.17 -33.46 87.76 -36.55 -34.22 coo 6.85 7.33 14.07 7.10 5.88 15.60 82.56 -37.87 -41.00 82.97 -37.16 -39.06 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 6 3 # 6 B 99 ARG B 135 ARG^? 22.88 O15 C8E B 209 B 101 ASP B 80 ASP^? 15.94 O15 C8E B 209 B 132 ASP B 149 ASP^? 14.91 O15 C8E B 209 coo 11.48 3.09 18.25 9.01 4.07 16.77 77.46 -42.45 -38.74 74.50 -42.61 -39.42 coo 11.83 0.33 13.01 10.88 1.04 14.81 82.56 -37.87 -41.00 82.97 -37.16 -39.06 coo 6.85 7.33 14.07 7.10 5.88 15.60 79.48 -42.39 -33.32 81.04 -41.48 -34.38 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 7 3 # 7 B 99 ARG B 135 ARG^? 22.88 O15 C8E B 209 B 101 ASP B 149 ASP^? 14.91 O15 C8E B 209 B 132 ASP B 80 ASP^? 15.94 O15 C8E B 209 coo 11.48 3.09 18.25 9.01 4.07 16.77 77.46 -42.45 -38.74 74.50 -42.61 -39.42 coo 11.83 0.33 13.01 10.88 1.04 14.81 79.48 -42.39 -33.32 81.04 -41.48 -34.38 coo 6.85 7.33 14.07 7.10 5.88 15.60 82.56 -37.87 -41.00 82.97 -37.16 -39.06 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 8 3 # 8 B 99 ARG C 36 ARG^? 17.98 C16 C8E C 210 B 101 ASP C 80 ASP^? 16.43 C13 C8E C 210 B 132 ASP C 149 ASP^? 16.02 C16 C8E C 210 coo 11.48 3.09 18.25 9.01 4.07 16.77 45.58 -52.92 -31.76 43.11 -54.70 -31.56 coo 11.83 0.33 13.01 10.88 1.04 14.81 47.10 -57.14 -28.79 45.64 -55.94 -27.77 coo 6.85 7.33 14.07 7.10 5.88 15.60 38.72 -55.19 -32.44 40.02 -55.93 -30.97 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 9 3 # 9 B 99 ARG C 101 ARG^? 13.82 C13 C8E C 210 B 101 ASP C 153 ASP^? 9.83 C13 C8E C 210 B 132 ASP C 80 ASP^? 16.43 C13 C8E C 210 coo 11.48 3.09 18.25 9.01 4.07 16.77 44.39 -56.56 -21.66 44.87 -57.05 -24.63 coo 11.83 0.33 13.01 10.88 1.04 14.81 40.09 -57.62 -20.90 41.26 -57.13 -22.61 coo 6.85 7.33 14.07 7.10 5.88 15.60 47.10 -57.14 -28.79 45.64 -55.94 -27.77 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 10 3 # 10 B 99 ARG C 135 ARG^? 23.87 C16 C8E C 210 B 101 ASP C 80 ASP^? 16.43 C13 C8E C 210 B 132 ASP C 149 ASP^? 16.02 C16 C8E C 210 coo 11.48 3.09 18.25 9.01 4.07 16.77 44.01 -56.05 -34.91 45.01 -54.65 -37.44 coo 11.83 0.33 13.01 10.88 1.04 14.81 47.10 -57.14 -28.79 45.64 -55.94 -27.77 coo 6.85 7.33 14.07 7.10 5.88 15.60 38.72 -55.19 -32.44 40.02 -55.93 -30.97 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 11 3 # 11 B 99 ARG C 135 ARG^? 23.87 C16 C8E C 210 B 101 ASP C 149 ASP^? 16.02 C16 C8E C 210 B 132 ASP C 80 ASP^? 16.43 C13 C8E C 210 coo 11.48 3.09 18.25 9.01 4.07 16.77 44.01 -56.05 -34.91 45.01 -54.65 -37.44 coo 11.83 0.33 13.01 10.88 1.04 14.81 38.72 -55.19 -32.44 40.02 -55.93 -30.97 coo 6.85 7.33 14.07 7.10 5.88 15.60 47.10 -57.14 -28.79 45.64 -55.94 -27.77 1nww_c03 source 1nww LIMONENE-1,2-EPOXIDE HYDROLASE : 11 hits 1nww_c03 naa= 3 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 1 3 # 1 A 62 SER A 5 SER^? 24.40 C2 C8E C 209 A 154 ASP A 26 ASP.? 24.86 C2 C8E C 209 A 261 ARG A 206 ARG^? 26.36 C2 C8E C 209 coo 16.10 74.10 3.11 17.18 73.52 5.20 55.35 -42.73 -25.42 56.65 -41.65 -23.68 coo 16.07 84.71 8.14 15.20 82.81 8.14 53.70 -37.11 -16.05 55.72 -36.42 -15.97 coo 10.59 77.85 4.81 13.09 76.36 5.76 56.35 -36.42 -23.90 57.63 -37.98 -21.56 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 2 3 # 2 A 62 SER A 78 SER^? 13.83 C1 C8E A 210 A 154 ASP A 149 ASP^? 14.85 C1 C8E A 210 A 261 ARG A 36 ARG^? 15.77 C1 C8E A 210 coo 16.10 74.10 3.11 17.18 73.52 5.20 55.97 -57.73 -19.67 57.70 -56.10 -19.98 coo 16.07 84.71 8.14 15.20 82.81 8.14 66.40 -51.17 -20.74 65.06 -51.90 -19.38 coo 10.59 77.85 4.81 13.09 76.36 5.76 59.00 -50.13 -20.90 61.68 -51.06 -19.88 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 3 3 # 3 A 62 SER A 175 SER^? 15.77 O21 C8E A 210 A 154 ASP A 185 ASP~? 11.73 O21 C8E A 210 A 261 ARG A 162 ARG^? 10.87 O21 C8E A 210 coo 16.10 74.10 3.11 17.18 73.52 5.20 53.84 -83.01 -22.59 51.54 -82.77 -21.91 coo 16.07 84.71 8.14 15.20 82.81 8.14 65.81 -86.27 -18.22 66.54 -87.64 -16.78 coo 10.59 77.85 4.81 13.09 76.36 5.76 60.16 -83.54 -27.36 63.31 -83.18 -27.03 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 4 3 # 4 A 62 SER B 5 SER^? 27.72 O15 C8E B 209 A 154 ASP B 26 ASP.? 33.07 O15 C8E B 209 A 261 ARG B 206 ARG^? 34.91 O15 C8E B 209 coo 16.10 74.10 3.11 17.18 73.52 5.20 68.96 -37.45 -41.77 69.21 -39.86 -42.14 coo 16.07 84.71 8.14 15.20 82.81 8.14 71.92 -43.11 -51.36 71.95 -45.06 -50.50 coo 10.59 77.85 4.81 13.09 76.36 5.76 66.21 -41.62 -44.73 64.06 -41.49 -46.91 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 5 3 # 5 A 62 SER C 5 SER^? 28.64 C16 C8E C 210 A 154 ASP C 26 ASP.? 24.60 O21 C8E A 209 A 261 ARG C 206 ARG^? 30.58 O21 C8E A 209 coo 16.10 74.10 3.11 17.18 73.52 5.20 50.03 -48.53 -38.83 49.40 -50.39 -40.21 coo 16.07 84.71 8.14 15.20 82.81 8.14 55.55 -58.08 -41.98 53.84 -58.94 -42.96 coo 10.59 77.85 4.81 13.09 76.36 5.76 51.48 -50.24 -44.52 54.38 -50.65 -45.44 1o98_c00 source 1o98 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT PHOSPHOGLY: 5 hits 1o98_c00 naa= 3 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 1 3 # 1 B 175 LYS C 63 LYS~? 4.21 CA CA C 208 B 208 GLN C 121 GLN^? 14.56 CA CA C 208 B 209 LYS C 119 LYS.? 22.44 CA CA C 208 coo 105.03 46.01 19.55 106.59 42.35 15.55 20.98 -41.61 -5.49 23.04 -43.67 -10.44 coo 113.93 46.99 13.56 113.37 48.52 14.95 32.69 -39.14 -1.40 32.53 -40.89 -0.21 coo 115.66 49.12 8.60 111.19 49.52 4.73 30.81 -32.05 -1.80 31.88 -31.87 3.92 1ohh_c07 source 1ohh ATP SYNTHASE ALPHA CHAIN HEART ISOFORM, MITOCH: 1 hits 1ohh_c07 naa= 3 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 A 24 ASP A 45 ASP.? -2.96 CA CA A 208s A 146 TYR A 51 TYR.? 9.92 O21 C8E A 210 A 177 LYS A 188 LYS~? 10.77 C20 C8E A 210 coo -3.50 124.89 25.05 -2.25 124.77 23.26 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo 1.87 119.38 16.45 1.41 122.11 16.84 71.70 -83.21 -22.40 69.97 -85.02 -21.17 coo -2.59 124.07 12.67 -0.91 126.17 18.42 68.32 -80.18 -18.11 71.95 -84.24 -15.84 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 A 24 ASP A 45 ASP.? -2.96 CA CA A 208s A 146 TYR A 109 TYR^? 10.85 CA CA A 208 A 177 LYS A 63 LYS~? 3.96 CA CA A 208 coo -3.50 124.89 25.05 -2.25 124.77 23.26 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo 1.87 119.38 16.45 1.41 122.11 16.84 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo -2.59 124.07 12.67 -0.91 126.17 18.42 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 A 24 ASP A 48 ASP.? 7.38 CA CA A 208 A 146 TYR A 109 TYR^? 10.85 CA CA A 208 A 177 LYS A 63 LYS~? 3.96 CA CA A 208 coo -3.50 124.89 25.05 -2.25 124.77 23.26 72.05 -78.20 -23.17 73.82 -77.79 -22.11 coo 1.87 119.38 16.45 1.41 122.11 16.84 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo -2.59 124.07 12.67 -0.91 126.17 18.42 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 A 24 ASP A 49 ASP.? -3.00 CA CA A 208s A 146 TYR A 109 TYR^? 10.85 CA CA A 208 A 177 LYS A 67 LYS~? 13.30 CA CA A 208 coo -3.50 124.89 25.05 -2.25 124.77 23.26 75.72 -77.89 -27.98 74.67 -77.10 -29.65 coo 1.87 119.38 16.45 1.41 122.11 16.84 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo -2.59 124.07 12.67 -0.91 126.17 18.42 73.21 -82.07 -40.14 71.59 -78.49 -41.85 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 A 24 ASP A 61 ASP~? 12.37 CA CA A 208 A 146 TYR A 109 TYR^? 10.85 CA CA A 208 A 177 LYS A 67 LYS~? 13.30 CA CA A 208 coo -3.50 124.89 25.05 -2.25 124.77 23.26 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo 1.87 119.38 16.45 1.41 122.11 16.84 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo -2.59 124.07 12.67 -0.91 126.17 18.42 73.21 -82.07 -40.14 71.59 -78.49 -41.85 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 A 24 ASP B 45 ASP.? -3.07 CA CA B 208s A 146 TYR B 51 TYR.? 9.95 O21 C8E B 210 A 177 LYS B 188 LYS~? 9.67 C16 C8E B 210 coo -3.50 124.89 25.05 -2.25 124.77 23.26 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo 1.87 119.38 16.45 1.41 122.11 16.84 102.03 -27.53 -15.19 104.12 -26.16 -16.40 coo -2.59 124.07 12.67 -0.91 126.17 18.42 102.16 -28.74 -21.10 106.15 -31.37 -17.86 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 A 24 ASP B 45 ASP.? -3.07 CA CA B 208s A 146 TYR B 109 TYR^? 10.54 CA CA B 208 A 177 LYS B 63 LYS~? 3.79 CA CA B 208 coo -3.50 124.89 25.05 -2.25 124.77 23.26 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo 1.87 119.38 16.45 1.41 122.11 16.84 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo -2.59 124.07 12.67 -0.91 126.17 18.42 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 A 24 ASP B 48 ASP.? 7.20 CA CA B 208 A 146 TYR B 109 TYR^? 10.54 CA CA B 208 A 177 LYS B 63 LYS~? 3.79 CA CA B 208 coo -3.50 124.89 25.05 -2.25 124.77 23.26 97.60 -30.12 -16.68 98.20 -32.01 -15.99 coo 1.87 119.38 16.45 1.41 122.11 16.84 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo -2.59 124.07 12.67 -0.91 126.17 18.42 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 A 24 ASP B 49 ASP.? -3.05 CA CA B 208s A 146 TYR B 109 TYR^? 10.54 CA CA B 208 A 177 LYS B 67 LYS~? 18.13 CA CA B 208 coo -3.50 124.89 25.05 -2.25 124.77 23.26 94.52 -28.97 -11.62 93.03 -30.41 -11.73 coo 1.87 119.38 16.45 1.41 122.11 16.84 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo -2.59 124.07 12.67 -0.91 126.17 18.42 89.12 -21.41 -4.23 87.66 -21.56 1.71 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 10 3 # 10 A 24 ASP B 61 ASP~? 12.48 CA CA B 208 A 146 TYR B 109 TYR^? 10.54 CA CA B 208 A 177 LYS B 67 LYS~? 18.13 CA CA B 208 coo -3.50 124.89 25.05 -2.25 124.77 23.26 98.68 -27.22 -4.60 99.30 -29.23 -4.23 coo 1.87 119.38 16.45 1.41 122.11 16.84 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo -2.59 124.07 12.67 -0.91 126.17 18.42 89.12 -21.41 -4.23 87.66 -21.56 1.71 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 11 3 # 11 A 24 ASP B 80 ASP^? 15.94 O15 C8E B 209 A 146 TYR B 83 TYR^? 23.90 C1 C8E B 209 A 177 LYS B 84 LYS.? 25.86 O15 C8E B 209 coo -3.50 124.89 25.05 -2.25 124.77 23.26 82.56 -37.87 -41.00 82.97 -37.16 -39.06 coo 1.87 119.38 16.45 1.41 122.11 16.84 84.86 -45.84 -46.52 87.07 -46.60 -44.97 coo -2.59 124.07 12.67 -0.91 126.17 18.42 79.44 -47.69 -46.65 75.97 -44.45 -44.18 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 12 3 # 12 A 24 ASP C 45 ASP.? 3.27 CA CA C 208s A 146 TYR C 51 TYR.? 10.04 O21 C8E C 209 A 177 LYS C 188 LYS~? 9.02 C16 C8E C 209 coo -3.50 124.89 25.05 -2.25 124.77 23.26 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo 1.87 119.38 16.45 1.41 122.11 16.84 26.09 -52.62 -2.60 27.54 -53.38 -0.32 coo -2.59 124.07 12.67 -0.91 126.17 18.42 31.07 -55.82 -4.30 26.58 -58.21 -2.57 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 13 3 # 13 A 24 ASP C 45 ASP.? 3.27 CA CA C 208s A 146 TYR C 109 TYR^? 10.73 CA CA C 208 A 177 LYS C 63 LYS~? 4.21 CA CA C 208 coo -3.50 124.89 25.05 -2.25 124.77 23.26 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo 1.87 119.38 16.45 1.41 122.11 16.84 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo -2.59 124.07 12.67 -0.91 126.17 18.42 20.98 -41.61 -5.49 23.04 -43.67 -10.44 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 14 3 # 14 A 24 ASP C 48 ASP.? 7.17 CA CA C 208 A 146 TYR C 109 TYR^? 10.73 CA CA C 208 A 177 LYS C 63 LYS~? 4.21 CA CA C 208 coo -3.50 124.89 25.05 -2.25 124.77 23.26 26.68 -52.06 -7.74 25.46 -53.53 -8.54 coo 1.87 119.38 16.45 1.41 122.11 16.84 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo -2.59 124.07 12.67 -0.91 126.17 18.42 20.98 -41.61 -5.49 23.04 -43.67 -10.44 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 15 3 # 15 A 24 ASP C 49 ASP.? -2.87 CA CA C 208s A 146 TYR C 109 TYR^? 10.73 CA CA C 208 A 177 LYS C 67 LYS.? 18.71 CA CA C 208 coo -3.50 124.89 25.05 -2.25 124.77 23.26 22.13 -48.50 -9.42 23.00 -46.66 -10.00 coo 1.87 119.38 16.45 1.41 122.11 16.84 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo -2.59 124.07 12.67 -0.91 126.17 18.42 20.04 -36.06 -6.98 16.11 -31.17 -7.78 1ok4_c00 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 15 hits 1ok4_c00 naa= 3 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 B 24 ASP A 45 ASP.? -2.96 CA CA A 208s B 146 TYR A 51 TYR.? 9.92 O21 C8E A 210 B 177 LYS A 188 LYS~? 10.77 C20 C8E A 210 coo -7.43 109.06 51.23 -5.84 110.54 50.86 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo 0.22 114.56 44.62 -0.76 115.18 47.18 71.70 -83.21 -22.40 69.97 -85.02 -21.17 coo -4.18 120.17 46.85 -4.02 115.31 51.00 68.32 -80.18 -18.11 71.95 -84.24 -15.84 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 B 24 ASP A 45 ASP.? -2.96 CA CA A 208s B 146 TYR A 109 TYR^? 10.85 CA CA A 208 B 177 LYS A 63 LYS~? 3.96 CA CA A 208 coo -7.43 109.06 51.23 -5.84 110.54 50.86 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo 0.22 114.56 44.62 -0.76 115.18 47.18 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo -4.18 120.17 46.85 -4.02 115.31 51.00 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 B 24 ASP A 48 ASP.? 7.38 CA CA A 208 B 146 TYR A 109 TYR^? 10.85 CA CA A 208 B 177 LYS A 63 LYS~? 3.96 CA CA A 208 coo -7.43 109.06 51.23 -5.84 110.54 50.86 72.05 -78.20 -23.17 73.82 -77.79 -22.11 coo 0.22 114.56 44.62 -0.76 115.18 47.18 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo -4.18 120.17 46.85 -4.02 115.31 51.00 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 B 24 ASP A 49 ASP.? -3.00 CA CA A 208s B 146 TYR A 109 TYR^? 10.85 CA CA A 208 B 177 LYS A 67 LYS~? 13.30 CA CA A 208 coo -7.43 109.06 51.23 -5.84 110.54 50.86 75.72 -77.89 -27.98 74.67 -77.10 -29.65 coo 0.22 114.56 44.62 -0.76 115.18 47.18 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo -4.18 120.17 46.85 -4.02 115.31 51.00 73.21 -82.07 -40.14 71.59 -78.49 -41.85 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 B 24 ASP A 61 ASP~? 12.37 CA CA A 208 B 146 TYR A 109 TYR^? 10.85 CA CA A 208 B 177 LYS A 67 LYS~? 13.30 CA CA A 208 coo -7.43 109.06 51.23 -5.84 110.54 50.86 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo 0.22 114.56 44.62 -0.76 115.18 47.18 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo -4.18 120.17 46.85 -4.02 115.31 51.00 73.21 -82.07 -40.14 71.59 -78.49 -41.85 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 B 24 ASP B 45 ASP.? -3.07 CA CA B 208s B 146 TYR B 51 TYR.? 9.95 O21 C8E B 210 B 177 LYS B 188 LYS~? 9.67 C16 C8E B 210 coo -7.43 109.06 51.23 -5.84 110.54 50.86 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo 0.22 114.56 44.62 -0.76 115.18 47.18 102.03 -27.53 -15.19 104.12 -26.16 -16.40 coo -4.18 120.17 46.85 -4.02 115.31 51.00 102.16 -28.74 -21.10 106.15 -31.37 -17.86 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 B 24 ASP B 45 ASP.? -3.07 CA CA B 208s B 146 TYR B 109 TYR^? 10.54 CA CA B 208 B 177 LYS B 63 LYS~? 3.79 CA CA B 208 coo -7.43 109.06 51.23 -5.84 110.54 50.86 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo 0.22 114.56 44.62 -0.76 115.18 47.18 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo -4.18 120.17 46.85 -4.02 115.31 51.00 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 B 24 ASP B 48 ASP.? 7.20 CA CA B 208 B 146 TYR B 109 TYR^? 10.54 CA CA B 208 B 177 LYS B 63 LYS~? 3.79 CA CA B 208 coo -7.43 109.06 51.23 -5.84 110.54 50.86 97.60 -30.12 -16.68 98.20 -32.01 -15.99 coo 0.22 114.56 44.62 -0.76 115.18 47.18 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo -4.18 120.17 46.85 -4.02 115.31 51.00 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 B 24 ASP B 49 ASP.? -3.05 CA CA B 208s B 146 TYR B 109 TYR^? 10.54 CA CA B 208 B 177 LYS B 67 LYS~? 18.13 CA CA B 208 coo -7.43 109.06 51.23 -5.84 110.54 50.86 94.52 -28.97 -11.62 93.03 -30.41 -11.73 coo 0.22 114.56 44.62 -0.76 115.18 47.18 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo -4.18 120.17 46.85 -4.02 115.31 51.00 89.12 -21.41 -4.23 87.66 -21.56 1.71 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 10 3 # 10 B 24 ASP B 61 ASP~? 12.48 CA CA B 208 B 146 TYR B 109 TYR^? 10.54 CA CA B 208 B 177 LYS B 67 LYS~? 18.13 CA CA B 208 coo -7.43 109.06 51.23 -5.84 110.54 50.86 98.68 -27.22 -4.60 99.30 -29.23 -4.23 coo 0.22 114.56 44.62 -0.76 115.18 47.18 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo -4.18 120.17 46.85 -4.02 115.31 51.00 89.12 -21.41 -4.23 87.66 -21.56 1.71 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 11 3 # 11 B 24 ASP B 80 ASP^? 15.94 O15 C8E B 209 B 146 TYR B 83 TYR^? 23.90 C1 C8E B 209 B 177 LYS B 84 LYS.? 25.86 O15 C8E B 209 coo -7.43 109.06 51.23 -5.84 110.54 50.86 82.56 -37.87 -41.00 82.97 -37.16 -39.06 coo 0.22 114.56 44.62 -0.76 115.18 47.18 84.86 -45.84 -46.52 87.07 -46.60 -44.97 coo -4.18 120.17 46.85 -4.02 115.31 51.00 79.44 -47.69 -46.65 75.97 -44.45 -44.18 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 12 3 # 12 B 24 ASP C 45 ASP.? 3.27 CA CA C 208s B 146 TYR C 51 TYR.? 10.04 O21 C8E C 209 B 177 LYS C 188 LYS~? 9.02 C16 C8E C 209 coo -7.43 109.06 51.23 -5.84 110.54 50.86 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo 0.22 114.56 44.62 -0.76 115.18 47.18 26.09 -52.62 -2.60 27.54 -53.38 -0.32 coo -4.18 120.17 46.85 -4.02 115.31 51.00 31.07 -55.82 -4.30 26.58 -58.21 -2.57 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 13 3 # 13 B 24 ASP C 45 ASP.? 3.27 CA CA C 208s B 146 TYR C 109 TYR^? 10.73 CA CA C 208 B 177 LYS C 63 LYS~? 4.21 CA CA C 208 coo -7.43 109.06 51.23 -5.84 110.54 50.86 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo 0.22 114.56 44.62 -0.76 115.18 47.18 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo -4.18 120.17 46.85 -4.02 115.31 51.00 20.98 -41.61 -5.49 23.04 -43.67 -10.44 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 14 3 # 14 B 24 ASP C 48 ASP.? 7.17 CA CA C 208 B 146 TYR C 109 TYR^? 10.73 CA CA C 208 B 177 LYS C 63 LYS~? 4.21 CA CA C 208 coo -7.43 109.06 51.23 -5.84 110.54 50.86 26.68 -52.06 -7.74 25.46 -53.53 -8.54 coo 0.22 114.56 44.62 -0.76 115.18 47.18 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo -4.18 120.17 46.85 -4.02 115.31 51.00 20.98 -41.61 -5.49 23.04 -43.67 -10.44 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 15 3 # 15 B 24 ASP C 49 ASP.? -2.87 CA CA C 208s B 146 TYR C 109 TYR^? 10.73 CA CA C 208 B 177 LYS C 67 LYS.? 18.71 CA CA C 208 coo -7.43 109.06 51.23 -5.84 110.54 50.86 22.13 -48.50 -9.42 23.00 -46.66 -10.00 coo 0.22 114.56 44.62 -0.76 115.18 47.18 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo -4.18 120.17 46.85 -4.02 115.31 51.00 20.04 -36.06 -6.98 16.11 -31.17 -7.78 1ok4_c01 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 15 hits 1ok4_c01 naa= 3 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 C 24 ASP A 45 ASP.? -2.96 CA CA A 208s C 146 TYR A 51 TYR.? 9.92 O21 C8E A 210 C 177 LYS A 188 LYS~? 10.77 C20 C8E A 210 coo -13.49 79.65 43.90 -12.13 80.29 45.45 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo -5.65 86.78 48.49 -7.16 84.72 49.65 71.70 -83.21 -22.40 69.97 -85.02 -21.17 coo -11.22 87.18 53.49 -10.94 81.64 50.31 68.32 -80.18 -18.11 71.95 -84.24 -15.84 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 C 24 ASP A 45 ASP.? -2.96 CA CA A 208s C 146 TYR A 109 TYR^? 10.85 CA CA A 208 C 177 LYS A 63 LYS~? 3.96 CA CA A 208 coo -13.49 79.65 43.90 -12.13 80.29 45.45 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo -5.65 86.78 48.49 -7.16 84.72 49.65 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo -11.22 87.18 53.49 -10.94 81.64 50.31 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 C 24 ASP A 48 ASP.? 7.38 CA CA A 208 C 146 TYR A 109 TYR^? 10.85 CA CA A 208 C 177 LYS A 63 LYS~? 3.96 CA CA A 208 coo -13.49 79.65 43.90 -12.13 80.29 45.45 72.05 -78.20 -23.17 73.82 -77.79 -22.11 coo -5.65 86.78 48.49 -7.16 84.72 49.65 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo -11.22 87.18 53.49 -10.94 81.64 50.31 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 C 24 ASP A 49 ASP.? -3.00 CA CA A 208s C 146 TYR A 109 TYR^? 10.85 CA CA A 208 C 177 LYS A 67 LYS~? 13.30 CA CA A 208 coo -13.49 79.65 43.90 -12.13 80.29 45.45 75.72 -77.89 -27.98 74.67 -77.10 -29.65 coo -5.65 86.78 48.49 -7.16 84.72 49.65 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo -11.22 87.18 53.49 -10.94 81.64 50.31 73.21 -82.07 -40.14 71.59 -78.49 -41.85 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 C 24 ASP A 61 ASP~? 12.37 CA CA A 208 C 146 TYR A 109 TYR^? 10.85 CA CA A 208 C 177 LYS A 67 LYS~? 13.30 CA CA A 208 coo -13.49 79.65 43.90 -12.13 80.29 45.45 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo -5.65 86.78 48.49 -7.16 84.72 49.65 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo -11.22 87.18 53.49 -10.94 81.64 50.31 73.21 -82.07 -40.14 71.59 -78.49 -41.85 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 C 24 ASP B 45 ASP.? -3.07 CA CA B 208s C 146 TYR B 51 TYR.? 9.95 O21 C8E B 210 C 177 LYS B 188 LYS~? 9.67 C16 C8E B 210 coo -13.49 79.65 43.90 -12.13 80.29 45.45 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo -5.65 86.78 48.49 -7.16 84.72 49.65 102.03 -27.53 -15.19 104.12 -26.16 -16.40 coo -11.22 87.18 53.49 -10.94 81.64 50.31 102.16 -28.74 -21.10 106.15 -31.37 -17.86 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 C 24 ASP B 45 ASP.? -3.07 CA CA B 208s C 146 TYR B 109 TYR^? 10.54 CA CA B 208 C 177 LYS B 63 LYS~? 3.79 CA CA B 208 coo -13.49 79.65 43.90 -12.13 80.29 45.45 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo -5.65 86.78 48.49 -7.16 84.72 49.65 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo -11.22 87.18 53.49 -10.94 81.64 50.31 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 C 24 ASP B 48 ASP.? 7.20 CA CA B 208 C 146 TYR B 109 TYR^? 10.54 CA CA B 208 C 177 LYS B 63 LYS~? 3.79 CA CA B 208 coo -13.49 79.65 43.90 -12.13 80.29 45.45 97.60 -30.12 -16.68 98.20 -32.01 -15.99 coo -5.65 86.78 48.49 -7.16 84.72 49.65 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo -11.22 87.18 53.49 -10.94 81.64 50.31 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 C 24 ASP B 49 ASP.? -3.05 CA CA B 208s C 146 TYR B 109 TYR^? 10.54 CA CA B 208 C 177 LYS B 67 LYS~? 18.13 CA CA B 208 coo -13.49 79.65 43.90 -12.13 80.29 45.45 94.52 -28.97 -11.62 93.03 -30.41 -11.73 coo -5.65 86.78 48.49 -7.16 84.72 49.65 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo -11.22 87.18 53.49 -10.94 81.64 50.31 89.12 -21.41 -4.23 87.66 -21.56 1.71 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 10 3 # 10 C 24 ASP B 61 ASP~? 12.48 CA CA B 208 C 146 TYR B 109 TYR^? 10.54 CA CA B 208 C 177 LYS B 67 LYS~? 18.13 CA CA B 208 coo -13.49 79.65 43.90 -12.13 80.29 45.45 98.68 -27.22 -4.60 99.30 -29.23 -4.23 coo -5.65 86.78 48.49 -7.16 84.72 49.65 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo -11.22 87.18 53.49 -10.94 81.64 50.31 89.12 -21.41 -4.23 87.66 -21.56 1.71 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 11 3 # 11 C 24 ASP B 80 ASP^? 15.94 O15 C8E B 209 C 146 TYR B 83 TYR^? 23.90 C1 C8E B 209 C 177 LYS B 84 LYS.? 25.86 O15 C8E B 209 coo -13.49 79.65 43.90 -12.13 80.29 45.45 82.56 -37.87 -41.00 82.97 -37.16 -39.06 coo -5.65 86.78 48.49 -7.16 84.72 49.65 84.86 -45.84 -46.52 87.07 -46.60 -44.97 coo -11.22 87.18 53.49 -10.94 81.64 50.31 79.44 -47.69 -46.65 75.97 -44.45 -44.18 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 12 3 # 12 C 24 ASP C 45 ASP.? 3.27 CA CA C 208s C 146 TYR C 51 TYR.? 10.04 O21 C8E C 209 C 177 LYS C 188 LYS~? 9.02 C16 C8E C 209 coo -13.49 79.65 43.90 -12.13 80.29 45.45 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo -5.65 86.78 48.49 -7.16 84.72 49.65 26.09 -52.62 -2.60 27.54 -53.38 -0.32 coo -11.22 87.18 53.49 -10.94 81.64 50.31 31.07 -55.82 -4.30 26.58 -58.21 -2.57 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 13 3 # 13 C 24 ASP C 45 ASP.? 3.27 CA CA C 208s C 146 TYR C 109 TYR^? 10.73 CA CA C 208 C 177 LYS C 63 LYS~? 4.21 CA CA C 208 coo -13.49 79.65 43.90 -12.13 80.29 45.45 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo -5.65 86.78 48.49 -7.16 84.72 49.65 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo -11.22 87.18 53.49 -10.94 81.64 50.31 20.98 -41.61 -5.49 23.04 -43.67 -10.44 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 14 3 # 14 C 24 ASP C 48 ASP.? 7.17 CA CA C 208 C 146 TYR C 109 TYR^? 10.73 CA CA C 208 C 177 LYS C 63 LYS~? 4.21 CA CA C 208 coo -13.49 79.65 43.90 -12.13 80.29 45.45 26.68 -52.06 -7.74 25.46 -53.53 -8.54 coo -5.65 86.78 48.49 -7.16 84.72 49.65 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo -11.22 87.18 53.49 -10.94 81.64 50.31 20.98 -41.61 -5.49 23.04 -43.67 -10.44 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 15 3 # 15 C 24 ASP C 49 ASP.? -2.87 CA CA C 208s C 146 TYR C 109 TYR^? 10.73 CA CA C 208 C 177 LYS C 67 LYS.? 18.71 CA CA C 208 coo -13.49 79.65 43.90 -12.13 80.29 45.45 22.13 -48.50 -9.42 23.00 -46.66 -10.00 coo -5.65 86.78 48.49 -7.16 84.72 49.65 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo -11.22 87.18 53.49 -10.94 81.64 50.31 20.04 -36.06 -6.98 16.11 -31.17 -7.78 1ok4_c02 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 15 hits 1ok4_c02 naa= 3 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 D 24 ASP A 45 ASP.? -2.96 CA CA A 208s D 146 TYR A 51 TYR.? 9.92 O21 C8E A 210 D 177 LYS A 188 LYS~? 10.77 C20 C8E A 210 coo -13.44 77.36 13.12 -12.53 75.97 14.48 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo -7.85 74.44 22.75 -9.22 72.86 20.89 71.70 -83.21 -22.40 69.97 -85.02 -21.17 coo -14.24 70.61 23.48 -12.55 71.73 17.42 68.32 -80.18 -18.11 71.95 -84.24 -15.84 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 D 24 ASP A 45 ASP.? -2.96 CA CA A 208s D 146 TYR A 109 TYR^? 10.85 CA CA A 208 D 177 LYS A 63 LYS~? 3.96 CA CA A 208 coo -13.44 77.36 13.12 -12.53 75.97 14.48 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo -7.85 74.44 22.75 -9.22 72.86 20.89 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo -14.24 70.61 23.48 -12.55 71.73 17.42 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 D 24 ASP A 48 ASP.? 7.38 CA CA A 208 D 146 TYR A 109 TYR^? 10.85 CA CA A 208 D 177 LYS A 63 LYS~? 3.96 CA CA A 208 coo -13.44 77.36 13.12 -12.53 75.97 14.48 72.05 -78.20 -23.17 73.82 -77.79 -22.11 coo -7.85 74.44 22.75 -9.22 72.86 20.89 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo -14.24 70.61 23.48 -12.55 71.73 17.42 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 D 24 ASP A 49 ASP.? -3.00 CA CA A 208s D 146 TYR A 109 TYR^? 10.85 CA CA A 208 D 177 LYS A 67 LYS~? 13.30 CA CA A 208 coo -13.44 77.36 13.12 -12.53 75.97 14.48 75.72 -77.89 -27.98 74.67 -77.10 -29.65 coo -7.85 74.44 22.75 -9.22 72.86 20.89 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo -14.24 70.61 23.48 -12.55 71.73 17.42 73.21 -82.07 -40.14 71.59 -78.49 -41.85 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 D 24 ASP A 61 ASP~? 12.37 CA CA A 208 D 146 TYR A 109 TYR^? 10.85 CA CA A 208 D 177 LYS A 67 LYS~? 13.30 CA CA A 208 coo -13.44 77.36 13.12 -12.53 75.97 14.48 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo -7.85 74.44 22.75 -9.22 72.86 20.89 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo -14.24 70.61 23.48 -12.55 71.73 17.42 73.21 -82.07 -40.14 71.59 -78.49 -41.85 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 D 24 ASP B 45 ASP.? -3.07 CA CA B 208s D 146 TYR B 51 TYR.? 9.95 O21 C8E B 210 D 177 LYS B 188 LYS~? 9.67 C16 C8E B 210 coo -13.44 77.36 13.12 -12.53 75.97 14.48 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo -7.85 74.44 22.75 -9.22 72.86 20.89 102.03 -27.53 -15.19 104.12 -26.16 -16.40 coo -14.24 70.61 23.48 -12.55 71.73 17.42 102.16 -28.74 -21.10 106.15 -31.37 -17.86 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 D 24 ASP B 45 ASP.? -3.07 CA CA B 208s D 146 TYR B 109 TYR^? 10.54 CA CA B 208 D 177 LYS B 63 LYS~? 3.79 CA CA B 208 coo -13.44 77.36 13.12 -12.53 75.97 14.48 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo -7.85 74.44 22.75 -9.22 72.86 20.89 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo -14.24 70.61 23.48 -12.55 71.73 17.42 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 D 24 ASP B 48 ASP.? 7.20 CA CA B 208 D 146 TYR B 109 TYR^? 10.54 CA CA B 208 D 177 LYS B 63 LYS~? 3.79 CA CA B 208 coo -13.44 77.36 13.12 -12.53 75.97 14.48 97.60 -30.12 -16.68 98.20 -32.01 -15.99 coo -7.85 74.44 22.75 -9.22 72.86 20.89 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo -14.24 70.61 23.48 -12.55 71.73 17.42 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 D 24 ASP B 49 ASP.? -3.05 CA CA B 208s D 146 TYR B 109 TYR^? 10.54 CA CA B 208 D 177 LYS B 67 LYS~? 18.13 CA CA B 208 coo -13.44 77.36 13.12 -12.53 75.97 14.48 94.52 -28.97 -11.62 93.03 -30.41 -11.73 coo -7.85 74.44 22.75 -9.22 72.86 20.89 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo -14.24 70.61 23.48 -12.55 71.73 17.42 89.12 -21.41 -4.23 87.66 -21.56 1.71 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 10 3 # 10 D 24 ASP B 61 ASP~? 12.48 CA CA B 208 D 146 TYR B 109 TYR^? 10.54 CA CA B 208 D 177 LYS B 67 LYS~? 18.13 CA CA B 208 coo -13.44 77.36 13.12 -12.53 75.97 14.48 98.68 -27.22 -4.60 99.30 -29.23 -4.23 coo -7.85 74.44 22.75 -9.22 72.86 20.89 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo -14.24 70.61 23.48 -12.55 71.73 17.42 89.12 -21.41 -4.23 87.66 -21.56 1.71 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 11 3 # 11 D 24 ASP B 80 ASP^? 15.94 O15 C8E B 209 D 146 TYR B 83 TYR^? 23.90 C1 C8E B 209 D 177 LYS B 84 LYS.? 25.86 O15 C8E B 209 coo -13.44 77.36 13.12 -12.53 75.97 14.48 82.56 -37.87 -41.00 82.97 -37.16 -39.06 coo -7.85 74.44 22.75 -9.22 72.86 20.89 84.86 -45.84 -46.52 87.07 -46.60 -44.97 coo -14.24 70.61 23.48 -12.55 71.73 17.42 79.44 -47.69 -46.65 75.97 -44.45 -44.18 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 12 3 # 12 D 24 ASP C 45 ASP.? 3.27 CA CA C 208s D 146 TYR C 51 TYR.? 10.04 O21 C8E C 209 D 177 LYS C 188 LYS~? 9.02 C16 C8E C 209 coo -13.44 77.36 13.12 -12.53 75.97 14.48 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo -7.85 74.44 22.75 -9.22 72.86 20.89 26.09 -52.62 -2.60 27.54 -53.38 -0.32 coo -14.24 70.61 23.48 -12.55 71.73 17.42 31.07 -55.82 -4.30 26.58 -58.21 -2.57 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 13 3 # 13 D 24 ASP C 45 ASP.? 3.27 CA CA C 208s D 146 TYR C 109 TYR^? 10.73 CA CA C 208 D 177 LYS C 63 LYS~? 4.21 CA CA C 208 coo -13.44 77.36 13.12 -12.53 75.97 14.48 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo -7.85 74.44 22.75 -9.22 72.86 20.89 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo -14.24 70.61 23.48 -12.55 71.73 17.42 20.98 -41.61 -5.49 23.04 -43.67 -10.44 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 14 3 # 14 D 24 ASP C 48 ASP.? 7.17 CA CA C 208 D 146 TYR C 109 TYR^? 10.73 CA CA C 208 D 177 LYS C 63 LYS~? 4.21 CA CA C 208 coo -13.44 77.36 13.12 -12.53 75.97 14.48 26.68 -52.06 -7.74 25.46 -53.53 -8.54 coo -7.85 74.44 22.75 -9.22 72.86 20.89 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo -14.24 70.61 23.48 -12.55 71.73 17.42 20.98 -41.61 -5.49 23.04 -43.67 -10.44 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 15 3 # 15 D 24 ASP C 49 ASP.? -2.87 CA CA C 208s D 146 TYR C 109 TYR^? 10.73 CA CA C 208 D 177 LYS C 67 LYS.? 18.71 CA CA C 208 coo -13.44 77.36 13.12 -12.53 75.97 14.48 22.13 -48.50 -9.42 23.00 -46.66 -10.00 coo -7.85 74.44 22.75 -9.22 72.86 20.89 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo -14.24 70.61 23.48 -12.55 71.73 17.42 20.04 -36.06 -6.98 16.11 -31.17 -7.78 1ok4_c03 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 15 hits 1ok4_c03 naa= 3 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 E 24 ASP A 45 ASP.? -2.96 CA CA A 208s E 146 TYR A 51 TYR.? 9.92 O21 C8E A 210 E 177 LYS A 188 LYS~? 10.77 C20 C8E A 210 coo -7.12 105.25 1.43 -6.30 103.34 0.77 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo -3.11 94.55 3.01 -3.83 95.92 0.66 71.70 -83.21 -22.40 69.97 -85.02 -21.17 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 68.32 -80.18 -18.11 71.95 -84.24 -15.84 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 E 24 ASP A 45 ASP.? -2.96 CA CA A 208s E 146 TYR A 109 TYR^? 10.85 CA CA A 208 E 177 LYS A 63 LYS~? 3.96 CA CA A 208 coo -7.12 105.25 1.43 -6.30 103.34 0.77 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo -3.11 94.55 3.01 -3.83 95.92 0.66 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 E 24 ASP A 48 ASP.? 7.38 CA CA A 208 E 146 TYR A 109 TYR^? 10.85 CA CA A 208 E 177 LYS A 63 LYS~? 3.96 CA CA A 208 coo -7.12 105.25 1.43 -6.30 103.34 0.77 72.05 -78.20 -23.17 73.82 -77.79 -22.11 coo -3.11 94.55 3.01 -3.83 95.92 0.66 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 E 24 ASP A 49 ASP.? -3.00 CA CA A 208s E 146 TYR A 109 TYR^? 10.85 CA CA A 208 E 177 LYS A 67 LYS~? 13.30 CA CA A 208 coo -7.12 105.25 1.43 -6.30 103.34 0.77 75.72 -77.89 -27.98 74.67 -77.10 -29.65 coo -3.11 94.55 3.01 -3.83 95.92 0.66 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 73.21 -82.07 -40.14 71.59 -78.49 -41.85 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 E 24 ASP A 61 ASP~? 12.37 CA CA A 208 E 146 TYR A 109 TYR^? 10.85 CA CA A 208 E 177 LYS A 67 LYS~? 13.30 CA CA A 208 coo -7.12 105.25 1.43 -6.30 103.34 0.77 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo -3.11 94.55 3.01 -3.83 95.92 0.66 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 73.21 -82.07 -40.14 71.59 -78.49 -41.85 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 E 24 ASP B 45 ASP.? -3.07 CA CA B 208s E 146 TYR B 51 TYR.? 9.95 O21 C8E B 210 E 177 LYS B 188 LYS~? 9.67 C16 C8E B 210 coo -7.12 105.25 1.43 -6.30 103.34 0.77 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo -3.11 94.55 3.01 -3.83 95.92 0.66 102.03 -27.53 -15.19 104.12 -26.16 -16.40 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 102.16 -28.74 -21.10 106.15 -31.37 -17.86 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 E 24 ASP B 45 ASP.? -3.07 CA CA B 208s E 146 TYR B 109 TYR^? 10.54 CA CA B 208 E 177 LYS B 63 LYS~? 3.79 CA CA B 208 coo -7.12 105.25 1.43 -6.30 103.34 0.77 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo -3.11 94.55 3.01 -3.83 95.92 0.66 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 E 24 ASP B 48 ASP.? 7.20 CA CA B 208 E 146 TYR B 109 TYR^? 10.54 CA CA B 208 E 177 LYS B 63 LYS~? 3.79 CA CA B 208 coo -7.12 105.25 1.43 -6.30 103.34 0.77 97.60 -30.12 -16.68 98.20 -32.01 -15.99 coo -3.11 94.55 3.01 -3.83 95.92 0.66 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 E 24 ASP B 49 ASP.? -3.05 CA CA B 208s E 146 TYR B 109 TYR^? 10.54 CA CA B 208 E 177 LYS B 67 LYS~? 18.13 CA CA B 208 coo -7.12 105.25 1.43 -6.30 103.34 0.77 94.52 -28.97 -11.62 93.03 -30.41 -11.73 coo -3.11 94.55 3.01 -3.83 95.92 0.66 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 89.12 -21.41 -4.23 87.66 -21.56 1.71 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 10 3 # 10 E 24 ASP B 61 ASP~? 12.48 CA CA B 208 E 146 TYR B 109 TYR^? 10.54 CA CA B 208 E 177 LYS B 67 LYS~? 18.13 CA CA B 208 coo -7.12 105.25 1.43 -6.30 103.34 0.77 98.68 -27.22 -4.60 99.30 -29.23 -4.23 coo -3.11 94.55 3.01 -3.83 95.92 0.66 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 89.12 -21.41 -4.23 87.66 -21.56 1.71 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 11 3 # 11 E 24 ASP B 80 ASP^? 15.94 O15 C8E B 209 E 146 TYR B 83 TYR^? 23.90 C1 C8E B 209 E 177 LYS B 84 LYS.? 25.86 O15 C8E B 209 coo -7.12 105.25 1.43 -6.30 103.34 0.77 82.56 -37.87 -41.00 82.97 -37.16 -39.06 coo -3.11 94.55 3.01 -3.83 95.92 0.66 84.86 -45.84 -46.52 87.07 -46.60 -44.97 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 79.44 -47.69 -46.65 75.97 -44.45 -44.18 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 12 3 # 12 E 24 ASP C 45 ASP.? 3.27 CA CA C 208s E 146 TYR C 51 TYR.? 10.04 O21 C8E C 209 E 177 LYS C 188 LYS~? 9.02 C16 C8E C 209 coo -7.12 105.25 1.43 -6.30 103.34 0.77 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo -3.11 94.55 3.01 -3.83 95.92 0.66 26.09 -52.62 -2.60 27.54 -53.38 -0.32 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 31.07 -55.82 -4.30 26.58 -58.21 -2.57 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 13 3 # 13 E 24 ASP C 45 ASP.? 3.27 CA CA C 208s E 146 TYR C 109 TYR^? 10.73 CA CA C 208 E 177 LYS C 63 LYS~? 4.21 CA CA C 208 coo -7.12 105.25 1.43 -6.30 103.34 0.77 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo -3.11 94.55 3.01 -3.83 95.92 0.66 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 20.98 -41.61 -5.49 23.04 -43.67 -10.44 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 14 3 # 14 E 24 ASP C 48 ASP.? 7.17 CA CA C 208 E 146 TYR C 109 TYR^? 10.73 CA CA C 208 E 177 LYS C 63 LYS~? 4.21 CA CA C 208 coo -7.12 105.25 1.43 -6.30 103.34 0.77 26.68 -52.06 -7.74 25.46 -53.53 -8.54 coo -3.11 94.55 3.01 -3.83 95.92 0.66 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 20.98 -41.61 -5.49 23.04 -43.67 -10.44 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 15 3 # 15 E 24 ASP C 49 ASP.? -2.87 CA CA C 208s E 146 TYR C 109 TYR^? 10.73 CA CA C 208 E 177 LYS C 67 LYS.? 18.71 CA CA C 208 coo -7.12 105.25 1.43 -6.30 103.34 0.77 22.13 -48.50 -9.42 23.00 -46.66 -10.00 coo -3.11 94.55 3.01 -3.83 95.92 0.66 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 20.04 -36.06 -6.98 16.11 -31.17 -7.78 1ok4_c04 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 15 hits 1ok4_c04 naa= 3 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 F 24 ASP A 45 ASP.? -2.96 CA CA A 208s F 146 TYR A 51 TYR.? 9.92 O21 C8E A 210 F 177 LYS A 188 LYS~? 10.77 C20 C8E A 210 coo -44.75 128.15 10.28 -45.68 129.67 11.55 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo -50.43 131.90 19.60 -49.04 133.31 17.60 71.70 -83.21 -22.40 69.97 -85.02 -21.17 coo -44.10 135.86 19.99 -45.67 134.21 14.07 68.32 -80.18 -18.11 71.95 -84.24 -15.84 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 F 24 ASP A 45 ASP.? -2.96 CA CA A 208s F 146 TYR A 109 TYR^? 10.85 CA CA A 208 F 177 LYS A 63 LYS~? 3.96 CA CA A 208 coo -44.75 128.15 10.28 -45.68 129.67 11.55 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo -50.43 131.90 19.60 -49.04 133.31 17.60 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo -44.10 135.86 19.99 -45.67 134.21 14.07 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 F 24 ASP A 48 ASP.? 7.38 CA CA A 208 F 146 TYR A 109 TYR^? 10.85 CA CA A 208 F 177 LYS A 63 LYS~? 3.96 CA CA A 208 coo -44.75 128.15 10.28 -45.68 129.67 11.55 72.05 -78.20 -23.17 73.82 -77.79 -22.11 coo -50.43 131.90 19.60 -49.04 133.31 17.60 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo -44.10 135.86 19.99 -45.67 134.21 14.07 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 F 24 ASP A 49 ASP.? -3.00 CA CA A 208s F 146 TYR A 109 TYR^? 10.85 CA CA A 208 F 177 LYS A 67 LYS~? 13.30 CA CA A 208 coo -44.75 128.15 10.28 -45.68 129.67 11.55 75.72 -77.89 -27.98 74.67 -77.10 -29.65 coo -50.43 131.90 19.60 -49.04 133.31 17.60 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo -44.10 135.86 19.99 -45.67 134.21 14.07 73.21 -82.07 -40.14 71.59 -78.49 -41.85 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 F 24 ASP A 61 ASP~? 12.37 CA CA A 208 F 146 TYR A 109 TYR^? 10.85 CA CA A 208 F 177 LYS A 67 LYS~? 13.30 CA CA A 208 coo -44.75 128.15 10.28 -45.68 129.67 11.55 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo -50.43 131.90 19.60 -49.04 133.31 17.60 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo -44.10 135.86 19.99 -45.67 134.21 14.07 73.21 -82.07 -40.14 71.59 -78.49 -41.85 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 F 24 ASP B 45 ASP.? -3.07 CA CA B 208s F 146 TYR B 51 TYR.? 9.95 O21 C8E B 210 F 177 LYS B 188 LYS~? 9.67 C16 C8E B 210 coo -44.75 128.15 10.28 -45.68 129.67 11.55 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo -50.43 131.90 19.60 -49.04 133.31 17.60 102.03 -27.53 -15.19 104.12 -26.16 -16.40 coo -44.10 135.86 19.99 -45.67 134.21 14.07 102.16 -28.74 -21.10 106.15 -31.37 -17.86 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 F 24 ASP B 45 ASP.? -3.07 CA CA B 208s F 146 TYR B 109 TYR^? 10.54 CA CA B 208 F 177 LYS B 63 LYS~? 3.79 CA CA B 208 coo -44.75 128.15 10.28 -45.68 129.67 11.55 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo -50.43 131.90 19.60 -49.04 133.31 17.60 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo -44.10 135.86 19.99 -45.67 134.21 14.07 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 F 24 ASP B 48 ASP.? 7.20 CA CA B 208 F 146 TYR B 109 TYR^? 10.54 CA CA B 208 F 177 LYS B 63 LYS~? 3.79 CA CA B 208 coo -44.75 128.15 10.28 -45.68 129.67 11.55 97.60 -30.12 -16.68 98.20 -32.01 -15.99 coo -50.43 131.90 19.60 -49.04 133.31 17.60 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo -44.10 135.86 19.99 -45.67 134.21 14.07 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 F 24 ASP B 49 ASP.? -3.05 CA CA B 208s F 146 TYR B 109 TYR^? 10.54 CA CA B 208 F 177 LYS B 67 LYS~? 18.13 CA CA B 208 coo -44.75 128.15 10.28 -45.68 129.67 11.55 94.52 -28.97 -11.62 93.03 -30.41 -11.73 coo -50.43 131.90 19.60 -49.04 133.31 17.60 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo -44.10 135.86 19.99 -45.67 134.21 14.07 89.12 -21.41 -4.23 87.66 -21.56 1.71 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 10 3 # 10 F 24 ASP B 61 ASP~? 12.48 CA CA B 208 F 146 TYR B 109 TYR^? 10.54 CA CA B 208 F 177 LYS B 67 LYS~? 18.13 CA CA B 208 coo -44.75 128.15 10.28 -45.68 129.67 11.55 98.68 -27.22 -4.60 99.30 -29.23 -4.23 coo -50.43 131.90 19.60 -49.04 133.31 17.60 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo -44.10 135.86 19.99 -45.67 134.21 14.07 89.12 -21.41 -4.23 87.66 -21.56 1.71 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 11 3 # 11 F 24 ASP B 80 ASP^? 15.94 O15 C8E B 209 F 146 TYR B 83 TYR^? 23.90 C1 C8E B 209 F 177 LYS B 84 LYS.? 25.86 O15 C8E B 209 coo -44.75 128.15 10.28 -45.68 129.67 11.55 82.56 -37.87 -41.00 82.97 -37.16 -39.06 coo -50.43 131.90 19.60 -49.04 133.31 17.60 84.86 -45.84 -46.52 87.07 -46.60 -44.97 coo -44.10 135.86 19.99 -45.67 134.21 14.07 79.44 -47.69 -46.65 75.97 -44.45 -44.18 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 12 3 # 12 F 24 ASP C 45 ASP.? 3.27 CA CA C 208s F 146 TYR C 51 TYR.? 10.04 O21 C8E C 209 F 177 LYS C 188 LYS~? 9.02 C16 C8E C 209 coo -44.75 128.15 10.28 -45.68 129.67 11.55 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo -50.43 131.90 19.60 -49.04 133.31 17.60 26.09 -52.62 -2.60 27.54 -53.38 -0.32 coo -44.10 135.86 19.99 -45.67 134.21 14.07 31.07 -55.82 -4.30 26.58 -58.21 -2.57 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 13 3 # 13 F 24 ASP C 45 ASP.? 3.27 CA CA C 208s F 146 TYR C 109 TYR^? 10.73 CA CA C 208 F 177 LYS C 63 LYS~? 4.21 CA CA C 208 coo -44.75 128.15 10.28 -45.68 129.67 11.55 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo -50.43 131.90 19.60 -49.04 133.31 17.60 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo -44.10 135.86 19.99 -45.67 134.21 14.07 20.98 -41.61 -5.49 23.04 -43.67 -10.44 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 14 3 # 14 F 24 ASP C 48 ASP.? 7.17 CA CA C 208 F 146 TYR C 109 TYR^? 10.73 CA CA C 208 F 177 LYS C 63 LYS~? 4.21 CA CA C 208 coo -44.75 128.15 10.28 -45.68 129.67 11.55 26.68 -52.06 -7.74 25.46 -53.53 -8.54 coo -50.43 131.90 19.60 -49.04 133.31 17.60 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo -44.10 135.86 19.99 -45.67 134.21 14.07 20.98 -41.61 -5.49 23.04 -43.67 -10.44 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 15 3 # 15 F 24 ASP C 49 ASP.? -2.87 CA CA C 208s F 146 TYR C 109 TYR^? 10.73 CA CA C 208 F 177 LYS C 67 LYS.? 18.71 CA CA C 208 coo -44.75 128.15 10.28 -45.68 129.67 11.55 22.13 -48.50 -9.42 23.00 -46.66 -10.00 coo -50.43 131.90 19.60 -49.04 133.31 17.60 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo -44.10 135.86 19.99 -45.67 134.21 14.07 20.04 -36.06 -6.98 16.11 -31.17 -7.78 1ok4_c05 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 15 hits 1ok4_c05 naa= 3 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 G 24 ASP A 45 ASP.? -2.96 CA CA A 208s G 146 TYR A 51 TYR.? 9.92 O21 C8E A 210 G 177 LYS A 188 LYS~? 10.77 C20 C8E A 210 coo -44.97 128.78 41.20 -46.32 128.26 42.83 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo -52.83 122.13 46.42 -51.31 124.30 47.39 71.70 -83.21 -22.40 69.97 -85.02 -21.17 coo -47.30 122.24 51.49 -47.46 127.44 47.81 68.32 -80.18 -18.11 71.95 -84.24 -15.84 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 G 24 ASP A 45 ASP.? -2.96 CA CA A 208s G 146 TYR A 109 TYR^? 10.85 CA CA A 208 G 177 LYS A 63 LYS~? 3.96 CA CA A 208 coo -44.97 128.78 41.20 -46.32 128.26 42.83 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo -52.83 122.13 46.42 -51.31 124.30 47.39 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo -47.30 122.24 51.49 -47.46 127.44 47.81 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 G 24 ASP A 48 ASP.? 7.38 CA CA A 208 G 146 TYR A 109 TYR^? 10.85 CA CA A 208 G 177 LYS A 63 LYS~? 3.96 CA CA A 208 coo -44.97 128.78 41.20 -46.32 128.26 42.83 72.05 -78.20 -23.17 73.82 -77.79 -22.11 coo -52.83 122.13 46.42 -51.31 124.30 47.39 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo -47.30 122.24 51.49 -47.46 127.44 47.81 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 G 24 ASP A 49 ASP.? -3.00 CA CA A 208s G 146 TYR A 109 TYR^? 10.85 CA CA A 208 G 177 LYS A 67 LYS~? 13.30 CA CA A 208 coo -44.97 128.78 41.20 -46.32 128.26 42.83 75.72 -77.89 -27.98 74.67 -77.10 -29.65 coo -52.83 122.13 46.42 -51.31 124.30 47.39 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo -47.30 122.24 51.49 -47.46 127.44 47.81 73.21 -82.07 -40.14 71.59 -78.49 -41.85 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 G 24 ASP A 61 ASP~? 12.37 CA CA A 208 G 146 TYR A 109 TYR^? 10.85 CA CA A 208 G 177 LYS A 67 LYS~? 13.30 CA CA A 208 coo -44.97 128.78 41.20 -46.32 128.26 42.83 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo -52.83 122.13 46.42 -51.31 124.30 47.39 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo -47.30 122.24 51.49 -47.46 127.44 47.81 73.21 -82.07 -40.14 71.59 -78.49 -41.85 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 G 24 ASP B 45 ASP.? -3.07 CA CA B 208s G 146 TYR B 51 TYR.? 9.95 O21 C8E B 210 G 177 LYS B 188 LYS~? 9.67 C16 C8E B 210 coo -44.97 128.78 41.20 -46.32 128.26 42.83 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo -52.83 122.13 46.42 -51.31 124.30 47.39 102.03 -27.53 -15.19 104.12 -26.16 -16.40 coo -47.30 122.24 51.49 -47.46 127.44 47.81 102.16 -28.74 -21.10 106.15 -31.37 -17.86 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 G 24 ASP B 45 ASP.? -3.07 CA CA B 208s G 146 TYR B 109 TYR^? 10.54 CA CA B 208 G 177 LYS B 63 LYS~? 3.79 CA CA B 208 coo -44.97 128.78 41.20 -46.32 128.26 42.83 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo -52.83 122.13 46.42 -51.31 124.30 47.39 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo -47.30 122.24 51.49 -47.46 127.44 47.81 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 G 24 ASP B 48 ASP.? 7.20 CA CA B 208 G 146 TYR B 109 TYR^? 10.54 CA CA B 208 G 177 LYS B 63 LYS~? 3.79 CA CA B 208 coo -44.97 128.78 41.20 -46.32 128.26 42.83 97.60 -30.12 -16.68 98.20 -32.01 -15.99 coo -52.83 122.13 46.42 -51.31 124.30 47.39 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo -47.30 122.24 51.49 -47.46 127.44 47.81 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 G 24 ASP B 49 ASP.? -3.05 CA CA B 208s G 146 TYR B 109 TYR^? 10.54 CA CA B 208 G 177 LYS B 67 LYS~? 18.13 CA CA B 208 coo -44.97 128.78 41.20 -46.32 128.26 42.83 94.52 -28.97 -11.62 93.03 -30.41 -11.73 coo -52.83 122.13 46.42 -51.31 124.30 47.39 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo -47.30 122.24 51.49 -47.46 127.44 47.81 89.12 -21.41 -4.23 87.66 -21.56 1.71 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 10 3 # 10 G 24 ASP B 61 ASP~? 12.48 CA CA B 208 G 146 TYR B 109 TYR^? 10.54 CA CA B 208 G 177 LYS B 67 LYS~? 18.13 CA CA B 208 coo -44.97 128.78 41.20 -46.32 128.26 42.83 98.68 -27.22 -4.60 99.30 -29.23 -4.23 coo -52.83 122.13 46.42 -51.31 124.30 47.39 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo -47.30 122.24 51.49 -47.46 127.44 47.81 89.12 -21.41 -4.23 87.66 -21.56 1.71 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 11 3 # 11 G 24 ASP B 80 ASP^? 15.94 O15 C8E B 209 G 146 TYR B 83 TYR^? 23.90 C1 C8E B 209 G 177 LYS B 84 LYS.? 25.86 O15 C8E B 209 coo -44.97 128.78 41.20 -46.32 128.26 42.83 82.56 -37.87 -41.00 82.97 -37.16 -39.06 coo -52.83 122.13 46.42 -51.31 124.30 47.39 84.86 -45.84 -46.52 87.07 -46.60 -44.97 coo -47.30 122.24 51.49 -47.46 127.44 47.81 79.44 -47.69 -46.65 75.97 -44.45 -44.18 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 12 3 # 12 G 24 ASP C 45 ASP.? 3.27 CA CA C 208s G 146 TYR C 51 TYR.? 10.04 O21 C8E C 209 G 177 LYS C 188 LYS~? 9.02 C16 C8E C 209 coo -44.97 128.78 41.20 -46.32 128.26 42.83 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo -52.83 122.13 46.42 -51.31 124.30 47.39 26.09 -52.62 -2.60 27.54 -53.38 -0.32 coo -47.30 122.24 51.49 -47.46 127.44 47.81 31.07 -55.82 -4.30 26.58 -58.21 -2.57 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 13 3 # 13 G 24 ASP C 45 ASP.? 3.27 CA CA C 208s G 146 TYR C 109 TYR^? 10.73 CA CA C 208 G 177 LYS C 63 LYS~? 4.21 CA CA C 208 coo -44.97 128.78 41.20 -46.32 128.26 42.83 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo -52.83 122.13 46.42 -51.31 124.30 47.39 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo -47.30 122.24 51.49 -47.46 127.44 47.81 20.98 -41.61 -5.49 23.04 -43.67 -10.44 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 14 3 # 14 G 24 ASP C 48 ASP.? 7.17 CA CA C 208 G 146 TYR C 109 TYR^? 10.73 CA CA C 208 G 177 LYS C 63 LYS~? 4.21 CA CA C 208 coo -44.97 128.78 41.20 -46.32 128.26 42.83 26.68 -52.06 -7.74 25.46 -53.53 -8.54 coo -52.83 122.13 46.42 -51.31 124.30 47.39 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo -47.30 122.24 51.49 -47.46 127.44 47.81 20.98 -41.61 -5.49 23.04 -43.67 -10.44 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 15 3 # 15 G 24 ASP C 49 ASP.? -2.87 CA CA C 208s G 146 TYR C 109 TYR^? 10.73 CA CA C 208 G 177 LYS C 67 LYS.? 18.71 CA CA C 208 coo -44.97 128.78 41.20 -46.32 128.26 42.83 22.13 -48.50 -9.42 23.00 -46.66 -10.00 coo -52.83 122.13 46.42 -51.31 124.30 47.39 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo -47.30 122.24 51.49 -47.46 127.44 47.81 20.04 -36.06 -6.98 16.11 -31.17 -7.78 1ok4_c06 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 15 hits 1ok4_c06 naa= 3 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 H 24 ASP A 45 ASP.? -2.96 CA CA A 208s H 146 TYR A 51 TYR.? 9.92 O21 C8E A 210 H 177 LYS A 188 LYS~? 10.77 C20 C8E A 210 coo -51.11 100.30 51.41 -52.67 98.82 51.12 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo -58.70 94.17 45.32 -57.76 93.82 47.92 71.70 -83.21 -22.40 69.97 -85.02 -21.17 coo -54.32 88.79 48.13 -54.61 94.04 51.74 68.32 -80.18 -18.11 71.95 -84.24 -15.84 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 H 24 ASP A 45 ASP.? -2.96 CA CA A 208s H 146 TYR A 109 TYR^? 10.85 CA CA A 208 H 177 LYS A 63 LYS~? 3.96 CA CA A 208 coo -51.11 100.30 51.41 -52.67 98.82 51.12 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo -58.70 94.17 45.32 -57.76 93.82 47.92 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo -54.32 88.79 48.13 -54.61 94.04 51.74 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 H 24 ASP A 48 ASP.? 7.38 CA CA A 208 H 146 TYR A 109 TYR^? 10.85 CA CA A 208 H 177 LYS A 63 LYS~? 3.96 CA CA A 208 coo -51.11 100.30 51.41 -52.67 98.82 51.12 72.05 -78.20 -23.17 73.82 -77.79 -22.11 coo -58.70 94.17 45.32 -57.76 93.82 47.92 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo -54.32 88.79 48.13 -54.61 94.04 51.74 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 H 24 ASP A 49 ASP.? -3.00 CA CA A 208s H 146 TYR A 109 TYR^? 10.85 CA CA A 208 H 177 LYS A 67 LYS~? 13.30 CA CA A 208 coo -51.11 100.30 51.41 -52.67 98.82 51.12 75.72 -77.89 -27.98 74.67 -77.10 -29.65 coo -58.70 94.17 45.32 -57.76 93.82 47.92 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo -54.32 88.79 48.13 -54.61 94.04 51.74 73.21 -82.07 -40.14 71.59 -78.49 -41.85 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 H 24 ASP A 61 ASP~? 12.37 CA CA A 208 H 146 TYR A 109 TYR^? 10.85 CA CA A 208 H 177 LYS A 67 LYS~? 13.30 CA CA A 208 coo -51.11 100.30 51.41 -52.67 98.82 51.12 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo -58.70 94.17 45.32 -57.76 93.82 47.92 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo -54.32 88.79 48.13 -54.61 94.04 51.74 73.21 -82.07 -40.14 71.59 -78.49 -41.85 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 H 24 ASP B 45 ASP.? -3.07 CA CA B 208s H 146 TYR B 51 TYR.? 9.95 O21 C8E B 210 H 177 LYS B 188 LYS~? 9.67 C16 C8E B 210 coo -51.11 100.30 51.41 -52.67 98.82 51.12 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo -58.70 94.17 45.32 -57.76 93.82 47.92 102.03 -27.53 -15.19 104.12 -26.16 -16.40 coo -54.32 88.79 48.13 -54.61 94.04 51.74 102.16 -28.74 -21.10 106.15 -31.37 -17.86 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 H 24 ASP B 45 ASP.? -3.07 CA CA B 208s H 146 TYR B 109 TYR^? 10.54 CA CA B 208 H 177 LYS B 63 LYS~? 3.79 CA CA B 208 coo -51.11 100.30 51.41 -52.67 98.82 51.12 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo -58.70 94.17 45.32 -57.76 93.82 47.92 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo -54.32 88.79 48.13 -54.61 94.04 51.74 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 H 24 ASP B 48 ASP.? 7.20 CA CA B 208 H 146 TYR B 109 TYR^? 10.54 CA CA B 208 H 177 LYS B 63 LYS~? 3.79 CA CA B 208 coo -51.11 100.30 51.41 -52.67 98.82 51.12 97.60 -30.12 -16.68 98.20 -32.01 -15.99 coo -58.70 94.17 45.32 -57.76 93.82 47.92 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo -54.32 88.79 48.13 -54.61 94.04 51.74 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 H 24 ASP B 49 ASP.? -3.05 CA CA B 208s H 146 TYR B 109 TYR^? 10.54 CA CA B 208 H 177 LYS B 67 LYS~? 18.13 CA CA B 208 coo -51.11 100.30 51.41 -52.67 98.82 51.12 94.52 -28.97 -11.62 93.03 -30.41 -11.73 coo -58.70 94.17 45.32 -57.76 93.82 47.92 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo -54.32 88.79 48.13 -54.61 94.04 51.74 89.12 -21.41 -4.23 87.66 -21.56 1.71 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 10 3 # 10 H 24 ASP B 61 ASP~? 12.48 CA CA B 208 H 146 TYR B 109 TYR^? 10.54 CA CA B 208 H 177 LYS B 67 LYS~? 18.13 CA CA B 208 coo -51.11 100.30 51.41 -52.67 98.82 51.12 98.68 -27.22 -4.60 99.30 -29.23 -4.23 coo -58.70 94.17 45.32 -57.76 93.82 47.92 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo -54.32 88.79 48.13 -54.61 94.04 51.74 89.12 -21.41 -4.23 87.66 -21.56 1.71 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 11 3 # 11 H 24 ASP B 80 ASP^? 15.94 O15 C8E B 209 H 146 TYR B 83 TYR^? 23.90 C1 C8E B 209 H 177 LYS B 84 LYS.? 25.86 O15 C8E B 209 coo -51.11 100.30 51.41 -52.67 98.82 51.12 82.56 -37.87 -41.00 82.97 -37.16 -39.06 coo -58.70 94.17 45.32 -57.76 93.82 47.92 84.86 -45.84 -46.52 87.07 -46.60 -44.97 coo -54.32 88.79 48.13 -54.61 94.04 51.74 79.44 -47.69 -46.65 75.97 -44.45 -44.18 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 12 3 # 12 H 24 ASP C 45 ASP.? 3.27 CA CA C 208s H 146 TYR C 51 TYR.? 10.04 O21 C8E C 209 H 177 LYS C 188 LYS~? 9.02 C16 C8E C 209 coo -51.11 100.30 51.41 -52.67 98.82 51.12 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo -58.70 94.17 45.32 -57.76 93.82 47.92 26.09 -52.62 -2.60 27.54 -53.38 -0.32 coo -54.32 88.79 48.13 -54.61 94.04 51.74 31.07 -55.82 -4.30 26.58 -58.21 -2.57 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 13 3 # 13 H 24 ASP C 45 ASP.? 3.27 CA CA C 208s H 146 TYR C 109 TYR^? 10.73 CA CA C 208 H 177 LYS C 63 LYS~? 4.21 CA CA C 208 coo -51.11 100.30 51.41 -52.67 98.82 51.12 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo -58.70 94.17 45.32 -57.76 93.82 47.92 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo -54.32 88.79 48.13 -54.61 94.04 51.74 20.98 -41.61 -5.49 23.04 -43.67 -10.44 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 14 3 # 14 H 24 ASP C 48 ASP.? 7.17 CA CA C 208 H 146 TYR C 109 TYR^? 10.73 CA CA C 208 H 177 LYS C 63 LYS~? 4.21 CA CA C 208 coo -51.11 100.30 51.41 -52.67 98.82 51.12 26.68 -52.06 -7.74 25.46 -53.53 -8.54 coo -58.70 94.17 45.32 -57.76 93.82 47.92 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo -54.32 88.79 48.13 -54.61 94.04 51.74 20.98 -41.61 -5.49 23.04 -43.67 -10.44 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 15 3 # 15 H 24 ASP C 49 ASP.? -2.87 CA CA C 208s H 146 TYR C 109 TYR^? 10.73 CA CA C 208 H 177 LYS C 67 LYS.? 18.71 CA CA C 208 coo -51.11 100.30 51.41 -52.67 98.82 51.12 22.13 -48.50 -9.42 23.00 -46.66 -10.00 coo -58.70 94.17 45.32 -57.76 93.82 47.92 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo -54.32 88.79 48.13 -54.61 94.04 51.74 20.04 -36.06 -6.98 16.11 -31.17 -7.78 1ok4_c07 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 15 hits 1ok4_c07 naa= 3 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 I 24 ASP A 45 ASP.? -2.96 CA CA A 208s I 146 TYR A 51 TYR.? 9.92 O21 C8E A 210 I 177 LYS A 188 LYS~? 10.77 C20 C8E A 210 coo -54.65 81.97 26.87 -55.88 81.89 25.07 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo -59.92 86.62 17.74 -59.42 83.94 18.40 71.70 -83.21 -22.40 69.97 -85.02 -21.17 coo -55.38 81.61 14.50 -57.11 80.05 20.41 68.32 -80.18 -18.11 71.95 -84.24 -15.84 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 I 24 ASP A 45 ASP.? -2.96 CA CA A 208s I 146 TYR A 109 TYR^? 10.85 CA CA A 208 I 177 LYS A 63 LYS~? 3.96 CA CA A 208 coo -54.65 81.97 26.87 -55.88 81.89 25.07 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo -59.92 86.62 17.74 -59.42 83.94 18.40 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo -55.38 81.61 14.50 -57.11 80.05 20.41 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 I 24 ASP A 48 ASP.? 7.38 CA CA A 208 I 146 TYR A 109 TYR^? 10.85 CA CA A 208 I 177 LYS A 63 LYS~? 3.96 CA CA A 208 coo -54.65 81.97 26.87 -55.88 81.89 25.07 72.05 -78.20 -23.17 73.82 -77.79 -22.11 coo -59.92 86.62 17.74 -59.42 83.94 18.40 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo -55.38 81.61 14.50 -57.11 80.05 20.41 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 I 24 ASP A 49 ASP.? -3.00 CA CA A 208s I 146 TYR A 109 TYR^? 10.85 CA CA A 208 I 177 LYS A 67 LYS~? 13.30 CA CA A 208 coo -54.65 81.97 26.87 -55.88 81.89 25.07 75.72 -77.89 -27.98 74.67 -77.10 -29.65 coo -59.92 86.62 17.74 -59.42 83.94 18.40 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo -55.38 81.61 14.50 -57.11 80.05 20.41 73.21 -82.07 -40.14 71.59 -78.49 -41.85 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 I 24 ASP A 61 ASP~? 12.37 CA CA A 208 I 146 TYR A 109 TYR^? 10.85 CA CA A 208 I 177 LYS A 67 LYS~? 13.30 CA CA A 208 coo -54.65 81.97 26.87 -55.88 81.89 25.07 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo -59.92 86.62 17.74 -59.42 83.94 18.40 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo -55.38 81.61 14.50 -57.11 80.05 20.41 73.21 -82.07 -40.14 71.59 -78.49 -41.85 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 I 24 ASP B 45 ASP.? -3.07 CA CA B 208s I 146 TYR B 51 TYR.? 9.95 O21 C8E B 210 I 177 LYS B 188 LYS~? 9.67 C16 C8E B 210 coo -54.65 81.97 26.87 -55.88 81.89 25.07 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo -59.92 86.62 17.74 -59.42 83.94 18.40 102.03 -27.53 -15.19 104.12 -26.16 -16.40 coo -55.38 81.61 14.50 -57.11 80.05 20.41 102.16 -28.74 -21.10 106.15 -31.37 -17.86 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 I 24 ASP B 45 ASP.? -3.07 CA CA B 208s I 146 TYR B 109 TYR^? 10.54 CA CA B 208 I 177 LYS B 63 LYS~? 3.79 CA CA B 208 coo -54.65 81.97 26.87 -55.88 81.89 25.07 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo -59.92 86.62 17.74 -59.42 83.94 18.40 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo -55.38 81.61 14.50 -57.11 80.05 20.41 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 I 24 ASP B 48 ASP.? 7.20 CA CA B 208 I 146 TYR B 109 TYR^? 10.54 CA CA B 208 I 177 LYS B 63 LYS~? 3.79 CA CA B 208 coo -54.65 81.97 26.87 -55.88 81.89 25.07 97.60 -30.12 -16.68 98.20 -32.01 -15.99 coo -59.92 86.62 17.74 -59.42 83.94 18.40 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo -55.38 81.61 14.50 -57.11 80.05 20.41 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 I 24 ASP B 49 ASP.? -3.05 CA CA B 208s I 146 TYR B 109 TYR^? 10.54 CA CA B 208 I 177 LYS B 67 LYS~? 18.13 CA CA B 208 coo -54.65 81.97 26.87 -55.88 81.89 25.07 94.52 -28.97 -11.62 93.03 -30.41 -11.73 coo -59.92 86.62 17.74 -59.42 83.94 18.40 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo -55.38 81.61 14.50 -57.11 80.05 20.41 89.12 -21.41 -4.23 87.66 -21.56 1.71 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 10 3 # 10 I 24 ASP B 61 ASP~? 12.48 CA CA B 208 I 146 TYR B 109 TYR^? 10.54 CA CA B 208 I 177 LYS B 67 LYS~? 18.13 CA CA B 208 coo -54.65 81.97 26.87 -55.88 81.89 25.07 98.68 -27.22 -4.60 99.30 -29.23 -4.23 coo -59.92 86.62 17.74 -59.42 83.94 18.40 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo -55.38 81.61 14.50 -57.11 80.05 20.41 89.12 -21.41 -4.23 87.66 -21.56 1.71 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 11 3 # 11 I 24 ASP B 80 ASP^? 15.94 O15 C8E B 209 I 146 TYR B 83 TYR^? 23.90 C1 C8E B 209 I 177 LYS B 84 LYS.? 25.86 O15 C8E B 209 coo -54.65 81.97 26.87 -55.88 81.89 25.07 82.56 -37.87 -41.00 82.97 -37.16 -39.06 coo -59.92 86.62 17.74 -59.42 83.94 18.40 84.86 -45.84 -46.52 87.07 -46.60 -44.97 coo -55.38 81.61 14.50 -57.11 80.05 20.41 79.44 -47.69 -46.65 75.97 -44.45 -44.18 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 12 3 # 12 I 24 ASP C 45 ASP.? 3.27 CA CA C 208s I 146 TYR C 51 TYR.? 10.04 O21 C8E C 209 I 177 LYS C 188 LYS~? 9.02 C16 C8E C 209 coo -54.65 81.97 26.87 -55.88 81.89 25.07 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo -59.92 86.62 17.74 -59.42 83.94 18.40 26.09 -52.62 -2.60 27.54 -53.38 -0.32 coo -55.38 81.61 14.50 -57.11 80.05 20.41 31.07 -55.82 -4.30 26.58 -58.21 -2.57 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 13 3 # 13 I 24 ASP C 45 ASP.? 3.27 CA CA C 208s I 146 TYR C 109 TYR^? 10.73 CA CA C 208 I 177 LYS C 63 LYS~? 4.21 CA CA C 208 coo -54.65 81.97 26.87 -55.88 81.89 25.07 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo -59.92 86.62 17.74 -59.42 83.94 18.40 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo -55.38 81.61 14.50 -57.11 80.05 20.41 20.98 -41.61 -5.49 23.04 -43.67 -10.44 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 14 3 # 14 I 24 ASP C 48 ASP.? 7.17 CA CA C 208 I 146 TYR C 109 TYR^? 10.73 CA CA C 208 I 177 LYS C 63 LYS~? 4.21 CA CA C 208 coo -54.65 81.97 26.87 -55.88 81.89 25.07 26.68 -52.06 -7.74 25.46 -53.53 -8.54 coo -59.92 86.62 17.74 -59.42 83.94 18.40 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo -55.38 81.61 14.50 -57.11 80.05 20.41 20.98 -41.61 -5.49 23.04 -43.67 -10.44 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 15 3 # 15 I 24 ASP C 49 ASP.? -2.87 CA CA C 208s I 146 TYR C 109 TYR^? 10.73 CA CA C 208 I 177 LYS C 67 LYS.? 18.71 CA CA C 208 coo -54.65 81.97 26.87 -55.88 81.89 25.07 22.13 -48.50 -9.42 23.00 -46.66 -10.00 coo -59.92 86.62 17.74 -59.42 83.94 18.40 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo -55.38 81.61 14.50 -57.11 80.05 20.41 20.04 -36.06 -6.98 16.11 -31.17 -7.78 1ok4_c08 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 15 hits 1ok4_c08 naa= 3 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 J 24 ASP A 45 ASP.? -2.96 CA CA A 208s J 146 TYR A 51 TYR.? 9.92 O21 C8E A 210 J 177 LYS A 188 LYS~? 10.77 C20 C8E A 210 coo -50.64 99.08 1.52 -51.52 100.83 0.67 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 71.70 -83.21 -22.40 69.97 -85.02 -21.17 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 68.32 -80.18 -18.11 71.95 -84.24 -15.84 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 J 24 ASP A 45 ASP.? -2.96 CA CA A 208s J 146 TYR A 109 TYR^? 10.85 CA CA A 208 J 177 LYS A 63 LYS~? 3.96 CA CA A 208 coo -50.64 99.08 1.52 -51.52 100.83 0.67 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 J 24 ASP A 48 ASP.? 7.38 CA CA A 208 J 146 TYR A 109 TYR^? 10.85 CA CA A 208 J 177 LYS A 63 LYS~? 3.96 CA CA A 208 coo -50.64 99.08 1.52 -51.52 100.83 0.67 72.05 -78.20 -23.17 73.82 -77.79 -22.11 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 J 24 ASP A 49 ASP.? -3.00 CA CA A 208s J 146 TYR A 109 TYR^? 10.85 CA CA A 208 J 177 LYS A 67 LYS~? 13.30 CA CA A 208 coo -50.64 99.08 1.52 -51.52 100.83 0.67 75.72 -77.89 -27.98 74.67 -77.10 -29.65 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 73.21 -82.07 -40.14 71.59 -78.49 -41.85 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 J 24 ASP A 61 ASP~? 12.37 CA CA A 208 J 146 TYR A 109 TYR^? 10.85 CA CA A 208 J 177 LYS A 67 LYS~? 13.30 CA CA A 208 coo -50.64 99.08 1.52 -51.52 100.83 0.67 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 73.21 -82.07 -40.14 71.59 -78.49 -41.85 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 J 24 ASP B 45 ASP.? -3.07 CA CA B 208s J 146 TYR B 51 TYR.? 9.95 O21 C8E B 210 J 177 LYS B 188 LYS~? 9.67 C16 C8E B 210 coo -50.64 99.08 1.52 -51.52 100.83 0.67 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 102.03 -27.53 -15.19 104.12 -26.16 -16.40 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 102.16 -28.74 -21.10 106.15 -31.37 -17.86 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 J 24 ASP B 45 ASP.? -3.07 CA CA B 208s J 146 TYR B 109 TYR^? 10.54 CA CA B 208 J 177 LYS B 63 LYS~? 3.79 CA CA B 208 coo -50.64 99.08 1.52 -51.52 100.83 0.67 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 J 24 ASP B 48 ASP.? 7.20 CA CA B 208 J 146 TYR B 109 TYR^? 10.54 CA CA B 208 J 177 LYS B 63 LYS~? 3.79 CA CA B 208 coo -50.64 99.08 1.52 -51.52 100.83 0.67 97.60 -30.12 -16.68 98.20 -32.01 -15.99 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 J 24 ASP B 49 ASP.? -3.05 CA CA B 208s J 146 TYR B 109 TYR^? 10.54 CA CA B 208 J 177 LYS B 67 LYS~? 18.13 CA CA B 208 coo -50.64 99.08 1.52 -51.52 100.83 0.67 94.52 -28.97 -11.62 93.03 -30.41 -11.73 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 89.12 -21.41 -4.23 87.66 -21.56 1.71 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 10 3 # 10 J 24 ASP B 61 ASP~? 12.48 CA CA B 208 J 146 TYR B 109 TYR^? 10.54 CA CA B 208 J 177 LYS B 67 LYS~? 18.13 CA CA B 208 coo -50.64 99.08 1.52 -51.52 100.83 0.67 98.68 -27.22 -4.60 99.30 -29.23 -4.23 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 89.12 -21.41 -4.23 87.66 -21.56 1.71 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 11 3 # 11 J 24 ASP B 80 ASP^? 15.94 O15 C8E B 209 J 146 TYR B 83 TYR^? 23.90 C1 C8E B 209 J 177 LYS B 84 LYS.? 25.86 O15 C8E B 209 coo -50.64 99.08 1.52 -51.52 100.83 0.67 82.56 -37.87 -41.00 82.97 -37.16 -39.06 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 84.86 -45.84 -46.52 87.07 -46.60 -44.97 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 79.44 -47.69 -46.65 75.97 -44.45 -44.18 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 12 3 # 12 J 24 ASP C 45 ASP.? 3.27 CA CA C 208s J 146 TYR C 51 TYR.? 10.04 O21 C8E C 209 J 177 LYS C 188 LYS~? 9.02 C16 C8E C 209 coo -50.64 99.08 1.52 -51.52 100.83 0.67 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 26.09 -52.62 -2.60 27.54 -53.38 -0.32 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 31.07 -55.82 -4.30 26.58 -58.21 -2.57 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 13 3 # 13 J 24 ASP C 45 ASP.? 3.27 CA CA C 208s J 146 TYR C 109 TYR^? 10.73 CA CA C 208 J 177 LYS C 63 LYS~? 4.21 CA CA C 208 coo -50.64 99.08 1.52 -51.52 100.83 0.67 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 20.98 -41.61 -5.49 23.04 -43.67 -10.44 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 14 3 # 14 J 24 ASP C 48 ASP.? 7.17 CA CA C 208 J 146 TYR C 109 TYR^? 10.73 CA CA C 208 J 177 LYS C 63 LYS~? 4.21 CA CA C 208 coo -50.64 99.08 1.52 -51.52 100.83 0.67 26.68 -52.06 -7.74 25.46 -53.53 -8.54 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 20.98 -41.61 -5.49 23.04 -43.67 -10.44 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 15 3 # 15 J 24 ASP C 49 ASP.? -2.87 CA CA C 208s J 146 TYR C 109 TYR^? 10.73 CA CA C 208 J 177 LYS C 67 LYS.? 18.71 CA CA C 208 coo -50.64 99.08 1.52 -51.52 100.83 0.67 22.13 -48.50 -9.42 23.00 -46.66 -10.00 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 20.04 -36.06 -6.98 16.11 -31.17 -7.78 1ok4_c09 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 15 hits 1ok4_c09 naa= 3 ULMN 3 1onr_c00 TRANSALDOLASE B user 1 3 # 1 A 17 ASP A 80 ASP^? 12.60 C1 C8E A 210 A 96 GLU A 93 GLU^? 23.51 C1 C8E A 210 A 132 LYS A 84 LYS.? 23.11 C2 C8E C 209 coo 31.23 12.29 16.44 30.82 11.56 18.39 58.12 -52.30 -15.93 59.10 -53.68 -17.13 coo 26.82 3.20 24.36 27.99 4.86 24.98 64.33 -40.66 -16.04 62.38 -40.13 -16.70 coo 29.99 0.62 22.18 30.38 6.69 20.81 61.58 -41.74 -11.00 58.66 -39.80 -16.04 ULMN 3 1onr_c00 TRANSALDOLASE B user 2 3 # 2 A 17 ASP A 114 ASP.? 22.11 CA CA A 208 A 96 GLU A 64 GLU~? 12.36 CA CA A 208 A 132 LYS A 63 LYS~? 3.96 CA CA A 208 coo 31.23 12.29 16.44 30.82 11.56 18.39 71.50 -87.46 -45.26 70.62 -89.18 -46.15 coo 26.82 3.20 24.36 27.99 4.86 24.98 79.25 -82.11 -37.14 78.75 -80.37 -38.23 coo 29.99 0.62 22.18 30.38 6.69 20.81 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 1onr_c00 TRANSALDOLASE B user 3 3 # 3 A 17 ASP A 149 ASP^? 14.85 C1 C8E A 210 A 96 GLU A 93 GLU^? 23.51 C1 C8E A 210 A 132 LYS A 84 LYS.? 23.11 C2 C8E C 209 coo 31.23 12.29 16.44 30.82 11.56 18.39 66.40 -51.17 -20.74 65.06 -51.90 -19.38 coo 26.82 3.20 24.36 27.99 4.86 24.98 64.33 -40.66 -16.04 62.38 -40.13 -16.70 coo 29.99 0.62 22.18 30.38 6.69 20.81 61.58 -41.74 -11.00 58.66 -39.80 -16.04 ULMN 3 1onr_c00 TRANSALDOLASE B user 4 3 # 4 A 17 ASP B 80 ASP^? 15.94 O15 C8E B 209 A 96 GLU B 93 GLU^? 27.23 O15 C8E B 209 A 132 LYS B 84 LYS.? 25.86 O15 C8E B 209 coo 31.23 12.29 16.44 30.82 11.56 18.39 82.56 -37.87 -41.00 82.97 -37.16 -39.06 coo 26.82 3.20 24.36 27.99 4.86 24.98 75.25 -49.35 -42.08 74.13 -47.63 -42.56 coo 29.99 0.62 22.18 30.38 6.69 20.81 79.44 -47.69 -46.65 75.97 -44.45 -44.18 ULMN 3 1onr_c00 TRANSALDOLASE B user 5 3 # 5 A 17 ASP B 114 ASP.? 22.07 CA CA B 208 A 96 GLU B 64 GLU~? 12.78 CA CA B 208 A 132 LYS B 63 LYS~? 3.79 CA CA B 208 coo 31.23 12.29 16.44 30.82 11.56 18.39 88.69 -13.97 -0.41 89.97 -12.27 -0.12 coo 26.82 3.20 24.36 27.99 4.86 24.98 92.75 -26.79 -1.73 90.87 -27.74 -1.56 coo 29.99 0.62 22.18 30.38 6.69 20.81 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1onr_c00 TRANSALDOLASE B user 6 3 # 6 A 17 ASP B 149 ASP^? 14.91 O15 C8E B 209 A 96 GLU B 93 GLU^? 27.23 O15 C8E B 209 A 132 LYS B 84 LYS.? 25.86 O15 C8E B 209 coo 31.23 12.29 16.44 30.82 11.56 18.39 79.48 -42.39 -33.32 81.04 -41.48 -34.38 coo 26.82 3.20 24.36 27.99 4.86 24.98 75.25 -49.35 -42.08 74.13 -47.63 -42.56 coo 29.99 0.62 22.18 30.38 6.69 20.81 79.44 -47.69 -46.65 75.97 -44.45 -44.18 ULMN 3 1onr_c00 TRANSALDOLASE B user 7 3 # 7 A 17 ASP C 48 ASP.? 7.17 CA CA C 208 A 96 GLU C 64 GLU~? 12.03 CA CA C 208 A 132 LYS C 63 LYS~? 4.21 CA CA C 208 coo 31.23 12.29 16.44 30.82 11.56 18.39 26.68 -52.06 -7.74 25.46 -53.53 -8.54 coo 26.82 3.20 24.36 27.99 4.86 24.98 16.47 -41.84 -8.31 14.60 -42.35 -9.15 coo 29.99 0.62 22.18 30.38 6.69 20.81 20.98 -41.61 -5.49 23.04 -43.67 -10.44 ULMN 3 1onr_c00 TRANSALDOLASE B user 8 3 # 8 A 17 ASP C 80 ASP^? 16.43 C13 C8E C 210 A 96 GLU C 93 GLU^? 26.90 C13 C8E C 210 A 132 LYS C 84 LYS.? 25.24 O21 C8E A 209 coo 31.23 12.29 16.44 30.82 11.56 18.39 47.10 -57.14 -28.79 45.64 -55.94 -27.77 coo 26.82 3.20 24.36 27.99 4.86 24.98 45.29 -60.19 -41.07 45.99 -58.52 -39.91 coo 29.99 0.62 22.18 30.38 6.69 20.81 49.01 -63.83 -38.44 48.10 -58.01 -38.38 ULMN 3 1onr_c00 TRANSALDOLASE B user 9 3 # 9 A 17 ASP C 114 ASP.? 22.22 CA CA C 208 A 96 GLU C 64 GLU~? 12.03 CA CA C 208 A 132 LYS C 63 LYS~? 4.21 CA CA C 208 coo 31.23 12.29 16.44 30.82 11.56 18.39 19.39 -30.14 -1.59 19.46 -28.98 0.18 coo 26.82 3.20 24.36 27.99 4.86 24.98 16.47 -41.84 -8.31 14.60 -42.35 -9.15 coo 29.99 0.62 22.18 30.38 6.69 20.81 20.98 -41.61 -5.49 23.04 -43.67 -10.44 ULMN 3 1onr_c00 TRANSALDOLASE B user 10 3 # 10 A 17 ASP C 149 ASP^? 16.02 C16 C8E C 210 A 96 GLU C 93 GLU^? 26.90 C13 C8E C 210 A 132 LYS C 84 LYS.? 25.24 O21 C8E A 209 coo 31.23 12.29 16.44 30.82 11.56 18.39 38.72 -55.19 -32.44 40.02 -55.93 -30.97 coo 26.82 3.20 24.36 27.99 4.86 24.98 45.29 -60.19 -41.07 45.99 -58.52 -39.91 coo 29.99 0.62 22.18 30.38 6.69 20.81 49.01 -63.83 -38.44 48.10 -58.01 -38.38 1onr_c00 source 1onr TRANSALDOLASE B : 10 hits 1onr_c00 naa= 3 ULMN 3 1onr_c01 TRANSALDOLASE B user 1 3 # 1 B 17 ASP A 80 ASP^? 12.60 C1 C8E A 210 B 96 GLU A 93 GLU^? 23.51 C1 C8E A 210 B 132 LYS A 84 LYS.? 23.11 C2 C8E C 209 coo 31.16 57.31 -0.94 30.73 56.64 1.01 58.12 -52.30 -15.93 59.10 -53.68 -17.13 coo 26.69 48.45 7.18 27.85 50.13 7.74 64.33 -40.66 -16.04 62.38 -40.13 -16.70 coo 29.82 45.80 5.07 30.26 51.81 3.56 61.58 -41.74 -11.00 58.66 -39.80 -16.04 ULMN 3 1onr_c01 TRANSALDOLASE B user 2 3 # 2 B 17 ASP A 114 ASP.? 22.11 CA CA A 208 B 96 GLU A 64 GLU~? 12.36 CA CA A 208 B 132 LYS A 63 LYS~? 3.96 CA CA A 208 coo 31.16 57.31 -0.94 30.73 56.64 1.01 71.50 -87.46 -45.26 70.62 -89.18 -46.15 coo 26.69 48.45 7.18 27.85 50.13 7.74 79.25 -82.11 -37.14 78.75 -80.37 -38.23 coo 29.82 45.80 5.07 30.26 51.81 3.56 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 1onr_c01 TRANSALDOLASE B user 3 3 # 3 B 17 ASP A 149 ASP^? 14.85 C1 C8E A 210 B 96 GLU A 93 GLU^? 23.51 C1 C8E A 210 B 132 LYS A 84 LYS.? 23.11 C2 C8E C 209 coo 31.16 57.31 -0.94 30.73 56.64 1.01 66.40 -51.17 -20.74 65.06 -51.90 -19.38 coo 26.69 48.45 7.18 27.85 50.13 7.74 64.33 -40.66 -16.04 62.38 -40.13 -16.70 coo 29.82 45.80 5.07 30.26 51.81 3.56 61.58 -41.74 -11.00 58.66 -39.80 -16.04 ULMN 3 1onr_c01 TRANSALDOLASE B user 4 3 # 4 B 17 ASP B 80 ASP^? 15.94 O15 C8E B 209 B 96 GLU B 93 GLU^? 27.23 O15 C8E B 209 B 132 LYS B 84 LYS.? 25.86 O15 C8E B 209 coo 31.16 57.31 -0.94 30.73 56.64 1.01 82.56 -37.87 -41.00 82.97 -37.16 -39.06 coo 26.69 48.45 7.18 27.85 50.13 7.74 75.25 -49.35 -42.08 74.13 -47.63 -42.56 coo 29.82 45.80 5.07 30.26 51.81 3.56 79.44 -47.69 -46.65 75.97 -44.45 -44.18 ULMN 3 1onr_c01 TRANSALDOLASE B user 5 3 # 5 B 17 ASP B 114 ASP.? 22.07 CA CA B 208 B 96 GLU B 64 GLU~? 12.78 CA CA B 208 B 132 LYS B 63 LYS~? 3.79 CA CA B 208 coo 31.16 57.31 -0.94 30.73 56.64 1.01 88.69 -13.97 -0.41 89.97 -12.27 -0.12 coo 26.69 48.45 7.18 27.85 50.13 7.74 92.75 -26.79 -1.73 90.87 -27.74 -1.56 coo 29.82 45.80 5.07 30.26 51.81 3.56 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1onr_c01 TRANSALDOLASE B user 6 3 # 6 B 17 ASP B 149 ASP^? 14.91 O15 C8E B 209 B 96 GLU B 93 GLU^? 27.23 O15 C8E B 209 B 132 LYS B 84 LYS.? 25.86 O15 C8E B 209 coo 31.16 57.31 -0.94 30.73 56.64 1.01 79.48 -42.39 -33.32 81.04 -41.48 -34.38 coo 26.69 48.45 7.18 27.85 50.13 7.74 75.25 -49.35 -42.08 74.13 -47.63 -42.56 coo 29.82 45.80 5.07 30.26 51.81 3.56 79.44 -47.69 -46.65 75.97 -44.45 -44.18 ULMN 3 1onr_c01 TRANSALDOLASE B user 7 3 # 7 B 17 ASP C 48 ASP.? 7.17 CA CA C 208 B 96 GLU C 64 GLU~? 12.03 CA CA C 208 B 132 LYS C 63 LYS~? 4.21 CA CA C 208 coo 31.16 57.31 -0.94 30.73 56.64 1.01 26.68 -52.06 -7.74 25.46 -53.53 -8.54 coo 26.69 48.45 7.18 27.85 50.13 7.74 16.47 -41.84 -8.31 14.60 -42.35 -9.15 coo 29.82 45.80 5.07 30.26 51.81 3.56 20.98 -41.61 -5.49 23.04 -43.67 -10.44 ULMN 3 1onr_c01 TRANSALDOLASE B user 8 3 # 8 B 17 ASP C 80 ASP^? 16.43 C13 C8E C 210 B 96 GLU C 93 GLU^? 26.90 C13 C8E C 210 B 132 LYS C 84 LYS.? 25.24 O21 C8E A 209 coo 31.16 57.31 -0.94 30.73 56.64 1.01 47.10 -57.14 -28.79 45.64 -55.94 -27.77 coo 26.69 48.45 7.18 27.85 50.13 7.74 45.29 -60.19 -41.07 45.99 -58.52 -39.91 coo 29.82 45.80 5.07 30.26 51.81 3.56 49.01 -63.83 -38.44 48.10 -58.01 -38.38 ULMN 3 1onr_c01 TRANSALDOLASE B user 9 3 # 9 B 17 ASP C 114 ASP.? 22.22 CA CA C 208 B 96 GLU C 64 GLU~? 12.03 CA CA C 208 B 132 LYS C 63 LYS~? 4.21 CA CA C 208 coo 31.16 57.31 -0.94 30.73 56.64 1.01 19.39 -30.14 -1.59 19.46 -28.98 0.18 coo 26.69 48.45 7.18 27.85 50.13 7.74 16.47 -41.84 -8.31 14.60 -42.35 -9.15 coo 29.82 45.80 5.07 30.26 51.81 3.56 20.98 -41.61 -5.49 23.04 -43.67 -10.44 ULMN 3 1onr_c01 TRANSALDOLASE B user 10 3 # 10 B 17 ASP C 149 ASP^? 16.02 C16 C8E C 210 B 96 GLU C 93 GLU^? 26.90 C13 C8E C 210 B 132 LYS C 84 LYS.? 25.24 O21 C8E A 209 coo 31.16 57.31 -0.94 30.73 56.64 1.01 38.72 -55.19 -32.44 40.02 -55.93 -30.97 coo 26.69 48.45 7.18 27.85 50.13 7.74 45.29 -60.19 -41.07 45.99 -58.52 -39.91 coo 29.82 45.80 5.07 30.26 51.81 3.56 49.01 -63.83 -38.44 48.10 -58.01 -38.38 1onr_c01 source 1onr TRANSALDOLASE B : 10 hits 1onr_c01 naa= 3 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 1 3 # 1 A 170 SER A 106 SER^? 9.35 O21 C8E A 209 A 239 VAL A 75 VAL^? 10.27 O21 C8E A 209 A 413 ASN A 74 ASN^? -3.00 O21 C8E A 209s coo 80.14 40.76 52.28 77.73 40.59 51.94 59.80 -72.53 -28.38 58.67 -71.24 -30.10 coo 75.67 35.37 52.30 76.00 35.96 50.23 58.31 -63.98 -26.96 56.88 -63.78 -28.61 coo 81.75 35.21 52.13 80.92 37.12 51.69 62.15 -65.86 -25.53 63.13 -67.52 -24.67 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 2 3 # 2 A 170 SER B 106 SER^? 9.90 C20 C8E B 209 A 239 VAL B 75 VAL^? 10.73 C20 C8E B 209 A 413 ASN B 74 ASN^? -3.28 C20 C8E B 209s coo 80.14 40.76 52.28 77.73 40.59 51.94 88.28 -22.25 -24.42 86.10 -21.26 -24.48 coo 75.67 35.37 52.30 76.00 35.96 50.23 82.95 -26.54 -29.63 81.51 -24.87 -29.78 coo 81.75 35.21 52.13 80.92 37.12 51.69 85.94 -28.94 -27.06 87.84 -29.20 -26.13 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 3 3 # 3 A 170 SER C 106 SER^? 9.17 O21 C8E C 210 A 239 VAL C 75 VAL^? 10.43 C20 C8E C 210 A 413 ASN C 74 ASN^? -3.17 C20 C8E C 210s coo 80.14 40.76 52.28 77.73 40.59 51.94 38.19 -43.96 -11.39 38.81 -41.96 -12.55 coo 75.67 35.37 52.30 76.00 35.96 50.23 41.88 -45.41 -19.23 42.87 -43.46 -19.44 coo 81.75 35.21 52.13 80.92 37.12 51.69 38.01 -47.64 -17.99 37.26 -48.68 -16.35 1oqz_c00 source 1oqz GLUTARYL ACYLASE : 3 hits 1oqz_c00 naa= 3 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 1 3 # 1 B 170 SER A 106 SER^? 9.35 O21 C8E A 209 B 239 VAL A 75 VAL^? 10.27 O21 C8E A 209 B 413 ASN A 74 ASN^? -3.00 O21 C8E A 209s coo 25.22 6.41 2.90 27.67 6.33 3.11 59.80 -72.53 -28.38 58.67 -71.24 -30.10 coo 29.71 1.00 2.66 29.43 1.57 4.74 58.31 -63.98 -26.96 56.88 -63.78 -28.61 coo 23.72 0.88 2.95 24.56 2.79 3.34 62.15 -65.86 -25.53 63.13 -67.52 -24.67 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 2 3 # 2 B 170 SER B 106 SER^? 9.90 C20 C8E B 209 B 239 VAL B 75 VAL^? 10.73 C20 C8E B 209 B 413 ASN B 74 ASN^? -3.28 C20 C8E B 209s coo 25.22 6.41 2.90 27.67 6.33 3.11 88.28 -22.25 -24.42 86.10 -21.26 -24.48 coo 29.71 1.00 2.66 29.43 1.57 4.74 82.95 -26.54 -29.63 81.51 -24.87 -29.78 coo 23.72 0.88 2.95 24.56 2.79 3.34 85.94 -28.94 -27.06 87.84 -29.20 -26.13 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 3 3 # 3 B 170 SER C 106 SER^? 9.17 O21 C8E C 210 B 239 VAL C 75 VAL^? 10.43 C20 C8E C 210 B 413 ASN C 74 ASN^? -3.17 C20 C8E C 210s coo 25.22 6.41 2.90 27.67 6.33 3.11 38.19 -43.96 -11.39 38.81 -41.96 -12.55 coo 29.71 1.00 2.66 29.43 1.57 4.74 41.88 -45.41 -19.23 42.87 -43.46 -19.44 coo 23.72 0.88 2.95 24.56 2.79 3.34 38.01 -47.64 -17.99 37.26 -48.68 -16.35 1oqz_c01 source 1oqz GLUTARYL ACYLASE : 3 hits 1oqz_c01 naa= 3 ULMN 3 1oyg_c00 LEVANSUCRASE user 1 3 # 1 A 86 ASP A 48 ASP.? 7.38 CA CA A 208 A 247 ASP A 45 ASP.? -2.96 CA CA A 208s A 342 GLU A 70 GLU^? -2.69 CA CA A 208s coo 44.36 35.68 9.71 43.29 36.20 11.51 72.05 -78.20 -23.17 73.82 -77.79 -22.11 coo 41.40 28.81 12.91 40.82 30.90 12.97 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo 40.37 33.11 18.06 39.99 34.93 17.06 68.79 -75.79 -31.87 70.14 -76.30 -30.27 ULMN 3 1oyg_c00 LEVANSUCRASE user 2 3 # 2 A 86 ASP A 49 ASP.? -3.00 CA CA A 208s A 247 ASP A 45 ASP.? -2.96 CA CA A 208s A 342 GLU A 70 GLU^? -2.69 CA CA A 208s coo 44.36 35.68 9.71 43.29 36.20 11.51 75.72 -77.89 -27.98 74.67 -77.10 -29.65 coo 41.40 28.81 12.91 40.82 30.90 12.97 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo 40.37 33.11 18.06 39.99 34.93 17.06 68.79 -75.79 -31.87 70.14 -76.30 -30.27 ULMN 3 1oyg_c00 LEVANSUCRASE user 3 3 # 3 A 86 ASP A 49 ASP.? -3.00 CA CA A 208s A 247 ASP A 61 ASP~? 12.37 CA CA A 208 A 342 GLU A 64 GLU~? 12.36 CA CA A 208 coo 44.36 35.68 9.71 43.29 36.20 11.51 75.72 -77.89 -27.98 74.67 -77.10 -29.65 coo 41.40 28.81 12.91 40.82 30.90 12.97 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo 40.37 33.11 18.06 39.99 34.93 17.06 79.25 -82.11 -37.14 78.75 -80.37 -38.23 ULMN 3 1oyg_c00 LEVANSUCRASE user 4 3 # 4 A 86 ASP A 80 ASP^? 12.60 C1 C8E A 210 A 247 ASP A 149 ASP^? 14.85 C1 C8E A 210 A 342 GLU A 7 GLU^? 19.52 C17 C8E A 209 coo 44.36 35.68 9.71 43.29 36.20 11.51 58.12 -52.30 -15.93 59.10 -53.68 -17.13 coo 41.40 28.81 12.91 40.82 30.90 12.97 66.40 -51.17 -20.74 65.06 -51.90 -19.38 coo 40.37 33.11 18.06 39.99 34.93 17.06 61.29 -47.52 -25.12 61.48 -48.69 -23.33 ULMN 3 1oyg_c00 LEVANSUCRASE user 5 3 # 5 A 86 ASP A 111 ASP.? 17.05 CA CA A 208 A 247 ASP A 167 ASP.? 22.50 CA CA A 208 A 342 GLU A 165 GLU^? 21.76 CA CA A 208 coo 44.36 35.68 9.71 43.29 36.20 11.51 65.36 -83.80 -40.24 66.17 -85.36 -41.35 coo 41.40 28.81 12.91 40.82 30.90 12.97 58.25 -87.45 -44.58 60.23 -87.13 -43.88 coo 40.37 33.11 18.06 39.99 34.93 17.06 55.17 -82.77 -39.51 54.39 -80.85 -40.05 ULMN 3 1oyg_c00 LEVANSUCRASE user 6 3 # 6 A 86 ASP A 167 ASP.? 22.50 CA CA A 208 A 247 ASP A 111 ASP.? 17.05 CA CA A 208 A 342 GLU A 113 GLU.? 20.24 CA CA A 208 coo 44.36 35.68 9.71 43.29 36.20 11.51 58.25 -87.45 -44.58 60.23 -87.13 -43.88 coo 41.40 28.81 12.91 40.82 30.90 12.97 65.36 -83.80 -40.24 66.17 -85.36 -41.35 coo 40.37 33.11 18.06 39.99 34.93 17.06 67.94 -85.82 -46.11 66.40 -86.46 -44.83 ULMN 3 1oyg_c00 LEVANSUCRASE user 7 3 # 7 A 86 ASP B 48 ASP.? 7.20 CA CA B 208 A 247 ASP B 45 ASP.? -3.07 CA CA B 208s A 342 GLU B 70 GLU^? -2.58 CA CA B 208s coo 44.36 35.68 9.71 43.29 36.20 11.51 97.60 -30.12 -16.68 98.20 -32.01 -15.99 coo 41.40 28.81 12.91 40.82 30.90 12.97 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo 40.37 33.11 18.06 39.99 34.93 17.06 89.83 -24.96 -14.47 91.03 -26.69 -14.39 ULMN 3 1oyg_c00 LEVANSUCRASE user 8 3 # 8 A 86 ASP B 49 ASP.? -3.05 CA CA B 208s A 247 ASP B 61 ASP~? 12.48 CA CA B 208 A 342 GLU B 64 GLU~? 12.78 CA CA B 208 coo 44.36 35.68 9.71 43.29 36.20 11.51 94.52 -28.97 -11.62 93.03 -30.41 -11.73 coo 41.40 28.81 12.91 40.82 30.90 12.97 98.68 -27.22 -4.60 99.30 -29.23 -4.23 coo 40.37 33.11 18.06 39.99 34.93 17.06 92.75 -26.79 -1.73 90.87 -27.74 -1.56 ULMN 3 1oyg_c00 LEVANSUCRASE user 9 3 # 9 A 86 ASP B 80 ASP^? 15.94 O15 C8E B 209 A 247 ASP B 149 ASP^? 14.91 O15 C8E B 209 A 342 GLU B 7 GLU^? 19.70 O15 C8E B 209 coo 44.36 35.68 9.71 43.29 36.20 11.51 82.56 -37.87 -41.00 82.97 -37.16 -39.06 coo 41.40 28.81 12.91 40.82 30.90 12.97 79.48 -42.39 -33.32 81.04 -41.48 -34.38 coo 40.37 33.11 18.06 39.99 34.93 17.06 73.39 -38.66 -35.65 75.17 -39.55 -36.49 ULMN 3 1oyg_c00 LEVANSUCRASE user 10 3 # 10 A 86 ASP B 111 ASP.? 16.97 CA CA B 208 A 247 ASP B 167 ASP.? 22.72 CA CA B 208 A 342 GLU B 165 GLU^? 20.64 CA CA B 208 coo 44.36 35.68 9.71 43.29 36.20 11.51 89.21 -14.92 -8.80 89.40 -13.99 -6.98 coo 41.40 28.81 12.91 40.82 30.90 12.97 88.92 -5.85 -9.56 88.92 -7.42 -8.19 coo 40.37 33.11 18.06 39.99 34.93 17.06 88.15 -8.84 -16.79 86.14 -9.46 -16.74 ULMN 3 1oyg_c00 LEVANSUCRASE user 11 3 # 11 A 86 ASP B 167 ASP.? 22.72 CA CA B 208 A 247 ASP B 111 ASP.? 16.97 CA CA B 208 A 342 GLU B 113 GLU.? 20.51 CA CA B 208 coo 44.36 35.68 9.71 43.29 36.20 11.51 88.92 -5.85 -9.56 88.92 -7.42 -8.19 coo 41.40 28.81 12.91 40.82 30.90 12.97 89.21 -14.92 -8.80 89.40 -13.99 -6.98 coo 40.37 33.11 18.06 39.99 34.93 17.06 86.78 -12.34 -3.10 88.60 -11.66 -4.00 ULMN 3 1oyg_c00 LEVANSUCRASE user 12 3 # 12 A 86 ASP C 48 ASP.? 7.17 CA CA C 208 A 247 ASP C 45 ASP.? 3.27 CA CA C 208s A 342 GLU C 70 GLU^? -2.71 CA CA C 208s coo 44.36 35.68 9.71 43.29 36.20 11.51 26.68 -52.06 -7.74 25.46 -53.53 -8.54 coo 41.40 28.81 12.91 40.82 30.90 12.97 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo 40.37 33.11 18.06 39.99 34.93 17.06 27.73 -42.94 -10.42 26.74 -44.79 -10.37 ULMN 3 1oyg_c00 LEVANSUCRASE user 13 3 # 13 A 86 ASP C 49 ASP.? -2.87 CA CA C 208s A 247 ASP C 45 ASP.? 3.27 CA CA C 208s A 342 GLU C 70 GLU^? -2.71 CA CA C 208s coo 44.36 35.68 9.71 43.29 36.20 11.51 22.13 -48.50 -9.42 23.00 -46.66 -10.00 coo 41.40 28.81 12.91 40.82 30.90 12.97 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo 40.37 33.11 18.06 39.99 34.93 17.06 27.73 -42.94 -10.42 26.74 -44.79 -10.37 ULMN 3 1oyg_c00 LEVANSUCRASE user 14 3 # 14 A 86 ASP C 49 ASP.? -2.87 CA CA C 208s A 247 ASP C 61 ASP~? 12.61 CA CA C 208 A 342 GLU C 64 GLU~? 12.03 CA CA C 208 coo 44.36 35.68 9.71 43.29 36.20 11.51 22.13 -48.50 -9.42 23.00 -46.66 -10.00 coo 41.40 28.81 12.91 40.82 30.90 12.97 16.71 -46.53 -3.05 15.59 -48.22 -3.69 coo 40.37 33.11 18.06 39.99 34.93 17.06 16.47 -41.84 -8.31 14.60 -42.35 -9.15 ULMN 3 1oyg_c00 LEVANSUCRASE user 15 3 # 15 A 86 ASP C 80 ASP^? 16.43 C13 C8E C 210 A 247 ASP C 149 ASP^? 16.02 C16 C8E C 210 A 342 GLU C 7 GLU^? 20.56 C16 C8E C 210 coo 44.36 35.68 9.71 43.29 36.20 11.51 47.10 -57.14 -28.79 45.64 -55.94 -27.77 coo 41.40 28.81 12.91 40.82 30.90 12.97 38.72 -55.19 -32.44 40.02 -55.93 -30.97 coo 40.37 33.11 18.06 39.99 34.93 17.06 43.33 -49.69 -35.12 43.56 -51.77 -34.52 ULMN 3 1oyg_c00 LEVANSUCRASE user 16 3 # 16 A 86 ASP C 111 ASP.? 17.21 CA CA C 208 A 247 ASP C 167 ASP.? 25.18 CA CA C 208 A 342 GLU C 165 GLU^? 20.98 CA CA C 208 coo 44.36 35.68 9.71 43.29 36.20 11.51 27.11 -33.17 -3.90 25.73 -31.94 -3.00 coo 41.40 28.81 12.91 40.82 30.90 12.97 31.39 -27.44 2.08 30.34 -25.78 1.31 coo 40.37 33.11 18.06 39.99 34.93 17.06 36.32 -31.59 -2.15 36.97 -31.00 -4.08 ULMN 3 1oyg_c00 LEVANSUCRASE user 17 3 # 17 A 86 ASP C 167 ASP.? 25.18 CA CA C 208 A 247 ASP C 111 ASP.? 17.21 CA CA C 208 A 342 GLU C 113 GLU.? 20.72 CA CA C 208 coo 44.36 35.68 9.71 43.29 36.20 11.51 31.39 -27.44 2.08 30.34 -25.78 1.31 coo 41.40 28.81 12.91 40.82 30.90 12.97 27.11 -33.17 -3.90 25.73 -31.94 -3.00 coo 40.37 33.11 18.06 39.99 34.93 17.06 22.93 -28.02 -2.65 24.78 -28.62 -1.78 1oyg_c00 source 1oyg LEVANSUCRASE : 17 hits 1oyg_c00 naa= 3 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 1 3 # 1 A 102 ASP A 61 ASP~? 12.37 CA CA A 208 A 167 LYS A 63 LYS~? 3.96 CA CA A 208 A 201 LYS A 67 LYS~? 13.30 CA CA A 208 coo 26.53 8.31 20.37 28.45 8.41 19.40 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo 24.92 6.08 13.38 27.75 4.33 18.83 73.63 -82.49 -34.44 73.43 -77.00 -32.37 coo 29.08 5.53 11.69 30.46 5.61 17.93 73.21 -82.07 -40.14 71.59 -78.49 -41.85 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 2 3 # 2 A 102 ASP A 111 ASP.? 17.05 CA CA A 208 A 167 LYS A 67 LYS~? 13.30 CA CA A 208 A 201 LYS A 63 LYS~? 3.96 CA CA A 208 coo 26.53 8.31 20.37 28.45 8.41 19.40 65.36 -83.80 -40.24 66.17 -85.36 -41.35 coo 24.92 6.08 13.38 27.75 4.33 18.83 73.21 -82.07 -40.14 71.59 -78.49 -41.85 coo 29.08 5.53 11.69 30.46 5.61 17.93 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 3 3 # 3 A 102 ASP B 61 ASP~? 12.48 CA CA B 208 A 167 LYS B 63 LYS~? 3.79 CA CA B 208 A 201 LYS B 67 LYS~? 18.13 CA CA B 208 coo 26.53 8.31 20.37 28.45 8.41 19.40 98.68 -27.22 -4.60 99.30 -29.23 -4.23 coo 24.92 6.08 13.38 27.75 4.33 18.83 93.18 -23.71 -7.17 90.77 -27.85 -10.83 coo 29.08 5.53 11.69 30.46 5.61 17.93 89.12 -21.41 -4.23 87.66 -21.56 1.71 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 4 3 # 4 A 102 ASP B 111 ASP.? 16.97 CA CA B 208 A 167 LYS B 67 LYS~? 18.13 CA CA B 208 A 201 LYS B 63 LYS~? 3.79 CA CA B 208 coo 26.53 8.31 20.37 28.45 8.41 19.40 89.21 -14.92 -8.80 89.40 -13.99 -6.98 coo 24.92 6.08 13.38 27.75 4.33 18.83 89.12 -21.41 -4.23 87.66 -21.56 1.71 coo 29.08 5.53 11.69 30.46 5.61 17.93 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 5 3 # 5 A 102 ASP C 111 ASP.? 17.21 CA CA C 208 A 167 LYS C 67 LYS.? 18.71 CA CA C 208 A 201 LYS C 63 LYS~? 4.21 CA CA C 208 coo 26.53 8.31 20.37 28.45 8.41 19.40 27.11 -33.17 -3.90 25.73 -31.94 -3.00 coo 24.92 6.08 13.38 27.75 4.33 18.83 20.04 -36.06 -6.98 16.11 -31.17 -7.78 coo 29.08 5.53 11.69 30.46 5.61 17.93 20.98 -41.61 -5.49 23.04 -43.67 -10.44 1p1x_c00 source 1p1x DEOXYRIBOSE-PHOSPHATE ALDOLASE : 5 hits 1p1x_c00 naa= 3 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 1 3 # 1 B1102 ASP A 61 ASP~? 12.37 CA CA A 208 B1167 LYS A 63 LYS~? 3.96 CA CA A 208 B1201 LYS A 67 LYS~? 13.30 CA CA A 208 coo 26.10 12.11 49.61 24.19 12.48 50.51 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo 27.70 11.69 56.92 24.82 8.55 52.12 73.63 -82.49 -34.44 73.43 -77.00 -32.37 coo 23.50 11.64 58.67 22.19 10.19 52.59 73.21 -82.07 -40.14 71.59 -78.49 -41.85 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 2 3 # 2 B1102 ASP A 111 ASP.? 17.05 CA CA A 208 B1167 LYS A 67 LYS~? 13.30 CA CA A 208 B1201 LYS A 63 LYS~? 3.96 CA CA A 208 coo 26.10 12.11 49.61 24.19 12.48 50.51 65.36 -83.80 -40.24 66.17 -85.36 -41.35 coo 27.70 11.69 56.92 24.82 8.55 52.12 73.21 -82.07 -40.14 71.59 -78.49 -41.85 coo 23.50 11.64 58.67 22.19 10.19 52.59 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 3 3 # 3 B1102 ASP B 61 ASP~? 12.48 CA CA B 208 B1167 LYS B 63 LYS~? 3.79 CA CA B 208 B1201 LYS B 67 LYS~? 18.13 CA CA B 208 coo 26.10 12.11 49.61 24.19 12.48 50.51 98.68 -27.22 -4.60 99.30 -29.23 -4.23 coo 27.70 11.69 56.92 24.82 8.55 52.12 93.18 -23.71 -7.17 90.77 -27.85 -10.83 coo 23.50 11.64 58.67 22.19 10.19 52.59 89.12 -21.41 -4.23 87.66 -21.56 1.71 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 4 3 # 4 B1102 ASP B 111 ASP.? 16.97 CA CA B 208 B1167 LYS B 67 LYS~? 18.13 CA CA B 208 B1201 LYS B 63 LYS~? 3.79 CA CA B 208 coo 26.10 12.11 49.61 24.19 12.48 50.51 89.21 -14.92 -8.80 89.40 -13.99 -6.98 coo 27.70 11.69 56.92 24.82 8.55 52.12 89.12 -21.41 -4.23 87.66 -21.56 1.71 coo 23.50 11.64 58.67 22.19 10.19 52.59 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 5 3 # 5 B1102 ASP C 111 ASP.? 17.21 CA CA C 208 B1167 LYS C 67 LYS.? 18.71 CA CA C 208 B1201 LYS C 63 LYS~? 4.21 CA CA C 208 coo 26.10 12.11 49.61 24.19 12.48 50.51 27.11 -33.17 -3.90 25.73 -31.94 -3.00 coo 27.70 11.69 56.92 24.82 8.55 52.12 20.04 -36.06 -6.98 16.11 -31.17 -7.78 coo 23.50 11.64 58.67 22.19 10.19 52.59 20.98 -41.61 -5.49 23.04 -43.67 -10.44 1p1x_c01 source 1p1x DEOXYRIBOSE-PHOSPHATE ALDOLASE : 5 hits 1p1x_c01 naa= 3 ULMN 3 1p7m_c00 DNA-3-METHYLADENINE GLYCOSYLASE I user 1 3 # 1 A 16 TYR C 109 TYR^? 10.73 CA CA C 208 A 38 GLU C 64 GLU~? 12.03 CA CA C 208 A 46 TRP C 59 TRP~? 6.20 CA CA C 208 coo 141.05 24.62 -1.85 142.62 22.60 -2.97 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo 142.20 14.40 -6.46 142.04 16.49 -6.62 16.47 -41.84 -8.31 14.60 -42.35 -9.15 coo 137.32 22.45 -5.52 140.17 20.39 -3.63 24.77 -46.37 -6.57 25.55 -42.98 -4.73 1p7m_c00 source 1p7m DNA-3-METHYLADENINE GLYCOSYLASE I : 1 hits 1p7m_c00 naa= 3 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 A 70 ALA B 95 ALA^? 23.65 O15 C8E B 209 A 126 LEU B 82 LEU^? 22.11 O15 C8E B 209 A 158 GLU B 25 GLU^? 27.65 O15 C8E B 209 coo -2.29 37.66 144.73 -1.46 37.12 145.87 80.64 -47.79 -41.68 79.75 -46.77 -42.37 coo -4.62 32.83 147.14 -5.50 32.85 149.12 80.08 -42.29 -43.96 79.29 -41.33 -42.23 coo -0.83 29.57 149.77 -0.39 31.47 148.95 73.50 -42.12 -45.68 71.97 -42.23 -44.24 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 A 70 ALA C 95 ALA^? 24.19 C13 C8E C 210 A 126 LEU C 82 LEU^? 22.72 C13 C8E C 210 A 158 GLU C 25 GLU.? 26.72 O21 C8E A 209 coo -2.29 37.66 144.73 -1.46 37.12 145.87 44.22 -62.46 -36.43 45.39 -61.49 -36.49 coo -4.62 32.83 147.14 -5.50 32.85 149.12 48.11 -59.72 -34.09 47.50 -57.64 -33.62 coo -0.83 29.57 149.77 -0.39 31.47 148.95 50.80 -55.81 -38.99 49.16 -55.90 -40.32 1pjh_c00 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 2 hits 1pjh_c00 naa= 3 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 B 70 ALA B 95 ALA^? 23.65 O15 C8E B 209 B 126 LEU B 82 LEU^? 22.11 O15 C8E B 209 B 158 GLU B 25 GLU^? 27.65 O15 C8E B 209 coo -39.79 4.61 147.27 -39.61 5.56 148.47 80.64 -47.79 -41.68 79.75 -46.77 -42.37 coo -34.22 5.06 149.25 -33.65 4.24 151.15 80.08 -42.29 -43.96 79.29 -41.33 -42.23 coo -33.03 9.93 151.71 -34.98 9.38 151.11 73.50 -42.12 -45.68 71.97 -42.23 -44.24 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 B 70 ALA C 95 ALA^? 24.19 C13 C8E C 210 B 126 LEU C 82 LEU^? 22.72 C13 C8E C 210 B 158 GLU C 25 GLU.? 26.72 O21 C8E A 209 coo -39.79 4.61 147.27 -39.61 5.56 148.47 44.22 -62.46 -36.43 45.39 -61.49 -36.49 coo -34.22 5.06 149.25 -33.65 4.24 151.15 48.11 -59.72 -34.09 47.50 -57.64 -33.62 coo -33.03 9.93 151.71 -34.98 9.38 151.11 50.80 -55.81 -38.99 49.16 -55.90 -40.32 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 B 70 ALA C 120 ALA^? 16.01 CA CA C 208 B 126 LEU C 116 LEU.? 16.14 CA CA C 208 B 158 GLU C 113 GLU.? 20.72 CA CA C 208 coo -39.79 4.61 147.27 -39.61 5.56 148.47 32.30 -34.87 -3.98 33.01 -34.28 -5.18 coo -34.22 5.06 149.25 -33.65 4.24 151.15 25.74 -33.77 -0.35 25.49 -35.13 -2.07 coo -33.03 9.93 151.71 -34.98 9.38 151.11 22.93 -28.02 -2.65 24.78 -28.62 -1.78 1pjh_c01 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 3 hits 1pjh_c01 naa= 3 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 C 70 ALA B 95 ALA^? 23.65 O15 C8E B 209 C 126 LEU B 82 LEU^? 22.11 O15 C8E B 209 C 158 GLU B 25 GLU^? 27.65 O15 C8E B 209 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 80.64 -47.79 -41.68 79.75 -46.77 -42.37 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 80.08 -42.29 -43.96 79.29 -41.33 -42.23 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 73.50 -42.12 -45.68 71.97 -42.23 -44.24 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 C 70 ALA C 95 ALA^? 24.19 C13 C8E C 210 C 126 LEU C 82 LEU^? 22.72 C13 C8E C 210 C 158 GLU C 25 GLU.? 26.72 O21 C8E A 209 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 44.22 -62.46 -36.43 45.39 -61.49 -36.49 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 48.11 -59.72 -34.09 47.50 -57.64 -33.62 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 50.80 -55.81 -38.99 49.16 -55.90 -40.32 1pjh_c02 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 2 hits 1pjh_c02 naa= 3 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 1 3 # 1 B 1 SER A 44 SER.? -2.67 O21 C8E A 209s B 69 ALA A 42 ALA^? 7.29 O18 C8E A 209 B 241 ASN A 74 ASN^? -3.00 O21 C8E A 209s coo 13.24 41.94 33.13 13.08 39.54 33.17 67.29 -68.39 -28.17 66.32 -69.65 -26.34 coo 9.15 37.89 36.69 10.55 37.76 37.22 64.59 -62.72 -29.30 65.26 -62.49 -27.92 coo 10.91 43.03 38.47 11.81 41.82 36.93 62.15 -65.86 -25.53 63.13 -67.52 -24.67 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 2 3 # 2 B 1 SER A 125 SER^? 8.08 O21 C8E A 210 B 69 ALA A 158 ALA.? 8.30 O15 C8E A 210 B 241 ASN A 126 ASN^? 12.66 O21 C8E A 209 coo 13.24 41.94 33.13 13.08 39.54 33.17 56.95 -73.80 -22.57 57.82 -74.32 -20.36 coo 9.15 37.89 36.69 10.55 37.76 37.22 56.38 -74.89 -16.34 55.90 -73.81 -17.22 coo 10.91 43.03 38.47 11.81 41.82 36.93 53.38 -70.73 -21.66 52.86 -71.17 -23.66 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 3 3 # 3 B 1 SER B 44 SER.? -2.63 C20 C8E B 209s B 69 ALA B 42 ALA^? 7.68 C19 C8E B 209 B 241 ASN B 74 ASN^? -3.28 C20 C8E B 209s coo 13.24 41.94 33.13 13.08 39.54 33.17 86.51 -29.99 -20.81 88.33 -29.21 -22.26 coo 9.15 37.89 36.69 10.55 37.76 37.22 81.57 -30.84 -24.70 82.39 -32.04 -25.12 coo 10.91 43.03 38.47 11.81 41.82 36.93 85.94 -28.94 -27.06 87.84 -29.20 -26.13 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 4 3 # 4 B 1 SER B 125 SER^? 8.02 O21 C8E B 210 B 69 ALA B 158 ALA.? 4.91 C2 C8E B 210 B 241 ASN B 126 ASN^? 11.28 C1 C8E B 210 coo 13.24 41.94 33.13 13.08 39.54 33.17 92.94 -22.19 -29.04 94.91 -23.58 -29.43 coo 9.15 37.89 36.69 10.55 37.76 37.22 97.94 -23.77 -32.61 96.50 -23.63 -32.93 coo 10.91 43.03 38.47 11.81 41.82 36.93 90.80 -21.61 -33.24 89.51 -20.33 -32.18 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 5 3 # 5 B 1 SER C 44 SER.? -2.60 O21 C8E C 210s B 69 ALA C 42 ALA^? 7.46 C19 C8E C 210 B 241 ASN C 74 ASN^? -3.17 C20 C8E C 210s coo 13.24 41.94 33.13 13.08 39.54 33.17 31.95 -46.42 -17.08 33.26 -47.96 -15.73 coo 9.15 37.89 36.69 10.55 37.76 37.22 35.72 -45.47 -22.06 35.55 -46.98 -22.23 coo 10.91 43.03 38.47 11.81 41.82 36.93 38.01 -47.64 -17.99 37.26 -48.68 -16.35 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 6 3 # 6 B 1 SER C 125 SER^? 7.77 O21 C8E C 209 B 69 ALA C 158 ALA.? 5.77 C3 C8E C 209 B 241 ASN C 126 ASN^? 12.17 C20 C8E C 210 coo 13.24 41.94 33.13 13.08 39.54 33.17 41.72 -48.67 -8.69 41.33 -51.09 -8.33 coo 9.15 37.89 36.69 10.55 37.76 37.22 43.81 -54.47 -6.60 44.31 -53.67 -7.75 coo 10.91 43.03 38.47 11.81 41.82 36.93 46.00 -48.72 -10.75 45.75 -46.60 -10.82 1pnl_c00 source 1pnl PENICILLIN AMIDOHYDROLASE : 6 hits 1pnl_c00 naa= 3 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 1 3 # 1 A 48 LEU B 27 LEU.? 28.69 C1 C8E B 210 A 58 ASP B 26 ASP.? 33.07 O15 C8E B 209 A 120 LYS B 84 LYS.? 25.86 O15 C8E B 209 coo 34.02 69.29 75.26 34.82 67.82 76.74 75.94 -38.69 -52.71 76.39 -37.35 -51.06 coo 34.46 72.45 78.57 32.82 72.75 77.28 71.92 -43.11 -51.36 71.95 -45.06 -50.50 coo 28.96 77.64 81.19 29.05 74.53 77.51 79.44 -47.69 -46.65 75.97 -44.45 -44.18 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 2 3 # 2 A 48 LEU B 47 LEU.? -6.00 CA CA B 208s A 58 ASP B 48 ASP.? 7.20 CA CA B 208 A 120 LYS B 188 LYS~? 9.67 C16 C8E B 210 coo 34.02 69.29 75.26 34.82 67.82 76.74 94.70 -25.22 -15.81 94.48 -23.30 -16.95 coo 34.46 72.45 78.57 32.82 72.75 77.28 97.60 -30.12 -16.68 98.20 -32.01 -15.99 coo 28.96 77.64 81.19 29.05 74.53 77.51 102.16 -28.74 -21.10 106.15 -31.37 -17.86 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 3 3 # 3 A 48 LEU B 116 LEU.? 16.00 CA CA B 208 A 58 ASP B 111 ASP.? 16.97 CA CA B 208 A 120 LYS B 63 LYS~? 3.79 CA CA B 208 coo 34.02 69.29 75.26 34.82 67.82 76.74 93.01 -14.13 -7.42 94.62 -14.92 -8.59 coo 34.46 72.45 78.57 32.82 72.75 77.28 89.21 -14.92 -8.80 89.40 -13.99 -6.98 coo 28.96 77.64 81.19 29.05 74.53 77.51 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 4 3 # 4 A 48 LEU C 27 LEU.? 18.62 O21 C8E A 209 A 58 ASP C 26 ASP.? 24.60 O21 C8E A 209 A 120 LYS C 84 LYS.? 25.24 O21 C8E A 209 coo 34.02 69.29 75.26 34.82 67.82 76.74 58.51 -57.89 -36.58 57.18 -56.75 -35.33 coo 34.46 72.45 78.57 32.82 72.75 77.28 55.55 -58.08 -41.98 53.84 -58.94 -42.96 coo 28.96 77.64 81.19 29.05 74.53 77.51 49.01 -63.83 -38.44 48.10 -58.01 -38.38 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 5 3 # 5 A 48 LEU C 47 LEU.? -6.24 CA CA C 208s A 58 ASP C 48 ASP.? 7.17 CA CA C 208 A 120 LYS C 188 LYS~? 9.02 C16 C8E C 209 coo 34.02 69.29 75.26 34.82 67.82 76.74 28.53 -46.84 -6.92 30.29 -45.63 -6.29 coo 34.46 72.45 78.57 32.82 72.75 77.28 26.68 -52.06 -7.74 25.46 -53.53 -8.54 coo 28.96 77.64 81.19 29.05 74.53 77.51 31.07 -55.82 -4.30 26.58 -58.21 -2.57 1pym_c00 source 1pym PHOSPHOENOLPYRUVATE MUTASE : 5 hits 1pym_c00 naa= 3 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 1 3 # 1 B 48 LEU B 27 LEU.? 28.69 C1 C8E B 210 B 58 ASP B 26 ASP.? 33.07 O15 C8E B 209 B 120 LYS B 84 LYS.? 25.86 O15 C8E B 209 coo 54.50 104.32 58.69 55.83 105.69 59.81 75.94 -38.69 -52.71 76.39 -37.35 -51.06 coo 57.63 101.19 59.83 56.60 100.89 57.99 71.92 -43.11 -51.36 71.95 -45.06 -50.50 coo 61.58 95.88 55.22 58.18 99.30 54.71 79.44 -47.69 -46.65 75.97 -44.45 -44.18 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 2 3 # 2 B 48 LEU B 47 LEU.? -6.00 CA CA B 208s B 58 ASP B 48 ASP.? 7.20 CA CA B 208 B 120 LYS B 188 LYS~? 9.67 C16 C8E B 210 coo 54.50 104.32 58.69 55.83 105.69 59.81 94.70 -25.22 -15.81 94.48 -23.30 -16.95 coo 57.63 101.19 59.83 56.60 100.89 57.99 97.60 -30.12 -16.68 98.20 -32.01 -15.99 coo 61.58 95.88 55.22 58.18 99.30 54.71 102.16 -28.74 -21.10 106.15 -31.37 -17.86 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 3 3 # 3 B 48 LEU B 116 LEU.? 16.00 CA CA B 208 B 58 ASP B 111 ASP.? 16.97 CA CA B 208 B 120 LYS B 63 LYS~? 3.79 CA CA B 208 coo 54.50 104.32 58.69 55.83 105.69 59.81 93.01 -14.13 -7.42 94.62 -14.92 -8.59 coo 57.63 101.19 59.83 56.60 100.89 57.99 89.21 -14.92 -8.80 89.40 -13.99 -6.98 coo 61.58 95.88 55.22 58.18 99.30 54.71 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 4 3 # 4 B 48 LEU C 27 LEU.? 18.62 O21 C8E A 209 B 58 ASP C 26 ASP.? 24.60 O21 C8E A 209 B 120 LYS C 84 LYS.? 25.24 O21 C8E A 209 coo 54.50 104.32 58.69 55.83 105.69 59.81 58.51 -57.89 -36.58 57.18 -56.75 -35.33 coo 57.63 101.19 59.83 56.60 100.89 57.99 55.55 -58.08 -41.98 53.84 -58.94 -42.96 coo 61.58 95.88 55.22 58.18 99.30 54.71 49.01 -63.83 -38.44 48.10 -58.01 -38.38 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 5 3 # 5 B 48 LEU C 47 LEU.? -6.24 CA CA C 208s B 58 ASP C 48 ASP.? 7.17 CA CA C 208 B 120 LYS C 188 LYS~? 9.02 C16 C8E C 209 coo 54.50 104.32 58.69 55.83 105.69 59.81 28.53 -46.84 -6.92 30.29 -45.63 -6.29 coo 57.63 101.19 59.83 56.60 100.89 57.99 26.68 -52.06 -7.74 25.46 -53.53 -8.54 coo 61.58 95.88 55.22 58.18 99.30 54.71 31.07 -55.82 -4.30 26.58 -58.21 -2.57 1pym_c01 source 1pym PHOSPHOENOLPYRUVATE MUTASE : 5 hits 1pym_c01 naa= 3 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 1 3 # 1 A 67 ASP A 26 ASP.? 24.86 C2 C8E C 209 A 68 ALA A 2 ALA.? 18.15 C20 C8E C 210 A 72 LEU A 27 LEU.? 17.39 C20 C8E C 210 coo 46.76 7.59 18.65 45.27 6.01 18.52 53.70 -37.11 -16.05 55.72 -36.42 -15.97 coo 48.88 4.35 16.59 48.73 5.09 15.20 49.63 -37.90 -18.66 48.30 -38.61 -18.78 coo 53.89 6.25 15.09 52.88 7.92 14.14 50.11 -41.52 -13.79 50.71 -43.29 -14.89 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 2 3 # 2 A 67 ASP A 26 ASP.? 24.86 C2 C8E C 209 A 68 ALA A 28 ALA.? 19.19 C20 C8E C 210 A 72 LEU A 27 LEU.? 17.39 C20 C8E C 210 coo 46.76 7.59 18.65 45.27 6.01 18.52 53.70 -37.11 -16.05 55.72 -36.42 -15.97 coo 48.88 4.35 16.59 48.73 5.09 15.20 49.40 -37.55 -11.60 49.27 -38.37 -10.35 coo 53.89 6.25 15.09 52.88 7.92 14.14 50.11 -41.52 -13.79 50.71 -43.29 -14.89 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 3 3 # 3 A 67 ASP A 26 ASP.? 24.86 C2 C8E C 209 A 68 ALA A 28 ALA.? 19.19 C20 C8E C 210 A 72 LEU A 31 LEU.? 19.24 C2 C8E C 209 coo 46.76 7.59 18.65 45.27 6.01 18.52 53.70 -37.11 -16.05 55.72 -36.42 -15.97 coo 48.88 4.35 16.59 48.73 5.09 15.20 49.40 -37.55 -11.60 49.27 -38.37 -10.35 coo 53.89 6.25 15.09 52.88 7.92 14.14 52.60 -39.79 -9.06 50.82 -40.32 -7.99 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 4 3 # 4 A 67 ASP A 45 ASP.? -2.96 CA CA A 208s A 68 ALA A 46 ALA.? 6.64 CA CA A 208 A 72 LEU A 47 LEU.? -6.16 CA CA A 208s coo 46.76 7.59 18.65 45.27 6.01 18.52 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo 48.88 4.35 16.59 48.73 5.09 15.20 66.69 -74.67 -27.61 65.67 -75.06 -28.70 coo 53.89 6.25 15.09 52.88 7.92 14.14 68.63 -79.08 -27.35 66.53 -79.28 -27.97 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 5 3 # 5 A 67 ASP B 26 ASP.? 33.07 O15 C8E B 209 A 68 ALA B 2 ALA.? 32.73 C1 C8E B 210 A 72 LEU B 27 LEU.? 28.69 C1 C8E B 210 coo 46.76 7.59 18.65 45.27 6.01 18.52 71.92 -43.11 -51.36 71.95 -45.06 -50.50 coo 48.88 4.35 16.59 48.73 5.09 15.20 69.72 -38.60 -51.81 70.83 -37.58 -51.87 coo 53.89 6.25 15.09 52.88 7.92 14.14 75.94 -38.69 -52.71 76.39 -37.35 -51.06 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 6 3 # 6 A 67 ASP B 45 ASP.? -3.07 CA CA B 208s A 68 ALA B 46 ALA.? 6.22 CA CA B 208 A 72 LEU B 47 LEU.? -6.00 CA CA B 208s coo 46.76 7.59 18.65 45.27 6.01 18.52 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo 48.88 4.35 16.59 48.73 5.09 15.20 91.46 -26.30 -19.06 90.82 -24.97 -18.73 coo 53.89 6.25 15.09 52.88 7.92 14.14 94.70 -25.22 -15.81 94.48 -23.30 -16.95 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 7 3 # 7 A 67 ASP C 26 ASP.? 24.60 O21 C8E A 209 A 68 ALA C 2 ALA.? 24.11 O21 C8E A 209 A 72 LEU C 27 LEU.? 18.62 O21 C8E A 209 coo 46.76 7.59 18.65 45.27 6.01 18.52 55.55 -58.08 -41.98 53.84 -58.94 -42.96 coo 48.88 4.35 16.59 48.73 5.09 15.20 58.21 -54.03 -41.91 59.51 -53.60 -41.18 coo 53.89 6.25 15.09 52.88 7.92 14.14 58.51 -57.89 -36.58 57.18 -56.75 -35.33 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 8 3 # 8 A 67 ASP C 26 ASP.? 24.60 O21 C8E A 209 A 68 ALA C 28 ALA.? 17.33 O21 C8E A 209 A 72 LEU C 27 LEU.? 18.62 O21 C8E A 209 coo 46.76 7.59 18.65 45.27 6.01 18.52 55.55 -58.08 -41.98 53.84 -58.94 -42.96 coo 48.88 4.35 16.59 48.73 5.09 15.20 60.78 -60.48 -39.80 61.54 -61.10 -38.64 coo 53.89 6.25 15.09 52.88 7.92 14.14 58.51 -57.89 -36.58 57.18 -56.75 -35.33 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 9 3 # 9 A 67 ASP C 26 ASP.? 24.60 O21 C8E A 209 A 68 ALA C 28 ALA.? 17.33 O21 C8E A 209 A 72 LEU C 31 LEU.? 15.22 O21 C8E A 209 coo 46.76 7.59 18.65 45.27 6.01 18.52 55.55 -58.08 -41.98 53.84 -58.94 -42.96 coo 48.88 4.35 16.59 48.73 5.09 15.20 60.78 -60.48 -39.80 61.54 -61.10 -38.64 coo 53.89 6.25 15.09 52.88 7.92 14.14 58.21 -64.86 -36.29 58.68 -62.71 -36.16 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 10 3 # 10 A 67 ASP C 45 ASP.? 3.27 CA CA C 208s A 68 ALA C 46 ALA.? 6.35 CA CA C 208 A 72 LEU C 47 LEU.? -6.24 CA CA C 208s coo 46.76 7.59 18.65 45.27 6.01 18.52 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo 48.88 4.35 16.59 48.73 5.09 15.20 31.22 -46.48 -10.69 31.43 -45.03 -10.31 coo 53.89 6.25 15.09 52.88 7.92 14.14 28.53 -46.84 -6.92 30.29 -45.63 -6.29 1q6l_c05 source 1q6l 3-KETO-L-GULONATE 6-PHOSPHATE DECARBOXYLASE : 10 hits 1q6l_c05 naa= 3 ULMN 3 1qaz_c00 ALGINATE LYASE A1-III user 1 3 # 1 A 191 ASN A 103 ASN^? 6.31 O21 C8E A 209 A 239 ARG A 101 ARG^? 8.92 C1 C8E A 210 A 246 TYR A 155 TYR^? 8.43 C17 C8E A 209 coo 2.50 7.27 18.06 0.76 7.28 16.81 58.51 -66.15 -21.33 59.95 -66.28 -22.87 coo -1.16 0.95 13.41 -2.50 3.71 13.61 59.10 -60.12 -16.06 60.30 -57.41 -15.78 coo 1.59 5.18 12.30 -0.74 6.52 11.61 60.87 -66.67 -17.05 60.42 -64.37 -18.53 ULMN 3 1qaz_c00 ALGINATE LYASE A1-III user 2 3 # 2 A 191 ASN C 103 ASN^? 6.32 C20 C8E C 210 A 239 ARG C 101 ARG^? 13.82 C13 C8E C 210 A 246 TYR C 155 TYR^? 7.32 C13 C8E C 210 coo 2.50 7.27 18.06 0.76 7.28 16.81 42.54 -50.86 -16.42 40.88 -49.65 -16.80 coo -1.16 0.95 13.41 -2.50 3.71 13.61 44.39 -56.56 -21.66 44.87 -57.05 -24.63 coo 1.59 5.18 12.30 -0.74 6.52 11.61 41.26 -55.52 -15.76 41.81 -54.24 -18.13 1qaz_c00 source 1qaz ALGINATE LYASE A1-III : 2 hits 1qaz_c00 naa= 3 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 1 3 # 1 A 396 ARG A 36 ARG^? 15.77 C1 C8E A 210 A 581 ARG A 200 ARG^? 11.17 C17 C8E A 209 A 713 ARG A 101 ARG^? 8.92 C1 C8E A 210 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 59.00 -50.13 -20.90 61.68 -51.06 -19.88 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 65.38 -54.68 -25.12 63.65 -56.91 -23.89 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 59.10 -60.12 -16.06 60.30 -57.41 -15.78 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 2 3 # 2 A 396 ARG B 36 ARG^? 17.08 O15 C8E B 209 A 581 ARG B 200 ARG^? 11.34 O15 C8E B 209 A 713 ARG B 101 ARG^? 13.86 O15 C8E B 209 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 77.67 -37.50 -38.51 79.47 -39.58 -37.24 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 78.82 -37.69 -29.59 80.99 -36.13 -31.14 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 87.52 -34.18 -37.50 85.80 -36.55 -38.16 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 3 3 # 3 A 396 ARG C 36 ARG^? 17.98 C16 C8E C 210 A 581 ARG C 200 ARG^? 12.04 C16 C8E C 210 A 713 ARG C 101 ARG^? 13.82 C13 C8E C 210 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 45.58 -52.92 -31.76 43.11 -54.70 -31.56 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 37.62 -50.12 -29.23 39.44 -51.00 -26.91 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 44.39 -56.56 -21.66 44.87 -57.05 -24.63 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 4 3 # 4 A 396 ARG C 200 ARG^? 12.04 C16 C8E C 210 A 581 ARG C 36 ARG^? 17.98 C16 C8E C 210 A 713 ARG C 101 ARG^? 13.82 C13 C8E C 210 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 37.62 -50.12 -29.23 39.44 -51.00 -26.91 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 45.58 -52.92 -31.76 43.11 -54.70 -31.56 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 44.39 -56.56 -21.66 44.87 -57.05 -24.63 1qb4_c01 source 1qb4 PHOSPHOENOLPYRUVATE CARBOXYLASE : 4 hits 1qb4_c01 naa= 3 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 155 HIS B 0 HIS.? 33.03 C1 C8E B 210 A 236 ASP B 80 ASP^? 15.94 O15 C8E B 209 A 261 LYS B 198 LYS^? 12.15 O15 C8E B 209 coo 55.45 46.76 42.08 57.34 46.16 42.75 70.48 -35.36 -55.71 72.36 -34.80 -54.96 coo 48.87 29.19 44.63 49.10 27.34 43.63 82.56 -37.87 -41.00 82.97 -37.16 -39.06 coo 47.58 17.35 41.83 51.40 20.85 40.83 85.01 -40.11 -29.09 83.85 -38.63 -34.53 1qgn_c00 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c00 naa= 3 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 155 HIS B 0 HIS.? 33.03 C1 C8E B 210 B 236 ASP B 80 ASP^? 15.94 O15 C8E B 209 B 261 LYS B 198 LYS^? 12.15 O15 C8E B 209 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 70.48 -35.36 -55.71 72.36 -34.80 -54.96 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 82.56 -37.87 -41.00 82.97 -37.16 -39.06 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 85.01 -40.11 -29.09 83.85 -38.63 -34.53 1qgn_c01 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c01 naa= 3 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 C 155 HIS B 0 HIS.? 33.03 C1 C8E B 210 C 236 ASP B 80 ASP^? 15.94 O15 C8E B 209 C 261 LYS B 198 LYS^? 12.15 O15 C8E B 209 coo 55.11 47.10 12.61 53.44 47.85 11.58 70.48 -35.36 -55.71 72.36 -34.80 -54.96 coo 45.78 31.11 9.51 44.25 30.06 10.53 82.56 -37.87 -41.00 82.97 -37.16 -39.06 coo 37.54 22.37 12.10 37.83 27.55 13.24 85.01 -40.11 -29.09 83.85 -38.63 -34.53 1qgn_c02 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c02 naa= 3 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 D 155 HIS B 0 HIS.? 33.03 C1 C8E B 210 D 236 ASP B 80 ASP^? 15.94 O15 C8E B 209 D 261 LYS B 198 LYS^? 12.15 O15 C8E B 209 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 70.48 -35.36 -55.71 72.36 -34.80 -54.96 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 82.56 -37.87 -41.00 82.97 -37.16 -39.06 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 85.01 -40.11 -29.09 83.85 -38.63 -34.53 1qgn_c03 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c03 naa= 3 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 155 HIS B 0 HIS.? 33.03 C1 C8E B 210 E 236 ASP B 80 ASP^? 15.94 O15 C8E B 209 E 261 LYS B 198 LYS^? 12.15 O15 C8E B 209 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 70.48 -35.36 -55.71 72.36 -34.80 -54.96 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 82.56 -37.87 -41.00 82.97 -37.16 -39.06 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 85.01 -40.11 -29.09 83.85 -38.63 -34.53 1qgn_c04 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c04 naa= 3 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 155 HIS B 0 HIS.? 33.03 C1 C8E B 210 F 236 ASP B 80 ASP^? 15.94 O15 C8E B 209 F 261 LYS B 198 LYS^? 12.15 O15 C8E B 209 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 70.48 -35.36 -55.71 72.36 -34.80 -54.96 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 82.56 -37.87 -41.00 82.97 -37.16 -39.06 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 85.01 -40.11 -29.09 83.85 -38.63 -34.53 1qgn_c05 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c05 naa= 3 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 G 155 HIS B 0 HIS.? 33.03 C1 C8E B 210 G 236 ASP B 80 ASP^? 15.94 O15 C8E B 209 G 261 LYS B 198 LYS^? 12.15 O15 C8E B 209 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 70.48 -35.36 -55.71 72.36 -34.80 -54.96 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 82.56 -37.87 -41.00 82.97 -37.16 -39.06 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 85.01 -40.11 -29.09 83.85 -38.63 -34.53 1qgn_c06 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c06 naa= 3 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 H 155 HIS B 0 HIS.? 33.03 C1 C8E B 210 H 236 ASP B 80 ASP^? 15.94 O15 C8E B 209 H 261 LYS B 198 LYS^? 12.15 O15 C8E B 209 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 70.48 -35.36 -55.71 72.36 -34.80 -54.96 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 82.56 -37.87 -41.00 82.97 -37.16 -39.06 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 85.01 -40.11 -29.09 83.85 -38.63 -34.53 1qgn_c07 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c07 naa= 3 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 110 ARG A 101 ARG^? 8.92 C1 C8E A 210 C 163 TYR A 13 TYR^? 6.88 C17 C8E A 209 C 236 ASP A 149 ASP^? 14.85 C1 C8E A 210 coo 39.01 29.77 22.02 37.48 31.30 19.84 59.10 -60.12 -16.06 60.30 -57.41 -15.78 coo 39.51 34.34 13.63 37.63 32.61 14.79 65.07 -60.93 -23.01 63.35 -61.54 -20.90 coo 45.78 31.11 9.51 44.25 30.06 10.53 66.40 -51.17 -20.74 65.06 -51.90 -19.38 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 110 ARG A 101 ARG^? 8.92 C1 C8E A 210 C 163 TYR A 97 TYR^? 11.99 C1 C8E A 210 C 236 ASP A 149 ASP^? 14.85 C1 C8E A 210 coo 39.01 29.77 22.02 37.48 31.30 19.84 59.10 -60.12 -16.06 60.30 -57.41 -15.78 coo 39.51 34.34 13.63 37.63 32.61 14.79 61.97 -51.46 -14.47 63.57 -52.89 -16.21 coo 45.78 31.11 9.51 44.25 30.06 10.53 66.40 -51.17 -20.74 65.06 -51.90 -19.38 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 110 ARG A 162 ARG^? 10.87 O21 C8E A 210 C 163 TYR A 109 TYR^? 10.85 CA CA A 208 C 236 ASP A 111 ASP.? 17.05 CA CA A 208 coo 39.01 29.77 22.02 37.48 31.30 19.84 60.16 -83.54 -27.36 63.31 -83.18 -27.03 coo 39.51 34.34 13.63 37.63 32.61 14.79 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo 45.78 31.11 9.51 44.25 30.06 10.53 65.36 -83.80 -40.24 66.17 -85.36 -41.35 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 110 ARG B 162 ARG^? 16.35 O21 C8E B 210 C 163 TYR B 109 TYR^? 10.54 CA CA B 208 C 236 ASP B 49 ASP.? -3.05 CA CA B 208s coo 39.01 29.77 22.02 37.48 31.30 19.84 96.21 -15.01 -19.71 98.63 -13.28 -19.03 coo 39.51 34.34 13.63 37.63 32.61 14.79 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo 45.78 31.11 9.51 44.25 30.06 10.53 94.52 -28.97 -11.62 93.03 -30.41 -11.73 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 A 110 ARG B 162 ARG^? 16.35 O21 C8E B 210 C 163 TYR B 109 TYR^? 10.54 CA CA B 208 C 236 ASP B 111 ASP.? 16.97 CA CA B 208 coo 39.01 29.77 22.02 37.48 31.30 19.84 96.21 -15.01 -19.71 98.63 -13.28 -19.03 coo 39.51 34.34 13.63 37.63 32.61 14.79 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo 45.78 31.11 9.51 44.25 30.06 10.53 89.21 -14.92 -8.80 89.40 -13.99 -6.98 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 A 110 ARG C 101 ARG^? 13.82 C13 C8E C 210 C 163 TYR C 102 TYR^? 9.73 C2 C8E C 209 C 236 ASP A 80 ASP^? 12.60 C1 C8E A 210 coo 39.01 29.77 22.02 37.48 31.30 19.84 44.39 -56.56 -21.66 44.87 -57.05 -24.63 coo 39.51 34.34 13.63 37.63 32.61 14.79 48.50 -51.08 -15.65 48.91 -50.66 -12.96 coo 45.78 31.11 9.51 44.25 30.06 10.53 58.12 -52.30 -15.93 59.10 -53.68 -17.13 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 A 110 ARG C 162 ARG^? 16.00 O21 C8E C 209 C 163 TYR C 109 TYR^? 10.73 CA CA C 208 C 236 ASP C 111 ASP.? 17.21 CA CA C 208 coo 39.01 29.77 22.02 37.48 31.30 19.84 35.66 -43.15 0.12 35.66 -43.03 3.18 coo 39.51 34.34 13.63 37.63 32.61 14.79 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo 45.78 31.11 9.51 44.25 30.06 10.53 27.11 -33.17 -3.90 25.73 -31.94 -3.00 1qgn_c16 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 7 hits 1qgn_c16 naa= 3 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 110 ARG A 101 ARG^? 8.92 C1 C8E A 210 D 163 TYR A 13 TYR^? 6.88 C17 C8E A 209 D 236 ASP A 149 ASP^? 14.85 C1 C8E A 210 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 59.10 -60.12 -16.06 60.30 -57.41 -15.78 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 65.07 -60.93 -23.01 63.35 -61.54 -20.90 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 66.40 -51.17 -20.74 65.06 -51.90 -19.38 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 110 ARG A 101 ARG^? 8.92 C1 C8E A 210 D 163 TYR A 97 TYR^? 11.99 C1 C8E A 210 D 236 ASP A 149 ASP^? 14.85 C1 C8E A 210 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 59.10 -60.12 -16.06 60.30 -57.41 -15.78 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 61.97 -51.46 -14.47 63.57 -52.89 -16.21 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 66.40 -51.17 -20.74 65.06 -51.90 -19.38 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 110 ARG A 162 ARG^? 10.87 O21 C8E A 210 D 163 TYR A 109 TYR^? 10.85 CA CA A 208 D 236 ASP A 111 ASP.? 17.05 CA CA A 208 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 60.16 -83.54 -27.36 63.31 -83.18 -27.03 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 65.36 -83.80 -40.24 66.17 -85.36 -41.35 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 110 ARG B 162 ARG^? 16.35 O21 C8E B 210 D 163 TYR B 109 TYR^? 10.54 CA CA B 208 D 236 ASP B 49 ASP.? -3.05 CA CA B 208s coo 23.05 -7.35 32.81 21.30 -7.38 35.33 96.21 -15.01 -19.71 98.63 -13.28 -19.03 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 94.52 -28.97 -11.62 93.03 -30.41 -11.73 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 110 ARG B 162 ARG^? 16.35 O21 C8E B 210 D 163 TYR B 109 TYR^? 10.54 CA CA B 208 D 236 ASP B 111 ASP.? 16.97 CA CA B 208 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 96.21 -15.01 -19.71 98.63 -13.28 -19.03 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 89.21 -14.92 -8.80 89.40 -13.99 -6.98 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 B 110 ARG C 101 ARG^? 13.82 C13 C8E C 210 D 163 TYR C 102 TYR^? 9.73 C2 C8E C 209 D 236 ASP A 80 ASP^? 12.60 C1 C8E A 210 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 44.39 -56.56 -21.66 44.87 -57.05 -24.63 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 48.50 -51.08 -15.65 48.91 -50.66 -12.96 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 58.12 -52.30 -15.93 59.10 -53.68 -17.13 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 B 110 ARG C 162 ARG^? 16.00 O21 C8E C 209 D 163 TYR C 109 TYR^? 10.73 CA CA C 208 D 236 ASP C 111 ASP.? 17.21 CA CA C 208 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 35.66 -43.15 0.12 35.66 -43.03 3.18 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 27.11 -33.17 -3.90 25.73 -31.94 -3.00 1qgn_c17 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 7 hits 1qgn_c17 naa= 3 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 163 TYR A 13 TYR^? 6.88 C17 C8E A 209 A 236 ASP A 149 ASP^? 14.85 C1 C8E A 210 C 110 ARG A 101 ARG^? 8.92 C1 C8E A 210 coo 55.48 26.51 40.65 55.39 23.99 39.43 65.07 -60.93 -23.01 63.35 -61.54 -20.90 coo 48.87 29.19 44.63 49.10 27.34 43.63 66.40 -51.17 -20.74 65.06 -51.90 -19.38 coo 52.39 23.42 32.10 54.51 23.27 34.29 59.10 -60.12 -16.06 60.30 -57.41 -15.78 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 163 TYR A 97 TYR^? 11.99 C1 C8E A 210 A 236 ASP A 149 ASP^? 14.85 C1 C8E A 210 C 110 ARG A 101 ARG^? 8.92 C1 C8E A 210 coo 55.48 26.51 40.65 55.39 23.99 39.43 61.97 -51.46 -14.47 63.57 -52.89 -16.21 coo 48.87 29.19 44.63 49.10 27.34 43.63 66.40 -51.17 -20.74 65.06 -51.90 -19.38 coo 52.39 23.42 32.10 54.51 23.27 34.29 59.10 -60.12 -16.06 60.30 -57.41 -15.78 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 163 TYR A 109 TYR^? 10.85 CA CA A 208 A 236 ASP A 111 ASP.? 17.05 CA CA A 208 C 110 ARG A 162 ARG^? 10.87 O21 C8E A 210 coo 55.48 26.51 40.65 55.39 23.99 39.43 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo 48.87 29.19 44.63 49.10 27.34 43.63 65.36 -83.80 -40.24 66.17 -85.36 -41.35 coo 52.39 23.42 32.10 54.51 23.27 34.29 60.16 -83.54 -27.36 63.31 -83.18 -27.03 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 163 TYR B 13 TYR^? 6.78 O15 C8E B 209 A 236 ASP B 149 ASP^? 14.91 O15 C8E B 209 C 110 ARG B 101 ARG^? 13.86 O15 C8E B 209 coo 55.48 26.51 40.65 55.39 23.99 39.43 84.65 -34.92 -28.70 86.28 -34.17 -30.84 coo 48.87 29.19 44.63 49.10 27.34 43.63 79.48 -42.39 -33.32 81.04 -41.48 -34.38 coo 52.39 23.42 32.10 54.51 23.27 34.29 87.52 -34.18 -37.50 85.80 -36.55 -38.16 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 A 163 TYR B 97 TYR^? 16.46 O15 C8E B 209 A 236 ASP B 149 ASP^? 14.91 O15 C8E B 209 C 110 ARG B 101 ARG^? 13.86 O15 C8E B 209 coo 55.48 26.51 40.65 55.39 23.99 39.43 83.74 -41.85 -39.80 83.62 -41.42 -37.05 coo 48.87 29.19 44.63 49.10 27.34 43.63 79.48 -42.39 -33.32 81.04 -41.48 -34.38 coo 52.39 23.42 32.10 54.51 23.27 34.29 87.52 -34.18 -37.50 85.80 -36.55 -38.16 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 A 163 TYR B 109 TYR^? 10.54 CA CA B 208 A 236 ASP B 111 ASP.? 16.97 CA CA B 208 C 110 ARG B 162 ARG^? 16.35 O21 C8E B 210 coo 55.48 26.51 40.65 55.39 23.99 39.43 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo 48.87 29.19 44.63 49.10 27.34 43.63 89.21 -14.92 -8.80 89.40 -13.99 -6.98 coo 52.39 23.42 32.10 54.51 23.27 34.29 96.21 -15.01 -19.71 98.63 -13.28 -19.03 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 A 163 TYR C 13 TYR^? 7.82 C16 C8E C 210 A 236 ASP C 149 ASP^? 16.02 C16 C8E C 210 C 110 ARG C 101 ARG^? 13.82 C13 C8E C 210 coo 55.48 26.51 40.65 55.39 23.99 39.43 37.24 -51.70 -23.13 39.21 -53.16 -21.84 coo 48.87 29.19 44.63 49.10 27.34 43.63 38.72 -55.19 -32.44 40.02 -55.93 -30.97 coo 52.39 23.42 32.10 54.51 23.27 34.29 44.39 -56.56 -21.66 44.87 -57.05 -24.63 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 A 163 TYR C 97 TYR^? 17.03 C13 C8E C 210 A 236 ASP C 149 ASP^? 16.02 C16 C8E C 210 C 110 ARG C 101 ARG^? 13.82 C13 C8E C 210 coo 55.48 26.51 40.65 55.39 23.99 39.43 44.42 -59.94 -30.24 42.23 -58.45 -29.40 coo 48.87 29.19 44.63 49.10 27.34 43.63 38.72 -55.19 -32.44 40.02 -55.93 -30.97 coo 52.39 23.42 32.10 54.51 23.27 34.29 44.39 -56.56 -21.66 44.87 -57.05 -24.63 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 A 163 TYR C 102 TYR^? 9.73 C2 C8E C 209 A 236 ASP A 80 ASP^? 12.60 C1 C8E A 210 C 110 ARG C 101 ARG^? 13.82 C13 C8E C 210 coo 55.48 26.51 40.65 55.39 23.99 39.43 48.50 -51.08 -15.65 48.91 -50.66 -12.96 coo 48.87 29.19 44.63 49.10 27.34 43.63 58.12 -52.30 -15.93 59.10 -53.68 -17.13 coo 52.39 23.42 32.10 54.51 23.27 34.29 44.39 -56.56 -21.66 44.87 -57.05 -24.63 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 A 163 TYR C 109 TYR^? 10.73 CA CA C 208 A 236 ASP C 111 ASP.? 17.21 CA CA C 208 C 110 ARG C 162 ARG^? 16.00 O21 C8E C 209 coo 55.48 26.51 40.65 55.39 23.99 39.43 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo 48.87 29.19 44.63 49.10 27.34 43.63 27.11 -33.17 -3.90 25.73 -31.94 -3.00 coo 52.39 23.42 32.10 54.51 23.27 34.29 35.66 -43.15 0.12 35.66 -43.03 3.18 1qgn_c18 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 10 hits 1qgn_c18 naa= 3 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 163 TYR A 97 TYR^? 11.99 C1 C8E A 210 B 236 ASP A 149 ASP^? 14.85 C1 C8E A 210 D 110 ARG A 101 ARG^? 8.92 C1 C8E A 210 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 61.97 -51.46 -14.47 63.57 -52.89 -16.21 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 66.40 -51.17 -20.74 65.06 -51.90 -19.38 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 59.10 -60.12 -16.06 60.30 -57.41 -15.78 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 163 TYR A 109 TYR^? 10.85 CA CA A 208 B 236 ASP A 111 ASP.? 17.05 CA CA A 208 D 110 ARG A 162 ARG^? 10.87 O21 C8E A 210 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 65.36 -83.80 -40.24 66.17 -85.36 -41.35 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 60.16 -83.54 -27.36 63.31 -83.18 -27.03 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 163 TYR B 109 TYR^? 10.54 CA CA B 208 B 236 ASP B 49 ASP.? -3.05 CA CA B 208s D 110 ARG B 162 ARG^? 16.35 O21 C8E B 210 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 94.52 -28.97 -11.62 93.03 -30.41 -11.73 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 96.21 -15.01 -19.71 98.63 -13.28 -19.03 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 163 TYR B 109 TYR^? 10.54 CA CA B 208 B 236 ASP B 111 ASP.? 16.97 CA CA B 208 D 110 ARG B 162 ARG^? 16.35 O21 C8E B 210 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 89.21 -14.92 -8.80 89.40 -13.99 -6.98 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 96.21 -15.01 -19.71 98.63 -13.28 -19.03 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 163 TYR C 102 TYR^? 9.73 C2 C8E C 209 B 236 ASP A 80 ASP^? 12.60 C1 C8E A 210 D 110 ARG C 101 ARG^? 13.82 C13 C8E C 210 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 48.50 -51.08 -15.65 48.91 -50.66 -12.96 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 58.12 -52.30 -15.93 59.10 -53.68 -17.13 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 44.39 -56.56 -21.66 44.87 -57.05 -24.63 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 B 163 TYR C 109 TYR^? 10.73 CA CA C 208 B 236 ASP C 111 ASP.? 17.21 CA CA C 208 D 110 ARG C 162 ARG^? 16.00 O21 C8E C 209 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 27.11 -33.17 -3.90 25.73 -31.94 -3.00 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 35.66 -43.15 0.12 35.66 -43.03 3.18 1qgn_c19 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 6 hits 1qgn_c19 naa= 3 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 110 ARG A 101 ARG^? 8.92 C1 C8E A 210 G 163 TYR A 13 TYR^? 6.88 C17 C8E A 209 G 236 ASP A 149 ASP^? 14.85 C1 C8E A 210 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 59.10 -60.12 -16.06 60.30 -57.41 -15.78 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 65.07 -60.93 -23.01 63.35 -61.54 -20.90 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 66.40 -51.17 -20.74 65.06 -51.90 -19.38 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 110 ARG A 101 ARG^? 8.92 C1 C8E A 210 G 163 TYR A 97 TYR^? 11.99 C1 C8E A 210 G 236 ASP A 149 ASP^? 14.85 C1 C8E A 210 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 59.10 -60.12 -16.06 60.30 -57.41 -15.78 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 61.97 -51.46 -14.47 63.57 -52.89 -16.21 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 66.40 -51.17 -20.74 65.06 -51.90 -19.38 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 E 110 ARG A 162 ARG^? 10.87 O21 C8E A 210 G 163 TYR A 109 TYR^? 10.85 CA CA A 208 G 236 ASP A 111 ASP.? 17.05 CA CA A 208 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 60.16 -83.54 -27.36 63.31 -83.18 -27.03 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 65.36 -83.80 -40.24 66.17 -85.36 -41.35 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 E 110 ARG B 162 ARG^? 16.35 O21 C8E B 210 G 163 TYR B 109 TYR^? 10.54 CA CA B 208 G 236 ASP B 49 ASP.? -3.05 CA CA B 208s coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 96.21 -15.01 -19.71 98.63 -13.28 -19.03 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 94.52 -28.97 -11.62 93.03 -30.41 -11.73 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 E 110 ARG B 162 ARG^? 16.35 O21 C8E B 210 G 163 TYR B 109 TYR^? 10.54 CA CA B 208 G 236 ASP B 111 ASP.? 16.97 CA CA B 208 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 96.21 -15.01 -19.71 98.63 -13.28 -19.03 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 89.21 -14.92 -8.80 89.40 -13.99 -6.98 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 E 110 ARG C 101 ARG^? 13.82 C13 C8E C 210 G 163 TYR C 102 TYR^? 9.73 C2 C8E C 209 G 236 ASP A 80 ASP^? 12.60 C1 C8E A 210 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 44.39 -56.56 -21.66 44.87 -57.05 -24.63 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 48.50 -51.08 -15.65 48.91 -50.66 -12.96 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 58.12 -52.30 -15.93 59.10 -53.68 -17.13 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 E 110 ARG C 162 ARG^? 16.00 O21 C8E C 209 G 163 TYR C 109 TYR^? 10.73 CA CA C 208 G 236 ASP C 111 ASP.? 17.21 CA CA C 208 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 35.66 -43.15 0.12 35.66 -43.03 3.18 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 27.11 -33.17 -3.90 25.73 -31.94 -3.00 1qgn_c20 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 7 hits 1qgn_c20 naa= 3 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 110 ARG A 101 ARG^? 8.92 C1 C8E A 210 H 163 TYR A 97 TYR^? 11.99 C1 C8E A 210 H 236 ASP A 149 ASP^? 14.85 C1 C8E A 210 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 59.10 -60.12 -16.06 60.30 -57.41 -15.78 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 61.97 -51.46 -14.47 63.57 -52.89 -16.21 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 66.40 -51.17 -20.74 65.06 -51.90 -19.38 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 110 ARG A 162 ARG^? 10.87 O21 C8E A 210 H 163 TYR A 109 TYR^? 10.85 CA CA A 208 H 236 ASP A 111 ASP.? 17.05 CA CA A 208 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 60.16 -83.54 -27.36 63.31 -83.18 -27.03 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 65.36 -83.80 -40.24 66.17 -85.36 -41.35 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 F 110 ARG B 162 ARG^? 16.35 O21 C8E B 210 H 163 TYR B 109 TYR^? 10.54 CA CA B 208 H 236 ASP B 49 ASP.? -3.05 CA CA B 208s coo 24.62 8.71 -44.89 24.77 10.53 -42.42 96.21 -15.01 -19.71 98.63 -13.28 -19.03 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 94.52 -28.97 -11.62 93.03 -30.41 -11.73 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 F 110 ARG B 162 ARG^? 16.35 O21 C8E B 210 H 163 TYR B 109 TYR^? 10.54 CA CA B 208 H 236 ASP B 111 ASP.? 16.97 CA CA B 208 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 96.21 -15.01 -19.71 98.63 -13.28 -19.03 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 89.21 -14.92 -8.80 89.40 -13.99 -6.98 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 F 110 ARG C 101 ARG^? 13.82 C13 C8E C 210 H 163 TYR C 102 TYR^? 9.73 C2 C8E C 209 H 236 ASP A 80 ASP^? 12.60 C1 C8E A 210 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 44.39 -56.56 -21.66 44.87 -57.05 -24.63 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 48.50 -51.08 -15.65 48.91 -50.66 -12.96 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 58.12 -52.30 -15.93 59.10 -53.68 -17.13 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 F 110 ARG C 162 ARG^? 16.00 O21 C8E C 209 H 163 TYR C 109 TYR^? 10.73 CA CA C 208 H 236 ASP C 111 ASP.? 17.21 CA CA C 208 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 35.66 -43.15 0.12 35.66 -43.03 3.18 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 27.11 -33.17 -3.90 25.73 -31.94 -3.00 1qgn_c21 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 6 hits 1qgn_c21 naa= 3 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 163 TYR A 97 TYR^? 11.99 C1 C8E A 210 E 236 ASP A 149 ASP^? 14.85 C1 C8E A 210 G 110 ARG A 101 ARG^? 8.92 C1 C8E A 210 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 61.97 -51.46 -14.47 63.57 -52.89 -16.21 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 66.40 -51.17 -20.74 65.06 -51.90 -19.38 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 59.10 -60.12 -16.06 60.30 -57.41 -15.78 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 163 TYR A 109 TYR^? 10.85 CA CA A 208 E 236 ASP A 111 ASP.? 17.05 CA CA A 208 G 110 ARG A 162 ARG^? 10.87 O21 C8E A 210 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 65.36 -83.80 -40.24 66.17 -85.36 -41.35 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 60.16 -83.54 -27.36 63.31 -83.18 -27.03 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 E 163 TYR B 97 TYR^? 16.46 O15 C8E B 209 E 236 ASP B 149 ASP^? 14.91 O15 C8E B 209 G 110 ARG B 101 ARG^? 13.86 O15 C8E B 209 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 83.74 -41.85 -39.80 83.62 -41.42 -37.05 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 79.48 -42.39 -33.32 81.04 -41.48 -34.38 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 87.52 -34.18 -37.50 85.80 -36.55 -38.16 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 E 163 TYR B 109 TYR^? 10.54 CA CA B 208 E 236 ASP B 111 ASP.? 16.97 CA CA B 208 G 110 ARG B 162 ARG^? 16.35 O21 C8E B 210 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 89.21 -14.92 -8.80 89.40 -13.99 -6.98 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 96.21 -15.01 -19.71 98.63 -13.28 -19.03 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 E 163 TYR C 13 TYR^? 7.82 C16 C8E C 210 E 236 ASP C 149 ASP^? 16.02 C16 C8E C 210 G 110 ARG C 101 ARG^? 13.82 C13 C8E C 210 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 37.24 -51.70 -23.13 39.21 -53.16 -21.84 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 38.72 -55.19 -32.44 40.02 -55.93 -30.97 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 44.39 -56.56 -21.66 44.87 -57.05 -24.63 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 E 163 TYR C 97 TYR^? 17.03 C13 C8E C 210 E 236 ASP C 149 ASP^? 16.02 C16 C8E C 210 G 110 ARG C 101 ARG^? 13.82 C13 C8E C 210 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 44.42 -59.94 -30.24 42.23 -58.45 -29.40 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 38.72 -55.19 -32.44 40.02 -55.93 -30.97 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 44.39 -56.56 -21.66 44.87 -57.05 -24.63 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 E 163 TYR C 102 TYR^? 9.73 C2 C8E C 209 E 236 ASP A 80 ASP^? 12.60 C1 C8E A 210 G 110 ARG C 101 ARG^? 13.82 C13 C8E C 210 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 48.50 -51.08 -15.65 48.91 -50.66 -12.96 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 58.12 -52.30 -15.93 59.10 -53.68 -17.13 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 44.39 -56.56 -21.66 44.87 -57.05 -24.63 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 E 163 TYR C 109 TYR^? 10.73 CA CA C 208 E 236 ASP C 111 ASP.? 17.21 CA CA C 208 G 110 ARG C 162 ARG^? 16.00 O21 C8E C 209 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 27.11 -33.17 -3.90 25.73 -31.94 -3.00 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 35.66 -43.15 0.12 35.66 -43.03 3.18 1qgn_c22 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 8 hits 1qgn_c22 naa= 3 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 163 TYR A 13 TYR^? 6.88 C17 C8E A 209 F 236 ASP A 149 ASP^? 14.85 C1 C8E A 210 H 110 ARG A 101 ARG^? 8.92 C1 C8E A 210 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 65.07 -60.93 -23.01 63.35 -61.54 -20.90 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 66.40 -51.17 -20.74 65.06 -51.90 -19.38 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 59.10 -60.12 -16.06 60.30 -57.41 -15.78 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 163 TYR A 97 TYR^? 11.99 C1 C8E A 210 F 236 ASP A 149 ASP^? 14.85 C1 C8E A 210 H 110 ARG A 101 ARG^? 8.92 C1 C8E A 210 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 61.97 -51.46 -14.47 63.57 -52.89 -16.21 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 66.40 -51.17 -20.74 65.06 -51.90 -19.38 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 59.10 -60.12 -16.06 60.30 -57.41 -15.78 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 F 163 TYR A 109 TYR^? 10.85 CA CA A 208 F 236 ASP A 111 ASP.? 17.05 CA CA A 208 H 110 ARG A 162 ARG^? 10.87 O21 C8E A 210 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 65.36 -83.80 -40.24 66.17 -85.36 -41.35 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 60.16 -83.54 -27.36 63.31 -83.18 -27.03 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 F 163 TYR B 109 TYR^? 10.54 CA CA B 208 F 236 ASP B 49 ASP.? -3.05 CA CA B 208s H 110 ARG B 162 ARG^? 16.35 O21 C8E B 210 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 94.52 -28.97 -11.62 93.03 -30.41 -11.73 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 96.21 -15.01 -19.71 98.63 -13.28 -19.03 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 F 163 TYR B 109 TYR^? 10.54 CA CA B 208 F 236 ASP B 111 ASP.? 16.97 CA CA B 208 H 110 ARG B 162 ARG^? 16.35 O21 C8E B 210 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 89.21 -14.92 -8.80 89.40 -13.99 -6.98 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 96.21 -15.01 -19.71 98.63 -13.28 -19.03 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 F 163 TYR C 102 TYR^? 9.73 C2 C8E C 209 F 236 ASP A 80 ASP^? 12.60 C1 C8E A 210 H 110 ARG C 101 ARG^? 13.82 C13 C8E C 210 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 48.50 -51.08 -15.65 48.91 -50.66 -12.96 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 58.12 -52.30 -15.93 59.10 -53.68 -17.13 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 44.39 -56.56 -21.66 44.87 -57.05 -24.63 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 F 163 TYR C 109 TYR^? 10.73 CA CA C 208 F 236 ASP C 111 ASP.? 17.21 CA CA C 208 H 110 ARG C 162 ARG^? 16.00 O21 C8E C 209 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 27.11 -33.17 -3.90 25.73 -31.94 -3.00 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 35.66 -43.15 0.12 35.66 -43.03 3.18 1qgn_c23 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 7 hits 1qgn_c23 naa= 3 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 1 3 # 1 A 49 ASP A 167 ASP.? 22.50 CA CA A 208 A 147 THR A 117 THR.? 21.33 CA CA A 208 A 294 ASP A 114 ASP.? 22.11 CA CA A 208 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 58.25 -87.45 -44.58 60.23 -87.13 -43.88 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 63.40 -90.39 -40.90 61.71 -90.63 -39.48 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 71.50 -87.46 -45.26 70.62 -89.18 -46.15 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 2 3 # 2 A 49 ASP C 167 ASP.? 25.18 CA CA C 208 A 147 THR C 117 THR.? 21.70 CA CA C 208 A 294 ASP C 114 ASP.? 22.22 CA CA C 208 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 31.39 -27.44 2.08 30.34 -25.78 1.31 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 27.55 -31.30 3.26 28.51 -32.70 4.67 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 19.39 -30.14 -1.59 19.46 -28.98 0.18 1qgx_c02 source 1qgx 3',5'-ADENOSINE BISPHOSPHATASE : 2 hits 1qgx_c02 naa= 3 ULMN 3 1qho_c04 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 185 ASP~? 11.73 O21 C8E A 210 A 256 GLU A 184 GLU~? 7.72 C16 C8E A 210 A 329 ASP A 180 ASP.? 14.47 O15 C8E A 210 coo 28.46 69.88 26.74 30.40 70.70 26.53 65.81 -86.27 -18.22 66.54 -87.64 -16.78 coo 30.54 71.65 32.58 31.73 72.26 30.92 63.73 -84.37 -12.45 63.45 -82.45 -11.70 coo 37.87 70.12 31.80 36.61 69.74 30.15 55.45 -86.10 -15.44 53.65 -85.04 -15.38 ULMN 3 1qho_c04 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP B 111 ASP.? 16.97 CA CA B 208 A 256 GLU B 113 GLU.? 20.51 CA CA B 208 A 329 ASP B 167 ASP.? 22.72 CA CA B 208 coo 28.46 69.88 26.74 30.40 70.70 26.53 89.21 -14.92 -8.80 89.40 -13.99 -6.98 coo 30.54 71.65 32.58 31.73 72.26 30.92 86.78 -12.34 -3.10 88.60 -11.66 -4.00 coo 37.87 70.12 31.80 36.61 69.74 30.15 88.92 -5.85 -9.56 88.92 -7.42 -8.19 ULMN 3 1qho_c04 ALPHA-AMYLASE user 3 3 # 3 A 228 ASP B 185 ASP~? 11.63 O21 C8E B 210 A 256 GLU B 184 GLU~? 8.45 C14 C8E B 210 A 329 ASP B 180 ASP.? 10.93 C4 C8E B 210 coo 28.46 69.88 26.74 30.40 70.70 26.53 106.30 -23.80 -20.43 108.26 -24.54 -20.08 coo 30.54 71.65 32.58 31.73 72.26 30.92 107.80 -26.84 -26.43 109.06 -28.52 -26.54 coo 37.87 70.12 31.80 36.61 69.74 30.15 106.50 -18.19 -29.27 105.54 -17.21 -30.85 ULMN 3 1qho_c04 ALPHA-AMYLASE user 4 3 # 4 A 228 ASP C 185 ASP~? 11.81 O21 C8E C 209 A 256 GLU C 184 GLU~? 7.93 C14 C8E C 209 A 329 ASP C 180 ASP.? 12.29 C5 C8E C 209 coo 28.46 69.88 26.74 30.40 70.70 26.53 31.89 -54.53 1.93 31.11 -55.91 3.29 coo 30.54 71.65 32.58 31.73 72.26 30.92 35.72 -59.91 1.24 36.69 -61.13 -0.21 coo 37.87 70.12 31.80 36.61 69.74 30.15 42.24 -54.49 3.97 44.24 -53.90 3.82 1qho_c04 source 1qho ALPHA-AMYLASE : 4 hits 1qho_c04 naa= 3 ULMN 3 1qho_c05 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 48 ASP.? 7.38 CA CA A 208 A 261 ASP A 111 ASP.? 17.05 CA CA A 208 A 329 ASP A 61 ASP~? 12.37 CA CA A 208 coo 28.46 69.88 26.74 30.40 70.70 26.53 72.05 -78.20 -23.17 73.82 -77.79 -22.11 coo 34.02 79.89 42.60 34.73 78.01 41.86 65.36 -83.80 -40.24 66.17 -85.36 -41.35 coo 37.87 70.12 31.80 36.61 69.74 30.15 78.34 -85.42 -30.67 80.16 -84.92 -29.71 ULMN 3 1qho_c05 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP A 149 ASP^? 14.85 C1 C8E A 210 A 261 ASP A 26 ASP.? 24.86 C2 C8E C 209 A 329 ASP A 80 ASP^? 12.60 C1 C8E A 210 coo 28.46 69.88 26.74 30.40 70.70 26.53 66.40 -51.17 -20.74 65.06 -51.90 -19.38 coo 34.02 79.89 42.60 34.73 78.01 41.86 53.70 -37.11 -16.05 55.72 -36.42 -15.97 coo 37.87 70.12 31.80 36.61 69.74 30.15 58.12 -52.30 -15.93 59.10 -53.68 -17.13 ULMN 3 1qho_c05 ALPHA-AMYLASE user 3 3 # 3 A 228 ASP A 185 ASP~? 11.73 O21 C8E A 210 A 261 ASP A 45 ASP.? -2.96 CA CA A 208s A 329 ASP A 52 ASP.? 15.11 CA CA A 208 coo 28.46 69.88 26.74 30.40 70.70 26.53 65.81 -86.27 -18.22 66.54 -87.64 -16.78 coo 34.02 79.89 42.60 34.73 78.01 41.86 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo 37.87 70.12 31.80 36.61 69.74 30.15 76.18 -86.89 -22.52 75.57 -87.62 -20.65 ULMN 3 1qho_c05 ALPHA-AMYLASE user 4 3 # 4 A 228 ASP B 48 ASP.? 7.20 CA CA B 208 A 261 ASP B 111 ASP.? 16.97 CA CA B 208 A 329 ASP B 61 ASP~? 12.48 CA CA B 208 coo 28.46 69.88 26.74 30.40 70.70 26.53 97.60 -30.12 -16.68 98.20 -32.01 -15.99 coo 34.02 79.89 42.60 34.73 78.01 41.86 89.21 -14.92 -8.80 89.40 -13.99 -6.98 coo 37.87 70.12 31.80 36.61 69.74 30.15 98.68 -27.22 -4.60 99.30 -29.23 -4.23 ULMN 3 1qho_c05 ALPHA-AMYLASE user 5 3 # 5 A 228 ASP B 149 ASP^? 14.91 O15 C8E B 209 A 261 ASP B 26 ASP.? 33.07 O15 C8E B 209 A 329 ASP B 80 ASP^? 15.94 O15 C8E B 209 coo 28.46 69.88 26.74 30.40 70.70 26.53 79.48 -42.39 -33.32 81.04 -41.48 -34.38 coo 34.02 79.89 42.60 34.73 78.01 41.86 71.92 -43.11 -51.36 71.95 -45.06 -50.50 coo 37.87 70.12 31.80 36.61 69.74 30.15 82.56 -37.87 -41.00 82.97 -37.16 -39.06 ULMN 3 1qho_c05 ALPHA-AMYLASE user 6 3 # 6 A 228 ASP C 48 ASP.? 7.17 CA CA C 208 A 261 ASP C 111 ASP.? 17.21 CA CA C 208 A 329 ASP C 61 ASP~? 12.61 CA CA C 208 coo 28.46 69.88 26.74 30.40 70.70 26.53 26.68 -52.06 -7.74 25.46 -53.53 -8.54 coo 34.02 79.89 42.60 34.73 78.01 41.86 27.11 -33.17 -3.90 25.73 -31.94 -3.00 coo 37.87 70.12 31.80 36.61 69.74 30.15 16.71 -46.53 -3.05 15.59 -48.22 -3.69 ULMN 3 1qho_c05 ALPHA-AMYLASE user 7 3 # 7 A 228 ASP C 149 ASP^? 16.02 C16 C8E C 210 A 261 ASP C 26 ASP.? 24.60 O21 C8E A 209 A 329 ASP C 80 ASP^? 16.43 C13 C8E C 210 coo 28.46 69.88 26.74 30.40 70.70 26.53 38.72 -55.19 -32.44 40.02 -55.93 -30.97 coo 34.02 79.89 42.60 34.73 78.01 41.86 55.55 -58.08 -41.98 53.84 -58.94 -42.96 coo 37.87 70.12 31.80 36.61 69.74 30.15 47.10 -57.14 -28.79 45.64 -55.94 -27.77 ULMN 3 1qho_c05 ALPHA-AMYLASE user 8 3 # 8 A 228 ASP C 149 ASP^? 16.02 C16 C8E C 210 A 261 ASP C 45 ASP.? 3.27 CA CA C 208s A 329 ASP C 153 ASP^? 9.83 C13 C8E C 210 coo 28.46 69.88 26.74 30.40 70.70 26.53 38.72 -55.19 -32.44 40.02 -55.93 -30.97 coo 34.02 79.89 42.60 34.73 78.01 41.86 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo 37.87 70.12 31.80 36.61 69.74 30.15 40.09 -57.62 -20.90 41.26 -57.13 -22.61 ULMN 3 1qho_c05 ALPHA-AMYLASE user 9 3 # 9 A 228 ASP C 185 ASP~? 11.81 O21 C8E C 209 A 261 ASP C 45 ASP.? 3.27 CA CA C 208s A 329 ASP C 52 ASP.? 15.77 CA CA C 208 coo 28.46 69.88 26.74 30.40 70.70 26.53 31.89 -54.53 1.93 31.11 -55.91 3.29 coo 34.02 79.89 42.60 34.73 78.01 41.86 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo 37.87 70.12 31.80 36.61 69.74 30.15 21.29 -54.58 -0.38 20.26 -54.47 1.43 1qho_c05 source 1qho ALPHA-AMYLASE : 9 hits 1qho_c05 naa= 3 ULMN 3 1qho_c07 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 111 ASP.? 17.05 CA CA A 208 A 260 ASP A 61 ASP~? 12.37 CA CA A 208 A 329 ASP A 114 ASP.? 22.11 CA CA A 208 coo 28.46 69.88 26.74 30.40 70.70 26.53 65.36 -83.80 -40.24 66.17 -85.36 -41.35 coo 30.73 81.29 37.61 31.23 82.07 35.69 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo 37.87 70.12 31.80 36.61 69.74 30.15 71.50 -87.46 -45.26 70.62 -89.18 -46.15 ULMN 3 1qho_c07 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP A 114 ASP.? 22.11 CA CA A 208 A 260 ASP A 61 ASP~? 12.37 CA CA A 208 A 329 ASP A 111 ASP.? 17.05 CA CA A 208 coo 28.46 69.88 26.74 30.40 70.70 26.53 71.50 -87.46 -45.26 70.62 -89.18 -46.15 coo 30.73 81.29 37.61 31.23 82.07 35.69 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo 37.87 70.12 31.80 36.61 69.74 30.15 65.36 -83.80 -40.24 66.17 -85.36 -41.35 ULMN 3 1qho_c07 ALPHA-AMYLASE user 3 3 # 3 A 228 ASP B 52 ASP.? 15.59 CA CA B 208 A 260 ASP B 45 ASP.? -3.07 CA CA B 208s A 329 ASP B 61 ASP~? 12.48 CA CA B 208 coo 28.46 69.88 26.74 30.40 70.70 26.53 105.61 -28.95 -11.53 106.78 -28.70 -9.81 coo 30.73 81.29 37.61 31.23 82.07 35.69 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo 37.87 70.12 31.80 36.61 69.74 30.15 98.68 -27.22 -4.60 99.30 -29.23 -4.23 1qho_c07 source 1qho ALPHA-AMYLASE : 3 hits 1qho_c07 naa= 3 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 A 51 ALA B 1 ALA.? 38.55 C1 C8E B 210 A 148 HIS B 0 HIS.? 33.03 C1 C8E B 210 A 163 ASP B 26 ASP.? 33.07 O15 C8E B 209 coo 1.42 19.18 21.84 1.11 19.57 23.28 67.07 -39.13 -54.53 66.87 -40.39 -55.35 coo 0.71 19.67 27.92 2.43 19.16 26.83 70.48 -35.36 -55.71 72.36 -34.80 -54.96 coo 7.15 16.22 27.50 6.15 18.00 27.94 71.92 -43.11 -51.36 71.95 -45.06 -50.50 1qol_c00 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 1 hits 1qol_c00 naa= 3 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 B 51 ALA B 1 ALA.? 38.55 C1 C8E B 210 B 148 HIS B 0 HIS.? 33.03 C1 C8E B 210 B 163 ASP B 26 ASP.? 33.07 O15 C8E B 209 coo -33.97 19.78 54.18 -33.40 20.11 52.82 67.07 -39.13 -54.53 66.87 -40.39 -55.35 coo -33.17 20.01 48.16 -34.95 19.37 49.06 70.48 -35.36 -55.71 72.36 -34.80 -54.96 coo -39.82 16.62 48.85 -38.59 18.24 48.48 71.92 -43.11 -51.36 71.95 -45.06 -50.50 1qol_c01 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 1 hits 1qol_c01 naa= 3 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 C 51 ALA B 1 ALA.? 38.55 C1 C8E B 210 C 148 HIS B 0 HIS.? 33.03 C1 C8E B 210 C 163 ASP B 26 ASP.? 33.07 O15 C8E B 209 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 67.07 -39.13 -54.53 66.87 -40.39 -55.35 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 70.48 -35.36 -55.71 72.36 -34.80 -54.96 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 71.92 -43.11 -51.36 71.95 -45.06 -50.50 1qol_c02 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 1 hits 1qol_c02 naa= 3 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 D 51 ALA B 1 ALA.? 38.55 C1 C8E B 210 D 148 HIS B 0 HIS.? 33.03 C1 C8E B 210 D 163 ASP B 26 ASP.? 33.07 O15 C8E B 209 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 67.07 -39.13 -54.53 66.87 -40.39 -55.35 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 70.48 -35.36 -55.71 72.36 -34.80 -54.96 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 71.92 -43.11 -51.36 71.95 -45.06 -50.50 1qol_c03 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 1 hits 1qol_c03 naa= 3 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 F 51 ALA B 1 ALA.? 38.55 C1 C8E B 210 F 148 HIS B 0 HIS.? 33.03 C1 C8E B 210 F 163 ASP B 26 ASP.? 33.07 O15 C8E B 209 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 67.07 -39.13 -54.53 66.87 -40.39 -55.35 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 70.48 -35.36 -55.71 72.36 -34.80 -54.96 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 71.92 -43.11 -51.36 71.95 -45.06 -50.50 1qol_c05 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 1 hits 1qol_c05 naa= 3 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 H 51 ALA B 1 ALA.? 38.55 C1 C8E B 210 H 148 HIS B 0 HIS.? 33.03 C1 C8E B 210 H 163 ASP B 26 ASP.? 33.07 O15 C8E B 209 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 67.07 -39.13 -54.53 66.87 -40.39 -55.35 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 70.48 -35.36 -55.71 72.36 -34.80 -54.96 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 71.92 -43.11 -51.36 71.95 -45.06 -50.50 1qol_c07 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 1 hits 1qol_c07 naa= 3 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 1 3 # 1 A 145 THR A 191 THR.? -4.98 C19 C8E A 209s A 182 TYR A 51 TYR.? 9.92 O21 C8E A 210 A 186 LYS A 188 LYS~? 10.77 C20 C8E A 210 coo 69.38 87.38 24.64 71.11 88.47 25.40 67.24 -74.39 -22.77 69.05 -73.78 -23.78 coo 73.61 90.42 31.12 71.36 89.66 29.64 71.70 -83.21 -22.40 69.97 -85.02 -21.17 coo 73.54 84.00 28.64 69.01 86.68 29.71 68.32 -80.18 -18.11 71.95 -84.24 -15.84 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 2 3 # 2 A 145 THR B 191 THR.? -5.05 O18 C8E B 209s A 182 TYR B 51 TYR.? 9.95 O21 C8E B 210 A 186 LYS B 188 LYS~? 9.67 C16 C8E B 210 coo 69.38 87.38 24.64 71.11 88.47 25.40 94.88 -29.06 -21.80 94.27 -29.66 -19.85 coo 73.61 90.42 31.12 71.36 89.66 29.64 102.03 -27.53 -15.19 104.12 -26.16 -16.40 coo 73.54 84.00 28.64 69.01 86.68 29.71 102.16 -28.74 -21.10 106.15 -31.37 -17.86 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 3 3 # 3 A 145 THR C 191 THR.? 5.18 C20 C8E C 209s A 182 TYR C 51 TYR.? 10.04 O21 C8E C 209 A 186 LYS C 188 LYS~? 9.02 C16 C8E C 209 coo 69.38 87.38 24.64 71.11 88.47 25.40 32.16 -51.72 -10.15 30.14 -51.15 -10.71 coo 73.61 90.42 31.12 71.36 89.66 29.64 26.09 -52.62 -2.60 27.54 -53.38 -0.32 coo 73.54 84.00 28.64 69.01 86.68 29.71 31.07 -55.82 -4.30 26.58 -58.21 -2.57 1qrr_c01 source 1qrr SULFOLIPID BIOSYNTHESIS (SQD1) PROTEIN : 3 hits 1qrr_c01 naa= 3 ULMN 3 1qz9_c02 KYNURENINASE user 1 3 # 1 A 129 PHE A 98 PHE^? 10.84 C1 C8E A 210 A 201 ASP A 80 ASP^? 12.60 C1 C8E A 210 A 227 LYS A 84 LYS.? 23.11 C2 C8E C 209 coo 23.39 49.81 32.16 21.33 51.68 32.26 58.55 -53.78 -9.03 56.20 -52.58 -8.10 coo 25.52 45.12 37.98 23.98 46.65 37.85 58.12 -52.30 -15.93 59.10 -53.68 -17.13 coo 12.68 46.83 36.69 18.26 48.67 34.51 61.58 -41.74 -11.00 58.66 -39.80 -16.04 ULMN 3 1qz9_c02 KYNURENINASE user 2 3 # 2 A 129 PHE A 105 PHE^? 4.85 O21 C8E A 209 A 201 ASP A 45 ASP.? -2.96 CA CA A 208s A 227 LYS A 188 LYS~? 10.77 C20 C8E A 210 coo 23.39 49.81 32.16 21.33 51.68 32.26 61.29 -71.83 -24.77 63.18 -73.65 -25.72 coo 25.52 45.12 37.98 23.98 46.65 37.85 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo 12.68 46.83 36.69 18.26 48.67 34.51 68.32 -80.18 -18.11 71.95 -84.24 -15.84 ULMN 3 1qz9_c02 KYNURENINASE user 3 3 # 3 A 129 PHE A 189 PHE~? 8.72 CA CA A 208 A 201 ASP A 52 ASP.? 15.11 CA CA A 208 A 227 LYS A 63 LYS~? 3.96 CA CA A 208 coo 23.39 49.81 32.16 21.33 51.68 32.26 68.20 -82.10 -23.88 68.92 -82.62 -26.53 coo 25.52 45.12 37.98 23.98 46.65 37.85 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo 12.68 46.83 36.69 18.26 48.67 34.51 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 1qz9_c02 KYNURENINASE user 4 3 # 4 A 129 PHE B 98 PHE^? 18.60 C8 C8E B 210 A 201 ASP B 80 ASP^? 15.94 O15 C8E B 209 A 227 LYS B 84 LYS.? 25.86 O15 C8E B 209 coo 23.39 49.81 32.16 21.33 51.68 32.26 88.93 -40.28 -43.85 88.97 -39.56 -46.61 coo 25.52 45.12 37.98 23.98 46.65 37.85 82.56 -37.87 -41.00 82.97 -37.16 -39.06 coo 12.68 46.83 36.69 18.26 48.67 34.51 79.44 -47.69 -46.65 75.97 -44.45 -44.18 ULMN 3 1qz9_c02 KYNURENINASE user 5 3 # 5 A 129 PHE B 105 PHE^? 5.21 C20 C8E B 209 A 201 ASP B 45 ASP.? -3.07 CA CA B 208s A 227 LYS B 188 LYS~? 9.67 C16 C8E B 210 coo 23.39 49.81 32.16 21.33 51.68 32.26 90.70 -25.26 -25.77 91.65 -25.28 -23.14 coo 25.52 45.12 37.98 23.98 46.65 37.85 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo 12.68 46.83 36.69 18.26 48.67 34.51 102.16 -28.74 -21.10 106.15 -31.37 -17.86 ULMN 3 1qz9_c02 KYNURENINASE user 6 3 # 6 A 129 PHE B 189 PHE~? 8.56 CA CA B 208 A 201 ASP B 52 ASP.? 15.59 CA CA B 208 A 227 LYS B 63 LYS~? 3.79 CA CA B 208 coo 23.39 49.81 32.16 21.33 51.68 32.26 99.55 -24.92 -16.99 98.05 -23.95 -14.81 coo 25.52 45.12 37.98 23.98 46.65 37.85 105.61 -28.95 -11.53 106.78 -28.70 -9.81 coo 12.68 46.83 36.69 18.26 48.67 34.51 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 1qz9_c02 KYNURENINASE user 7 3 # 7 A 129 PHE C 98 PHE^? 16.93 O21 C8E A 209 A 201 ASP C 80 ASP^? 16.43 C13 C8E C 210 A 227 LYS C 84 LYS.? 25.24 O21 C8E A 209 coo 23.39 49.81 32.16 21.33 51.68 32.26 48.24 -64.04 -26.66 50.81 -64.73 -27.68 coo 25.52 45.12 37.98 23.98 46.65 37.85 47.10 -57.14 -28.79 45.64 -55.94 -27.77 coo 12.68 46.83 36.69 18.26 48.67 34.51 49.01 -63.83 -38.44 48.10 -58.01 -38.38 ULMN 3 1qz9_c02 KYNURENINASE user 8 3 # 8 A 129 PHE C 105 PHE^? -4.13 O21 C8E C 210s A 201 ASP C 45 ASP.? 3.27 CA CA C 208s A 227 LYS C 188 LYS~? 9.02 C16 C8E C 209 coo 23.39 49.81 32.16 21.33 51.68 32.26 37.70 -47.93 -11.88 35.28 -47.45 -10.64 coo 25.52 45.12 37.98 23.98 46.65 37.85 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo 12.68 46.83 36.69 18.26 48.67 34.51 31.07 -55.82 -4.30 26.58 -58.21 -2.57 ULMN 3 1qz9_c02 KYNURENINASE user 9 3 # 9 A 129 PHE C 189 PHE~? 9.03 CA CA C 208 A 201 ASP C 52 ASP.? 15.77 CA CA C 208 A 227 LYS C 63 LYS~? 4.21 CA CA C 208 coo 23.39 49.81 32.16 21.33 51.68 32.26 29.10 -50.14 -3.03 27.67 -47.71 -3.13 coo 25.52 45.12 37.98 23.98 46.65 37.85 21.29 -54.58 -0.38 20.26 -54.47 1.43 coo 12.68 46.83 36.69 18.26 48.67 34.51 20.98 -41.61 -5.49 23.04 -43.67 -10.44 1qz9_c02 source 1qz9 KYNURENINASE : 9 hits 1qz9_c02 naa= 3 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 1 3 # 1 A 10 ASP A 153 ASP^? 8.28 C1 C8E A 210 A 186 ASN A 103 ASN^? 6.31 O21 C8E A 209 A 260 ALA A 42 ALA^? 7.29 O18 C8E A 209 coo 11.81 33.10 11.71 13.07 31.45 11.40 63.37 -61.81 -16.17 62.75 -59.91 -16.84 coo 11.43 26.53 7.41 13.01 27.56 8.43 58.51 -66.15 -21.33 59.95 -66.28 -22.87 coo 21.53 26.33 6.96 20.26 25.69 7.52 64.59 -62.72 -29.30 65.26 -62.49 -27.92 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 2 3 # 2 A 10 ASP B 111 ASP.? 16.97 CA CA B 208 A 186 ASN B 115 ASN.? 17.18 CA CA B 208 A 260 ALA B 65 ALA~? 14.85 CA CA B 208 coo 11.81 33.10 11.71 13.07 31.45 11.40 89.21 -14.92 -8.80 89.40 -13.99 -6.98 coo 11.43 26.53 7.41 13.01 27.56 8.43 92.58 -14.49 -1.90 92.83 -16.48 -2.65 coo 21.53 26.33 6.96 20.26 25.69 7.52 94.01 -22.60 -1.56 95.53 -22.30 -1.57 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 3 3 # 3 A 10 ASP B 153 ASP^? 9.57 O15 C8E B 209 A 186 ASN B 103 ASN^? 6.73 O21 C8E B 209 A 260 ALA B 42 ALA^? 7.68 C19 C8E B 209 coo 11.81 33.10 11.71 13.07 31.45 11.40 89.74 -36.17 -33.46 87.76 -36.55 -34.22 coo 11.43 26.53 7.41 13.01 27.56 8.43 88.46 -28.09 -32.02 87.63 -28.23 -30.06 coo 21.53 26.33 6.96 20.26 25.69 7.52 81.57 -30.84 -24.70 82.39 -32.04 -25.12 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 4 3 # 4 A 10 ASP B 185 ASP~? 11.63 O21 C8E B 210 A 186 ASN B 187 ASN~? -3.44 O21 C8E B 210s A 260 ALA B 158 ALA.? 4.91 C2 C8E B 210 coo 11.81 33.10 11.71 13.07 31.45 11.40 106.30 -23.80 -20.43 108.26 -24.54 -20.08 coo 11.43 26.53 7.41 13.01 27.56 8.43 101.97 -26.81 -25.28 100.76 -28.02 -26.55 coo 21.53 26.33 6.96 20.26 25.69 7.52 97.94 -23.77 -32.61 96.50 -23.63 -32.93 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 5 3 # 5 A 10 ASP C 111 ASP.? 17.21 CA CA C 208 A 186 ASN C 115 ASN.? 18.23 CA CA C 208 A 260 ALA C 65 ALA~? 14.61 CA CA C 208 coo 11.81 33.10 11.71 13.07 31.45 11.40 27.11 -33.17 -3.90 25.73 -31.94 -3.00 coo 11.43 26.53 7.41 13.01 27.56 8.43 21.18 -32.86 2.02 20.57 -34.73 1.19 coo 21.53 26.33 6.96 20.26 25.69 7.52 16.79 -39.18 -3.13 16.65 -40.15 -1.97 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 6 3 # 6 A 10 ASP C 153 ASP^? 9.83 C13 C8E C 210 A 186 ASN C 103 ASN^? 6.32 C20 C8E C 210 A 260 ALA C 42 ALA^? 7.46 C19 C8E C 210 coo 11.81 33.10 11.71 13.07 31.45 11.40 40.09 -57.62 -20.90 41.26 -57.13 -22.61 coo 11.43 26.53 7.41 13.01 27.56 8.43 42.54 -50.86 -16.42 40.88 -49.65 -16.80 coo 21.53 26.33 6.96 20.26 25.69 7.52 35.72 -45.47 -22.06 35.55 -46.98 -22.23 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 7 3 # 7 A 10 ASP C 185 ASP~? 11.81 O21 C8E C 209 A 186 ASN C 187 ASN~? -2.70 C14 C8E C 209s A 260 ALA C 158 ALA.? 5.77 C3 C8E C 209 coo 11.81 33.10 11.71 13.07 31.45 11.40 31.89 -54.53 1.93 31.11 -55.91 3.29 coo 11.43 26.53 7.41 13.01 27.56 8.43 35.59 -56.00 -3.84 36.37 -56.79 -5.68 coo 21.53 26.33 6.96 20.26 25.69 7.52 43.81 -54.47 -6.60 44.31 -53.67 -7.75 1r4f_c00 source 1r4f IAG-NUCLEOSIDE HYDROLASE : 7 hits 1r4f_c00 naa= 3 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 1 3 # 1 A 137 GLU C 164 GLU^? 20.06 CA CA C 208 A 288 HIS A 0 HIS.? 19.31 C20 C8E C 210 A 329 LYS A 3 LYS^? 24.80 C20 C8E C 210 coo 29.27 18.78 14.99 27.16 18.62 14.76 34.72 -37.11 1.76 34.46 -37.46 3.82 coo 49.52 10.06 10.36 50.99 9.65 8.92 44.54 -33.06 -16.20 42.49 -32.93 -16.64 coo 57.80 12.92 13.83 53.77 8.42 12.15 52.63 -38.57 -20.93 53.13 -33.95 -19.17 1roz_c00 source 1roz DEOXYHYPUSINE SYNTHASE : 1 hits 1roz_c00 naa= 3 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 1 3 # 1 B 137 GLU C 164 GLU^? 20.06 CA CA C 208 B 288 HIS A 0 HIS.? 19.31 C20 C8E C 210 B 329 LYS A 3 LYS^? 24.80 C20 C8E C 210 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 34.72 -37.11 1.76 34.46 -37.46 3.82 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 44.54 -33.06 -16.20 42.49 -32.93 -16.64 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 52.63 -38.57 -20.93 53.13 -33.95 -19.17 1roz_c01 source 1roz DEOXYHYPUSINE SYNTHASE : 1 hits 1roz_c01 naa= 3 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 1 3 # 1 E 166 ASP A 48 ASP.? 7.38 CA CA A 208 E 168 LYS A 188 LYS~? 10.77 C20 C8E A 210 E 201 THR A 191 THR.? -4.98 C19 C8E A 209s coo 5.36 16.20 22.10 3.88 17.00 23.31 72.05 -78.20 -23.17 73.82 -77.79 -22.11 coo 5.06 22.32 18.11 1.02 22.08 22.74 68.32 -80.18 -18.11 71.95 -84.24 -15.84 coo -1.79 18.29 19.05 -1.19 20.28 19.71 67.24 -74.39 -22.77 69.05 -73.78 -23.78 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 2 3 # 2 E 166 ASP A 49 ASP.? -3.00 CA CA A 208s E 168 LYS A 63 LYS~? 3.96 CA CA A 208 E 201 THR A 58 THR~? 10.52 CA CA A 208 coo 5.36 16.20 22.10 3.88 17.00 23.31 75.72 -77.89 -27.98 74.67 -77.10 -29.65 coo 5.06 22.32 18.11 1.02 22.08 22.74 73.63 -82.49 -34.44 73.43 -77.00 -32.37 coo -1.79 18.29 19.05 -1.19 20.28 19.71 76.40 -85.04 -26.81 78.11 -83.80 -26.40 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 3 3 # 3 E 166 ASP A 166 ASP.? 23.45 CA CA A 208 E 168 LYS A 119 LYS.? 17.79 CA CA A 208 E 201 THR A 117 THR.? 21.33 CA CA A 208 coo 5.36 16.20 22.10 3.88 17.00 23.31 55.95 -88.25 -40.15 55.99 -89.39 -38.36 coo 5.06 22.32 18.11 1.02 22.08 22.74 60.88 -84.29 -40.26 61.29 -87.76 -35.50 coo -1.79 18.29 19.05 -1.19 20.28 19.71 63.40 -90.39 -40.90 61.71 -90.63 -39.48 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 4 3 # 4 E 166 ASP A 167 ASP.? 22.50 CA CA A 208 E 168 LYS A 119 LYS.? 17.79 CA CA A 208 E 201 THR A 117 THR.? 21.33 CA CA A 208 coo 5.36 16.20 22.10 3.88 17.00 23.31 58.25 -87.45 -44.58 60.23 -87.13 -43.88 coo 5.06 22.32 18.11 1.02 22.08 22.74 60.88 -84.29 -40.26 61.29 -87.76 -35.50 coo -1.79 18.29 19.05 -1.19 20.28 19.71 63.40 -90.39 -40.90 61.71 -90.63 -39.48 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 5 3 # 5 E 166 ASP B 49 ASP.? -3.05 CA CA B 208s E 168 LYS B 63 LYS~? 3.79 CA CA B 208 E 201 THR B 58 THR~? 10.41 CA CA B 208 coo 5.36 16.20 22.10 3.88 17.00 23.31 94.52 -28.97 -11.62 93.03 -30.41 -11.73 coo 5.06 22.32 18.11 1.02 22.08 22.74 93.18 -23.71 -7.17 90.77 -27.85 -10.83 coo -1.79 18.29 19.05 -1.19 20.28 19.71 100.65 -27.90 -8.43 100.12 -29.92 -7.97 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 6 3 # 6 E 166 ASP B 166 ASP.? 24.17 CA CA B 208 E 168 LYS B 119 LYS.? 18.40 CA CA B 208 E 201 THR B 117 THR.? 21.30 CA CA B 208 coo 5.36 16.20 22.10 3.88 17.00 23.31 91.14 -5.33 -14.11 93.17 -5.00 -14.63 coo 5.06 22.32 18.11 1.02 22.08 22.74 89.22 -11.21 -11.71 95.34 -11.17 -12.31 coo -1.79 18.29 19.05 -1.19 20.28 19.71 93.17 -9.31 -6.81 94.03 -8.66 -8.75 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 7 3 # 7 E 166 ASP B 167 ASP.? 22.72 CA CA B 208 E 168 LYS B 119 LYS.? 18.40 CA CA B 208 E 201 THR B 117 THR.? 21.30 CA CA B 208 coo 5.36 16.20 22.10 3.88 17.00 23.31 88.92 -5.85 -9.56 88.92 -7.42 -8.19 coo 5.06 22.32 18.11 1.02 22.08 22.74 89.22 -11.21 -11.71 95.34 -11.17 -12.31 coo -1.79 18.29 19.05 -1.19 20.28 19.71 93.17 -9.31 -6.81 94.03 -8.66 -8.75 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 8 3 # 8 E 166 ASP C 49 ASP.? -2.87 CA CA C 208s E 168 LYS C 63 LYS~? 4.21 CA CA C 208 E 201 THR C 58 THR~? 10.65 CA CA C 208 coo 5.36 16.20 22.10 3.88 17.00 23.31 22.13 -48.50 -9.42 23.00 -46.66 -10.00 coo 5.06 22.32 18.11 1.02 22.08 22.74 20.98 -41.61 -5.49 23.04 -43.67 -10.44 coo -1.79 18.29 19.05 -1.19 20.28 19.71 19.91 -49.60 -2.59 18.80 -50.74 -4.02 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 9 3 # 9 E 166 ASP C 166 ASP.? 24.81 CA CA C 208 E 168 LYS C 119 LYS.? 22.44 CA CA C 208 E 201 THR C 117 THR.? 21.70 CA CA C 208 coo 5.36 16.20 22.10 3.88 17.00 23.31 35.75 -30.25 2.83 35.54 -31.07 4.76 coo 5.06 22.32 18.11 1.02 22.08 22.74 30.81 -32.05 -1.80 31.88 -31.87 3.92 coo -1.79 18.29 19.05 -1.19 20.28 19.71 27.55 -31.30 3.26 28.51 -32.70 4.67 1stc_c02 source 1stc CAMP-DEPENDENT PROTEIN KINASE : 9 hits 1stc_c02 naa= 3 ULMN 3 1stc_c03 CAMP-DEPENDENT PROTEIN KINASE user 1 3 # 1 E 166 ASP A 166 ASP.? 23.45 CA CA A 208 E 168 LYS A 171 LYS^? 22.02 O21 C8E A 209 E 171 ASN A 170 ASN.? 28.35 CA CA A 208 coo 5.36 16.20 22.10 3.88 17.00 23.31 55.95 -88.25 -40.15 55.99 -89.39 -38.36 coo 5.06 22.32 18.11 1.02 22.08 22.74 51.77 -85.30 -36.11 51.41 -79.16 -37.75 coo 6.68 21.78 22.39 5.28 20.74 23.60 51.62 -88.52 -39.42 50.91 -89.41 -41.21 ULMN 3 1stc_c03 CAMP-DEPENDENT PROTEIN KINASE user 2 3 # 2 E 166 ASP A 185 ASP~? 11.73 O21 C8E A 210 E 168 LYS A 188 LYS~? 10.77 C20 C8E A 210 E 171 ASN A 187 ASN~? -3.11 O18 C8E A 210s coo 5.36 16.20 22.10 3.88 17.00 23.31 65.81 -86.27 -18.22 66.54 -87.64 -16.78 coo 5.06 22.32 18.11 1.02 22.08 22.74 68.32 -80.18 -18.11 71.95 -84.24 -15.84 coo 6.68 21.78 22.39 5.28 20.74 23.60 63.91 -79.43 -16.81 63.89 -77.36 -16.28 ULMN 3 1stc_c03 CAMP-DEPENDENT PROTEIN KINASE user 3 3 # 3 E 166 ASP B 166 ASP.? 24.17 CA CA B 208 E 168 LYS B 171 LYS^? 22.17 C20 C8E B 209 E 171 ASN B 170 ASN.? 27.83 CA CA B 208 coo 5.36 16.20 22.10 3.88 17.00 23.31 91.14 -5.33 -14.11 93.17 -5.00 -14.63 coo 5.06 22.32 18.11 1.02 22.08 22.74 90.66 -6.85 -20.43 84.87 -8.89 -21.63 coo 6.68 21.78 22.39 5.28 20.74 23.60 90.80 -3.32 -17.55 90.23 -1.46 -16.71 ULMN 3 1stc_c03 CAMP-DEPENDENT PROTEIN KINASE user 4 3 # 4 E 166 ASP B 185 ASP~? 11.63 O21 C8E B 210 E 168 LYS B 188 LYS~? 9.67 C16 C8E B 210 E 171 ASN B 187 ASN~? -3.44 O21 C8E B 210s coo 5.36 16.20 22.10 3.88 17.00 23.31 106.30 -23.80 -20.43 108.26 -24.54 -20.08 coo 5.06 22.32 18.11 1.02 22.08 22.74 102.16 -28.74 -21.10 106.15 -31.37 -17.86 coo 6.68 21.78 22.39 5.28 20.74 23.60 101.97 -26.81 -25.28 100.76 -28.02 -26.55 ULMN 3 1stc_c03 CAMP-DEPENDENT PROTEIN KINASE user 5 3 # 5 E 166 ASP C 166 ASP.? 24.81 CA CA C 208 E 168 LYS C 171 LYS^? 21.29 O21 C8E C 210 E 171 ASN C 170 ASN.? 28.31 CA CA C 208 coo 5.36 16.20 22.10 3.88 17.00 23.31 35.75 -30.25 2.83 35.54 -31.07 4.76 coo 5.06 22.32 18.11 1.02 22.08 22.74 40.39 -33.45 0.65 41.79 -31.81 -5.33 coo 6.68 21.78 22.39 5.28 20.74 23.60 39.40 -29.88 3.55 39.46 -27.84 4.11 ULMN 3 1stc_c03 CAMP-DEPENDENT PROTEIN KINASE user 6 3 # 6 E 166 ASP C 185 ASP~? 11.81 O21 C8E C 209 E 168 LYS C 188 LYS~? 9.02 C16 C8E C 209 E 171 ASN C 187 ASN~? -2.70 C14 C8E C 209s coo 5.36 16.20 22.10 3.88 17.00 23.31 31.89 -54.53 1.93 31.11 -55.91 3.29 coo 5.06 22.32 18.11 1.02 22.08 22.74 31.07 -55.82 -4.30 26.58 -58.21 -2.57 coo 6.68 21.78 22.39 5.28 20.74 23.60 35.59 -56.00 -3.84 36.37 -56.79 -5.68 1stc_c03 source 1stc CAMP-DEPENDENT PROTEIN KINASE : 6 hits 1stc_c03 naa= 3 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 1 3 # 1 A 261 GLY A 202 GLY^? 20.08 C17 C8E A 209 B 17 GLN A 19 GLN^? 15.77 C17 C8E A 209 B 140 GLU A 7 GLU^? 19.52 C17 C8E A 209 coo 61.49 19.86 5.96 61.52 19.46 5.16 66.56 -47.95 -27.86 66.94 -47.39 -27.39 coo 63.76 11.90 7.93 65.18 13.07 6.77 61.68 -53.90 -25.59 60.40 -53.32 -23.97 coo 66.44 19.00 7.38 67.69 17.67 8.37 61.29 -47.52 -25.12 61.48 -48.69 -23.33 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 2 3 # 2 A 261 GLY B 179 GLY.? 8.43 C4 C8E B 210 B 17 GLN B 157 GLN.? -3.32 O12 C8E B 210s B 140 GLU B 184 GLU~? 8.45 C14 C8E B 210 coo 61.49 19.86 5.96 61.52 19.46 5.16 107.26 -22.38 -31.47 107.28 -21.61 -31.88 coo 63.76 11.90 7.93 65.18 13.07 6.77 100.90 -28.16 -30.62 102.98 -28.51 -30.67 coo 66.44 19.00 7.38 67.69 17.67 8.37 107.80 -26.84 -26.43 109.06 -28.52 -26.54 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 3 3 # 3 A 261 GLY B 202 GLY^? 20.20 O15 C8E B 209 B 17 GLN B 19 GLN^? 14.72 O15 C8E B 209 B 140 GLU B 7 GLU^? 19.70 O15 C8E B 209 coo 61.49 19.86 5.96 61.52 19.46 5.16 72.27 -41.27 -30.46 72.24 -42.05 -30.66 coo 63.76 11.90 7.93 65.18 13.07 6.77 77.54 -34.58 -33.49 79.23 -35.13 -34.67 coo 66.44 19.00 7.38 67.69 17.67 8.37 73.39 -38.66 -35.65 75.17 -39.55 -36.49 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 4 3 # 4 A 261 GLY C 179 GLY.? 9.08 C5 C8E C 209 B 17 GLN C 157 GLN.? -3.51 O9 C8E C 209s B 140 GLU C 184 GLU~? 7.93 C14 C8E C 209 coo 61.49 19.86 5.96 61.52 19.46 5.16 42.35 -58.77 1.88 43.04 -58.32 2.32 coo 63.76 11.90 7.93 65.18 13.07 6.77 41.36 -58.73 -6.38 40.23 -59.71 -4.93 coo 66.44 19.00 7.38 67.69 17.67 8.37 35.72 -59.91 1.24 36.69 -61.13 -0.21 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 5 3 # 5 A 261 GLY C 202 GLY^? 20.55 C16 C8E C 210 B 17 GLN C 19 GLN^? 15.24 C19 C8E C 210 B 140 GLU C 7 GLU^? 20.56 C16 C8E C 210 coo 61.49 19.86 5.96 61.52 19.46 5.16 37.69 -48.46 -36.70 37.66 -49.11 -37.22 coo 63.76 11.90 7.93 65.18 13.07 6.77 42.90 -48.48 -28.27 43.27 -50.57 -28.10 coo 66.44 19.00 7.38 67.69 17.67 8.37 43.33 -49.69 -35.12 43.56 -51.77 -34.52 1t4c_c02 source 1t4c FORMYL-COENZYME A TRANSFERASE : 5 hits 1t4c_c02 naa= 3 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 1 3 # 1 A 250 ALA A 46 ALA.? 6.64 CA CA A 208 A 251 GLY A 72 GLY^? 7.13 O21 C8E A 209 A 252 ASP A 45 ASP.? -2.96 CA CA A 208s coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 66.69 -74.67 -27.61 65.67 -75.06 -28.70 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 64.73 -71.23 -30.71 64.86 -70.64 -31.29 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 70.45 -71.75 -27.39 71.06 -73.65 -26.89 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 2 3 # 2 A 250 ALA A 136 ALA^? 18.84 C1 C8E A 209 A 251 GLY A 148 GLY^? 17.63 C1 C8E A 209 A 252 ASP A 149 ASP^? 14.85 C1 C8E A 210 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 67.89 -44.74 -18.16 69.42 -44.83 -18.22 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 69.03 -47.69 -21.86 68.24 -47.54 -21.53 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 66.40 -51.17 -20.74 65.06 -51.90 -19.38 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 3 3 # 3 A 250 ALA B 46 ALA.? 6.22 CA CA B 208 A 251 GLY B 72 GLY^? 7.04 C20 C8E B 209 A 252 ASP B 45 ASP.? -3.07 CA CA B 208s coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 91.46 -26.30 -19.06 90.82 -24.97 -18.73 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 86.64 -25.55 -20.04 85.82 -25.67 -19.86 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 90.60 -30.65 -18.50 91.26 -30.99 -16.60 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 4 3 # 4 A 250 ALA B 136 ALA^? 22.19 O15 C8E B 209 A 251 GLY B 148 GLY^? 19.08 O15 C8E B 209 A 252 ASP B 149 ASP^? 14.91 O15 C8E B 209 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 76.87 -47.95 -36.51 77.18 -48.96 -35.45 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 76.61 -45.51 -32.17 76.71 -45.21 -33.00 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 79.48 -42.39 -33.32 81.04 -41.48 -34.38 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 5 3 # 5 A 250 ALA C 46 ALA.? 6.35 CA CA C 208 A 251 GLY C 72 GLY^? 6.51 O21 C8E C 210 A 252 ASP C 45 ASP.? 3.27 CA CA C 208s coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 31.22 -46.48 -10.69 31.43 -45.03 -10.31 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 32.98 -43.26 -14.24 32.91 -42.76 -14.86 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 28.98 -48.61 -14.39 27.54 -48.99 -12.93 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 6 3 # 6 A 250 ALA C 136 ALA^? 23.08 C16 C8E C 210 A 251 GLY C 148 GLY^? 19.87 C16 C8E C 210 A 252 ASP C 149 ASP^? 16.02 C16 C8E C 210 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 39.69 -58.64 -38.49 38.27 -59.07 -38.64 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 36.86 -55.05 -36.49 37.69 -55.22 -36.43 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 38.72 -55.19 -32.44 40.02 -55.93 -30.97 1tz3_c02 source 1tz3 PUTATIVE SUGAR KINASE : 6 hits 1tz3_c02 naa= 3 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 1 3 # 1 B 250 ALA A 46 ALA.? 6.64 CA CA A 208 B 251 GLY A 72 GLY^? 7.13 O21 C8E A 209 B 252 ASP A 45 ASP.? -2.96 CA CA A 208s coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 66.69 -74.67 -27.61 65.67 -75.06 -28.70 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 64.73 -71.23 -30.71 64.86 -70.64 -31.29 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 70.45 -71.75 -27.39 71.06 -73.65 -26.89 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 2 3 # 2 B 250 ALA A 136 ALA^? 18.84 C1 C8E A 209 B 251 GLY A 148 GLY^? 17.63 C1 C8E A 209 B 252 ASP A 149 ASP^? 14.85 C1 C8E A 210 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 67.89 -44.74 -18.16 69.42 -44.83 -18.22 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 69.03 -47.69 -21.86 68.24 -47.54 -21.53 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 66.40 -51.17 -20.74 65.06 -51.90 -19.38 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 3 3 # 3 B 250 ALA B 46 ALA.? 6.22 CA CA B 208 B 251 GLY B 72 GLY^? 7.04 C20 C8E B 209 B 252 ASP B 45 ASP.? -3.07 CA CA B 208s coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 91.46 -26.30 -19.06 90.82 -24.97 -18.73 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 86.64 -25.55 -20.04 85.82 -25.67 -19.86 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 90.60 -30.65 -18.50 91.26 -30.99 -16.60 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 4 3 # 4 B 250 ALA B 136 ALA^? 22.19 O15 C8E B 209 B 251 GLY B 148 GLY^? 19.08 O15 C8E B 209 B 252 ASP B 149 ASP^? 14.91 O15 C8E B 209 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 76.87 -47.95 -36.51 77.18 -48.96 -35.45 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 76.61 -45.51 -32.17 76.71 -45.21 -33.00 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 79.48 -42.39 -33.32 81.04 -41.48 -34.38 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 5 3 # 5 B 250 ALA C 46 ALA.? 6.35 CA CA C 208 B 251 GLY C 72 GLY^? 6.51 O21 C8E C 210 B 252 ASP C 45 ASP.? 3.27 CA CA C 208s coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 31.22 -46.48 -10.69 31.43 -45.03 -10.31 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 32.98 -43.26 -14.24 32.91 -42.76 -14.86 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 28.98 -48.61 -14.39 27.54 -48.99 -12.93 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 6 3 # 6 B 250 ALA C 136 ALA^? 23.08 C16 C8E C 210 B 251 GLY C 148 GLY^? 19.87 C16 C8E C 210 B 252 ASP C 149 ASP^? 16.02 C16 C8E C 210 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 39.69 -58.64 -38.49 38.27 -59.07 -38.64 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 36.86 -55.05 -36.49 37.69 -55.22 -36.43 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 38.72 -55.19 -32.44 40.02 -55.93 -30.97 1tz3_c03 source 1tz3 PUTATIVE SUGAR KINASE : 6 hits 1tz3_c03 naa= 3 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 1 3 # 1 A 46 GLU B 164 GLU^? 19.99 CA CA B 208 A 126 LYS B 171 LYS^? 22.17 C20 C8E B 209 A 171 ALA B 120 ALA^? 15.95 CA CA B 208 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 94.70 -10.70 -16.52 96.59 -9.81 -16.07 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 90.66 -6.85 -20.43 84.87 -8.89 -21.63 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 89.14 -13.81 -14.52 87.79 -13.74 -15.22 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 2 3 # 2 A 46 GLU C 164 GLU^? 20.06 CA CA C 208 A 126 LYS C 171 LYS^? 21.29 O21 C8E C 210 A 171 ALA C 120 ALA^? 16.01 CA CA C 208 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 34.72 -37.11 1.76 34.46 -37.46 3.82 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 40.39 -33.45 0.65 41.79 -31.81 -5.33 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 32.30 -34.87 -3.98 33.01 -34.28 -5.18 1uf7_c00 source 1uf7 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLASE : 2 hits 1uf7_c00 naa= 3 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 1 3 # 1 B 46 GLU B 164 GLU^? 19.99 CA CA B 208 B 126 LYS B 171 LYS^? 22.17 C20 C8E B 209 B 171 ALA B 120 ALA^? 15.95 CA CA B 208 coo 20.47 87.42 16.54 20.16 87.17 14.45 94.70 -10.70 -16.52 96.59 -9.81 -16.07 coo 24.73 94.37 14.59 21.08 89.84 11.98 90.66 -6.85 -20.43 84.87 -8.89 -21.63 coo 24.38 86.32 12.71 22.88 86.54 12.71 89.14 -13.81 -14.52 87.79 -13.74 -15.22 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 2 3 # 2 B 46 GLU C 164 GLU^? 20.06 CA CA C 208 B 126 LYS C 171 LYS^? 21.29 O21 C8E C 210 B 171 ALA C 120 ALA^? 16.01 CA CA C 208 coo 20.47 87.42 16.54 20.16 87.17 14.45 34.72 -37.11 1.76 34.46 -37.46 3.82 coo 24.73 94.37 14.59 21.08 89.84 11.98 40.39 -33.45 0.65 41.79 -31.81 -5.33 coo 24.38 86.32 12.71 22.88 86.54 12.71 32.30 -34.87 -3.98 33.01 -34.28 -5.18 1uf7_c01 source 1uf7 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLASE : 2 hits 1uf7_c01 naa= 3 ULMN 3 1un1_c00 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 1 3 # 1 A 85 GLU B 164 GLU^? 19.99 CA CA B 208 A 87 ASP B 166 ASP.? 24.17 CA CA B 208 A 89 GLU B 165 GLU^? 20.64 CA CA B 208 coo 22.84 137.30 -8.23 24.70 136.75 -9.08 94.70 -10.70 -16.52 96.59 -9.81 -16.07 coo 25.07 140.95 -5.73 24.98 139.34 -7.10 91.14 -5.33 -14.11 93.17 -5.00 -14.63 coo 29.50 140.95 -4.45 30.03 140.88 -6.51 88.15 -8.84 -16.79 86.14 -9.46 -16.74 1un1_c00 source 1un1 XYLOGLUCAN ENDOTRANSGLYCOSYLASE : 1 hits 1un1_c00 naa= 3 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 185 ASP~? 11.73 O21 C8E A 210 255 GLU A 184 GLU~? 7.72 C16 C8E A 210 329 ASP A 180 ASP.? 14.47 O15 C8E A 210 coo 49.16 35.16 15.19 51.08 34.43 15.65 65.81 -86.27 -18.22 66.54 -87.64 -16.78 coo 52.57 37.12 10.17 53.37 35.95 11.75 63.73 -84.37 -12.45 63.45 -82.45 -11.70 coo 59.16 37.82 13.95 57.63 37.03 15.12 55.45 -86.10 -15.44 53.65 -85.04 -15.38 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP B 111 ASP.? 16.97 CA CA B 208 255 GLU B 113 GLU.? 20.51 CA CA B 208 329 ASP B 167 ASP.? 22.72 CA CA B 208 coo 49.16 35.16 15.19 51.08 34.43 15.65 89.21 -14.92 -8.80 89.40 -13.99 -6.98 coo 52.57 37.12 10.17 53.37 35.95 11.75 86.78 -12.34 -3.10 88.60 -11.66 -4.00 coo 59.16 37.82 13.95 57.63 37.03 15.12 88.92 -5.85 -9.56 88.92 -7.42 -8.19 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP B 185 ASP~? 11.63 O21 C8E B 210 255 GLU B 184 GLU~? 8.45 C14 C8E B 210 329 ASP B 180 ASP.? 10.93 C4 C8E B 210 coo 49.16 35.16 15.19 51.08 34.43 15.65 106.30 -23.80 -20.43 108.26 -24.54 -20.08 coo 52.57 37.12 10.17 53.37 35.95 11.75 107.80 -26.84 -26.43 109.06 -28.52 -26.54 coo 59.16 37.82 13.95 57.63 37.03 15.12 106.50 -18.19 -29.27 105.54 -17.21 -30.85 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 4 3 # 4 199 ASP C 45 ASP.? 3.27 CA CA C 208s 255 GLU C 70 GLU^? -2.71 CA CA C 208s 329 ASP C 49 ASP.? -2.87 CA CA C 208s coo 49.16 35.16 15.19 51.08 34.43 15.65 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo 52.57 37.12 10.17 53.37 35.95 11.75 27.73 -42.94 -10.42 26.74 -44.79 -10.37 coo 59.16 37.82 13.95 57.63 37.03 15.12 22.13 -48.50 -9.42 23.00 -46.66 -10.00 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 5 3 # 5 199 ASP C 49 ASP.? -2.87 CA CA C 208s 255 GLU C 70 GLU^? -2.71 CA CA C 208s 329 ASP C 45 ASP.? 3.27 CA CA C 208s coo 49.16 35.16 15.19 51.08 34.43 15.65 22.13 -48.50 -9.42 23.00 -46.66 -10.00 coo 52.57 37.12 10.17 53.37 35.95 11.75 27.73 -42.94 -10.42 26.74 -44.79 -10.37 coo 59.16 37.82 13.95 57.63 37.03 15.12 28.98 -48.61 -14.39 27.54 -48.99 -12.93 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 6 3 # 6 199 ASP C 61 ASP~? 12.61 CA CA C 208 255 GLU C 64 GLU~? 12.03 CA CA C 208 329 ASP C 49 ASP.? -2.87 CA CA C 208s coo 49.16 35.16 15.19 51.08 34.43 15.65 16.71 -46.53 -3.05 15.59 -48.22 -3.69 coo 52.57 37.12 10.17 53.37 35.95 11.75 16.47 -41.84 -8.31 14.60 -42.35 -9.15 coo 59.16 37.82 13.95 57.63 37.03 15.12 22.13 -48.50 -9.42 23.00 -46.66 -10.00 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 7 3 # 7 199 ASP C 166 ASP.? 24.81 CA CA C 208 255 GLU C 165 GLU^? 20.98 CA CA C 208 329 ASP C 111 ASP.? 17.21 CA CA C 208 coo 49.16 35.16 15.19 51.08 34.43 15.65 35.75 -30.25 2.83 35.54 -31.07 4.76 coo 52.57 37.12 10.17 53.37 35.95 11.75 36.32 -31.59 -2.15 36.97 -31.00 -4.08 coo 59.16 37.82 13.95 57.63 37.03 15.12 27.11 -33.17 -3.90 25.73 -31.94 -3.00 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 8 3 # 8 199 ASP C 167 ASP.? 25.18 CA CA C 208 255 GLU C 165 GLU^? 20.98 CA CA C 208 329 ASP C 111 ASP.? 17.21 CA CA C 208 coo 49.16 35.16 15.19 51.08 34.43 15.65 31.39 -27.44 2.08 30.34 -25.78 1.31 coo 52.57 37.12 10.17 53.37 35.95 11.75 36.32 -31.59 -2.15 36.97 -31.00 -4.08 coo 59.16 37.82 13.95 57.63 37.03 15.12 27.11 -33.17 -3.90 25.73 -31.94 -3.00 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 9 3 # 9 199 ASP C 185 ASP~? 11.81 O21 C8E C 209 255 GLU C 184 GLU~? 7.93 C14 C8E C 209 329 ASP C 180 ASP.? 12.29 C5 C8E C 209 coo 49.16 35.16 15.19 51.08 34.43 15.65 31.89 -54.53 1.93 31.11 -55.91 3.29 coo 52.57 37.12 10.17 53.37 35.95 11.75 35.72 -59.91 1.24 36.69 -61.13 -0.21 coo 59.16 37.82 13.95 57.63 37.03 15.12 42.24 -54.49 3.97 44.24 -53.90 3.82 1uok_c03 source 1uok OLIGO-1,6-GLUCOSIDASE : 9 hits 1uok_c03 naa= 3 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 80 ASP^? 12.60 C1 C8E A 210 218 GLU A 70 GLU^? -2.69 CA CA A 208s 329 ASP A 149 ASP^? 14.85 C1 C8E A 210 coo 49.16 35.16 15.19 51.08 34.43 15.65 58.12 -52.30 -15.93 59.10 -53.68 -17.13 coo 70.09 11.71 8.46 70.56 12.89 6.77 68.79 -75.79 -31.87 70.14 -76.30 -30.27 coo 59.16 37.82 13.95 57.63 37.03 15.12 66.40 -51.17 -20.74 65.06 -51.90 -19.38 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP A 111 ASP.? 17.05 CA CA A 208 218 GLU C 93 GLU^? 26.90 C13 C8E C 210 329 ASP A 166 ASP.? 23.45 CA CA A 208 coo 49.16 35.16 15.19 51.08 34.43 15.65 65.36 -83.80 -40.24 66.17 -85.36 -41.35 coo 70.09 11.71 8.46 70.56 12.89 6.77 45.29 -60.19 -41.07 45.99 -58.52 -39.91 coo 59.16 37.82 13.95 57.63 37.03 15.12 55.95 -88.25 -40.15 55.99 -89.39 -38.36 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP A 111 ASP.? 17.05 CA CA A 208 218 GLU C 93 GLU^? 26.90 C13 C8E C 210 329 ASP A 167 ASP.? 22.50 CA CA A 208 coo 49.16 35.16 15.19 51.08 34.43 15.65 65.36 -83.80 -40.24 66.17 -85.36 -41.35 coo 70.09 11.71 8.46 70.56 12.89 6.77 45.29 -60.19 -41.07 45.99 -58.52 -39.91 coo 59.16 37.82 13.95 57.63 37.03 15.12 58.25 -87.45 -44.58 60.23 -87.13 -43.88 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 4 3 # 4 199 ASP A 114 ASP.? 22.11 CA CA A 208 218 GLU A 184 GLU~? 7.72 C16 C8E A 210 329 ASP A 111 ASP.? 17.05 CA CA A 208 coo 49.16 35.16 15.19 51.08 34.43 15.65 71.50 -87.46 -45.26 70.62 -89.18 -46.15 coo 70.09 11.71 8.46 70.56 12.89 6.77 63.73 -84.37 -12.45 63.45 -82.45 -11.70 coo 59.16 37.82 13.95 57.63 37.03 15.12 65.36 -83.80 -40.24 66.17 -85.36 -41.35 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 5 3 # 5 199 ASP A 149 ASP^? 14.85 C1 C8E A 210 218 GLU C 93 GLU^? 26.90 C13 C8E C 210 329 ASP A 80 ASP^? 12.60 C1 C8E A 210 coo 49.16 35.16 15.19 51.08 34.43 15.65 66.40 -51.17 -20.74 65.06 -51.90 -19.38 coo 70.09 11.71 8.46 70.56 12.89 6.77 45.29 -60.19 -41.07 45.99 -58.52 -39.91 coo 59.16 37.82 13.95 57.63 37.03 15.12 58.12 -52.30 -15.93 59.10 -53.68 -17.13 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 6 3 # 6 199 ASP A 149 ASP^? 14.85 C1 C8E A 210 218 GLU C 194 GLU.? 3.24 O15 C8E C 209s 329 ASP A 153 ASP^? 8.28 C1 C8E A 210 coo 49.16 35.16 15.19 51.08 34.43 15.65 66.40 -51.17 -20.74 65.06 -51.90 -19.38 coo 70.09 11.71 8.46 70.56 12.89 6.77 36.17 -59.59 -12.28 34.91 -60.51 -10.83 coo 59.16 37.82 13.95 57.63 37.03 15.12 63.37 -61.81 -16.17 62.75 -59.91 -16.84 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 7 3 # 7 199 ASP A 153 ASP^? 8.28 C1 C8E A 210 218 GLU B 7 GLU^? 19.70 O15 C8E B 209 329 ASP A 80 ASP^? 12.60 C1 C8E A 210 coo 49.16 35.16 15.19 51.08 34.43 15.65 63.37 -61.81 -16.17 62.75 -59.91 -16.84 coo 70.09 11.71 8.46 70.56 12.89 6.77 73.39 -38.66 -35.65 75.17 -39.55 -36.49 coo 59.16 37.82 13.95 57.63 37.03 15.12 58.12 -52.30 -15.93 59.10 -53.68 -17.13 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 8 3 # 8 199 ASP A 153 ASP^? 8.28 C1 C8E A 210 218 GLU C 7 GLU^? 20.56 C16 C8E C 210 329 ASP A 149 ASP^? 14.85 C1 C8E A 210 coo 49.16 35.16 15.19 51.08 34.43 15.65 63.37 -61.81 -16.17 62.75 -59.91 -16.84 coo 70.09 11.71 8.46 70.56 12.89 6.77 43.33 -49.69 -35.12 43.56 -51.77 -34.52 coo 59.16 37.82 13.95 57.63 37.03 15.12 66.40 -51.17 -20.74 65.06 -51.90 -19.38 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 9 3 # 9 199 ASP A 153 ASP^? 8.28 C1 C8E A 210 218 GLU C 93 GLU^? 26.90 C13 C8E C 210 329 ASP A 80 ASP^? 12.60 C1 C8E A 210 coo 49.16 35.16 15.19 51.08 34.43 15.65 63.37 -61.81 -16.17 62.75 -59.91 -16.84 coo 70.09 11.71 8.46 70.56 12.89 6.77 45.29 -60.19 -41.07 45.99 -58.52 -39.91 coo 59.16 37.82 13.95 57.63 37.03 15.12 58.12 -52.30 -15.93 59.10 -53.68 -17.13 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 10 3 # 10 199 ASP A 153 ASP^? 8.28 C1 C8E A 210 218 GLU C 93 GLU^? 26.90 C13 C8E C 210 329 ASP A 149 ASP^? 14.85 C1 C8E A 210 coo 49.16 35.16 15.19 51.08 34.43 15.65 63.37 -61.81 -16.17 62.75 -59.91 -16.84 coo 70.09 11.71 8.46 70.56 12.89 6.77 45.29 -60.19 -41.07 45.99 -58.52 -39.91 coo 59.16 37.82 13.95 57.63 37.03 15.12 66.40 -51.17 -20.74 65.06 -51.90 -19.38 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 11 3 # 11 199 ASP A 153 ASP^? 8.28 C1 C8E A 210 218 GLU C 184 GLU~? 7.93 C14 C8E C 209 329 ASP A 80 ASP^? 12.60 C1 C8E A 210 coo 49.16 35.16 15.19 51.08 34.43 15.65 63.37 -61.81 -16.17 62.75 -59.91 -16.84 coo 70.09 11.71 8.46 70.56 12.89 6.77 35.72 -59.91 1.24 36.69 -61.13 -0.21 coo 59.16 37.82 13.95 57.63 37.03 15.12 58.12 -52.30 -15.93 59.10 -53.68 -17.13 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 12 3 # 12 199 ASP A 166 ASP.? 23.45 CA CA A 208 218 GLU A 194 GLU.? 3.11 C17 C8E A 210s 329 ASP A 111 ASP.? 17.05 CA CA A 208 coo 49.16 35.16 15.19 51.08 34.43 15.65 55.95 -88.25 -40.15 55.99 -89.39 -38.36 coo 70.09 11.71 8.46 70.56 12.89 6.77 66.12 -70.72 -14.05 67.03 -72.48 -13.31 coo 59.16 37.82 13.95 57.63 37.03 15.12 65.36 -83.80 -40.24 66.17 -85.36 -41.35 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 13 3 # 13 199 ASP A 167 ASP.? 22.50 CA CA A 208 218 GLU A 184 GLU~? 7.72 C16 C8E A 210 329 ASP A 111 ASP.? 17.05 CA CA A 208 coo 49.16 35.16 15.19 51.08 34.43 15.65 58.25 -87.45 -44.58 60.23 -87.13 -43.88 coo 70.09 11.71 8.46 70.56 12.89 6.77 63.73 -84.37 -12.45 63.45 -82.45 -11.70 coo 59.16 37.82 13.95 57.63 37.03 15.12 65.36 -83.80 -40.24 66.17 -85.36 -41.35 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 14 3 # 14 199 ASP A 180 ASP.? 14.47 O15 C8E A 210 218 GLU A 113 GLU.? 20.24 CA CA A 208 329 ASP A 185 ASP~? 11.73 O21 C8E A 210 coo 49.16 35.16 15.19 51.08 34.43 15.65 55.45 -86.10 -15.44 53.65 -85.04 -15.38 coo 70.09 11.71 8.46 70.56 12.89 6.77 67.94 -85.82 -46.11 66.40 -86.46 -44.83 coo 59.16 37.82 13.95 57.63 37.03 15.12 65.81 -86.27 -18.22 66.54 -87.64 -16.78 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 15 3 # 15 199 ASP B 80 ASP^? 15.94 O15 C8E B 209 218 GLU B 70 GLU^? -2.58 CA CA B 208s 329 ASP B 149 ASP^? 14.91 O15 C8E B 209 coo 49.16 35.16 15.19 51.08 34.43 15.65 82.56 -37.87 -41.00 82.97 -37.16 -39.06 coo 70.09 11.71 8.46 70.56 12.89 6.77 89.83 -24.96 -14.47 91.03 -26.69 -14.39 coo 59.16 37.82 13.95 57.63 37.03 15.12 79.48 -42.39 -33.32 81.04 -41.48 -34.38 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 16 3 # 16 199 ASP B 153 ASP^? 9.57 O15 C8E B 209 218 GLU A 7 GLU^? 19.52 C17 C8E A 209 329 ASP B 80 ASP^? 15.94 O15 C8E B 209 coo 49.16 35.16 15.19 51.08 34.43 15.65 89.74 -36.17 -33.46 87.76 -36.55 -34.22 coo 70.09 11.71 8.46 70.56 12.89 6.77 61.29 -47.52 -25.12 61.48 -48.69 -23.33 coo 59.16 37.82 13.95 57.63 37.03 15.12 82.56 -37.87 -41.00 82.97 -37.16 -39.06 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 17 3 # 17 199 ASP B 166 ASP.? 24.17 CA CA B 208 218 GLU B 194 GLU.? 2.86 C13 C8E B 210s 329 ASP B 111 ASP.? 16.97 CA CA B 208 coo 49.16 35.16 15.19 51.08 34.43 15.65 91.14 -5.33 -14.11 93.17 -5.00 -14.63 coo 70.09 11.71 8.46 70.56 12.89 6.77 97.88 -33.97 -28.78 99.62 -34.16 -27.58 coo 59.16 37.82 13.95 57.63 37.03 15.12 89.21 -14.92 -8.80 89.40 -13.99 -6.98 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 18 3 # 18 199 ASP B 167 ASP.? 22.72 CA CA B 208 218 GLU B 184 GLU~? 8.45 C14 C8E B 210 329 ASP B 111 ASP.? 16.97 CA CA B 208 coo 49.16 35.16 15.19 51.08 34.43 15.65 88.92 -5.85 -9.56 88.92 -7.42 -8.19 coo 70.09 11.71 8.46 70.56 12.89 6.77 107.80 -26.84 -26.43 109.06 -28.52 -26.54 coo 59.16 37.82 13.95 57.63 37.03 15.12 89.21 -14.92 -8.80 89.40 -13.99 -6.98 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 19 3 # 19 199 ASP B 180 ASP.? 10.93 C4 C8E B 210 218 GLU B 113 GLU.? 20.51 CA CA B 208 329 ASP B 185 ASP~? 11.63 O21 C8E B 210 coo 49.16 35.16 15.19 51.08 34.43 15.65 106.50 -18.19 -29.27 105.54 -17.21 -30.85 coo 70.09 11.71 8.46 70.56 12.89 6.77 86.78 -12.34 -3.10 88.60 -11.66 -4.00 coo 59.16 37.82 13.95 57.63 37.03 15.12 106.30 -23.80 -20.43 108.26 -24.54 -20.08 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 20 3 # 20 199 ASP C 80 ASP^? 16.43 C13 C8E C 210 218 GLU C 70 GLU^? -2.71 CA CA C 208s 329 ASP C 149 ASP^? 16.02 C16 C8E C 210 coo 49.16 35.16 15.19 51.08 34.43 15.65 47.10 -57.14 -28.79 45.64 -55.94 -27.77 coo 70.09 11.71 8.46 70.56 12.89 6.77 27.73 -42.94 -10.42 26.74 -44.79 -10.37 coo 59.16 37.82 13.95 57.63 37.03 15.12 38.72 -55.19 -32.44 40.02 -55.93 -30.97 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 21 3 # 21 199 ASP C 114 ASP.? 22.22 CA CA C 208 218 GLU C 184 GLU~? 7.93 C14 C8E C 209 329 ASP C 111 ASP.? 17.21 CA CA C 208 coo 49.16 35.16 15.19 51.08 34.43 15.65 19.39 -30.14 -1.59 19.46 -28.98 0.18 coo 70.09 11.71 8.46 70.56 12.89 6.77 35.72 -59.91 1.24 36.69 -61.13 -0.21 coo 59.16 37.82 13.95 57.63 37.03 15.12 27.11 -33.17 -3.90 25.73 -31.94 -3.00 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 22 3 # 22 199 ASP C 149 ASP^? 16.02 C16 C8E C 210 218 GLU A 93 GLU^? 23.51 C1 C8E A 210 329 ASP C 80 ASP^? 16.43 C13 C8E C 210 coo 49.16 35.16 15.19 51.08 34.43 15.65 38.72 -55.19 -32.44 40.02 -55.93 -30.97 coo 70.09 11.71 8.46 70.56 12.89 6.77 64.33 -40.66 -16.04 62.38 -40.13 -16.70 coo 59.16 37.82 13.95 57.63 37.03 15.12 47.10 -57.14 -28.79 45.64 -55.94 -27.77 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 23 3 # 23 199 ASP C 149 ASP^? 16.02 C16 C8E C 210 218 GLU A 93 GLU^? 23.51 C1 C8E A 210 329 ASP C 153 ASP^? 9.83 C13 C8E C 210 coo 49.16 35.16 15.19 51.08 34.43 15.65 38.72 -55.19 -32.44 40.02 -55.93 -30.97 coo 70.09 11.71 8.46 70.56 12.89 6.77 64.33 -40.66 -16.04 62.38 -40.13 -16.70 coo 59.16 37.82 13.95 57.63 37.03 15.12 40.09 -57.62 -20.90 41.26 -57.13 -22.61 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 24 3 # 24 199 ASP C 149 ASP^? 16.02 C16 C8E C 210 218 GLU A 165 GLU^? 21.76 CA CA A 208 329 ASP C 80 ASP^? 16.43 C13 C8E C 210 coo 49.16 35.16 15.19 51.08 34.43 15.65 38.72 -55.19 -32.44 40.02 -55.93 -30.97 coo 70.09 11.71 8.46 70.56 12.89 6.77 55.17 -82.77 -39.51 54.39 -80.85 -40.05 coo 59.16 37.82 13.95 57.63 37.03 15.12 47.10 -57.14 -28.79 45.64 -55.94 -27.77 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 25 3 # 25 199 ASP C 166 ASP.? 24.81 CA CA C 208 218 GLU C 194 GLU.? 3.24 O15 C8E C 209s 329 ASP C 111 ASP.? 17.21 CA CA C 208 coo 49.16 35.16 15.19 51.08 34.43 15.65 35.75 -30.25 2.83 35.54 -31.07 4.76 coo 70.09 11.71 8.46 70.56 12.89 6.77 36.17 -59.59 -12.28 34.91 -60.51 -10.83 coo 59.16 37.82 13.95 57.63 37.03 15.12 27.11 -33.17 -3.90 25.73 -31.94 -3.00 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 26 3 # 26 199 ASP C 167 ASP.? 25.18 CA CA C 208 218 GLU C 184 GLU~? 7.93 C14 C8E C 209 329 ASP C 111 ASP.? 17.21 CA CA C 208 coo 49.16 35.16 15.19 51.08 34.43 15.65 31.39 -27.44 2.08 30.34 -25.78 1.31 coo 70.09 11.71 8.46 70.56 12.89 6.77 35.72 -59.91 1.24 36.69 -61.13 -0.21 coo 59.16 37.82 13.95 57.63 37.03 15.12 27.11 -33.17 -3.90 25.73 -31.94 -3.00 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 27 3 # 27 199 ASP C 180 ASP.? 12.29 C5 C8E C 209 218 GLU C 113 GLU.? 20.72 CA CA C 208 329 ASP C 185 ASP~? 11.81 O21 C8E C 209 coo 49.16 35.16 15.19 51.08 34.43 15.65 42.24 -54.49 3.97 44.24 -53.90 3.82 coo 70.09 11.71 8.46 70.56 12.89 6.77 22.93 -28.02 -2.65 24.78 -28.62 -1.78 coo 59.16 37.82 13.95 57.63 37.03 15.12 31.89 -54.53 1.93 31.11 -55.91 3.29 1uok_c04 source 1uok OLIGO-1,6-GLUCOSIDASE : 27 hits 1uok_c04 naa= 3 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 149 ASP^? 14.85 C1 C8E A 210 242 GLU B 7 GLU^? 19.70 O15 C8E B 209 329 ASP A 80 ASP^? 12.60 C1 C8E A 210 coo 49.16 35.16 15.19 51.08 34.43 15.65 66.40 -51.17 -20.74 65.06 -51.90 -19.38 coo 30.42 34.74 5.00 29.09 35.09 3.38 73.39 -38.66 -35.65 75.17 -39.55 -36.49 coo 59.16 37.82 13.95 57.63 37.03 15.12 58.12 -52.30 -15.93 59.10 -53.68 -17.13 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP A 149 ASP^? 14.85 C1 C8E A 210 242 GLU B 7 GLU^? 19.70 O15 C8E B 209 329 ASP A 153 ASP^? 8.28 C1 C8E A 210 coo 49.16 35.16 15.19 51.08 34.43 15.65 66.40 -51.17 -20.74 65.06 -51.90 -19.38 coo 30.42 34.74 5.00 29.09 35.09 3.38 73.39 -38.66 -35.65 75.17 -39.55 -36.49 coo 59.16 37.82 13.95 57.63 37.03 15.12 63.37 -61.81 -16.17 62.75 -59.91 -16.84 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP A 149 ASP^? 14.85 C1 C8E A 210 242 GLU B 93 GLU^? 27.23 O15 C8E B 209 329 ASP A 80 ASP^? 12.60 C1 C8E A 210 coo 49.16 35.16 15.19 51.08 34.43 15.65 66.40 -51.17 -20.74 65.06 -51.90 -19.38 coo 30.42 34.74 5.00 29.09 35.09 3.38 75.25 -49.35 -42.08 74.13 -47.63 -42.56 coo 59.16 37.82 13.95 57.63 37.03 15.12 58.12 -52.30 -15.93 59.10 -53.68 -17.13 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 4 3 # 4 199 ASP A 149 ASP^? 14.85 C1 C8E A 210 242 GLU B 93 GLU^? 27.23 O15 C8E B 209 329 ASP A 153 ASP^? 8.28 C1 C8E A 210 coo 49.16 35.16 15.19 51.08 34.43 15.65 66.40 -51.17 -20.74 65.06 -51.90 -19.38 coo 30.42 34.74 5.00 29.09 35.09 3.38 75.25 -49.35 -42.08 74.13 -47.63 -42.56 coo 59.16 37.82 13.95 57.63 37.03 15.12 63.37 -61.81 -16.17 62.75 -59.91 -16.84 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 5 3 # 5 199 ASP A 153 ASP^? 8.28 C1 C8E A 210 242 GLU A 70 GLU^? -2.69 CA CA A 208s 329 ASP A 80 ASP^? 12.60 C1 C8E A 210 coo 49.16 35.16 15.19 51.08 34.43 15.65 63.37 -61.81 -16.17 62.75 -59.91 -16.84 coo 30.42 34.74 5.00 29.09 35.09 3.38 68.79 -75.79 -31.87 70.14 -76.30 -30.27 coo 59.16 37.82 13.95 57.63 37.03 15.12 58.12 -52.30 -15.93 59.10 -53.68 -17.13 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 6 3 # 6 199 ASP B 149 ASP^? 14.91 O15 C8E B 209 242 GLU A 7 GLU^? 19.52 C17 C8E A 209 329 ASP B 153 ASP^? 9.57 O15 C8E B 209 coo 49.16 35.16 15.19 51.08 34.43 15.65 79.48 -42.39 -33.32 81.04 -41.48 -34.38 coo 30.42 34.74 5.00 29.09 35.09 3.38 61.29 -47.52 -25.12 61.48 -48.69 -23.33 coo 59.16 37.82 13.95 57.63 37.03 15.12 89.74 -36.17 -33.46 87.76 -36.55 -34.22 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 7 3 # 7 199 ASP B 149 ASP^? 14.91 O15 C8E B 209 242 GLU A 93 GLU^? 23.51 C1 C8E A 210 329 ASP B 80 ASP^? 15.94 O15 C8E B 209 coo 49.16 35.16 15.19 51.08 34.43 15.65 79.48 -42.39 -33.32 81.04 -41.48 -34.38 coo 30.42 34.74 5.00 29.09 35.09 3.38 64.33 -40.66 -16.04 62.38 -40.13 -16.70 coo 59.16 37.82 13.95 57.63 37.03 15.12 82.56 -37.87 -41.00 82.97 -37.16 -39.06 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 8 3 # 8 199 ASP B 149 ASP^? 14.91 O15 C8E B 209 242 GLU A 93 GLU^? 23.51 C1 C8E A 210 329 ASP B 153 ASP^? 9.57 O15 C8E B 209 coo 49.16 35.16 15.19 51.08 34.43 15.65 79.48 -42.39 -33.32 81.04 -41.48 -34.38 coo 30.42 34.74 5.00 29.09 35.09 3.38 64.33 -40.66 -16.04 62.38 -40.13 -16.70 coo 59.16 37.82 13.95 57.63 37.03 15.12 89.74 -36.17 -33.46 87.76 -36.55 -34.22 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 9 3 # 9 199 ASP B 153 ASP^? 9.57 O15 C8E B 209 242 GLU B 70 GLU^? -2.58 CA CA B 208s 329 ASP B 80 ASP^? 15.94 O15 C8E B 209 coo 49.16 35.16 15.19 51.08 34.43 15.65 89.74 -36.17 -33.46 87.76 -36.55 -34.22 coo 30.42 34.74 5.00 29.09 35.09 3.38 89.83 -24.96 -14.47 91.03 -26.69 -14.39 coo 59.16 37.82 13.95 57.63 37.03 15.12 82.56 -37.87 -41.00 82.97 -37.16 -39.06 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 10 3 # 10 199 ASP B 153 ASP^? 9.57 O15 C8E B 209 242 GLU B 184 GLU~? 8.45 C14 C8E B 210 329 ASP B 80 ASP^? 15.94 O15 C8E B 209 coo 49.16 35.16 15.19 51.08 34.43 15.65 89.74 -36.17 -33.46 87.76 -36.55 -34.22 coo 30.42 34.74 5.00 29.09 35.09 3.38 107.80 -26.84 -26.43 109.06 -28.52 -26.54 coo 59.16 37.82 13.95 57.63 37.03 15.12 82.56 -37.87 -41.00 82.97 -37.16 -39.06 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 11 3 # 11 199 ASP B 185 ASP~? 11.63 O21 C8E B 210 242 GLU B 64 GLU~? 12.78 CA CA B 208 329 ASP B 180 ASP.? 10.93 C4 C8E B 210 coo 49.16 35.16 15.19 51.08 34.43 15.65 106.30 -23.80 -20.43 108.26 -24.54 -20.08 coo 30.42 34.74 5.00 29.09 35.09 3.38 92.75 -26.79 -1.73 90.87 -27.74 -1.56 coo 59.16 37.82 13.95 57.63 37.03 15.12 106.50 -18.19 -29.27 105.54 -17.21 -30.85 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 12 3 # 12 199 ASP C 153 ASP^? 9.83 C13 C8E C 210 242 GLU C 70 GLU^? -2.71 CA CA C 208s 329 ASP C 80 ASP^? 16.43 C13 C8E C 210 coo 49.16 35.16 15.19 51.08 34.43 15.65 40.09 -57.62 -20.90 41.26 -57.13 -22.61 coo 30.42 34.74 5.00 29.09 35.09 3.38 27.73 -42.94 -10.42 26.74 -44.79 -10.37 coo 59.16 37.82 13.95 57.63 37.03 15.12 47.10 -57.14 -28.79 45.64 -55.94 -27.77 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 13 3 # 13 199 ASP C 153 ASP^? 9.83 C13 C8E C 210 242 GLU C 184 GLU~? 7.93 C14 C8E C 209 329 ASP C 80 ASP^? 16.43 C13 C8E C 210 coo 49.16 35.16 15.19 51.08 34.43 15.65 40.09 -57.62 -20.90 41.26 -57.13 -22.61 coo 30.42 34.74 5.00 29.09 35.09 3.38 35.72 -59.91 1.24 36.69 -61.13 -0.21 coo 59.16 37.82 13.95 57.63 37.03 15.12 47.10 -57.14 -28.79 45.64 -55.94 -27.77 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 14 3 # 14 199 ASP C 185 ASP~? 11.81 O21 C8E C 209 242 GLU C 64 GLU~? 12.03 CA CA C 208 329 ASP C 180 ASP.? 12.29 C5 C8E C 209 coo 49.16 35.16 15.19 51.08 34.43 15.65 31.89 -54.53 1.93 31.11 -55.91 3.29 coo 30.42 34.74 5.00 29.09 35.09 3.38 16.47 -41.84 -8.31 14.60 -42.35 -9.15 coo 59.16 37.82 13.95 57.63 37.03 15.12 42.24 -54.49 3.97 44.24 -53.90 3.82 1uok_c05 source 1uok OLIGO-1,6-GLUCOSIDASE : 14 hits 1uok_c05 naa= 3 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 1 3 # 1 A 100 PHE A 104 PHE^? 12.68 O21 C8E A 209 A 197 ASN A 74 ASN^? -3.00 O21 C8E A 209s A 198 PRO A 193 PRO.? -3.59 C20 C8E A 209s coo 5.24 -2.19 28.74 3.83 -0.30 30.29 54.10 -67.12 -25.17 51.89 -66.22 -23.71 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 62.15 -65.86 -25.53 63.13 -67.52 -24.67 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 62.99 -68.36 -21.23 64.14 -69.92 -20.16 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 2 3 # 2 A 100 PHE A 104 PHE^? 12.68 O21 C8E A 209 A 197 ASN A 103 ASN^? 6.31 O21 C8E A 209 A 198 PRO A 193 PRO.? -3.59 C20 C8E A 209s coo 5.24 -2.19 28.74 3.83 -0.30 30.29 54.10 -67.12 -25.17 51.89 -66.22 -23.71 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 58.51 -66.15 -21.33 59.95 -66.28 -22.87 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 62.99 -68.36 -21.23 64.14 -69.92 -20.16 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 3 3 # 3 A 100 PHE B 41 PHE^? 11.29 C20 C8E B 209 A 197 ASN B 74 ASN^? -3.28 C20 C8E B 209s A 198 PRO B 193 PRO.? -3.08 O21 C8E B 209s coo 5.24 -2.19 28.74 3.83 -0.30 30.29 78.91 -27.63 -25.83 79.60 -26.32 -23.43 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 85.94 -28.94 -27.06 87.84 -29.20 -26.13 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 90.66 -29.80 -28.19 92.68 -30.26 -27.36 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 4 3 # 4 A 100 PHE B 104 PHE^? 13.28 C1 C8E B 210 A 197 ASN B 74 ASN^? -3.28 C20 C8E B 209s A 198 PRO B 193 PRO.? -3.08 O21 C8E B 209s coo 5.24 -2.19 28.74 3.83 -0.30 30.29 85.81 -22.57 -32.36 85.48 -21.80 -35.06 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 85.94 -28.94 -27.06 87.84 -29.20 -26.13 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 90.66 -29.80 -28.19 92.68 -30.26 -27.36 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 5 3 # 5 A 100 PHE B 104 PHE^? 13.28 C1 C8E B 210 A 197 ASN B 103 ASN^? 6.73 O21 C8E B 209 A 198 PRO B 193 PRO.? -3.08 O21 C8E B 209s coo 5.24 -2.19 28.74 3.83 -0.30 30.29 85.81 -22.57 -32.36 85.48 -21.80 -35.06 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 88.46 -28.09 -32.02 87.63 -28.23 -30.06 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 90.66 -29.80 -28.19 92.68 -30.26 -27.36 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 6 3 # 6 A 100 PHE C 41 PHE^? 11.26 C20 C8E C 210 A 197 ASN C 74 ASN^? -3.17 C20 C8E C 210s A 198 PRO C 193 PRO.? -3.52 C20 C8E C 210s coo 5.24 -2.19 28.74 3.83 -0.30 30.29 38.53 -42.08 -22.17 36.81 -40.66 -20.50 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 38.01 -47.64 -17.99 37.26 -48.68 -16.35 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 38.01 -51.99 -15.07 36.74 -53.25 -13.74 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 7 3 # 7 A 100 PHE C 104 PHE^? 12.59 C20 C8E C 210 A 197 ASN C 74 ASN^? -3.17 C20 C8E C 210s A 198 PRO C 193 PRO.? -3.52 C20 C8E C 210s coo 5.24 -2.19 28.74 3.83 -0.30 30.29 45.31 -45.69 -15.13 48.07 -46.01 -15.44 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 38.01 -47.64 -17.99 37.26 -48.68 -16.35 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 38.01 -51.99 -15.07 36.74 -53.25 -13.74 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 8 3 # 8 A 100 PHE C 104 PHE^? 12.59 C20 C8E C 210 A 197 ASN C 103 ASN^? 6.32 C20 C8E C 210 A 198 PRO C 193 PRO.? -3.52 C20 C8E C 210s coo 5.24 -2.19 28.74 3.83 -0.30 30.29 45.31 -45.69 -15.13 48.07 -46.01 -15.44 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 42.54 -50.86 -16.42 40.88 -49.65 -16.80 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 38.01 -51.99 -15.07 36.74 -53.25 -13.74 1vq1_c00 source 1vq1 N5-GLUTAMINE METHYLTRANSFERASE, HEMK : 8 hits 1vq1_c00 naa= 3 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 1 3 # 1 B 100 PHE A 104 PHE^? 12.68 O21 C8E A 209 B 197 ASN A 74 ASN^? -3.00 O21 C8E A 209s B 198 PRO A 193 PRO.? -3.59 C20 C8E A 209s coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 54.10 -67.12 -25.17 51.89 -66.22 -23.71 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 62.15 -65.86 -25.53 63.13 -67.52 -24.67 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 62.99 -68.36 -21.23 64.14 -69.92 -20.16 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 2 3 # 2 B 100 PHE A 104 PHE^? 12.68 O21 C8E A 209 B 197 ASN A 103 ASN^? 6.31 O21 C8E A 209 B 198 PRO A 193 PRO.? -3.59 C20 C8E A 209s coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 54.10 -67.12 -25.17 51.89 -66.22 -23.71 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 58.51 -66.15 -21.33 59.95 -66.28 -22.87 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 62.99 -68.36 -21.23 64.14 -69.92 -20.16 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 3 3 # 3 B 100 PHE B 41 PHE^? 11.29 C20 C8E B 209 B 197 ASN B 74 ASN^? -3.28 C20 C8E B 209s B 198 PRO B 193 PRO.? -3.08 O21 C8E B 209s coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 78.91 -27.63 -25.83 79.60 -26.32 -23.43 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 85.94 -28.94 -27.06 87.84 -29.20 -26.13 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 90.66 -29.80 -28.19 92.68 -30.26 -27.36 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 4 3 # 4 B 100 PHE B 104 PHE^? 13.28 C1 C8E B 210 B 197 ASN B 74 ASN^? -3.28 C20 C8E B 209s B 198 PRO B 193 PRO.? -3.08 O21 C8E B 209s coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 85.81 -22.57 -32.36 85.48 -21.80 -35.06 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 85.94 -28.94 -27.06 87.84 -29.20 -26.13 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 90.66 -29.80 -28.19 92.68 -30.26 -27.36 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 5 3 # 5 B 100 PHE B 104 PHE^? 13.28 C1 C8E B 210 B 197 ASN B 103 ASN^? 6.73 O21 C8E B 209 B 198 PRO B 193 PRO.? -3.08 O21 C8E B 209s coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 85.81 -22.57 -32.36 85.48 -21.80 -35.06 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 88.46 -28.09 -32.02 87.63 -28.23 -30.06 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 90.66 -29.80 -28.19 92.68 -30.26 -27.36 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 6 3 # 6 B 100 PHE C 41 PHE^? 11.26 C20 C8E C 210 B 197 ASN C 74 ASN^? -3.17 C20 C8E C 210s B 198 PRO C 193 PRO.? -3.52 C20 C8E C 210s coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 38.53 -42.08 -22.17 36.81 -40.66 -20.50 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 38.01 -47.64 -17.99 37.26 -48.68 -16.35 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 38.01 -51.99 -15.07 36.74 -53.25 -13.74 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 7 3 # 7 B 100 PHE C 104 PHE^? 12.59 C20 C8E C 210 B 197 ASN C 74 ASN^? -3.17 C20 C8E C 210s B 198 PRO C 193 PRO.? -3.52 C20 C8E C 210s coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 45.31 -45.69 -15.13 48.07 -46.01 -15.44 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 38.01 -47.64 -17.99 37.26 -48.68 -16.35 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 38.01 -51.99 -15.07 36.74 -53.25 -13.74 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 8 3 # 8 B 100 PHE C 104 PHE^? 12.59 C20 C8E C 210 B 197 ASN C 103 ASN^? 6.32 C20 C8E C 210 B 198 PRO C 193 PRO.? -3.52 C20 C8E C 210s coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 45.31 -45.69 -15.13 48.07 -46.01 -15.44 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 42.54 -50.86 -16.42 40.88 -49.65 -16.80 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 38.01 -51.99 -15.07 36.74 -53.25 -13.74 1vq1_c01 source 1vq1 N5-GLUTAMINE METHYLTRANSFERASE, HEMK : 8 hits 1vq1_c01 naa= 3 ULMN 3 1vzx_c02 2.04.01.0087 user 1 3 # 1 A 314 TYR A 183 TYR~? 7.18 C16 C8E A 210 A 317 GLU A 184 GLU~? 7.72 C16 C8E A 210 A 365 ARG A 162 ARG^? 10.87 O21 C8E A 210 coo 1.77 6.56 57.05 3.05 7.44 59.37 59.65 -81.82 -15.52 59.58 -79.01 -15.74 coo 3.06 2.85 52.79 4.83 3.89 53.24 63.73 -84.37 -12.45 63.45 -82.45 -11.70 coo 3.82 17.09 49.56 4.09 14.32 50.84 60.16 -83.54 -27.36 63.31 -83.18 -27.03 1vzx_c02 source 1vzx 2.04.01.0087 : 1 hits 1vzx_c02 naa= 3 ULMN 3 1vzx_c03 2.04.01.0087 user 1 3 # 1 B1314 TYR A 183 TYR~? 7.18 C16 C8E A 210 B1317 GLU A 184 GLU~? 7.72 C16 C8E A 210 B1365 ARG A 162 ARG^? 10.87 O21 C8E A 210 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 59.65 -81.82 -15.52 59.58 -79.01 -15.74 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 63.73 -84.37 -12.45 63.45 -82.45 -11.70 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 60.16 -83.54 -27.36 63.31 -83.18 -27.03 1vzx_c03 source 1vzx 2.04.01.0087 : 1 hits 1vzx_c03 naa= 3 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 1 3 # 1 A 16 TYR A 13 TYR^? 6.88 C17 C8E A 209 A 40 ASP A 149 ASP^? 14.85 C1 C8E A 210 A 103 LEU A 199 LEU^? 10.78 C1 C8E A 209 coo 12.09 16.13 10.57 11.28 18.80 10.73 65.07 -60.93 -23.01 63.35 -61.54 -20.90 coo 7.55 25.51 14.34 9.65 25.73 14.24 66.40 -51.17 -20.74 65.06 -51.90 -19.38 coo 11.83 18.73 16.99 10.99 19.71 15.26 71.88 -55.87 -21.82 73.59 -54.65 -21.37 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 2 3 # 2 A 16 TYR A 51 TYR.? 9.92 O21 C8E A 210 A 40 ASP A 45 ASP.? -2.96 CA CA A 208s A 103 LEU A 47 LEU.? -6.16 CA CA A 208s coo 12.09 16.13 10.57 11.28 18.80 10.73 71.70 -83.21 -22.40 69.97 -85.02 -21.17 coo 7.55 25.51 14.34 9.65 25.73 14.24 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo 11.83 18.73 16.99 10.99 19.71 15.26 68.63 -79.08 -27.35 66.53 -79.28 -27.97 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 3 3 # 3 A 16 TYR A 51 TYR.? 9.92 O21 C8E A 210 A 40 ASP A 61 ASP~? 12.37 CA CA A 208 A 103 LEU A 53 LEU.? 12.26 CA CA A 208 coo 12.09 16.13 10.57 11.28 18.80 10.73 71.70 -83.21 -22.40 69.97 -85.02 -21.17 coo 7.55 25.51 14.34 9.65 25.73 14.24 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo 11.83 18.73 16.99 10.99 19.71 15.26 71.93 -88.29 -26.11 70.93 -86.53 -26.97 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 4 3 # 4 A 16 TYR A 83 TYR^? -19.24 C2 C8E C 209s A 40 ASP A 26 ASP.? 24.86 C2 C8E C 209 A 103 LEU A 31 LEU.? 19.24 C2 C8E C 209 coo 12.09 16.13 10.57 11.28 18.80 10.73 59.25 -44.27 -7.74 58.41 -42.23 -6.03 coo 7.55 25.51 14.34 9.65 25.73 14.24 53.70 -37.11 -16.05 55.72 -36.42 -15.97 coo 11.83 18.73 16.99 10.99 19.71 15.26 52.60 -39.79 -9.06 50.82 -40.32 -7.99 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 5 3 # 5 A 16 TYR A 83 TYR^? -19.24 C2 C8E C 209s A 40 ASP A 26 ASP.? 24.86 C2 C8E C 209 A 103 LEU A 33 LEU^? 15.98 C2 C8E C 209 coo 12.09 16.13 10.57 11.28 18.80 10.73 59.25 -44.27 -7.74 58.41 -42.23 -6.03 coo 7.55 25.51 14.34 9.65 25.73 14.24 53.70 -37.11 -16.05 55.72 -36.42 -15.97 coo 11.83 18.73 16.99 10.99 19.71 15.26 53.84 -43.82 -10.58 54.72 -44.80 -8.87 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 6 3 # 6 A 16 TYR A 97 TYR^? 11.99 C1 C8E A 210 A 40 ASP A 153 ASP^? 8.28 C1 C8E A 210 A 103 LEU A 132 LEU^? 6.01 C1 C8E A 210 coo 12.09 16.13 10.57 11.28 18.80 10.73 61.97 -51.46 -14.47 63.57 -52.89 -16.21 coo 7.55 25.51 14.34 9.65 25.73 14.24 63.37 -61.81 -16.17 62.75 -59.91 -16.84 coo 11.83 18.73 16.99 10.99 19.71 15.26 64.80 -56.61 -10.52 64.08 -56.26 -8.61 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 7 3 # 7 A 16 TYR A 102 TYR^? 9.25 C1 C8E C 209 A 40 ASP C 80 ASP^? 16.43 C13 C8E C 210 A 103 LEU A 77 LEU^? 14.89 C1 C8E C 209 coo 12.09 16.13 10.57 11.28 18.80 10.73 52.54 -63.26 -18.57 51.08 -62.17 -16.42 coo 7.55 25.51 14.34 9.65 25.73 14.24 47.10 -57.14 -28.79 45.64 -55.94 -27.77 coo 11.83 18.73 16.99 10.99 19.71 15.26 53.57 -60.43 -22.55 52.63 -60.94 -24.40 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 8 3 # 8 A 16 TYR A 109 TYR^? 10.85 CA CA A 208 A 40 ASP A 45 ASP.? -2.96 CA CA A 208s A 103 LEU A 47 LEU.? -6.16 CA CA A 208s coo 12.09 16.13 10.57 11.28 18.80 10.73 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo 7.55 25.51 14.34 9.65 25.73 14.24 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo 11.83 18.73 16.99 10.99 19.71 15.26 68.63 -79.08 -27.35 66.53 -79.28 -27.97 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 9 3 # 9 A 16 TYR A 109 TYR^? 10.85 CA CA A 208 A 40 ASP A 49 ASP.? -3.00 CA CA A 208s A 103 LEU A 47 LEU.? -6.16 CA CA A 208s coo 12.09 16.13 10.57 11.28 18.80 10.73 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo 7.55 25.51 14.34 9.65 25.73 14.24 75.72 -77.89 -27.98 74.67 -77.10 -29.65 coo 11.83 18.73 16.99 10.99 19.71 15.26 68.63 -79.08 -27.35 66.53 -79.28 -27.97 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 10 3 # 10 A 16 TYR B 13 TYR^? 6.78 O15 C8E B 209 A 40 ASP B 149 ASP^? 14.91 O15 C8E B 209 A 103 LEU B 199 LEU^? 12.84 O15 C8E B 209 coo 12.09 16.13 10.57 11.28 18.80 10.73 84.65 -34.92 -28.70 86.28 -34.17 -30.84 coo 7.55 25.51 14.34 9.65 25.73 14.24 79.48 -42.39 -33.32 81.04 -41.48 -34.38 coo 11.83 18.73 16.99 10.99 19.71 15.26 82.54 -43.14 -26.59 81.90 -45.17 -26.26 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 11 3 # 11 A 16 TYR B 51 TYR.? 9.95 O21 C8E B 210 A 40 ASP B 45 ASP.? -3.07 CA CA B 208s A 103 LEU B 47 LEU.? -6.00 CA CA B 208s coo 12.09 16.13 10.57 11.28 18.80 10.73 102.03 -27.53 -15.19 104.12 -26.16 -16.40 coo 7.55 25.51 14.34 9.65 25.73 14.24 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo 11.83 18.73 16.99 10.99 19.71 15.26 94.70 -25.22 -15.81 94.48 -23.30 -16.95 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 12 3 # 12 A 16 TYR B 51 TYR.? 9.95 O21 C8E B 210 A 40 ASP B 61 ASP~? 12.48 CA CA B 208 A 103 LEU B 53 LEU.? 12.38 CA CA B 208 coo 12.09 16.13 10.57 11.28 18.80 10.73 102.03 -27.53 -15.19 104.12 -26.16 -16.40 coo 7.55 25.51 14.34 9.65 25.73 14.24 98.68 -27.22 -4.60 99.30 -29.23 -4.23 coo 11.83 18.73 16.99 10.99 19.71 15.26 103.25 -23.70 -10.31 101.33 -23.24 -11.26 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 13 3 # 13 A 16 TYR B 97 TYR^? 16.46 O15 C8E B 209 A 40 ASP B 153 ASP^? 9.57 O15 C8E B 209 A 103 LEU B 132 LEU^? 15.23 C3 C8E B 209 coo 12.09 16.13 10.57 11.28 18.80 10.73 83.74 -41.85 -39.80 83.62 -41.42 -37.05 coo 7.55 25.51 14.34 9.65 25.73 14.24 89.74 -36.17 -33.46 87.76 -36.55 -34.22 coo 11.83 18.73 16.99 10.99 19.71 15.26 89.72 -42.61 -38.67 91.33 -43.84 -37.88 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 14 3 # 14 A 16 TYR B 109 TYR^? 10.54 CA CA B 208 A 40 ASP B 45 ASP.? -3.07 CA CA B 208s A 103 LEU B 47 LEU.? -6.00 CA CA B 208s coo 12.09 16.13 10.57 11.28 18.80 10.73 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo 7.55 25.51 14.34 9.65 25.73 14.24 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo 11.83 18.73 16.99 10.99 19.71 15.26 94.70 -25.22 -15.81 94.48 -23.30 -16.95 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 15 3 # 15 A 16 TYR C 13 TYR^? 7.82 C16 C8E C 210 A 40 ASP C 149 ASP^? 16.02 C16 C8E C 210 A 103 LEU C 199 LEU^? 13.24 C16 C8E C 210 coo 12.09 16.13 10.57 11.28 18.80 10.73 37.24 -51.70 -23.13 39.21 -53.16 -21.84 coo 7.55 25.51 14.34 9.65 25.73 14.24 38.72 -55.19 -32.44 40.02 -55.93 -30.97 coo 11.83 18.73 16.99 10.99 19.71 15.26 32.21 -54.84 -29.49 31.17 -56.09 -30.91 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 16 3 # 16 A 16 TYR C 51 TYR.? 10.04 O21 C8E C 209 A 40 ASP C 45 ASP.? 3.27 CA CA C 208s A 103 LEU C 47 LEU.? -6.24 CA CA C 208s coo 12.09 16.13 10.57 11.28 18.80 10.73 26.09 -52.62 -2.60 27.54 -53.38 -0.32 coo 7.55 25.51 14.34 9.65 25.73 14.24 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo 11.83 18.73 16.99 10.99 19.71 15.26 28.53 -46.84 -6.92 30.29 -45.63 -6.29 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 17 3 # 17 A 16 TYR C 51 TYR.? 10.04 O21 C8E C 209 A 40 ASP C 61 ASP~? 12.61 CA CA C 208 A 103 LEU C 53 LEU.? 12.37 CA CA C 208 coo 12.09 16.13 10.57 11.28 18.80 10.73 26.09 -52.62 -2.60 27.54 -53.38 -0.32 coo 7.55 25.51 14.34 9.65 25.73 14.24 16.71 -46.53 -3.05 15.59 -48.22 -3.69 coo 11.83 18.73 16.99 10.99 19.71 15.26 23.26 -49.22 1.59 23.57 -48.08 -0.23 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 18 3 # 18 A 16 TYR C 83 TYR^? 19.88 O21 C8E A 209 A 40 ASP C 26 ASP.? 24.60 O21 C8E A 209 A 103 LEU C 33 LEU^? 15.73 O21 C8E A 209 coo 12.09 16.13 10.57 11.28 18.80 10.73 49.20 -66.70 -34.88 49.82 -68.82 -36.60 coo 7.55 25.51 14.34 9.65 25.73 14.24 55.55 -58.08 -41.98 53.84 -58.94 -42.96 coo 11.83 18.73 16.99 10.99 19.71 15.26 54.27 -62.49 -33.74 53.97 -64.25 -32.48 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 19 3 # 19 A 16 TYR C 83 TYR^? 19.88 O21 C8E A 209 A 40 ASP C 80 ASP^? 16.43 C13 C8E C 210 A 103 LEU C 33 LEU^? 15.73 O21 C8E A 209 coo 12.09 16.13 10.57 11.28 18.80 10.73 49.20 -66.70 -34.88 49.82 -68.82 -36.60 coo 7.55 25.51 14.34 9.65 25.73 14.24 47.10 -57.14 -28.79 45.64 -55.94 -27.77 coo 11.83 18.73 16.99 10.99 19.71 15.26 54.27 -62.49 -33.74 53.97 -64.25 -32.48 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 20 3 # 20 A 16 TYR C 97 TYR^? 17.03 C13 C8E C 210 A 40 ASP C 153 ASP^? 9.83 C13 C8E C 210 A 103 LEU C 132 LEU^? 14.98 C1 C8E C 210 coo 12.09 16.13 10.57 11.28 18.80 10.73 44.42 -59.94 -30.24 42.23 -58.45 -29.40 coo 7.55 25.51 14.34 9.65 25.73 14.24 40.09 -57.62 -20.90 41.26 -57.13 -22.61 coo 11.83 18.73 16.99 10.99 19.71 15.26 42.56 -63.92 -25.92 41.14 -65.31 -25.20 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 21 3 # 21 A 16 TYR C 102 TYR^? 9.73 C2 C8E C 209 A 40 ASP A 80 ASP^? 12.60 C1 C8E A 210 A 103 LEU A 37 LEU^? 14.39 C2 C8E C 209 coo 12.09 16.13 10.57 11.28 18.80 10.73 48.50 -51.08 -15.65 48.91 -50.66 -12.96 coo 7.55 25.51 14.34 9.65 25.73 14.24 58.12 -52.30 -15.93 59.10 -53.68 -17.13 coo 11.83 18.73 16.99 10.99 19.71 15.26 52.42 -52.66 -21.70 50.67 -52.28 -20.66 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 22 3 # 22 A 16 TYR C 109 TYR^? 10.73 CA CA C 208 A 40 ASP C 45 ASP.? 3.27 CA CA C 208s A 103 LEU C 47 LEU.? -6.24 CA CA C 208s coo 12.09 16.13 10.57 11.28 18.80 10.73 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo 7.55 25.51 14.34 9.65 25.73 14.24 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo 11.83 18.73 16.99 10.99 19.71 15.26 28.53 -46.84 -6.92 30.29 -45.63 -6.29 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 23 3 # 23 A 16 TYR C 109 TYR^? 10.73 CA CA C 208 A 40 ASP C 49 ASP.? -2.87 CA CA C 208s A 103 LEU C 47 LEU.? -6.24 CA CA C 208s coo 12.09 16.13 10.57 11.28 18.80 10.73 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo 7.55 25.51 14.34 9.65 25.73 14.24 22.13 -48.50 -9.42 23.00 -46.66 -10.00 coo 11.83 18.73 16.99 10.99 19.71 15.26 28.53 -46.84 -6.92 30.29 -45.63 -6.29 1vzz_c00 source 1vzz STEROID DELTA-ISOMERASE : 23 hits 1vzz_c00 naa= 3 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 1 3 # 1 B 16 TYR A 13 TYR^? 6.88 C17 C8E A 209 B 40 ASP A 149 ASP^? 14.85 C1 C8E A 210 B 103 LEU A 199 LEU^? 10.78 C1 C8E A 209 coo 14.25 20.09 37.35 13.48 17.40 37.38 65.07 -60.93 -23.01 63.35 -61.54 -20.90 coo 9.39 10.77 34.53 11.50 10.63 34.41 66.40 -51.17 -20.74 65.06 -51.90 -19.38 coo 12.89 17.60 31.13 12.34 16.51 32.90 71.88 -55.87 -21.82 73.59 -54.65 -21.37 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 2 3 # 2 B 16 TYR A 51 TYR.? 9.92 O21 C8E A 210 B 40 ASP A 45 ASP.? -2.96 CA CA A 208s B 103 LEU A 47 LEU.? -6.16 CA CA A 208s coo 14.25 20.09 37.35 13.48 17.40 37.38 71.70 -83.21 -22.40 69.97 -85.02 -21.17 coo 9.39 10.77 34.53 11.50 10.63 34.41 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo 12.89 17.60 31.13 12.34 16.51 32.90 68.63 -79.08 -27.35 66.53 -79.28 -27.97 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 3 3 # 3 B 16 TYR A 51 TYR.? 9.92 O21 C8E A 210 B 40 ASP A 61 ASP~? 12.37 CA CA A 208 B 103 LEU A 53 LEU.? 12.26 CA CA A 208 coo 14.25 20.09 37.35 13.48 17.40 37.38 71.70 -83.21 -22.40 69.97 -85.02 -21.17 coo 9.39 10.77 34.53 11.50 10.63 34.41 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo 12.89 17.60 31.13 12.34 16.51 32.90 71.93 -88.29 -26.11 70.93 -86.53 -26.97 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 4 3 # 4 B 16 TYR A 83 TYR^? -19.24 C2 C8E C 209s B 40 ASP A 26 ASP.? 24.86 C2 C8E C 209 B 103 LEU A 31 LEU.? 19.24 C2 C8E C 209 coo 14.25 20.09 37.35 13.48 17.40 37.38 59.25 -44.27 -7.74 58.41 -42.23 -6.03 coo 9.39 10.77 34.53 11.50 10.63 34.41 53.70 -37.11 -16.05 55.72 -36.42 -15.97 coo 12.89 17.60 31.13 12.34 16.51 32.90 52.60 -39.79 -9.06 50.82 -40.32 -7.99 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 5 3 # 5 B 16 TYR A 83 TYR^? -19.24 C2 C8E C 209s B 40 ASP A 26 ASP.? 24.86 C2 C8E C 209 B 103 LEU A 33 LEU^? 15.98 C2 C8E C 209 coo 14.25 20.09 37.35 13.48 17.40 37.38 59.25 -44.27 -7.74 58.41 -42.23 -6.03 coo 9.39 10.77 34.53 11.50 10.63 34.41 53.70 -37.11 -16.05 55.72 -36.42 -15.97 coo 12.89 17.60 31.13 12.34 16.51 32.90 53.84 -43.82 -10.58 54.72 -44.80 -8.87 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 6 3 # 6 B 16 TYR A 97 TYR^? 11.99 C1 C8E A 210 B 40 ASP A 153 ASP^? 8.28 C1 C8E A 210 B 103 LEU A 132 LEU^? 6.01 C1 C8E A 210 coo 14.25 20.09 37.35 13.48 17.40 37.38 61.97 -51.46 -14.47 63.57 -52.89 -16.21 coo 9.39 10.77 34.53 11.50 10.63 34.41 63.37 -61.81 -16.17 62.75 -59.91 -16.84 coo 12.89 17.60 31.13 12.34 16.51 32.90 64.80 -56.61 -10.52 64.08 -56.26 -8.61 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 7 3 # 7 B 16 TYR A 109 TYR^? 10.85 CA CA A 208 B 40 ASP A 45 ASP.? -2.96 CA CA A 208s B 103 LEU A 47 LEU.? -6.16 CA CA A 208s coo 14.25 20.09 37.35 13.48 17.40 37.38 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo 9.39 10.77 34.53 11.50 10.63 34.41 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo 12.89 17.60 31.13 12.34 16.51 32.90 68.63 -79.08 -27.35 66.53 -79.28 -27.97 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 8 3 # 8 B 16 TYR A 109 TYR^? 10.85 CA CA A 208 B 40 ASP A 49 ASP.? -3.00 CA CA A 208s B 103 LEU A 47 LEU.? -6.16 CA CA A 208s coo 14.25 20.09 37.35 13.48 17.40 37.38 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo 9.39 10.77 34.53 11.50 10.63 34.41 75.72 -77.89 -27.98 74.67 -77.10 -29.65 coo 12.89 17.60 31.13 12.34 16.51 32.90 68.63 -79.08 -27.35 66.53 -79.28 -27.97 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 9 3 # 9 B 16 TYR B 13 TYR^? 6.78 O15 C8E B 209 B 40 ASP B 149 ASP^? 14.91 O15 C8E B 209 B 103 LEU B 199 LEU^? 12.84 O15 C8E B 209 coo 14.25 20.09 37.35 13.48 17.40 37.38 84.65 -34.92 -28.70 86.28 -34.17 -30.84 coo 9.39 10.77 34.53 11.50 10.63 34.41 79.48 -42.39 -33.32 81.04 -41.48 -34.38 coo 12.89 17.60 31.13 12.34 16.51 32.90 82.54 -43.14 -26.59 81.90 -45.17 -26.26 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 10 3 # 10 B 16 TYR B 51 TYR.? 9.95 O21 C8E B 210 B 40 ASP B 45 ASP.? -3.07 CA CA B 208s B 103 LEU B 47 LEU.? -6.00 CA CA B 208s coo 14.25 20.09 37.35 13.48 17.40 37.38 102.03 -27.53 -15.19 104.12 -26.16 -16.40 coo 9.39 10.77 34.53 11.50 10.63 34.41 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo 12.89 17.60 31.13 12.34 16.51 32.90 94.70 -25.22 -15.81 94.48 -23.30 -16.95 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 11 3 # 11 B 16 TYR B 51 TYR.? 9.95 O21 C8E B 210 B 40 ASP B 61 ASP~? 12.48 CA CA B 208 B 103 LEU B 53 LEU.? 12.38 CA CA B 208 coo 14.25 20.09 37.35 13.48 17.40 37.38 102.03 -27.53 -15.19 104.12 -26.16 -16.40 coo 9.39 10.77 34.53 11.50 10.63 34.41 98.68 -27.22 -4.60 99.30 -29.23 -4.23 coo 12.89 17.60 31.13 12.34 16.51 32.90 103.25 -23.70 -10.31 101.33 -23.24 -11.26 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 12 3 # 12 B 16 TYR B 97 TYR^? 16.46 O15 C8E B 209 B 40 ASP B 153 ASP^? 9.57 O15 C8E B 209 B 103 LEU B 132 LEU^? 15.23 C3 C8E B 209 coo 14.25 20.09 37.35 13.48 17.40 37.38 83.74 -41.85 -39.80 83.62 -41.42 -37.05 coo 9.39 10.77 34.53 11.50 10.63 34.41 89.74 -36.17 -33.46 87.76 -36.55 -34.22 coo 12.89 17.60 31.13 12.34 16.51 32.90 89.72 -42.61 -38.67 91.33 -43.84 -37.88 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 13 3 # 13 B 16 TYR B 109 TYR^? 10.54 CA CA B 208 B 40 ASP B 45 ASP.? -3.07 CA CA B 208s B 103 LEU B 47 LEU.? -6.00 CA CA B 208s coo 14.25 20.09 37.35 13.48 17.40 37.38 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo 9.39 10.77 34.53 11.50 10.63 34.41 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo 12.89 17.60 31.13 12.34 16.51 32.90 94.70 -25.22 -15.81 94.48 -23.30 -16.95 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 14 3 # 14 B 16 TYR C 13 TYR^? 7.82 C16 C8E C 210 B 40 ASP C 149 ASP^? 16.02 C16 C8E C 210 B 103 LEU C 199 LEU^? 13.24 C16 C8E C 210 coo 14.25 20.09 37.35 13.48 17.40 37.38 37.24 -51.70 -23.13 39.21 -53.16 -21.84 coo 9.39 10.77 34.53 11.50 10.63 34.41 38.72 -55.19 -32.44 40.02 -55.93 -30.97 coo 12.89 17.60 31.13 12.34 16.51 32.90 32.21 -54.84 -29.49 31.17 -56.09 -30.91 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 15 3 # 15 B 16 TYR C 51 TYR.? 10.04 O21 C8E C 209 B 40 ASP C 45 ASP.? 3.27 CA CA C 208s B 103 LEU C 47 LEU.? -6.24 CA CA C 208s coo 14.25 20.09 37.35 13.48 17.40 37.38 26.09 -52.62 -2.60 27.54 -53.38 -0.32 coo 9.39 10.77 34.53 11.50 10.63 34.41 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo 12.89 17.60 31.13 12.34 16.51 32.90 28.53 -46.84 -6.92 30.29 -45.63 -6.29 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 16 3 # 16 B 16 TYR C 51 TYR.? 10.04 O21 C8E C 209 B 40 ASP C 61 ASP~? 12.61 CA CA C 208 B 103 LEU C 53 LEU.? 12.37 CA CA C 208 coo 14.25 20.09 37.35 13.48 17.40 37.38 26.09 -52.62 -2.60 27.54 -53.38 -0.32 coo 9.39 10.77 34.53 11.50 10.63 34.41 16.71 -46.53 -3.05 15.59 -48.22 -3.69 coo 12.89 17.60 31.13 12.34 16.51 32.90 23.26 -49.22 1.59 23.57 -48.08 -0.23 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 17 3 # 17 B 16 TYR C 83 TYR^? 19.88 O21 C8E A 209 B 40 ASP C 26 ASP.? 24.60 O21 C8E A 209 B 103 LEU C 33 LEU^? 15.73 O21 C8E A 209 coo 14.25 20.09 37.35 13.48 17.40 37.38 49.20 -66.70 -34.88 49.82 -68.82 -36.60 coo 9.39 10.77 34.53 11.50 10.63 34.41 55.55 -58.08 -41.98 53.84 -58.94 -42.96 coo 12.89 17.60 31.13 12.34 16.51 32.90 54.27 -62.49 -33.74 53.97 -64.25 -32.48 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 18 3 # 18 B 16 TYR C 83 TYR^? 19.88 O21 C8E A 209 B 40 ASP C 80 ASP^? 16.43 C13 C8E C 210 B 103 LEU C 33 LEU^? 15.73 O21 C8E A 209 coo 14.25 20.09 37.35 13.48 17.40 37.38 49.20 -66.70 -34.88 49.82 -68.82 -36.60 coo 9.39 10.77 34.53 11.50 10.63 34.41 47.10 -57.14 -28.79 45.64 -55.94 -27.77 coo 12.89 17.60 31.13 12.34 16.51 32.90 54.27 -62.49 -33.74 53.97 -64.25 -32.48 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 19 3 # 19 B 16 TYR C 97 TYR^? 17.03 C13 C8E C 210 B 40 ASP C 153 ASP^? 9.83 C13 C8E C 210 B 103 LEU C 132 LEU^? 14.98 C1 C8E C 210 coo 14.25 20.09 37.35 13.48 17.40 37.38 44.42 -59.94 -30.24 42.23 -58.45 -29.40 coo 9.39 10.77 34.53 11.50 10.63 34.41 40.09 -57.62 -20.90 41.26 -57.13 -22.61 coo 12.89 17.60 31.13 12.34 16.51 32.90 42.56 -63.92 -25.92 41.14 -65.31 -25.20 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 20 3 # 20 B 16 TYR C 102 TYR^? 9.73 C2 C8E C 209 B 40 ASP A 80 ASP^? 12.60 C1 C8E A 210 B 103 LEU A 37 LEU^? 14.39 C2 C8E C 209 coo 14.25 20.09 37.35 13.48 17.40 37.38 48.50 -51.08 -15.65 48.91 -50.66 -12.96 coo 9.39 10.77 34.53 11.50 10.63 34.41 58.12 -52.30 -15.93 59.10 -53.68 -17.13 coo 12.89 17.60 31.13 12.34 16.51 32.90 52.42 -52.66 -21.70 50.67 -52.28 -20.66 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 21 3 # 21 B 16 TYR C 109 TYR^? 10.73 CA CA C 208 B 40 ASP C 45 ASP.? 3.27 CA CA C 208s B 103 LEU C 47 LEU.? -6.24 CA CA C 208s coo 14.25 20.09 37.35 13.48 17.40 37.38 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo 9.39 10.77 34.53 11.50 10.63 34.41 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo 12.89 17.60 31.13 12.34 16.51 32.90 28.53 -46.84 -6.92 30.29 -45.63 -6.29 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 22 3 # 22 B 16 TYR C 109 TYR^? 10.73 CA CA C 208 B 40 ASP C 49 ASP.? -2.87 CA CA C 208s B 103 LEU C 47 LEU.? -6.24 CA CA C 208s coo 14.25 20.09 37.35 13.48 17.40 37.38 28.40 -39.89 -5.18 28.52 -40.13 -2.40 coo 9.39 10.77 34.53 11.50 10.63 34.41 22.13 -48.50 -9.42 23.00 -46.66 -10.00 coo 12.89 17.60 31.13 12.34 16.51 32.90 28.53 -46.84 -6.92 30.29 -45.63 -6.29 1vzz_c01 source 1vzz STEROID DELTA-ISOMERASE : 22 hits 1vzz_c01 naa= 3 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 1 3 # 1 A 183 GLY A 9 GLY^? 17.25 C17 C8E A 209 B 419 GLY A 202 GLY^? 20.08 C17 C8E A 209 B 420 ALA A 203 ALA^? 24.35 C17 C8E A 209 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 64.71 -51.29 -28.16 64.32 -51.77 -28.65 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 66.56 -47.95 -27.86 66.94 -47.39 -27.39 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 64.54 -44.79 -28.25 64.77 -44.19 -29.63 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 2 3 # 2 A 183 GLY A 11 GLY^? 12.60 O18 C8E A 209 B 419 GLY A 17 GLY^? 10.84 O18 C8E A 209 B 420 ALA A 42 ALA^? 7.29 O18 C8E A 209 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 69.81 -55.88 -27.59 69.20 -56.35 -27.77 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 66.16 -59.55 -30.47 66.70 -58.93 -30.18 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 64.59 -62.72 -29.30 65.26 -62.49 -27.92 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 3 3 # 3 A 183 GLY A 14 GLY.? -3.37 O18 C8E A 209s B 419 GLY A 15 GLY.? 5.65 O18 C8E A 209 B 420 ALA A 42 ALA^? 7.29 O18 C8E A 209 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 69.00 -64.43 -23.63 69.02 -63.91 -24.27 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 69.71 -63.96 -27.30 69.55 -63.21 -26.86 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 64.59 -62.72 -29.30 65.26 -62.49 -27.92 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 4 3 # 4 A 183 GLY A 17 GLY^? 10.84 O18 C8E A 209 B 419 GLY A 11 GLY^? 12.60 O18 C8E A 209 B 420 ALA A 10 ALA^? 16.05 O18 C8E A 209 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 66.16 -59.55 -30.47 66.70 -58.93 -30.18 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 69.81 -55.88 -27.59 69.20 -56.35 -27.77 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 67.31 -53.72 -29.40 67.90 -53.34 -30.78 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 5 3 # 5 A 183 GLY A 17 GLY^? 10.84 O18 C8E A 209 B 419 GLY A 18 GLY^? 13.28 O18 C8E A 209 B 420 ALA A 10 ALA^? 16.05 O18 C8E A 209 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 66.16 -59.55 -30.47 66.70 -58.93 -30.18 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 64.23 -56.43 -29.63 63.79 -57.08 -29.36 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 67.31 -53.72 -29.40 67.90 -53.34 -30.78 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 6 3 # 6 A 183 GLY A 18 GLY^? 13.28 O18 C8E A 209 B 419 GLY A 9 GLY^? 17.25 C17 C8E A 209 B 420 ALA A 8 ALA^? 20.71 O18 C8E A 209 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 64.23 -56.43 -29.63 63.79 -57.08 -29.36 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 64.71 -51.29 -28.16 64.32 -51.77 -28.65 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 61.58 -49.53 -29.33 61.65 -49.30 -30.88 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 7 3 # 7 A 183 GLY A 18 GLY^? 13.28 O18 C8E A 209 B 419 GLY A 17 GLY^? 10.84 O18 C8E A 209 B 420 ALA A 42 ALA^? 7.29 O18 C8E A 209 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 64.23 -56.43 -29.63 63.79 -57.08 -29.36 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 66.16 -59.55 -30.47 66.70 -58.93 -30.18 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 64.59 -62.72 -29.30 65.26 -62.49 -27.92 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 8 3 # 8 A 183 GLY A 108 GLY^? 9.22 CA CA A 208 B 419 GLY A 107 GLY^? 8.81 O21 C8E A 209 B 420 ALA A 46 ALA.? 6.64 CA CA A 208 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 63.77 -77.60 -31.68 64.12 -76.93 -32.11 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 62.40 -74.29 -30.50 61.92 -74.87 -30.13 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 66.69 -74.67 -27.61 65.67 -75.06 -28.70 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 9 3 # 9 A 183 GLY A 202 GLY^? 20.08 C17 C8E A 209 B 419 GLY A 9 GLY^? 17.25 C17 C8E A 209 B 420 ALA A 8 ALA^? 20.71 O18 C8E A 209 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 66.56 -47.95 -27.86 66.94 -47.39 -27.39 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 64.71 -51.29 -28.16 64.32 -51.77 -28.65 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 61.58 -49.53 -29.33 61.65 -49.30 -30.88 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 10 3 # 10 A 183 GLY A 202 GLY^? 20.08 C17 C8E A 209 B 419 GLY A 9 GLY^? 17.25 C17 C8E A 209 B 420 ALA A 10 ALA^? 16.05 O18 C8E A 209 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 66.56 -47.95 -27.86 66.94 -47.39 -27.39 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 64.71 -51.29 -28.16 64.32 -51.77 -28.65 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 67.31 -53.72 -29.40 67.90 -53.34 -30.78 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 11 3 # 11 A 183 GLY B 9 GLY^? 17.41 C16 C8E B 209 B 419 GLY B 202 GLY^? 20.20 O15 C8E B 209 B 420 ALA B 203 ALA^? 24.58 O15 C8E B 209 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 74.15 -37.97 -30.01 74.20 -37.18 -29.91 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 72.27 -41.27 -30.46 72.24 -42.05 -30.66 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 69.42 -41.50 -32.95 68.05 -41.38 -32.31 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 12 3 # 12 A 183 GLY B 11 GLY^? 12.70 C16 C8E B 209 B 419 GLY B 17 GLY^? 11.57 C19 C8E B 209 B 420 ALA B 42 ALA^? 7.68 C19 C8E B 209 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 78.59 -39.04 -24.96 78.74 -38.24 -25.03 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 78.40 -33.46 -24.16 78.51 -34.26 -24.36 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 81.57 -30.84 -24.70 82.39 -32.04 -25.12 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 13 3 # 13 A 183 GLY B 14 GLY.? -3.42 C16 C8E B 209s B 419 GLY B 15 GLY.? 5.95 C19 C8E B 209 B 420 ALA B 42 ALA^? 7.68 C19 C8E B 209 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 87.36 -35.68 -24.06 86.56 -35.48 -24.06 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 84.63 -34.31 -21.87 84.45 -35.02 -22.31 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 81.57 -30.84 -24.70 82.39 -32.04 -25.12 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 14 3 # 14 A 183 GLY B 17 GLY^? 11.57 C19 C8E B 209 B 419 GLY B 11 GLY^? 12.70 C16 C8E B 209 B 420 ALA B 10 ALA^? 16.31 C16 C8E B 209 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 78.40 -33.46 -24.16 78.51 -34.26 -24.36 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 78.59 -39.04 -24.96 78.74 -38.24 -25.03 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 75.45 -37.67 -26.46 74.31 -37.81 -25.41 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 15 3 # 15 A 183 GLY B 17 GLY^? 11.57 C19 C8E B 209 B 419 GLY B 18 GLY^? 13.41 C16 C8E B 209 B 420 ALA B 10 ALA^? 16.31 C16 C8E B 209 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 78.40 -33.46 -24.16 78.51 -34.26 -24.36 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 77.02 -34.15 -27.57 77.48 -33.52 -27.66 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 75.45 -37.67 -26.46 74.31 -37.81 -25.41 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 16 3 # 16 A 183 GLY B 18 GLY^? 13.41 C16 C8E B 209 B 419 GLY B 9 GLY^? 17.41 C16 C8E B 209 B 420 ALA B 8 ALA^? 20.90 C16 C8E B 209 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 77.02 -34.15 -27.57 77.48 -33.52 -27.66 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 74.15 -37.97 -30.01 74.20 -37.18 -29.91 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 71.81 -36.32 -32.47 70.60 -35.68 -31.80 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 17 3 # 17 A 183 GLY B 18 GLY^? 13.41 C16 C8E B 209 B 419 GLY B 17 GLY^? 11.57 C19 C8E B 209 B 420 ALA B 42 ALA^? 7.68 C19 C8E B 209 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 77.02 -34.15 -27.57 77.48 -33.52 -27.66 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 78.40 -33.46 -24.16 78.51 -34.26 -24.36 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 81.57 -30.84 -24.70 82.39 -32.04 -25.12 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 18 3 # 18 A 183 GLY B 108 GLY^? 8.97 CA CA B 208 B 419 GLY B 107 GLY^? 8.76 C20 C8E B 209 B 420 ALA B 46 ALA.? 6.22 CA CA B 208 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 90.48 -20.92 -17.58 89.78 -21.35 -17.37 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 88.75 -22.32 -20.64 89.23 -21.73 -20.93 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 91.46 -26.30 -19.06 90.82 -24.97 -18.73 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 19 3 # 19 A 183 GLY B 202 GLY^? 20.20 O15 C8E B 209 B 419 GLY B 9 GLY^? 17.41 C16 C8E B 209 B 420 ALA B 8 ALA^? 20.90 C16 C8E B 209 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 72.27 -41.27 -30.46 72.24 -42.05 -30.66 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 74.15 -37.97 -30.01 74.20 -37.18 -29.91 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 71.81 -36.32 -32.47 70.60 -35.68 -31.80 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 20 3 # 20 A 183 GLY B 202 GLY^? 20.20 O15 C8E B 209 B 419 GLY B 9 GLY^? 17.41 C16 C8E B 209 B 420 ALA B 10 ALA^? 16.31 C16 C8E B 209 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 72.27 -41.27 -30.46 72.24 -42.05 -30.66 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 74.15 -37.97 -30.01 74.20 -37.18 -29.91 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 75.45 -37.67 -26.46 74.31 -37.81 -25.41 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 21 3 # 21 A 183 GLY C 9 GLY^? 17.67 C16 C8E C 210 B 419 GLY C 202 GLY^? 20.55 C16 C8E C 210 B 420 ALA C 203 ALA^? 24.88 C16 C8E C 210 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 38.63 -47.72 -33.07 38.75 -47.02 -32.59 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 37.69 -48.46 -36.70 37.66 -49.11 -37.22 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 40.30 -47.76 -39.37 39.98 -46.52 -40.19 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 22 3 # 22 A 183 GLY C 11 GLY^? 12.79 C16 C8E C 210 B 419 GLY C 17 GLY^? 11.43 C19 C8E C 210 B 420 ALA C 42 ALA^? 7.46 C19 C8E C 210 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 32.80 -49.06 -29.57 33.28 -48.67 -28.99 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 34.61 -45.03 -25.87 34.39 -45.63 -26.41 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 35.72 -45.47 -22.06 35.55 -46.98 -22.23 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 23 3 # 23 A 183 GLY C 17 GLY^? 11.43 C19 C8E C 210 B 419 GLY C 11 GLY^? 12.79 C16 C8E C 210 B 420 ALA C 10 ALA^? 16.38 C16 C8E C 210 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 34.61 -45.03 -25.87 34.39 -45.63 -26.41 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 32.80 -49.06 -29.57 33.28 -48.67 -28.99 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 35.38 -46.95 -31.32 34.79 -45.75 -31.96 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 24 3 # 24 A 183 GLY C 17 GLY^? 11.43 C19 C8E C 210 B 419 GLY C 18 GLY^? 13.60 C19 C8E C 210 B 420 ALA C 10 ALA^? 16.38 C16 C8E C 210 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 34.61 -45.03 -25.87 34.39 -45.63 -26.41 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 37.51 -45.80 -28.16 37.81 -45.75 -27.39 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 35.38 -46.95 -31.32 34.79 -45.75 -31.96 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 25 3 # 25 A 183 GLY C 18 GLY^? 13.60 C19 C8E C 210 B 419 GLY C 9 GLY^? 17.67 C16 C8E C 210 B 420 ALA C 8 ALA^? 21.06 C19 C8E C 210 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 37.51 -45.80 -28.16 37.81 -45.75 -27.39 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 38.63 -47.72 -33.07 38.75 -47.02 -32.59 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 41.60 -45.69 -34.21 41.31 -44.27 -34.65 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 26 3 # 26 A 183 GLY C 18 GLY^? 13.60 C19 C8E C 210 B 419 GLY C 17 GLY^? 11.43 C19 C8E C 210 B 420 ALA C 42 ALA^? 7.46 C19 C8E C 210 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 37.51 -45.80 -28.16 37.81 -45.75 -27.39 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 34.61 -45.03 -25.87 34.39 -45.63 -26.41 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 35.72 -45.47 -22.06 35.55 -46.98 -22.23 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 27 3 # 27 A 183 GLY C 108 GLY^? 9.19 CA CA C 208 B 419 GLY C 107 GLY^? 7.61 O21 C8E C 210 B 420 ALA C 46 ALA.? 6.35 CA CA C 208 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 32.28 -41.91 -7.84 31.99 -41.73 -8.59 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 34.65 -42.83 -10.66 35.11 -42.76 -9.95 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 31.22 -46.48 -10.69 31.43 -45.03 -10.31 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 28 3 # 28 A 183 GLY C 202 GLY^? 20.55 C16 C8E C 210 B 419 GLY C 9 GLY^? 17.67 C16 C8E C 210 B 420 ALA C 8 ALA^? 21.06 C19 C8E C 210 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 37.69 -48.46 -36.70 37.66 -49.11 -37.22 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 38.63 -47.72 -33.07 38.75 -47.02 -32.59 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 41.60 -45.69 -34.21 41.31 -44.27 -34.65 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 29 3 # 29 A 183 GLY C 202 GLY^? 20.55 C16 C8E C 210 B 419 GLY C 9 GLY^? 17.67 C16 C8E C 210 B 420 ALA C 10 ALA^? 16.38 C16 C8E C 210 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 37.69 -48.46 -36.70 37.66 -49.11 -37.22 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 38.63 -47.72 -33.07 38.75 -47.02 -32.59 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 35.38 -46.95 -31.32 34.79 -45.75 -31.96 1xny_c00 source 1xny PROPIONYL-COA CARBOXYLASE COMPLEX B SUBUNIT : 29 hits 1xny_c00 naa= 3 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 1 3 # 1 A 420 ALA A 8 ALA^? 20.71 O18 C8E A 209 B 182 GLY A 17 GLY^? 10.84 O18 C8E A 209 B 183 GLY A 18 GLY^? 13.28 O18 C8E A 209 coo 38.36-101.47-135.52 39.62-101.29-136.35 61.58 -49.53 -29.33 61.65 -49.30 -30.88 coo 41.93-102.35-126.87 41.52-101.89-126.30 66.16 -59.55 -30.47 66.70 -58.93 -30.18 coo 38.37-101.99-128.11 38.63-102.24-127.37 64.23 -56.43 -29.63 63.79 -57.08 -29.36 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 2 3 # 2 A 420 ALA A 8 ALA^? 20.71 O18 C8E A 209 B 182 GLY A 40 GLY^? 12.19 O21 C8E A 209 B 183 GLY A 18 GLY^? 13.28 O18 C8E A 209 coo 38.36-101.47-135.52 39.62-101.29-136.35 61.58 -49.53 -29.33 61.65 -49.30 -30.88 coo 41.93-102.35-126.87 41.52-101.89-126.30 59.98 -58.78 -26.79 59.34 -59.26 -26.97 coo 38.37-101.99-128.11 38.63-102.24-127.37 64.23 -56.43 -29.63 63.79 -57.08 -29.36 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 3 3 # 3 A 420 ALA A 21 ALA^? 19.23 C17 C8E A 209 B 182 GLY A 18 GLY^? 13.28 O18 C8E A 209 B 183 GLY A 9 GLY^? 17.25 C17 C8E A 209 coo 38.36-101.47-135.52 39.62-101.29-136.35 56.59 -50.97 -25.51 57.52 -51.00 -24.26 coo 41.93-102.35-126.87 41.52-101.89-126.30 64.23 -56.43 -29.63 63.79 -57.08 -29.36 coo 38.37-101.99-128.11 38.63-102.24-127.37 64.71 -51.29 -28.16 64.32 -51.77 -28.65 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 4 3 # 4 A 420 ALA A 21 ALA^? 19.23 C17 C8E A 209 B 182 GLY A 18 GLY^? 13.28 O18 C8E A 209 B 183 GLY A 40 GLY^? 12.19 O21 C8E A 209 coo 38.36-101.47-135.52 39.62-101.29-136.35 56.59 -50.97 -25.51 57.52 -51.00 -24.26 coo 41.93-102.35-126.87 41.52-101.89-126.30 64.23 -56.43 -29.63 63.79 -57.08 -29.36 coo 38.37-101.99-128.11 38.63-102.24-127.37 59.98 -58.78 -26.79 59.34 -59.26 -26.97 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 5 3 # 5 A 420 ALA A 21 ALA^? 19.23 C17 C8E A 209 B 182 GLY A 202 GLY^? 20.08 C17 C8E A 209 B 183 GLY A 9 GLY^? 17.25 C17 C8E A 209 coo 38.36-101.47-135.52 39.62-101.29-136.35 56.59 -50.97 -25.51 57.52 -51.00 -24.26 coo 41.93-102.35-126.87 41.52-101.89-126.30 66.56 -47.95 -27.86 66.94 -47.39 -27.39 coo 38.37-101.99-128.11 38.63-102.24-127.37 64.71 -51.29 -28.16 64.32 -51.77 -28.65 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 6 3 # 6 A 420 ALA A 120 ALA^? 16.19 CA CA A 208 B 182 GLY A 107 GLY^? 8.81 O21 C8E A 209 B 183 GLY A 108 GLY^? 9.22 CA CA A 208 coo 38.36-101.47-135.52 39.62-101.29-136.35 60.81 -81.68 -37.46 59.90 -80.57 -38.00 coo 41.93-102.35-126.87 41.52-101.89-126.30 62.40 -74.29 -30.50 61.92 -74.87 -30.13 coo 38.37-101.99-128.11 38.63-102.24-127.37 63.77 -77.60 -31.68 64.12 -76.93 -32.11 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 7 3 # 7 A 420 ALA A 204 ALA^? 24.86 C17 C8E A 209 B 182 GLY A 9 GLY^? 17.25 C17 C8E A 209 B 183 GLY A 202 GLY^? 20.08 C17 C8E A 209 coo 38.36-101.47-135.52 39.62-101.29-136.35 61.22 -43.46 -27.01 60.98 -43.47 -25.53 coo 41.93-102.35-126.87 41.52-101.89-126.30 64.71 -51.29 -28.16 64.32 -51.77 -28.65 coo 38.37-101.99-128.11 38.63-102.24-127.37 66.56 -47.95 -27.86 66.94 -47.39 -27.39 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 8 3 # 8 A 420 ALA B 8 ALA^? 20.90 C16 C8E B 209 B 182 GLY B 11 GLY^? 12.70 C16 C8E B 209 B 183 GLY B 18 GLY^? 13.41 C16 C8E B 209 coo 38.36-101.47-135.52 39.62-101.29-136.35 71.81 -36.32 -32.47 70.60 -35.68 -31.80 coo 41.93-102.35-126.87 41.52-101.89-126.30 78.59 -39.04 -24.96 78.74 -38.24 -25.03 coo 38.37-101.99-128.11 38.63-102.24-127.37 77.02 -34.15 -27.57 77.48 -33.52 -27.66 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 9 3 # 9 A 420 ALA B 8 ALA^? 20.90 C16 C8E B 209 B 182 GLY B 17 GLY^? 11.57 C19 C8E B 209 B 183 GLY B 18 GLY^? 13.41 C16 C8E B 209 coo 38.36-101.47-135.52 39.62-101.29-136.35 71.81 -36.32 -32.47 70.60 -35.68 -31.80 coo 41.93-102.35-126.87 41.52-101.89-126.30 78.40 -33.46 -24.16 78.51 -34.26 -24.36 coo 38.37-101.99-128.11 38.63-102.24-127.37 77.02 -34.15 -27.57 77.48 -33.52 -27.66 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 10 3 # 10 A 420 ALA B 8 ALA^? 20.90 C16 C8E B 209 B 182 GLY B 40 GLY^? 12.62 C20 C8E B 209 B 183 GLY B 18 GLY^? 13.41 C16 C8E B 209 coo 38.36-101.47-135.52 39.62-101.29-136.35 71.81 -36.32 -32.47 70.60 -35.68 -31.80 coo 41.93-102.35-126.87 41.52-101.89-126.30 79.65 -30.64 -31.14 79.77 -29.85 -31.21 coo 38.37-101.99-128.11 38.63-102.24-127.37 77.02 -34.15 -27.57 77.48 -33.52 -27.66 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 11 3 # 11 A 420 ALA B 21 ALA^? 19.24 O15 C8E B 209 B 182 GLY B 18 GLY^? 13.41 C16 C8E B 209 B 183 GLY B 9 GLY^? 17.41 C16 C8E B 209 coo 38.36-101.47-135.52 39.62-101.29-136.35 74.65 -33.46 -37.41 75.65 -34.62 -37.46 coo 41.93-102.35-126.87 41.52-101.89-126.30 77.02 -34.15 -27.57 77.48 -33.52 -27.66 coo 38.37-101.99-128.11 38.63-102.24-127.37 74.15 -37.97 -30.01 74.20 -37.18 -29.91 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 12 3 # 12 A 420 ALA B 21 ALA^? 19.24 O15 C8E B 209 B 182 GLY B 18 GLY^? 13.41 C16 C8E B 209 B 183 GLY B 40 GLY^? 12.62 C20 C8E B 209 coo 38.36-101.47-135.52 39.62-101.29-136.35 74.65 -33.46 -37.41 75.65 -34.62 -37.46 coo 41.93-102.35-126.87 41.52-101.89-126.30 77.02 -34.15 -27.57 77.48 -33.52 -27.66 coo 38.37-101.99-128.11 38.63-102.24-127.37 79.65 -30.64 -31.14 79.77 -29.85 -31.21 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 13 3 # 13 A 420 ALA B 21 ALA^? 19.24 O15 C8E B 209 B 182 GLY B 202 GLY^? 20.20 O15 C8E B 209 B 183 GLY B 9 GLY^? 17.41 C16 C8E B 209 coo 38.36-101.47-135.52 39.62-101.29-136.35 74.65 -33.46 -37.41 75.65 -34.62 -37.46 coo 41.93-102.35-126.87 41.52-101.89-126.30 72.27 -41.27 -30.46 72.24 -42.05 -30.66 coo 38.37-101.99-128.11 38.63-102.24-127.37 74.15 -37.97 -30.01 74.20 -37.18 -29.91 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 14 3 # 14 A 420 ALA B 42 ALA^? 7.68 C19 C8E B 209 B 182 GLY B 11 GLY^? 12.70 C16 C8E B 209 B 183 GLY B 18 GLY^? 13.41 C16 C8E B 209 coo 38.36-101.47-135.52 39.62-101.29-136.35 81.57 -30.84 -24.70 82.39 -32.04 -25.12 coo 41.93-102.35-126.87 41.52-101.89-126.30 78.59 -39.04 -24.96 78.74 -38.24 -25.03 coo 38.37-101.99-128.11 38.63-102.24-127.37 77.02 -34.15 -27.57 77.48 -33.52 -27.66 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 15 3 # 15 A 420 ALA B 42 ALA^? 7.68 C19 C8E B 209 B 182 GLY B 14 GLY.? -3.42 C16 C8E B 209s B 183 GLY B 15 GLY.? 5.95 C19 C8E B 209 coo 38.36-101.47-135.52 39.62-101.29-136.35 81.57 -30.84 -24.70 82.39 -32.04 -25.12 coo 41.93-102.35-126.87 41.52-101.89-126.30 87.36 -35.68 -24.06 86.56 -35.48 -24.06 coo 38.37-101.99-128.11 38.63-102.24-127.37 84.63 -34.31 -21.87 84.45 -35.02 -22.31 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 16 3 # 16 A 420 ALA B 120 ALA^? 15.95 CA CA B 208 B 182 GLY B 107 GLY^? 8.76 C20 C8E B 209 B 183 GLY B 108 GLY^? 8.97 CA CA B 208 coo 38.36-101.47-135.52 39.62-101.29-136.35 89.14 -13.81 -14.52 87.79 -13.74 -15.22 coo 41.93-102.35-126.87 41.52-101.89-126.30 88.75 -22.32 -20.64 89.23 -21.73 -20.93 coo 38.37-101.99-128.11 38.63-102.24-127.37 90.48 -20.92 -17.58 89.78 -21.35 -17.37 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 17 3 # 17 A 420 ALA B 204 ALA^? 24.79 O15 C8E B 209 B 182 GLY B 9 GLY^? 17.41 C16 C8E B 209 B 183 GLY B 202 GLY^? 20.20 O15 C8E B 209 coo 38.36-101.47-135.52 39.62-101.29-136.35 69.10 -40.47 -36.57 70.05 -40.95 -37.62 coo 41.93-102.35-126.87 41.52-101.89-126.30 74.15 -37.97 -30.01 74.20 -37.18 -29.91 coo 38.37-101.99-128.11 38.63-102.24-127.37 72.27 -41.27 -30.46 72.24 -42.05 -30.66 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 18 3 # 18 A 420 ALA C 8 ALA^? 21.06 C19 C8E C 210 B 182 GLY C 17 GLY^? 11.43 C19 C8E C 210 B 183 GLY C 18 GLY^? 13.60 C19 C8E C 210 coo 38.36-101.47-135.52 39.62-101.29-136.35 41.60 -45.69 -34.21 41.31 -44.27 -34.65 coo 41.93-102.35-126.87 41.52-101.89-126.30 34.61 -45.03 -25.87 34.39 -45.63 -26.41 coo 38.37-101.99-128.11 38.63-102.24-127.37 37.51 -45.80 -28.16 37.81 -45.75 -27.39 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 19 3 # 19 A 420 ALA C 8 ALA^? 21.06 C19 C8E C 210 B 182 GLY C 40 GLY^? 12.46 C19 C8E C 210 B 183 GLY C 18 GLY^? 13.60 C19 C8E C 210 coo 38.36-101.47-135.52 39.62-101.29-136.35 41.60 -45.69 -34.21 41.31 -44.27 -34.65 coo 41.93-102.35-126.87 41.52-101.89-126.30 41.84 -46.53 -24.70 42.24 -46.19 -24.08 coo 38.37-101.99-128.11 38.63-102.24-127.37 37.51 -45.80 -28.16 37.81 -45.75 -27.39 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 20 3 # 20 A 420 ALA C 21 ALA^? 19.73 C19 C8E C 210 B 182 GLY C 18 GLY^? 13.60 C19 C8E C 210 B 183 GLY C 9 GLY^? 17.67 C16 C8E C 210 coo 38.36-101.47-135.52 39.62-101.29-136.35 46.78 -47.73 -31.34 46.03 -49.05 -31.56 coo 41.93-102.35-126.87 41.52-101.89-126.30 37.51 -45.80 -28.16 37.81 -45.75 -27.39 coo 38.37-101.99-128.11 38.63-102.24-127.37 38.63 -47.72 -33.07 38.75 -47.02 -32.59 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 21 3 # 21 A 420 ALA C 21 ALA^? 19.73 C19 C8E C 210 B 182 GLY C 18 GLY^? 13.60 C19 C8E C 210 B 183 GLY C 40 GLY^? 12.46 C19 C8E C 210 coo 38.36-101.47-135.52 39.62-101.29-136.35 46.78 -47.73 -31.34 46.03 -49.05 -31.56 coo 41.93-102.35-126.87 41.52-101.89-126.30 37.51 -45.80 -28.16 37.81 -45.75 -27.39 coo 38.37-101.99-128.11 38.63-102.24-127.37 41.84 -46.53 -24.70 42.24 -46.19 -24.08 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 22 3 # 22 A 420 ALA C 21 ALA^? 19.73 C19 C8E C 210 B 182 GLY C 202 GLY^? 20.55 C16 C8E C 210 B 183 GLY C 9 GLY^? 17.67 C16 C8E C 210 coo 38.36-101.47-135.52 39.62-101.29-136.35 46.78 -47.73 -31.34 46.03 -49.05 -31.56 coo 41.93-102.35-126.87 41.52-101.89-126.30 37.69 -48.46 -36.70 37.66 -49.11 -37.22 coo 38.37-101.99-128.11 38.63-102.24-127.37 38.63 -47.72 -33.07 38.75 -47.02 -32.59 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 23 3 # 23 A 420 ALA C 42 ALA^? 7.46 C19 C8E C 210 B 182 GLY C 14 GLY.? -3.25 C16 C8E C 210s B 183 GLY C 15 GLY.? 5.81 C16 C8E C 210 coo 38.36-101.47-135.52 39.62-101.29-136.35 35.72 -45.47 -22.06 35.55 -46.98 -22.23 coo 41.93-102.35-126.87 41.52-101.89-126.30 32.71 -52.13 -20.48 32.57 -51.60 -21.08 coo 38.37-101.99-128.11 38.63-102.24-127.37 30.97 -48.94 -21.56 31.55 -49.29 -22.18 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 24 3 # 24 A 420 ALA C 120 ALA^? 16.01 CA CA C 208 B 182 GLY C 107 GLY^? 7.61 O21 C8E C 210 B 183 GLY C 108 GLY^? 9.19 CA CA C 208 coo 38.36-101.47-135.52 39.62-101.29-136.35 32.30 -34.87 -3.98 33.01 -34.28 -5.18 coo 41.93-102.35-126.87 41.52-101.89-126.30 34.65 -42.83 -10.66 35.11 -42.76 -9.95 coo 38.37-101.99-128.11 38.63-102.24-127.37 32.28 -41.91 -7.84 31.99 -41.73 -8.59 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 25 3 # 25 A 420 ALA C 204 ALA^? 25.35 C16 C8E C 210 B 182 GLY C 9 GLY^? 17.67 C16 C8E C 210 B 183 GLY C 202 GLY^? 20.55 C16 C8E C 210 coo 38.36-101.47-135.52 39.62-101.29-136.35 44.01 -48.39 -39.77 44.55 -49.75 -39.34 coo 41.93-102.35-126.87 41.52-101.89-126.30 38.63 -47.72 -33.07 38.75 -47.02 -32.59 coo 38.37-101.99-128.11 38.63-102.24-127.37 37.69 -48.46 -36.70 37.66 -49.11 -37.22 1xny_c01 source 1xny PROPIONYL-COA CARBOXYLASE COMPLEX B SUBUNIT : 25 hits 1xny_c01 naa= 3 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 1 3 # 1 B 137 GLY A 34 GLY^? 16.97 C2 C8E C 209 B 175 ARG A 36 ARG^? 15.77 C1 C8E A 210 B 242 TYR A 97 TYR^? 11.99 C1 C8E A 210 coo 99.45 58.28 3.33 99.57 58.61 4.10 55.45 -44.86 -14.56 55.21 -45.43 -13.93 coo 106.37 63.53 0.89 108.02 63.40 -1.62 59.00 -50.13 -20.90 61.68 -51.06 -19.88 coo 100.93 69.04 4.38 99.52 68.48 2.09 61.97 -51.46 -14.47 63.57 -52.89 -16.21 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 2 3 # 2 B 137 GLY A 38 GLY^? 17.41 C17 C8E A 209 B 175 ARG A 101 ARG^? 8.92 C1 C8E A 210 B 242 TYR A 13 TYR^? 6.88 C17 C8E A 209 coo 99.45 58.28 3.33 99.57 58.61 4.10 56.17 -54.24 -23.69 55.70 -54.84 -23.39 coo 106.37 63.53 0.89 108.02 63.40 -1.62 59.10 -60.12 -16.06 60.30 -57.41 -15.78 coo 100.93 69.04 4.38 99.52 68.48 2.09 65.07 -60.93 -23.01 63.35 -61.54 -20.90 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 3 3 # 3 B 137 GLY A 38 GLY^? 17.41 C17 C8E A 209 B 175 ARG A 101 ARG^? 8.92 C1 C8E A 210 B 242 TYR A 97 TYR^? 11.99 C1 C8E A 210 coo 99.45 58.28 3.33 99.57 58.61 4.10 56.17 -54.24 -23.69 55.70 -54.84 -23.39 coo 106.37 63.53 0.89 108.02 63.40 -1.62 59.10 -60.12 -16.06 60.30 -57.41 -15.78 coo 100.93 69.04 4.38 99.52 68.48 2.09 61.97 -51.46 -14.47 63.57 -52.89 -16.21 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 4 3 # 4 B 137 GLY A 38 GLY^? 17.41 C17 C8E A 209 B 175 ARG A 101 ARG^? 8.92 C1 C8E A 210 B 242 TYR A 102 TYR^? 9.25 C1 C8E C 209 coo 99.45 58.28 3.33 99.57 58.61 4.10 56.17 -54.24 -23.69 55.70 -54.84 -23.39 coo 106.37 63.53 0.89 108.02 63.40 -1.62 59.10 -60.12 -16.06 60.30 -57.41 -15.78 coo 100.93 69.04 4.38 99.52 68.48 2.09 52.54 -63.26 -18.57 51.08 -62.17 -16.42 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 5 3 # 5 B 137 GLY A 38 GLY^? 17.41 C17 C8E A 209 B 175 ARG A 200 ARG^? 11.17 C17 C8E A 209 B 242 TYR A 13 TYR^? 6.88 C17 C8E A 209 coo 99.45 58.28 3.33 99.57 58.61 4.10 56.17 -54.24 -23.69 55.70 -54.84 -23.39 coo 106.37 63.53 0.89 108.02 63.40 -1.62 65.38 -54.68 -25.12 63.65 -56.91 -23.89 coo 100.93 69.04 4.38 99.52 68.48 2.09 65.07 -60.93 -23.01 63.35 -61.54 -20.90 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 6 3 # 6 B 137 GLY A 40 GLY^? 12.19 O21 C8E A 209 B 175 ARG A 101 ARG^? 8.92 C1 C8E A 210 B 242 TYR A 102 TYR^? 9.25 C1 C8E C 209 coo 99.45 58.28 3.33 99.57 58.61 4.10 59.98 -58.78 -26.79 59.34 -59.26 -26.97 coo 106.37 63.53 0.89 108.02 63.40 -1.62 59.10 -60.12 -16.06 60.30 -57.41 -15.78 coo 100.93 69.04 4.38 99.52 68.48 2.09 52.54 -63.26 -18.57 51.08 -62.17 -16.42 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 7 3 # 7 B 137 GLY A 40 GLY^? 12.19 O21 C8E A 209 B 175 ARG A 101 ARG^? 8.92 C1 C8E A 210 B 242 TYR A 155 TYR^? 8.43 C17 C8E A 209 coo 99.45 58.28 3.33 99.57 58.61 4.10 59.98 -58.78 -26.79 59.34 -59.26 -26.97 coo 106.37 63.53 0.89 108.02 63.40 -1.62 59.10 -60.12 -16.06 60.30 -57.41 -15.78 coo 100.93 69.04 4.38 99.52 68.48 2.09 60.87 -66.67 -17.05 60.42 -64.37 -18.53 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 8 3 # 8 B 137 GLY A 133 GLY^? 10.29 C1 C8E A 210 B 175 ARG A 101 ARG^? 8.92 C1 C8E A 210 B 242 TYR A 13 TYR^? 6.88 C17 C8E A 209 coo 99.45 58.28 3.33 99.57 58.61 4.10 65.83 -53.45 -13.52 65.37 -53.02 -13.01 coo 106.37 63.53 0.89 108.02 63.40 -1.62 59.10 -60.12 -16.06 60.30 -57.41 -15.78 coo 100.93 69.04 4.38 99.52 68.48 2.09 65.07 -60.93 -23.01 63.35 -61.54 -20.90 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 9 3 # 9 B 137 GLY A 148 GLY^? 17.63 C1 C8E A 209 B 175 ARG A 36 ARG^? 15.77 C1 C8E A 210 B 242 TYR A 97 TYR^? 11.99 C1 C8E A 210 coo 99.45 58.28 3.33 99.57 58.61 4.10 69.03 -47.69 -21.86 68.24 -47.54 -21.53 coo 106.37 63.53 0.89 108.02 63.40 -1.62 59.00 -50.13 -20.90 61.68 -51.06 -19.88 coo 100.93 69.04 4.38 99.52 68.48 2.09 61.97 -51.46 -14.47 63.57 -52.89 -16.21 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 10 3 # 10 B 137 GLY A 151 GLY^? 9.44 C2 C8E A 209 B 175 ARG A 101 ARG^? 8.92 C1 C8E A 210 B 242 TYR A 13 TYR^? 6.88 C17 C8E A 209 coo 99.45 58.28 3.33 99.57 58.61 4.10 67.42 -55.91 -15.92 67.92 -56.29 -16.40 coo 106.37 63.53 0.89 108.02 63.40 -1.62 59.10 -60.12 -16.06 60.30 -57.41 -15.78 coo 100.93 69.04 4.38 99.52 68.48 2.09 65.07 -60.93 -23.01 63.35 -61.54 -20.90 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 11 3 # 11 B 137 GLY A 151 GLY^? 9.44 C2 C8E A 209 B 175 ARG A 101 ARG^? 8.92 C1 C8E A 210 B 242 TYR A 154 TYR^? -3.93 C5 C8E A 210s coo 99.45 58.28 3.33 99.57 58.61 4.10 67.42 -55.91 -15.92 67.92 -56.29 -16.40 coo 106.37 63.53 0.89 108.02 63.40 -1.62 59.10 -60.12 -16.06 60.30 -57.41 -15.78 coo 100.93 69.04 4.38 99.52 68.48 2.09 63.59 -66.74 -11.40 63.46 -69.45 -10.84 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 12 3 # 12 B 137 GLY A 151 GLY^? 9.44 C2 C8E A 209 B 175 ARG A 101 ARG^? 8.92 C1 C8E A 210 B 242 TYR A 155 TYR^? 8.43 C17 C8E A 209 coo 99.45 58.28 3.33 99.57 58.61 4.10 67.42 -55.91 -15.92 67.92 -56.29 -16.40 coo 106.37 63.53 0.89 108.02 63.40 -1.62 59.10 -60.12 -16.06 60.30 -57.41 -15.78 coo 100.93 69.04 4.38 99.52 68.48 2.09 60.87 -66.67 -17.05 60.42 -64.37 -18.53 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 13 3 # 13 B 137 GLY A 151 GLY^? 9.44 C2 C8E A 209 B 175 ARG A 200 ARG^? 11.17 C17 C8E A 209 B 242 TYR A 13 TYR^? 6.88 C17 C8E A 209 coo 99.45 58.28 3.33 99.57 58.61 4.10 67.42 -55.91 -15.92 67.92 -56.29 -16.40 coo 106.37 63.53 0.89 108.02 63.40 -1.62 65.38 -54.68 -25.12 63.65 -56.91 -23.89 coo 100.93 69.04 4.38 99.52 68.48 2.09 65.07 -60.93 -23.01 63.35 -61.54 -20.90 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 14 3 # 14 B 137 GLY B 34 GLY^? 26.08 O15 C8E B 209 B 175 ARG B 36 ARG^? 17.08 O15 C8E B 209 B 242 TYR B 97 TYR^? 16.46 O15 C8E B 209 coo 99.45 58.28 3.33 99.57 58.61 4.10 77.89 -40.59 -47.26 78.78 -40.41 -47.34 coo 106.37 63.53 0.89 108.02 63.40 -1.62 77.67 -37.50 -38.51 79.47 -39.58 -37.24 coo 100.93 69.04 4.38 99.52 68.48 2.09 83.74 -41.85 -39.80 83.62 -41.42 -37.05 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 15 3 # 15 B 137 GLY B 38 GLY^? 17.30 O15 C8E B 209 B 175 ARG B 101 ARG^? 13.86 O15 C8E B 209 B 242 TYR B 13 TYR^? 6.78 O15 C8E B 209 coo 99.45 58.28 3.33 99.57 58.61 4.10 78.31 -32.08 -37.28 78.82 -31.54 -37.56 coo 106.37 63.53 0.89 108.02 63.40 -1.62 87.52 -34.18 -37.50 85.80 -36.55 -38.16 coo 100.93 69.04 4.38 99.52 68.48 2.09 84.65 -34.92 -28.70 86.28 -34.17 -30.84 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 16 3 # 16 B 137 GLY B 38 GLY^? 17.30 O15 C8E B 209 B 175 ARG B 101 ARG^? 13.86 O15 C8E B 209 B 242 TYR B 97 TYR^? 16.46 O15 C8E B 209 coo 99.45 58.28 3.33 99.57 58.61 4.10 78.31 -32.08 -37.28 78.82 -31.54 -37.56 coo 106.37 63.53 0.89 108.02 63.40 -1.62 87.52 -34.18 -37.50 85.80 -36.55 -38.16 coo 100.93 69.04 4.38 99.52 68.48 2.09 83.74 -41.85 -39.80 83.62 -41.42 -37.05 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 17 3 # 17 B 137 GLY B 38 GLY^? 17.30 O15 C8E B 209 B 175 ARG B 101 ARG^? 13.86 O15 C8E B 209 B 242 TYR B 102 TYR^? 9.00 C1 C8E B 210 coo 99.45 58.28 3.33 99.57 58.61 4.10 78.31 -32.08 -37.28 78.82 -31.54 -37.56 coo 106.37 63.53 0.89 108.02 63.40 -1.62 87.52 -34.18 -37.50 85.80 -36.55 -38.16 coo 100.93 69.04 4.38 99.52 68.48 2.09 88.26 -25.14 -37.39 89.63 -22.79 -36.84 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 18 3 # 18 B 137 GLY B 38 GLY^? 17.30 O15 C8E B 209 B 175 ARG B 200 ARG^? 11.34 O15 C8E B 209 B 242 TYR B 13 TYR^? 6.78 O15 C8E B 209 coo 99.45 58.28 3.33 99.57 58.61 4.10 78.31 -32.08 -37.28 78.82 -31.54 -37.56 coo 106.37 63.53 0.89 108.02 63.40 -1.62 78.82 -37.69 -29.59 80.99 -36.13 -31.14 coo 100.93 69.04 4.38 99.52 68.48 2.09 84.65 -34.92 -28.70 86.28 -34.17 -30.84 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 19 3 # 19 B 137 GLY B 40 GLY^? 12.62 C20 C8E B 209 B 175 ARG B 101 ARG^? 13.86 O15 C8E B 209 B 242 TYR B 102 TYR^? 9.00 C1 C8E B 210 coo 99.45 58.28 3.33 99.57 58.61 4.10 79.65 -30.64 -31.14 79.77 -29.85 -31.21 coo 106.37 63.53 0.89 108.02 63.40 -1.62 87.52 -34.18 -37.50 85.80 -36.55 -38.16 coo 100.93 69.04 4.38 99.52 68.48 2.09 88.26 -25.14 -37.39 89.63 -22.79 -36.84 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 20 3 # 20 B 137 GLY B 40 GLY^? 12.62 C20 C8E B 209 B 175 ARG B 101 ARG^? 13.86 O15 C8E B 209 B 242 TYR B 155 TYR^? 7.60 C13 C8E B 209 coo 99.45 58.28 3.33 99.57 58.61 4.10 79.65 -30.64 -31.14 79.77 -29.85 -31.21 coo 106.37 63.53 0.89 108.02 63.40 -1.62 87.52 -34.18 -37.50 85.80 -36.55 -38.16 coo 100.93 69.04 4.38 99.52 68.48 2.09 92.02 -31.30 -32.58 89.26 -31.61 -33.00 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 21 3 # 21 B 137 GLY B 133 GLY^? 15.21 O15 C8E B 209 B 175 ARG B 101 ARG^? 13.86 O15 C8E B 209 B 242 TYR B 13 TYR^? 6.78 O15 C8E B 209 coo 99.45 58.28 3.33 99.57 58.61 4.10 86.08 -43.87 -36.38 86.09 -44.05 -37.22 coo 106.37 63.53 0.89 108.02 63.40 -1.62 87.52 -34.18 -37.50 85.80 -36.55 -38.16 coo 100.93 69.04 4.38 99.52 68.48 2.09 84.65 -34.92 -28.70 86.28 -34.17 -30.84 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 22 3 # 22 B 137 GLY B 148 GLY^? 19.08 O15 C8E B 209 B 175 ARG B 36 ARG^? 17.08 O15 C8E B 209 B 242 TYR B 97 TYR^? 16.46 O15 C8E B 209 coo 99.45 58.28 3.33 99.57 58.61 4.10 76.61 -45.51 -32.17 76.71 -45.21 -33.00 coo 106.37 63.53 0.89 108.02 63.40 -1.62 77.67 -37.50 -38.51 79.47 -39.58 -37.24 coo 100.93 69.04 4.38 99.52 68.48 2.09 83.74 -41.85 -39.80 83.62 -41.42 -37.05 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 23 3 # 23 B 137 GLY B 151 GLY^? 12.05 O15 C8E B 209 B 175 ARG B 101 ARG^? 13.86 O15 C8E B 209 B 242 TYR B 13 TYR^? 6.78 O15 C8E B 209 coo 99.45 58.28 3.33 99.57 58.61 4.10 86.36 -42.67 -33.06 86.31 -42.52 -32.28 coo 106.37 63.53 0.89 108.02 63.40 -1.62 87.52 -34.18 -37.50 85.80 -36.55 -38.16 coo 100.93 69.04 4.38 99.52 68.48 2.09 84.65 -34.92 -28.70 86.28 -34.17 -30.84 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 24 3 # 24 B 137 GLY B 151 GLY^? 12.05 O15 C8E B 209 B 175 ARG B 101 ARG^? 13.86 O15 C8E B 209 B 242 TYR B 154 TYR^? 5.13 C1 C8E B 209s coo 99.45 58.28 3.33 99.57 58.61 4.10 86.36 -42.67 -33.06 86.31 -42.52 -32.28 coo 106.37 63.53 0.89 108.02 63.40 -1.62 87.52 -34.18 -37.50 85.80 -36.55 -38.16 coo 100.93 69.04 4.38 99.52 68.48 2.09 96.51 -35.71 -33.91 98.87 -34.53 -33.06 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 25 3 # 25 B 137 GLY B 151 GLY^? 12.05 O15 C8E B 209 B 175 ARG B 101 ARG^? 13.86 O15 C8E B 209 B 242 TYR B 155 TYR^? 7.60 C13 C8E B 209 coo 99.45 58.28 3.33 99.57 58.61 4.10 86.36 -42.67 -33.06 86.31 -42.52 -32.28 coo 106.37 63.53 0.89 108.02 63.40 -1.62 87.52 -34.18 -37.50 85.80 -36.55 -38.16 coo 100.93 69.04 4.38 99.52 68.48 2.09 92.02 -31.30 -32.58 89.26 -31.61 -33.00 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 26 3 # 26 B 137 GLY B 151 GLY^? 12.05 O15 C8E B 209 B 175 ARG B 200 ARG^? 11.34 O15 C8E B 209 B 242 TYR B 13 TYR^? 6.78 O15 C8E B 209 coo 99.45 58.28 3.33 99.57 58.61 4.10 86.36 -42.67 -33.06 86.31 -42.52 -32.28 coo 106.37 63.53 0.89 108.02 63.40 -1.62 78.82 -37.69 -29.59 80.99 -36.13 -31.14 coo 100.93 69.04 4.38 99.52 68.48 2.09 84.65 -34.92 -28.70 86.28 -34.17 -30.84 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 27 3 # 27 B 137 GLY C 34 GLY^? 20.14 O21 C8E A 209 B 175 ARG C 36 ARG^? 17.98 C16 C8E C 210 B 242 TYR C 97 TYR^? 17.03 C13 C8E C 210 coo 99.45 58.28 3.33 99.57 58.61 4.10 52.44 -58.67 -35.04 52.34 -59.13 -34.28 coo 106.37 63.53 0.89 108.02 63.40 -1.62 45.58 -52.92 -31.76 43.11 -54.70 -31.56 coo 100.93 69.04 4.38 99.52 68.48 2.09 44.42 -59.94 -30.24 42.23 -58.45 -29.40 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 28 3 # 28 B 137 GLY C 38 GLY^? 17.56 C19 C8E C 210 B 175 ARG C 101 ARG^? 13.82 C13 C8E C 210 B 242 TYR C 13 TYR^? 7.82 C16 C8E C 210 coo 99.45 58.28 3.33 99.57 58.61 4.10 47.08 -49.08 -27.59 47.53 -49.11 -26.94 coo 106.37 63.53 0.89 108.02 63.40 -1.62 44.39 -56.56 -21.66 44.87 -57.05 -24.63 coo 100.93 69.04 4.38 99.52 68.48 2.09 37.24 -51.70 -23.13 39.21 -53.16 -21.84 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 29 3 # 29 B 137 GLY C 38 GLY^? 17.56 C19 C8E C 210 B 175 ARG C 101 ARG^? 13.82 C13 C8E C 210 B 242 TYR C 97 TYR^? 17.03 C13 C8E C 210 coo 99.45 58.28 3.33 99.57 58.61 4.10 47.08 -49.08 -27.59 47.53 -49.11 -26.94 coo 106.37 63.53 0.89 108.02 63.40 -1.62 44.39 -56.56 -21.66 44.87 -57.05 -24.63 coo 100.93 69.04 4.38 99.52 68.48 2.09 44.42 -59.94 -30.24 42.23 -58.45 -29.40 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 30 3 # 30 B 137 GLY C 38 GLY^? 17.56 C19 C8E C 210 B 175 ARG C 101 ARG^? 13.82 C13 C8E C 210 B 242 TYR C 102 TYR^? 9.73 C2 C8E C 209 coo 99.45 58.28 3.33 99.57 58.61 4.10 47.08 -49.08 -27.59 47.53 -49.11 -26.94 coo 106.37 63.53 0.89 108.02 63.40 -1.62 44.39 -56.56 -21.66 44.87 -57.05 -24.63 coo 100.93 69.04 4.38 99.52 68.48 2.09 48.50 -51.08 -15.65 48.91 -50.66 -12.96 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 31 3 # 31 B 137 GLY C 40 GLY^? 12.46 C19 C8E C 210 B 175 ARG C 101 ARG^? 13.82 C13 C8E C 210 B 242 TYR C 102 TYR^? 9.73 C2 C8E C 209 coo 99.45 58.28 3.33 99.57 58.61 4.10 41.84 -46.53 -24.70 42.24 -46.19 -24.08 coo 106.37 63.53 0.89 108.02 63.40 -1.62 44.39 -56.56 -21.66 44.87 -57.05 -24.63 coo 100.93 69.04 4.38 99.52 68.48 2.09 48.50 -51.08 -15.65 48.91 -50.66 -12.96 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 32 3 # 32 B 137 GLY C 40 GLY^? 12.46 C19 C8E C 210 B 175 ARG C 101 ARG^? 13.82 C13 C8E C 210 B 242 TYR C 155 TYR^? 7.32 C13 C8E C 210 coo 99.45 58.28 3.33 99.57 58.61 4.10 41.84 -46.53 -24.70 42.24 -46.19 -24.08 coo 106.37 63.53 0.89 108.02 63.40 -1.62 44.39 -56.56 -21.66 44.87 -57.05 -24.63 coo 100.93 69.04 4.38 99.52 68.48 2.09 41.26 -55.52 -15.76 41.81 -54.24 -18.13 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 33 3 # 33 B 137 GLY C 133 GLY^? 15.62 C13 C8E C 210 B 175 ARG C 101 ARG^? 13.82 C13 C8E C 210 B 242 TYR C 13 TYR^? 7.82 C16 C8E C 210 coo 99.45 58.28 3.33 99.57 58.61 4.10 40.42 -61.48 -28.89 41.03 -62.00 -29.17 coo 106.37 63.53 0.89 108.02 63.40 -1.62 44.39 -56.56 -21.66 44.87 -57.05 -24.63 coo 100.93 69.04 4.38 99.52 68.48 2.09 37.24 -51.70 -23.13 39.21 -53.16 -21.84 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 34 3 # 34 B 137 GLY C 148 GLY^? 19.87 C16 C8E C 210 B 175 ARG C 36 ARG^? 17.98 C16 C8E C 210 B 242 TYR C 97 TYR^? 17.03 C13 C8E C 210 coo 99.45 58.28 3.33 99.57 58.61 4.10 36.86 -55.05 -36.49 37.69 -55.22 -36.43 coo 106.37 63.53 0.89 108.02 63.40 -1.62 45.58 -52.92 -31.76 43.11 -54.70 -31.56 coo 100.93 69.04 4.38 99.52 68.48 2.09 44.42 -59.94 -30.24 42.23 -58.45 -29.40 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 35 3 # 35 B 137 GLY C 151 GLY^? 12.60 C13 C8E C 210 B 175 ARG C 101 ARG^? 13.82 C13 C8E C 210 B 242 TYR C 154 TYR^? -5.05 C10 C8E C 209s coo 99.45 58.28 3.33 99.57 58.61 4.10 37.96 -59.28 -27.29 37.21 -59.08 -27.12 coo 106.37 63.53 0.89 108.02 63.40 -1.62 44.39 -56.56 -21.66 44.87 -57.05 -24.63 coo 100.93 69.04 4.38 99.52 68.48 2.09 40.20 -61.77 -15.26 39.91 -62.08 -12.52 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 36 3 # 36 B 137 GLY C 151 GLY^? 12.60 C13 C8E C 210 B 175 ARG C 101 ARG^? 13.82 C13 C8E C 210 B 242 TYR C 155 TYR^? 7.32 C13 C8E C 210 coo 99.45 58.28 3.33 99.57 58.61 4.10 37.96 -59.28 -27.29 37.21 -59.08 -27.12 coo 106.37 63.53 0.89 108.02 63.40 -1.62 44.39 -56.56 -21.66 44.87 -57.05 -24.63 coo 100.93 69.04 4.38 99.52 68.48 2.09 41.26 -55.52 -15.76 41.81 -54.24 -18.13 1xva_c03 source 1xva GLYCINE N-METHYLTRANSFERASE : 36 hits 1xva_c03 naa= 3 ULMN 3 1ybv_c00 TRIHYDROXYNAPHTHALENE REDUCTASE user 1 3 # 1 A 164 SER A 69 SER^? 11.97 CA CA A 208 A 178 TYR A 109 TYR^? 10.85 CA CA A 208 A 182 LYS A 63 LYS~? 3.96 CA CA A 208 coo 81.46 10.53 21.66 82.20 10.82 19.39 69.09 -77.26 -37.91 68.86 -76.80 -40.31 coo 87.67 8.69 17.10 86.62 10.83 18.52 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo 85.30 6.17 22.83 87.26 11.02 23.50 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 1ybv_c00 TRIHYDROXYNAPHTHALENE REDUCTASE user 2 3 # 2 A 164 SER A 86 SER.? 26.41 C2 C8E C 209 A 178 TYR A 83 TYR^? -19.24 C2 C8E C 209s A 182 LYS A 84 LYS.? 23.11 C2 C8E C 209 coo 81.46 10.53 21.66 82.20 10.82 19.39 63.25 -36.36 -7.87 60.84 -35.97 -7.64 coo 87.67 8.69 17.10 86.62 10.83 18.52 59.25 -44.27 -7.74 58.41 -42.23 -6.03 coo 85.30 6.17 22.83 87.26 11.02 23.50 61.58 -41.74 -11.00 58.66 -39.80 -16.04 ULMN 3 1ybv_c00 TRIHYDROXYNAPHTHALENE REDUCTASE user 3 3 # 3 A 164 SER B 69 SER^? 12.05 CA CA B 208 A 178 TYR B 109 TYR^? 10.54 CA CA B 208 A 182 LYS B 63 LYS~? 3.79 CA CA B 208 coo 81.46 10.53 21.66 82.20 10.82 19.39 86.53 -22.01 -10.29 84.57 -20.83 -9.39 coo 87.67 8.69 17.10 86.62 10.83 18.52 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo 85.30 6.17 22.83 87.26 11.02 23.50 93.18 -23.71 -7.17 90.77 -27.85 -10.83 1ybv_c00 source 1ybv TRIHYDROXYNAPHTHALENE REDUCTASE : 3 hits 1ybv_c00 naa= 3 ULMN 3 1ybv_c01 TRIHYDROXYNAPHTHALENE REDUCTASE user 1 3 # 1 B 164 SER A 69 SER^? 11.97 CA CA A 208 B 178 TYR A 109 TYR^? 10.85 CA CA A 208 B 182 LYS A 63 LYS~? 3.96 CA CA A 208 coo 61.22 3.61 34.51 60.46 1.86 35.98 69.09 -77.26 -37.91 68.86 -76.80 -40.31 coo 54.99 -1.20 35.40 56.04 1.15 36.44 66.11 -81.19 -34.21 65.29 -83.76 -33.55 coo 57.40 2.23 30.19 55.43 5.44 33.87 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 1ybv_c01 TRIHYDROXYNAPHTHALENE REDUCTASE user 2 3 # 2 B 164 SER A 86 SER.? 26.41 C2 C8E C 209 B 178 TYR A 83 TYR^? -19.24 C2 C8E C 209s B 182 LYS A 84 LYS.? 23.11 C2 C8E C 209 coo 61.22 3.61 34.51 60.46 1.86 35.98 63.25 -36.36 -7.87 60.84 -35.97 -7.64 coo 54.99 -1.20 35.40 56.04 1.15 36.44 59.25 -44.27 -7.74 58.41 -42.23 -6.03 coo 57.40 2.23 30.19 55.43 5.44 33.87 61.58 -41.74 -11.00 58.66 -39.80 -16.04 ULMN 3 1ybv_c01 TRIHYDROXYNAPHTHALENE REDUCTASE user 3 3 # 3 B 164 SER B 69 SER^? 12.05 CA CA B 208 B 178 TYR B 109 TYR^? 10.54 CA CA B 208 B 182 LYS B 63 LYS~? 3.79 CA CA B 208 coo 61.22 3.61 34.51 60.46 1.86 35.98 86.53 -22.01 -10.29 84.57 -20.83 -9.39 coo 54.99 -1.20 35.40 56.04 1.15 36.44 91.74 -19.55 -12.92 94.01 -17.92 -12.82 coo 57.40 2.23 30.19 55.43 5.44 33.87 93.18 -23.71 -7.17 90.77 -27.85 -10.83 1ybv_c01 source 1ybv TRIHYDROXYNAPHTHALENE REDUCTASE : 3 hits 1ybv_c01 naa= 3 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 A 14 LYS B 67 LYS~? 18.13 CA CA B 208 A 74 LYS B 63 LYS~? 3.79 CA CA B 208 A 165 GLU B 164 GLU^? 19.99 CA CA B 208 coo 18.28 7.83 36.39 22.82 8.75 39.52 89.12 -21.41 -4.23 87.66 -21.56 1.71 coo 14.16 13.09 37.03 20.00 12.44 37.49 93.18 -23.71 -7.17 90.77 -27.85 -10.83 coo 22.22 16.06 48.76 23.94 15.33 49.78 94.70 -10.70 -16.52 96.59 -9.81 -16.07 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 A 14 LYS C 67 LYS.? 18.71 CA CA C 208 A 74 LYS C 63 LYS~? 4.21 CA CA C 208 A 165 GLU C 164 GLU^? 20.06 CA CA C 208 coo 18.28 7.83 36.39 22.82 8.75 39.52 20.04 -36.06 -6.98 16.11 -31.17 -7.78 coo 14.16 13.09 37.03 20.00 12.44 37.49 20.98 -41.61 -5.49 23.04 -43.67 -10.44 coo 22.22 16.06 48.76 23.94 15.33 49.78 34.72 -37.11 1.76 34.46 -37.46 3.82 1ylu_c00 source 1ylu OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 2 hits 1ylu_c00 naa= 3 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 B 14 LYS B 67 LYS~? 18.13 CA CA B 208 B 74 LYS B 63 LYS~? 3.79 CA CA B 208 B 165 GLU B 164 GLU^? 19.99 CA CA B 208 coo 13.51 0.92 76.10 12.98 6.13 74.68 89.12 -21.41 -4.23 87.66 -21.56 1.71 coo 19.89 -0.55 76.51 17.10 4.32 77.43 93.18 -23.71 -7.17 90.77 -27.85 -10.83 coo 21.39 11.56 68.52 20.24 13.13 67.73 94.70 -10.70 -16.52 96.59 -9.81 -16.07 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 B 14 LYS C 67 LYS.? 18.71 CA CA C 208 B 74 LYS C 63 LYS~? 4.21 CA CA C 208 B 165 GLU C 164 GLU^? 20.06 CA CA C 208 coo 13.51 0.92 76.10 12.98 6.13 74.68 20.04 -36.06 -6.98 16.11 -31.17 -7.78 coo 19.89 -0.55 76.51 17.10 4.32 77.43 20.98 -41.61 -5.49 23.04 -43.67 -10.44 coo 21.39 11.56 68.52 20.24 13.13 67.73 34.72 -37.11 1.76 34.46 -37.46 3.82 1ylu_c01 source 1ylu OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 2 hits 1ylu_c01 naa= 3 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 1 3 # 1 A 369 ASP A 48 ASP.? 7.38 CA CA A 208 A 371 LYS A 188 LYS~? 10.77 C20 C8E A 210 A 407 THR A 191 THR.? -4.98 C19 C8E A 209s coo -5.17 31.09 15.73 -7.07 31.12 16.73 72.05 -78.20 -23.17 73.82 -77.79 -22.11 coo -4.43 30.92 22.89 -6.61 31.91 19.71 68.32 -80.18 -18.11 71.95 -84.24 -15.84 coo -8.38 36.02 19.06 -8.83 34.10 19.89 67.24 -74.39 -22.77 69.05 -73.78 -23.78 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 2 3 # 2 A 369 ASP A 49 ASP.? -3.00 CA CA A 208s A 371 LYS A 63 LYS~? 3.96 CA CA A 208 A 407 THR A 58 THR~? 10.52 CA CA A 208 coo -5.17 31.09 15.73 -7.07 31.12 16.73 75.72 -77.89 -27.98 74.67 -77.10 -29.65 coo -4.43 30.92 22.89 -6.61 31.91 19.71 73.63 -82.49 -34.44 73.43 -77.00 -32.37 coo -8.38 36.02 19.06 -8.83 34.10 19.89 76.40 -85.04 -26.81 78.11 -83.80 -26.40 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 3 3 # 3 A 369 ASP A 166 ASP.? 23.45 CA CA A 208 A 371 LYS A 119 LYS.? 17.79 CA CA A 208 A 407 THR A 117 THR.? 21.33 CA CA A 208 coo -5.17 31.09 15.73 -7.07 31.12 16.73 55.95 -88.25 -40.15 55.99 -89.39 -38.36 coo -4.43 30.92 22.89 -6.61 31.91 19.71 60.88 -84.29 -40.26 61.29 -87.76 -35.50 coo -8.38 36.02 19.06 -8.83 34.10 19.89 63.40 -90.39 -40.90 61.71 -90.63 -39.48 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 4 3 # 4 A 369 ASP A 167 ASP.? 22.50 CA CA A 208 A 371 LYS A 119 LYS.? 17.79 CA CA A 208 A 407 THR A 117 THR.? 21.33 CA CA A 208 coo -5.17 31.09 15.73 -7.07 31.12 16.73 58.25 -87.45 -44.58 60.23 -87.13 -43.88 coo -4.43 30.92 22.89 -6.61 31.91 19.71 60.88 -84.29 -40.26 61.29 -87.76 -35.50 coo -8.38 36.02 19.06 -8.83 34.10 19.89 63.40 -90.39 -40.90 61.71 -90.63 -39.48 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 5 3 # 5 A 369 ASP B 48 ASP.? 7.20 CA CA B 208 A 371 LYS B 188 LYS~? 9.67 C16 C8E B 210 A 407 THR B 191 THR.? -5.05 O18 C8E B 209s coo -5.17 31.09 15.73 -7.07 31.12 16.73 97.60 -30.12 -16.68 98.20 -32.01 -15.99 coo -4.43 30.92 22.89 -6.61 31.91 19.71 102.16 -28.74 -21.10 106.15 -31.37 -17.86 coo -8.38 36.02 19.06 -8.83 34.10 19.89 94.88 -29.06 -21.80 94.27 -29.66 -19.85 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 6 3 # 6 A 369 ASP B 49 ASP.? -3.05 CA CA B 208s A 371 LYS B 63 LYS~? 3.79 CA CA B 208 A 407 THR B 58 THR~? 10.41 CA CA B 208 coo -5.17 31.09 15.73 -7.07 31.12 16.73 94.52 -28.97 -11.62 93.03 -30.41 -11.73 coo -4.43 30.92 22.89 -6.61 31.91 19.71 93.18 -23.71 -7.17 90.77 -27.85 -10.83 coo -8.38 36.02 19.06 -8.83 34.10 19.89 100.65 -27.90 -8.43 100.12 -29.92 -7.97 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 7 3 # 7 A 369 ASP B 166 ASP.? 24.17 CA CA B 208 A 371 LYS B 119 LYS.? 18.40 CA CA B 208 A 407 THR B 117 THR.? 21.30 CA CA B 208 coo -5.17 31.09 15.73 -7.07 31.12 16.73 91.14 -5.33 -14.11 93.17 -5.00 -14.63 coo -4.43 30.92 22.89 -6.61 31.91 19.71 89.22 -11.21 -11.71 95.34 -11.17 -12.31 coo -8.38 36.02 19.06 -8.83 34.10 19.89 93.17 -9.31 -6.81 94.03 -8.66 -8.75 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 8 3 # 8 A 369 ASP B 167 ASP.? 22.72 CA CA B 208 A 371 LYS B 119 LYS.? 18.40 CA CA B 208 A 407 THR B 117 THR.? 21.30 CA CA B 208 coo -5.17 31.09 15.73 -7.07 31.12 16.73 88.92 -5.85 -9.56 88.92 -7.42 -8.19 coo -4.43 30.92 22.89 -6.61 31.91 19.71 89.22 -11.21 -11.71 95.34 -11.17 -12.31 coo -8.38 36.02 19.06 -8.83 34.10 19.89 93.17 -9.31 -6.81 94.03 -8.66 -8.75 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 9 3 # 9 A 369 ASP C 48 ASP.? 7.17 CA CA C 208 A 371 LYS C 188 LYS~? 9.02 C16 C8E C 209 A 407 THR C 191 THR.? 5.18 C20 C8E C 209s coo -5.17 31.09 15.73 -7.07 31.12 16.73 26.68 -52.06 -7.74 25.46 -53.53 -8.54 coo -4.43 30.92 22.89 -6.61 31.91 19.71 31.07 -55.82 -4.30 26.58 -58.21 -2.57 coo -8.38 36.02 19.06 -8.83 34.10 19.89 32.16 -51.72 -10.15 30.14 -51.15 -10.71 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 10 3 # 10 A 369 ASP C 49 ASP.? -2.87 CA CA C 208s A 371 LYS C 63 LYS~? 4.21 CA CA C 208 A 407 THR C 58 THR~? 10.65 CA CA C 208 coo -5.17 31.09 15.73 -7.07 31.12 16.73 22.13 -48.50 -9.42 23.00 -46.66 -10.00 coo -4.43 30.92 22.89 -6.61 31.91 19.71 20.98 -41.61 -5.49 23.04 -43.67 -10.44 coo -8.38 36.02 19.06 -8.83 34.10 19.89 19.91 -49.60 -2.59 18.80 -50.74 -4.02 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 11 3 # 11 A 369 ASP C 166 ASP.? 24.81 CA CA C 208 A 371 LYS C 119 LYS.? 22.44 CA CA C 208 A 407 THR C 117 THR.? 21.70 CA CA C 208 coo -5.17 31.09 15.73 -7.07 31.12 16.73 35.75 -30.25 2.83 35.54 -31.07 4.76 coo -4.43 30.92 22.89 -6.61 31.91 19.71 30.81 -32.05 -1.80 31.88 -31.87 3.92 coo -8.38 36.02 19.06 -8.83 34.10 19.89 27.55 -31.30 3.26 28.51 -32.70 4.67 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 12 3 # 12 A 369 ASP C 167 ASP.? 25.18 CA CA C 208 A 371 LYS C 119 LYS.? 22.44 CA CA C 208 A 407 THR C 117 THR.? 21.70 CA CA C 208 coo -5.17 31.09 15.73 -7.07 31.12 16.73 31.39 -27.44 2.08 30.34 -25.78 1.31 coo -4.43 30.92 22.89 -6.61 31.91 19.71 30.81 -32.05 -1.80 31.88 -31.87 3.92 coo -8.38 36.02 19.06 -8.83 34.10 19.89 27.55 -31.30 3.26 28.51 -32.70 4.67 1zrz_c02 source 1zrz PROTEIN KINASE C, IOTA : 12 hits 1zrz_c02 naa= 3 ULMN 3 1zrz_c03 PROTEIN KINASE C, IOTA user 1 3 # 1 A 369 ASP A 166 ASP.? 23.45 CA CA A 208 A 371 LYS A 171 LYS^? 22.02 O21 C8E A 209 A 374 ASN A 170 ASN.? 28.35 CA CA A 208 coo -5.17 31.09 15.73 -7.07 31.12 16.73 55.95 -88.25 -40.15 55.99 -89.39 -38.36 coo -4.43 30.92 22.89 -6.61 31.91 19.71 51.77 -85.30 -36.11 51.41 -79.16 -37.75 coo -4.84 27.04 20.49 -6.40 27.76 19.26 51.62 -88.52 -39.42 50.91 -89.41 -41.21 ULMN 3 1zrz_c03 PROTEIN KINASE C, IOTA user 2 3 # 2 A 369 ASP A 185 ASP~? 11.73 O21 C8E A 210 A 371 LYS A 188 LYS~? 10.77 C20 C8E A 210 A 374 ASN A 187 ASN~? -3.11 O18 C8E A 210s coo -5.17 31.09 15.73 -7.07 31.12 16.73 65.81 -86.27 -18.22 66.54 -87.64 -16.78 coo -4.43 30.92 22.89 -6.61 31.91 19.71 68.32 -80.18 -18.11 71.95 -84.24 -15.84 coo -4.84 27.04 20.49 -6.40 27.76 19.26 63.91 -79.43 -16.81 63.89 -77.36 -16.28 ULMN 3 1zrz_c03 PROTEIN KINASE C, IOTA user 3 3 # 3 A 369 ASP B 185 ASP~? 11.63 O21 C8E B 210 A 371 LYS B 188 LYS~? 9.67 C16 C8E B 210 A 374 ASN B 187 ASN~? -3.44 O21 C8E B 210s coo -5.17 31.09 15.73 -7.07 31.12 16.73 106.30 -23.80 -20.43 108.26 -24.54 -20.08 coo -4.43 30.92 22.89 -6.61 31.91 19.71 102.16 -28.74 -21.10 106.15 -31.37 -17.86 coo -4.84 27.04 20.49 -6.40 27.76 19.26 101.97 -26.81 -25.28 100.76 -28.02 -26.55 ULMN 3 1zrz_c03 PROTEIN KINASE C, IOTA user 4 3 # 4 A 369 ASP C 185 ASP~? 11.81 O21 C8E C 209 A 371 LYS C 188 LYS~? 9.02 C16 C8E C 209 A 374 ASN C 187 ASN~? -2.70 C14 C8E C 209s coo -5.17 31.09 15.73 -7.07 31.12 16.73 31.89 -54.53 1.93 31.11 -55.91 3.29 coo -4.43 30.92 22.89 -6.61 31.91 19.71 31.07 -55.82 -4.30 26.58 -58.21 -2.57 coo -4.84 27.04 20.49 -6.40 27.76 19.26 35.59 -56.00 -3.84 36.37 -56.79 -5.68 1zrz_c03 source 1zrz PROTEIN KINASE C, IOTA : 4 hits 1zrz_c03 naa= 3 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 1 3 # 1 142 TRP A 195 TRP^? -4.38 C5 C8E A 209s 223 ASP A 153 ASP^? 8.28 C1 C8E A 210 258 ALA A 158 ALA.? 8.30 O15 C8E A 210 coo 128.40 33.01 26.67 128.12 36.28 28.81 68.76 -68.24 -12.51 67.44 -65.53 -9.97 coo 127.91 41.73 23.55 129.18 40.35 24.44 63.37 -61.81 -16.17 62.75 -59.91 -16.84 coo 141.00 37.49 25.74 139.80 37.53 24.78 56.38 -74.89 -16.34 55.90 -73.81 -17.22 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 2 3 # 2 142 TRP B 195 TRP^? -4.79 C3 C8E B 209s 223 ASP B 153 ASP^? 9.57 O15 C8E B 209 258 ALA B 158 ALA.? 4.91 C2 C8E B 210 coo 128.40 33.01 26.67 128.12 36.28 28.81 97.59 -37.97 -29.26 96.99 -39.82 -32.71 coo 127.91 41.73 23.55 129.18 40.35 24.44 89.74 -36.17 -33.46 87.76 -36.55 -34.22 coo 141.00 37.49 25.74 139.80 37.53 24.78 97.94 -23.77 -32.61 96.50 -23.63 -32.93 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 3 3 # 3 142 TRP C 195 TRP^? -4.37 C3 C8E C 210s 223 ASP C 153 ASP^? 9.83 C13 C8E C 210 258 ALA C 158 ALA.? 5.77 C3 C8E C 209 coo 128.40 33.01 26.67 128.12 36.28 28.81 34.65 -62.08 -15.07 37.18 -64.29 -17.10 coo 127.91 41.73 23.55 129.18 40.35 24.44 40.09 -57.62 -20.90 41.26 -57.13 -22.61 coo 141.00 37.49 25.74 139.80 37.53 24.78 43.81 -54.47 -6.60 44.31 -53.67 -7.75 2aat_c01 source 2aat ASPARTATE AMINOTRANSFERASE (E.C.2.6.1.1) MUTAN: 3 hits 2aat_c01 naa= 3 ULMN 3 2adm_c00 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 1 3 # 1 A 105 ASN A 74 ASN^? -3.00 O21 C8E A 209s A 106 PRO A 193 PRO.? -3.59 C20 C8E A 209s A 108 TYR A 13 TYR^? 6.88 C17 C8E A 209 coo 34.91 38.94 20.48 33.53 38.20 19.00 62.15 -65.86 -25.53 63.13 -67.52 -24.67 coo 36.18 33.51 20.99 37.11 35.33 20.14 62.99 -68.36 -21.23 64.14 -69.92 -20.16 coo 33.01 33.46 15.68 31.96 34.97 17.80 65.07 -60.93 -23.01 63.35 -61.54 -20.90 ULMN 3 2adm_c00 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 2 3 # 2 A 105 ASN A 74 ASN^? -3.00 O21 C8E A 209s A 106 PRO A 193 PRO.? -3.59 C20 C8E A 209s A 108 TYR A 155 TYR^? 8.43 C17 C8E A 209 coo 34.91 38.94 20.48 33.53 38.20 19.00 62.15 -65.86 -25.53 63.13 -67.52 -24.67 coo 36.18 33.51 20.99 37.11 35.33 20.14 62.99 -68.36 -21.23 64.14 -69.92 -20.16 coo 33.01 33.46 15.68 31.96 34.97 17.80 60.87 -66.67 -17.05 60.42 -64.37 -18.53 ULMN 3 2adm_c00 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 3 3 # 3 A 105 ASN A 103 ASN^? 6.31 O21 C8E A 209 A 106 PRO A 193 PRO.? -3.59 C20 C8E A 209s A 108 TYR A 13 TYR^? 6.88 C17 C8E A 209 coo 34.91 38.94 20.48 33.53 38.20 19.00 58.51 -66.15 -21.33 59.95 -66.28 -22.87 coo 36.18 33.51 20.99 37.11 35.33 20.14 62.99 -68.36 -21.23 64.14 -69.92 -20.16 coo 33.01 33.46 15.68 31.96 34.97 17.80 65.07 -60.93 -23.01 63.35 -61.54 -20.90 ULMN 3 2adm_c00 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 4 3 # 4 A 105 ASN B 74 ASN^? -3.28 C20 C8E B 209s A 106 PRO B 193 PRO.? -3.08 O21 C8E B 209s A 108 TYR B 13 TYR^? 6.78 O15 C8E B 209 coo 34.91 38.94 20.48 33.53 38.20 19.00 85.94 -28.94 -27.06 87.84 -29.20 -26.13 coo 36.18 33.51 20.99 37.11 35.33 20.14 90.66 -29.80 -28.19 92.68 -30.26 -27.36 coo 33.01 33.46 15.68 31.96 34.97 17.80 84.65 -34.92 -28.70 86.28 -34.17 -30.84 ULMN 3 2adm_c00 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 5 3 # 5 A 105 ASN B 74 ASN^? -3.28 C20 C8E B 209s A 106 PRO B 193 PRO.? -3.08 O21 C8E B 209s A 108 TYR B 155 TYR^? 7.60 C13 C8E B 209 coo 34.91 38.94 20.48 33.53 38.20 19.00 85.94 -28.94 -27.06 87.84 -29.20 -26.13 coo 36.18 33.51 20.99 37.11 35.33 20.14 90.66 -29.80 -28.19 92.68 -30.26 -27.36 coo 33.01 33.46 15.68 31.96 34.97 17.80 92.02 -31.30 -32.58 89.26 -31.61 -33.00 ULMN 3 2adm_c00 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 6 3 # 6 A 105 ASN B 103 ASN^? 6.73 O21 C8E B 209 A 106 PRO B 193 PRO.? -3.08 O21 C8E B 209s A 108 TYR B 13 TYR^? 6.78 O15 C8E B 209 coo 34.91 38.94 20.48 33.53 38.20 19.00 88.46 -28.09 -32.02 87.63 -28.23 -30.06 coo 36.18 33.51 20.99 37.11 35.33 20.14 90.66 -29.80 -28.19 92.68 -30.26 -27.36 coo 33.01 33.46 15.68 31.96 34.97 17.80 84.65 -34.92 -28.70 86.28 -34.17 -30.84 ULMN 3 2adm_c00 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 7 3 # 7 A 105 ASN C 74 ASN^? -3.17 C20 C8E C 210s A 106 PRO C 193 PRO.? -3.52 C20 C8E C 210s A 108 TYR C 13 TYR^? 7.82 C16 C8E C 210 coo 34.91 38.94 20.48 33.53 38.20 19.00 38.01 -47.64 -17.99 37.26 -48.68 -16.35 coo 36.18 33.51 20.99 37.11 35.33 20.14 38.01 -51.99 -15.07 36.74 -53.25 -13.74 coo 33.01 33.46 15.68 31.96 34.97 17.80 37.24 -51.70 -23.13 39.21 -53.16 -21.84 ULMN 3 2adm_c00 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 8 3 # 8 A 105 ASN C 74 ASN^? -3.17 C20 C8E C 210s A 106 PRO C 193 PRO.? -3.52 C20 C8E C 210s A 108 TYR C 155 TYR^? 7.32 C13 C8E C 210 coo 34.91 38.94 20.48 33.53 38.20 19.00 38.01 -47.64 -17.99 37.26 -48.68 -16.35 coo 36.18 33.51 20.99 37.11 35.33 20.14 38.01 -51.99 -15.07 36.74 -53.25 -13.74 coo 33.01 33.46 15.68 31.96 34.97 17.80 41.26 -55.52 -15.76 41.81 -54.24 -18.13 ULMN 3 2adm_c00 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 9 3 # 9 A 105 ASN C 103 ASN^? 6.32 C20 C8E C 210 A 106 PRO C 193 PRO.? -3.52 C20 C8E C 210s A 108 TYR C 13 TYR^? 7.82 C16 C8E C 210 coo 34.91 38.94 20.48 33.53 38.20 19.00 42.54 -50.86 -16.42 40.88 -49.65 -16.80 coo 36.18 33.51 20.99 37.11 35.33 20.14 38.01 -51.99 -15.07 36.74 -53.25 -13.74 coo 33.01 33.46 15.68 31.96 34.97 17.80 37.24 -51.70 -23.13 39.21 -53.16 -21.84 2adm_c00 source 2adm ADENINE-N6-DNA-METHYLTRANSFERASE TAQI : 9 hits 2adm_c00 naa= 3 ULMN 3 2adm_c01 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 1 3 # 1 B 105 ASN A 74 ASN^? -3.00 O21 C8E A 209s B 106 PRO A 193 PRO.? -3.59 C20 C8E A 209s B 108 TYR A 13 TYR^? 6.88 C17 C8E A 209 coo 5.98 38.14 46.94 7.30 38.92 45.46 62.15 -65.86 -25.53 63.13 -67.52 -24.67 coo 4.66 43.53 47.47 3.74 41.73 46.59 62.99 -68.36 -21.23 64.14 -69.92 -20.16 coo 7.86 43.80 42.15 8.87 42.26 44.27 65.07 -60.93 -23.01 63.35 -61.54 -20.90 ULMN 3 2adm_c01 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 2 3 # 2 B 105 ASN A 74 ASN^? -3.00 O21 C8E A 209s B 106 PRO A 193 PRO.? -3.59 C20 C8E A 209s B 108 TYR A 155 TYR^? 8.43 C17 C8E A 209 coo 5.98 38.14 46.94 7.30 38.92 45.46 62.15 -65.86 -25.53 63.13 -67.52 -24.67 coo 4.66 43.53 47.47 3.74 41.73 46.59 62.99 -68.36 -21.23 64.14 -69.92 -20.16 coo 7.86 43.80 42.15 8.87 42.26 44.27 60.87 -66.67 -17.05 60.42 -64.37 -18.53 ULMN 3 2adm_c01 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 3 3 # 3 B 105 ASN A 103 ASN^? 6.31 O21 C8E A 209 B 106 PRO A 193 PRO.? -3.59 C20 C8E A 209s B 108 TYR A 13 TYR^? 6.88 C17 C8E A 209 coo 5.98 38.14 46.94 7.30 38.92 45.46 58.51 -66.15 -21.33 59.95 -66.28 -22.87 coo 4.66 43.53 47.47 3.74 41.73 46.59 62.99 -68.36 -21.23 64.14 -69.92 -20.16 coo 7.86 43.80 42.15 8.87 42.26 44.27 65.07 -60.93 -23.01 63.35 -61.54 -20.90 ULMN 3 2adm_c01 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 4 3 # 4 B 105 ASN B 74 ASN^? -3.28 C20 C8E B 209s B 106 PRO B 193 PRO.? -3.08 O21 C8E B 209s B 108 TYR B 13 TYR^? 6.78 O15 C8E B 209 coo 5.98 38.14 46.94 7.30 38.92 45.46 85.94 -28.94 -27.06 87.84 -29.20 -26.13 coo 4.66 43.53 47.47 3.74 41.73 46.59 90.66 -29.80 -28.19 92.68 -30.26 -27.36 coo 7.86 43.80 42.15 8.87 42.26 44.27 84.65 -34.92 -28.70 86.28 -34.17 -30.84 ULMN 3 2adm_c01 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 5 3 # 5 B 105 ASN B 74 ASN^? -3.28 C20 C8E B 209s B 106 PRO B 193 PRO.? -3.08 O21 C8E B 209s B 108 TYR B 155 TYR^? 7.60 C13 C8E B 209 coo 5.98 38.14 46.94 7.30 38.92 45.46 85.94 -28.94 -27.06 87.84 -29.20 -26.13 coo 4.66 43.53 47.47 3.74 41.73 46.59 90.66 -29.80 -28.19 92.68 -30.26 -27.36 coo 7.86 43.80 42.15 8.87 42.26 44.27 92.02 -31.30 -32.58 89.26 -31.61 -33.00 ULMN 3 2adm_c01 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 6 3 # 6 B 105 ASN B 103 ASN^? 6.73 O21 C8E B 209 B 106 PRO B 193 PRO.? -3.08 O21 C8E B 209s B 108 TYR B 13 TYR^? 6.78 O15 C8E B 209 coo 5.98 38.14 46.94 7.30 38.92 45.46 88.46 -28.09 -32.02 87.63 -28.23 -30.06 coo 4.66 43.53 47.47 3.74 41.73 46.59 90.66 -29.80 -28.19 92.68 -30.26 -27.36 coo 7.86 43.80 42.15 8.87 42.26 44.27 84.65 -34.92 -28.70 86.28 -34.17 -30.84 ULMN 3 2adm_c01 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 7 3 # 7 B 105 ASN C 74 ASN^? -3.17 C20 C8E C 210s B 106 PRO C 193 PRO.? -3.52 C20 C8E C 210s B 108 TYR C 13 TYR^? 7.82 C16 C8E C 210 coo 5.98 38.14 46.94 7.30 38.92 45.46 38.01 -47.64 -17.99 37.26 -48.68 -16.35 coo 4.66 43.53 47.47 3.74 41.73 46.59 38.01 -51.99 -15.07 36.74 -53.25 -13.74 coo 7.86 43.80 42.15 8.87 42.26 44.27 37.24 -51.70 -23.13 39.21 -53.16 -21.84 ULMN 3 2adm_c01 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 8 3 # 8 B 105 ASN C 74 ASN^? -3.17 C20 C8E C 210s B 106 PRO C 193 PRO.? -3.52 C20 C8E C 210s B 108 TYR C 155 TYR^? 7.32 C13 C8E C 210 coo 5.98 38.14 46.94 7.30 38.92 45.46 38.01 -47.64 -17.99 37.26 -48.68 -16.35 coo 4.66 43.53 47.47 3.74 41.73 46.59 38.01 -51.99 -15.07 36.74 -53.25 -13.74 coo 7.86 43.80 42.15 8.87 42.26 44.27 41.26 -55.52 -15.76 41.81 -54.24 -18.13 ULMN 3 2adm_c01 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 9 3 # 9 B 105 ASN C 103 ASN^? 6.32 C20 C8E C 210 B 106 PRO C 193 PRO.? -3.52 C20 C8E C 210s B 108 TYR C 13 TYR^? 7.82 C16 C8E C 210 coo 5.98 38.14 46.94 7.30 38.92 45.46 42.54 -50.86 -16.42 40.88 -49.65 -16.80 coo 4.66 43.53 47.47 3.74 41.73 46.59 38.01 -51.99 -15.07 36.74 -53.25 -13.74 coo 7.86 43.80 42.15 8.87 42.26 44.27 37.24 -51.70 -23.13 39.21 -53.16 -21.84 2adm_c01 source 2adm ADENINE-N6-DNA-METHYLTRANSFERASE TAQI : 9 hits 2adm_c01 naa= 3 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 1 3 # 1 193 ASP A 45 ASP.? -2.96 CA CA A 208s 219 GLU A 70 GLU^? -2.69 CA CA A 208s 294 ASP A 49 ASP.? -3.00 CA CA A 208s coo 27.89 102.52 14.98 29.35 101.92 13.57 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo 25.84 105.87 9.06 27.86 105.55 8.74 68.79 -75.79 -31.87 70.14 -76.30 -30.27 coo 33.16 106.80 7.72 33.34 104.87 6.92 75.72 -77.89 -27.98 74.67 -77.10 -29.65 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 2 3 # 2 193 ASP A 49 ASP.? -3.00 CA CA A 208s 219 GLU A 70 GLU^? -2.69 CA CA A 208s 294 ASP A 45 ASP.? -2.96 CA CA A 208s coo 27.89 102.52 14.98 29.35 101.92 13.57 75.72 -77.89 -27.98 74.67 -77.10 -29.65 coo 25.84 105.87 9.06 27.86 105.55 8.74 68.79 -75.79 -31.87 70.14 -76.30 -30.27 coo 33.16 106.80 7.72 33.34 104.87 6.92 70.45 -71.75 -27.39 71.06 -73.65 -26.89 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 3 3 # 3 193 ASP A 180 ASP.? 14.47 O15 C8E A 210 219 GLU A 184 GLU~? 7.72 C16 C8E A 210 294 ASP A 185 ASP~? 11.73 O21 C8E A 210 coo 27.89 102.52 14.98 29.35 101.92 13.57 55.45 -86.10 -15.44 53.65 -85.04 -15.38 coo 25.84 105.87 9.06 27.86 105.55 8.74 63.73 -84.37 -12.45 63.45 -82.45 -11.70 coo 33.16 106.80 7.72 33.34 104.87 6.92 65.81 -86.27 -18.22 66.54 -87.64 -16.78 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 4 3 # 4 193 ASP A 185 ASP~? 11.73 O21 C8E A 210 219 GLU A 184 GLU~? 7.72 C16 C8E A 210 294 ASP A 180 ASP.? 14.47 O15 C8E A 210 coo 27.89 102.52 14.98 29.35 101.92 13.57 65.81 -86.27 -18.22 66.54 -87.64 -16.78 coo 25.84 105.87 9.06 27.86 105.55 8.74 63.73 -84.37 -12.45 63.45 -82.45 -11.70 coo 33.16 106.80 7.72 33.34 104.87 6.92 55.45 -86.10 -15.44 53.65 -85.04 -15.38 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 5 3 # 5 193 ASP B 45 ASP.? -3.07 CA CA B 208s 219 GLU B 70 GLU^? -2.58 CA CA B 208s 294 ASP B 49 ASP.? -3.05 CA CA B 208s coo 27.89 102.52 14.98 29.35 101.92 13.57 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo 25.84 105.87 9.06 27.86 105.55 8.74 89.83 -24.96 -14.47 91.03 -26.69 -14.39 coo 33.16 106.80 7.72 33.34 104.87 6.92 94.52 -28.97 -11.62 93.03 -30.41 -11.73 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 6 3 # 6 193 ASP B 49 ASP.? -3.05 CA CA B 208s 219 GLU B 70 GLU^? -2.58 CA CA B 208s 294 ASP B 45 ASP.? -3.07 CA CA B 208s coo 27.89 102.52 14.98 29.35 101.92 13.57 94.52 -28.97 -11.62 93.03 -30.41 -11.73 coo 25.84 105.87 9.06 27.86 105.55 8.74 89.83 -24.96 -14.47 91.03 -26.69 -14.39 coo 33.16 106.80 7.72 33.34 104.87 6.92 90.60 -30.65 -18.50 91.26 -30.99 -16.60 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 7 3 # 7 193 ASP B 111 ASP.? 16.97 CA CA B 208 219 GLU B 113 GLU.? 20.51 CA CA B 208 294 ASP B 167 ASP.? 22.72 CA CA B 208 coo 27.89 102.52 14.98 29.35 101.92 13.57 89.21 -14.92 -8.80 89.40 -13.99 -6.98 coo 25.84 105.87 9.06 27.86 105.55 8.74 86.78 -12.34 -3.10 88.60 -11.66 -4.00 coo 33.16 106.80 7.72 33.34 104.87 6.92 88.92 -5.85 -9.56 88.92 -7.42 -8.19 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 8 3 # 8 193 ASP B 185 ASP~? 11.63 O21 C8E B 210 219 GLU B 184 GLU~? 8.45 C14 C8E B 210 294 ASP B 180 ASP.? 10.93 C4 C8E B 210 coo 27.89 102.52 14.98 29.35 101.92 13.57 106.30 -23.80 -20.43 108.26 -24.54 -20.08 coo 25.84 105.87 9.06 27.86 105.55 8.74 107.80 -26.84 -26.43 109.06 -28.52 -26.54 coo 33.16 106.80 7.72 33.34 104.87 6.92 106.50 -18.19 -29.27 105.54 -17.21 -30.85 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 9 3 # 9 193 ASP C 45 ASP.? 3.27 CA CA C 208s 219 GLU C 70 GLU^? -2.71 CA CA C 208s 294 ASP C 49 ASP.? -2.87 CA CA C 208s coo 27.89 102.52 14.98 29.35 101.92 13.57 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo 25.84 105.87 9.06 27.86 105.55 8.74 27.73 -42.94 -10.42 26.74 -44.79 -10.37 coo 33.16 106.80 7.72 33.34 104.87 6.92 22.13 -48.50 -9.42 23.00 -46.66 -10.00 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 10 3 # 10 193 ASP C 49 ASP.? -2.87 CA CA C 208s 219 GLU C 64 GLU~? 12.03 CA CA C 208 294 ASP C 61 ASP~? 12.61 CA CA C 208 coo 27.89 102.52 14.98 29.35 101.92 13.57 22.13 -48.50 -9.42 23.00 -46.66 -10.00 coo 25.84 105.87 9.06 27.86 105.55 8.74 16.47 -41.84 -8.31 14.60 -42.35 -9.15 coo 33.16 106.80 7.72 33.34 104.87 6.92 16.71 -46.53 -3.05 15.59 -48.22 -3.69 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 11 3 # 11 193 ASP C 49 ASP.? -2.87 CA CA C 208s 219 GLU C 70 GLU^? -2.71 CA CA C 208s 294 ASP C 45 ASP.? 3.27 CA CA C 208s coo 27.89 102.52 14.98 29.35 101.92 13.57 22.13 -48.50 -9.42 23.00 -46.66 -10.00 coo 25.84 105.87 9.06 27.86 105.55 8.74 27.73 -42.94 -10.42 26.74 -44.79 -10.37 coo 33.16 106.80 7.72 33.34 104.87 6.92 28.98 -48.61 -14.39 27.54 -48.99 -12.93 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 12 3 # 12 193 ASP C 61 ASP~? 12.61 CA CA C 208 219 GLU C 64 GLU~? 12.03 CA CA C 208 294 ASP C 49 ASP.? -2.87 CA CA C 208s coo 27.89 102.52 14.98 29.35 101.92 13.57 16.71 -46.53 -3.05 15.59 -48.22 -3.69 coo 25.84 105.87 9.06 27.86 105.55 8.74 16.47 -41.84 -8.31 14.60 -42.35 -9.15 coo 33.16 106.80 7.72 33.34 104.87 6.92 22.13 -48.50 -9.42 23.00 -46.66 -10.00 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 13 3 # 13 193 ASP C 180 ASP.? 12.29 C5 C8E C 209 219 GLU C 184 GLU~? 7.93 C14 C8E C 209 294 ASP C 185 ASP~? 11.81 O21 C8E C 209 coo 27.89 102.52 14.98 29.35 101.92 13.57 42.24 -54.49 3.97 44.24 -53.90 3.82 coo 25.84 105.87 9.06 27.86 105.55 8.74 35.72 -59.91 1.24 36.69 -61.13 -0.21 coo 33.16 106.80 7.72 33.34 104.87 6.92 31.89 -54.53 1.93 31.11 -55.91 3.29 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 14 3 # 14 193 ASP C 185 ASP~? 11.81 O21 C8E C 209 219 GLU C 184 GLU~? 7.93 C14 C8E C 209 294 ASP C 180 ASP.? 12.29 C5 C8E C 209 coo 27.89 102.52 14.98 29.35 101.92 13.57 31.89 -54.53 1.93 31.11 -55.91 3.29 coo 25.84 105.87 9.06 27.86 105.55 8.74 35.72 -59.91 1.24 36.69 -61.13 -0.21 coo 33.16 106.80 7.72 33.34 104.87 6.92 42.24 -54.49 3.97 44.24 -53.90 3.82 2amg_c02 source 2amg 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLASE : 14 hits 2amg_c02 naa= 3 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 1 3 # 1 193 ASP A 45 ASP.? -2.96 CA CA A 208s 231 ASP A 180 ASP.? 14.47 O15 C8E A 210 294 ASP A 49 ASP.? -3.00 CA CA A 208s coo 27.89 102.52 14.98 29.35 101.92 13.57 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo 14.74 93.05 -1.00 14.30 94.22 0.73 55.45 -86.10 -15.44 53.65 -85.04 -15.38 coo 33.16 106.80 7.72 33.34 104.87 6.92 75.72 -77.89 -27.98 74.67 -77.10 -29.65 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 2 3 # 2 193 ASP A 48 ASP.? 7.38 CA CA A 208 231 ASP A 114 ASP.? 22.11 CA CA A 208 294 ASP A 52 ASP.? 15.11 CA CA A 208 coo 27.89 102.52 14.98 29.35 101.92 13.57 72.05 -78.20 -23.17 73.82 -77.79 -22.11 coo 14.74 93.05 -1.00 14.30 94.22 0.73 71.50 -87.46 -45.26 70.62 -89.18 -46.15 coo 33.16 106.80 7.72 33.34 104.87 6.92 76.18 -86.89 -22.52 75.57 -87.62 -20.65 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 3 3 # 3 193 ASP A 52 ASP.? 15.11 CA CA A 208 231 ASP A 114 ASP.? 22.11 CA CA A 208 294 ASP A 48 ASP.? 7.38 CA CA A 208 coo 27.89 102.52 14.98 29.35 101.92 13.57 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo 14.74 93.05 -1.00 14.30 94.22 0.73 71.50 -87.46 -45.26 70.62 -89.18 -46.15 coo 33.16 106.80 7.72 33.34 104.87 6.92 72.05 -78.20 -23.17 73.82 -77.79 -22.11 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 4 3 # 4 193 ASP A 52 ASP.? 15.11 CA CA A 208 231 ASP A 180 ASP.? 14.47 O15 C8E A 210 294 ASP A 49 ASP.? -3.00 CA CA A 208s coo 27.89 102.52 14.98 29.35 101.92 13.57 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo 14.74 93.05 -1.00 14.30 94.22 0.73 55.45 -86.10 -15.44 53.65 -85.04 -15.38 coo 33.16 106.80 7.72 33.34 104.87 6.92 75.72 -77.89 -27.98 74.67 -77.10 -29.65 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 5 3 # 5 193 ASP A 61 ASP~? 12.37 CA CA A 208 231 ASP A 166 ASP.? 23.45 CA CA A 208 294 ASP A 49 ASP.? -3.00 CA CA A 208s coo 27.89 102.52 14.98 29.35 101.92 13.57 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo 14.74 93.05 -1.00 14.30 94.22 0.73 55.95 -88.25 -40.15 55.99 -89.39 -38.36 coo 33.16 106.80 7.72 33.34 104.87 6.92 75.72 -77.89 -27.98 74.67 -77.10 -29.65 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 6 3 # 6 193 ASP A 61 ASP~? 12.37 CA CA A 208 231 ASP A 167 ASP.? 22.50 CA CA A 208 294 ASP A 49 ASP.? -3.00 CA CA A 208s coo 27.89 102.52 14.98 29.35 101.92 13.57 78.34 -85.42 -30.67 80.16 -84.92 -29.71 coo 14.74 93.05 -1.00 14.30 94.22 0.73 58.25 -87.45 -44.58 60.23 -87.13 -43.88 coo 33.16 106.80 7.72 33.34 104.87 6.92 75.72 -77.89 -27.98 74.67 -77.10 -29.65 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 7 3 # 7 193 ASP A 111 ASP.? 17.05 CA CA A 208 231 ASP A 52 ASP.? 15.11 CA CA A 208 294 ASP A 114 ASP.? 22.11 CA CA A 208 coo 27.89 102.52 14.98 29.35 101.92 13.57 65.36 -83.80 -40.24 66.17 -85.36 -41.35 coo 14.74 93.05 -1.00 14.30 94.22 0.73 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo 33.16 106.80 7.72 33.34 104.87 6.92 71.50 -87.46 -45.26 70.62 -89.18 -46.15 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 8 3 # 8 193 ASP A 111 ASP.? 17.05 CA CA A 208 231 ASP A 185 ASP~? 11.73 O21 C8E A 210 294 ASP A 166 ASP.? 23.45 CA CA A 208 coo 27.89 102.52 14.98 29.35 101.92 13.57 65.36 -83.80 -40.24 66.17 -85.36 -41.35 coo 14.74 93.05 -1.00 14.30 94.22 0.73 65.81 -86.27 -18.22 66.54 -87.64 -16.78 coo 33.16 106.80 7.72 33.34 104.87 6.92 55.95 -88.25 -40.15 55.99 -89.39 -38.36 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 9 3 # 9 193 ASP A 149 ASP^? 14.85 C1 C8E A 210 231 ASP A 45 ASP.? -2.96 CA CA A 208s 294 ASP A 80 ASP^? 12.60 C1 C8E A 210 coo 27.89 102.52 14.98 29.35 101.92 13.57 66.40 -51.17 -20.74 65.06 -51.90 -19.38 coo 14.74 93.05 -1.00 14.30 94.22 0.73 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo 33.16 106.80 7.72 33.34 104.87 6.92 58.12 -52.30 -15.93 59.10 -53.68 -17.13 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 10 3 # 10 193 ASP A 185 ASP~? 11.73 O21 C8E A 210 231 ASP A 153 ASP^? 8.28 C1 C8E A 210 294 ASP A 180 ASP.? 14.47 O15 C8E A 210 coo 27.89 102.52 14.98 29.35 101.92 13.57 65.81 -86.27 -18.22 66.54 -87.64 -16.78 coo 14.74 93.05 -1.00 14.30 94.22 0.73 63.37 -61.81 -16.17 62.75 -59.91 -16.84 coo 33.16 106.80 7.72 33.34 104.87 6.92 55.45 -86.10 -15.44 53.65 -85.04 -15.38 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 11 3 # 11 193 ASP A 185 ASP~? 11.73 O21 C8E A 210 231 ASP A 166 ASP.? 23.45 CA CA A 208 294 ASP A 48 ASP.? 7.38 CA CA A 208 coo 27.89 102.52 14.98 29.35 101.92 13.57 65.81 -86.27 -18.22 66.54 -87.64 -16.78 coo 14.74 93.05 -1.00 14.30 94.22 0.73 55.95 -88.25 -40.15 55.99 -89.39 -38.36 coo 33.16 106.80 7.72 33.34 104.87 6.92 72.05 -78.20 -23.17 73.82 -77.79 -22.11 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 12 3 # 12 193 ASP A 185 ASP~? 11.73 O21 C8E A 210 231 ASP A 166 ASP.? 23.45 CA CA A 208 294 ASP A 180 ASP.? 14.47 O15 C8E A 210 coo 27.89 102.52 14.98 29.35 101.92 13.57 65.81 -86.27 -18.22 66.54 -87.64 -16.78 coo 14.74 93.05 -1.00 14.30 94.22 0.73 55.95 -88.25 -40.15 55.99 -89.39 -38.36 coo 33.16 106.80 7.72 33.34 104.87 6.92 55.45 -86.10 -15.44 53.65 -85.04 -15.38 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 13 3 # 13 193 ASP B 45 ASP.? -3.07 CA CA B 208s 231 ASP B 180 ASP.? 10.93 C4 C8E B 210 294 ASP B 49 ASP.? -3.05 CA CA B 208s coo 27.89 102.52 14.98 29.35 101.92 13.57 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo 14.74 93.05 -1.00 14.30 94.22 0.73 106.50 -18.19 -29.27 105.54 -17.21 -30.85 coo 33.16 106.80 7.72 33.34 104.87 6.92 94.52 -28.97 -11.62 93.03 -30.41 -11.73 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 14 3 # 14 193 ASP B 48 ASP.? 7.20 CA CA B 208 231 ASP B 114 ASP.? 22.07 CA CA B 208 294 ASP B 52 ASP.? 15.59 CA CA B 208 coo 27.89 102.52 14.98 29.35 101.92 13.57 97.60 -30.12 -16.68 98.20 -32.01 -15.99 coo 14.74 93.05 -1.00 14.30 94.22 0.73 88.69 -13.97 -0.41 89.97 -12.27 -0.12 coo 33.16 106.80 7.72 33.34 104.87 6.92 105.61 -28.95 -11.53 106.78 -28.70 -9.81 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 15 3 # 15 193 ASP B 49 ASP.? -3.05 CA CA B 208s 231 ASP B 166 ASP.? 24.17 CA CA B 208 294 ASP B 45 ASP.? -3.07 CA CA B 208s coo 27.89 102.52 14.98 29.35 101.92 13.57 94.52 -28.97 -11.62 93.03 -30.41 -11.73 coo 14.74 93.05 -1.00 14.30 94.22 0.73 91.14 -5.33 -14.11 93.17 -5.00 -14.63 coo 33.16 106.80 7.72 33.34 104.87 6.92 90.60 -30.65 -18.50 91.26 -30.99 -16.60 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 16 3 # 16 193 ASP B 49 ASP.? -3.05 CA CA B 208s 231 ASP B 166 ASP.? 24.17 CA CA B 208 294 ASP B 61 ASP~? 12.48 CA CA B 208 coo 27.89 102.52 14.98 29.35 101.92 13.57 94.52 -28.97 -11.62 93.03 -30.41 -11.73 coo 14.74 93.05 -1.00 14.30 94.22 0.73 91.14 -5.33 -14.11 93.17 -5.00 -14.63 coo 33.16 106.80 7.72 33.34 104.87 6.92 98.68 -27.22 -4.60 99.30 -29.23 -4.23 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 17 3 # 17 193 ASP B 49 ASP.? -3.05 CA CA B 208s 231 ASP B 167 ASP.? 22.72 CA CA B 208 294 ASP B 45 ASP.? -3.07 CA CA B 208s coo 27.89 102.52 14.98 29.35 101.92 13.57 94.52 -28.97 -11.62 93.03 -30.41 -11.73 coo 14.74 93.05 -1.00 14.30 94.22 0.73 88.92 -5.85 -9.56 88.92 -7.42 -8.19 coo 33.16 106.80 7.72 33.34 104.87 6.92 90.60 -30.65 -18.50 91.26 -30.99 -16.60 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 18 3 # 18 193 ASP B 49 ASP.? -3.05 CA CA B 208s 231 ASP B 167 ASP.? 22.72 CA CA B 208 294 ASP B 61 ASP~? 12.48 CA CA B 208 coo 27.89 102.52 14.98 29.35 101.92 13.57 94.52 -28.97 -11.62 93.03 -30.41 -11.73 coo 14.74 93.05 -1.00 14.30 94.22 0.73 88.92 -5.85 -9.56 88.92 -7.42 -8.19 coo 33.16 106.80 7.72 33.34 104.87 6.92 98.68 -27.22 -4.60 99.30 -29.23 -4.23 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 19 3 # 19 193 ASP B 49 ASP.? -3.05 CA CA B 208s 231 ASP B 180 ASP.? 10.93 C4 C8E B 210 294 ASP B 45 ASP.? -3.07 CA CA B 208s coo 27.89 102.52 14.98 29.35 101.92 13.57 94.52 -28.97 -11.62 93.03 -30.41 -11.73 coo 14.74 93.05 -1.00 14.30 94.22 0.73 106.50 -18.19 -29.27 105.54 -17.21 -30.85 coo 33.16 106.80 7.72 33.34 104.87 6.92 90.60 -30.65 -18.50 91.26 -30.99 -16.60 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 20 3 # 20 193 ASP B 61 ASP~? 12.48 CA CA B 208 231 ASP B 167 ASP.? 22.72 CA CA B 208 294 ASP B 49 ASP.? -3.05 CA CA B 208s coo 27.89 102.52 14.98 29.35 101.92 13.57 98.68 -27.22 -4.60 99.30 -29.23 -4.23 coo 14.74 93.05 -1.00 14.30 94.22 0.73 88.92 -5.85 -9.56 88.92 -7.42 -8.19 coo 33.16 106.80 7.72 33.34 104.87 6.92 94.52 -28.97 -11.62 93.03 -30.41 -11.73 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 21 3 # 21 193 ASP B 111 ASP.? 16.97 CA CA B 208 231 ASP B 52 ASP.? 15.59 CA CA B 208 294 ASP B 114 ASP.? 22.07 CA CA B 208 coo 27.89 102.52 14.98 29.35 101.92 13.57 89.21 -14.92 -8.80 89.40 -13.99 -6.98 coo 14.74 93.05 -1.00 14.30 94.22 0.73 105.61 -28.95 -11.53 106.78 -28.70 -9.81 coo 33.16 106.80 7.72 33.34 104.87 6.92 88.69 -13.97 -0.41 89.97 -12.27 -0.12 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 22 3 # 22 193 ASP B 111 ASP.? 16.97 CA CA B 208 231 ASP B 185 ASP~? 11.63 O21 C8E B 210 294 ASP B 166 ASP.? 24.17 CA CA B 208 coo 27.89 102.52 14.98 29.35 101.92 13.57 89.21 -14.92 -8.80 89.40 -13.99 -6.98 coo 14.74 93.05 -1.00 14.30 94.22 0.73 106.30 -23.80 -20.43 108.26 -24.54 -20.08 coo 33.16 106.80 7.72 33.34 104.87 6.92 91.14 -5.33 -14.11 93.17 -5.00 -14.63 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 23 3 # 23 193 ASP B 149 ASP^? 14.91 O15 C8E B 209 231 ASP B 45 ASP.? -3.07 CA CA B 208s 294 ASP B 80 ASP^? 15.94 O15 C8E B 209 coo 27.89 102.52 14.98 29.35 101.92 13.57 79.48 -42.39 -33.32 81.04 -41.48 -34.38 coo 14.74 93.05 -1.00 14.30 94.22 0.73 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo 33.16 106.80 7.72 33.34 104.87 6.92 82.56 -37.87 -41.00 82.97 -37.16 -39.06 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 24 3 # 24 193 ASP B 185 ASP~? 11.63 O21 C8E B 210 231 ASP B 153 ASP^? 9.57 O15 C8E B 209 294 ASP B 180 ASP.? 10.93 C4 C8E B 210 coo 27.89 102.52 14.98 29.35 101.92 13.57 106.30 -23.80 -20.43 108.26 -24.54 -20.08 coo 14.74 93.05 -1.00 14.30 94.22 0.73 89.74 -36.17 -33.46 87.76 -36.55 -34.22 coo 33.16 106.80 7.72 33.34 104.87 6.92 106.50 -18.19 -29.27 105.54 -17.21 -30.85 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 25 3 # 25 193 ASP B 185 ASP~? 11.63 O21 C8E B 210 231 ASP B 166 ASP.? 24.17 CA CA B 208 294 ASP B 48 ASP.? 7.20 CA CA B 208 coo 27.89 102.52 14.98 29.35 101.92 13.57 106.30 -23.80 -20.43 108.26 -24.54 -20.08 coo 14.74 93.05 -1.00 14.30 94.22 0.73 91.14 -5.33 -14.11 93.17 -5.00 -14.63 coo 33.16 106.80 7.72 33.34 104.87 6.92 97.60 -30.12 -16.68 98.20 -32.01 -15.99 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 26 3 # 26 193 ASP B 185 ASP~? 11.63 O21 C8E B 210 231 ASP B 166 ASP.? 24.17 CA CA B 208 294 ASP B 180 ASP.? 10.93 C4 C8E B 210 coo 27.89 102.52 14.98 29.35 101.92 13.57 106.30 -23.80 -20.43 108.26 -24.54 -20.08 coo 14.74 93.05 -1.00 14.30 94.22 0.73 91.14 -5.33 -14.11 93.17 -5.00 -14.63 coo 33.16 106.80 7.72 33.34 104.87 6.92 106.50 -18.19 -29.27 105.54 -17.21 -30.85 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 27 3 # 27 193 ASP C 45 ASP.? 3.27 CA CA C 208s 231 ASP C 180 ASP.? 12.29 C5 C8E C 209 294 ASP C 49 ASP.? -2.87 CA CA C 208s coo 27.89 102.52 14.98 29.35 101.92 13.57 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo 14.74 93.05 -1.00 14.30 94.22 0.73 42.24 -54.49 3.97 44.24 -53.90 3.82 coo 33.16 106.80 7.72 33.34 104.87 6.92 22.13 -48.50 -9.42 23.00 -46.66 -10.00 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 28 3 # 28 193 ASP C 48 ASP.? 7.17 CA CA C 208 231 ASP C 114 ASP.? 22.22 CA CA C 208 294 ASP C 52 ASP.? 15.77 CA CA C 208 coo 27.89 102.52 14.98 29.35 101.92 13.57 26.68 -52.06 -7.74 25.46 -53.53 -8.54 coo 14.74 93.05 -1.00 14.30 94.22 0.73 19.39 -30.14 -1.59 19.46 -28.98 0.18 coo 33.16 106.80 7.72 33.34 104.87 6.92 21.29 -54.58 -0.38 20.26 -54.47 1.43 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 29 3 # 29 193 ASP C 52 ASP.? 15.77 CA CA C 208 231 ASP C 111 ASP.? 17.21 CA CA C 208 294 ASP C 185 ASP~? 11.81 O21 C8E C 209 coo 27.89 102.52 14.98 29.35 101.92 13.57 21.29 -54.58 -0.38 20.26 -54.47 1.43 coo 14.74 93.05 -1.00 14.30 94.22 0.73 27.11 -33.17 -3.90 25.73 -31.94 -3.00 coo 33.16 106.80 7.72 33.34 104.87 6.92 31.89 -54.53 1.93 31.11 -55.91 3.29 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 30 3 # 30 193 ASP C 52 ASP.? 15.77 CA CA C 208 231 ASP C 114 ASP.? 22.22 CA CA C 208 294 ASP C 48 ASP.? 7.17 CA CA C 208 coo 27.89 102.52 14.98 29.35 101.92 13.57 21.29 -54.58 -0.38 20.26 -54.47 1.43 coo 14.74 93.05 -1.00 14.30 94.22 0.73 19.39 -30.14 -1.59 19.46 -28.98 0.18 coo 33.16 106.80 7.72 33.34 104.87 6.92 26.68 -52.06 -7.74 25.46 -53.53 -8.54 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 31 3 # 31 193 ASP C 52 ASP.? 15.77 CA CA C 208 231 ASP C 180 ASP.? 12.29 C5 C8E C 209 294 ASP C 49 ASP.? -2.87 CA CA C 208s coo 27.89 102.52 14.98 29.35 101.92 13.57 21.29 -54.58 -0.38 20.26 -54.47 1.43 coo 14.74 93.05 -1.00 14.30 94.22 0.73 42.24 -54.49 3.97 44.24 -53.90 3.82 coo 33.16 106.80 7.72 33.34 104.87 6.92 22.13 -48.50 -9.42 23.00 -46.66 -10.00 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 32 3 # 32 193 ASP C 61 ASP~? 12.61 CA CA C 208 231 ASP C 167 ASP.? 25.18 CA CA C 208 294 ASP C 49 ASP.? -2.87 CA CA C 208s coo 27.89 102.52 14.98 29.35 101.92 13.57 16.71 -46.53 -3.05 15.59 -48.22 -3.69 coo 14.74 93.05 -1.00 14.30 94.22 0.73 31.39 -27.44 2.08 30.34 -25.78 1.31 coo 33.16 106.80 7.72 33.34 104.87 6.92 22.13 -48.50 -9.42 23.00 -46.66 -10.00 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 33 3 # 33 193 ASP C 80 ASP^? 16.43 C13 C8E C 210 231 ASP A 26 ASP.? 24.86 C2 C8E C 209 294 ASP C 153 ASP^? 9.83 C13 C8E C 210 coo 27.89 102.52 14.98 29.35 101.92 13.57 47.10 -57.14 -28.79 45.64 -55.94 -27.77 coo 14.74 93.05 -1.00 14.30 94.22 0.73 53.70 -37.11 -16.05 55.72 -36.42 -15.97 coo 33.16 106.80 7.72 33.34 104.87 6.92 40.09 -57.62 -20.90 41.26 -57.13 -22.61 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 34 3 # 34 193 ASP C 80 ASP^? 16.43 C13 C8E C 210 231 ASP A 153 ASP^? 8.28 C1 C8E A 210 294 ASP C 153 ASP^? 9.83 C13 C8E C 210 coo 27.89 102.52 14.98 29.35 101.92 13.57 47.10 -57.14 -28.79 45.64 -55.94 -27.77 coo 14.74 93.05 -1.00 14.30 94.22 0.73 63.37 -61.81 -16.17 62.75 -59.91 -16.84 coo 33.16 106.80 7.72 33.34 104.87 6.92 40.09 -57.62 -20.90 41.26 -57.13 -22.61 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 35 3 # 35 193 ASP C 111 ASP.? 17.21 CA CA C 208 231 ASP C 52 ASP.? 15.77 CA CA C 208 294 ASP C 114 ASP.? 22.22 CA CA C 208 coo 27.89 102.52 14.98 29.35 101.92 13.57 27.11 -33.17 -3.90 25.73 -31.94 -3.00 coo 14.74 93.05 -1.00 14.30 94.22 0.73 21.29 -54.58 -0.38 20.26 -54.47 1.43 coo 33.16 106.80 7.72 33.34 104.87 6.92 19.39 -30.14 -1.59 19.46 -28.98 0.18 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 36 3 # 36 193 ASP C 111 ASP.? 17.21 CA CA C 208 231 ASP C 185 ASP~? 11.81 O21 C8E C 209 294 ASP C 166 ASP.? 24.81 CA CA C 208 coo 27.89 102.52 14.98 29.35 101.92 13.57 27.11 -33.17 -3.90 25.73 -31.94 -3.00 coo 14.74 93.05 -1.00 14.30 94.22 0.73 31.89 -54.53 1.93 31.11 -55.91 3.29 coo 33.16 106.80 7.72 33.34 104.87 6.92 35.75 -30.25 2.83 35.54 -31.07 4.76 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 37 3 # 37 193 ASP C 149 ASP^? 16.02 C16 C8E C 210 231 ASP C 45 ASP.? 3.27 CA CA C 208s 294 ASP C 80 ASP^? 16.43 C13 C8E C 210 coo 27.89 102.52 14.98 29.35 101.92 13.57 38.72 -55.19 -32.44 40.02 -55.93 -30.97 coo 14.74 93.05 -1.00 14.30 94.22 0.73 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo 33.16 106.80 7.72 33.34 104.87 6.92 47.10 -57.14 -28.79 45.64 -55.94 -27.77 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 38 3 # 38 193 ASP C 166 ASP.? 24.81 CA CA C 208 231 ASP C 185 ASP~? 11.81 O21 C8E C 209 294 ASP C 111 ASP.? 17.21 CA CA C 208 coo 27.89 102.52 14.98 29.35 101.92 13.57 35.75 -30.25 2.83 35.54 -31.07 4.76 coo 14.74 93.05 -1.00 14.30 94.22 0.73 31.89 -54.53 1.93 31.11 -55.91 3.29 coo 33.16 106.80 7.72 33.34 104.87 6.92 27.11 -33.17 -3.90 25.73 -31.94 -3.00 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 39 3 # 39 193 ASP C 185 ASP~? 11.81 O21 C8E C 209 231 ASP C 153 ASP^? 9.83 C13 C8E C 210 294 ASP C 180 ASP.? 12.29 C5 C8E C 209 coo 27.89 102.52 14.98 29.35 101.92 13.57 31.89 -54.53 1.93 31.11 -55.91 3.29 coo 14.74 93.05 -1.00 14.30 94.22 0.73 40.09 -57.62 -20.90 41.26 -57.13 -22.61 coo 33.16 106.80 7.72 33.34 104.87 6.92 42.24 -54.49 3.97 44.24 -53.90 3.82 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 40 3 # 40 193 ASP C 185 ASP~? 11.81 O21 C8E C 209 231 ASP C 166 ASP.? 24.81 CA CA C 208 294 ASP C 48 ASP.? 7.17 CA CA C 208 coo 27.89 102.52 14.98 29.35 101.92 13.57 31.89 -54.53 1.93 31.11 -55.91 3.29 coo 14.74 93.05 -1.00 14.30 94.22 0.73 35.75 -30.25 2.83 35.54 -31.07 4.76 coo 33.16 106.80 7.72 33.34 104.87 6.92 26.68 -52.06 -7.74 25.46 -53.53 -8.54 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 41 3 # 41 193 ASP C 185 ASP~? 11.81 O21 C8E C 209 231 ASP C 166 ASP.? 24.81 CA CA C 208 294 ASP C 180 ASP.? 12.29 C5 C8E C 209 coo 27.89 102.52 14.98 29.35 101.92 13.57 31.89 -54.53 1.93 31.11 -55.91 3.29 coo 14.74 93.05 -1.00 14.30 94.22 0.73 35.75 -30.25 2.83 35.54 -31.07 4.76 coo 33.16 106.80 7.72 33.34 104.87 6.92 42.24 -54.49 3.97 44.24 -53.90 3.82 2amg_c06 source 2amg 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLASE : 41 hits 2amg_c06 naa= 3 ULMN 3 2ayh_c00 1,3-1,4-BETA-D-GLUCAN 4 GLUCANOHYDROuser 1 3 # 1 105 GLU B 164 GLU^? 19.99 CA CA B 208 107 ASP B 166 ASP.? 24.17 CA CA B 208 109 GLU B 165 GLU^? 20.64 CA CA B 208 coo 15.97 13.58 10.29 15.12 15.36 9.48 94.70 -10.70 -16.52 96.59 -9.81 -16.07 coo 20.07 16.34 11.47 18.03 16.15 11.04 91.14 -5.33 -14.11 93.17 -5.00 -14.63 coo 20.99 19.84 9.56 19.07 20.34 10.22 88.15 -8.84 -16.79 86.14 -9.46 -16.74 ULMN 3 2ayh_c00 1,3-1,4-BETA-D-GLUCAN 4 GLUCANOHYDROuser 2 3 # 2 105 GLU C 164 GLU^? 20.06 CA CA C 208 107 ASP C 166 ASP.? 24.81 CA CA C 208 109 GLU C 165 GLU^? 20.98 CA CA C 208 coo 15.97 13.58 10.29 15.12 15.36 9.48 34.72 -37.11 1.76 34.46 -37.46 3.82 coo 20.07 16.34 11.47 18.03 16.15 11.04 35.75 -30.25 2.83 35.54 -31.07 4.76 coo 20.99 19.84 9.56 19.07 20.34 10.22 36.32 -31.59 -2.15 36.97 -31.00 -4.08 2ayh_c00 source 2ayh 1,3-1,4-BETA-D-GLUCAN 4 GLUCANOHYDROLASE (E.C.: 2 hits 2ayh_c00 naa= 3 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 1 3 # 1 A 14 ARG A 135 ARG^? 21.29 C1 C8E A 210 A 161 ASP A 153 ASP^? 8.28 C1 C8E A 210 A 174 TYR A 13 TYR^? 6.88 C17 C8E A 209 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 62.45 -46.81 -18.85 61.41 -44.79 -20.90 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 63.37 -61.81 -16.17 62.75 -59.91 -16.84 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 65.07 -60.93 -23.01 63.35 -61.54 -20.90 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 2 3 # 2 A 14 ARG B 135 ARG^? 22.88 O15 C8E B 209 A 161 ASP B 153 ASP^? 9.57 O15 C8E B 209 A 174 TYR B 13 TYR^? 6.78 O15 C8E B 209 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 77.46 -42.45 -38.74 74.50 -42.61 -39.42 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 89.74 -36.17 -33.46 87.76 -36.55 -34.22 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 84.65 -34.92 -28.70 86.28 -34.17 -30.84 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 3 3 # 3 A 14 ARG B 162 ARG^? 16.35 O21 C8E B 210 A 161 ASP B 48 ASP.? 7.20 CA CA B 208 A 174 TYR B 51 TYR.? 9.95 O21 C8E B 210 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 96.21 -15.01 -19.71 98.63 -13.28 -19.03 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 97.60 -30.12 -16.68 98.20 -32.01 -15.99 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 102.03 -27.53 -15.19 104.12 -26.16 -16.40 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 4 3 # 4 A 14 ARG B 162 ARG^? 16.35 O21 C8E B 210 A 161 ASP B 49 ASP.? -3.05 CA CA B 208s A 174 TYR B 51 TYR.? 9.95 O21 C8E B 210 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 96.21 -15.01 -19.71 98.63 -13.28 -19.03 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 94.52 -28.97 -11.62 93.03 -30.41 -11.73 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 102.03 -27.53 -15.19 104.12 -26.16 -16.40 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 5 3 # 5 A 14 ARG B 162 ARG^? 16.35 O21 C8E B 210 A 161 ASP B 180 ASP.? 10.93 C4 C8E B 210 A 174 TYR B 183 TYR~? 7.74 O12 C8E B 210 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 96.21 -15.01 -19.71 98.63 -13.28 -19.03 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 106.50 -18.19 -29.27 105.54 -17.21 -30.85 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 104.05 -23.05 -28.11 101.72 -24.25 -29.01 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 6 3 # 6 A 14 ARG B 162 ARG^? 16.35 O21 C8E B 210 A 161 ASP B 185 ASP~? 11.63 O21 C8E B 210 A 174 TYR B 51 TYR.? 9.95 O21 C8E B 210 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 96.21 -15.01 -19.71 98.63 -13.28 -19.03 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 106.30 -23.80 -20.43 108.26 -24.54 -20.08 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 102.03 -27.53 -15.19 104.12 -26.16 -16.40 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 7 3 # 7 A 14 ARG B 162 ARG^? 16.35 O21 C8E B 210 A 161 ASP B 185 ASP~? 11.63 O21 C8E B 210 A 174 TYR B 183 TYR~? 7.74 O12 C8E B 210 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 96.21 -15.01 -19.71 98.63 -13.28 -19.03 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 106.30 -23.80 -20.43 108.26 -24.54 -20.08 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 104.05 -23.05 -28.11 101.72 -24.25 -29.01 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 8 3 # 8 A 14 ARG C 135 ARG^? 23.87 C16 C8E C 210 A 161 ASP C 153 ASP^? 9.83 C13 C8E C 210 A 174 TYR C 13 TYR^? 7.82 C16 C8E C 210 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 44.01 -56.05 -34.91 45.01 -54.65 -37.44 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 40.09 -57.62 -20.90 41.26 -57.13 -22.61 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 37.24 -51.70 -23.13 39.21 -53.16 -21.84 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 9 3 # 9 A 14 ARG C 162 ARG^? 16.00 O21 C8E C 209 A 161 ASP C 48 ASP.? 7.17 CA CA C 208 A 174 TYR C 51 TYR.? 10.04 O21 C8E C 209 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 35.66 -43.15 0.12 35.66 -43.03 3.18 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 26.68 -52.06 -7.74 25.46 -53.53 -8.54 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 26.09 -52.62 -2.60 27.54 -53.38 -0.32 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 10 3 # 10 A 14 ARG C 162 ARG^? 16.00 O21 C8E C 209 A 161 ASP C 180 ASP.? 12.29 C5 C8E C 209 A 174 TYR C 183 TYR~? 7.45 C14 C8E C 209 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 35.66 -43.15 0.12 35.66 -43.03 3.18 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 42.24 -54.49 3.97 44.24 -53.90 3.82 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 39.42 -55.89 -0.59 40.02 -55.54 -3.26 2c7v_c08 source 2c7v PTERIDINE REDUCTASE : 10 hits 2c7v_c08 naa= 3 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 1 3 # 1 B 14 ARG A 135 ARG^? 21.29 C1 C8E A 210 B 161 ASP A 153 ASP^? 8.28 C1 C8E A 210 B 174 TYR A 13 TYR^? 6.88 C17 C8E A 209 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 62.45 -46.81 -18.85 61.41 -44.79 -20.90 coo -14.86 10.19 8.14 -14.82 12.31 8.42 63.37 -61.81 -16.17 62.75 -59.91 -16.84 coo -21.46 12.70 8.53 -19.04 12.30 7.24 65.07 -60.93 -23.01 63.35 -61.54 -20.90 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 2 3 # 2 B 14 ARG B 135 ARG^? 22.88 O15 C8E B 209 B 161 ASP B 153 ASP^? 9.57 O15 C8E B 209 B 174 TYR B 13 TYR^? 6.78 O15 C8E B 209 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 77.46 -42.45 -38.74 74.50 -42.61 -39.42 coo -14.86 10.19 8.14 -14.82 12.31 8.42 89.74 -36.17 -33.46 87.76 -36.55 -34.22 coo -21.46 12.70 8.53 -19.04 12.30 7.24 84.65 -34.92 -28.70 86.28 -34.17 -30.84 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 3 3 # 3 B 14 ARG B 162 ARG^? 16.35 O21 C8E B 210 B 161 ASP B 48 ASP.? 7.20 CA CA B 208 B 174 TYR B 51 TYR.? 9.95 O21 C8E B 210 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 96.21 -15.01 -19.71 98.63 -13.28 -19.03 coo -14.86 10.19 8.14 -14.82 12.31 8.42 97.60 -30.12 -16.68 98.20 -32.01 -15.99 coo -21.46 12.70 8.53 -19.04 12.30 7.24 102.03 -27.53 -15.19 104.12 -26.16 -16.40 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 4 3 # 4 B 14 ARG B 162 ARG^? 16.35 O21 C8E B 210 B 161 ASP B 49 ASP.? -3.05 CA CA B 208s B 174 TYR B 51 TYR.? 9.95 O21 C8E B 210 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 96.21 -15.01 -19.71 98.63 -13.28 -19.03 coo -14.86 10.19 8.14 -14.82 12.31 8.42 94.52 -28.97 -11.62 93.03 -30.41 -11.73 coo -21.46 12.70 8.53 -19.04 12.30 7.24 102.03 -27.53 -15.19 104.12 -26.16 -16.40 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 5 3 # 5 B 14 ARG B 162 ARG^? 16.35 O21 C8E B 210 B 161 ASP B 180 ASP.? 10.93 C4 C8E B 210 B 174 TYR B 183 TYR~? 7.74 O12 C8E B 210 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 96.21 -15.01 -19.71 98.63 -13.28 -19.03 coo -14.86 10.19 8.14 -14.82 12.31 8.42 106.50 -18.19 -29.27 105.54 -17.21 -30.85 coo -21.46 12.70 8.53 -19.04 12.30 7.24 104.05 -23.05 -28.11 101.72 -24.25 -29.01 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 6 3 # 6 B 14 ARG B 162 ARG^? 16.35 O21 C8E B 210 B 161 ASP B 185 ASP~? 11.63 O21 C8E B 210 B 174 TYR B 51 TYR.? 9.95 O21 C8E B 210 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 96.21 -15.01 -19.71 98.63 -13.28 -19.03 coo -14.86 10.19 8.14 -14.82 12.31 8.42 106.30 -23.80 -20.43 108.26 -24.54 -20.08 coo -21.46 12.70 8.53 -19.04 12.30 7.24 102.03 -27.53 -15.19 104.12 -26.16 -16.40 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 7 3 # 7 B 14 ARG B 162 ARG^? 16.35 O21 C8E B 210 B 161 ASP B 185 ASP~? 11.63 O21 C8E B 210 B 174 TYR B 183 TYR~? 7.74 O12 C8E B 210 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 96.21 -15.01 -19.71 98.63 -13.28 -19.03 coo -14.86 10.19 8.14 -14.82 12.31 8.42 106.30 -23.80 -20.43 108.26 -24.54 -20.08 coo -21.46 12.70 8.53 -19.04 12.30 7.24 104.05 -23.05 -28.11 101.72 -24.25 -29.01 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 8 3 # 8 B 14 ARG C 135 ARG^? 23.87 C16 C8E C 210 B 161 ASP C 153 ASP^? 9.83 C13 C8E C 210 B 174 TYR C 13 TYR^? 7.82 C16 C8E C 210 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 44.01 -56.05 -34.91 45.01 -54.65 -37.44 coo -14.86 10.19 8.14 -14.82 12.31 8.42 40.09 -57.62 -20.90 41.26 -57.13 -22.61 coo -21.46 12.70 8.53 -19.04 12.30 7.24 37.24 -51.70 -23.13 39.21 -53.16 -21.84 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 9 3 # 9 B 14 ARG C 162 ARG^? 16.00 O21 C8E C 209 B 161 ASP C 48 ASP.? 7.17 CA CA C 208 B 174 TYR C 51 TYR.? 10.04 O21 C8E C 209 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 35.66 -43.15 0.12 35.66 -43.03 3.18 coo -14.86 10.19 8.14 -14.82 12.31 8.42 26.68 -52.06 -7.74 25.46 -53.53 -8.54 coo -21.46 12.70 8.53 -19.04 12.30 7.24 26.09 -52.62 -2.60 27.54 -53.38 -0.32 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 10 3 # 10 B 14 ARG C 162 ARG^? 16.00 O21 C8E C 209 B 161 ASP C 180 ASP.? 12.29 C5 C8E C 209 B 174 TYR C 183 TYR~? 7.45 C14 C8E C 209 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 35.66 -43.15 0.12 35.66 -43.03 3.18 coo -14.86 10.19 8.14 -14.82 12.31 8.42 42.24 -54.49 3.97 44.24 -53.90 3.82 coo -21.46 12.70 8.53 -19.04 12.30 7.24 39.42 -55.89 -0.59 40.02 -55.54 -3.26 2c7v_c09 source 2c7v PTERIDINE REDUCTASE : 10 hits 2c7v_c09 naa= 3 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 1 3 # 1 C 14 ARG A 135 ARG^? 21.29 C1 C8E A 210 C 161 ASP A 153 ASP^? 8.28 C1 C8E A 210 C 174 TYR A 13 TYR^? 6.88 C17 C8E A 209 coo 2.84 19.43 40.34 1.59 20.35 37.65 62.45 -46.81 -18.85 61.41 -44.79 -20.90 coo -0.62 11.10 28.05 -0.65 13.15 27.46 63.37 -61.81 -16.17 62.75 -59.91 -16.84 coo 5.94 13.28 27.17 3.53 13.05 28.58 65.07 -60.93 -23.01 63.35 -61.54 -20.90 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 2 3 # 2 C 14 ARG B 135 ARG^? 22.88 O15 C8E B 209 C 161 ASP B 153 ASP^? 9.57 O15 C8E B 209 C 174 TYR B 13 TYR^? 6.78 O15 C8E B 209 coo 2.84 19.43 40.34 1.59 20.35 37.65 77.46 -42.45 -38.74 74.50 -42.61 -39.42 coo -0.62 11.10 28.05 -0.65 13.15 27.46 89.74 -36.17 -33.46 87.76 -36.55 -34.22 coo 5.94 13.28 27.17 3.53 13.05 28.58 84.65 -34.92 -28.70 86.28 -34.17 -30.84 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 3 3 # 3 C 14 ARG B 162 ARG^? 16.35 O21 C8E B 210 C 161 ASP B 48 ASP.? 7.20 CA CA B 208 C 174 TYR B 51 TYR.? 9.95 O21 C8E B 210 coo 2.84 19.43 40.34 1.59 20.35 37.65 96.21 -15.01 -19.71 98.63 -13.28 -19.03 coo -0.62 11.10 28.05 -0.65 13.15 27.46 97.60 -30.12 -16.68 98.20 -32.01 -15.99 coo 5.94 13.28 27.17 3.53 13.05 28.58 102.03 -27.53 -15.19 104.12 -26.16 -16.40 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 4 3 # 4 C 14 ARG B 162 ARG^? 16.35 O21 C8E B 210 C 161 ASP B 49 ASP.? -3.05 CA CA B 208s C 174 TYR B 51 TYR.? 9.95 O21 C8E B 210 coo 2.84 19.43 40.34 1.59 20.35 37.65 96.21 -15.01 -19.71 98.63 -13.28 -19.03 coo -0.62 11.10 28.05 -0.65 13.15 27.46 94.52 -28.97 -11.62 93.03 -30.41 -11.73 coo 5.94 13.28 27.17 3.53 13.05 28.58 102.03 -27.53 -15.19 104.12 -26.16 -16.40 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 5 3 # 5 C 14 ARG B 162 ARG^? 16.35 O21 C8E B 210 C 161 ASP B 180 ASP.? 10.93 C4 C8E B 210 C 174 TYR B 183 TYR~? 7.74 O12 C8E B 210 coo 2.84 19.43 40.34 1.59 20.35 37.65 96.21 -15.01 -19.71 98.63 -13.28 -19.03 coo -0.62 11.10 28.05 -0.65 13.15 27.46 106.50 -18.19 -29.27 105.54 -17.21 -30.85 coo 5.94 13.28 27.17 3.53 13.05 28.58 104.05 -23.05 -28.11 101.72 -24.25 -29.01 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 6 3 # 6 C 14 ARG B 162 ARG^? 16.35 O21 C8E B 210 C 161 ASP B 185 ASP~? 11.63 O21 C8E B 210 C 174 TYR B 51 TYR.? 9.95 O21 C8E B 210 coo 2.84 19.43 40.34 1.59 20.35 37.65 96.21 -15.01 -19.71 98.63 -13.28 -19.03 coo -0.62 11.10 28.05 -0.65 13.15 27.46 106.30 -23.80 -20.43 108.26 -24.54 -20.08 coo 5.94 13.28 27.17 3.53 13.05 28.58 102.03 -27.53 -15.19 104.12 -26.16 -16.40 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 7 3 # 7 C 14 ARG B 162 ARG^? 16.35 O21 C8E B 210 C 161 ASP B 185 ASP~? 11.63 O21 C8E B 210 C 174 TYR B 183 TYR~? 7.74 O12 C8E B 210 coo 2.84 19.43 40.34 1.59 20.35 37.65 96.21 -15.01 -19.71 98.63 -13.28 -19.03 coo -0.62 11.10 28.05 -0.65 13.15 27.46 106.30 -23.80 -20.43 108.26 -24.54 -20.08 coo 5.94 13.28 27.17 3.53 13.05 28.58 104.05 -23.05 -28.11 101.72 -24.25 -29.01 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 8 3 # 8 C 14 ARG C 135 ARG^? 23.87 C16 C8E C 210 C 161 ASP C 153 ASP^? 9.83 C13 C8E C 210 C 174 TYR C 13 TYR^? 7.82 C16 C8E C 210 coo 2.84 19.43 40.34 1.59 20.35 37.65 44.01 -56.05 -34.91 45.01 -54.65 -37.44 coo -0.62 11.10 28.05 -0.65 13.15 27.46 40.09 -57.62 -20.90 41.26 -57.13 -22.61 coo 5.94 13.28 27.17 3.53 13.05 28.58 37.24 -51.70 -23.13 39.21 -53.16 -21.84 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 9 3 # 9 C 14 ARG C 162 ARG^? 16.00 O21 C8E C 209 C 161 ASP C 48 ASP.? 7.17 CA CA C 208 C 174 TYR C 51 TYR.? 10.04 O21 C8E C 209 coo 2.84 19.43 40.34 1.59 20.35 37.65 35.66 -43.15 0.12 35.66 -43.03 3.18 coo -0.62 11.10 28.05 -0.65 13.15 27.46 26.68 -52.06 -7.74 25.46 -53.53 -8.54 coo 5.94 13.28 27.17 3.53 13.05 28.58 26.09 -52.62 -2.60 27.54 -53.38 -0.32 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 10 3 # 10 C 14 ARG C 162 ARG^? 16.00 O21 C8E C 209 C 161 ASP C 180 ASP.? 12.29 C5 C8E C 209 C 174 TYR C 183 TYR~? 7.45 C14 C8E C 209 coo 2.84 19.43 40.34 1.59 20.35 37.65 35.66 -43.15 0.12 35.66 -43.03 3.18 coo -0.62 11.10 28.05 -0.65 13.15 27.46 42.24 -54.49 3.97 44.24 -53.90 3.82 coo 5.94 13.28 27.17 3.53 13.05 28.58 39.42 -55.89 -0.59 40.02 -55.54 -3.26 2c7v_c10 source 2c7v PTERIDINE REDUCTASE : 10 hits 2c7v_c10 naa= 3 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 1 3 # 1 D 14 ARG A 135 ARG^? 21.29 C1 C8E A 210 D 161 ASP A 153 ASP^? 8.28 C1 C8E A 210 D 174 TYR A 13 TYR^? 6.88 C17 C8E A 209 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 62.45 -46.81 -18.85 61.41 -44.79 -20.90 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 63.37 -61.81 -16.17 62.75 -59.91 -16.84 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 65.07 -60.93 -23.01 63.35 -61.54 -20.90 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 2 3 # 2 D 14 ARG B 135 ARG^? 22.88 O15 C8E B 209 D 161 ASP B 153 ASP^? 9.57 O15 C8E B 209 D 174 TYR B 13 TYR^? 6.78 O15 C8E B 209 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 77.46 -42.45 -38.74 74.50 -42.61 -39.42 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 89.74 -36.17 -33.46 87.76 -36.55 -34.22 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 84.65 -34.92 -28.70 86.28 -34.17 -30.84 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 3 3 # 3 D 14 ARG B 162 ARG^? 16.35 O21 C8E B 210 D 161 ASP B 48 ASP.? 7.20 CA CA B 208 D 174 TYR B 51 TYR.? 9.95 O21 C8E B 210 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 96.21 -15.01 -19.71 98.63 -13.28 -19.03 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 97.60 -30.12 -16.68 98.20 -32.01 -15.99 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 102.03 -27.53 -15.19 104.12 -26.16 -16.40 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 4 3 # 4 D 14 ARG B 162 ARG^? 16.35 O21 C8E B 210 D 161 ASP B 49 ASP.? -3.05 CA CA B 208s D 174 TYR B 51 TYR.? 9.95 O21 C8E B 210 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 96.21 -15.01 -19.71 98.63 -13.28 -19.03 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 94.52 -28.97 -11.62 93.03 -30.41 -11.73 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 102.03 -27.53 -15.19 104.12 -26.16 -16.40 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 5 3 # 5 D 14 ARG B 162 ARG^? 16.35 O21 C8E B 210 D 161 ASP B 180 ASP.? 10.93 C4 C8E B 210 D 174 TYR B 183 TYR~? 7.74 O12 C8E B 210 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 96.21 -15.01 -19.71 98.63 -13.28 -19.03 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 106.50 -18.19 -29.27 105.54 -17.21 -30.85 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 104.05 -23.05 -28.11 101.72 -24.25 -29.01 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 6 3 # 6 D 14 ARG B 162 ARG^? 16.35 O21 C8E B 210 D 161 ASP B 185 ASP~? 11.63 O21 C8E B 210 D 174 TYR B 51 TYR.? 9.95 O21 C8E B 210 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 96.21 -15.01 -19.71 98.63 -13.28 -19.03 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 106.30 -23.80 -20.43 108.26 -24.54 -20.08 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 102.03 -27.53 -15.19 104.12 -26.16 -16.40 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 7 3 # 7 D 14 ARG B 162 ARG^? 16.35 O21 C8E B 210 D 161 ASP B 185 ASP~? 11.63 O21 C8E B 210 D 174 TYR B 183 TYR~? 7.74 O12 C8E B 210 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 96.21 -15.01 -19.71 98.63 -13.28 -19.03 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 106.30 -23.80 -20.43 108.26 -24.54 -20.08 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 104.05 -23.05 -28.11 101.72 -24.25 -29.01 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 8 3 # 8 D 14 ARG C 135 ARG^? 23.87 C16 C8E C 210 D 161 ASP C 153 ASP^? 9.83 C13 C8E C 210 D 174 TYR C 13 TYR^? 7.82 C16 C8E C 210 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 44.01 -56.05 -34.91 45.01 -54.65 -37.44 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 40.09 -57.62 -20.90 41.26 -57.13 -22.61 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 37.24 -51.70 -23.13 39.21 -53.16 -21.84 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 9 3 # 9 D 14 ARG C 162 ARG^? 16.00 O21 C8E C 209 D 161 ASP C 48 ASP.? 7.17 CA CA C 208 D 174 TYR C 51 TYR.? 10.04 O21 C8E C 209 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 35.66 -43.15 0.12 35.66 -43.03 3.18 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 26.68 -52.06 -7.74 25.46 -53.53 -8.54 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 26.09 -52.62 -2.60 27.54 -53.38 -0.32 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 10 3 # 10 D 14 ARG C 162 ARG^? 16.00 O21 C8E C 209 D 161 ASP C 180 ASP.? 12.29 C5 C8E C 209 D 174 TYR C 183 TYR~? 7.45 C14 C8E C 209 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 35.66 -43.15 0.12 35.66 -43.03 3.18 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 42.24 -54.49 3.97 44.24 -53.90 3.82 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 39.42 -55.89 -0.59 40.02 -55.54 -3.26 2c7v_c11 source 2c7v PTERIDINE REDUCTASE : 10 hits 2c7v_c11 naa= 3 ULMN 3 2cpu_c01 ALPHA-AMYLASE user 1 3 # 1 A 197 ASP A 167 ASP.? 22.50 CA CA A 208 A 233 GLU A 165 GLU^? 21.76 CA CA A 208 A 300 ASN A 170 ASN.? 28.35 CA CA A 208 coo 12.51 17.07 49.46 12.44 16.89 47.35 58.25 -87.45 -44.58 60.23 -87.13 -43.88 coo 6.52 19.14 48.16 7.77 18.42 46.61 55.17 -82.77 -39.51 54.39 -80.85 -40.05 coo 9.30 22.40 41.76 10.10 20.96 40.36 51.62 -88.52 -39.42 50.91 -89.41 -41.21 ULMN 3 2cpu_c01 ALPHA-AMYLASE user 2 3 # 2 A 197 ASP B 167 ASP.? 22.72 CA CA B 208 A 233 GLU B 165 GLU^? 20.64 CA CA B 208 A 300 ASN B 170 ASN.? 27.83 CA CA B 208 coo 12.51 17.07 49.46 12.44 16.89 47.35 88.92 -5.85 -9.56 88.92 -7.42 -8.19 coo 6.52 19.14 48.16 7.77 18.42 46.61 88.15 -8.84 -16.79 86.14 -9.46 -16.74 coo 9.30 22.40 41.76 10.10 20.96 40.36 90.80 -3.32 -17.55 90.23 -1.46 -16.71 ULMN 3 2cpu_c01 ALPHA-AMYLASE user 3 3 # 3 A 197 ASP C 111 ASP.? 17.21 CA CA C 208 A 233 GLU C 113 GLU.? 20.72 CA CA C 208 A 300 ASN C 115 ASN.? 18.23 CA CA C 208 coo 12.51 17.07 49.46 12.44 16.89 47.35 27.11 -33.17 -3.90 25.73 -31.94 -3.00 coo 6.52 19.14 48.16 7.77 18.42 46.61 22.93 -28.02 -2.65 24.78 -28.62 -1.78 coo 9.30 22.40 41.76 10.10 20.96 40.36 21.18 -32.86 2.02 20.57 -34.73 1.19 ULMN 3 2cpu_c01 ALPHA-AMYLASE user 4 3 # 4 A 197 ASP C 167 ASP.? 25.18 CA CA C 208 A 233 GLU C 165 GLU^? 20.98 CA CA C 208 A 300 ASN C 170 ASN.? 28.31 CA CA C 208 coo 12.51 17.07 49.46 12.44 16.89 47.35 31.39 -27.44 2.08 30.34 -25.78 1.31 coo 6.52 19.14 48.16 7.77 18.42 46.61 36.32 -31.59 -2.15 36.97 -31.00 -4.08 coo 9.30 22.40 41.76 10.10 20.96 40.36 39.40 -29.88 3.55 39.46 -27.84 4.11 2cpu_c01 source 2cpu ALPHA-AMYLASE : 4 hits 2cpu_c01 naa= 3 ULMN 3 2dbt_c00 CHITINASE C user 1 3 # 1 A 147 GLU A 7 GLU^? 19.52 C17 C8E A 209 A 156 GLU A 25 GLU^? 22.98 C2 C8E C 209 A 194 ASN A 143 ASN.? 30.79 C20 C8E C 210 coo 74.14 15.91 8.55 72.08 15.36 8.63 61.29 -47.52 -25.12 61.48 -48.69 -23.33 coo 67.47 20.07 1.34 65.99 20.06 2.88 56.22 -40.62 -18.58 57.98 -41.28 -19.55 coo 67.44 25.26 13.91 67.54 23.65 15.28 58.63 -35.72 -29.30 57.21 -34.21 -28.85 ULMN 3 2dbt_c00 CHITINASE C user 2 3 # 2 A 147 GLU A 7 GLU^? 19.52 C17 C8E A 209 A 156 GLU A 93 GLU^? 23.51 C1 C8E A 210 A 194 ASN A 143 ASN.? 30.79 C20 C8E C 210 coo 74.14 15.91 8.55 72.08 15.36 8.63 61.29 -47.52 -25.12 61.48 -48.69 -23.33 coo 67.47 20.07 1.34 65.99 20.06 2.88 64.33 -40.66 -16.04 62.38 -40.13 -16.70 coo 67.44 25.26 13.91 67.54 23.65 15.28 58.63 -35.72 -29.30 57.21 -34.21 -28.85 ULMN 3 2dbt_c00 CHITINASE C user 3 3 # 3 A 147 GLU A 25 GLU^? 22.98 C2 C8E C 209 A 156 GLU A 7 GLU^? 19.52 C17 C8E A 209 A 194 ASN A 143 ASN.? 30.79 C20 C8E C 210 coo 74.14 15.91 8.55 72.08 15.36 8.63 56.22 -40.62 -18.58 57.98 -41.28 -19.55 coo 67.47 20.07 1.34 65.99 20.06 2.88 61.29 -47.52 -25.12 61.48 -48.69 -23.33 coo 67.44 25.26 13.91 67.54 23.65 15.28 58.63 -35.72 -29.30 57.21 -34.21 -28.85 ULMN 3 2dbt_c00 CHITINASE C user 4 3 # 4 A 147 GLU B 7 GLU^? 19.70 O15 C8E B 209 A 156 GLU B 25 GLU^? 27.65 O15 C8E B 209 A 194 ASN B 143 ASN.? 32.74 O18 C8E A 209 coo 74.14 15.91 8.55 72.08 15.36 8.63 73.39 -38.66 -35.65 75.17 -39.55 -36.49 coo 67.47 20.07 1.34 65.99 20.06 2.88 73.50 -42.12 -45.68 71.97 -42.23 -44.24 coo 67.44 25.26 13.91 67.54 23.65 15.28 61.43 -41.97 -40.31 60.77 -41.84 -42.32 ULMN 3 2dbt_c00 CHITINASE C user 5 3 # 5 A 147 GLU B 25 GLU^? 27.65 O15 C8E B 209 A 156 GLU B 7 GLU^? 19.70 O15 C8E B 209 A 194 ASN B 143 ASN.? 32.74 O18 C8E A 209 coo 74.14 15.91 8.55 72.08 15.36 8.63 73.50 -42.12 -45.68 71.97 -42.23 -44.24 coo 67.47 20.07 1.34 65.99 20.06 2.88 73.39 -38.66 -35.65 75.17 -39.55 -36.49 coo 67.44 25.26 13.91 67.54 23.65 15.28 61.43 -41.97 -40.31 60.77 -41.84 -42.32 ULMN 3 2dbt_c00 CHITINASE C user 6 3 # 6 A 147 GLU C 7 GLU^? 20.56 C16 C8E C 210 A 156 GLU C 25 GLU.? 26.72 O21 C8E A 209 A 194 ASN C 143 ASN.? 36.02 C16 C8E C 210 coo 74.14 15.91 8.55 72.08 15.36 8.63 43.33 -49.69 -35.12 43.56 -51.77 -34.52 coo 67.47 20.07 1.34 65.99 20.06 2.88 50.80 -55.81 -38.99 49.16 -55.90 -40.32 coo 67.44 25.26 13.91 67.54 23.65 15.28 48.00 -46.73 -47.20 49.81 -46.99 -48.30 ULMN 3 2dbt_c00 CHITINASE C user 7 3 # 7 A 147 GLU C 7 GLU^? 20.56 C16 C8E C 210 A 156 GLU C 93 GLU^? 26.90 C13 C8E C 210 A 194 ASN C 143 ASN.? 36.02 C16 C8E C 210 coo 74.14 15.91 8.55 72.08 15.36 8.63 43.33 -49.69 -35.12 43.56 -51.77 -34.52 coo 67.47 20.07 1.34 65.99 20.06 2.88 45.29 -60.19 -41.07 45.99 -58.52 -39.91 coo 67.44 25.26 13.91 67.54 23.65 15.28 48.00 -46.73 -47.20 49.81 -46.99 -48.30 ULMN 3 2dbt_c00 CHITINASE C user 8 3 # 8 A 147 GLU C 25 GLU.? 26.72 O21 C8E A 209 A 156 GLU C 7 GLU^? 20.56 C16 C8E C 210 A 194 ASN C 143 ASN.? 36.02 C16 C8E C 210 coo 74.14 15.91 8.55 72.08 15.36 8.63 50.80 -55.81 -38.99 49.16 -55.90 -40.32 coo 67.47 20.07 1.34 65.99 20.06 2.88 43.33 -49.69 -35.12 43.56 -51.77 -34.52 coo 67.44 25.26 13.91 67.54 23.65 15.28 48.00 -46.73 -47.20 49.81 -46.99 -48.30 2dbt_c00 source 2dbt CHITINASE C : 8 hits 2dbt_c00 naa= 3 ULMN 3 2dbt_c01 CHITINASE C user 1 3 # 1 B 147 GLU A 7 GLU^? 19.52 C17 C8E A 209 B 156 GLU A 25 GLU^? 22.98 C2 C8E C 209 B 194 ASN A 143 ASN.? 30.79 C20 C8E C 210 coo 45.64 63.11 17.20 47.48 62.43 16.45 61.29 -47.52 -25.12 61.48 -48.69 -23.33 coo 54.43 67.89 19.82 55.62 67.90 18.07 56.22 -40.62 -18.58 57.98 -41.28 -19.55 coo 49.79 70.75 7.78 50.10 68.90 6.86 58.63 -35.72 -29.30 57.21 -34.21 -28.85 ULMN 3 2dbt_c01 CHITINASE C user 2 3 # 2 B 147 GLU A 25 GLU^? 22.98 C2 C8E C 209 B 156 GLU A 7 GLU^? 19.52 C17 C8E A 209 B 194 ASN A 143 ASN.? 30.79 C20 C8E C 210 coo 45.64 63.11 17.20 47.48 62.43 16.45 56.22 -40.62 -18.58 57.98 -41.28 -19.55 coo 54.43 67.89 19.82 55.62 67.90 18.07 61.29 -47.52 -25.12 61.48 -48.69 -23.33 coo 49.79 70.75 7.78 50.10 68.90 6.86 58.63 -35.72 -29.30 57.21 -34.21 -28.85 ULMN 3 2dbt_c01 CHITINASE C user 3 3 # 3 B 147 GLU B 7 GLU^? 19.70 O15 C8E B 209 B 156 GLU B 25 GLU^? 27.65 O15 C8E B 209 B 194 ASN B 143 ASN.? 32.74 O18 C8E A 209 coo 45.64 63.11 17.20 47.48 62.43 16.45 73.39 -38.66 -35.65 75.17 -39.55 -36.49 coo 54.43 67.89 19.82 55.62 67.90 18.07 73.50 -42.12 -45.68 71.97 -42.23 -44.24 coo 49.79 70.75 7.78 50.10 68.90 6.86 61.43 -41.97 -40.31 60.77 -41.84 -42.32 ULMN 3 2dbt_c01 CHITINASE C user 4 3 # 4 B 147 GLU B 25 GLU^? 27.65 O15 C8E B 209 B 156 GLU B 7 GLU^? 19.70 O15 C8E B 209 B 194 ASN B 143 ASN.? 32.74 O18 C8E A 209 coo 45.64 63.11 17.20 47.48 62.43 16.45 73.50 -42.12 -45.68 71.97 -42.23 -44.24 coo 54.43 67.89 19.82 55.62 67.90 18.07 73.39 -38.66 -35.65 75.17 -39.55 -36.49 coo 49.79 70.75 7.78 50.10 68.90 6.86 61.43 -41.97 -40.31 60.77 -41.84 -42.32 ULMN 3 2dbt_c01 CHITINASE C user 5 3 # 5 B 147 GLU C 7 GLU^? 20.56 C16 C8E C 210 B 156 GLU C 25 GLU.? 26.72 O21 C8E A 209 B 194 ASN C 143 ASN.? 36.02 C16 C8E C 210 coo 45.64 63.11 17.20 47.48 62.43 16.45 43.33 -49.69 -35.12 43.56 -51.77 -34.52 coo 54.43 67.89 19.82 55.62 67.90 18.07 50.80 -55.81 -38.99 49.16 -55.90 -40.32 coo 49.79 70.75 7.78 50.10 68.90 6.86 48.00 -46.73 -47.20 49.81 -46.99 -48.30 ULMN 3 2dbt_c01 CHITINASE C user 6 3 # 6 B 147 GLU C 7 GLU^? 20.56 C16 C8E C 210 B 156 GLU C 93 GLU^? 26.90 C13 C8E C 210 B 194 ASN C 143 ASN.? 36.02 C16 C8E C 210 coo 45.64 63.11 17.20 47.48 62.43 16.45 43.33 -49.69 -35.12 43.56 -51.77 -34.52 coo 54.43 67.89 19.82 55.62 67.90 18.07 45.29 -60.19 -41.07 45.99 -58.52 -39.91 coo 49.79 70.75 7.78 50.10 68.90 6.86 48.00 -46.73 -47.20 49.81 -46.99 -48.30 ULMN 3 2dbt_c01 CHITINASE C user 7 3 # 7 B 147 GLU C 25 GLU.? 26.72 O21 C8E A 209 B 156 GLU C 7 GLU^? 20.56 C16 C8E C 210 B 194 ASN C 143 ASN.? 36.02 C16 C8E C 210 coo 45.64 63.11 17.20 47.48 62.43 16.45 50.80 -55.81 -38.99 49.16 -55.90 -40.32 coo 54.43 67.89 19.82 55.62 67.90 18.07 43.33 -49.69 -35.12 43.56 -51.77 -34.52 coo 49.79 70.75 7.78 50.10 68.90 6.86 48.00 -46.73 -47.20 49.81 -46.99 -48.30 2dbt_c01 source 2dbt CHITINASE C : 7 hits 2dbt_c01 naa= 3 ULMN 3 2dbt_c02 CHITINASE C user 1 3 # 1 C 147 GLU A 7 GLU^? 19.52 C17 C8E A 209 C 156 GLU A 25 GLU^? 22.98 C2 C8E C 209 C 194 ASN A 143 ASN.? 30.79 C20 C8E C 210 coo 41.23 29.31 13.28 43.03 29.85 12.29 61.29 -47.52 -25.12 61.48 -48.69 -23.33 coo 44.75 23.09 5.51 46.77 22.91 6.12 56.22 -40.62 -18.58 57.98 -41.28 -19.55 coo 49.75 21.00 18.12 50.45 23.02 18.26 58.63 -35.72 -29.30 57.21 -34.21 -28.85 ULMN 3 2dbt_c02 CHITINASE C user 2 3 # 2 C 147 GLU A 7 GLU^? 19.52 C17 C8E A 209 C 156 GLU A 93 GLU^? 23.51 C1 C8E A 210 C 194 ASN A 143 ASN.? 30.79 C20 C8E C 210 coo 41.23 29.31 13.28 43.03 29.85 12.29 61.29 -47.52 -25.12 61.48 -48.69 -23.33 coo 44.75 23.09 5.51 46.77 22.91 6.12 64.33 -40.66 -16.04 62.38 -40.13 -16.70 coo 49.75 21.00 18.12 50.45 23.02 18.26 58.63 -35.72 -29.30 57.21 -34.21 -28.85 ULMN 3 2dbt_c02 CHITINASE C user 3 3 # 3 C 147 GLU A 25 GLU^? 22.98 C2 C8E C 209 C 156 GLU A 7 GLU^? 19.52 C17 C8E A 209 C 194 ASN A 143 ASN.? 30.79 C20 C8E C 210 coo 41.23 29.31 13.28 43.03 29.85 12.29 56.22 -40.62 -18.58 57.98 -41.28 -19.55 coo 44.75 23.09 5.51 46.77 22.91 6.12 61.29 -47.52 -25.12 61.48 -48.69 -23.33 coo 49.75 21.00 18.12 50.45 23.02 18.26 58.63 -35.72 -29.30 57.21 -34.21 -28.85 ULMN 3 2dbt_c02 CHITINASE C user 4 3 # 4 C 147 GLU B 7 GLU^? 19.70 O15 C8E B 209 C 156 GLU B 25 GLU^? 27.65 O15 C8E B 209 C 194 ASN B 143 ASN.? 32.74 O18 C8E A 209 coo 41.23 29.31 13.28 43.03 29.85 12.29 73.39 -38.66 -35.65 75.17 -39.55 -36.49 coo 44.75 23.09 5.51 46.77 22.91 6.12 73.50 -42.12 -45.68 71.97 -42.23 -44.24 coo 49.75 21.00 18.12 50.45 23.02 18.26 61.43 -41.97 -40.31 60.77 -41.84 -42.32 ULMN 3 2dbt_c02 CHITINASE C user 5 3 # 5 C 147 GLU B 25 GLU^? 27.65 O15 C8E B 209 C 156 GLU B 7 GLU^? 19.70 O15 C8E B 209 C 194 ASN B 143 ASN.? 32.74 O18 C8E A 209 coo 41.23 29.31 13.28 43.03 29.85 12.29 73.50 -42.12 -45.68 71.97 -42.23 -44.24 coo 44.75 23.09 5.51 46.77 22.91 6.12 73.39 -38.66 -35.65 75.17 -39.55 -36.49 coo 49.75 21.00 18.12 50.45 23.02 18.26 61.43 -41.97 -40.31 60.77 -41.84 -42.32 ULMN 3 2dbt_c02 CHITINASE C user 6 3 # 6 C 147 GLU C 7 GLU^? 20.56 C16 C8E C 210 C 156 GLU C 25 GLU.? 26.72 O21 C8E A 209 C 194 ASN C 143 ASN.? 36.02 C16 C8E C 210 coo 41.23 29.31 13.28 43.03 29.85 12.29 43.33 -49.69 -35.12 43.56 -51.77 -34.52 coo 44.75 23.09 5.51 46.77 22.91 6.12 50.80 -55.81 -38.99 49.16 -55.90 -40.32 coo 49.75 21.00 18.12 50.45 23.02 18.26 48.00 -46.73 -47.20 49.81 -46.99 -48.30 ULMN 3 2dbt_c02 CHITINASE C user 7 3 # 7 C 147 GLU C 7 GLU^? 20.56 C16 C8E C 210 C 156 GLU C 93 GLU^? 26.90 C13 C8E C 210 C 194 ASN C 143 ASN.? 36.02 C16 C8E C 210 coo 41.23 29.31 13.28 43.03 29.85 12.29 43.33 -49.69 -35.12 43.56 -51.77 -34.52 coo 44.75 23.09 5.51 46.77 22.91 6.12 45.29 -60.19 -41.07 45.99 -58.52 -39.91 coo 49.75 21.00 18.12 50.45 23.02 18.26 48.00 -46.73 -47.20 49.81 -46.99 -48.30 ULMN 3 2dbt_c02 CHITINASE C user 8 3 # 8 C 147 GLU C 25 GLU.? 26.72 O21 C8E A 209 C 156 GLU C 7 GLU^? 20.56 C16 C8E C 210 C 194 ASN C 143 ASN.? 36.02 C16 C8E C 210 coo 41.23 29.31 13.28 43.03 29.85 12.29 50.80 -55.81 -38.99 49.16 -55.90 -40.32 coo 44.75 23.09 5.51 46.77 22.91 6.12 43.33 -49.69 -35.12 43.56 -51.77 -34.52 coo 49.75 21.00 18.12 50.45 23.02 18.26 48.00 -46.73 -47.20 49.81 -46.99 -48.30 2dbt_c02 source 2dbt CHITINASE C : 8 hits 2dbt_c02 naa= 3 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 1 3 # 1 B 182 LYS A 63 LYS~? 3.96 CA CA A 208 B 184 LYS A 67 LYS~? 13.30 CA CA A 208 B 345 ASP A 45 ASP.? -2.96 CA CA A 208s coo 38.76 2.27 4.00 34.00 5.99 4.37 73.63 -82.49 -34.44 73.43 -77.00 -32.37 coo 40.63 7.13 9.06 35.85 7.36 8.95 73.21 -82.07 -40.14 71.59 -78.49 -41.85 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 70.45 -71.75 -27.39 71.06 -73.65 -26.89 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 2 3 # 2 B 182 LYS A 63 LYS~? 3.96 CA CA A 208 B 184 LYS A 67 LYS~? 13.30 CA CA A 208 B 345 ASP A 48 ASP.? 7.38 CA CA A 208 coo 38.76 2.27 4.00 34.00 5.99 4.37 73.63 -82.49 -34.44 73.43 -77.00 -32.37 coo 40.63 7.13 9.06 35.85 7.36 8.95 73.21 -82.07 -40.14 71.59 -78.49 -41.85 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 72.05 -78.20 -23.17 73.82 -77.79 -22.11 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 3 3 # 3 B 182 LYS B 63 LYS~? 3.79 CA CA B 208 B 184 LYS B 67 LYS~? 18.13 CA CA B 208 B 345 ASP B 45 ASP.? -3.07 CA CA B 208s coo 38.76 2.27 4.00 34.00 5.99 4.37 93.18 -23.71 -7.17 90.77 -27.85 -10.83 coo 40.63 7.13 9.06 35.85 7.36 8.95 89.12 -21.41 -4.23 87.66 -21.56 1.71 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 90.60 -30.65 -18.50 91.26 -30.99 -16.60 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 4 3 # 4 B 182 LYS B 63 LYS~? 3.79 CA CA B 208 B 184 LYS B 67 LYS~? 18.13 CA CA B 208 B 345 ASP B 48 ASP.? 7.20 CA CA B 208 coo 38.76 2.27 4.00 34.00 5.99 4.37 93.18 -23.71 -7.17 90.77 -27.85 -10.83 coo 40.63 7.13 9.06 35.85 7.36 8.95 89.12 -21.41 -4.23 87.66 -21.56 1.71 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 97.60 -30.12 -16.68 98.20 -32.01 -15.99 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 5 3 # 5 B 182 LYS C 63 LYS~? 4.21 CA CA C 208 B 184 LYS C 67 LYS.? 18.71 CA CA C 208 B 345 ASP C 45 ASP.? 3.27 CA CA C 208s coo 38.76 2.27 4.00 34.00 5.99 4.37 20.98 -41.61 -5.49 23.04 -43.67 -10.44 coo 40.63 7.13 9.06 35.85 7.36 8.95 20.04 -36.06 -6.98 16.11 -31.17 -7.78 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 28.98 -48.61 -14.39 27.54 -48.99 -12.93 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 6 3 # 6 B 182 LYS C 63 LYS~? 4.21 CA CA C 208 B 184 LYS C 67 LYS.? 18.71 CA CA C 208 B 345 ASP C 48 ASP.? 7.17 CA CA C 208 coo 38.76 2.27 4.00 34.00 5.99 4.37 20.98 -41.61 -5.49 23.04 -43.67 -10.44 coo 40.63 7.13 9.06 35.85 7.36 8.95 20.04 -36.06 -6.98 16.11 -31.17 -7.78 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 26.68 -52.06 -7.74 25.46 -53.53 -8.54 2dw7_c33 source 2dw7 BLL6730 PROTEIN : 6 hits 2dw7_c33 naa= 3 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 1 3 # 1 J 182 LYS A 63 LYS~? 3.96 CA CA A 208 J 184 LYS A 67 LYS~? 13.30 CA CA A 208 J 345 ASP A 45 ASP.? -2.96 CA CA A 208s coo 25.22 70.55 14.03 27.64 73.07 18.65 73.63 -82.49 -34.44 73.43 -77.00 -32.37 coo 31.73 69.87 11.50 32.73 70.19 16.40 73.21 -82.07 -40.14 71.59 -78.49 -41.85 coo 25.87 58.42 18.79 23.95 58.54 17.90 70.45 -71.75 -27.39 71.06 -73.65 -26.89 2dw7_c41 source 2dw7 BLL6730 PROTEIN : 1 hits 2dw7_c41 naa= 3 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 1 3 # 1 L 182 LYS A 63 LYS~? 3.96 CA CA A 208 L 184 LYS A 67 LYS~? 13.30 CA CA A 208 L 345 ASP A 45 ASP.? -2.96 CA CA A 208s coo 20.72 21.86 -37.85 25.46 24.17 -34.95 73.63 -82.49 -34.44 73.43 -77.00 -32.37 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 73.21 -82.07 -40.14 71.59 -78.49 -41.85 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 70.45 -71.75 -27.39 71.06 -73.65 -26.89 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 2 3 # 2 L 182 LYS A 63 LYS~? 3.96 CA CA A 208 L 184 LYS A 67 LYS~? 13.30 CA CA A 208 L 345 ASP A 48 ASP.? 7.38 CA CA A 208 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 73.63 -82.49 -34.44 73.43 -77.00 -32.37 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 73.21 -82.07 -40.14 71.59 -78.49 -41.85 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 72.05 -78.20 -23.17 73.82 -77.79 -22.11 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 3 3 # 3 L 182 LYS B 63 LYS~? 3.79 CA CA B 208 L 184 LYS B 67 LYS~? 18.13 CA CA B 208 L 345 ASP B 45 ASP.? -3.07 CA CA B 208s coo 20.72 21.86 -37.85 25.46 24.17 -34.95 93.18 -23.71 -7.17 90.77 -27.85 -10.83 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 89.12 -21.41 -4.23 87.66 -21.56 1.71 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 90.60 -30.65 -18.50 91.26 -30.99 -16.60 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 4 3 # 4 L 182 LYS B 63 LYS~? 3.79 CA CA B 208 L 184 LYS B 67 LYS~? 18.13 CA CA B 208 L 345 ASP B 48 ASP.? 7.20 CA CA B 208 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 93.18 -23.71 -7.17 90.77 -27.85 -10.83 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 89.12 -21.41 -4.23 87.66 -21.56 1.71 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 97.60 -30.12 -16.68 98.20 -32.01 -15.99 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 5 3 # 5 L 182 LYS C 63 LYS~? 4.21 CA CA C 208 L 184 LYS C 67 LYS.? 18.71 CA CA C 208 L 345 ASP C 45 ASP.? 3.27 CA CA C 208s coo 20.72 21.86 -37.85 25.46 24.17 -34.95 20.98 -41.61 -5.49 23.04 -43.67 -10.44 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 20.04 -36.06 -6.98 16.11 -31.17 -7.78 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 28.98 -48.61 -14.39 27.54 -48.99 -12.93 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 6 3 # 6 L 182 LYS C 63 LYS~? 4.21 CA CA C 208 L 184 LYS C 67 LYS.? 18.71 CA CA C 208 L 345 ASP C 48 ASP.? 7.17 CA CA C 208 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 20.98 -41.61 -5.49 23.04 -43.67 -10.44 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 20.04 -36.06 -6.98 16.11 -31.17 -7.78 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 26.68 -52.06 -7.74 25.46 -53.53 -8.54 2dw7_c43 source 2dw7 BLL6730 PROTEIN : 6 hits 2dw7_c43 naa= 3 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 1 3 # 1 M 182 LYS A 63 LYS~? 3.96 CA CA A 208 M 184 LYS A 67 LYS~? 13.30 CA CA A 208 M 345 ASP A 45 ASP.? -2.96 CA CA A 208s coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 73.63 -82.49 -34.44 73.43 -77.00 -32.37 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 73.21 -82.07 -40.14 71.59 -78.49 -41.85 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 70.45 -71.75 -27.39 71.06 -73.65 -26.89 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 2 3 # 2 M 182 LYS A 63 LYS~? 3.96 CA CA A 208 M 184 LYS A 67 LYS~? 13.30 CA CA A 208 M 345 ASP A 48 ASP.? 7.38 CA CA A 208 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 73.63 -82.49 -34.44 73.43 -77.00 -32.37 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 73.21 -82.07 -40.14 71.59 -78.49 -41.85 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 72.05 -78.20 -23.17 73.82 -77.79 -22.11 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 3 3 # 3 M 182 LYS B 63 LYS~? 3.79 CA CA B 208 M 184 LYS B 67 LYS~? 18.13 CA CA B 208 M 345 ASP B 45 ASP.? -3.07 CA CA B 208s coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 93.18 -23.71 -7.17 90.77 -27.85 -10.83 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 89.12 -21.41 -4.23 87.66 -21.56 1.71 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 90.60 -30.65 -18.50 91.26 -30.99 -16.60 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 4 3 # 4 M 182 LYS B 63 LYS~? 3.79 CA CA B 208 M 184 LYS B 67 LYS~? 18.13 CA CA B 208 M 345 ASP B 48 ASP.? 7.20 CA CA B 208 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 93.18 -23.71 -7.17 90.77 -27.85 -10.83 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 89.12 -21.41 -4.23 87.66 -21.56 1.71 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 97.60 -30.12 -16.68 98.20 -32.01 -15.99 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 5 3 # 5 M 182 LYS C 63 LYS~? 4.21 CA CA C 208 M 184 LYS C 67 LYS.? 18.71 CA CA C 208 M 345 ASP C 45 ASP.? 3.27 CA CA C 208s coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 20.98 -41.61 -5.49 23.04 -43.67 -10.44 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 20.04 -36.06 -6.98 16.11 -31.17 -7.78 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 28.98 -48.61 -14.39 27.54 -48.99 -12.93 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 6 3 # 6 M 182 LYS C 63 LYS~? 4.21 CA CA C 208 M 184 LYS C 67 LYS.? 18.71 CA CA C 208 M 345 ASP C 48 ASP.? 7.17 CA CA C 208 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 20.98 -41.61 -5.49 23.04 -43.67 -10.44 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 20.04 -36.06 -6.98 16.11 -31.17 -7.78 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 26.68 -52.06 -7.74 25.46 -53.53 -8.54 2dw7_c44 source 2dw7 BLL6730 PROTEIN : 6 hits 2dw7_c44 naa= 3 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 1 3 # 1 P 182 LYS A 63 LYS~? 3.96 CA CA A 208 P 184 LYS A 67 LYS~? 13.30 CA CA A 208 P 345 ASP A 45 ASP.? -2.96 CA CA A 208s coo 14.97 -47.15 29.92 18.26 -47.80 24.89 73.63 -82.49 -34.44 73.43 -77.00 -32.37 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 73.21 -82.07 -40.14 71.59 -78.49 -41.85 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 70.45 -71.75 -27.39 71.06 -73.65 -26.89 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 2 3 # 2 P 182 LYS A 63 LYS~? 3.96 CA CA A 208 P 184 LYS A 67 LYS~? 13.30 CA CA A 208 P 345 ASP A 48 ASP.? 7.38 CA CA A 208 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 73.63 -82.49 -34.44 73.43 -77.00 -32.37 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 73.21 -82.07 -40.14 71.59 -78.49 -41.85 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 72.05 -78.20 -23.17 73.82 -77.79 -22.11 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 3 3 # 3 P 182 LYS B 63 LYS~? 3.79 CA CA B 208 P 184 LYS B 67 LYS~? 18.13 CA CA B 208 P 345 ASP B 45 ASP.? -3.07 CA CA B 208s coo 14.97 -47.15 29.92 18.26 -47.80 24.89 93.18 -23.71 -7.17 90.77 -27.85 -10.83 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 89.12 -21.41 -4.23 87.66 -21.56 1.71 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 90.60 -30.65 -18.50 91.26 -30.99 -16.60 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 4 3 # 4 P 182 LYS B 63 LYS~? 3.79 CA CA B 208 P 184 LYS B 67 LYS~? 18.13 CA CA B 208 P 345 ASP B 48 ASP.? 7.20 CA CA B 208 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 93.18 -23.71 -7.17 90.77 -27.85 -10.83 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 89.12 -21.41 -4.23 87.66 -21.56 1.71 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 97.60 -30.12 -16.68 98.20 -32.01 -15.99 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 5 3 # 5 P 182 LYS C 63 LYS~? 4.21 CA CA C 208 P 184 LYS C 67 LYS.? 18.71 CA CA C 208 P 345 ASP C 45 ASP.? 3.27 CA CA C 208s coo 14.97 -47.15 29.92 18.26 -47.80 24.89 20.98 -41.61 -5.49 23.04 -43.67 -10.44 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 20.04 -36.06 -6.98 16.11 -31.17 -7.78 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 28.98 -48.61 -14.39 27.54 -48.99 -12.93 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 6 3 # 6 P 182 LYS C 63 LYS~? 4.21 CA CA C 208 P 184 LYS C 67 LYS.? 18.71 CA CA C 208 P 345 ASP C 48 ASP.? 7.17 CA CA C 208 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 20.98 -41.61 -5.49 23.04 -43.67 -10.44 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 20.04 -36.06 -6.98 16.11 -31.17 -7.78 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 26.68 -52.06 -7.74 25.46 -53.53 -8.54 2dw7_c47 source 2dw7 BLL6730 PROTEIN : 6 hits 2dw7_c47 naa= 3 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 3 # 1 A 157 PHE A 4 PHE^? 17.62 C20 C8E C 210 A 245 ASP A 26 ASP.? 24.86 C2 C8E C 209 A 273 LYS A 84 LYS.? 23.11 C2 C8E C 209 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 49.89 -42.01 -22.91 47.86 -42.25 -21.03 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 53.70 -37.11 -16.05 55.72 -36.42 -15.97 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 61.58 -41.74 -11.00 58.66 -39.80 -16.04 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 2 3 # 2 A 157 PHE A 98 PHE^? 10.84 C1 C8E A 210 A 245 ASP A 80 ASP^? 12.60 C1 C8E A 210 A 273 LYS A 198 LYS^? 12.09 C1 C8E A 210 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 58.55 -53.78 -9.03 56.20 -52.58 -8.10 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 58.12 -52.30 -15.93 59.10 -53.68 -17.13 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 68.28 -58.05 -20.21 63.11 -55.44 -18.88 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 3 3 # 3 A 157 PHE A 105 PHE^? 4.85 O21 C8E A 209 A 245 ASP A 45 ASP.? -2.96 CA CA A 208s A 273 LYS A 63 LYS~? 3.96 CA CA A 208 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 61.29 -71.83 -24.77 63.18 -73.65 -25.72 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 4 3 # 4 A 157 PHE A 189 PHE~? 8.72 CA CA A 208 A 245 ASP A 49 ASP.? -3.00 CA CA A 208s A 273 LYS A 67 LYS~? 13.30 CA CA A 208 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 68.20 -82.10 -23.88 68.92 -82.62 -26.53 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 75.72 -77.89 -27.98 74.67 -77.10 -29.65 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 73.21 -82.07 -40.14 71.59 -78.49 -41.85 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 5 3 # 5 A 157 PHE B 4 PHE^? 30.68 O15 C8E B 209 A 245 ASP B 26 ASP.? 33.07 O15 C8E B 209 A 273 LYS B 84 LYS.? 25.86 O15 C8E B 209 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 69.58 -34.85 -47.09 70.86 -34.01 -49.45 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 71.92 -43.11 -51.36 71.95 -45.06 -50.50 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 79.44 -47.69 -46.65 75.97 -44.45 -44.18 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 6 3 # 6 A 157 PHE B 98 PHE^? 18.60 C8 C8E B 210 A 245 ASP B 80 ASP^? 15.94 O15 C8E B 209 A 273 LYS B 198 LYS^? 12.15 O15 C8E B 209 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 88.93 -40.28 -43.85 88.97 -39.56 -46.61 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 82.56 -37.87 -41.00 82.97 -37.16 -39.06 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 85.01 -40.11 -29.09 83.85 -38.63 -34.53 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 7 3 # 7 A 157 PHE B 105 PHE^? 5.21 C20 C8E B 209 A 245 ASP B 45 ASP.? -3.07 CA CA B 208s A 273 LYS B 63 LYS~? 3.79 CA CA B 208 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 90.70 -25.26 -25.77 91.65 -25.28 -23.14 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 8 3 # 8 A 157 PHE B 189 PHE~? 8.56 CA CA B 208 A 245 ASP B 49 ASP.? -3.05 CA CA B 208s A 273 LYS B 67 LYS~? 18.13 CA CA B 208 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 99.55 -24.92 -16.99 98.05 -23.95 -14.81 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 94.52 -28.97 -11.62 93.03 -30.41 -11.73 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 89.12 -21.41 -4.23 87.66 -21.56 1.71 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 9 3 # 9 A 157 PHE C 98 PHE^? 16.93 O21 C8E A 209 A 245 ASP C 80 ASP^? 16.43 C13 C8E C 210 A 273 LYS C 198 LYS^? 12.94 C13 C8E C 210 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 48.24 -64.04 -26.66 50.81 -64.73 -27.68 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 47.10 -57.14 -28.79 45.64 -55.94 -27.77 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 35.43 -55.44 -26.10 41.10 -55.85 -26.89 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 10 3 # 10 A 157 PHE C 105 PHE^? -4.13 O21 C8E C 210s A 245 ASP C 45 ASP.? 3.27 CA CA C 208s A 273 LYS C 63 LYS~? 4.21 CA CA C 208 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 37.70 -47.93 -11.88 35.28 -47.45 -10.64 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 20.98 -41.61 -5.49 23.04 -43.67 -10.44 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 11 3 # 11 A 157 PHE C 189 PHE~? 9.03 CA CA C 208 A 245 ASP C 49 ASP.? -2.87 CA CA C 208s A 273 LYS C 67 LYS.? 18.71 CA CA C 208 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 29.10 -50.14 -3.03 27.67 -47.71 -3.13 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 22.13 -48.50 -9.42 23.00 -46.66 -10.00 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 20.04 -36.06 -6.98 16.11 -31.17 -7.78 2gsa_c04 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 11 hits 2gsa_c04 naa= 3 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 A 177 PHE A 105 PHE^? 4.85 O21 C8E A 209 A 263 ASP A 45 ASP.? -2.96 CA CA A 208s A 292 LYS A 188 LYS~? 10.77 C20 C8E A 210 coo 51.51 50.32 16.39 52.13 49.68 13.75 61.29 -71.83 -24.77 63.18 -73.65 -25.72 coo 54.43 44.82 23.74 55.21 45.06 21.80 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo 63.95 45.30 16.71 59.11 49.15 16.05 68.32 -80.18 -18.11 71.95 -84.24 -15.84 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 A 177 PHE A 189 PHE~? 8.72 CA CA A 208 A 263 ASP A 45 ASP.? -2.96 CA CA A 208s A 292 LYS A 63 LYS~? 3.96 CA CA A 208 coo 51.51 50.32 16.39 52.13 49.68 13.75 68.20 -82.10 -23.88 68.92 -82.62 -26.53 coo 54.43 44.82 23.74 55.21 45.06 21.80 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo 63.95 45.30 16.71 59.11 49.15 16.05 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 A 177 PHE A 189 PHE~? 8.72 CA CA A 208 A 263 ASP A 52 ASP.? 15.11 CA CA A 208 A 292 LYS A 63 LYS~? 3.96 CA CA A 208 coo 51.51 50.32 16.39 52.13 49.68 13.75 68.20 -82.10 -23.88 68.92 -82.62 -26.53 coo 54.43 44.82 23.74 55.21 45.06 21.80 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo 63.95 45.30 16.71 59.11 49.15 16.05 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 A 177 PHE B 105 PHE^? 5.21 C20 C8E B 209 A 263 ASP B 45 ASP.? -3.07 CA CA B 208s A 292 LYS B 188 LYS~? 9.67 C16 C8E B 210 coo 51.51 50.32 16.39 52.13 49.68 13.75 90.70 -25.26 -25.77 91.65 -25.28 -23.14 coo 54.43 44.82 23.74 55.21 45.06 21.80 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo 63.95 45.30 16.71 59.11 49.15 16.05 102.16 -28.74 -21.10 106.15 -31.37 -17.86 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 A 177 PHE B 189 PHE~? 8.56 CA CA B 208 A 263 ASP B 45 ASP.? -3.07 CA CA B 208s A 292 LYS B 63 LYS~? 3.79 CA CA B 208 coo 51.51 50.32 16.39 52.13 49.68 13.75 99.55 -24.92 -16.99 98.05 -23.95 -14.81 coo 54.43 44.82 23.74 55.21 45.06 21.80 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo 63.95 45.30 16.71 59.11 49.15 16.05 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 6 3 # 6 A 177 PHE C 105 PHE^? -4.13 O21 C8E C 210s A 263 ASP C 45 ASP.? 3.27 CA CA C 208s A 292 LYS C 188 LYS~? 9.02 C16 C8E C 209 coo 51.51 50.32 16.39 52.13 49.68 13.75 37.70 -47.93 -11.88 35.28 -47.45 -10.64 coo 54.43 44.82 23.74 55.21 45.06 21.80 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo 63.95 45.30 16.71 59.11 49.15 16.05 31.07 -55.82 -4.30 26.58 -58.21 -2.57 2oat_c03 source 2oat ORNITHINE AMINOTRANSFERASE : 6 hits 2oat_c03 naa= 3 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 B 177 PHE A 105 PHE^? 4.85 O21 C8E A 209 B 263 ASP A 45 ASP.? -2.96 CA CA A 208s B 292 LYS A 188 LYS~? 10.77 C20 C8E A 210 coo 49.99 26.05 6.28 51.46 26.87 8.49 61.29 -71.83 -24.77 63.18 -73.65 -25.72 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo 60.53 31.67 0.97 57.79 27.51 3.63 68.32 -80.18 -18.11 71.95 -84.24 -15.84 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 B 177 PHE A 189 PHE~? 8.72 CA CA A 208 B 263 ASP A 45 ASP.? -2.96 CA CA A 208s B 292 LYS A 63 LYS~? 3.96 CA CA A 208 coo 49.99 26.05 6.28 51.46 26.87 8.49 68.20 -82.10 -23.88 68.92 -82.62 -26.53 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo 60.53 31.67 0.97 57.79 27.51 3.63 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 B 177 PHE A 189 PHE~? 8.72 CA CA A 208 B 263 ASP A 52 ASP.? 15.11 CA CA A 208 B 292 LYS A 63 LYS~? 3.96 CA CA A 208 coo 49.99 26.05 6.28 51.46 26.87 8.49 68.20 -82.10 -23.88 68.92 -82.62 -26.53 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo 60.53 31.67 0.97 57.79 27.51 3.63 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 B 177 PHE B 105 PHE^? 5.21 C20 C8E B 209 B 263 ASP B 45 ASP.? -3.07 CA CA B 208s B 292 LYS B 188 LYS~? 9.67 C16 C8E B 210 coo 49.99 26.05 6.28 51.46 26.87 8.49 90.70 -25.26 -25.77 91.65 -25.28 -23.14 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo 60.53 31.67 0.97 57.79 27.51 3.63 102.16 -28.74 -21.10 106.15 -31.37 -17.86 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 B 177 PHE B 189 PHE~? 8.56 CA CA B 208 B 263 ASP B 45 ASP.? -3.07 CA CA B 208s B 292 LYS B 63 LYS~? 3.79 CA CA B 208 coo 49.99 26.05 6.28 51.46 26.87 8.49 99.55 -24.92 -16.99 98.05 -23.95 -14.81 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo 60.53 31.67 0.97 57.79 27.51 3.63 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 6 3 # 6 B 177 PHE C 105 PHE^? -4.13 O21 C8E C 210s B 263 ASP C 45 ASP.? 3.27 CA CA C 208s B 292 LYS C 188 LYS~? 9.02 C16 C8E C 209 coo 49.99 26.05 6.28 51.46 26.87 8.49 37.70 -47.93 -11.88 35.28 -47.45 -10.64 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo 60.53 31.67 0.97 57.79 27.51 3.63 31.07 -55.82 -4.30 26.58 -58.21 -2.57 2oat_c04 source 2oat ORNITHINE AMINOTRANSFERASE : 6 hits 2oat_c04 naa= 3 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 C 177 PHE A 105 PHE^? 4.85 O21 C8E A 209 C 263 ASP A 45 ASP.? -2.96 CA CA A 208s C 292 LYS A 188 LYS~? 10.77 C20 C8E A 210 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 61.29 -71.83 -24.77 63.18 -73.65 -25.72 coo 19.84 12.02 9.33 18.68 11.23 7.75 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo 12.82 3.49 4.98 17.80 5.59 1.90 68.32 -80.18 -18.11 71.95 -84.24 -15.84 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 C 177 PHE A 189 PHE~? 8.72 CA CA A 208 C 263 ASP A 45 ASP.? -2.96 CA CA A 208s C 292 LYS A 63 LYS~? 3.96 CA CA A 208 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 68.20 -82.10 -23.88 68.92 -82.62 -26.53 coo 19.84 12.02 9.33 18.68 11.23 7.75 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo 12.82 3.49 4.98 17.80 5.59 1.90 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 C 177 PHE A 189 PHE~? 8.72 CA CA A 208 C 263 ASP A 52 ASP.? 15.11 CA CA A 208 C 292 LYS A 63 LYS~? 3.96 CA CA A 208 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 68.20 -82.10 -23.88 68.92 -82.62 -26.53 coo 19.84 12.02 9.33 18.68 11.23 7.75 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo 12.82 3.49 4.98 17.80 5.59 1.90 73.63 -82.49 -34.44 73.43 -77.00 -32.37 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 C 177 PHE B 105 PHE^? 5.21 C20 C8E B 209 C 263 ASP B 45 ASP.? -3.07 CA CA B 208s C 292 LYS B 188 LYS~? 9.67 C16 C8E B 210 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 90.70 -25.26 -25.77 91.65 -25.28 -23.14 coo 19.84 12.02 9.33 18.68 11.23 7.75 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo 12.82 3.49 4.98 17.80 5.59 1.90 102.16 -28.74 -21.10 106.15 -31.37 -17.86 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 C 177 PHE B 189 PHE~? 8.56 CA CA B 208 C 263 ASP B 45 ASP.? -3.07 CA CA B 208s C 292 LYS B 63 LYS~? 3.79 CA CA B 208 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 99.55 -24.92 -16.99 98.05 -23.95 -14.81 coo 19.84 12.02 9.33 18.68 11.23 7.75 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo 12.82 3.49 4.98 17.80 5.59 1.90 93.18 -23.71 -7.17 90.77 -27.85 -10.83 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 6 3 # 6 C 177 PHE C 105 PHE^? -4.13 O21 C8E C 210s C 263 ASP C 45 ASP.? 3.27 CA CA C 208s C 292 LYS C 188 LYS~? 9.02 C16 C8E C 209 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 37.70 -47.93 -11.88 35.28 -47.45 -10.64 coo 19.84 12.02 9.33 18.68 11.23 7.75 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo 12.82 3.49 4.98 17.80 5.59 1.90 31.07 -55.82 -4.30 26.58 -58.21 -2.57 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 7 3 # 7 C 177 PHE C 189 PHE~? 9.03 CA CA C 208 C 263 ASP C 45 ASP.? 3.27 CA CA C 208s C 292 LYS C 63 LYS~? 4.21 CA CA C 208 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 29.10 -50.14 -3.03 27.67 -47.71 -3.13 coo 19.84 12.02 9.33 18.68 11.23 7.75 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo 12.82 3.49 4.98 17.80 5.59 1.90 20.98 -41.61 -5.49 23.04 -43.67 -10.44 2oat_c05 source 2oat ORNITHINE AMINOTRANSFERASE : 7 hits 2oat_c05 naa= 3 ULMN 3 2phk_c02 MC-PEPTIDE user 1 3 # 1 A 149 ASP A 48 ASP.? 7.38 CA CA A 208 A 151 LYS A 188 LYS~? 10.77 C20 C8E A 210 A 186 THR A 191 THR.? -4.98 C19 C8E A 209s coo 41.42 17.90 44.98 43.39 18.36 45.61 72.05 -78.20 -23.17 73.82 -77.79 -22.11 coo 45.75 16.58 39.61 47.43 18.26 45.54 68.32 -80.18 -18.11 71.95 -84.24 -15.84 coo 45.88 23.02 44.72 46.99 21.16 44.68 67.24 -74.39 -22.77 69.05 -73.78 -23.78 ULMN 3 2phk_c02 MC-PEPTIDE user 2 3 # 2 A 149 ASP A 49 ASP.? -3.00 CA CA A 208s A 151 LYS A 63 LYS~? 3.96 CA CA A 208 A 186 THR A 58 THR~? 10.52 CA CA A 208 coo 41.42 17.90 44.98 43.39 18.36 45.61 75.72 -77.89 -27.98 74.67 -77.10 -29.65 coo 45.75 16.58 39.61 47.43 18.26 45.54 73.63 -82.49 -34.44 73.43 -77.00 -32.37 coo 45.88 23.02 44.72 46.99 21.16 44.68 76.40 -85.04 -26.81 78.11 -83.80 -26.40 ULMN 3 2phk_c02 MC-PEPTIDE user 3 3 # 3 A 149 ASP A 166 ASP.? 23.45 CA CA A 208 A 151 LYS A 119 LYS.? 17.79 CA CA A 208 A 186 THR A 117 THR.? 21.33 CA CA A 208 coo 41.42 17.90 44.98 43.39 18.36 45.61 55.95 -88.25 -40.15 55.99 -89.39 -38.36 coo 45.75 16.58 39.61 47.43 18.26 45.54 60.88 -84.29 -40.26 61.29 -87.76 -35.50 coo 45.88 23.02 44.72 46.99 21.16 44.68 63.40 -90.39 -40.90 61.71 -90.63 -39.48 ULMN 3 2phk_c02 MC-PEPTIDE user 4 3 # 4 A 149 ASP A 167 ASP.? 22.50 CA CA A 208 A 151 LYS A 119 LYS.? 17.79 CA CA A 208 A 186 THR A 117 THR.? 21.33 CA CA A 208 coo 41.42 17.90 44.98 43.39 18.36 45.61 58.25 -87.45 -44.58 60.23 -87.13 -43.88 coo 45.75 16.58 39.61 47.43 18.26 45.54 60.88 -84.29 -40.26 61.29 -87.76 -35.50 coo 45.88 23.02 44.72 46.99 21.16 44.68 63.40 -90.39 -40.90 61.71 -90.63 -39.48 ULMN 3 2phk_c02 MC-PEPTIDE user 5 3 # 5 A 149 ASP B 48 ASP.? 7.20 CA CA B 208 A 151 LYS B 188 LYS~? 9.67 C16 C8E B 210 A 186 THR B 191 THR.? -5.05 O18 C8E B 209s coo 41.42 17.90 44.98 43.39 18.36 45.61 97.60 -30.12 -16.68 98.20 -32.01 -15.99 coo 45.75 16.58 39.61 47.43 18.26 45.54 102.16 -28.74 -21.10 106.15 -31.37 -17.86 coo 45.88 23.02 44.72 46.99 21.16 44.68 94.88 -29.06 -21.80 94.27 -29.66 -19.85 ULMN 3 2phk_c02 MC-PEPTIDE user 6 3 # 6 A 149 ASP B 49 ASP.? -3.05 CA CA B 208s A 151 LYS B 63 LYS~? 3.79 CA CA B 208 A 186 THR B 58 THR~? 10.41 CA CA B 208 coo 41.42 17.90 44.98 43.39 18.36 45.61 94.52 -28.97 -11.62 93.03 -30.41 -11.73 coo 45.75 16.58 39.61 47.43 18.26 45.54 93.18 -23.71 -7.17 90.77 -27.85 -10.83 coo 45.88 23.02 44.72 46.99 21.16 44.68 100.65 -27.90 -8.43 100.12 -29.92 -7.97 ULMN 3 2phk_c02 MC-PEPTIDE user 7 3 # 7 A 149 ASP B 166 ASP.? 24.17 CA CA B 208 A 151 LYS B 119 LYS.? 18.40 CA CA B 208 A 186 THR B 117 THR.? 21.30 CA CA B 208 coo 41.42 17.90 44.98 43.39 18.36 45.61 91.14 -5.33 -14.11 93.17 -5.00 -14.63 coo 45.75 16.58 39.61 47.43 18.26 45.54 89.22 -11.21 -11.71 95.34 -11.17 -12.31 coo 45.88 23.02 44.72 46.99 21.16 44.68 93.17 -9.31 -6.81 94.03 -8.66 -8.75 ULMN 3 2phk_c02 MC-PEPTIDE user 8 3 # 8 A 149 ASP B 167 ASP.? 22.72 CA CA B 208 A 151 LYS B 119 LYS.? 18.40 CA CA B 208 A 186 THR B 117 THR.? 21.30 CA CA B 208 coo 41.42 17.90 44.98 43.39 18.36 45.61 88.92 -5.85 -9.56 88.92 -7.42 -8.19 coo 45.75 16.58 39.61 47.43 18.26 45.54 89.22 -11.21 -11.71 95.34 -11.17 -12.31 coo 45.88 23.02 44.72 46.99 21.16 44.68 93.17 -9.31 -6.81 94.03 -8.66 -8.75 ULMN 3 2phk_c02 MC-PEPTIDE user 9 3 # 9 A 149 ASP C 48 ASP.? 7.17 CA CA C 208 A 151 LYS C 188 LYS~? 9.02 C16 C8E C 209 A 186 THR C 191 THR.? 5.18 C20 C8E C 209s coo 41.42 17.90 44.98 43.39 18.36 45.61 26.68 -52.06 -7.74 25.46 -53.53 -8.54 coo 45.75 16.58 39.61 47.43 18.26 45.54 31.07 -55.82 -4.30 26.58 -58.21 -2.57 coo 45.88 23.02 44.72 46.99 21.16 44.68 32.16 -51.72 -10.15 30.14 -51.15 -10.71 ULMN 3 2phk_c02 MC-PEPTIDE user 10 3 # 10 A 149 ASP C 49 ASP.? -2.87 CA CA C 208s A 151 LYS C 63 LYS~? 4.21 CA CA C 208 A 186 THR C 58 THR~? 10.65 CA CA C 208 coo 41.42 17.90 44.98 43.39 18.36 45.61 22.13 -48.50 -9.42 23.00 -46.66 -10.00 coo 45.75 16.58 39.61 47.43 18.26 45.54 20.98 -41.61 -5.49 23.04 -43.67 -10.44 coo 45.88 23.02 44.72 46.99 21.16 44.68 19.91 -49.60 -2.59 18.80 -50.74 -4.02 2phk_c02 source 2phk MC-PEPTIDE : 10 hits 2phk_c02 naa= 3 ULMN 3 2phk_c03 MC-PEPTIDE user 1 3 # 1 A 149 ASP A 166 ASP.? 23.45 CA CA A 208 A 151 LYS A 171 LYS^? 22.02 O21 C8E A 209 A 154 ASN A 170 ASN.? 28.35 CA CA A 208 coo 41.42 17.90 44.98 43.39 18.36 45.61 55.95 -88.25 -40.15 55.99 -89.39 -38.36 coo 45.75 16.58 39.61 47.43 18.26 45.54 51.77 -85.30 -36.11 51.41 -79.16 -37.75 coo 44.77 13.10 43.25 45.01 14.21 45.03 51.62 -88.52 -39.42 50.91 -89.41 -41.21 ULMN 3 2phk_c03 MC-PEPTIDE user 2 3 # 2 A 149 ASP A 185 ASP~? 11.73 O21 C8E A 210 A 151 LYS A 188 LYS~? 10.77 C20 C8E A 210 A 154 ASN A 187 ASN~? -3.11 O18 C8E A 210s coo 41.42 17.90 44.98 43.39 18.36 45.61 65.81 -86.27 -18.22 66.54 -87.64 -16.78 coo 45.75 16.58 39.61 47.43 18.26 45.54 68.32 -80.18 -18.11 71.95 -84.24 -15.84 coo 44.77 13.10 43.25 45.01 14.21 45.03 63.91 -79.43 -16.81 63.89 -77.36 -16.28 ULMN 3 2phk_c03 MC-PEPTIDE user 3 3 # 3 A 149 ASP B 185 ASP~? 11.63 O21 C8E B 210 A 151 LYS B 188 LYS~? 9.67 C16 C8E B 210 A 154 ASN B 187 ASN~? -3.44 O21 C8E B 210s coo 41.42 17.90 44.98 43.39 18.36 45.61 106.30 -23.80 -20.43 108.26 -24.54 -20.08 coo 45.75 16.58 39.61 47.43 18.26 45.54 102.16 -28.74 -21.10 106.15 -31.37 -17.86 coo 44.77 13.10 43.25 45.01 14.21 45.03 101.97 -26.81 -25.28 100.76 -28.02 -26.55 ULMN 3 2phk_c03 MC-PEPTIDE user 4 3 # 4 A 149 ASP C 185 ASP~? 11.81 O21 C8E C 209 A 151 LYS C 188 LYS~? 9.02 C16 C8E C 209 A 154 ASN C 187 ASN~? -2.70 C14 C8E C 209s coo 41.42 17.90 44.98 43.39 18.36 45.61 31.89 -54.53 1.93 31.11 -55.91 3.29 coo 45.75 16.58 39.61 47.43 18.26 45.54 31.07 -55.82 -4.30 26.58 -58.21 -2.57 coo 44.77 13.10 43.25 45.01 14.21 45.03 35.59 -56.00 -3.84 36.37 -56.79 -5.68 2phk_c03 source 2phk MC-PEPTIDE : 4 hits 2phk_c03 naa= 3 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 1 3 # 1 141 ASP A 26 ASP.? 24.86 C2 C8E C 209 166 GLY C 38 GLY^? 17.56 C19 C8E C 210 169 GLU C 7 GLU^? 20.56 C16 C8E C 210 coo 8.28 6.87 1.62 10.08 5.77 1.34 53.70 -37.11 -16.05 55.72 -36.42 -15.97 coo -8.58 13.22 3.21 -8.90 13.15 4.05 47.08 -49.08 -27.59 47.53 -49.11 -26.94 coo -16.67 7.89 2.78 -17.65 6.56 1.49 43.33 -49.69 -35.12 43.56 -51.77 -34.52 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 2 3 # 2 141 ASP A 26 ASP.? 24.86 C2 C8E C 209 166 GLY C 40 GLY^? 12.46 C19 C8E C 210 169 GLU C 7 GLU^? 20.56 C16 C8E C 210 coo 8.28 6.87 1.62 10.08 5.77 1.34 53.70 -37.11 -16.05 55.72 -36.42 -15.97 coo -8.58 13.22 3.21 -8.90 13.15 4.05 41.84 -46.53 -24.70 42.24 -46.19 -24.08 coo -16.67 7.89 2.78 -17.65 6.56 1.49 43.33 -49.69 -35.12 43.56 -51.77 -34.52 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 3 3 # 3 141 ASP A 45 ASP.? -2.96 CA CA A 208s 166 GLY A 18 GLY^? 13.28 O18 C8E A 209 169 GLU A 7 GLU^? 19.52 C17 C8E A 209 coo 8.28 6.87 1.62 10.08 5.77 1.34 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo -8.58 13.22 3.21 -8.90 13.15 4.05 64.23 -56.43 -29.63 63.79 -57.08 -29.36 coo -16.67 7.89 2.78 -17.65 6.56 1.49 61.29 -47.52 -25.12 61.48 -48.69 -23.33 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 4 3 # 4 141 ASP A 45 ASP.? -2.96 CA CA A 208s 166 GLY A 40 GLY^? 12.19 O21 C8E A 209 169 GLU A 7 GLU^? 19.52 C17 C8E A 209 coo 8.28 6.87 1.62 10.08 5.77 1.34 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo -8.58 13.22 3.21 -8.90 13.15 4.05 59.98 -58.78 -26.79 59.34 -59.26 -26.97 coo -16.67 7.89 2.78 -17.65 6.56 1.49 61.29 -47.52 -25.12 61.48 -48.69 -23.33 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 5 3 # 5 141 ASP A 45 ASP.? -2.96 CA CA A 208s 166 GLY A 66 GLY~? 14.40 CA CA A 208 169 GLU A 113 GLU.? 20.24 CA CA A 208 coo 8.28 6.87 1.62 10.08 5.77 1.34 70.45 -71.75 -27.39 71.06 -73.65 -26.89 coo -8.58 13.22 3.21 -8.90 13.15 4.05 72.89 -85.69 -39.00 73.32 -85.02 -38.92 coo -16.67 7.89 2.78 -17.65 6.56 1.49 67.94 -85.82 -46.11 66.40 -86.46 -44.83 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 6 3 # 6 141 ASP A 48 ASP.? 7.38 CA CA A 208 166 GLY A 66 GLY~? 14.40 CA CA A 208 169 GLU A 113 GLU.? 20.24 CA CA A 208 coo 8.28 6.87 1.62 10.08 5.77 1.34 72.05 -78.20 -23.17 73.82 -77.79 -22.11 coo -8.58 13.22 3.21 -8.90 13.15 4.05 72.89 -85.69 -39.00 73.32 -85.02 -38.92 coo -16.67 7.89 2.78 -17.65 6.56 1.49 67.94 -85.82 -46.11 66.40 -86.46 -44.83 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 7 3 # 7 141 ASP A 52 ASP.? 15.11 CA CA A 208 166 GLY A 66 GLY~? 14.40 CA CA A 208 169 GLU A 113 GLU.? 20.24 CA CA A 208 coo 8.28 6.87 1.62 10.08 5.77 1.34 76.18 -86.89 -22.52 75.57 -87.62 -20.65 coo -8.58 13.22 3.21 -8.90 13.15 4.05 72.89 -85.69 -39.00 73.32 -85.02 -38.92 coo -16.67 7.89 2.78 -17.65 6.56 1.49 67.94 -85.82 -46.11 66.40 -86.46 -44.83 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 8 3 # 8 141 ASP A 80 ASP^? 12.60 C1 C8E A 210 166 GLY C 38 GLY^? 17.56 C19 C8E C 210 169 GLU C 7 GLU^? 20.56 C16 C8E C 210 coo 8.28 6.87 1.62 10.08 5.77 1.34 58.12 -52.30 -15.93 59.10 -53.68 -17.13 coo -8.58 13.22 3.21 -8.90 13.15 4.05 47.08 -49.08 -27.59 47.53 -49.11 -26.94 coo -16.67 7.89 2.78 -17.65 6.56 1.49 43.33 -49.69 -35.12 43.56 -51.77 -34.52 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 9 3 # 9 141 ASP A 80 ASP^? 12.60 C1 C8E A 210 166 GLY C 40 GLY^? 12.46 C19 C8E C 210 169 GLU C 7 GLU^? 20.56 C16 C8E C 210 coo 8.28 6.87 1.62 10.08 5.77 1.34 58.12 -52.30 -15.93 59.10 -53.68 -17.13 coo -8.58 13.22 3.21 -8.90 13.15 4.05 41.84 -46.53 -24.70 42.24 -46.19 -24.08 coo -16.67 7.89 2.78 -17.65 6.56 1.49 43.33 -49.69 -35.12 43.56 -51.77 -34.52 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 10 3 # 10 141 ASP A 149 ASP^? 14.85 C1 C8E A 210 166 GLY B 148 GLY^? 19.08 O15 C8E B 209 169 GLU B 93 GLU^? 27.23 O15 C8E B 209 coo 8.28 6.87 1.62 10.08 5.77 1.34 66.40 -51.17 -20.74 65.06 -51.90 -19.38 coo -8.58 13.22 3.21 -8.90 13.15 4.05 76.61 -45.51 -32.17 76.71 -45.21 -33.00 coo -16.67 7.89 2.78 -17.65 6.56 1.49 75.25 -49.35 -42.08 74.13 -47.63 -42.56 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 11 3 # 11 141 ASP A 185 ASP~? 11.73 O21 C8E A 210 166 GLY A 60 GLY~? 6.96 CA CA A 208 169 GLU A 64 GLU~? 12.36 CA CA A 208 coo 8.28 6.87 1.62 10.08 5.77 1.34 65.81 -86.27 -18.22 66.54 -87.64 -16.78 coo -8.58 13.22 3.21 -8.90 13.15 4.05 76.07 -81.13 -30.14 75.99 -81.96 -30.16 coo -16.67 7.89 2.78 -17.65 6.56 1.49 79.25 -82.11 -37.14 78.75 -80.37 -38.23 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 12 3 # 12 141 ASP B 45 ASP.? -3.07 CA CA B 208s 166 GLY B 18 GLY^? 13.41 C16 C8E B 209 169 GLU B 7 GLU^? 19.70 O15 C8E B 209 coo 8.28 6.87 1.62 10.08 5.77 1.34 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo -8.58 13.22 3.21 -8.90 13.15 4.05 77.02 -34.15 -27.57 77.48 -33.52 -27.66 coo -16.67 7.89 2.78 -17.65 6.56 1.49 73.39 -38.66 -35.65 75.17 -39.55 -36.49 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 13 3 # 13 141 ASP B 45 ASP.? -3.07 CA CA B 208s 166 GLY B 40 GLY^? 12.62 C20 C8E B 209 169 GLU B 7 GLU^? 19.70 O15 C8E B 209 coo 8.28 6.87 1.62 10.08 5.77 1.34 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo -8.58 13.22 3.21 -8.90 13.15 4.05 79.65 -30.64 -31.14 79.77 -29.85 -31.21 coo -16.67 7.89 2.78 -17.65 6.56 1.49 73.39 -38.66 -35.65 75.17 -39.55 -36.49 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 14 3 # 14 141 ASP B 45 ASP.? -3.07 CA CA B 208s 166 GLY B 66 GLY~? 14.07 CA CA B 208 169 GLU B 113 GLU.? 20.51 CA CA B 208 coo 8.28 6.87 1.62 10.08 5.77 1.34 90.60 -30.65 -18.50 91.26 -30.99 -16.60 coo -8.58 13.22 3.21 -8.90 13.15 4.05 92.54 -19.82 -3.71 92.06 -20.48 -3.56 coo -16.67 7.89 2.78 -17.65 6.56 1.49 86.78 -12.34 -3.10 88.60 -11.66 -4.00 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 15 3 # 15 141 ASP B 48 ASP.? 7.20 CA CA B 208 166 GLY B 66 GLY~? 14.07 CA CA B 208 169 GLU B 113 GLU.? 20.51 CA CA B 208 coo 8.28 6.87 1.62 10.08 5.77 1.34 97.60 -30.12 -16.68 98.20 -32.01 -15.99 coo -8.58 13.22 3.21 -8.90 13.15 4.05 92.54 -19.82 -3.71 92.06 -20.48 -3.56 coo -16.67 7.89 2.78 -17.65 6.56 1.49 86.78 -12.34 -3.10 88.60 -11.66 -4.00 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 16 3 # 16 141 ASP B 52 ASP.? 15.59 CA CA B 208 166 GLY B 66 GLY~? 14.07 CA CA B 208 169 GLU B 113 GLU.? 20.51 CA CA B 208 coo 8.28 6.87 1.62 10.08 5.77 1.34 105.61 -28.95 -11.53 106.78 -28.70 -9.81 coo -8.58 13.22 3.21 -8.90 13.15 4.05 92.54 -19.82 -3.71 92.06 -20.48 -3.56 coo -16.67 7.89 2.78 -17.65 6.56 1.49 86.78 -12.34 -3.10 88.60 -11.66 -4.00 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 17 3 # 17 141 ASP B 149 ASP^? 14.91 O15 C8E B 209 166 GLY A 148 GLY^? 17.63 C1 C8E A 209 169 GLU A 93 GLU^? 23.51 C1 C8E A 210 coo 8.28 6.87 1.62 10.08 5.77 1.34 79.48 -42.39 -33.32 81.04 -41.48 -34.38 coo -8.58 13.22 3.21 -8.90 13.15 4.05 69.03 -47.69 -21.86 68.24 -47.54 -21.53 coo -16.67 7.89 2.78 -17.65 6.56 1.49 64.33 -40.66 -16.04 62.38 -40.13 -16.70 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 18 3 # 18 141 ASP C 45 ASP.? 3.27 CA CA C 208s 166 GLY C 18 GLY^? 13.60 C19 C8E C 210 169 GLU C 7 GLU^? 20.56 C16 C8E C 210 coo 8.28 6.87 1.62 10.08 5.77 1.34 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo -8.58 13.22 3.21 -8.90 13.15 4.05 37.51 -45.80 -28.16 37.81 -45.75 -27.39 coo -16.67 7.89 2.78 -17.65 6.56 1.49 43.33 -49.69 -35.12 43.56 -51.77 -34.52 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 19 3 # 19 141 ASP C 45 ASP.? 3.27 CA CA C 208s 166 GLY C 40 GLY^? 12.46 C19 C8E C 210 169 GLU C 7 GLU^? 20.56 C16 C8E C 210 coo 8.28 6.87 1.62 10.08 5.77 1.34 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo -8.58 13.22 3.21 -8.90 13.15 4.05 41.84 -46.53 -24.70 42.24 -46.19 -24.08 coo -16.67 7.89 2.78 -17.65 6.56 1.49 43.33 -49.69 -35.12 43.56 -51.77 -34.52 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 20 3 # 20 141 ASP C 45 ASP.? 3.27 CA CA C 208s 166 GLY C 66 GLY.? 14.13 CA CA C 208 169 GLU C 113 GLU.? 20.72 CA CA C 208 coo 8.28 6.87 1.62 10.08 5.77 1.34 28.98 -48.61 -14.39 27.54 -48.99 -12.93 coo -8.58 13.22 3.21 -8.90 13.15 4.05 19.82 -36.88 -3.28 19.56 -37.04 -4.05 coo -16.67 7.89 2.78 -17.65 6.56 1.49 22.93 -28.02 -2.65 24.78 -28.62 -1.78 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 21 3 # 21 141 ASP C 48 ASP.? 7.17 CA CA C 208 166 GLY C 66 GLY.? 14.13 CA CA C 208 169 GLU C 113 GLU.? 20.72 CA CA C 208 coo 8.28 6.87 1.62 10.08 5.77 1.34 26.68 -52.06 -7.74 25.46 -53.53 -8.54 coo -8.58 13.22 3.21 -8.90 13.15 4.05 19.82 -36.88 -3.28 19.56 -37.04 -4.05 coo -16.67 7.89 2.78 -17.65 6.56 1.49 22.93 -28.02 -2.65 24.78 -28.62 -1.78 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 22 3 # 22 141 ASP C 52 ASP.? 15.77 CA CA C 208 166 GLY C 66 GLY.? 14.13 CA CA C 208 169 GLU C 113 GLU.? 20.72 CA CA C 208 coo 8.28 6.87 1.62 10.08 5.77 1.34 21.29 -54.58 -0.38 20.26 -54.47 1.43 coo -8.58 13.22 3.21 -8.90 13.15 4.05 19.82 -36.88 -3.28 19.56 -37.04 -4.05 coo -16.67 7.89 2.78 -17.65 6.56 1.49 22.93 -28.02 -2.65 24.78 -28.62 -1.78 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 23 3 # 23 141 ASP C 149 ASP^? 16.02 C16 C8E C 210 166 GLY A 38 GLY^? 17.41 C17 C8E A 209 169 GLU A 7 GLU^? 19.52 C17 C8E A 209 coo 8.28 6.87 1.62 10.08 5.77 1.34 38.72 -55.19 -32.44 40.02 -55.93 -30.97 coo -8.58 13.22 3.21 -8.90 13.15 4.05 56.17 -54.24 -23.69 55.70 -54.84 -23.39 coo -16.67 7.89 2.78 -17.65 6.56 1.49 61.29 -47.52 -25.12 61.48 -48.69 -23.33 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 24 3 # 24 141 ASP C 153 ASP^? 9.83 C13 C8E C 210 166 GLY A 38 GLY^? 17.41 C17 C8E A 209 169 GLU A 7 GLU^? 19.52 C17 C8E A 209 coo 8.28 6.87 1.62 10.08 5.77 1.34 40.09 -57.62 -20.90 41.26 -57.13 -22.61 coo -8.58 13.22 3.21 -8.90 13.15 4.05 56.17 -54.24 -23.69 55.70 -54.84 -23.39 coo -16.67 7.89 2.78 -17.65 6.56 1.49 61.29 -47.52 -25.12 61.48 -48.69 -23.33 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 25 3 # 25 141 ASP C 166 ASP.? 24.81 CA CA C 208 166 GLY C 66 GLY.? 14.13 CA CA C 208 169 GLU C 64 GLU~? 12.03 CA CA C 208 coo 8.28 6.87 1.62 10.08 5.77 1.34 35.75 -30.25 2.83 35.54 -31.07 4.76 coo -8.58 13.22 3.21 -8.90 13.15 4.05 19.82 -36.88 -3.28 19.56 -37.04 -4.05 coo -16.67 7.89 2.78 -17.65 6.56 1.49 16.47 -41.84 -8.31 14.60 -42.35 -9.15 2tdt_c00 source 2tdt TETRAHYDRODIPICOLINATE N-SUCCINYLTRANSFERASE : 25 hits 2tdt_c00 naa= 3 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 1 3 # 1 A 122 TYR A 51 TYR.? 9.92 O21 C8E A 210 A 214 ASP A 49 ASP.? -3.00 CA CA A 208s A 256 LYS A 67 LYS~? 13.30 CA CA A 208 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 71.70 -83.21 -22.40 69.97 -85.02 -21.17 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 75.72 -77.89 -27.98 74.67 -77.10 -29.65 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 73.21 -82.07 -40.14 71.59 -78.49 -41.85 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 2 3 # 2 A 122 TYR A 83 TYR^? -19.24 C2 C8E C 209s A 214 ASP A 80 ASP^? 12.60 C1 C8E A 210 A 256 LYS A 198 LYS^? 12.09 C1 C8E A 210 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 59.25 -44.27 -7.74 58.41 -42.23 -6.03 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 58.12 -52.30 -15.93 59.10 -53.68 -17.13 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 68.28 -58.05 -20.21 63.11 -55.44 -18.88 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 3 3 # 3 A 122 TYR B 51 TYR.? 9.95 O21 C8E B 210 A 214 ASP B 49 ASP.? -3.05 CA CA B 208s A 256 LYS B 67 LYS~? 18.13 CA CA B 208 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 102.03 -27.53 -15.19 104.12 -26.16 -16.40 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 94.52 -28.97 -11.62 93.03 -30.41 -11.73 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 89.12 -21.41 -4.23 87.66 -21.56 1.71 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 4 3 # 4 A 122 TYR B 83 TYR^? 23.90 C1 C8E B 209 A 214 ASP B 80 ASP^? 15.94 O15 C8E B 209 A 256 LYS B 198 LYS^? 12.15 O15 C8E B 209 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 84.86 -45.84 -46.52 87.07 -46.60 -44.97 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 82.56 -37.87 -41.00 82.97 -37.16 -39.06 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 85.01 -40.11 -29.09 83.85 -38.63 -34.53 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 5 3 # 5 A 122 TYR C 51 TYR.? 10.04 O21 C8E C 209 A 214 ASP C 49 ASP.? -2.87 CA CA C 208s A 256 LYS C 67 LYS.? 18.71 CA CA C 208 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 26.09 -52.62 -2.60 27.54 -53.38 -0.32 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 22.13 -48.50 -9.42 23.00 -46.66 -10.00 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 20.04 -36.06 -6.98 16.11 -31.17 -7.78 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 6 3 # 6 A 122 TYR C 51 TYR.? 10.04 O21 C8E C 209 A 214 ASP C 61 ASP~? 12.61 CA CA C 208 A 256 LYS C 67 LYS.? 18.71 CA CA C 208 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 26.09 -52.62 -2.60 27.54 -53.38 -0.32 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 16.71 -46.53 -3.05 15.59 -48.22 -3.69 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 20.04 -36.06 -6.98 16.11 -31.17 -7.78 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 7 3 # 7 A 122 TYR C 83 TYR^? 19.88 O21 C8E A 209 A 214 ASP C 80 ASP^? 16.43 C13 C8E C 210 A 256 LYS C 198 LYS^? 12.94 C13 C8E C 210 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 49.20 -66.70 -34.88 49.82 -68.82 -36.60 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 47.10 -57.14 -28.79 45.64 -55.94 -27.77 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 35.43 -55.44 -26.10 41.10 -55.85 -26.89 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 8 3 # 8 A 122 TYR C 102 TYR^? 9.73 C2 C8E C 209 A 214 ASP A 80 ASP^? 12.60 C1 C8E A 210 A 256 LYS A 198 LYS^? 12.09 C1 C8E A 210 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 48.50 -51.08 -15.65 48.91 -50.66 -12.96 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 58.12 -52.30 -15.93 59.10 -53.68 -17.13 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 68.28 -58.05 -20.21 63.11 -55.44 -18.88 2tpl_c04 source 2tpl TYROSINE PHENOL-LYASE : 8 hits 2tpl_c04 naa= 3 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 1 3 # 1 B 122 TYR A 51 TYR.? 9.92 O21 C8E A 210 B 214 ASP A 49 ASP.? -3.00 CA CA A 208s B 256 LYS A 67 LYS~? 13.30 CA CA A 208 coo -32.67 22.74 10.17 -32.85 23.98 7.70 71.70 -83.21 -22.40 69.97 -85.02 -21.17 coo -26.88 17.61 16.89 -26.08 17.11 15.00 75.72 -77.89 -27.98 74.67 -77.10 -29.65 coo -16.04 12.06 11.09 -17.97 10.54 5.71 73.21 -82.07 -40.14 71.59 -78.49 -41.85 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 2 3 # 2 B 122 TYR A 83 TYR^? -19.24 C2 C8E C 209s B 214 ASP A 80 ASP^? 12.60 C1 C8E A 210 B 256 LYS A 198 LYS^? 12.09 C1 C8E A 210 coo -32.67 22.74 10.17 -32.85 23.98 7.70 59.25 -44.27 -7.74 58.41 -42.23 -6.03 coo -26.88 17.61 16.89 -26.08 17.11 15.00 58.12 -52.30 -15.93 59.10 -53.68 -17.13 coo -16.04 12.06 11.09 -17.97 10.54 5.71 68.28 -58.05 -20.21 63.11 -55.44 -18.88 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 3 3 # 3 B 122 TYR B 51 TYR.? 9.95 O21 C8E B 210 B 214 ASP B 49 ASP.? -3.05 CA CA B 208s B 256 LYS B 67 LYS~? 18.13 CA CA B 208 coo -32.67 22.74 10.17 -32.85 23.98 7.70 102.03 -27.53 -15.19 104.12 -26.16 -16.40 coo -26.88 17.61 16.89 -26.08 17.11 15.00 94.52 -28.97 -11.62 93.03 -30.41 -11.73 coo -16.04 12.06 11.09 -17.97 10.54 5.71 89.12 -21.41 -4.23 87.66 -21.56 1.71 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 4 3 # 4 B 122 TYR B 83 TYR^? 23.90 C1 C8E B 209 B 214 ASP B 80 ASP^? 15.94 O15 C8E B 209 B 256 LYS B 198 LYS^? 12.15 O15 C8E B 209 coo -32.67 22.74 10.17 -32.85 23.98 7.70 84.86 -45.84 -46.52 87.07 -46.60 -44.97 coo -26.88 17.61 16.89 -26.08 17.11 15.00 82.56 -37.87 -41.00 82.97 -37.16 -39.06 coo -16.04 12.06 11.09 -17.97 10.54 5.71 85.01 -40.11 -29.09 83.85 -38.63 -34.53 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 5 3 # 5 B 122 TYR C 51 TYR.? 10.04 O21 C8E C 209 B 214 ASP C 49 ASP.? -2.87 CA CA C 208s B 256 LYS C 67 LYS.? 18.71 CA CA C 208 coo -32.67 22.74 10.17 -32.85 23.98 7.70 26.09 -52.62 -2.60 27.54 -53.38 -0.32 coo -26.88 17.61 16.89 -26.08 17.11 15.00 22.13 -48.50 -9.42 23.00 -46.66 -10.00 coo -16.04 12.06 11.09 -17.97 10.54 5.71 20.04 -36.06 -6.98 16.11 -31.17 -7.78 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 6 3 # 6 B 122 TYR C 51 TYR.? 10.04 O21 C8E C 209 B 214 ASP C 61 ASP~? 12.61 CA CA C 208 B 256 LYS C 67 LYS.? 18.71 CA CA C 208 coo -32.67 22.74 10.17 -32.85 23.98 7.70 26.09 -52.62 -2.60 27.54 -53.38 -0.32 coo -26.88 17.61 16.89 -26.08 17.11 15.00 16.71 -46.53 -3.05 15.59 -48.22 -3.69 coo -16.04 12.06 11.09 -17.97 10.54 5.71 20.04 -36.06 -6.98 16.11 -31.17 -7.78 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 7 3 # 7 B 122 TYR C 83 TYR^? 19.88 O21 C8E A 209 B 214 ASP C 80 ASP^? 16.43 C13 C8E C 210 B 256 LYS C 198 LYS^? 12.94 C13 C8E C 210 coo -32.67 22.74 10.17 -32.85 23.98 7.70 49.20 -66.70 -34.88 49.82 -68.82 -36.60 coo -26.88 17.61 16.89 -26.08 17.11 15.00 47.10 -57.14 -28.79 45.64 -55.94 -27.77 coo -16.04 12.06 11.09 -17.97 10.54 5.71 35.43 -55.44 -26.10 41.10 -55.85 -26.89 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 8 3 # 8 B 122 TYR C 102 TYR^? 9.73 C2 C8E C 209 B 214 ASP A 80 ASP^? 12.60 C1 C8E A 210 B 256 LYS A 198 LYS^? 12.09 C1 C8E A 210 coo -32.67 22.74 10.17 -32.85 23.98 7.70 48.50 -51.08 -15.65 48.91 -50.66 -12.96 coo -26.88 17.61 16.89 -26.08 17.11 15.00 58.12 -52.30 -15.93 59.10 -53.68 -17.13 coo -16.04 12.06 11.09 -17.97 10.54 5.71 68.28 -58.05 -20.21 63.11 -55.44 -18.88 2tpl_c05 source 2tpl TYROSINE PHENOL-LYASE : 8 hits 2tpl_c05 naa= 3 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 1 3 # 1 A 59 ARG A 200 ARG^? 11.17 C17 C8E A 209 A 130 SER A 78 SER^? 13.83 C1 C8E A 210 A 159 LYS A 198 LYS^? 12.09 C1 C8E A 210 coo 18.35 45.84 20.99 16.20 47.83 21.89 65.38 -54.68 -25.12 63.65 -56.91 -23.89 coo 15.14 43.67 10.77 15.61 44.43 13.04 55.97 -57.73 -19.67 57.70 -56.10 -19.98 coo 11.57 48.49 22.18 13.51 49.99 17.21 68.28 -58.05 -20.21 63.11 -55.44 -18.88 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 2 3 # 2 A 59 ARG B 200 ARG^? 11.34 O15 C8E B 209 A 130 SER B 78 SER^? 13.33 O15 C8E B 209 A 159 LYS B 198 LYS^? 12.15 O15 C8E B 209 coo 18.35 45.84 20.99 16.20 47.83 21.89 78.82 -37.69 -29.59 80.99 -36.13 -31.14 coo 15.14 43.67 10.77 15.61 44.43 13.04 83.33 -32.12 -37.91 83.81 -34.26 -36.79 coo 11.57 48.49 22.18 13.51 49.99 17.21 85.01 -40.11 -29.09 83.85 -38.63 -34.53 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 3 3 # 3 A 59 ARG C 200 ARG^? 12.04 C16 C8E C 210 A 130 SER C 78 SER^? 13.93 C13 C8E C 210 A 159 LYS C 198 LYS^? 12.94 C13 C8E C 210 coo 18.35 45.84 20.99 16.20 47.83 21.89 37.62 -50.12 -29.23 39.44 -51.00 -26.91 coo 15.14 43.67 10.77 15.61 44.43 13.04 46.95 -52.32 -23.90 45.02 -53.63 -24.63 coo 11.57 48.49 22.18 13.51 49.99 17.21 35.43 -55.44 -26.10 41.10 -55.85 -26.89 2tps_c00 source 2tps THIAMIN PHOSPHATE SYNTHASE : 3 hits 2tps_c00 naa= 3 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 1 3 # 1 B 59 ARG A 200 ARG^? 11.17 C17 C8E A 209 B 130 SER A 78 SER^? 13.83 C1 C8E A 210 B 159 LYS A 198 LYS^? 12.09 C1 C8E A 210 coo 58.72 31.58 20.45 60.80 29.39 20.94 65.38 -54.68 -25.12 63.65 -56.91 -23.89 coo 61.66 35.17 10.39 61.29 34.14 12.56 55.97 -57.73 -19.67 57.70 -56.10 -19.98 coo 65.38 28.77 21.17 63.49 28.03 16.12 68.28 -58.05 -20.21 63.11 -55.44 -18.88 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 2 3 # 2 B 59 ARG B 200 ARG^? 11.34 O15 C8E B 209 B 130 SER B 78 SER^? 13.33 O15 C8E B 209 B 159 LYS B 198 LYS^? 12.15 O15 C8E B 209 coo 58.72 31.58 20.45 60.80 29.39 20.94 78.82 -37.69 -29.59 80.99 -36.13 -31.14 coo 61.66 35.17 10.39 61.29 34.14 12.56 83.33 -32.12 -37.91 83.81 -34.26 -36.79 coo 65.38 28.77 21.17 63.49 28.03 16.12 85.01 -40.11 -29.09 83.85 -38.63 -34.53 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 3 3 # 3 B 59 ARG C 200 ARG^? 12.04 C16 C8E C 210 B 130 SER C 78 SER^? 13.93 C13 C8E C 210 B 159 LYS C 198 LYS^? 12.94 C13 C8E C 210 coo 58.72 31.58 20.45 60.80 29.39 20.94 37.62 -50.12 -29.23 39.44 -51.00 -26.91 coo 61.66 35.17 10.39 61.29 34.14 12.56 46.95 -52.32 -23.90 45.02 -53.63 -24.63 coo 65.38 28.77 21.17 63.49 28.03 16.12 35.43 -55.44 -26.10 41.10 -55.85 -26.89 2tps_c01 source 2tps THIAMIN PHOSPHATE SYNTHASE : 3 hits 2tps_c01 naa= 3 ULMN 3 1hkd_p00 PEA LECTIN ALPHA CHAIN user 1 3 # 1 A 81 ASP A 153 ASP^? 8.28 C1 C8E A 210 A 99 GLY A 129 GLY^? 7.87 C1 C8E A 210 A 125 ASN A 103 ASN^? 6.31 O21 C8E A 209 coo -12.71 41.15 -12.81 -13.46 42.96 -13.57 63.37 -61.81 -16.17 62.75 -59.91 -16.84 coo -9.98 44.30 -14.04 -9.74 44.63 -13.34 58.31 -64.58 -14.62 57.65 -64.21 -14.49 coo -9.28 44.56 -19.45 -10.46 44.31 -17.70 58.51 -66.15 -21.33 59.95 -66.28 -22.87 ULMN 3 1hkd_p00 PEA LECTIN ALPHA CHAIN user 2 3 # 2 A 81 ASP B 153 ASP^? 9.57 O15 C8E B 209 A 99 GLY B 129 GLY^? 8.67 C1 C8E B 210 A 125 ASN B 103 ASN^? 6.73 O21 C8E B 209 coo -12.71 41.15 -12.81 -13.46 42.96 -13.57 89.74 -36.17 -33.46 87.76 -36.55 -34.22 coo -9.98 44.30 -14.04 -9.74 44.63 -13.34 92.24 -31.68 -37.02 91.94 -31.53 -37.72 coo -9.28 44.56 -19.45 -10.46 44.31 -17.70 88.46 -28.09 -32.02 87.63 -28.23 -30.06 ULMN 3 1hkd_p00 PEA LECTIN ALPHA CHAIN user 3 3 # 3 A 81 ASP C 153 ASP^? 9.83 C13 C8E C 210 A 99 GLY C 129 GLY^? 8.32 C1 C8E C 209 A 125 ASN C 103 ASN^? 6.32 C20 C8E C 210 coo -12.71 41.15 -12.81 -13.46 42.96 -13.57 40.09 -57.62 -20.90 41.26 -57.13 -22.61 coo -9.98 44.30 -14.04 -9.74 44.63 -13.34 44.60 -57.45 -16.86 45.41 -57.44 -17.05 coo -9.28 44.56 -19.45 -10.46 44.31 -17.70 42.54 -50.86 -16.42 40.88 -49.65 -16.80 1hkd_p00 source 1hkd PEA LECTIN ALPHA CHAIN : 3 hits 1hkd_p00 naa= 3 ULMN 4 1jac_p00 JACALIN user 1 4 # 1 A 121 GLY C 50 GLY.? 8.32 CA CA C 208 A 122 TYR C 51 TYR.? 10.04 O21 C8E C 209 A 123 TRP C 59 TRP~? 6.20 CA CA C 208 A 125 ASP C 61 ASP~? 12.61 CA CA C 208 coo 31.37 62.85 70.38 31.13 63.29 71.19 21.11 -51.78 -6.22 21.90 -51.63 -6.15 coo 31.42 58.52 73.70 30.84 55.96 72.79 26.09 -52.62 -2.60 27.54 -53.38 -0.32 coo 32.48 62.35 78.03 34.57 59.23 76.91 24.77 -46.37 -6.57 25.55 -42.98 -4.73 coo 36.34 66.76 70.69 35.25 64.99 70.58 16.71 -46.53 -3.05 15.59 -48.22 -3.69 1jac_p00 source 1jac JACALIN : 1 hits 1jac_p00 naa= 4 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 1 1 # 1 A 461 ASN A 74 ASN^? -3.00 O21 C8E A 209s coo 5.80 63.03 55.85 5.52 65.03 56.45 62.15 -65.86 -25.53 63.13 -67.52 -24.67 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 2 1 # 2 A 461 ASN A 103 ASN^? 6.31 O21 C8E A 209 coo 5.80 63.03 55.85 5.52 65.03 56.45 58.51 -66.15 -21.33 59.95 -66.28 -22.87 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 3 1 # 3 A 461 ASN A 115 ASN.? 17.38 CA CA A 208 coo 5.80 63.03 55.85 5.52 65.03 56.45 70.48 -89.68 -41.10 71.99 -88.25 -40.64 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 4 1 # 4 A 461 ASN A 126 ASN^? 12.66 O21 C8E A 209 coo 5.80 63.03 55.85 5.52 65.03 56.45 53.38 -70.73 -21.66 52.86 -71.17 -23.66 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 5 1 # 5 A 461 ASN A 143 ASN.? 30.79 C20 C8E C 210 coo 5.80 63.03 55.85 5.52 65.03 56.45 58.63 -35.72 -29.30 57.21 -34.21 -28.85 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 6 1 # 6 A 461 ASN A 170 ASN.? 28.35 CA CA A 208 coo 5.80 63.03 55.85 5.52 65.03 56.45 51.62 -88.52 -39.42 50.91 -89.41 -41.21 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 7 1 # 7 A 461 ASN A 187 ASN~? -3.11 O18 C8E A 210s coo 5.80 63.03 55.85 5.52 65.03 56.45 63.91 -79.43 -16.81 63.89 -77.36 -16.28 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 8 1 # 8 A 461 ASN B 74 ASN^? -3.28 C20 C8E B 209s coo 5.80 63.03 55.85 5.52 65.03 56.45 85.94 -28.94 -27.06 87.84 -29.20 -26.13 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 9 1 # 9 A 461 ASN B 103 ASN^? 6.73 O21 C8E B 209 coo 5.80 63.03 55.85 5.52 65.03 56.45 88.46 -28.09 -32.02 87.63 -28.23 -30.06 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 10 1 # 10 A 461 ASN B 115 ASN.? 17.18 CA CA B 208 coo 5.80 63.03 55.85 5.52 65.03 56.45 92.58 -14.49 -1.90 92.83 -16.48 -2.65 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 11 1 # 11 A 461 ASN B 126 ASN^? 11.28 C1 C8E B 210 coo 5.80 63.03 55.85 5.52 65.03 56.45 90.80 -21.61 -33.24 89.51 -20.33 -32.18 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 12 1 # 12 A 461 ASN B 143 ASN.? 32.74 O18 C8E A 209 coo 5.80 63.03 55.85 5.52 65.03 56.45 61.43 -41.97 -40.31 60.77 -41.84 -42.32 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 13 1 # 13 A 461 ASN B 170 ASN.? 27.83 CA CA B 208 coo 5.80 63.03 55.85 5.52 65.03 56.45 90.80 -3.32 -17.55 90.23 -1.46 -16.71 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 14 1 # 14 A 461 ASN B 187 ASN~? -3.44 O21 C8E B 210s coo 5.80 63.03 55.85 5.52 65.03 56.45 101.97 -26.81 -25.28 100.76 -28.02 -26.55 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 15 1 # 15 A 461 ASN C 74 ASN^? -3.17 C20 C8E C 210s coo 5.80 63.03 55.85 5.52 65.03 56.45 38.01 -47.64 -17.99 37.26 -48.68 -16.35 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 16 1 # 16 A 461 ASN C 103 ASN^? 6.32 C20 C8E C 210 coo 5.80 63.03 55.85 5.52 65.03 56.45 42.54 -50.86 -16.42 40.88 -49.65 -16.80 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 17 1 # 17 A 461 ASN C 115 ASN.? 18.23 CA CA C 208 coo 5.80 63.03 55.85 5.52 65.03 56.45 21.18 -32.86 2.02 20.57 -34.73 1.19 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 18 1 # 18 A 461 ASN C 126 ASN^? 12.17 C20 C8E C 210 coo 5.80 63.03 55.85 5.52 65.03 56.45 46.00 -48.72 -10.75 45.75 -46.60 -10.82 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 19 1 # 19 A 461 ASN C 143 ASN.? 36.02 C16 C8E C 210 coo 5.80 63.03 55.85 5.52 65.03 56.45 48.00 -46.73 -47.20 49.81 -46.99 -48.30 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 20 1 # 20 A 461 ASN C 170 ASN.? 28.31 CA CA C 208 coo 5.80 63.03 55.85 5.52 65.03 56.45 39.40 -29.88 3.55 39.46 -27.84 4.11 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 21 1 # 21 A 461 ASN C 187 ASN~? -2.70 C14 C8E C 209s coo 5.80 63.03 55.85 5.52 65.03 56.45 35.59 -56.00 -3.84 36.37 -56.79 -5.68 1kbk_p00 source 1kbk ALPHA-AMYLASE, PANCREATIC : 21 hits 1kbk_p00 naa= 1 ULMN 3 1o8s_p00 PUTATIVE ENDO-XYLANASE user 1 3 # 1 A 56 TYR A 102 TYR^? 9.25 C1 C8E C 209 A 112 PHE A 104 PHE^? 12.68 O21 C8E A 209 A 140 ASN A 103 ASN^? 6.31 O21 C8E A 209 coo -6.29 44.15 17.65 -9.00 44.92 17.68 52.54 -63.26 -18.57 51.08 -62.17 -16.42 coo -7.38 52.77 16.75 -5.54 52.71 18.82 54.10 -67.12 -25.17 51.89 -66.22 -23.71 coo -4.46 50.64 12.29 -5.69 49.89 13.85 58.51 -66.15 -21.33 59.95 -66.28 -22.87 ULMN 3 1o8s_p00 PUTATIVE ENDO-XYLANASE user 2 3 # 2 A 56 TYR A 102 TYR^? 9.25 C1 C8E C 209 A 112 PHE A 104 PHE^? 12.68 O21 C8E A 209 A 140 ASN A 126 ASN^? 12.66 O21 C8E A 209 coo -6.29 44.15 17.65 -9.00 44.92 17.68 52.54 -63.26 -18.57 51.08 -62.17 -16.42 coo -7.38 52.77 16.75 -5.54 52.71 18.82 54.10 -67.12 -25.17 51.89 -66.22 -23.71 coo -4.46 50.64 12.29 -5.69 49.89 13.85 53.38 -70.73 -21.66 52.86 -71.17 -23.66 ULMN 3 1o8s_p00 PUTATIVE ENDO-XYLANASE user 3 3 # 3 A 56 TYR A 155 TYR^? 8.43 C17 C8E A 209 A 112 PHE A 104 PHE^? 12.68 O21 C8E A 209 A 140 ASN A 126 ASN^? 12.66 O21 C8E A 209 coo -6.29 44.15 17.65 -9.00 44.92 17.68 60.87 -66.67 -17.05 60.42 -64.37 -18.53 coo -7.38 52.77 16.75 -5.54 52.71 18.82 54.10 -67.12 -25.17 51.89 -66.22 -23.71 coo -4.46 50.64 12.29 -5.69 49.89 13.85 53.38 -70.73 -21.66 52.86 -71.17 -23.66 ULMN 3 1o8s_p00 PUTATIVE ENDO-XYLANASE user 4 3 # 4 A 56 TYR A 155 TYR^? 8.43 C17 C8E A 209 A 112 PHE A 105 PHE^? 4.85 O21 C8E A 209 A 140 ASN A 74 ASN^? -3.00 O21 C8E A 209s coo -6.29 44.15 17.65 -9.00 44.92 17.68 60.87 -66.67 -17.05 60.42 -64.37 -18.53 coo -7.38 52.77 16.75 -5.54 52.71 18.82 61.29 -71.83 -24.77 63.18 -73.65 -25.72 coo -4.46 50.64 12.29 -5.69 49.89 13.85 62.15 -65.86 -25.53 63.13 -67.52 -24.67 ULMN 3 1o8s_p00 PUTATIVE ENDO-XYLANASE user 5 3 # 5 A 56 TYR B 155 TYR^? 7.60 C13 C8E B 209 A 112 PHE B 105 PHE^? 5.21 C20 C8E B 209 A 140 ASN B 74 ASN^? -3.28 C20 C8E B 209s coo -6.29 44.15 17.65 -9.00 44.92 17.68 92.02 -31.30 -32.58 89.26 -31.61 -33.00 coo -7.38 52.77 16.75 -5.54 52.71 18.82 90.70 -25.26 -25.77 91.65 -25.28 -23.14 coo -4.46 50.64 12.29 -5.69 49.89 13.85 85.94 -28.94 -27.06 87.84 -29.20 -26.13 ULMN 3 1o8s_p00 PUTATIVE ENDO-XYLANASE user 6 3 # 6 A 56 TYR C 155 TYR^? 7.32 C13 C8E C 210 A 112 PHE C 104 PHE^? 12.59 C20 C8E C 210 A 140 ASN C 126 ASN^? 12.17 C20 C8E C 210 coo -6.29 44.15 17.65 -9.00 44.92 17.68 41.26 -55.52 -15.76 41.81 -54.24 -18.13 coo -7.38 52.77 16.75 -5.54 52.71 18.82 45.31 -45.69 -15.13 48.07 -46.01 -15.44 coo -4.46 50.64 12.29 -5.69 49.89 13.85 46.00 -48.72 -10.75 45.75 -46.60 -10.82 ULMN 3 1o8s_p00 PUTATIVE ENDO-XYLANASE user 7 3 # 7 A 56 TYR C 155 TYR^? 7.32 C13 C8E C 210 A 112 PHE C 105 PHE^? -4.13 O21 C8E C 210s A 140 ASN C 74 ASN^? -3.17 C20 C8E C 210s coo -6.29 44.15 17.65 -9.00 44.92 17.68 41.26 -55.52 -15.76 41.81 -54.24 -18.13 coo -7.38 52.77 16.75 -5.54 52.71 18.82 37.70 -47.93 -11.88 35.28 -47.45 -10.64 coo -4.46 50.64 12.29 -5.69 49.89 13.85 38.01 -47.64 -17.99 37.26 -48.68 -16.35 1o8s_p00 source 1o8s PUTATIVE ENDO-XYLANASE : 7 hits 1o8s_p00 naa= 3 ULMN 5 1u4j_p00 PHOSPHOLIPASE A2 ISOFORM 2 user 1 5 # 1 A 2 LEU B 37 LEU^? 20.28 C1 C8E B 210 A 31 TYR B 97 TYR^? 16.46 O15 C8E B 209 A 32 GLY B 133 GLY^? 15.21 O15 C8E B 209 A 49 ASP B 149 ASP^? 14.91 O15 C8E B 209 A 64 LEU B 79 LEU^? 17.22 C1 C8E B 210 coo 17.65 19.60 -6.47 17.30 21.43 -5.38 78.21 -31.47 -42.04 79.02 -29.38 -41.96 coo 14.61 30.95 -3.62 14.67 31.99 -6.22 83.74 -41.85 -39.80 83.62 -41.42 -37.05 coo 18.00 33.20 -2.62 17.94 32.79 -1.95 86.08 -43.87 -36.38 86.09 -44.05 -37.22 coo 23.82 30.85 -3.15 21.80 30.70 -2.93 79.48 -42.39 -33.32 81.04 -41.48 -34.38 coo 17.75 22.71 -10.33 17.59 24.38 -8.98 83.57 -32.27 -42.66 82.79 -32.39 -44.72 ULMN 5 1u4j_p00 PHOSPHOLIPASE A2 ISOFORM 2 user 2 5 # 2 A 2 LEU C 37 LEU^? 21.51 C1 C8E C 209 A 31 TYR C 97 TYR^? 17.03 C13 C8E C 210 A 32 GLY C 133 GLY^? 15.62 C13 C8E C 210 A 49 ASP C 149 ASP^? 16.02 C16 C8E C 210 A 64 LEU C 79 LEU^? 16.93 C1 C8E C 209 coo 17.65 19.60 -6.47 17.30 21.43 -5.38 51.45 -50.32 -28.68 53.28 -51.34 -28.15 coo 14.61 30.95 -3.62 14.67 31.99 -6.22 44.42 -59.94 -30.24 42.23 -58.45 -29.40 coo 18.00 33.20 -2.62 17.94 32.79 -1.95 40.42 -61.48 -28.89 41.03 -62.00 -29.17 coo 23.82 30.85 -3.15 21.80 30.70 -2.93 38.72 -55.19 -32.44 40.02 -55.93 -30.97 coo 17.75 22.71 -10.33 17.59 24.38 -8.98 50.79 -54.70 -24.94 52.53 -55.79 -25.69 1u4j_p00 source 1u4j PHOSPHOLIPASE A2 ISOFORM 2 : 2 hits 1u4j_p00 naa= 5 ULMN 4 1ux7_p00 ENDO-1,4-BETA-XYLANASE D user 1 4 # 1 A 40 TYR A 51 TYR.? 9.92 O21 C8E A 210 A 116 ASP A 49 ASP.? -3.00 CA CA A 208s A 118 GLY A 60 GLY~? 6.96 CA CA A 208 A 121 ASP A 48 ASP.? 7.38 CA CA A 208 coo 1.23 20.09 -8.77 -1.43 19.35 -9.06 71.70 -83.21 -22.40 69.97 -85.02 -21.17 coo 8.44 21.40 -4.34 8.12 19.68 -5.55 75.72 -77.89 -27.98 74.67 -77.10 -29.65 coo 9.75 15.96 -6.06 9.75 15.96 -5.24 76.07 -81.13 -30.14 75.99 -81.96 -30.16 coo 1.59 17.86 -4.64 2.63 16.93 -6.25 72.05 -78.20 -23.17 73.82 -77.79 -22.11 ULMN 4 1ux7_p00 ENDO-1,4-BETA-XYLANASE D user 2 4 # 2 A 40 TYR C 51 TYR.? 10.04 O21 C8E C 209 A 116 ASP C 49 ASP.? -2.87 CA CA C 208s A 118 GLY C 60 GLY~? 7.28 CA CA C 208 A 121 ASP C 48 ASP.? 7.17 CA CA C 208 coo 1.23 20.09 -8.77 -1.43 19.35 -9.06 26.09 -52.62 -2.60 27.54 -53.38 -0.32 coo 8.44 21.40 -4.34 8.12 19.68 -5.55 22.13 -48.50 -9.42 23.00 -46.66 -10.00 coo 9.75 15.96 -6.06 9.75 15.96 -5.24 19.85 -46.69 -6.80 19.80 -46.54 -5.98 coo 1.59 17.86 -4.64 2.63 16.93 -6.25 26.68 -52.06 -7.74 25.46 -53.53 -8.54 1ux7_p00 source 1ux7 ENDO-1,4-BETA-XYLANASE D : 2 hits 1ux7_p00 naa= 4 ULMN 4 2g3n_p00 ALPHA-GLUCOSIDASE user 1 4 # 1 A 87 ASP A 80 ASP^? 12.60 C1 C8E A 210 A 184 TYR A 13 TYR^? 6.88 C17 C8E A 209 A 400 ARG A 36 ARG^? 15.77 C1 C8E A 210 A 416 ASP A 149 ASP^? 14.85 C1 C8E A 210 coo -0.32 21.89 76.95 -2.29 21.43 77.55 58.12 -52.30 -15.93 59.10 -53.68 -17.13 coo -13.84 24.02 81.30 -13.39 23.42 78.61 65.07 -60.93 -23.01 63.35 -61.54 -20.90 coo -2.45 25.99 82.19 -2.93 24.57 79.52 59.00 -50.13 -20.90 61.68 -51.06 -19.88 coo -5.39 20.15 83.91 -5.94 21.73 82.59 66.40 -51.17 -20.74 65.06 -51.90 -19.38 ULMN 4 2g3n_p00 ALPHA-GLUCOSIDASE user 2 4 # 2 A 87 ASP A 149 ASP^? 14.85 C1 C8E A 210 A 184 TYR A 83 TYR^? -19.24 C2 C8E C 209s A 400 ARG A 135 ARG^? 21.29 C1 C8E A 210 A 416 ASP A 80 ASP^? 12.60 C1 C8E A 210 coo -0.32 21.89 76.95 -2.29 21.43 77.55 66.40 -51.17 -20.74 65.06 -51.90 -19.38 coo -13.84 24.02 81.30 -13.39 23.42 78.61 59.25 -44.27 -7.74 58.41 -42.23 -6.03 coo -2.45 25.99 82.19 -2.93 24.57 79.52 62.45 -46.81 -18.85 61.41 -44.79 -20.90 coo -5.39 20.15 83.91 -5.94 21.73 82.59 58.12 -52.30 -15.93 59.10 -53.68 -17.13 ULMN 4 2g3n_p00 ALPHA-GLUCOSIDASE user 3 4 # 3 A 87 ASP B 80 ASP^? 15.94 O15 C8E B 209 A 184 TYR B 13 TYR^? 6.78 O15 C8E B 209 A 400 ARG B 36 ARG^? 17.08 O15 C8E B 209 A 416 ASP B 149 ASP^? 14.91 O15 C8E B 209 coo -0.32 21.89 76.95 -2.29 21.43 77.55 82.56 -37.87 -41.00 82.97 -37.16 -39.06 coo -13.84 24.02 81.30 -13.39 23.42 78.61 84.65 -34.92 -28.70 86.28 -34.17 -30.84 coo -2.45 25.99 82.19 -2.93 24.57 79.52 77.67 -37.50 -38.51 79.47 -39.58 -37.24 coo -5.39 20.15 83.91 -5.94 21.73 82.59 79.48 -42.39 -33.32 81.04 -41.48 -34.38 ULMN 4 2g3n_p00 ALPHA-GLUCOSIDASE user 4 4 # 4 A 87 ASP B 149 ASP^? 14.91 O15 C8E B 209 A 184 TYR B 83 TYR^? 23.90 C1 C8E B 209 A 400 ARG B 135 ARG^? 22.88 O15 C8E B 209 A 416 ASP B 80 ASP^? 15.94 O15 C8E B 209 coo -0.32 21.89 76.95 -2.29 21.43 77.55 79.48 -42.39 -33.32 81.04 -41.48 -34.38 coo -13.84 24.02 81.30 -13.39 23.42 78.61 84.86 -45.84 -46.52 87.07 -46.60 -44.97 coo -2.45 25.99 82.19 -2.93 24.57 79.52 77.46 -42.45 -38.74 74.50 -42.61 -39.42 coo -5.39 20.15 83.91 -5.94 21.73 82.59 82.56 -37.87 -41.00 82.97 -37.16 -39.06 ULMN 4 2g3n_p00 ALPHA-GLUCOSIDASE user 5 4 # 5 A 87 ASP C 80 ASP^? 16.43 C13 C8E C 210 A 184 TYR C 13 TYR^? 7.82 C16 C8E C 210 A 400 ARG C 36 ARG^? 17.98 C16 C8E C 210 A 416 ASP C 149 ASP^? 16.02 C16 C8E C 210 coo -0.32 21.89 76.95 -2.29 21.43 77.55 47.10 -57.14 -28.79 45.64 -55.94 -27.77 coo -13.84 24.02 81.30 -13.39 23.42 78.61 37.24 -51.70 -23.13 39.21 -53.16 -21.84 coo -2.45 25.99 82.19 -2.93 24.57 79.52 45.58 -52.92 -31.76 43.11 -54.70 -31.56 coo -5.39 20.15 83.91 -5.94 21.73 82.59 38.72 -55.19 -32.44 40.02 -55.93 -30.97 ULMN 4 2g3n_p00 ALPHA-GLUCOSIDASE user 6 4 # 6 A 87 ASP C 149 ASP^? 16.02 C16 C8E C 210 A 184 TYR C 83 TYR^? 19.88 O21 C8E A 209 A 400 ARG C 135 ARG^? 23.87 C16 C8E C 210 A 416 ASP C 80 ASP^? 16.43 C13 C8E C 210 coo -0.32 21.89 76.95 -2.29 21.43 77.55 38.72 -55.19 -32.44 40.02 -55.93 -30.97 coo -13.84 24.02 81.30 -13.39 23.42 78.61 49.20 -66.70 -34.88 49.82 -68.82 -36.60 coo -2.45 25.99 82.19 -2.93 24.57 79.52 44.01 -56.05 -34.91 45.01 -54.65 -37.44 coo -5.39 20.15 83.91 -5.94 21.73 82.59 47.10 -57.14 -28.79 45.64 -55.94 -27.77 2g3n_p00 source 2g3n ALPHA-GLUCOSIDASE : 6 hits 2g3n_p00 naa= 4 ULMN 3 2p3i_p00 VP4 user 1 3 # 1 A 101 ARG C 206 ARG^? 30.58 O21 C8E A 209 A 188 TYR C 205 TYR^? 27.50 C19 C8E C 210 A 190 SER C 5 SER^? 28.64 C16 C8E C 210 coo 37.69 7.64 13.51 38.82 8.84 16.11 51.48 -50.24 -44.52 54.38 -50.65 -45.44 coo 47.14 12.10 13.73 48.75 12.33 16.01 44.79 -44.04 -41.24 42.28 -43.19 -40.34 coo 43.77 6.93 15.46 45.49 7.21 17.11 50.03 -48.53 -38.83 49.40 -50.39 -40.21 2p3i_p00 source 2p3i VP4 : 1 hits 2p3i_p00 naa= 3 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 1 3 # 1 A 270 ASN A 126 ASN^? 12.66 O21 C8E A 209 A 384 ASN A 170 ASN.? 28.35 CA CA A 208 A 385 GLU A 165 GLU^? 21.76 CA CA A 208 coo 22.28 63.17 110.61 22.47 65.06 111.53 53.38 -70.73 -21.66 52.86 -71.17 -23.66 coo 7.06 50.07 96.17 8.50 48.54 96.31 51.62 -88.52 -39.42 50.91 -89.41 -41.21 coo 11.59 49.83 99.41 10.92 47.97 100.16 55.17 -82.77 -39.51 54.39 -80.85 -40.05 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 2 3 # 2 A 270 ASN B 126 ASN^? 11.28 C1 C8E B 210 A 384 ASN B 170 ASN.? 27.83 CA CA B 208 A 385 GLU B 165 GLU^? 20.64 CA CA B 208 coo 22.28 63.17 110.61 22.47 65.06 111.53 90.80 -21.61 -33.24 89.51 -20.33 -32.18 coo 7.06 50.07 96.17 8.50 48.54 96.31 90.80 -3.32 -17.55 90.23 -1.46 -16.71 coo 11.59 49.83 99.41 10.92 47.97 100.16 88.15 -8.84 -16.79 86.14 -9.46 -16.74 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 3 3 # 3 A 270 ASN C 126 ASN^? 12.17 C20 C8E C 210 A 384 ASN C 170 ASN.? 28.31 CA CA C 208 A 385 GLU C 165 GLU^? 20.98 CA CA C 208 coo 22.28 63.17 110.61 22.47 65.06 111.53 46.00 -48.72 -10.75 45.75 -46.60 -10.82 coo 7.06 50.07 96.17 8.50 48.54 96.31 39.40 -29.88 3.55 39.46 -27.84 4.11 coo 11.59 49.83 99.41 10.92 47.97 100.16 36.32 -31.59 -2.15 36.97 -31.00 -4.08 2v3r_p00 source 2v3r EXOGLUCANASE 1 : 3 hits 2v3r_p00 naa= 3 ULMN 3 1b01_d00 GENE REGULATION/DNA user 1 3 # 1 B 4 ARG A 162 ARG^? 10.87 O21 C8E A 210 B 6 THR A 122 THR^? 13.62 O21 C8E A 209 B 8 THR A 110 THR^? 13.46 CA CA A 208 coo 40.52 16.08 100.90 37.97 16.41 102.60 60.16 -83.54 -27.36 63.31 -83.18 -27.03 coo 36.11 13.64 95.03 34.54 14.86 95.91 59.48 -78.76 -31.56 58.50 -77.15 -32.63 coo 32.72 8.05 92.39 31.25 9.11 91.35 64.57 -79.69 -38.47 64.29 -77.82 -39.49 1b01_d00 source 1b01 GENE REGULATION/DNA : 1 hits 1b01_d00 naa= 3 ULMN 3 1bdv_d00 GENE REGULATION/DNA user 1 3 # 1 A 9 GLN C 127 GLN^? 6.69 C11 C8E C 209 A 11 ASN C 103 ASN^? 6.32 C20 C8E C 210 A 13 ARG C 101 ARG^? 13.82 C13 C8E C 210 coo 33.45 2.10 7.21 34.51 1.09 5.67 42.39 -53.01 -11.20 40.42 -53.72 -11.54 coo 38.37 -1.60 11.46 39.03 -3.43 10.75 42.54 -50.86 -16.42 40.88 -49.65 -16.80 coo 41.73 -6.32 12.94 43.25 -5.49 10.40 44.39 -56.56 -21.66 44.87 -57.05 -24.63 ULMN 3 1bdv_d00 GENE REGULATION/DNA user 2 3 # 2 A 9 GLN C 192 GLN.? 2.81 O21 C8E C 209s A 11 ASN C 103 ASN^? 6.32 C20 C8E C 210 A 13 ARG C 101 ARG^? 13.82 C13 C8E C 210 coo 33.45 2.10 7.21 34.51 1.09 5.67 37.88 -52.49 -10.10 36.97 -53.88 -8.75 coo 38.37 -1.60 11.46 39.03 -3.43 10.75 42.54 -50.86 -16.42 40.88 -49.65 -16.80 coo 41.73 -6.32 12.94 43.25 -5.49 10.40 44.39 -56.56 -21.66 44.87 -57.05 -24.63 1bdv_d00 source 1bdv GENE REGULATION/DNA : 2 hits 1bdv_d00 naa= 3 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 1 3 # 1 I 303 TYR A 13 TYR^? 6.88 C17 C8E A 209 I 306 VAL A 75 VAL^? 10.27 O21 C8E A 209 I 308 VAL A 39 VAL^? 15.36 O21 C8E A 209 coo 26.18 35.24 6.87 24.33 35.18 8.97 65.07 -60.93 -23.01 63.35 -61.54 -20.90 coo 23.55 29.53 9.81 23.15 27.39 10.24 58.31 -63.98 -26.96 56.88 -63.78 -28.61 coo 16.43 30.18 9.35 15.05 30.67 11.01 56.65 -57.17 -25.99 55.61 -57.72 -27.81 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 2 3 # 2 I 303 TYR A 97 TYR^? 11.99 C1 C8E A 210 I 306 VAL A 35 VAL^? 13.71 C2 C8E C 209 I 308 VAL A 22 VAL^? 19.55 C2 C8E C 209 coo 26.18 35.24 6.87 24.33 35.18 8.97 61.97 -51.46 -14.47 63.57 -52.89 -16.21 coo 23.55 29.53 9.81 23.15 27.39 10.24 54.03 -47.97 -16.20 52.15 -48.80 -15.61 coo 16.43 30.18 9.35 15.05 30.67 11.01 54.15 -48.28 -24.50 51.93 -48.23 -24.31 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 3 3 # 3 I 303 TYR A 97 TYR^? 11.99 C1 C8E A 210 I 306 VAL A 35 VAL^? 13.71 C2 C8E C 209 I 308 VAL A 23 VAL^? 19.69 C2 C8E C 209 coo 26.18 35.24 6.87 24.33 35.18 8.97 61.97 -51.46 -14.47 63.57 -52.89 -16.21 coo 23.55 29.53 9.81 23.15 27.39 10.24 54.03 -47.97 -16.20 52.15 -48.80 -15.61 coo 16.43 30.18 9.35 15.05 30.67 11.01 55.06 -46.20 -21.45 57.12 -45.79 -20.99 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 4 3 # 4 I 303 TYR A 97 TYR^? 11.99 C1 C8E A 210 I 306 VAL A 81 VAL^? 11.87 C2 C8E C 209 I 308 VAL A 100 VAL^? 8.33 C1 C8E C 209 coo 26.18 35.24 6.87 24.33 35.18 8.97 61.97 -51.46 -14.47 63.57 -52.89 -16.21 coo 23.55 29.53 9.81 23.15 27.39 10.24 56.11 -50.29 -12.59 54.75 -50.24 -10.87 coo 16.43 30.18 9.35 15.05 30.67 11.01 55.82 -59.38 -13.97 53.67 -59.79 -13.91 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 5 3 # 5 I 303 TYR A 97 TYR^? 11.99 C1 C8E A 210 I 306 VAL A 134 VAL^? 14.15 C1 C8E A 209 I 308 VAL A 94 VAL^? 20.22 C1 C8E A 210 coo 26.18 35.24 6.87 24.33 35.18 8.97 61.97 -51.46 -14.47 63.57 -52.89 -16.21 coo 23.55 29.53 9.81 23.15 27.39 10.24 66.85 -49.89 -14.22 68.83 -49.66 -13.28 coo 16.43 30.18 9.35 15.05 30.67 11.01 67.15 -43.28 -14.02 69.00 -43.10 -12.90 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 6 3 # 6 I 303 TYR A 102 TYR^? 9.25 C1 C8E C 209 I 306 VAL C 100 VAL^? 11.61 C1 C8E C 209 I 308 VAL C 81 VAL^? 17.52 O21 C8E A 209 coo 26.18 35.24 6.87 24.33 35.18 8.97 52.54 -63.26 -18.57 51.08 -62.17 -16.42 coo 23.55 29.53 9.81 23.15 27.39 10.24 48.42 -57.82 -21.21 50.38 -57.25 -20.38 coo 16.43 30.18 9.35 15.05 30.67 11.01 50.39 -60.03 -29.82 52.11 -61.18 -29.13 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 7 3 # 7 I 303 TYR A 138 TYR^? 19.17 C16 C8E B 209 I 306 VAL A 92 VAL.? 21.10 C19 C8E B 209 I 308 VAL A 94 VAL^? 20.22 C1 C8E A 210 coo 26.18 35.24 6.87 24.33 35.18 8.97 70.50 -38.06 -22.60 71.93 -35.69 -22.96 coo 23.55 29.53 9.81 23.15 27.39 10.24 70.02 -38.66 -17.26 71.83 -39.78 -17.57 coo 16.43 30.18 9.35 15.05 30.67 11.01 67.15 -43.28 -14.02 69.00 -43.10 -12.90 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 8 3 # 8 I 303 TYR A 155 TYR^? 8.43 C17 C8E A 209 I 306 VAL A 196 VAL^? 4.55 C17 C8E A 209 I 308 VAL A 152 VAL^? 5.71 C2 C8E A 209 coo 26.18 35.24 6.87 24.33 35.18 8.97 60.87 -66.67 -17.05 60.42 -64.37 -18.53 coo 23.55 29.53 9.81 23.15 27.39 10.24 67.64 -63.89 -17.99 66.16 -64.18 -19.64 coo 16.43 30.18 9.35 15.05 30.67 11.01 67.24 -59.51 -14.71 68.94 -60.40 -13.59 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 9 3 # 9 I 303 TYR A 183 TYR~? 7.18 C16 C8E A 210 I 306 VAL A 186 VAL~? 7.40 O21 C8E A 210 I 308 VAL A 190 VAL~? 4.63 O21 C8E A 210 coo 26.18 35.24 6.87 24.33 35.18 8.97 59.65 -81.82 -15.52 59.58 -79.01 -15.74 coo 23.55 29.53 9.81 23.15 27.39 10.24 63.83 -82.84 -20.23 61.86 -82.88 -21.10 coo 16.43 30.18 9.35 15.05 30.67 11.01 65.92 -77.91 -22.89 63.79 -78.15 -23.56 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 10 3 # 10 I 303 TYR A 205 TYR^? 30.20 C20 C8E C 210 I 306 VAL A 6 VAL^? 25.12 C2 C8E C 209 I 308 VAL A 23 VAL^? 19.69 C2 C8E C 209 coo 26.18 35.24 6.87 24.33 35.18 8.97 57.96 -40.35 -31.16 56.81 -38.18 -32.51 coo 23.55 29.53 9.81 23.15 27.39 10.24 56.15 -45.66 -27.60 55.77 -45.97 -29.79 coo 16.43 30.18 9.35 15.05 30.67 11.01 55.06 -46.20 -21.45 57.12 -45.79 -20.99 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 11 3 # 11 I 303 TYR A 205 TYR^? 30.20 C20 C8E C 210 I 306 VAL A 6 VAL^? 25.12 C2 C8E C 209 I 308 VAL C 22 VAL^? 24.18 C19 C8E C 210 coo 26.18 35.24 6.87 24.33 35.18 8.97 57.96 -40.35 -31.16 56.81 -38.18 -32.51 coo 23.55 29.53 9.81 23.15 27.39 10.24 56.15 -45.66 -27.60 55.77 -45.97 -29.79 coo 16.43 30.18 9.35 15.05 30.67 11.01 49.97 -48.50 -33.16 51.91 -47.53 -32.92 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 12 3 # 12 I 303 TYR B 13 TYR^? 6.78 O15 C8E B 209 I 306 VAL B 75 VAL^? 10.73 C20 C8E B 209 I 308 VAL B 39 VAL^? 15.93 C20 C8E B 209 coo 26.18 35.24 6.87 24.33 35.18 8.97 84.65 -34.92 -28.70 86.28 -34.17 -30.84 coo 23.55 29.53 9.81 23.15 27.39 10.24 82.95 -26.54 -29.63 81.51 -24.87 -29.78 coo 16.43 30.18 9.35 15.05 30.67 11.01 78.58 -29.46 -34.61 77.54 -27.66 -34.03 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 13 3 # 13 I 303 TYR B 97 TYR^? 16.46 O15 C8E B 209 I 306 VAL B 35 VAL^? 23.51 C1 C8E B 210 I 308 VAL B 22 VAL^? 24.13 O15 C8E B 209 coo 26.18 35.24 6.87 24.33 35.18 8.97 83.74 -41.85 -39.80 83.62 -41.42 -37.05 coo 23.55 29.53 9.81 23.15 27.39 10.24 78.88 -37.40 -45.53 79.03 -35.77 -47.03 coo 16.43 30.18 9.35 15.05 30.67 11.01 73.23 -33.83 -40.83 72.09 -32.38 -42.01 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 14 3 # 14 I 303 TYR B 97 TYR^? 16.46 O15 C8E B 209 I 306 VAL B 35 VAL^? 23.51 C1 C8E B 210 I 308 VAL B 23 VAL^? 23.71 O15 C8E B 209 coo 26.18 35.24 6.87 24.33 35.18 8.97 83.74 -41.85 -39.80 83.62 -41.42 -37.05 coo 23.55 29.53 9.81 23.15 27.39 10.24 78.88 -37.40 -45.53 79.03 -35.77 -47.03 coo 16.43 30.18 9.35 15.05 30.67 11.01 74.07 -37.06 -42.67 74.51 -38.99 -41.68 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 15 3 # 15 I 303 TYR B 97 TYR^? 16.46 O15 C8E B 209 I 306 VAL B 81 VAL^? 21.13 C1 C8E B 210 I 308 VAL B 100 VAL^? 12.29 C1 C8E B 210 coo 26.18 35.24 6.87 24.33 35.18 8.97 83.74 -41.85 -39.80 83.62 -41.42 -37.05 coo 23.55 29.53 9.81 23.15 27.39 10.24 83.36 -39.09 -45.25 84.59 -38.82 -47.03 coo 16.43 30.18 9.35 15.05 30.67 11.01 88.50 -33.08 -41.00 88.21 -31.27 -42.30 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 16 3 # 16 I 303 TYR B 97 TYR^? 16.46 O15 C8E B 209 I 306 VAL B 134 VAL^? 18.50 O15 C8E B 209 I 308 VAL B 94 VAL^? 24.44 O15 C8E B 209 coo 26.18 35.24 6.87 24.33 35.18 8.97 83.74 -41.85 -39.80 83.62 -41.42 -37.05 coo 23.55 29.53 9.81 23.15 27.39 10.24 83.19 -46.23 -37.05 83.91 -48.21 -36.40 coo 16.43 30.18 9.35 15.05 30.67 11.01 78.72 -50.26 -39.56 79.66 -51.97 -38.65 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 17 3 # 17 I 303 TYR B 138 TYR^? 18.52 O18 C8E A 209 I 306 VAL B 92 VAL.? 20.66 O18 C8E A 209 I 308 VAL B 94 VAL^? 24.44 O15 C8E B 209 coo 26.18 35.24 6.87 24.33 35.18 8.97 69.87 -51.92 -34.99 68.26 -54.21 -34.65 coo 23.55 29.53 9.81 23.15 27.39 10.24 73.51 -53.72 -38.04 74.89 -53.45 -36.32 coo 16.43 30.18 9.35 15.05 30.67 11.01 78.72 -50.26 -39.56 79.66 -51.97 -38.65 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 18 3 # 18 I 303 TYR B 155 TYR^? 7.60 C13 C8E B 209 I 306 VAL B 196 VAL^? 3.52 O15 C8E B 209 I 308 VAL B 152 VAL^? 9.88 C13 C8E B 209 coo 26.18 35.24 6.87 24.33 35.18 8.97 92.02 -31.30 -32.58 89.26 -31.61 -33.00 coo 23.55 29.53 9.81 23.15 27.39 10.24 90.63 -37.06 -28.37 89.46 -35.20 -28.36 coo 16.43 30.18 9.35 15.05 30.67 11.01 89.63 -40.94 -32.34 91.60 -41.81 -32.43 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 19 3 # 19 I 303 TYR B 183 TYR~? 7.74 O12 C8E B 210 I 306 VAL B 186 VAL~? 7.56 O21 C8E B 210 I 308 VAL B 190 VAL~? 4.94 O21 C8E B 210 coo 26.18 35.24 6.87 24.33 35.18 8.97 104.05 -23.05 -28.11 101.72 -24.25 -29.01 coo 23.55 29.53 9.81 23.15 27.39 10.24 102.03 -23.25 -21.93 101.21 -21.29 -22.72 coo 16.43 30.18 9.35 15.05 30.67 11.01 97.01 -26.06 -20.89 96.38 -24.15 -21.83 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 20 3 # 20 I 303 TYR B 205 TYR^? 31.23 O15 C8E B 209 I 306 VAL B 6 VAL^? 25.37 O15 C8E B 209 I 308 VAL B 23 VAL^? 23.71 O15 C8E B 209 coo 26.18 35.24 6.87 24.33 35.18 8.97 63.66 -38.04 -37.77 60.98 -37.67 -38.58 coo 23.55 29.53 9.81 23.15 27.39 10.24 69.31 -35.26 -38.72 68.34 -33.48 -38.01 coo 16.43 30.18 9.35 15.05 30.67 11.01 74.07 -37.06 -42.67 74.51 -38.99 -41.68 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 21 3 # 21 I 303 TYR C 13 TYR^? 7.82 C16 C8E C 210 I 306 VAL C 75 VAL^? 10.43 C20 C8E C 210 I 308 VAL C 39 VAL^? 15.77 C20 C8E C 210 coo 26.18 35.24 6.87 24.33 35.18 8.97 37.24 -51.70 -23.13 39.21 -53.16 -21.84 coo 23.55 29.53 9.81 23.15 27.39 10.24 41.88 -45.41 -19.23 42.87 -43.46 -19.44 coo 16.43 30.18 9.35 15.05 30.67 11.01 45.59 -46.48 -25.31 46.87 -44.90 -24.49 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 22 3 # 22 I 303 TYR C 97 TYR^? 17.03 C13 C8E C 210 I 306 VAL C 35 VAL^? 19.71 O21 C8E A 209 I 308 VAL A 39 VAL^? 15.36 O21 C8E A 209 coo 26.18 35.24 6.87 24.33 35.18 8.97 44.42 -59.94 -30.24 42.23 -58.45 -29.40 coo 23.55 29.53 9.81 23.15 27.39 10.24 52.01 -56.27 -32.20 53.78 -56.04 -30.95 coo 16.43 30.18 9.35 15.05 30.67 11.01 56.65 -57.17 -25.99 55.61 -57.72 -27.81 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 23 3 # 23 I 303 TYR C 97 TYR^? 17.03 C13 C8E C 210 I 306 VAL C 35 VAL^? 19.71 O21 C8E A 209 I 308 VAL C 22 VAL^? 24.18 C19 C8E C 210 coo 26.18 35.24 6.87 24.33 35.18 8.97 44.42 -59.94 -30.24 42.23 -58.45 -29.40 coo 23.55 29.53 9.81 23.15 27.39 10.24 52.01 -56.27 -32.20 53.78 -56.04 -30.95 coo 16.43 30.18 9.35 15.05 30.67 11.01 49.97 -48.50 -33.16 51.91 -47.53 -32.92 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 24 3 # 24 I 303 TYR C 97 TYR^? 17.03 C13 C8E C 210 I 306 VAL C 35 VAL^? 19.71 O21 C8E A 209 I 308 VAL C 23 VAL^? 24.75 C19 C8E C 210 coo 26.18 35.24 6.87 24.33 35.18 8.97 44.42 -59.94 -30.24 42.23 -58.45 -29.40 coo 23.55 29.53 9.81 23.15 27.39 10.24 52.01 -56.27 -32.20 53.78 -56.04 -30.95 coo 16.43 30.18 9.35 15.05 30.67 11.01 50.26 -51.76 -35.05 48.45 -52.77 -35.68 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 25 3 # 25 I 303 TYR C 97 TYR^? 17.03 C13 C8E C 210 I 306 VAL C 81 VAL^? 17.52 O21 C8E A 209 I 308 VAL A 39 VAL^? 15.36 O21 C8E A 209 coo 26.18 35.24 6.87 24.33 35.18 8.97 44.42 -59.94 -30.24 42.23 -58.45 -29.40 coo 23.55 29.53 9.81 23.15 27.39 10.24 50.39 -60.03 -29.82 52.11 -61.18 -29.13 coo 16.43 30.18 9.35 15.05 30.67 11.01 56.65 -57.17 -25.99 55.61 -57.72 -27.81 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 26 3 # 26 I 303 TYR C 97 TYR^? 17.03 C13 C8E C 210 I 306 VAL C 81 VAL^? 17.52 O21 C8E A 209 I 308 VAL C 100 VAL^? 11.61 C1 C8E C 209 coo 26.18 35.24 6.87 24.33 35.18 8.97 44.42 -59.94 -30.24 42.23 -58.45 -29.40 coo 23.55 29.53 9.81 23.15 27.39 10.24 50.39 -60.03 -29.82 52.11 -61.18 -29.13 coo 16.43 30.18 9.35 15.05 30.67 11.01 48.42 -57.82 -21.21 50.38 -57.25 -20.38 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 27 3 # 27 I 303 TYR C 97 TYR^? 17.03 C13 C8E C 210 I 306 VAL C 134 VAL^? 19.43 C13 C8E C 210 I 308 VAL C 94 VAL^? 25.46 C13 C8E C 210 coo 26.18 35.24 6.87 24.33 35.18 8.97 44.42 -59.94 -30.24 42.23 -58.45 -29.40 coo 23.55 29.53 9.81 23.15 27.39 10.24 40.06 -61.56 -32.67 39.22 -63.26 -33.71 coo 16.43 30.18 9.35 15.05 30.67 11.01 41.78 -62.37 -39.35 39.83 -63.39 -39.30 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 28 3 # 28 I 303 TYR C 102 TYR^? 9.73 C2 C8E C 209 I 306 VAL A 35 VAL^? 13.71 C2 C8E C 209 I 308 VAL A 22 VAL^? 19.55 C2 C8E C 209 coo 26.18 35.24 6.87 24.33 35.18 8.97 48.50 -51.08 -15.65 48.91 -50.66 -12.96 coo 23.55 29.53 9.81 23.15 27.39 10.24 54.03 -47.97 -16.20 52.15 -48.80 -15.61 coo 16.43 30.18 9.35 15.05 30.67 11.01 54.15 -48.28 -24.50 51.93 -48.23 -24.31 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 29 3 # 29 I 303 TYR C 102 TYR^? 9.73 C2 C8E C 209 I 306 VAL A 35 VAL^? 13.71 C2 C8E C 209 I 308 VAL A 23 VAL^? 19.69 C2 C8E C 209 coo 26.18 35.24 6.87 24.33 35.18 8.97 48.50 -51.08 -15.65 48.91 -50.66 -12.96 coo 23.55 29.53 9.81 23.15 27.39 10.24 54.03 -47.97 -16.20 52.15 -48.80 -15.61 coo 16.43 30.18 9.35 15.05 30.67 11.01 55.06 -46.20 -21.45 57.12 -45.79 -20.99 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 30 3 # 30 I 303 TYR C 102 TYR^? 9.73 C2 C8E C 209 I 306 VAL A 81 VAL^? 11.87 C2 C8E C 209 I 308 VAL A 100 VAL^? 8.33 C1 C8E C 209 coo 26.18 35.24 6.87 24.33 35.18 8.97 48.50 -51.08 -15.65 48.91 -50.66 -12.96 coo 23.55 29.53 9.81 23.15 27.39 10.24 56.11 -50.29 -12.59 54.75 -50.24 -10.87 coo 16.43 30.18 9.35 15.05 30.67 11.01 55.82 -59.38 -13.97 53.67 -59.79 -13.91 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 31 3 # 31 I 303 TYR C 138 TYR^? 29.21 C16 C8E C 210 I 306 VAL C 92 VAL.? 29.56 C16 C8E C 210 I 308 VAL C 94 VAL^? 25.46 C13 C8E C 210 coo 26.18 35.24 6.87 24.33 35.18 8.97 37.44 -55.85 -45.58 34.94 -55.10 -46.63 coo 23.55 29.53 9.81 23.15 27.39 10.24 40.48 -60.24 -45.20 38.37 -59.86 -44.83 coo 16.43 30.18 9.35 15.05 30.67 11.01 41.78 -62.37 -39.35 39.83 -63.39 -39.30 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 32 3 # 32 I 303 TYR C 155 TYR^? 7.32 C13 C8E C 210 I 306 VAL C 196 VAL^? 4.13 C13 C8E C 210 I 308 VAL C 152 VAL^? 9.85 C13 C8E C 210 coo 26.18 35.24 6.87 24.33 35.18 8.97 41.26 -55.52 -15.76 41.81 -54.24 -18.13 coo 23.55 29.53 9.81 23.15 27.39 10.24 35.37 -56.79 -19.77 36.43 -54.90 -19.55 coo 16.43 30.18 9.35 15.05 30.67 11.01 37.53 -60.45 -23.70 36.18 -62.01 -23.03 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 33 3 # 33 I 303 TYR C 183 TYR~? 7.45 C14 C8E C 209 I 306 VAL C 186 VAL~? 7.62 O21 C8E C 209 I 308 VAL C 190 VAL~? 4.79 O21 C8E C 209 coo 26.18 35.24 6.87 24.33 35.18 8.97 39.42 -55.89 -0.59 40.02 -55.54 -3.26 coo 23.55 29.53 9.81 23.15 27.39 10.24 34.01 -52.32 -1.19 35.56 -50.92 -0.64 coo 16.43 30.18 9.35 15.05 30.67 11.01 32.42 -50.64 -6.54 34.20 -49.46 -6.05 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 34 3 # 34 I 303 TYR C 205 TYR^? 27.50 C19 C8E C 210 I 306 VAL C 6 VAL^? 25.62 C19 C8E C 210 I 308 VAL C 23 VAL^? 24.75 C19 C8E C 210 coo 26.18 35.24 6.87 24.33 35.18 8.97 44.79 -44.04 -41.24 42.28 -43.19 -40.34 coo 23.55 29.53 9.81 23.15 27.39 10.24 48.09 -46.15 -36.64 47.69 -44.03 -36.90 coo 16.43 30.18 9.35 15.05 30.67 11.01 50.26 -51.76 -35.05 48.45 -52.77 -35.68 1cqt_d00 source 1cqt GENE REGULATION/DNA : 34 hits 1cqt_d00 naa= 3 ULMN 3 1emh_d00 HYDROLASE/DNA user 1 3 # 1 A 271 PRO A 96 PRO^? 15.14 C1 C8E A 210 A 272 LEU A 82 LEU^? 16.79 C1 C8E A 210 A 276 ARG A 36 ARG^? 15.77 C1 C8E A 210 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 64.09 -46.77 -9.22 64.32 -47.70 -11.21 coo 10.97 0.43 16.73 11.31 2.11 18.06 59.00 -46.86 -14.13 59.29 -47.61 -16.11 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 59.00 -50.13 -20.90 61.68 -51.06 -19.88 ULMN 3 1emh_d00 HYDROLASE/DNA user 2 3 # 2 A 271 PRO A 142 PRO.? 28.13 C16 C8E B 209 A 272 LEU A 144 LEU^? 27.65 C16 C8E B 209 A 276 ARG A 206 ARG^? 26.36 C2 C8E C 209 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 62.52 -31.12 -30.93 62.60 -32.90 -29.60 coo 10.97 0.43 16.73 11.31 2.11 18.06 63.26 -38.20 -29.97 64.00 -39.75 -31.23 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 56.35 -36.42 -23.90 57.63 -37.98 -21.56 ULMN 3 1emh_d00 HYDROLASE/DNA user 3 3 # 3 A 271 PRO B 96 PRO^? 22.26 O15 C8E B 209 A 272 LEU B 82 LEU^? 22.11 O15 C8E B 209 A 276 ARG B 36 ARG^? 17.08 O15 C8E B 209 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 84.77 -48.46 -42.66 83.62 -47.04 -41.32 coo 10.97 0.43 16.73 11.31 2.11 18.06 80.08 -42.29 -43.96 79.29 -41.33 -42.23 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 77.67 -37.50 -38.51 79.47 -39.58 -37.24 ULMN 3 1emh_d00 HYDROLASE/DNA user 4 3 # 4 A 271 PRO B 142 PRO.? 27.56 O18 C8E A 209 A 272 LEU B 144 LEU^? 27.40 O18 C8E A 209 A 276 ARG B 206 ARG^? 34.91 O15 C8E B 209 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 57.74 -46.81 -38.90 59.89 -46.30 -38.59 coo 10.97 0.43 16.73 11.31 2.11 18.06 63.34 -43.54 -35.61 63.92 -42.46 -33.82 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 66.21 -41.62 -44.73 64.06 -41.49 -46.91 ULMN 3 1emh_d00 HYDROLASE/DNA user 5 3 # 5 A 271 PRO C 96 PRO^? 22.62 C13 C8E C 210 A 272 LEU C 82 LEU^? 22.72 C13 C8E C 210 A 276 ARG C 36 ARG^? 17.98 C16 C8E C 210 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 44.35 -66.07 -34.06 43.66 -63.95 -33.73 coo 10.97 0.43 16.73 11.31 2.11 18.06 48.11 -59.72 -34.09 47.50 -57.64 -33.62 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 45.58 -52.92 -31.76 43.11 -54.70 -31.56 1emh_d00 source 1emh HYDROLASE/DNA : 5 hits 1emh_d00 naa= 3 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 1 3 # 1 E 40 ARG A 36 ARG^? 15.77 C1 C8E A 210 E 41 TYR A 97 TYR^? 11.99 C1 C8E A 210 E 83 ARG B 162 ARG^? 16.35 O21 C8E B 210 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 59.00 -50.13 -20.90 61.68 -51.06 -19.88 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 61.97 -51.46 -14.47 63.57 -52.89 -16.21 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 96.21 -15.01 -19.71 98.63 -13.28 -19.03 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 2 3 # 2 E 40 ARG B 36 ARG^? 17.08 O15 C8E B 209 E 41 TYR B 97 TYR^? 16.46 O15 C8E B 209 E 83 ARG A 162 ARG^? 10.87 O21 C8E A 210 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 77.67 -37.50 -38.51 79.47 -39.58 -37.24 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 83.74 -41.85 -39.80 83.62 -41.42 -37.05 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 60.16 -83.54 -27.36 63.31 -83.18 -27.03 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 3 3 # 3 E 40 ARG B 101 ARG^? 13.86 O15 C8E B 209 E 41 TYR B 13 TYR^? 6.78 O15 C8E B 209 E 83 ARG C 200 ARG^? 12.04 C16 C8E C 210 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 87.52 -34.18 -37.50 85.80 -36.55 -38.16 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 84.65 -34.92 -28.70 86.28 -34.17 -30.84 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 37.62 -50.12 -29.23 39.44 -51.00 -26.91 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 4 3 # 4 E 40 ARG B 101 ARG^? 13.86 O15 C8E B 209 E 41 TYR B 97 TYR^? 16.46 O15 C8E B 209 E 83 ARG C 200 ARG^? 12.04 C16 C8E C 210 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 87.52 -34.18 -37.50 85.80 -36.55 -38.16 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 83.74 -41.85 -39.80 83.62 -41.42 -37.05 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 37.62 -50.12 -29.23 39.44 -51.00 -26.91 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 5 3 # 5 E 40 ARG C 101 ARG^? 13.82 C13 C8E C 210 E 41 TYR C 97 TYR^? 17.03 C13 C8E C 210 E 83 ARG B 101 ARG^? 13.86 O15 C8E B 209 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 44.39 -56.56 -21.66 44.87 -57.05 -24.63 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 44.42 -59.94 -30.24 42.23 -58.45 -29.40 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 87.52 -34.18 -37.50 85.80 -36.55 -38.16 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 6 3 # 6 E 40 ARG C 101 ARG^? 13.82 C13 C8E C 210 E 41 TYR C 102 TYR^? 9.73 C2 C8E C 209 E 83 ARG B 101 ARG^? 13.86 O15 C8E B 209 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 44.39 -56.56 -21.66 44.87 -57.05 -24.63 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 48.50 -51.08 -15.65 48.91 -50.66 -12.96 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 87.52 -34.18 -37.50 85.80 -36.55 -38.16 1id3_d00 source 1id3 STRUCTURAL PROTEIN/DNA : 6 hits 1id3_d00 naa= 3 ULMN 3 1mjo_d00 TRANSCRIPTION/DNA user 1 3 # 1 D 23 LYS B 119 LYS.? 18.40 CA CA B 208 D 25 THR B 110 THR^? 13.41 CA CA B 208 D 27 SER B 69 SER^? 12.05 CA CA B 208 coo 86.60 33.38 44.00 87.05 39.52 42.71 89.22 -11.21 -11.71 95.34 -11.17 -12.31 coo 81.20 31.58 48.03 79.23 32.24 47.54 87.52 -17.28 -12.27 85.40 -17.48 -12.64 coo 79.09 29.82 54.20 77.17 28.90 53.05 86.53 -22.01 -10.29 84.57 -20.83 -9.39 1mjo_d00 source 1mjo TRANSCRIPTION/DNA : 1 hits 1mjo_d00 naa= 3 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 1 3 # 1 A1290 LYS B 188 LYS~? 9.67 C16 C8E B 210 A1294 ASN B 187 ASN~? -3.44 O21 C8E B 210s A1297 GLU B 194 GLU.? 2.86 C13 C8E B 210s coo 39.24 18.84-161.99 36.62 21.47-165.99 102.16 -28.74 -21.10 106.15 -31.37 -17.86 coo 33.53 17.37-161.81 34.31 17.81-163.76 101.97 -26.81 -25.28 100.76 -28.02 -26.55 coo 29.78 23.31-161.30 31.23 23.66-162.84 97.88 -33.97 -28.78 99.62 -34.16 -27.58 1xpx_d00 source 1xpx TRANSCRIPTION REGULATION/DNA : 1 hits 1xpx_d00 naa= 3 ULMN 4 2bgw_d00 HYDROLASE user 1 4 # 1 A 86 ALA A 137 ALA^? 23.51 C1 C8E A 210 A 87 GLU A 93 GLU^? 23.51 C1 C8E A 210 A 123 TYR A 138 TYR^? 19.17 C16 C8E B 209 A 182 ARG A 135 ARG^? 21.29 C1 C8E A 210 coo 33.66 63.14 16.62 34.95 63.46 15.91 66.42 -42.01 -20.39 64.95 -41.78 -20.29 coo 28.97 64.99 12.92 27.92 64.06 11.28 64.33 -40.66 -16.04 62.38 -40.13 -16.70 coo 38.40 63.73 13.00 38.79 62.53 10.47 70.50 -38.06 -22.60 71.93 -35.69 -22.96 coo 29.35 67.59 19.60 30.93 68.47 17.09 62.45 -46.81 -18.85 61.41 -44.79 -20.90 ULMN 4 2bgw_d00 HYDROLASE user 2 4 # 2 A 86 ALA B 95 ALA^? 23.65 O15 C8E B 209 A 87 GLU B 93 GLU^? 27.23 O15 C8E B 209 A 123 TYR B 83 TYR^? 23.90 C1 C8E B 209 A 182 ARG B 135 ARG^? 22.88 O15 C8E B 209 coo 33.66 63.14 16.62 34.95 63.46 15.91 80.64 -47.79 -41.68 79.75 -46.77 -42.37 coo 28.97 64.99 12.92 27.92 64.06 11.28 75.25 -49.35 -42.08 74.13 -47.63 -42.56 coo 38.40 63.73 13.00 38.79 62.53 10.47 84.86 -45.84 -46.52 87.07 -46.60 -44.97 coo 29.35 67.59 19.60 30.93 68.47 17.09 77.46 -42.45 -38.74 74.50 -42.61 -39.42 ULMN 4 2bgw_d00 HYDROLASE user 3 4 # 3 A 86 ALA B 137 ALA^? 25.29 O15 C8E B 209 A 87 GLU B 93 GLU^? 27.23 O15 C8E B 209 A 123 TYR B 138 TYR^? 18.52 O18 C8E A 209 A 182 ARG B 135 ARG^? 22.88 O15 C8E B 209 coo 33.66 63.14 16.62 34.95 63.46 15.91 73.22 -47.55 -37.42 72.92 -46.75 -38.62 coo 28.97 64.99 12.92 27.92 64.06 11.28 75.25 -49.35 -42.08 74.13 -47.63 -42.56 coo 38.40 63.73 13.00 38.79 62.53 10.47 69.87 -51.92 -34.99 68.26 -54.21 -34.65 coo 29.35 67.59 19.60 30.93 68.47 17.09 77.46 -42.45 -38.74 74.50 -42.61 -39.42 ULMN 4 2bgw_d00 HYDROLASE user 4 4 # 4 A 86 ALA C 95 ALA^? 24.19 C13 C8E C 210 A 87 GLU C 93 GLU^? 26.90 C13 C8E C 210 A 123 TYR C 83 TYR^? 19.88 O21 C8E A 209 A 182 ARG C 135 ARG^? 23.87 C16 C8E C 210 coo 33.66 63.14 16.62 34.95 63.46 15.91 44.22 -62.46 -36.43 45.39 -61.49 -36.49 coo 28.97 64.99 12.92 27.92 64.06 11.28 45.29 -60.19 -41.07 45.99 -58.52 -39.91 coo 38.40 63.73 13.00 38.79 62.53 10.47 49.20 -66.70 -34.88 49.82 -68.82 -36.60 coo 29.35 67.59 19.60 30.93 68.47 17.09 44.01 -56.05 -34.91 45.01 -54.65 -37.44 ULMN 4 2bgw_d00 HYDROLASE user 5 4 # 5 A 86 ALA C 136 ALA^? 23.08 C16 C8E C 210 A 87 GLU C 93 GLU^? 26.90 C13 C8E C 210 A 123 TYR C 138 TYR^? 29.21 C16 C8E C 210 A 182 ARG C 135 ARG^? 23.87 C16 C8E C 210 coo 33.66 63.14 16.62 34.95 63.46 15.91 39.69 -58.64 -38.49 38.27 -59.07 -38.64 coo 28.97 64.99 12.92 27.92 64.06 11.28 45.29 -60.19 -41.07 45.99 -58.52 -39.91 coo 38.40 63.73 13.00 38.79 62.53 10.47 37.44 -55.85 -45.58 34.94 -55.10 -46.63 coo 29.35 67.59 19.60 30.93 68.47 17.09 44.01 -56.05 -34.91 45.01 -54.65 -37.44 ULMN 4 2bgw_d00 HYDROLASE user 6 4 # 6 A 86 ALA C 137 ALA^? 25.83 C16 C8E C 210 A 87 GLU C 93 GLU^? 26.90 C13 C8E C 210 A 123 TYR C 138 TYR^? 29.21 C16 C8E C 210 A 182 ARG C 135 ARG^? 23.87 C16 C8E C 210 coo 33.66 63.14 16.62 34.95 63.46 15.91 41.11 -56.22 -41.00 42.54 -55.78 -40.81 coo 28.97 64.99 12.92 27.92 64.06 11.28 45.29 -60.19 -41.07 45.99 -58.52 -39.91 coo 38.40 63.73 13.00 38.79 62.53 10.47 37.44 -55.85 -45.58 34.94 -55.10 -46.63 coo 29.35 67.59 19.60 30.93 68.47 17.09 44.01 -56.05 -34.91 45.01 -54.65 -37.44 2bgw_d00 source 2bgw HYDROLASE : 6 hits 2bgw_d00 naa= 4 ULMN 3 2bsq_d00 TRANSCRIPTION user 1 3 # 1 E 3 SER A 78 SER^? 13.83 C1 C8E A 210 E 5 VAL C 100 VAL^? 11.61 C1 C8E C 209 E 7 ARG C 101 ARG^? 13.82 C13 C8E C 210 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 55.97 -57.73 -19.67 57.70 -56.10 -19.98 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 48.42 -57.82 -21.21 50.38 -57.25 -20.38 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 44.39 -56.56 -21.66 44.87 -57.05 -24.63 ULMN 3 2bsq_d00 TRANSCRIPTION user 2 3 # 2 E 3 SER A 145 SER^? 27.15 C1 C8E A 210 E 5 VAL A 147 VAL^? 21.31 C1 C8E A 209 E 7 ARG A 135 ARG^? 21.29 C1 C8E A 210 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 64.96 -39.73 -25.95 63.25 -39.86 -24.22 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 66.77 -45.16 -23.58 64.72 -45.57 -23.13 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 62.45 -46.81 -18.85 61.41 -44.79 -20.90 ULMN 3 2bsq_d00 TRANSCRIPTION user 3 3 # 3 E 3 SER B 145 SER^? 27.20 O18 C8E A 209 E 5 VAL B 147 VAL^? 21.61 O15 C8E B 209 E 7 ARG B 135 ARG^? 22.88 O15 C8E B 209 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 67.49 -45.58 -36.35 68.68 -44.91 -38.37 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 73.43 -44.63 -34.00 73.71 -43.11 -35.55 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 77.46 -42.45 -38.74 74.50 -42.61 -39.42 ULMN 3 2bsq_d00 TRANSCRIPTION user 4 3 # 4 E 3 SER C 78 SER^? 13.93 C13 C8E C 210 E 5 VAL A 22 VAL^? 19.55 C2 C8E C 209 E 7 ARG A 36 ARG^? 15.77 C1 C8E A 210 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 46.95 -52.32 -23.90 45.02 -53.63 -24.63 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 54.15 -48.28 -24.50 51.93 -48.23 -24.31 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 59.00 -50.13 -20.90 61.68 -51.06 -19.88 ULMN 3 2bsq_d00 TRANSCRIPTION user 5 3 # 5 E 3 SER C 145 SER^? 28.85 C16 C8E C 210 E 5 VAL C 147 VAL^? 22.25 C16 C8E C 210 E 7 ARG C 135 ARG^? 23.87 C16 C8E C 210 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 41.87 -50.77 -43.64 43.47 -52.56 -43.92 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 39.20 -53.01 -38.65 41.10 -52.74 -37.62 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 44.01 -56.05 -34.91 45.01 -54.65 -37.44 2bsq_d00 source 2bsq TRANSCRIPTION : 5 hits 2bsq_d00 naa= 3 ULMN 3 2hos_d00 TRANSCRIPTION/DNA user 1 3 # 1 A 5 ARG C 162 ARG^? 16.00 O21 C8E C 209 A 50 LYS C 188 LYS~? 9.02 C16 C8E C 209 A 51 ASN C 187 ASN~? -2.70 C14 C8E C 209s coo 28.68 23.77 42.74 27.76 26.72 42.93 35.66 -43.15 0.12 35.66 -43.03 3.18 coo 14.40 30.33 40.28 14.25 28.31 45.36 31.07 -55.82 -4.30 26.58 -58.21 -2.57 coo 19.09 30.55 41.51 19.09 28.89 42.82 35.59 -56.00 -3.84 36.37 -56.79 -5.68 2hos_d00 source 2hos TRANSCRIPTION/DNA : 1 hits 2hos_d00 naa= 3 ULMN 3 2ky8_d00 TRANSCRIPTION/DNA user 1 3 # 1 A 24 ARG A 200 ARG^? 11.17 C17 C8E A 209 A 32 LYS A 198 LYS^? 12.09 C1 C8E A 210 A 46 ARG A 135 ARG^? 21.29 C1 C8E A 210 coo -8.00 4.27 27.74 -7.09 2.66 30.09 65.38 -54.68 -25.12 63.65 -56.91 -23.89 coo -5.15 8.65 26.69 -4.26 5.48 32.02 68.28 -58.05 -20.21 63.11 -55.44 -18.88 coo -0.17 -5.20 27.14 -1.15 -5.34 29.97 62.45 -46.81 -18.85 61.41 -44.79 -20.90 ULMN 3 2ky8_d00 TRANSCRIPTION/DNA user 2 3 # 2 A 24 ARG A 206 ARG^? 26.36 C2 C8E C 209 A 32 LYS A 3 LYS^? 24.80 C20 C8E C 210 A 46 ARG A 36 ARG^? 15.77 C1 C8E A 210 coo -8.00 4.27 27.74 -7.09 2.66 30.09 56.35 -36.42 -23.90 57.63 -37.98 -21.56 coo -5.15 8.65 26.69 -4.26 5.48 32.02 52.63 -38.57 -20.93 53.13 -33.95 -19.17 coo -0.17 -5.20 27.14 -1.15 -5.34 29.97 59.00 -50.13 -20.90 61.68 -51.06 -19.88 ULMN 3 2ky8_d00 TRANSCRIPTION/DNA user 3 3 # 3 A 24 ARG A 206 ARG^? 26.36 C2 C8E C 209 A 32 LYS A 3 LYS^? 24.80 C20 C8E C 210 A 46 ARG A 135 ARG^? 21.29 C1 C8E A 210 coo -8.00 4.27 27.74 -7.09 2.66 30.09 56.35 -36.42 -23.90 57.63 -37.98 -21.56 coo -5.15 8.65 26.69 -4.26 5.48 32.02 52.63 -38.57 -20.93 53.13 -33.95 -19.17 coo -0.17 -5.20 27.14 -1.15 -5.34 29.97 62.45 -46.81 -18.85 61.41 -44.79 -20.90 ULMN 3 2ky8_d00 TRANSCRIPTION/DNA user 4 3 # 4 A 24 ARG B 206 ARG^? 34.91 O15 C8E B 209 A 32 LYS B 3 LYS^? 35.51 O15 C8E B 209 A 46 ARG B 36 ARG^? 17.08 O15 C8E B 209 coo -8.00 4.27 27.74 -7.09 2.66 30.09 66.21 -41.62 -44.73 64.06 -41.49 -46.91 coo -5.15 8.65 26.69 -4.26 5.48 32.02 68.65 -39.32 -48.24 67.06 -43.09 -50.47 coo -0.17 -5.20 27.14 -1.15 -5.34 29.97 77.67 -37.50 -38.51 79.47 -39.58 -37.24 ULMN 3 2ky8_d00 TRANSCRIPTION/DNA user 5 3 # 5 A 24 ARG B 206 ARG^? 34.91 O15 C8E B 209 A 32 LYS B 3 LYS^? 35.51 O15 C8E B 209 A 46 ARG B 135 ARG^? 22.88 O15 C8E B 209 coo -8.00 4.27 27.74 -7.09 2.66 30.09 66.21 -41.62 -44.73 64.06 -41.49 -46.91 coo -5.15 8.65 26.69 -4.26 5.48 32.02 68.65 -39.32 -48.24 67.06 -43.09 -50.47 coo -0.17 -5.20 27.14 -1.15 -5.34 29.97 77.46 -42.45 -38.74 74.50 -42.61 -39.42 ULMN 3 2ky8_d00 TRANSCRIPTION/DNA user 6 3 # 6 A 24 ARG C 206 ARG^? 30.58 O21 C8E A 209 A 32 LYS C 3 LYS.? 29.42 O21 C8E A 209 A 46 ARG C 135 ARG^? 23.87 C16 C8E C 210 coo -8.00 4.27 27.74 -7.09 2.66 30.09 51.48 -50.24 -44.52 54.38 -50.65 -45.44 coo -5.15 8.65 26.69 -4.26 5.48 32.02 54.64 -52.54 -41.89 51.76 -56.14 -46.37 coo -0.17 -5.20 27.14 -1.15 -5.34 29.97 44.01 -56.05 -34.91 45.01 -54.65 -37.44 2ky8_d00 source 2ky8 TRANSCRIPTION/DNA : 6 hits 2ky8_d00 naa= 3 ULMN 5 2y7h_d01 TRANSFERASE/DNA user 1 5 # 1 B 148 GLN B 157 GLN.? -3.32 O12 C8E B 210s B 266 ASN B 126 ASN^? 11.28 C1 C8E B 210 B 269 PHE B 160 PHE^? 5.74 O21 C8E B 210 B 345 PHE B 105 PHE^? 5.21 C20 C8E B 209 B 350 VAL B 190 VAL~? 4.94 O21 C8E B 210 coo -11.48 1.73 -11.41 -11.74 2.77 -9.56 100.90 -28.16 -30.62 102.98 -28.51 -30.67 coo -22.06 -0.80 -10.65 -21.00 -0.28 -8.86 90.80 -21.61 -33.24 89.51 -20.33 -32.18 coo -17.42 4.26 -6.81 -19.55 2.69 -5.98 97.82 -21.95 -26.27 98.06 -24.71 -26.08 coo -17.10 -2.86 -4.31 -19.81 -2.77 -4.87 90.70 -25.26 -25.77 91.65 -25.28 -23.14 coo -15.18 2.68 -0.37 -14.75 2.05 -2.32 97.01 -26.06 -20.89 96.38 -24.15 -21.83 2y7h_d01 source 2y7h TRANSFERASE/DNA : 1 hits 2y7h_d01 naa= 5 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 B 34 SER A 44 SER.? -2.67 O21 C8E A 209s B 37 ASN A 74 ASN^? -3.00 O21 C8E A 209s B 45 THR A 161 THR^? 14.36 O21 C8E A 210 coo -19.49 41.97 71.08 -17.37 40.80 71.17 67.29 -68.39 -28.17 66.32 -69.65 -26.34 coo -23.05 39.62 69.74 -22.86 39.59 67.61 62.15 -65.86 -25.53 63.13 -67.52 -24.67 coo -30.87 34.84 80.57 -28.94 34.51 81.49 54.89 -79.58 -24.95 52.94 -78.87 -25.32 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 B 34 SER A 168 SER.? 28.11 CA CA A 208 B 37 ASN A 170 ASN.? 28.35 CA CA A 208 B 45 THR A 110 THR^? 13.46 CA CA A 208 coo -19.49 41.97 71.08 -17.37 40.80 71.17 53.74 -87.86 -44.66 54.17 -90.24 -44.48 coo -23.05 39.62 69.74 -22.86 39.59 67.61 51.62 -88.52 -39.42 50.91 -89.41 -41.21 coo -30.87 34.84 80.57 -28.94 34.51 81.49 64.57 -79.69 -38.47 64.29 -77.82 -39.49 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 3 3 # 3 B 34 SER A 168 SER.? 28.11 CA CA A 208 B 37 ASN A 170 ASN.? 28.35 CA CA A 208 B 45 THR A 122 THR^? 13.62 O21 C8E A 209 coo -19.49 41.97 71.08 -17.37 40.80 71.17 53.74 -87.86 -44.66 54.17 -90.24 -44.48 coo -23.05 39.62 69.74 -22.86 39.59 67.61 51.62 -88.52 -39.42 50.91 -89.41 -41.21 coo -30.87 34.84 80.57 -28.94 34.51 81.49 59.48 -78.76 -31.56 58.50 -77.15 -32.63 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 4 3 # 4 B 34 SER B 44 SER.? -2.63 C20 C8E B 209s B 37 ASN B 74 ASN^? -3.28 C20 C8E B 209s B 45 THR B 161 THR^? 13.87 C2 C8E B 210 coo -19.49 41.97 71.08 -17.37 40.80 71.17 86.51 -29.99 -20.81 88.33 -29.21 -22.26 coo -23.05 39.62 69.74 -22.86 39.59 67.61 85.94 -28.94 -27.06 87.84 -29.20 -26.13 coo -30.87 34.84 80.57 -28.94 34.51 81.49 95.26 -16.61 -26.72 94.31 -15.20 -28.05 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 5 3 # 5 B 34 SER B 168 SER.? 28.34 CA CA B 208 B 37 ASN B 170 ASN.? 27.83 CA CA B 208 B 45 THR B 122 THR^? 13.77 C20 C8E B 209 coo -19.49 41.97 71.08 -17.37 40.80 71.17 87.65 -2.97 -12.63 88.84 -1.07 -11.63 coo -23.05 39.62 69.74 -22.86 39.59 67.61 90.80 -3.32 -17.55 90.23 -1.46 -16.71 coo -30.87 34.84 80.57 -28.94 34.51 81.49 90.88 -17.14 -20.14 88.92 -16.94 -20.94 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 6 3 # 6 B 34 SER C 44 SER.? -2.60 O21 C8E C 210s B 37 ASN C 74 ASN^? -3.17 C20 C8E C 210s B 45 THR C 161 THR^? 14.40 O21 C8E C 209 coo -19.49 41.97 71.08 -17.37 40.80 71.17 31.95 -46.42 -17.08 33.26 -47.96 -15.73 coo -23.05 39.62 69.74 -22.86 39.59 67.61 38.01 -47.64 -17.99 37.26 -48.68 -16.35 coo -30.87 34.84 80.57 -28.94 34.51 81.49 41.89 -45.49 -3.13 43.84 -44.64 -3.41 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 7 3 # 7 B 34 SER C 168 SER.? 28.61 CA CA C 208 B 37 ASN C 170 ASN.? 28.31 CA CA C 208 B 45 THR C 110 THR^? 13.52 CA CA C 208 coo -19.49 41.97 71.08 -17.37 40.80 71.17 35.58 -25.74 2.02 35.23 -25.15 4.34 coo -23.05 39.62 69.74 -22.86 39.59 67.61 39.40 -29.88 3.55 39.46 -27.84 4.11 coo -30.87 34.84 80.57 -28.94 34.51 81.49 29.51 -35.46 -6.90 30.13 -34.54 -8.74 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 8 3 # 8 B 34 SER C 168 SER.? 28.61 CA CA C 208 B 37 ASN C 170 ASN.? 28.31 CA CA C 208 B 45 THR C 122 THR^? 12.77 O21 C8E C 210 coo -19.49 41.97 71.08 -17.37 40.80 71.17 35.58 -25.74 2.02 35.23 -25.15 4.34 coo -23.05 39.62 69.74 -22.86 39.59 67.61 39.40 -29.88 3.55 39.46 -27.84 4.11 coo -30.87 34.84 80.57 -28.94 34.51 81.49 35.98 -40.36 -5.91 37.15 -39.19 -7.33 2z3x_d00 source 2z3x DNA BINDING PROTEIN/DNA : 8 hits 2z3x_d00 naa= 3 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 1 2 # 1 246 SER A 5 SER^? 24.40 C2 C8E C 209 360 GLU A 7 GLU^? 19.52 C17 C8E A 209 coo -2.27 5.01 11.02 -1.56 7.27 11.54 55.35 -42.73 -25.42 56.65 -41.65 -23.68 coo 3.38 8.39 11.51 1.79 8.22 12.92 61.29 -47.52 -25.12 61.48 -48.69 -23.33 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 2 2 # 2 246 SER A 5 SER^? 24.40 C2 C8E C 209 360 GLU A 25 GLU^? 22.98 C2 C8E C 209 coo -2.27 5.01 11.02 -1.56 7.27 11.54 55.35 -42.73 -25.42 56.65 -41.65 -23.68 coo 3.38 8.39 11.51 1.79 8.22 12.92 56.22 -40.62 -18.58 57.98 -41.28 -19.55 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 3 2 # 3 246 SER A 44 SER.? -2.67 O21 C8E A 209s 360 GLU A 70 GLU^? -2.69 CA CA A 208s coo -2.27 5.01 11.02 -1.56 7.27 11.54 67.29 -68.39 -28.17 66.32 -69.65 -26.34 coo 3.38 8.39 11.51 1.79 8.22 12.92 68.79 -75.79 -31.87 70.14 -76.30 -30.27 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 4 2 # 4 246 SER A 69 SER^? 11.97 CA CA A 208 360 GLU A 70 GLU^? -2.69 CA CA A 208s coo -2.27 5.01 11.02 -1.56 7.27 11.54 69.09 -77.26 -37.91 68.86 -76.80 -40.31 coo 3.38 8.39 11.51 1.79 8.22 12.92 68.79 -75.79 -31.87 70.14 -76.30 -30.27 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 5 2 # 5 246 SER A 168 SER.? 28.11 CA CA A 208 360 GLU A 165 GLU^? 21.76 CA CA A 208 coo -2.27 5.01 11.02 -1.56 7.27 11.54 53.74 -87.86 -44.66 54.17 -90.24 -44.48 coo 3.38 8.39 11.51 1.79 8.22 12.92 55.17 -82.77 -39.51 54.39 -80.85 -40.05 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 6 2 # 6 246 SER A 172 SER^? 21.14 O21 C8E A 210 360 GLU A 164 GLU^? 19.19 O21 C8E A 210 coo -2.27 5.01 11.02 -1.56 7.27 11.54 52.39 -86.47 -32.61 53.25 -88.25 -31.26 coo 3.38 8.39 11.51 1.79 8.22 12.92 57.65 -86.15 -32.10 58.08 -88.26 -31.94 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 7 2 # 7 246 SER A 172 SER^? 21.14 O21 C8E A 210 360 GLU A 165 GLU^? 21.76 CA CA A 208 coo -2.27 5.01 11.02 -1.56 7.27 11.54 52.39 -86.47 -32.61 53.25 -88.25 -31.26 coo 3.38 8.39 11.51 1.79 8.22 12.92 55.17 -82.77 -39.51 54.39 -80.85 -40.05 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 8 2 # 8 246 SER A 174 SER^? 15.95 O21 C8E A 210 360 GLU A 164 GLU^? 19.19 O21 C8E A 210 coo -2.27 5.01 11.02 -1.56 7.27 11.54 52.92 -84.93 -25.72 55.12 -85.87 -26.20 coo 3.38 8.39 11.51 1.79 8.22 12.92 57.65 -86.15 -32.10 58.08 -88.26 -31.94 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 9 2 # 9 246 SER A 181 SER.? 16.72 O21 C8E A 210 360 GLU A 184 GLU~? 7.72 C16 C8E A 210 coo -2.27 5.01 11.02 -1.56 7.27 11.54 58.57 -88.95 -14.85 59.28 -91.21 -15.34 coo 3.38 8.39 11.51 1.79 8.22 12.92 63.73 -84.37 -12.45 63.45 -82.45 -11.70 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 10 2 # 10 246 SER B 5 SER^? 27.72 O15 C8E B 209 360 GLU B 7 GLU^? 19.70 O15 C8E B 209 coo -2.27 5.01 11.02 -1.56 7.27 11.54 68.96 -37.45 -41.77 69.21 -39.86 -42.14 coo 3.38 8.39 11.51 1.79 8.22 12.92 73.39 -38.66 -35.65 75.17 -39.55 -36.49 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 11 2 # 11 246 SER B 5 SER^? 27.72 O15 C8E B 209 360 GLU B 25 GLU^? 27.65 O15 C8E B 209 coo -2.27 5.01 11.02 -1.56 7.27 11.54 68.96 -37.45 -41.77 69.21 -39.86 -42.14 coo 3.38 8.39 11.51 1.79 8.22 12.92 73.50 -42.12 -45.68 71.97 -42.23 -44.24 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 12 2 # 12 246 SER B 69 SER^? 12.05 CA CA B 208 360 GLU B 70 GLU^? -2.58 CA CA B 208s coo -2.27 5.01 11.02 -1.56 7.27 11.54 86.53 -22.01 -10.29 84.57 -20.83 -9.39 coo 3.38 8.39 11.51 1.79 8.22 12.92 89.83 -24.96 -14.47 91.03 -26.69 -14.39 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 13 2 # 13 246 SER B 168 SER.? 28.34 CA CA B 208 360 GLU B 165 GLU^? 20.64 CA CA B 208 coo -2.27 5.01 11.02 -1.56 7.27 11.54 87.65 -2.97 -12.63 88.84 -1.07 -11.63 coo 3.38 8.39 11.51 1.79 8.22 12.92 88.15 -8.84 -16.79 86.14 -9.46 -16.74 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 14 2 # 14 246 SER B 172 SER^? 21.23 O21 C8E B 210 360 GLU B 164 GLU^? 19.99 CA CA B 208 coo -2.27 5.01 11.02 -1.56 7.27 11.54 94.19 -7.30 -21.74 95.99 -8.03 -20.24 coo 3.38 8.39 11.51 1.79 8.22 12.92 94.70 -10.70 -16.52 96.59 -9.81 -16.07 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 15 2 # 15 246 SER B 172 SER^? 21.23 O21 C8E B 210 360 GLU B 165 GLU^? 20.64 CA CA B 208 coo -2.27 5.01 11.02 -1.56 7.27 11.54 94.19 -7.30 -21.74 95.99 -8.03 -20.24 coo 3.38 8.39 11.51 1.79 8.22 12.92 88.15 -8.84 -16.79 86.14 -9.46 -16.74 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 16 2 # 16 246 SER B 181 SER.? 16.71 O21 C8E B 210 360 GLU B 184 GLU~? 8.45 C14 C8E B 210 coo -2.27 5.01 11.02 -1.56 7.27 11.54 109.85 -19.10 -26.67 111.12 -18.08 -24.82 coo 3.38 8.39 11.51 1.79 8.22 12.92 107.80 -26.84 -26.43 109.06 -28.52 -26.54 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 17 2